  // ===== From cardiovascular-diseases.js =====
  "dilated-cardiomyopathy": {
    zh: "擴張型心肌病",
    en: "Dilated Cardiomyopathy (DCM)",
    definition: "心肌收縮功能障礙導致心室擴張、心壁變薄、心輸出量降低的原發性心肌疾病。",
    synonyms: ["DCM", "擴張性心肌病", "充血性心肌病", "Congestive Cardiomyopathy"],
    epidemiology: {
      species: "主要影響犬，貓罕見（多與牛磺酸缺乏相關）",
      age: "中大型犬4-10歲，杜賓犬可更早發病",
      sex: "公犬較母犬更常見（約2-3:1）",
      riskFactors: ["大型及巨型犬種", "杜賓犬", "拳師犬", "大丹犬", "愛爾蘭獵狼犬", "可卡犬", "牛磺酸缺乏（貓）", "左旋肉鹼缺乏", "某些穀物無關飼料（FDA調查中）"]
    },
    clinicalPresentation: {
      history: ["運動不耐", "虛弱", "咳嗽", "呼吸困難", "腹部膨大（腹水）", "昏厥", "突然死亡（尤其杜賓犬）", "食慾下降", "體重減輕"],
      physicalExam: ["心搏過速", "心律不整（心房顫動、心室早搏）", "第三心音（奔馬律）", "心雜音（二尖瓣/三尖瓣逆流）", "脈搏弱或脈搏缺失", "肺部濕囉音", "頸靜脈怒張", "肝腫大", "腹水", "黏膜蒼白"]
    },
    pathophysiology: "心肌細胞功能障礙或喪失 → 心室收縮力下降 → 心室擴張（Frank-Starling代償）→ 心壁變薄 → 二尖瓣/三尖瓣環擴大致瓣膜逆流 → 心房擴張 → 神經內分泌活化（RAAS、交感神經）→ 液體滯留 → 充血性心衰竭",
    diagnosis: {
      overview: "心臟超聲是確診金標準，顯示心室擴張和收縮功能下降",
      differentials: ["二尖瓣疾病", "心包積液", "心律不整誘發的心肌病", "缺血性心肌病", "牛磺酸缺乏性心肌病"],
      initialDB: ["心臟超聲（LVIDD↑、LVIDS↑、FS↓<20%、EPSS↑）", "胸腔X光（心臟擴大、肺水腫）", "ECG（心房顫動、心室早搏、寬QRS）", "NT-proBNP或cTnI"],
      advanced: ["24小時Holter監測（隱匿性DCM篩檢）", "牛磺酸和左旋肉鹼濃度", "基因檢測（杜賓犬PDK4突變）"]
    },
    treatment: {
      overview: "改善心臟功能、減輕心臟負擔、控制心律不整、改善生活品質",
      acute: [
        "急性充血性心衰竭：",
        "- 氧氣支持",
        "- Furosemide: 2-4 mg/kg IV q1-4h直到穩定",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（正性肌力+血管擴張）",
        "- 硝酸甘油軟膏（降低前負荷）",
        "- 嚴重低心輸出量：Dobutamine 2.5-10 μg/kg/min CRI",
        "心房顫動急性控制：Diltiazem IV或口服"
      ],
      chronic: [
        "Pimobendan: 0.25-0.3 mg/kg PO q12h（首選正性肌力藥）",
        "ACEI: Enalapril 0.5 mg/kg PO q12-24h 或 Benazepril 0.25-0.5 mg/kg PO q12-24h",
        "Furosemide: 1-4 mg/kg PO q8-12h（依需要調整）",
        "Spironolactone: 1-2 mg/kg PO q12-24h",
        "心房顫動：Diltiazem 0.5-1.5 mg/kg PO q8h 或 Digoxin",
        "心室早搏：Sotalol 1-2 mg/kg PO q12h 或 Mexiletine",
        "牛磺酸補充（若缺乏）：250-500 mg PO q12h",
        "L-carnitine（若缺乏）：50-100 mg/kg PO q8h",
        "Omega-3脂肪酸",
        "限鈉飲食"
      ]
    },
    prognosis: "預後謹慎至差。杜賓犬DCM預後最差（確診後中位生存期約6-8週至數月）。其他犬種確診CHF後中位生存期約6-24個月。隱匿期DCM可存活較長。",
    pearls: [
      "杜賓犬DCM有高達30-50%終生罹患率，建議年度Holter和Echo篩檢",
      "心房顫動在DCM犬中很常見，需控制心率",
      "Pimobendan可延長DCM犬的存活時間",
      "隱匿期DCM（無症狀）仍需治療",
      "某些無穀飼料與DCM的關聯仍在研究中",
      "貓DCM多與牛磺酸缺乏相關，補充後可能改善"
    ],
    monitoring: ["呼吸頻率（家中監測RRR<30）", "心臟超聲", "胸腔X光", "ECG/Holter", "腎功能和電解質", "體重", "NT-proBNP"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "hypertrophic-cardiomyopathy": {
    zh: "肥厚型心肌病",
    en: "Hypertrophic Cardiomyopathy (HCM)",
    definition: "原發性心肌肥厚導致心室壁增厚、心室腔縮小、舒張功能障礙的心肌疾病，是貓最常見的心臟病。",
    synonyms: ["HCM", "肥厚性心肌病", "Hypertrophic Obstructive Cardiomyopathy (HOCM)"],
    epidemiology: {
      species: "貓最常見，犬罕見",
      age: "貓多在5-7歲診斷，但可在任何年齡發生（6個月至16歲）",
      sex: "公貓較常見（約3:1）",
      riskFactors: ["緬因貓", "布偶貓", "英國短毛貓", "波斯貓", "斯芬克斯貓", "家族遺傳", "甲狀腺機能亢進（繼發性）", "系統性高血壓（繼發性）", "生長激素過多"]
    },
    clinicalPresentation: {
      history: ["可能完全無症狀", "呼吸困難", "呼吸急促", "張口呼吸", "運動不耐", "後肢癱瘓（動脈血栓栓塞）", "昏厥", "突然死亡", "食慾下降"],
      physicalExam: ["心雜音（收縮期，動態性流出道阻塞或SAM）", "奔馬律（S4）", "心律不整", "心搏過速", "股動脈脈搏減弱或消失（ATE）", "後肢冰冷、疼痛（ATE）", "肺部濕囉音（肺水腫）", "呼吸音減弱（胸腔積液）"]
    },
    pathophysiology: "基因突變（肌節蛋白）→ 心肌細胞肥大和排列紊亂 → 左心室壁肥厚 → 舒張功能障礙（順應性下降）→ 左心房擴張 → 肺靜脈壓升高 → 肺水腫/胸腔積液。SAM（二尖瓣收縮期前向運動）→ 動態性流出道阻塞。左心房擴張和血流淤滯 → 血栓形成 → ATE",
    diagnosis: {
      overview: "心臟超聲確診，需排除繼發性心肌肥厚原因",
      differentials: ["甲狀腺機能亢進（繼發性肥厚）", "系統性高血壓（繼發性肥厚）", "主動脈狹窄", "脫水假性肥厚", "限制型心肌病", "未分類心肌病"],
      initialDB: ["心臟超聲（LVW或IVS≥6mm、LA/Ao>1.5、SAM、動態流出道阻塞）", "胸腔X光", "血壓測量", "T4（排除甲亢）", "ECG", "心肌標記物（cTnI、NT-proBNP）"],
      advanced: ["基因檢測（緬因貓MYBPC3、布偶貓MYBPC3突變）", "24小時Holter", "進階超聲（組織多普勒、應變成像）"]
    },
    treatment: {
      overview: "控制心率、改善舒張功能、預防血栓、治療充血症狀",
      acute: [
        "急性CHF：",
        "- 氧氣支持（最小化應激）",
        "- Furosemide: 1-2 mg/kg IV/IM q1-4h",
        "- 胸腔穿刺（若有大量胸腔積液）",
        "- 避免過度處置造成應激",
        "動脈血栓栓塞（ATE）：",
        "- 止痛（極重要）：Methadone、Buprenorphine",
        "- 抗凝：Heparin或低分子肝素",
        "- 支持治療"
      ],
      chronic: [
        "無症狀HCM治療爭議：",
        "- 輕度：可能不需治療或Atenolol",
        "- 中重度心房擴大：建議抗血小板/抗凝",
        "β-blocker: Atenolol 6.25-12.5 mg/貓 PO q12-24h",
        "Diltiazem: 7.5-15 mg/貓 PO q8h（替代β-blocker）",
        "CHF穩定後：Furosemide 1-2 mg/kg PO q12-24h",
        "血栓預防：",
        "- Clopidogrel: 18.75 mg/貓 PO q24h（首選）",
        "- 或 Aspirin: 81 mg/貓 PO q72h",
        "- 高風險：加上Rivaroxaban或低分子肝素",
        "ACEI: Benazepril 0.5-1 mg/kg PO q24h（CHF時）"
      ]
    },
    prognosis: "高度變異。無症狀貓可存活多年。一旦發展CHF，中位生存期約3-18個月。ATE後預後差，中位生存期約2-6個月，但復發率高。",
    pearls: [
      "貓HCM是最常見的心臟病，但許多貓終生無症狀",
      "心雜音不代表HCM，約1/3 HCM貓無雜音",
      "NT-proBNP可用於篩檢，但需結合超聲確診",
      "ATE是HCM最嚴重的併發症之一",
      "應激可誘發急性失代償，處置時需溫和",
      "繼發性肥厚（甲亢、高血壓）需排除並治療原因"
    ],
    monitoring: ["呼吸頻率（家中RRR<30）", "心臟超聲（每6-12個月）", "T4", "血壓", "腎功能", "NT-proBNP"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "mitral-valve-disease": {
    zh: "二尖瓣疾病",
    en: "Mitral Valve Disease (MVD)",
    definition: "二尖瓣結構退化導致瓣膜閉鎖不全和逆流的慢性進行性疾病，是犬最常見的心臟病。",
    synonyms: ["MVD", "MMVD", "二尖瓣黏液瘤性退化", "Myxomatous Mitral Valve Disease", "Endocardiosis", "二尖瓣閉鎖不全", "Mitral Regurgitation"],
    epidemiology: {
      species: "犬最常見，貓罕見",
      age: "中老年犬（>5歲），年齡增加罹患率增加",
      sex: "公犬較常見（約1.5:1）",
      riskFactors: ["小型犬種", "騎士查理王小獵犬（早發且嚴重）", "臘腸犬", "貴賓犬", "約克夏梗", "吉娃娃", "博美犬", "年齡"]
    },
    clinicalPresentation: {
      history: ["早期無症狀（僅雜音）", "咳嗽（尤其夜間或興奮時）", "運動不耐", "呼吸困難", "昏厥", "腹部膨大", "食慾下降", "體重減輕"],
      physicalExam: ["收縮期心尖區心雜音（左側最響，可輻射至右側）", "雜音強度與疾病嚴重度相關", "心搏過速", "竇性心律不整消失", "脈搏品質變化", "肺部濕囉音", "頸靜脈怒張（若右心衰竭）", "腹水", "體重減輕/肌肉消耗"]
    },
    pathophysiology: "瓣膜黏液瘤性退化 → 瓣葉增厚、脫垂 → 腱索延長或斷裂 → 二尖瓣逆流 → 左心房容量超負荷和擴張 → 肺靜脈壓升高 → 肺水腫。慢性容量超負荷 → 離心性左心室重塑 → 最終收縮功能下降 → 低心輸出量",
    diagnosis: {
      overview: "聽診發現雜音後以心臟超聲確診和分期",
      differentials: ["擴張型心肌病", "先天性二尖瓣發育不良", "感染性心內膜炎", "心肌梗塞後二尖瓣逆流"],
      initialDB: ["胸腔X光（VHS評估心臟大小、肺水腫）", "心臟超聲（LA/Ao、LVIDD、E波速度、逆流評估）", "血壓", "基本血檢"],
      advanced: ["NT-proBNP", "cTnI", "ECG/Holter"]
    },
    treatment: {
      overview: "依ACVIM分期指引治療。目標：延長壽命、延緩疾病進展、改善生活品質",
      acute: [
        "急性CHF（肺水腫）：",
        "- 氧氣支持",
        "- Furosemide: 2-4 mg/kg IV q1-2h直到呼吸改善",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（立即開始）",
        "- 硝酸甘油（降低前負荷）",
        "- 嚴重時：Nitroprusside CRI",
        "腱索斷裂急性惡化：密切監測，可能需要手術"
      ],
      chronic: [
        "ACVIM B1期（雜音但無心臟擴大）：監測，無需藥物",
        "ACVIM B2期（心臟擴大但無症狀）：",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（EPIC研究證實延長無症狀期）",
        "ACVIM C期（有或曾有CHF症狀）：",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h",
        "- Furosemide: 1-4 mg/kg PO q8-12h（最低有效劑量）",
        "- ACEI: Enalapril或Benazepril 0.5 mg/kg PO q12h",
        "- Spironolactone: 1-2 mg/kg PO q12-24h",
        "ACVIM D期（難治性CHF）：",
        "- 增加Furosemide劑量或頻率",
        "- 加上Torasemide",
        "- Amlodipine（降低後負荷）",
        "- 飲食調整",
        "- 考慮外科修復（若可行）"
      ]
    },
    prognosis: "早期MVD進展緩慢，許多犬可存活數年。一旦發展CHF，平均存活約9-12個月（有治療）。EPIC研究顯示Pimobendan在B2期可延長約15個月無症狀期。",
    pearls: [
      "雜音強度≥3/6且有心臟擴大才建議開始Pimobendan（B2期）",
      "家中呼吸頻率監測是最重要的居家監測指標",
      "咳嗽可能是肺水腫或左主支氣管受壓，需區分",
      "騎士查理王小獵犬常早發且進展快",
      "外科二尖瓣修復在專業中心有良好成果",
      "心房顫動預後較差"
    ],
    monitoring: ["家中呼吸頻率（RRR<30/min）", "胸腔X光", "心臟超聲（每6-12個月）", "腎功能和電解質", "體重", "血壓"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ACVIM Consensus Guidelines 2019"
  },

  "tricuspid-valve-dysplasia": {
    zh: "三尖瓣發育不良",
    en: "Tricuspid Valve Dysplasia (TVD)",
    definition: "先天性三尖瓣結構異常導致三尖瓣閉鎖不全和右心容量超負荷的心臟畸形。",
    synonyms: ["TVD", "三尖瓣畸形", "先天性三尖瓣逆流", "Ebstein異常（嚴重形式）"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "先天性，年輕時診斷（通常<1歲）",
      sex: "公犬略多",
      riskFactors: ["拉布拉多犬", "德國牧羊犬", "大丹犬", "愛爾蘭雪達犬", "魏瑪犬", "舊英國牧羊犬", "遺傳"]
    },
    clinicalPresentation: {
      history: ["可能無症狀", "運動不耐", "腹部膨大（腹水）", "發育遲緩", "昏厥", "呼吸困難"],
      physicalExam: ["右側心尖區收縮期雜音", "可能有頸靜脈搏動", "肝腫大", "腹水", "頸靜脈怒張", "周邊水腫"]
    },
    pathophysiology: "三尖瓣葉發育異常（增厚、黏連、位置下移）→ 三尖瓣閉鎖不全 → 右心房和右心室容量超負荷 → 右心擴張 → 右心衰竭 → 體靜脈淤血 → 腹水、肝腫大",
    diagnosis: {
      overview: "心臟超聲確診，評估瓣膜結構和逆流嚴重程度",
      differentials: ["三尖瓣黏液瘤性退化", "心絲蟲相關三尖瓣逆流", "肺動脈高血壓繼發三尖瓣逆流", "心內膜墊缺損"],
      initialDB: ["心臟超聲（瓣膜結構異常、RA/RV擴張、三尖瓣逆流）", "胸腔X光（右心擴大）", "ECG（右心房擴大、右束支傳導阻滯、心室早搏）"],
      advanced: ["心血管造影", "CT血管造影"]
    },
    treatment: {
      overview: "目前無法治癒，治療以控制右心衰竭症狀為主",
      acute: [
        "急性右心衰竭：",
        "- Furosemide: 2-4 mg/kg IV",
        "- 腹腔穿刺（大量腹水影響呼吸時）",
        "- 氧氣支持（若需要）"
      ],
      chronic: [
        "輕度無症狀：監測，無需藥物",
        "右心衰竭：",
        "- Furosemide: 1-4 mg/kg PO q8-12h",
        "- Spironolactone: 1-2 mg/kg PO q12-24h",
        "- ACEI: Enalapril 0.5 mg/kg PO q12h",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（可能有益）",
        "- 限鈉飲食",
        "- 定期腹腔穿刺（難治性腹水）",
        "心律不整治療（若需要）",
        "外科治療：目前仍在發展中"
      ]
    },
    prognosis: "高度變異。輕度病例可存活數年。中重度病例預後較差，尤其發展右心衰竭後。Ebstein異常（嚴重形式）預後差。",
    pearls: [
      "三尖瓣發育不良與二尖瓣發育不良可同時存在",
      "腹水可能是首要臨床表現",
      "ECG可見右心房擴大（P波增高）和右軸偏移",
      "與心絲蟲病鑑別很重要，尤其在流行區",
      "外科修復技術仍在發展中"
    ],
    monitoring: ["腹水量", "體重", "呼吸頻率", "心臟超聲", "肝功能", "ECG"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "patent-ductus-arteriosus": {
    zh: "開放性動脈導管",
    en: "Patent Ductus Arteriosus (PDA)",
    definition: "出生後動脈導管未能正常關閉，導致主動脈和肺動脈之間持續存在異常通道的先天性心臟缺陷。",
    synonyms: ["PDA", "動脈導管未閉", "開存性動脈導管"],
    epidemiology: {
      species: "犬較貓常見",
      age: "先天性，通常幼年診斷",
      sex: "母犬較公犬常見（約3:1）",
      riskFactors: ["貴賓犬", "馬爾濟斯犬", "博美犬", "可卡犬", "德國牧羊犬", "柯利犬", "設得蘭牧羊犬", "遺傳"]
    },
    clinicalPresentation: {
      history: ["可能無症狀", "運動不耐", "呼吸困難", "發育遲緩", "後肢無力（若反向PDA）", "昏厥"],
      physicalExam: ["連續性機械樣心雜音（左基底部，雜音在S2時最響）", "「洗衣機樣雜音」", "跳躍脈（水沖脈）", "股動脈脈搏強勁", "心前區震顫", "若左心衰竭：肺部濕囉音", "若反向PDA：後肢發紺、差異性發紺"]
    },
    pathophysiology: "正常：胎兒期動脈導管連接主動脈和肺動脈，出生後數日關閉。PDA：導管未閉 → 血液從高壓主動脈分流至低壓肺動脈（左向右分流）→ 肺過度灌注 → 肺靜脈回流增加 → 左心房和左心室容量超負荷 → 左心衰竭。反向PDA：肺動脈高血壓 → 右向左分流 → 差異性發紺",
    diagnosis: {
      overview: "典型連續性雜音高度提示，心臟超聲確診",
      differentials: ["主動脈-肺動脈窗", "冠狀動脈瘻管", "主動脈竇動脈瘤破裂", "動靜脈瘻管"],
      initialDB: ["胸腔X光（左心擴大、肺血管擴張、導管膨大「3」或「D」形）", "心臟超聲（導管可視化、左心容量超負荷、多普勒確認分流）", "ECG（左心室肥大）"],
      advanced: ["心血管造影", "CT血管造影", "反向PDA需評估肺動脈壓"]
    },
    treatment: {
      overview: "確診後應盡早關閉導管，外科結紮或經導管關閉",
      acute: [
        "急性CHF穩定：",
        "- Furosemide: 2-4 mg/kg IV",
        "- 氧氣支持",
        "- 穩定後盡快安排手術"
      ],
      chronic: [
        "導管關閉（首選治療）：",
        "- 經導管關閉（Amplatz Canine Ductal Occluder, ACDO）：微創，成功率高",
        "- 外科結紮：開胸手術",
        "- 建議在2-3月齡時進行",
        "術前CHF管理：",
        "- Furosemide",
        "- ACEI",
        "反向PDA：禁忌關閉導管，僅支持治療",
        "- 避免激動和運動",
        "- 可能使用羥基脲（減少紅血球生成）"
      ]
    },
    prognosis: "未治療：約64%在1歲內死於CHF。早期導管關閉後：預後極佳，可接近正常壽命。反向PDA：預後差，平均存活約2-3年。",
    pearls: [
      "連續性機械樣雜音是PDA的經典特徵",
      "早期診斷和治療至關重要",
      "經導管關閉已成為首選治療方式",
      "反向PDA（Eisenmenger綜合症）不可關閉導管",
      "差異性發紺（前肢正常，後肢發紺）提示反向PDA",
      "遺傳性疾病，受影響動物不應繁殖"
    ],
    monitoring: ["術前：心臟超聲、CHF監測", "術後：心臟超聲確認關閉完全、左心大小恢復"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "aortic-stenosis": {
    zh: "主動脈狹窄",
    en: "Aortic Stenosis (AS)",
    definition: "主動脈瓣或其周圍區域狹窄導致左心室流出道阻塞的先天性心臟缺陷，最常見為瓣膜下型。",
    synonyms: ["AS", "SAS", "Subaortic Stenosis", "瓣膜下主動脈狹窄", "主動脈口狹窄"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "先天性，通常年輕時診斷",
      sex: "公犬略多",
      riskFactors: ["紐芬蘭犬", "金毛尋回犬", "拳師犬", "德國牧羊犬", "羅威納犬", "拉布拉多犬", "大丹犬", "遺傳"]
    },
    clinicalPresentation: {
      history: ["可能無症狀", "運動不耐", "昏厥（尤其運動時）", "突然死亡", "呼吸困難"],
      physicalExam: ["收縮期遞增遞減型雜音（左基底部，輻射至頸部和胸骨右側）", "雜音輻射至頸動脈", "股動脈脈搏弱且遲緩上升（pulsus parvus et tardus）", "心前區震顫", "若CHF：肺部濕囉音"]
    },
    pathophysiology: "主動脈瓣下纖維環或纖維肌性狹窄 → 左心室流出道阻塞 → 左心室壓力超負荷 → 向心性左心室肥厚 → 舒張功能障礙。高速血流損傷主動脈瓣 → 主動脈瓣逆流。冠狀動脈灌注受損 + 心肌氧需增加 → 心肌缺血 → 心律不整 → 昏厥/猝死",
    diagnosis: {
      overview: "心臟超聲結合多普勒確診並評估嚴重程度",
      differentials: ["主動脈瓣狹窄", "肺動脈狹窄", "心室中隔缺損", "動態流出道阻塞"],
      initialDB: ["心臟超聲（瓣膜下狹窄可視化、多普勒流速測量壓力梯度）", "胸腔X光（心臟大小可能正常、主動脈後狹窄擴張）", "ECG（左心室肥大、心律不整）"],
      advanced: ["24小時Holter監測", "心血管造影"]
    },
    treatment: {
      overview: "目前無法完全矯正，治療目標為減少症狀和猝死風險",
      acute: [
        "昏厥急性處理：支持治療",
        "急性CHF：標準CHF治療"
      ],
      chronic: [
        "輕度（壓力梯度<50 mmHg）：監測，無需藥物",
        "中重度（壓力梯度≥50 mmHg）：",
        "- β-blocker: Atenolol 0.5-1 mg/kg PO q12-24h（減少心肌氧需、預防心律不整）",
        "- 活動限制（避免激烈運動）",
        "- 抗生素預防（牙科或其他手術時，預防心內膜炎）",
        "球囊擴張術：效果不如肺動脈狹窄，改善有限",
        "外科切除：風險高，效果不確定",
        "CHF：標準治療"
      ]
    },
    prognosis: "取決於嚴重程度。輕度（壓力梯度<50 mmHg）：預後良好，接近正常壽命。重度（壓力梯度>80 mmHg）：高猝死風險，3年存活率約50%。",
    pearls: [
      "瓣膜下型（SAS）是犬最常見的主動脈狹窄類型",
      "紐芬蘭犬SAS有遺傳基礎，建議篩檢繁殖犬",
      "雜音在成長過程中可能加重（病變進展）",
      "避免激烈運動可減少猝死風險",
      "感染性心內膜炎風險增加",
      "β-blocker可能減少症狀但未證實延長壽命"
    ],
    monitoring: ["心臟超聲（每6-12個月）", "Holter監測（評估心律不整）", "活動耐受度"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "pulmonic-stenosis": {
    zh: "肺動脈狹窄",
    en: "Pulmonic Stenosis (PS)",
    definition: "肺動脈瓣或其周圍區域狹窄導致右心室流出道阻塞的先天性心臟缺陷。",
    synonyms: ["PS", "肺動脈瓣狹窄", "肺動脈口狹窄", "右心室流出道阻塞"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "先天性，通常年輕時診斷",
      sex: "無明顯性別傾向",
      riskFactors: ["英國鬥牛犬", "法國鬥牛犬", "拳師犬", "獒犬", "比乙獵犬", "可卡犬", "西高地白梗", "薩摩耶犬", "迷你雪納瑞"]
    },
    clinicalPresentation: {
      history: ["可能無症狀", "運動不耐", "昏厥", "腹部膨大（若右心衰竭）", "發紺（若有右向左分流）"],
      physicalExam: ["收縮期遞增遞減型雜音（左基底部，肺動脈區）", "心前區震顫", "頸靜脈怒張（若右心衰竭）", "腹水", "肝腫大"]
    },
    pathophysiology: "肺動脈瓣發育不良或融合 → 右心室流出道阻塞 → 右心室壓力超負荷 → 向心性右心室肥厚 → 最終可能發展右心衰竭。若存在ASD或開放性卵圓孔 → 右向左分流 → 發紺",
    diagnosis: {
      overview: "心臟超聲結合多普勒確診並評估嚴重程度",
      differentials: ["主動脈狹窄", "心室中隔缺損", "法洛四聯症", "右心室雙出口"],
      initialDB: ["心臟超聲（瓣膜增厚/融合、右心室肥厚、多普勒壓力梯度）", "胸腔X光（右心擴大、主肺動脈後狹窄擴張）", "ECG（右心室肥大、右軸偏移）"],
      advanced: ["血管造影", "CT血管造影"]
    },
    treatment: {
      overview: "球囊瓣膜成形術是首選治療，可顯著降低壓力梯度",
      acute: [
        "急性右心衰竭：",
        "- Furosemide: 2-4 mg/kg IV",
        "- 腹腔穿刺（大量腹水時）",
        "- 氧氣支持"
      ],
      chronic: [
        "輕度（壓力梯度<50 mmHg）：監測，無需干預",
        "中重度（壓力梯度≥50-80 mmHg）：",
        "- 球囊瓣膜成形術（首選）：成功率高，可降低50%以上壓力梯度",
        "- β-blocker: Atenolol 0.5-1 mg/kg PO q12-24h（若不適合手術）",
        "Type B發育不良（瓣膜下肥厚型）：球囊效果較差，可能需外科",
        "右心衰竭：",
        "- Furosemide",
        "- ACEI",
        "- 低鈉飲食"
      ]
    },
    prognosis: "球囊瓣膜成形術後預後良好。輕度PS通常預後極佳。重度未治療PS：預後較差，可能發展右心衰竭或猝死。Type A（瓣膜融合型）治療反應比Type B（發育不良型）好。",
    pearls: [
      "Type A（瓣膜融合型）球囊擴張效果最好",
      "Type B（發育不良型，常見於英國鬥牛犬）球囊效果較差",
      "壓力梯度>80 mmHg為重度，建議介入",
      "球囊瓣膜成形術是微創且效果良好的選擇",
      "短頭犬種PS常合併冠狀動脈異常（R2A）",
      "遺傳性疾病，受影響動物不應繁殖"
    ],
    monitoring: ["心臟超聲（術後追蹤壓力梯度）", "ECG", "右心衰竭徵象"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "ventricular-septal-defect": {
    zh: "心室中隔缺損",
    en: "Ventricular Septal Defect (VSD)",
    definition: "心室中隔先天性缺損導致左右心室之間存在異常通道的心臟畸形。",
    synonyms: ["VSD", "心室間隔缺損", "室間隔缺損"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "先天性",
      sex: "無明顯性別傾向",
      riskFactors: ["英國鬥牛犬", "西高地白梗", "拉布拉多犬", "英國史賓格犬", "遺傳"]
    },
    clinicalPresentation: {
      history: ["小型限制性VSD可能無症狀", "運動不耐", "呼吸困難", "發育遲緩", "發紺（若反向分流）"],
      physicalExam: ["收縮期心雜音（右側胸骨旁最響）", "心前區震顫", "若大型VSD左心衰竭：肺部濕囉音", "若反向VSD：發紺"]
    },
    pathophysiology: "心室中隔發育不完全 → 左右心室間異常通道。小型限制性VSD：高速左向右分流，血流動力學影響小。大型非限制性VSD：大量左向右分流 → 肺過度灌注 → 左心容量超負荷 → 左心衰竭。慢性肺過度灌注 → 肺動脈高血壓 → 反向分流（Eisenmenger綜合症）",
    diagnosis: {
      overview: "心臟超聲可直接觀察缺損並評估分流方向和量",
      differentials: ["心內膜墊缺損", "主動脈瓣逆流", "二尖瓣逆流", "三尖瓣逆流"],
      initialDB: ["心臟超聲（缺損可視化、彩色多普勒分流、Qp:Qs比值）", "胸腔X光（心臟擴大程度、肺血管）", "ECG"],
      advanced: ["心導管檢查", "CT血管造影"]
    },
    treatment: {
      overview: "依缺損大小和血流動力學影響決定治療策略",
      acute: [
        "急性CHF：標準CHF治療"
      ],
      chronic: [
        "小型限制性VSD（無心臟擴大）：",
        "- 通常不需治療",
        "- 定期監測",
        "- 抗生素預防（手術時）",
        "中大型VSD有血流動力學影響：",
        "- CHF藥物治療（Furosemide、ACEI、Pimobendan）",
        "- 經導管關閉或外科修復（技術上可行時）",
        "Eisenmenger綜合症（反向VSD）：",
        "- 禁忌關閉缺損",
        "- 支持治療",
        "- 肺動脈高血壓治療（Sildenafil）"
      ]
    },
    prognosis: "小型限制性VSD：預後極佳，可正常壽命。大型VSD：取決於是否能成功關閉。Eisenmenger綜合症：預後差。",
    pearls: [
      "VSD位置多在膜周部（perimembranous）",
      "雜音強度不一定反映缺損大小（小缺損高速血流可產生響亮雜音）",
      "Qp:Qs>2:1提示顯著分流",
      "小型VSD可能自發性縮小或關閉",
      "大型VSD應考慮早期關閉以防止Eisenmenger綜合症",
      "感染性心內膜炎風險增加"
    ],
    monitoring: ["心臟超聲定期追蹤", "心臟大小變化", "肺動脈壓估計"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "atrial-septal-defect": {
    zh: "心房中隔缺損",
    en: "Atrial Septal Defect (ASD)",
    definition: "心房中隔先天性缺損導致左右心房之間存在異常通道的心臟畸形。",
    synonyms: ["ASD", "心房間隔缺損", "房間隔缺損"],
    epidemiology: {
      species: "犬貓皆可發生，犬較常見",
      age: "先天性",
      sex: "無明顯性別傾向",
      riskFactors: ["薩摩耶犬", "拳師犬", "杜賓犬", "遺傳", "常與其他先天性心臟病合併"]
    },
    clinicalPresentation: {
      history: ["多數無症狀", "運動不耐（大型缺損）", "呼吸困難", "發紺（若反向分流）"],
      physicalExam: ["可能無雜音或有輕微收縮期雜音（肺動脈區相對狹窄）", "第二心音固定分裂", "若大型ASD合併三尖瓣逆流：右側收縮期雜音"]
    },
    pathophysiology: "心房中隔缺損 → 左向右分流（因左心房壓力略高於右心房）→ 右心容量超負荷 → 右心擴張 → 可能發展肺動脈高血壓 → 反向分流（Eisenmenger，罕見）",
    diagnosis: {
      overview: "心臟超聲可直接觀察缺損，但可能被誤診或漏診",
      differentials: ["開放性卵圓孔（PFO）", "肺靜脈異常回流", "三尖瓣疾病"],
      initialDB: ["心臟超聲（缺損可視化、右心擴張、彩色多普勒分流）", "胸腔X光（右心擴大、肺血管擴張）", "ECG（右心擴大、不完全右束支傳導阻滯）"],
      advanced: ["氣泡對比超聲", "經食道超聲", "心導管檢查"]
    },
    treatment: {
      overview: "多數ASD血流動力學影響小，不需治療",
      acute: [
        "若有急性右心衰竭：標準治療"
      ],
      chronic: [
        "小型ASD：不需治療，定期監測",
        "大型ASD有顯著右心擴張：",
        "- 經導管關閉（若技術可行）",
        "- 外科修復",
        "右心衰竭：利尿劑、ACEI",
        "反向ASD：禁忌關閉，支持治療"
      ]
    },
    prognosis: "多數ASD預後良好，尤其小型缺損。大型ASD若能成功關閉預後也好。Eisenmenger綜合症罕見但預後差。",
    pearls: [
      "單純ASD較VSD和PDA少見",
      "ASD常與其他先天性心臟病合併",
      "開放性卵圓孔（PFO）與真正ASD不同",
      "ASD可能終生無症狀",
      "經導管關閉技術在獸醫領域發展中"
    ],
    monitoring: ["心臟超聲定期追蹤", "右心大小", "肺動脈壓"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "heartworm-disease": {
    zh: "心絲蟲病",
    en: "Heartworm Disease",
    definition: "由犬心絲蟲(Dirofilaria immitis)感染引起的嚴重心肺疾病，成蟲寄生於肺動脈和右心。",
    synonyms: ["Dirofilariasis", "犬心絲蟲感染", "Canine Heartworm Disease"],
    epidemiology: {
      species: "犬為主要宿主，貓為非典型宿主（感染較輕但症狀可能更嚴重）",
      age: "任何年齡，感染需數月至數年才出現症狀",
      sex: "無性別傾向",
      riskFactors: ["生活在流行區", "未使用預防藥物", "戶外活動", "蚊蟲暴露"]
    },
    clinicalPresentation: {
      history: ["早期可能無症狀", "咳嗽（慢性、輕度）", "運動不耐", "呼吸困難", "昏厥", "腹部膨大（腹水）", "體重減輕", "咳血"],
      physicalExam: ["心雜音（三尖瓣逆流）", "肺部異常音", "肝腫大", "腹水", "頸靜脈搏動", "休克徵象（腔靜脈症候群）", "貓：呼吸困難、嘔吐、神經症狀"]
    },
    pathophysiology: "蚊蟲傳播L3幼蟲 → 皮下移行發育 → 進入血管 → 到達肺動脈成熟（約6個月）→ 成蟲引起血管內皮損傷 → 肺動脈炎和栓塞 → 肺動脈高血壓 → 右心衰竭。腔靜脈症候群：大量蟲體阻塞三尖瓣和腔靜脈 → 急性右心衰竭和溶血",
    diagnosis: {
      overview: "抗原檢測是主要篩檢方法，結合微絲蚴檢查",
      differentials: ["原發性肺動脈高血壓", "肺血栓栓塞", "慢性呼吸道疾病", "右心衰竭其他原因"],
      initialDB: ["心絲蟲抗原檢測（檢測成蟲，感染後6-7個月才陽性）", "微絲蚴檢查（改良Knott法或濃縮法）", "胸腔X光（肺動脈擴張、扭曲、肺實質病變）", "心臟超聲（蟲體可視化、右心擴張、三尖瓣逆流）"],
      advanced: ["CBC（嗜酸性球增多、貧血）", "生化（肝腎功能）", "尿液分析", "貓：抗體檢測"]
    },
    treatment: {
      overview: "殺蟲治療前需評估風險和分期，嚴重病例需先穩定",
      acute: [
        "腔靜脈症候群：",
        "- 緊急外科取蟲（經頸靜脈）",
        "- 輸液支持",
        "- 氧氣",
        "急性肺血栓栓塞：",
        "- 籠內休息",
        "- 氧氣",
        "- 抗炎劑量類固醇",
        "- 支持治療"
      ],
      chronic: [
        "美國心絲蟲學會（AHS）治療指南：",
        "治療前準備：",
        "- 開始口服預防藥（殺死微絲蚴和幼蟲）",
        "- Doxycycline 10 mg/kg PO q12h x 4週（殺死Wolbachia共生菌）",
        "- 限制運動",
        "殺成蟲治療（Melarsomine）：",
        "- 第1天：2.5 mg/kg IM深層腰部肌肉",
        "- 等待30天",
        "- 第31天：2.5 mg/kg IM",
        "- 第32天：2.5 mg/kg IM（對側）",
        "術後管理：",
        "- 嚴格限制運動6-8週",
        "- Prednisone漸減",
        "- 監測血栓栓塞併發症",
        "抗原測試追蹤（治療後6-9個月）"
      ]
    },
    prognosis: "輕度感染：治療後預後良好。中重度感染：預後謹慎，取決於肺動脈和心臟損傷程度。腔靜脈症候群：急性死亡率高。貓：預後更難預測。",
    pearls: [
      "預防勝於治療 - 每月預防藥是最佳策略",
      "抗原檢測可能有假陰性（低蟲量、全公蟲、免疫複合物阻斷）",
      "殺蟲後血栓栓塞是主要併發症，嚴格限制運動很重要",
      "Doxycycline可減少殺蟲後的肺部反應",
      "貓心絲蟲病診斷和治療更具挑戰性",
      "年度篩檢建議所有狗，即使使用預防藥"
    ],
    monitoring: ["治療期間臨床症狀", "胸腔X光", "抗原測試（治療後6-9個月確認清除）"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; American Heartworm Society Guidelines"
  },

  "pericardial-effusion": {
    zh: "心包積液",
    en: "Pericardial Effusion",
    definition: "心包腔內異常液體積聚，可能導致心臟壓塞和循環障礙的病理狀態。",
    synonyms: ["心包滲出液", "心包積水", "Pericardial Fluid Accumulation"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "中老年犬（腫瘤相關），任何年齡（特發性或感染性）",
      sex: "公犬較常見（血管肉瘤）",
      riskFactors: ["大型犬", "金毛尋回犬（血管肉瘤）", "德國牧羊犬（血管肉瘤）", "短頭犬種（心臟基底腫瘤）", "心臟腫瘤", "凝血障礙"]
    },
    clinicalPresentation: {
      history: ["虛弱", "運動不耐", "腹部膨大（腹水）", "昏厥", "突然倒下", "呼吸困難", "食慾下降"],
      physicalExam: ["Beck三徵：低血壓、頸靜脈怒張、心音低沉", "心搏過速", "脈搏弱", "奇脈", "腹水", "肝腫大", "黏膜蒼白", "CRT延長"]
    },
    pathophysiology: "心包積液積聚 → 心包腔壓力升高 → 心室舒張充盈受限（心臟壓塞）→ 心輸出量下降 → 代償性心搏過速和全身血管收縮 → 組織灌注不足。病因：腫瘤（血管肉瘤、心臟基底腫瘤、間皮瘤）、特發性、感染、凝血障礙、尿毒症、心臟破裂",
    diagnosis: {
      overview: "心臟超聲快速確診，需同時評估病因",
      differentials: ["腹腔積液其他原因", "充血性心衰竭", "休克其他原因"],
      initialDB: ["心臟超聲（心包積液、心臟壓塞徵象、腫瘤評估）", "胸腔X光（球形心影）", "ECG（低電壓、電交替）", "心包液分析"],
      advanced: ["CT（尋找腫瘤）", "心包液細胞學", "心臟標記物（cTnI）"]
    },
    treatment: {
      overview: "心包穿刺是急性處理的關鍵，長期管理取決於病因",
      acute: [
        "心包穿刺術：",
        "- 右側臥位，4-6肋間心尖區",
        "- 超聲引導下更安全",
        "- 使用大口徑導管（14-16G）",
        "- 引流直到負壓或臨床改善",
        "- 保存液體送檢",
        "輸液支持",
        "ECG監測（穿刺中可能心律不整）"
      ],
      chronic: [
        "特發性心包積液：",
        "- 可能需反覆穿刺",
        "- 心包切除術（經常復發者）",
        "- 預後較好",
        "腫瘤相關：",
        "- 血管肉瘤：預後差，化療（Doxorubicin）可能延長數月",
        "- 心臟基底腫瘤：進展慢，心包切除術後可能存活1-2年",
        "- 間皮瘤：化療或胸腔內藥物",
        "感染性：抗生素治療",
        "心包切除術：",
        "- 經常復發的特發性",
        "- 結紮性心包炎",
        "- 緩解腫瘤相關心包積液"
      ]
    },
    prognosis: "特發性：心包切除術後預後良好，5年存活率可達50%以上。血管肉瘤：預後差，中位生存期約1-4個月。心臟基底腫瘤：進展慢，中位生存期可達1-2年。",
    pearls: [
      "積液量和速度決定症狀嚴重度 - 慢性積聚可耐受更大量",
      "血性心包積液不一定是腫瘤（特發性也可能血性）",
      "心包液pH<7.0或葡萄糖低提示感染",
      "心包液細胞學對腫瘤診斷敏感度低（約50%）",
      "穿刺後立即改善具有診斷價值（確認壓塞）",
      "金毛尋回犬心包積液高度懷疑血管肉瘤"
    ],
    monitoring: ["臨床症狀", "超聲追蹤積液再積聚", "腫瘤篩查"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "infective-endocarditis": {
    zh: "感染性心內膜炎",
    en: "Infective Endocarditis (IE)",
    definition: "心臟瓣膜或心內膜的微生物感染，形成疣狀贅生物導致瓣膜功能障礙和全身性併發症。",
    synonyms: ["IE", "細菌性心內膜炎", "Bacterial Endocarditis", "心內膜炎"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "中大型犬，中老年",
      sex: "公犬較常見",
      riskFactors: ["大型犬", "主動脈瓣疾病", "先天性心臟病", "免疫抑制", "長期導管留置", "口腔疾病", "椎間盤炎", "前列腺炎", "先前心臟手術"]
    },
    clinicalPresentation: {
      history: ["發燒（可能間歇性）", "嗜睡", "食慾下降", "體重減輕", "跛行（栓塞性關節炎）", "呼吸困難", "昏厥", "急性神經症狀（腦栓塞）"],
      physicalExam: ["發燒", "新出現的心雜音或雜音變化", "心律不整", "跛行/關節腫脹", "脾腫大", "瘀點", "眼部病變", "神經缺損"]
    },
    pathophysiology: "菌血症 + 心內膜損傷 → 細菌定植 → 形成感染性疣狀贅生物（細菌、纖維蛋白、血小板）→ 瓣膜破壞 → 瓣膜逆流 → 充血性心衰竭。贅生物碎片脫落 → 敗血性栓塞 → 多器官感染/梗塞（腎、脾、腦、關節）",
    diagnosis: {
      overview: "基於臨床表現、血液培養陽性、心臟超聲發現疣狀贅生物（改良Duke標準）",
      differentials: ["非感染性瓣膜疾病", "其他發燒原因", "免疫介導性疾病", "腫瘤"],
      initialDB: ["血液培養（多次、抗生素使用前、動脈和靜脈）", "心臟超聲（疣狀贅生物、瓣膜逆流、心臟擴大）", "CBC（白血球增多、貧血、血小板減少）", "生化（腎功能、肝功能）", "尿液分析（蛋白尿、血尿）"],
      advanced: ["尿液培養", "關節液分析", "C-反應蛋白", "ECG（傳導阻滯提示膿腫）"]
    },
    treatment: {
      overview: "長期靜脈抗生素治療，支持性心臟藥物",
      acute: [
        "經驗性抗生素（血液培養結果前）：",
        "- Ampicillin 22 mg/kg IV q8h + Enrofloxacin 5-10 mg/kg IV q24h",
        "- 或 Ampicillin + Gentamicin（監測腎功能）",
        "急性CHF：標準CHF治療"
      ],
      chronic: [
        "根據血液培養和藥敏調整抗生素",
        "抗生素療程：至少6-8週",
        "- 前2-4週IV",
        "- 之後可轉口服（若臨床改善）",
        "常見致病菌：",
        "- Staphylococcus（最常見）",
        "- Streptococcus",
        "- E. coli",
        "- Bartonella（需特殊培養）",
        "心臟藥物（若有CHF或瓣膜逆流）：",
        "- Furosemide",
        "- ACEI",
        "- Pimobendan",
        "外科瓣膜置換：在獸醫很少進行"
      ]
    },
    prognosis: "預後謹慎至差。主動脈瓣受累預後較二尖瓣差。早期診斷和積極治療可改善預後。死亡率約50-70%。",
    pearls: [
      "主動脈瓣是犬最常受累的瓣膜",
      "「發燒+新雜音」高度懷疑IE",
      "血液培養陰性不能排除（可能已使用抗生素或Bartonella等難培養菌）",
      "Bartonella是重要病因，尤其在流行區",
      "椎間盤炎和IE可能同時存在",
      "口腔健康維護可能預防IE"
    ],
    monitoring: ["體溫", "心臟超聲（疣狀物大小變化）", "血液培養複查", "腎功能", "心律"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "arterial-thromboembolism": {
    zh: "動脈血栓栓塞",
    en: "Arterial Thromboembolism (ATE)",
    definition: "血栓從心臟脫落並栓塞至周邊動脈，導致急性缺血的危急狀態，最常見於貓並累及後肢。",
    synonyms: ["ATE", "貓主動脈血栓栓塞", "Feline Aortic Thromboembolism", "FATE", "騎跨式栓塞", "Saddle Thrombus"],
    epidemiology: {
      species: "貓最常見（與HCM相關），犬罕見",
      age: "中老年貓（平均8-12歲）",
      sex: "公貓略多",
      riskFactors: ["肥厚型心肌病（HCM）", "其他心肌病", "左心房擴張", "自發性回聲對比", "先前ATE病史", "心房顫動"]
    },
    clinicalPresentation: {
      history: ["突然發作後肢癱瘓", "劇烈疼痛/嚎叫", "無法行走", "拖行後肢", "可能有已知心臟病史"],
      physicalExam: ["後肢癱瘓（最常見）", "股動脈脈搏消失", "後肢冰冷", "肉墊發紺或蒼白", "後肢肌肉僵硬（晚期）", "劇烈疼痛", "過度換氣", "低體溫", "心雜音或奔馬律", "呼吸急促/困難"]
    },
    pathophysiology: "心臟病（HCM等）→ 左心房擴張和血流淤滯 → 血栓形成（通常在左心耳）→ 血栓脫落 → 主動脈遠端分叉處栓塞（最常見）→ 後肢急性缺血 → 缺血性神經肌肉損傷。血管收縮物質釋放 → 側枝循環受損 → 加重缺血",
    diagnosis: {
      overview: "典型臨床表現（5P's）結合股動脈脈搏消失即可臨床診斷",
      differentials: ["椎間盤疾病", "脊髓栓塞", "下運動神經元疾病", "創傷"],
      initialDB: ["體檢（5P's：Pain疼痛、Pulselessness無脈、Paralysis癱瘓、Pallor蒼白、Poikilothermia溫差）", "心臟超聲（心臟病評估、左心房血栓）", "多普勒超聲（確認血流阻斷）", "血糖（患肢血糖通常低於前肢）"],
      advanced: ["肌酸激酶（CK，顯著升高）", "電解質（高血鉀）", "凝血功能", "乳酸"]
    },
    treatment: {
      overview: "止痛是首要任務，抗凝治療，支持性心臟治療",
      acute: [
        "止痛（極重要）：",
        "- Methadone 0.1-0.3 mg/kg IV/IM q4-6h",
        "- 或 Buprenorphine 0.01-0.02 mg/kg IV/IM q6-8h",
        "- 或 Fentanyl CRI",
        "抗凝治療：",
        "- Heparin: 250-300 IU/kg IV，然後150-250 IU/kg SC q8h",
        "- 或 低分子肝素（Enoxaparin）: 1 mg/kg SC q12h",
        "溶栓治療（效果和風險爭議）：",
        "- tPA或Streptokinase（出血風險高）",
        "心臟病治療：",
        "- CHF：Furosemide",
        "- 氧氣支持",
        "支持治療：",
        "- 維持水合",
        "- 監測高血鉀",
        "- 體溫管理"
      ],
      chronic: [
        "長期抗血小板/抗凝治療：",
        "- Clopidogrel 18.75 mg/貓 PO q24h（首選）",
        "- 或 Aspirin 81 mg/貓 PO q72h",
        "- 高風險：加上Rivaroxaban 1.25-2.5 mg/貓 PO q24h",
        "心臟病管理：",
        "- β-blocker或Diltiazem",
        "- ACEI（若CHF）",
        "物理治療（恢復期）"
      ]
    },
    prognosis: "整體預後謹慎。短期存活率約30-40%。有些貓可在數週內恢復功能。預後不良因素：低體溫、多肢受累、嚴重心臟病、高血鉀、休克。復發率高（約25-50%在1年內）。",
    pearls: [
      "ATE是獸醫急診最痛苦的病症之一，止痛是第一優先",
      "約90%的貓ATE有潛在心臟病（主要是HCM）",
      "股動脈脈搏消失是診斷關鍵",
      "患肢血糖低於前肢有診斷價值",
      "恢復功能可能需要數週，主人教育很重要",
      "即使恢復，復發風險高",
      "Clopidogrel比Aspirin預防效果更好（FAT CAT研究）"
    ],
    monitoring: ["疼痛控制", "心臟功能", "電解質（尤其鉀）", "肢體循環恢復", "復發徵象"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "systemic-hypertension": {
    zh: "系統性高血壓",
    en: "Systemic Hypertension",
    definition: "持續性動脈血壓升高，可導致靶器官損傷（眼、腎、心、腦）的病理狀態。",
    synonyms: ["高血壓", "Arterial Hypertension", "全身性高血壓"],
    epidemiology: {
      species: "犬貓皆可發生，貓較常見",
      age: "中老年動物",
      sex: "無明顯性別傾向",
      riskFactors: ["慢性腎病（最常見原因）", "甲狀腺機能亢進（貓）", "腎上腺皮質機能亢進", "嗜鉻細胞瘤", "醛固酮過多症", "糖尿病", "肥胖"]
    },
    clinicalPresentation: {
      history: ["可能無症狀", "突然失明", "眼睛異常", "神經症狀（癲癇、步態異常）", "多飲多尿", "體重變化"],
      physicalExam: ["眼部：視網膜出血、水腫、剝離、眼前房出血、失明", "心臟：心雜音、奔馬律、左心室肥厚", "神經：精神改變、癲癇、共濟失調、頭部傾斜", "腎臟：可能觸及腎臟異常"]
    },
    pathophysiology: "血壓持續升高 → 血管壁應力增加 → 內皮損傷和動脈硬化。靶器官損傷：眼（小血管出血/剝離）、腎（腎小球硬化）、心（壓力超負荷致左心室肥厚）、腦（出血/缺血）",
    diagnosis: {
      overview: "多次測量確認持續高血壓，並評估靶器官損傷和潛在病因",
      differentials: ["白袍高血壓（焦慮性）", "測量誤差"],
      initialDB: ["血壓測量（Doppler或oscillometric，多次測量）", "眼科檢查（眼底檢查）", "CBC、生化（腎功能、電解質）", "尿液分析和UPC", "T4（貓）"],
      advanced: ["心臟超聲", "腹部超聲", "低劑量地塞米松抑制試驗（懷疑庫欣）", "醛固酮/腎素比", "腹部CT（腎上腺腫瘤）"]
    },
    treatment: {
      overview: "降壓藥物控制血壓，治療潛在病因，防止靶器官損傷",
      acute: [
        "高血壓急症（嚴重眼或神經症狀）：",
        "- Amlodipine（首選）: 犬 0.1-0.25 mg/kg PO q24h；貓 0.625-1.25 mg/貓 PO q24h",
        "- 嚴重時：Hydralazine或Nitroprusside CRI",
        "- 避免血壓下降過快（維持腦灌注）"
      ],
      chronic: [
        "貓首選：Amlodipine 0.625-1.25 mg/貓 PO q24h",
        "- 若效果不足可增至2.5 mg/貓",
        "- 可加上Telmisartan 2 mg/kg PO q24h",
        "犬：",
        "- Amlodipine 0.1-0.5 mg/kg PO q24h",
        "- ACEI: Enalapril或Benazepril 0.5 mg/kg PO q12-24h",
        "- β-blocker: Atenolol（若心搏過速）",
        "治療潛在病因：",
        "- 甲亢：抗甲狀腺藥物",
        "- 腎病：腎病管理",
        "- 庫欣：相應治療",
        "目標血壓：",
        "- 收縮壓 <140-160 mmHg（無靶器官損傷）",
        "- 收縮壓 <140 mmHg（有靶器官損傷）"
      ]
    },
    prognosis: "取決於潛在病因和靶器官損傷程度。早期發現和控制可預防或延緩靶器官損傷。視網膜剝離若及時降壓可能恢復部分視力。",
    pearls: [
      "貓高血壓常與CKD和甲亢相關",
      "突然失明可能是高血壓的首要表現",
      "眼底檢查是評估靶器官損傷的重要方法",
      "測量血壓需要正確技術和動物放鬆",
      "Amlodipine是貓高血壓的首選藥物",
      "血壓分級：正常<140，低風險140-159，中風險160-179，高風險≥180 mmHg",
      "治療高血壓可能揭露潛在的CKD進展"
    ],
    monitoring: ["血壓（每1-2週直到穩定，之後每3-6個月）", "眼底檢查", "腎功能", "心臟超聲（若有左心室肥厚）"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ACVIM Consensus on Hypertension"
  },

  "pulmonary-hypertension": {
    zh: "肺動脈高血壓",
    en: "Pulmonary Hypertension (PH)",
    definition: "肺動脈壓力異常升高的病理狀態，可能是原發性或繼發於心臟、肺部或血栓栓塞疾病。",
    synonyms: ["PH", "肺高壓", "Pulmonary Arterial Hypertension", "PAH"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "中老年犬",
      sex: "無明顯性別傾向",
      riskFactors: ["心絲蟲病", "慢性呼吸道疾病", "左心疾病（二尖瓣病變）", "先天性心臟病", "肺血栓栓塞", "高海拔"]
    },
    clinicalPresentation: {
      history: ["運動不耐", "呼吸困難", "咳嗽", "昏厥", "腹部膨大（腹水）", "發紺"],
      physicalExam: ["心雜音（三尖瓣逆流或肺動脈瓣逆流）", "第二心音分裂或增強", "頸靜脈怒張", "肝腫大", "腹水", "發紺", "心搏過速"]
    },
    pathophysiology: "各種原因導致肺血管阻力增加 → 肺動脈壓升高 → 右心室壓力超負荷 → 右心室肥厚 → 右心衰竭。分類（基於人類WHO分組）：第1組：肺動脈高血壓（原發性）；第2組：左心疾病相關；第3組：肺疾病/低氧相關；第4組：血栓栓塞相關；第5組：多因素",
    diagnosis: {
      overview: "心臟超聲估計肺動脈壓是主要診斷方法，同時需尋找病因",
      differentials: ["右心衰竭其他原因", "三尖瓣疾病"],
      initialDB: ["心臟超聲（三尖瓣逆流速度估計PAP、右心擴張/肥厚、中隔平坦化）", "胸腔X光（肺動脈擴張、右心擴大、肺部病變）", "心絲蟲抗原測試", "動脈血氣（低氧血症）"],
      advanced: ["心導管（確診金標準，獸醫少用）", "CT血管造影（肺栓塞）", "凝血功能", "D-dimer", "6分鐘步行試驗"]
    },
    treatment: {
      overview: "治療潛在病因，使用肺血管擴張劑，支持性右心衰竭治療",
      acute: [
        "急性右心衰竭：",
        "- 氧氣支持",
        "- Furosemide: 2-4 mg/kg IV",
        "- 減少應激",
        "嚴重低氧：氧氣，可能需機械通氣"
      ],
      chronic: [
        "肺血管擴張劑：",
        "- Sildenafil（首選）: 1-2 mg/kg PO q8-12h",
        "- Tadalafil: 1 mg/kg PO q24h",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（正性肌力+血管擴張）",
        "右心衰竭治療：",
        "- Furosemide: 1-4 mg/kg PO q8-12h",
        "- Spironolactone: 1-2 mg/kg PO q12-24h",
        "治療潛在病因：",
        "- 心絲蟲：殺蟲治療",
        "- 左心病：心臟藥物",
        "- 呼吸道疾病：支氣管擴張劑、類固醇",
        "- 血栓栓塞：抗凝治療",
        "氧氣治療（若慢性低氧）",
        "限制運動"
      ]
    },
    prognosis: "取決於病因和嚴重程度。繼發於可治療病因（心絲蟲）預後較好。原發性或嚴重繼發性PH預後較差。中位存活期可能為數月至1-2年。",
    pearls: [
      "三尖瓣逆流速度>3 m/s提示肺動脈高血壓",
      "心臟超聲估計的肺動脈壓可能低估實際壓力",
      "Sildenafil是目前獸醫最常用的肺血管擴張劑",
      "心絲蟲是犬PH的重要且可預防的原因",
      "昏厥在PH犬中常見且預後較差",
      "需要尋找和治療潛在病因"
    ],
    monitoring: ["臨床症狀", "心臟超聲（三尖瓣逆流速度、右心大小）", "運動耐受度", "血氧"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ACVIM Consensus on PH"
  }
  // ===== From neurological-diseases.js =====

  // ==================== 脊髓疾病 ====================

  "intervertebral-disc-disease": {
    zh: "椎間盤疾病",
    en: "Intervertebral Disc Disease (IVDD)",
    definition: "椎間盤退化導致髓核突出或纖維環膨出壓迫脊髓或神經根，引起疼痛和神經功能障礙的常見脊髓疾病。",
    synonyms: ["IVDD", "椎間盤突出", "Herniated Disc", "Slipped Disc", "椎間盤脫出", "Disc Extrusion", "Disc Protrusion"],
    epidemiology: {
      species: "犬最常見，貓罕見",
      age: "Hansen Type I: 3-7歲；Hansen Type II: 8歲以上",
      sex: "無明顯性別傾向",
      riskFactors: ["軟骨發育不良品種（Dachshund、Beagle、Shih Tzu、Pekingese、Cocker Spaniel、French Bulldog）", "肥胖", "高衝擊活動（跳躍、爬樓梯）", "遺傳因素"]
    },
    clinicalPresentation: {
      history: ["急性或漸進性後肢無力/癱瘓", "頸部或背部疼痛", "不願行走或跳躍", "哭叫（尤其移動時）", "步態異常", "大小便失禁（嚴重）"],
      physicalExam: ["脊椎疼痛（觸診或活動時）", "本體感覺缺失", "運動失調", "輕癱或癱瘓", "反射異常（依病變位置）", "肌肉萎縮（慢性）", "深部痛覺缺失（嚴重）"]
    },
    pathophysiology: "Hansen Type I（突出型）：髓核急性突出穿過纖維環 → 脊髓急性壓迫和挫傷。Hansen Type II（膨出型）：纖維環慢性退化變厚 → 慢性脊髓壓迫。壓迫導致：缺血、水腫、神經細胞損傷、軸突退化。頸椎好發C2-C3、C3-C4；胸腰椎好發T11-L2（T12-T13最常見）。",
    diagnosis: {
      overview: "神經學檢查定位病變，影像學確認",
      differentials: ["纖維軟骨栓塞(FCE)", "脊髓腫瘤", "脊髓炎", "椎體骨折/脫位", "退化性脊髓病", "椎間盤脊椎炎", "先天性脊髓異常"],
      initialDB: ["完整神經學檢查", "脊椎X光（椎間隙變窄、礦化椎間盤）", "血液檢查（排除系統性疾病）"],
      advanced: ["MRI（首選：可見軟組織、脊髓變化）", "CT（骨骼細節、礦化椎間盤）", "脊髓造影（若無MRI）", "腦脊液分析"]
    },
    treatment: {
      overview: "依嚴重程度分級治療：保守治療或手術減壓",
      acute: [
        "神經功能分級：",
        "  Grade I: 僅疼痛 → 保守治療",
        "  Grade II: 輕度運動失調，可行走 → 保守或手術",
        "  Grade III: 嚴重運動失調，輕癱 → 手術建議",
        "  Grade IV: 癱瘓，保留深部痛覺 → 手術",
        "  Grade V: 癱瘓，無深部痛覺 → 緊急手術（48小時內）",
        "保守治療（Grade I-II）：",
        "  - 嚴格籠休4-6週",
        "  - 止痛：Gabapentin 5-10 mg/kg PO q8-12h",
        "  - 肌肉鬆弛：Methocarbamol 15-20 mg/kg PO q8h",
        "  - NSAIDs（無類固醇使用時）：Carprofen 2.2 mg/kg PO q12h",
        "  - 避免類固醇（爭議且副作用多）",
        "手術治療：",
        "  - 半椎板切除術(Hemilaminectomy)：胸腰椎",
        "  - 腹側開窗術(Ventral Slot)：頸椎",
        "  - 目的：減壓、移除突出物質"
      ],
      chronic: [
        "物理治療和復健",
        "水療（水中跑步機）",
        "輪椅輔助（永久癱瘓）",
        "膀胱管理（神經性膀胱）",
        "體重管理",
        "環境調整（防滑地板、斜坡）"
      ]
    },
    prognosis: "Grade I-II: 保守治療成功率85-95%。Grade III-IV: 手術成功率80-95%。Grade V: 手術成功率50-60%（深部痛覺喪失<48小時較佳）。深部痛覺喪失>48小時預後差。復發率約15-20%。",
    pearls: [
      "深部痛覺是最重要的預後指標",
      "Dachshund的IVDD風險是其他品種的10-12倍",
      "進行性脊髓軟化(PMM)是致命併發症，約10% Grade V病例",
      "「籠休」必須嚴格，僅允許出籠大小便",
      "類固醇與NSAIDs不可併用",
      "MRI可發現X光看不到的軟組織壓迫"
    ],
    monitoring: ["神經功能評估（每日→每週）", "疼痛評估", "膀胱功能", "復健進展", "體重"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Brisson BA: Intervertebral disc disease in dogs. Vet Clin North Am Small Anim Pract 40:829-858, 2010"
  },

  "fibrocartilaginous-embolism": {
    zh: "纖維軟骨栓塞",
    en: "Fibrocartilaginous Embolism (FCE)",
    definition: "椎間盤纖維軟骨物質栓塞脊髓血管導致缺血性脊髓病變，引起急性、非進行性、通常非疼痛性的神經功能障礙。",
    synonyms: ["FCE", "脊髓梗塞", "Spinal Cord Infarction", "Ischemic Myelopathy", "纖維軟骨栓塞性脊髓病"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "年輕至中年成犬（平均3-6歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["大型和巨型犬種（German Shepherd、Labrador、Great Dane）", "小型犬中Miniature Schnauzer和Shetland Sheepdog較常見", "運動或輕微創傷後發作"]
    },
    clinicalPresentation: {
      history: ["急性發作（通常與運動或輕微創傷相關）", "發作時可能尖叫", "初期疼痛後迅速消退", "非進行性（24小時內穩定）", "不對稱性神經缺損常見"],
      physicalExam: ["不對稱性輕癱或癱瘓", "發作後24小時內無疼痛", "下運動神經元或上運動神經元徵象（依病變位置）", "一側肢體可能比另一側嚴重", "脊椎觸診不痛"]
    },
    pathophysiology: "椎間盤纖維軟骨物質（髓核來源）→ 進入脊髓血管系統（動脈或靜脈）→ 栓塞脊髓節段血管 → 缺血 → 脊髓壞死。確切進入機制不明，可能與椎間盤退化和新生血管有關。病變範圍取決於栓塞血管分布。",
    diagnosis: {
      overview: "臨床特徵高度提示，MRI確認，排除其他疾病",
      differentials: ["IVDD（Hansen Type I）", "脊髓創傷", "脊髓腫瘤", "脊髓炎", "出血", "動靜脈畸形"],
      initialDB: ["完整神經學檢查", "脊椎X光（通常正常）", "血液檢查"],
      advanced: ["MRI（首選）：急性期可見T2高信號脊髓內病變", "腦脊液分析（輕度蛋白升高或正常）", "排除壓迫性病變"]
    },
    treatment: {
      overview: "支持治療和物理復健為主，無特異性治療",
      acute: [
        "無手術指征（非壓迫性病變）",
        "支持治療：",
        "  - 舒適的墊褥（預防褥瘡）",
        "  - 輔助翻身（癱瘓動物每4小時）",
        "  - 膀胱管理（手動擠壓或導尿）",
        "  - 營養支持",
        "止痛（若有殘餘疼痛）：Gabapentin 5-10 mg/kg PO q8-12h",
        "類固醇無明確療效，不建議使用"
      ],
      chronic: [
        "物理治療是關鍵：",
        "  - 被動關節活動",
        "  - 站立訓練",
        "  - 水療",
        "  - 神經肌肉電刺激",
        "輪椅輔助（部分病例）",
        "持續膀胱管理（若需要）"
      ]
    },
    prognosis: "整體預後較好。約75-85%犬隻在數週至數月內恢復行走能力。預後因素：深部痛覺保留者預後好；病變範圍小者預後好；一週內有改善者預後好。完全恢復可能，但部分可能有殘餘缺損。",
    pearls: [
      "「急性、非進行性、非疼痛性、不對稱性」是FCE的典型特徵",
      "與IVDD鑑別：IVDD通常疼痛且對稱",
      "MRI的急性脊髓內T2高信號支持診斷",
      "確診需排除壓迫性病變",
      "物理治療對恢復至關重要",
      "貓的FCE極為罕見"
    ],
    monitoring: ["每日神經功能評估（前1-2週）", "膀胱功能", "皮膚完整性", "肌肉量", "復健進展"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; De Risio L et al: Fibrocartilaginous embolic myelopathy in small animals. Vet Clin North Am Small Anim Pract 40:859-869, 2010"
  },

  "degenerative-myelopathy": {
    zh: "退化性脊髓病",
    en: "Degenerative Myelopathy (DM)",
    definition: "成年犬的進行性、非疼痛性脊髓退化疾病，特徵為後肢進行性運動失調和輕癱，最終導致四肢癱瘓。與SOD1基因突變相關。",
    synonyms: ["DM", "German Shepherd Degenerative Myelopathy", "慢性退化性脊髓病", "Canine Degenerative Myelopathy"],
    epidemiology: {
      species: "犬，貓極罕見",
      age: "中老年犬（通常8歲以上）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種：German Shepherd（最常見）、Pembroke Welsh Corgi、Boxer、Rhodesian Ridgeback、Chesapeake Bay Retriever", "SOD1基因突變純合子"]
    },
    clinicalPresentation: {
      history: ["隱匿性起病，進行性惡化", "後肢無力和運動失調", "指甲磨損", "腳背著地", "非疼痛性", "大小便功能初期正常", "病程6-12個月後可能發展為四肢無力"],
      physicalExam: ["後肢上運動神經元性輕癱", "本體感覺缺失", "跨步反應延遲或缺失", "後肢肌肉萎縮", "脊椎觸診無疼痛", "晚期可能出現前肢異常", "晚期可能有下運動神經元徵象"]
    },
    pathophysiology: "SOD1(Superoxide dismutase 1)基因突變 → 蛋白質異常聚集 → 軸突和髓鞘退化 → 脊髓白質變性。病變主要在胸腰脊髓，後期擴展至頸髓和腦幹。類似人類肌萎縮側索硬化症(ALS)的動物模型。",
    diagnosis: {
      overview: "排除性診斷；確診需要病理學檢查",
      differentials: ["IVDD（Hansen Type II）", "腰薦椎狹窄", "脊髓腫瘤", "髖關節疾病", "多發性神經根病", "退化性關節炎"],
      initialDB: ["完整神經學檢查", "脊椎X光（排除骨病變）", "SOD1基因檢測（風險評估，非確診）", "血液檢查"],
      advanced: ["MRI（排除壓迫性病變；DM時脊髓可能萎縮）", "腦脊液分析（通常正常）", "電生理檢查", "肌肉/神經活檢", "確診：死後脊髓病理"]
    },
    treatment: {
      overview: "無治癒方法，以支持治療和延緩進展為主",
      acute: [
        "無急性治療需求（進行性疾病）",
        "向主人解釋疾病本質和預後"
      ],
      chronic: [
        "物理治療：",
        "  - 持續運動（維持肌肉量）",
        "  - 水療（減重運動）",
        "  - 被動關節活動",
        "  - 站立訓練",
        "營養補充（理論效益，證據有限）：",
        "  - 維生素E",
        "  - Omega-3脂肪酸",
        "  - N-乙醯半胱氨酸",
        "輔助設備：",
        "  - 後肢支撐帶",
        "  - 輪椅",
        "  - 防滑靴套",
        "環境調整：防滑地板",
        "安樂死時機討論（生活品質考量）"
      ]
    },
    prognosis: "預後差，疾病不可逆且持續進行。從後肢癱瘓到需要安樂死通常6-12個月。維持運動可能減緩進展。最終因呼吸肌麻痺或生活品質考量而安樂死。",
    pearls: [
      "DM是排除性診斷，確診需要病理",
      "SOD1基因檢測：純合子突變=高風險，但非所有都會發病",
      "與IVDD Type II鑑別：DM非疼痛性，兩側對稱",
      "保持運動是目前最佳「治療」",
      "類似人類ALS，是重要的研究模型",
      "早期MRI可能正常或僅見脊髓輕度萎縮"
    ],
    monitoring: ["定期神經功能評估", "肌肉量", "生活品質評估", "膀胱功能（晚期）"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Coates JR, Wininger FA: Canine degenerative myelopathy. Vet Clin North Am Small Anim Pract 40:929-950, 2010"
  },

  // ==================== 癲癇和發炎性疾病 ====================

  "idiopathic-epilepsy": {
    zh: "特發性癲癇",
    en: "Idiopathic Epilepsy",
    definition: "排除結構性和代謝性原因後，反覆發生的癲癇發作。被認為有遺傳基礎，是犬最常見的癲癇病因。",
    synonyms: ["原發性癲癇", "Primary Epilepsy", "Genetic Epilepsy", "遺傳性癲癇", "IE"],
    epidemiology: {
      species: "犬最常見，貓較少見",
      age: "首次發作通常6個月至6歲（多數1-5歲）",
      sex: "公犬略多（某些品種）",
      riskFactors: ["品種傾向：Labrador Retriever、Golden Retriever、German Shepherd、Beagle、Belgian Shepherd（Tervuren）、Border Collie、Australian Shepherd、Vizsla", "家族史"]
    },
    clinicalPresentation: {
      history: ["反覆發生的癲癇發作", "發作間期完全正常", "可能有前兆期（焦慮、躲藏、尋求主人）", "發作類型：全身性強直-陣攣最常見", "發作後期：混亂、失明、飢餓"],
      physicalExam: ["發作間期：神經學檢查完全正常", "發作時：意識喪失、強直-陣攣、流涎、排尿排便", "發作後：短暫意識模糊、失明、運動失調"]
    },
    pathophysiology: "遺傳因素導致神經元興奮性和抑制性平衡失調 → 神經元異常同步放電 → 癲癇發作。某些品種已確認特定基因突變（如LGI2 in Lagotto Romagnolo）。大多數為多基因遺傳。",
    diagnosis: {
      overview: "排除性診斷：排除結構性、代謝性和中毒原因",
      differentials: ["結構性癲癇（腦腫瘤、腦炎、腦積水）", "代謝性癲癇（低血糖、肝腦病、電解質異常）", "反應性癲癇（中毒）", "運動障礙", "暈厥", "發作性睡病"],
      initialDB: ["完整神經學檢查（應正常）", "CBC、生化全套、電解質", "血糖（發作時和空腹）", "甲狀腺功能", "膽汁酸或血氨（排除肝腦病）", "尿液分析"],
      advanced: ["腦部MRI（>6歲首發或神經學異常者必要）", "腦脊液分析", "腦電圖（EEG）（可用性有限）", "基因檢測（特定品種）"]
    },
    treatment: {
      overview: "抗癲癇藥物(AED)控制發作頻率和嚴重度",
      acute: [
        "叢集發作或癲癇持續狀態（見急診章節）：",
        "  - Diazepam: 0.5-1 mg/kg IV/rectal",
        "  - Midazolam: 0.2-0.5 mg/kg IM/IN",
        "  - 若無效：Levetiracetam 60 mg/kg IV",
        "居家發作處理教育"
      ],
      chronic: [
        "開始長期AED治療的指征：",
        "  - 發作頻率>1次/月",
        "  - 叢集發作史",
        "  - 癲癇持續狀態史",
        "  - 發作後期嚴重或延長",
        "一線藥物選擇（犬）：",
        "  - Phenobarbital: 2.5-3 mg/kg PO q12h（目標血藥濃度25-35 ug/mL）",
        "  - Levetiracetam (Keppra): 20-30 mg/kg PO q8h（安全性高）",
        "  - Zonisamide: 5-10 mg/kg PO q12h",
        "  - Potassium bromide: 30-40 mg/kg PO q24h（負荷量可更快）",
        "貓：",
        "  - Phenobarbital: 1-2 mg/kg PO q12h",
        "  - Levetiracetam: 20 mg/kg PO q8h（首選）",
        "難治性癲癇：聯合用藥或加用Imepitoin"
      ]
    },
    prognosis: "約70-80%犬隻可用藥物達到良好控制（發作減少>50%）。約20-30%為難治性（藥物反應差）。預後因素：發作頻率高、叢集發作、早發型預後較差。大多數需終身治療。",
    pearls: [
      "「排除性診斷」- 必須排除其他原因",
      "首發年齡>6歲應高度懷疑結構性病變",
      "Phenobarbital需定期監測血藥濃度和肝功能",
      "不可突然停藥（誘發反彈發作）",
      "叢集發作是急診",
      "建議主人記錄發作日誌"
    ],
    monitoring: ["發作日誌（頻率、持續時間、類型）", "血藥濃度（Phenobarbital、Bromide）", "肝功能（Phenobarbital）", "腎功能（Bromide）", "CBC", "生活品質"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Podell M et al: 2015 ACVIM small animal consensus statement on seizure management in dogs. J Vet Intern Med 30:477-490, 2016"
  },

  "granulomatous-meningoencephalitis": {
    zh: "肉芽腫性腦膜腦炎",
    en: "Granulomatous Meningoencephalitis (GME)",
    definition: "犬的非感染性、免疫介導的中樞神經系統炎症性疾病，特徵為單核細胞和組織細胞在腦和脊髓形成肉芽腫性病變。",
    synonyms: ["GME", "Inflammatory Reticulosis", "網狀細胞增生症", "Meningoencephalitis of Unknown Etiology (MUE)"],
    epidemiology: {
      species: "犬，貓極罕見",
      age: "年輕至中年（平均5歲，但1-12歲皆可）",
      sex: "母犬可能略多",
      riskFactors: ["小型犬品種：Maltese、Yorkshire Terrier、Poodle、Chihuahua、Pug", "中型犬亦可發生"]
    },
    clinicalPresentation: {
      history: ["急性或亞急性起病", "進行性神經功能障礙", "依病變位置表現：前腦徵象（癲癇、行為改變、盲目）、腦幹徵象（運動失調、頭歪斜、顏面麻痺）、脊髓徵象（輕癱）", "頸部疼痛常見"],
      physicalExam: ["多灶性神經學缺損（最常見）", "或單灶性病變（占位型GME）", "或僅眼部病變（眼部GME）", "發燒（部分病例）", "頸部僵硬或疼痛"]
    },
    pathophysiology: "確切病因不明，被認為是免疫介導的炎症反應。病理特徵：血管周圍淋巴細胞、單核細胞、組織細胞浸潤，形成肉芽腫。三種形式：播散型（多灶性，最常見且最具侵襲性）、局灶型（占位效應）、眼部型（視神經和眼部）。",
    diagnosis: {
      overview: "MRI和腦脊液支持診斷，確診需組織病理",
      differentials: ["壞死性腦膜腦炎(NME)", "壞死性白質腦炎(NLE)", "感染性腦炎（犬瘟熱、隱球菌、弓漿蟲）", "腦腫瘤", "腦梗塞"],
      initialDB: ["完整神經學檢查", "眼底檢查（視神經乳頭水腫、視網膜炎）", "CBC、生化（通常正常）", "傳染病篩檢"],
      advanced: ["腦部MRI：T2高信號病變、可能有強化和占位效應", "腦脊液分析：單核細胞增多、蛋白升高", "確診：腦組織活檢或死後病理（臨床上常依MRI+CSF推定診斷）"]
    },
    treatment: {
      overview: "免疫抑制治療",
      acute: [
        "高劑量類固醇起始：",
        "  - Prednisone/Prednisolone: 1-2 mg/kg PO q12h x 2-4週",
        "  - 或 Dexamethasone: 0.25-0.5 mg/kg IV q12-24h（急性嚴重）",
        "癲癇控制：抗癲癇藥物",
        "腦水腫管理（若有）：Mannitol"
      ],
      chronic: [
        "類固醇逐漸減量至最低有效劑量",
        "添加類固醇節約藥物（steroid-sparing）：",
        "  - Cytosine arabinoside (Ara-C): 50 mg/m2 SQ q12h x 2天，每3-4週",
        "  - 或 Cyclosporine: 5-10 mg/kg PO q12h",
        "  - 或 Mycophenolate mofetil: 10-20 mg/kg PO q12h",
        "  - 或 Leflunomide: 2-4 mg/kg PO q24h",
        "  - 或 Procarbazine: 25-50 mg/m2 PO q24h",
        "維持治療通常需要終身"
      ]
    },
    prognosis: "預後謹慎至差。播散型預後最差，中位生存期數月。局灶型和眼部型預後較好，部分可存活1-2年以上。治療反應良好者預後較佳。復發常見。",
    pearls: [
      "GME屬於「不明原因腦膜腦炎(MUE)」大類",
      "與NME和NLE統稱為「犬特發性非感染性腦炎」",
      "Ara-C是小動物腫瘤科常用藥物，在GME有良好效果",
      "MRI雖高度提示但無法與NME/NLE或腫瘤完全區分",
      "早期積極治療可能改善預後",
      "類固醇副作用在長期治療中是顯著問題"
    ],
    monitoring: ["神經功能評估", "類固醇副作用（PU/PD、食慾、皮膚、肌肉）", "追蹤MRI（評估療效）", "腦脊液複查（部分病例）"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Granger N et al: Canine meningoencephalomyelitis of unknown origin. Vet Clin North Am Small Anim Pract 40:881-900, 2010"
  },

  "necrotizing-meningoencephalitis": {
    zh: "壞死性腦膜腦炎",
    en: "Necrotizing Meningoencephalitis (NME)",
    definition: "犬的非感染性、免疫介導的腦部炎症性疾病，特徵為腦實質壞死病變，主要影響灰質和白質交界處，高度品種相關。",
    synonyms: ["NME", "Pug Dog Encephalitis", "巴哥腦炎", "Necrotizing Encephalitis"],
    epidemiology: {
      species: "犬（特定品種），貓極罕見",
      age: "年輕成犬（多數1-7歲，平均2-4歲）",
      sex: "母犬可能略多",
      riskFactors: ["高度品種相關：Pug（最典型）、Yorkshire Terrier、Maltese、Chihuahua、French Bulldog、Shih Tzu", "可能有遺傳傾向"]
    },
    clinicalPresentation: {
      history: ["急性或亞急性起病", "快速進行性", "癲癇發作（最常見，常難以控制）", "視力障礙/失明", "行為改變", "意識改變（昏迷）"],
      physicalExam: ["前腦徵象為主：癲癇、失明、盤旋、頭壓牆、行為改變", "可能有運動失調", "頸部疼痛或僵硬", "進行性惡化"]
    },
    pathophysiology: "病因不明，認為是免疫介導。病理特徵：灰質和白質廣泛壞死，炎症細胞浸潤，主要影響大腦皮質。與GME不同，NME以壞死為主，血管周圍炎症較輕。Pug犬中可能與DLA II類基因型相關。",
    diagnosis: {
      overview: "MRI高度提示，確診需病理學",
      differentials: ["GME", "壞死性白質腦炎(NLE)", "感染性腦炎", "腦腫瘤", "腦梗塞", "代謝性腦病"],
      initialDB: ["神經學檢查", "眼底檢查", "CBC、生化（通常正常）", "傳染病篩檢"],
      advanced: ["腦部MRI：多灶性T2高信號，主要在灰白質交界，不對稱性，可能有腦萎縮", "腦脊液：單核細胞增多、蛋白升高", "確診：病理學"]
    },
    treatment: {
      overview: "與GME相似的免疫抑制治療，但療效較差",
      acute: [
        "高劑量類固醇：",
        "  - Prednisone: 1-2 mg/kg PO q12h",
        "積極癲癇控制（常難治）：",
        "  - Levetiracetam: 20-30 mg/kg PO q8h",
        "  - 加用Phenobarbital或Zonisamide",
        "腦水腫處理：Mannitol 0.5-1 g/kg IV"
      ],
      chronic: [
        "免疫抑制藥物（同GME）：",
        "  - Cytosine arabinoside",
        "  - Cyclosporine",
        "  - Mycophenolate",
        "持續癲癇管理",
        "支持治療"
      ]
    },
    prognosis: "預後差，通常比GME更具侵襲性。中位生存期通常僅數週至數月。癲癇控制困難是主要問題。少數病例可較長期存活。早期積極治療可能改善預後。",
    pearls: [
      "NME在Pug犬中特別典型（Pug Dog Encephalitis）",
      "癲癇常是首發症狀且難以控制",
      "與NLE區分：NLE主要影響白質",
      "MRI上壞死病變和萎縮是特徵",
      "比GME進展更快且預後更差",
      "需要與主人充分溝通預後"
    ],
    monitoring: ["癲癇頻率和嚴重度", "神經功能", "生活品質", "藥物副作用"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Levine JM et al: Necrotizing meningoencephalitis in Pug Dogs. J Vet Intern Med 22:1128-1134, 2008"
  },

  // ==================== 前庭和其他腦部疾病 ====================

  "vestibular-disease": {
    zh: "前庭疾病",
    en: "Vestibular Disease",
    definition: "影響前庭系統（維持平衡和空間定向）的疾病總稱，分為周邊型（內耳和前庭神經）和中樞型（腦幹前庭核）。",
    synonyms: ["Vestibular Syndrome", "前庭症候群", "Old Dog Vestibular Disease", "老犬前庭疾病", "Geriatric Vestibular Syndrome"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "周邊型：犬老年（特發性）、貓任何年齡；中樞型：任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["老年（特發性）", "中耳/內耳感染", "甲狀腺功能低下（犬）", "耳毒性藥物", "顱內病變（中樞型）"]
    },
    clinicalPresentation: {
      history: ["急性發作的傾斜/倒向一側", "眼球震顫", "嘔吐", "食慾下降", "頭傾斜", "轉圈"],
      physicalExam: [
        "周邊型徵象：",
        "  - 頭傾斜向病變側",
        "  - 水平或旋轉眼球震顫（快相向對側）",
        "  - 跌倒或滾向病變側",
        "  - 無本體感覺缺失",
        "  - 可能有顏面麻痺或霍納氏症候群（同側）",
        "中樞型徵象：",
        "  - 垂直或方向改變的眼球震顫",
        "  - 本體感覺缺失",
        "  - 意識改變",
        "  - 其他顱神經缺損",
        "  - 運動失調超過傾斜程度"
      ]
    },
    pathophysiology: "周邊型：內耳前庭器官或前庭神經(CN VIII)病變 → 兩側前庭輸入不平衡 → 傾斜和眼球震顫。中樞型：腦幹前庭核或其聯繫病變 → 類似但常伴其他神經缺損。犬特發性前庭疾病原因不明，可能與血管問題相關。",
    diagnosis: {
      overview: "區分周邊型和中樞型是關鍵，指導進一步檢查",
      differentials: [
        "周邊型：特發性（老犬最常見）、中耳/內耳炎、耳毒性藥物、甲狀腺功能低下、多發性神經病、耳腫瘤",
        "中樞型：腦腫瘤、腦幹腦炎、腦梗塞、腦外傷、硫胺缺乏"
      ],
      initialDB: ["完整神經學檢查（區分周邊/中樞）", "耳鏡檢查", "耳道和鼓室X光或CT", "血液檢查（含甲狀腺功能）"],
      advanced: ["腦部MRI（中樞型或對治療無反應者）", "耳道和鼓室CT", "腦脊液分析", "BAER（腦幹聽覺誘發反應）"]
    },
    treatment: {
      overview: "治療原發病因；特發性以支持治療為主",
      acute: [
        "特發性前庭疾病：",
        "  - 支持治療",
        "  - 防跌倒和受傷",
        "  - 輸液（若嘔吐導致脫水）",
        "止吐/抗暈：",
        "  - Maropitant (Cerenia): 1 mg/kg SQ/PO q24h",
        "  - 或 Meclizine: 犬 25 mg PO q8-24h",
        "  - 或 Diphenhydramine: 2-4 mg/kg PO/IM q8h",
        "中耳炎：抗生素（全身和/或局部）",
        "中樞型：治療原發病因"
      ],
      chronic: [
        "物理治療（恢復期）",
        "環境調整（防滑墊）",
        "中耳炎：可能需要手術（鼓室切開、全耳道切除）",
        "甲狀腺功能低下：補充甲狀腺素"
      ]
    },
    prognosis: "特發性前庭疾病：預後良好，多數2-4週明顯改善，部分殘餘頭傾斜。中耳炎：治療原發感染後預後良好。中樞型：依病因而異。腫瘤相關者預後差。",
    pearls: [
      "犬特發性前庭病是老犬「中風樣」發作最常見原因",
      "周邊型和中樞型的區分至關重要",
      "本體感覺缺失提示中樞型",
      "垂直眼球震顫幾乎確定是中樞型",
      "特發性無需影像學（除非懷疑中樞）",
      "恢復期頭傾斜可能永久存在"
    ],
    monitoring: ["神經功能進展", "食慾和水分攝取", "嘔吐情況", "行走能力"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Rossmeisl JH: Vestibular disease in dogs and cats. Vet Clin North Am Small Anim Pract 40:81-100, 2010"
  },

  "hydrocephalus": {
    zh: "水腦症",
    en: "Hydrocephalus",
    definition: "腦室內腦脊液(CSF)異常積聚導致腦室擴張和顱內壓升高的疾病，分為先天性和後天性。",
    synonyms: ["腦積水", "水頭症", "Ventriculomegaly"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "先天性：幼犬/幼貓；後天性：任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["先天性：玩具犬和短頭品種（Chihuahua、Yorkshire Terrier、Pomeranian、Maltese、Pug、Boston Terrier、English Bulldog）", "後天性：腦腫瘤、腦炎、出血、創傷"]
    },
    clinicalPresentation: {
      history: ["先天性：幼年時發現、發育遲緩、學習困難", "後天性：進行性神經功能惡化", "癲癇", "失明", "行為異常"],
      physicalExam: ["先天性：圓頂狀頭顱、開放囟門、雙眼外斜（落日徵）、發育不良", "前腦徵象：行為改變、盤旋、失明、癲癇", "可能有運動失調", "嚴重者昏迷"]
    },
    pathophysiology: "CSF生成（脈絡叢）、循環或吸收（蛛網膜顆粒）障礙 → CSF積聚 → 腦室擴張 → 腦實質壓迫 → 神經功能障礙。先天性常因腦中導水管狹窄（阻塞性）。後天性可因腫瘤、感染、出血阻塞CSF流動。",
    diagnosis: {
      overview: "影像學確認腦室擴張",
      differentials: ["腦萎縮（腦室擴大但因腦實質減少）", "腦囊腫", "其他先天性腦畸形"],
      initialDB: ["神經學檢查", "頭顱觸診（開放囟門）", "眼底檢查（視神經乳頭水腫）"],
      advanced: ["腦部MRI（首選）或CT", "超音波（經開放囟門）", "腦脊液分析（謹慎，顱內壓高時風險）"]
    },
    treatment: {
      overview: "藥物減少CSF產生或手術引流",
      acute: [
        "急性神經惡化/顱內壓升高：",
        "  - Mannitol: 0.5-1 g/kg IV over 15-20min",
        "  - 頭部抬高15-30度",
        "  - 避免頸部壓迫"
      ],
      chronic: [
        "藥物治療：",
        "  - Omeprazole: 0.5-1 mg/kg PO q12-24h（減少CSF產生）",
        "  - Furosemide: 0.5-1 mg/kg PO q12h（輔助）",
        "  - Prednisone: 0.25-0.5 mg/kg PO q12-24h（減少水腫）",
        "癲癇控制：抗癲癇藥物",
        "手術治療：",
        "  - 腦室-腹膜分流術(Ventriculoperitoneal shunt)",
        "  - 適用於藥物無效或嚴重病例",
        "  - 併發症：感染、阻塞、過度引流"
      ]
    },
    prognosis: "先天性輕度：可能無症狀或穩定，預後可良好。有症狀者：藥物控制可能有效，嚴重者需手術。手術成功率約80%，但分流相關併發症常見。後天性：依原發病因而異。",
    pearls: [
      "「腦室擴大」不等於「水腦症」- 需有臨床症狀或進行性",
      "許多短頭犬種有無症狀的腦室擴大",
      "開放囟門本身非診斷標準",
      "Omeprazole減少CSF產生的機制未完全明瞭",
      "分流手術需長期追蹤監測",
      "後天性需尋找和治療原發病因"
    ],
    monitoring: ["神經功能", "頭圍（幼年）", "囟門大小", "追蹤MRI", "分流功能（若手術）"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Thomas WB: Hydrocephalus in dogs and cats. Vet Clin North Am Small Anim Pract 40:143-159, 2010"
  },

  "syringomyelia": {
    zh: "脊髓空洞症",
    en: "Syringomyelia (SM)",
    definition: "脊髓內形成液體腔洞（脊髓空洞）的疾病，常繼發於Chiari樣畸形(CM)，導致脊髓損傷和神經性疼痛。",
    synonyms: ["SM", "脊髓空洞", "Chiari-like Malformation and Syringomyelia (CMSM)", "Chiari樣畸形伴脊髓空洞症"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "症狀通常1-7歲出現（6月齡至>10歲皆可）",
      sex: "無明顯性別傾向",
      riskFactors: ["高度品種相關：Cavalier King Charles Spaniel（>95%有CM，約35-70%有SM）", "King Charles Spaniel、Brussels Griffon、Affenpinscher、Chihuahua、Yorkshire Terrier、Maltese等"]
    },
    clinicalPresentation: {
      history: ["神經性疼痛（最典型）：抓搔頸肩部（尤其牽繩行走時）", "幻搔(Phantom scratching)：腳不接觸皮膚的搔抓動作", "頸部疼痛", "對頭頸觸摸敏感", "夜間嗚咽", "行走異常"],
      physicalExam: ["頸部疼痛或過敏", "脊柱側彎（部分病例）", "輕度運動失調", "前肢無力", "肌肉萎縮（嚴重）", "頭傾斜（部分）"]
    },
    pathophysiology: "Chiari樣畸形：枕骨發育不全 → 後顱窩過小 → 小腦扁桃體疝入枕骨大孔 → 阻礙CSF正常流動 → CSF脈動壓力異常 → CSF進入脊髓中央管 → 形成脊髓空洞 → 壓迫脊髓背角（感覺神經元）→ 神經性疼痛和感覺異常。",
    diagnosis: {
      overview: "MRI是診斷金標準",
      differentials: ["頸椎間盤疾病", "脊髓腫瘤", "脊髓炎", "過敏性皮膚病（搔癢行為）", "肩關節問題"],
      initialDB: ["神經學檢查", "皮膚科評估（排除搔癢其他原因）"],
      advanced: ["頸胸椎MRI（必要）：可見小腦扁桃體疝出、枕骨大孔擁擠、脊髓空洞（T2高信號管狀結構）", "全脊髓MRI（空洞範圍評估）"]
    },
    treatment: {
      overview: "藥物控制疼痛；手術減壓適用於嚴重或進行性病例",
      acute: [
        "疼痛控制：",
        "  - Gabapentin: 10-20 mg/kg PO q8h（首選）",
        "  - 或 Pregabalin: 2-4 mg/kg PO q8-12h",
        "  - 可加用NSAIDs：Carprofen 2.2 mg/kg PO q12h",
        "減少CSF壓力：",
        "  - Omeprazole: 0.5-1 mg/kg PO q12-24h",
        "  - 或 Cimetidine: 5-10 mg/kg PO q6-12h",
        "類固醇（短期）：Prednisone 0.5-1 mg/kg PO q24h"
      ],
      chronic: [
        "長期藥物管理（同上）",
        "手術治療：",
        "  - 枕骨大孔減壓術(Foramen Magnum Decompression)",
        "  - 適應症：藥物無效、症狀嚴重或進行性",
        "  - 成功率約80%症狀改善，但約25-50%可能復發",
        "避免頸部牽引（使用胸背帶）",
        "避免極端頸部位置"
      ]
    },
    prognosis: "進行性疾病，症狀可能逐漸惡化。藥物可控制多數輕中度病例。手術可改善症狀但不能治癒。早期空洞預後較好。嚴重神經缺損預後較差。生活品質管理是重點。",
    pearls: [
      "Cavalier King Charles Spaniel是「代表品種」",
      "幻搔是高度特異性徵象",
      "MRI是唯一可靠診斷方法",
      "「有SM」不等於「有症狀」- 許多為亞臨床",
      "胸背帶取代項圈非常重要",
      "遺傳篩檢和負責任繁殖可減少發病率"
    ],
    monitoring: ["疼痛評估量表", "神經功能", "藥物副作用", "生活品質", "追蹤MRI（手術後或進行性惡化）"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Rusbridge C et al: Syringomyelia in Cavalier King Charles Spaniels. J Am Vet Med Assoc 232:1870-1876, 2008"
  },

  // ==================== 神經肌肉疾病 ====================

  "myasthenia-gravis": {
    zh: "重症肌無力",
    en: "Myasthenia Gravis (MG)",
    definition: "神經肌肉接合處乙醯膽鹼受體(AChR)功能障礙導致的骨骼肌無力疾病，分為先天性（受體缺乏）和後天性（自體免疫抗體介導）。",
    synonyms: ["MG", "肌無力症", "重症肌無力症"],
    epidemiology: {
      species: "犬較常見，貓亦可發生",
      age: "先天性：幼年發病；後天性：雙峰（1-4歲和9-13歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（後天性）：Akita、German Shepherd、Golden Retriever、Labrador、Dachshund", "先天性：Jack Russell Terrier、Smooth Fox Terrier、Springer Spaniel", "胸腺瘤相關"]
    },
    clinicalPresentation: {
      history: ["運動不耐（運動後惡化，休息後改善）", "虛弱", "吞嚥困難", "反覆吸入性肺炎", "巨食道症狀（逆流、嘔吐）", "聲音改變"],
      physicalExam: [
        "局部型：僅影響特定肌群",
        "  - 食道型：巨食道（最常見局部型）",
        "  - 咽喉型：吞嚥困難、發聲異常",
        "  - 眼型：眼瞼下垂（罕見）",
        "全身型：",
        "  - 進行性全身肌肉無力",
        "  - 運動後明顯惡化",
        "  - 脊椎反射正常",
        "  - 可能有巨食道"
      ]
    },
    pathophysiology: "後天性：自體抗體攻擊神經肌肉接合處的AChR → 受體減少和功能障礙 → 乙醯膽鹼訊號傳導失敗 → 肌肉無力。先天性：AChR或其他接合處蛋白的遺傳缺陷。與胸腺瘤相關病例中，胸腺異常可能觸發自體免疫。",
    diagnosis: {
      overview: "臨床表現、血清抗體檢測和藥物試驗",
      differentials: ["多發性肌炎", "其他原因的巨食道", "代謝性肌病", "急性多發性神經根炎", "蜱麻痺", "肉毒桿菌中毒"],
      initialDB: ["神經學檢查", "Tensilon試驗(Edrophonium): 0.1-0.2 mg/kg IV（短暫改善支持診斷）", "AChR抗體滴度（確診後天性）", "胸腔X光（巨食道、胸腺瘤）"],
      advanced: ["胸腔CT（胸腺瘤評估）", "肌電圖(EMG)：遞減反應", "肌肉活檢（先天性）"]
    },
    treatment: {
      overview: "抗膽鹼酯酶藥物、免疫抑制（後天性）、處理併發症",
      acute: [
        "Pyridostigmine (Mestinon): 0.5-3 mg/kg PO q8-12h",
        "若無法口服：Neostigmine 0.04 mg/kg IM q6h",
        "吸入性肺炎治療：廣譜抗生素",
        "肌無力危象：",
        "  - 呼吸支持（氧氣、可能需機械通氣）",
        "  - 謹慎使用抗膽鹼酯酶（避免膽鹼能危象）"
      ],
      chronic: [
        "抗膽鹼酯酶藥物維持",
        "免疫抑制（後天性，尤其抗體高滴度）：",
        "  - Prednisone: 1-2 mg/kg PO q12-24h（緩慢增量以避免惡化）",
        "  - Azathioprine: 2 mg/kg PO q24h",
        "  - Mycophenolate: 10-20 mg/kg PO q12h",
        "胸腺切除術（胸腺瘤相關）",
        "巨食道管理：",
        "  - 高位餵食（Bailey椅）",
        "  - 少量多餐",
        "  - 餵食後維持直立15-30分鐘",
        "  - 飲食調整（稠度）"
      ]
    },
    prognosis: "後天性：部分可自發緩解（約30-50%在6-18個月內）。治療反應良好者預後較佳。與胸腺瘤相關者需手術，預後較謹慎。吸入性肺炎是主要死亡原因。先天性：預後依嚴重程度和品種而異。",
    pearls: [
      "巨食道可以是MG的唯一表現",
      "Tensilon試驗陰性不能排除MG",
      "抗體滴度與嚴重度不完全相關",
      "類固醇初期可能暫時惡化症狀",
      "吸入性肺炎預防是護理重點",
      "部分病例可自發緩解"
    ],
    monitoring: ["肌肉力量評估", "體重", "胸腔X光（巨食道、肺炎）", "AChR抗體滴度追蹤", "藥物副作用"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Shelton GD: Myasthenia gravis and disorders of neuromuscular transmission. Vet Clin North Am Small Anim Pract 32:189-206, 2002"
  },

  "polymyositis": {
    zh: "多發性肌炎",
    en: "Polymyositis",
    definition: "骨骼肌的免疫介導性炎症疾病，特徵為肌肉炎症、壞死和再生，導致虛弱和肌肉萎縮。",
    synonyms: ["免疫介導性肌炎", "Immune-mediated Myositis", "Inflammatory Myopathy", "炎症性肌病"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "任何年齡，成犬最常見",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向：German Shepherd、Boxer、Newfoundland、Hungarian Vizsla", "可能與感染、腫瘤或其他自體免疫疾病相關"]
    },
    clinicalPresentation: {
      history: ["進行性肌肉無力", "僵硬步態", "運動不耐", "吞嚥困難（咽部肌肉受累）", "發聲改變", "肌肉萎縮", "肌肉疼痛"],
      physicalExam: ["全身肌肉無力", "肌肉萎縮", "肌肉觸診疼痛", "顳肌和咀嚼肌萎縮（特定類型）", "發燒（部分病例）", "脊椎反射正常或降低"]
    },
    pathophysiology: "免疫介導機制（可能T細胞介導）→ 淋巴細胞和巨噬細胞浸潤肌肉 → 肌纖維損傷和壞死 → 肌肉再生嘗試 → 進行性肌肉萎縮和纖維化。某些型式有特定自體抗體（如抗2M型肌纖維抗體）。",
    diagnosis: {
      overview: "肌肉酵素升高、EMG異常、肌肉活檢確診",
      differentials: ["重症肌無力", "感染性肌炎（弓漿蟲、Neospora）", "代謝性肌病", "內分泌性肌病（甲狀腺功能低下、庫欣症）", "皮肌炎", "咀嚼肌肌炎"],
      initialDB: ["肌肉酵素：CK（通常明顯升高）、AST、LDH", "CBC、生化全套", "甲狀腺功能", "傳染病篩檢（弓漿蟲、Neospora抗體）"],
      advanced: ["肌電圖(EMG)：自發活動、纖顫電位", "肌肉活檢（確診）：炎症細胞浸潤、肌纖維壞死和再生", "2M抗體檢測（特定型式）", "ANA（排除SLE）"]
    },
    treatment: {
      overview: "免疫抑制治療",
      acute: [
        "類固醇：",
        "  - Prednisone: 2-4 mg/kg/day PO 分次給予",
        "  - 急性嚴重：Dexamethasone 0.2-0.5 mg/kg IV",
        "支持治療：",
        "  - 輸液",
        "  - 營養支持（吞嚥困難者）",
        "  - 褥瘡預防（臥床者）"
      ],
      chronic: [
        "類固醇漸減至最低有效劑量",
        "類固醇節約藥物：",
        "  - Azathioprine: 2 mg/kg PO q24h",
        "  - 或 Mycophenolate: 10-20 mg/kg PO q12h",
        "  - 或 Cyclosporine: 5-10 mg/kg PO q12h",
        "物理治療（恢復期）",
        "長期監測復發"
      ]
    },
    prognosis: "預後變異大。多數對免疫抑制治療反應良好，但可能需要長期治療。復發常見。吞嚥困難和呼吸肌受累預後較差。慢性肌肉萎縮可能不完全恢復。",
    pearls: [
      "CK明顯升高是重要線索，但不特異",
      "必須排除感染性原因（弓漿蟲、Neospora）",
      "肌肉活檢是確診金標準",
      "咀嚼肌肌炎是特殊的局部型式",
      "治療反應通常需2-4週才明顯",
      "完全停藥後復發率高"
    ],
    monitoring: ["CK（治療反應指標）", "肌肉力量和萎縮", "體重", "類固醇副作用", "複查EMG（部分病例）"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Evans J et al: Canine inflammatory myopathies: A clinicopathological review of 200 cases. J Vet Intern Med 18:679-691, 2004"
  },

  // ==================== 老年和其他神經疾病 ====================

  "cognitive-dysfunction-syndrome": {
    zh: "認知功能障礙症候群",
    en: "Cognitive Dysfunction Syndrome (CDS)",
    definition: "老年犬貓的進行性神經退化性疾病，特徵為行為改變、認知能力下降，類似人類阿茲海默症。",
    synonyms: ["CDS", "認知障礙", "Canine/Feline Dementia", "犬貓痴呆", "老年痴呆", "認知功能退化"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "老年（犬>8歲，貓>11歲；患病率隨年齡增加）",
      sex: "無明顯性別傾向",
      riskFactors: ["高齡是主要因素", "某些品種可能更易患病", "缺乏心智刺激"]
    },
    clinicalPresentation: {
      history: [
        "DISHA徵象：",
        "  - D: Disorientation（定向障礙）- 迷路、盯著牆壁",
        "  - I: Interaction changes（互動改變）- 對主人反應減少",
        "  - S: Sleep-wake cycle disturbances（睡眠週期紊亂）- 夜間嚎叫、日夜顛倒",
        "  - H: House soiling（居家排泄異常）- 忘記訓練",
        "  - A: Activity changes（活動改變）- 減少或重複行為",
        "可能有焦慮增加"
      ],
      physicalExam: ["神經學檢查通常正常（除年齡相關變化）", "可能有反應遲鈍", "可能有聽力或視力下降", "需排除其他醫學問題"]
    },
    pathophysiology: "類似人類阿茲海默症的病理改變：β-澱粉樣蛋白在腦內沉積 → 老年斑形成 → 神經元損傷和死亡 → 腦萎縮 → 認知功能下降。氧化壓力、血管病變和神經傳導物質（如多巴胺）減少也參與病程。",
    diagnosis: {
      overview: "排除性診斷；需排除其他導致類似行為改變的疾病",
      differentials: ["腦腫瘤", "腦炎", "代謝性腦病（肝腦病、尿毒症）", "甲狀腺功能異常", "高血壓性腦病", "疼痛", "聽力/視力喪失", "其他行為問題"],
      initialDB: ["完整神經學檢查", "CBC、生化全套", "甲狀腺功能", "血壓測量", "尿液分析"],
      advanced: ["腦部MRI（排除結構性病變，可能見腦萎縮）", "認知功能評估量表"]
    },
    treatment: {
      overview: "多模式治療：環境管理、飲食調整、藥物和營養補充",
      acute: [
        "無急性治療（慢性退化性疾病）",
        "處理任何共病問題"
      ],
      chronic: [
        "環境富化：",
        "  - 維持規律的日常作息",
        "  - 心智刺激（益智玩具、訓練）",
        "  - 適度運動",
        "  - 維持社交互動",
        "飲食：",
        "  - 抗氧化飲食（Hill's b/d等）",
        "  - Medium-chain triglycerides (MCT)",
        "藥物治療：",
        "  - Selegiline (Anipryl): 0.5-1 mg/kg PO q24h AM（MAO-B抑制劑）",
        "  - 效果通常在4-8週後評估",
        "營養補充：",
        "  - SAMe (S-adenosyl-L-methionine): 18-20 mg/kg PO q24h",
        "  - Omega-3脂肪酸（DHA/EPA）",
        "  - 維生素E和C",
        "  - Apoaequorin (Neutricks)",
        "焦慮管理：",
        "  - Trazodone（夜間嚎叫）",
        "  - 費洛蒙產品"
      ]
    },
    prognosis: "進行性疾病，無法治癒。治療目標是減緩進展和維持生活品質。部分狗貓對治療有良好反應。平均存活期診斷後1-2年。",
    pearls: [
      "CDS常被低估 - 主人可能認為「只是老了」",
      "需徹底排除其他醫學原因",
      "早期介入可能更有效",
      "夜間嚎叫是常見且困擾主人的症狀",
      "多模式治療優於單一方法",
      "「用進廢退」- 心智刺激很重要"
    ],
    monitoring: ["行為日誌", "認知功能評估量表", "生活品質評估", "定期複診"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Landsberg GM et al: Cognitive dysfunction in cats: A syndrome we used to dismiss as old age. J Feline Med Surg 12:837-848, 2010"
  },

  "horners-syndrome": {
    zh: "霍納氏症候群",
    en: "Horner's Syndrome",
    definition: "眼部交感神經支配中斷導致的典型徵象群，包括瞳孔縮小、眼瞼下垂、眼球內陷和第三眼瞼突出。",
    synonyms: ["Horner氏症候群", "Oculosympathetic Paresis", "眼交感神經麻痺"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，依病因而異",
      sex: "無明顯性別傾向，Golden Retriever在特發性病例中較多",
      riskFactors: ["中耳/內耳疾病", "頸部創傷或手術", "胸腔腫瘤", "臂神經叢病變", "品種：Golden Retriever、Cocker Spaniel（特發性）"]
    },
    clinicalPresentation: {
      history: ["眼睛「外觀異常」", "可能有耳部疾病、頸部創傷或手術史", "可能無其他症狀"],
      physicalExam: [
        "霍納氏症候群四徵：",
        "  - Miosis（瞳孔縮小）- 患側瞳孔較小",
        "  - Ptosis（上眼瞼下垂）",
        "  - Enophthalmos（眼球內陷）",
        "  - Third eyelid protrusion（第三眼瞼突出）",
        "可能伴隨：",
        "  - 同側結膜充血",
        "  - 若為周邊病變，可能有前庭徵象、顏面麻痺"
      ]
    },
    pathophysiology: "交感神經傳導路徑三級：一級（下視丘→胸椎T1-T3脊髓）→ 二級（脊髓→頸前神經節）→ 三級（神經節→眼部）。任一級中斷都會導致霍納氏症候群。犬貓最常見：三級（中耳、鼓室泡）>特發性>二級（胸腔）>一級（頸椎/腦幹）。",
    diagnosis: {
      overview: "臨床徵象確診；藥理試驗定位病變層級；影像學找病因",
      differentials: ["前葡萄膜炎（瞳孔縮小的其他原因）", "眼眶疾病"],
      initialDB: ["完整眼科檢查", "神經學檢查", "耳鏡檢查", "藥理定位試驗：", "  - Phenylephrine 10%滴眼：三級病變<20分鐘瞳孔散大；二級或一級>40分鐘"],
      advanced: ["胸腔X光（胸腔腫瘤）", "頸椎X光/MRI", "耳道和鼓室CT/MRI", "臂神經叢評估"]
    },
    treatment: {
      overview: "治療潛在病因；特發性多數自行恢復",
      acute: [
        "無緊急處理需求（霍納本身不損害視力）",
        "針對原發病因治療：",
        "  - 中耳炎：抗生素、可能手術",
        "  - 腫瘤：依類型和位置",
        "  - 創傷：支持治療"
      ],
      chronic: [
        "特發性：觀察，多數8-16週內自行恢復",
        "若有美觀考量：Phenylephrine 10% q12h（暫時性改善）",
        "長期未恢復者可能為永久性"
      ]
    },
    prognosis: "取決於病因。特發性（最常見）：預後良好，多數自行恢復。中耳炎相關：治療感染後恢復。腫瘤相關：依腫瘤類型和位置。部分病例可能永久存在但不影響視力。",
    pearls: [
      "霍納氏症候群本身不影響視力",
      "藥理試驗幫助定位但不總是準確",
      "中耳疾病是犬貓最常見病因",
      "Golden Retriever的特發性病例常見",
      "若有其他神經徵象，需更積極尋找病因",
      "特發性通常自行恢復，需耐心等待"
    ],
    monitoring: ["霍納徵象變化", "原發疾病治療反應", "神經功能"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Kern TJ et al: Horner's syndrome in dogs and cats: 100 cases. J Am Vet Med Assoc 195:369-373, 1989"
  },

  "facial-nerve-paralysis": {
    zh: "顏面神經麻痺",
    en: "Facial Nerve Paralysis",
    definition: "第七對顱神經（顏面神經）功能障礙導致的面部表情肌麻痺，表現為眼瞼閉合障礙、耳朵下垂和嘴唇下垂。",
    synonyms: ["顏面神經癱瘓", "Facial Palsy", "Bell's Palsy（特發性）", "CN VII Paralysis"],
    epidemiology: {
      species: "犬較常見，貓亦可發生",
      age: "任何年齡，中老年較多",
      sex: "無明顯性別傾向",
      riskFactors: ["中耳/內耳疾病", "甲狀腺功能低下", "外傷", "腫瘤（顏面神經相關）", "品種：Cocker Spaniel、Cavalier King Charles Spaniel、Pembroke Welsh Corgi較常見特發性"]
    },
    clinicalPresentation: {
      history: ["眼睛無法閉合", "嘴唇一側下垂", "流涎（從患側流出）", "進食困難（食物卡在患側）", "可能有耳部疾病史"],
      physicalExam: [
        "患側徵象：",
        "  - 眼瞼無法閉合（眨眼反射缺失）",
        "  - 上下嘴唇下垂",
        "  - 耳朵位置下垂",
        "  - 鼻孔不對稱",
        "  - 角膜反射傳入正常但傳出缺失",
        "雙側麻痺（罕見）：表情呆滯",
        "可能伴隨：霍納氏症候群、前庭徵象（若中耳疾病）"
      ]
    },
    pathophysiology: "顏面神經經內耳道、面神經管和鼓室走行 → 控制面部表情肌、淚腺和唾液腺。病變可在顱內段、岩骨段或周邊段。中耳病變常影響面神經（解剖位置接近）。犬貓最常見原因：特發性>中耳炎>甲狀腺功能低下>創傷>腫瘤。",
    diagnosis: {
      overview: "臨床診斷明確；尋找潛在病因",
      differentials: ["腦幹病變（顱內）", "神經肌肉疾病（若雙側或伴全身症狀）"],
      initialDB: ["完整神經學檢查", "眼科檢查（Schirmer淚液試驗、角膜狀況）", "耳鏡檢查", "甲狀腺功能檢測", "血液檢查"],
      advanced: ["耳道和鼓室CT/MRI", "腦部MRI（若懷疑顱內病變）", "肌電圖", "淚液分泌功能評估"]
    },
    treatment: {
      overview: "保護角膜、治療潛在病因",
      acute: [
        "角膜保護（最重要）：",
        "  - 人工淚液：q4-6h（頻繁使用）",
        "  - 潤滑眼膏：夜間",
        "  - 若Schirmer淚液試驗降低：",
        "    Cyclosporine 0.2%眼藥 q12h或",
        "    Tacrolimus 0.03%眼藥 q12h",
        "治療原發病因：",
        "  - 中耳炎：抗生素",
        "  - 甲狀腺功能低下：Levothyroxine補充"
      ],
      chronic: [
        "持續眼部護理",
        "特發性：觀察，部分可自行恢復",
        "若中耳炎：可能需要手術（全耳道切除術）",
        "物理治療（部分建議）"
      ]
    },
    prognosis: "特發性：約50%在數週至數月內恢復。中耳炎相關：治療感染後約50%恢復。甲狀腺功能低下相關：補充治療後可能改善。創傷/腫瘤：依嚴重程度。部分永久性麻痺但可管理併發症。",
    pearls: [
      "角膜保護是最重要的治療目標",
      "眼瞼閉合障礙導致暴露性角膜炎",
      "特發性是排除性診斷",
      "顏面麻痺伴前庭徵象強烈提示中耳疾病",
      "甲狀腺功能低下可導致多發性顱神經病變",
      "恢復後可能有殘餘不對稱"
    ],
    monitoring: ["角膜健康（染色檢查）", "Schirmer淚液試驗", "神經功能恢復", "原發疾病治療反應"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Garosi LS et al: Results of diagnostic investigations and long-term outcome of 33 dogs with brain infarction. J Vet Intern Med 19:725-731, 2005"
  },

  "trigeminal-neuritis": {
    zh: "三叉神經炎",
    en: "Trigeminal Neuritis",
    definition: "三叉神經（第五對顱神經）的特發性炎症性疾病，主要影響運動支，導致急性雙側下顎麻痺，無法閉合口部。",
    synonyms: ["特發性三叉神經炎", "Idiopathic Trigeminal Neuropathy", "Mandibular Paralysis", "Dropped Jaw", "下顎麻痺", "張口症"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "任何年齡，成犬最常見",
      sex: "無明顯性別傾向",
      riskFactors: ["無特定品種傾向（任何品種可發生）", "病因不明"]
    },
    clinicalPresentation: {
      history: ["急性發作（24-48小時內）", "無法閉合嘴巴", "進食和飲水困難", "流涎", "無法撿起玩具/物品"],
      physicalExam: [
        "典型徵象：",
        "  - 下顎下垂、無法閉合",
        "  - 雙側咀嚼肌張力喪失",
        "  - 舌頭功能正常",
        "  - 吞嚥功能正常（可以吞嚥，但無法抓取食物）",
        "感覺功能：",
        "  - 純運動型：面部感覺正常",
        "  - 混合型（少數）：面部感覺減退",
        "霍納氏症候群可能伴隨（部分病例）"
      ]
    },
    pathophysiology: "確切病因不明。病理特徵：三叉神經雙側非化膿性炎症和脫髓鞘，主要影響運動支（支配咀嚼肌）。被認為可能是免疫介導或病毒相關。感覺支通常保留，但部分病例可能受累。自限性疾病。",
    diagnosis: {
      overview: "臨床診斷為主；需排除其他原因",
      differentials: ["狂犬病（重要排除！）", "肉毒桿菌中毒", "多發性肌炎（咀嚼肌肌炎）", "三叉神經腫瘤", "下顎骨折/脫臼", "顳顎關節疾病", "破傷風"],
      initialDB: ["完整神經學檢查", "口腔檢查（排除骨折/脫臼）", "咀嚼肌觸診", "面部感覺測試", "狂犬病風險評估"],
      advanced: ["肌電圖：咀嚼肌去神經支配", "MRI：可見三叉神經增粗和強化", "肌肉活檢（排除肌炎）", "腦脊液分析"]
    },
    treatment: {
      overview: "支持治療為主；通常自行恢復",
      acute: [
        "營養支持（最重要）：",
        "  - 輔助進食：將食物放入口腔後方",
        "  - 高位餵食（抬高碗）",
        "  - 軟食或流質飲食（成球狀放入口腔）",
        "  - 用注射器給水（小心吸入）",
        "  - 嚴重者：食道餵管或胃管",
        "保護口腔：",
        "  - 軟繃帶/吊帶支撐下顎（部分建議，需小心）",
        "  - 保持口腔清潔"
      ],
      chronic: [
        "持續營養支持直到恢復",
        "物理治療：被動開合下顎（維持關節活動）",
        "類固醇效果不確定：",
        "  - 部分建議Prednisone 1 mg/kg PO q24h",
        "  - 但多數病例自行恢復，類固醇效果不明",
        "等待自然恢復"
      ]
    },
    prognosis: "預後良好。約90%病例在2-4週內開始恢復，多數在4-8週內完全恢復。少數可能需要更長時間或有殘餘肌肉萎縮。復發罕見。主要風險是恢復前的營養不良和吸入性肺炎。",
    pearls: [
      "「下顎下垂但吞嚥功能正常」是典型特徵",
      "必須排除狂犬病（尤其在疫區）",
      "營養支持是治療關鍵",
      "通常2-4週開始改善",
      "咀嚼肌萎縮可能在恢復後仍存在",
      "與咀嚼肌肌炎鑑別：肌炎會痛且不能張口"
    ],
    monitoring: ["體重", "進食能力", "下顎功能恢復", "咀嚼肌萎縮程度", "吸入性肺炎徵象"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Mayhew PD et al: Trigeminal neuropathy in dogs: A retrospective study of 29 cases. J Am Anim Hosp Assoc 38:262-270, 2002"
  }

};
const NEUROLOGICAL_DISEASE_ALIASES = {
  // 脊髓疾病
  "IVDD": "intervertebral-disc-disease",
  "椎間盤突出": "intervertebral-disc-disease",
  "椎間盤脫出": "intervertebral-disc-disease",
  "椎間盤疾病": "intervertebral-disc-disease",
  "disc disease": "intervertebral-disc-disease",
  "herniated disc": "intervertebral-disc-disease",
  "slipped disc": "intervertebral-disc-disease",
  "intervertebral disc": "intervertebral-disc-disease",

  "FCE": "fibrocartilaginous-embolism",
  "纖維軟骨栓塞": "fibrocartilaginous-embolism",
  "脊髓梗塞": "fibrocartilaginous-embolism",
  "spinal cord infarction": "fibrocartilaginous-embolism",
  "ischemic myelopathy": "fibrocartilaginous-embolism",

  "DM": "degenerative-myelopathy",
  "退化性脊髓病": "degenerative-myelopathy",
  "degenerative myelopathy": "degenerative-myelopathy",
  "慢性退化性脊髓病": "degenerative-myelopathy",

  // 癲癇和發炎性疾病
  "癲癇": "idiopathic-epilepsy",
  "特發性癲癇": "idiopathic-epilepsy",
  "原發性癲癇": "idiopathic-epilepsy",
  "epilepsy": "idiopathic-epilepsy",
  "seizure disorder": "idiopathic-epilepsy",

  "GME": "granulomatous-meningoencephalitis",
  "肉芽腫性腦膜腦炎": "granulomatous-meningoencephalitis",
  "肉芽腫性腦炎": "granulomatous-meningoencephalitis",
  "MUE": "granulomatous-meningoencephalitis",

  "NME": "necrotizing-meningoencephalitis",
  "壞死性腦膜腦炎": "necrotizing-meningoencephalitis",
  "壞死性腦炎": "necrotizing-meningoencephalitis",
  "巴哥腦炎": "necrotizing-meningoencephalitis",
  "pug dog encephalitis": "necrotizing-meningoencephalitis",

  // 前庭和其他腦部疾病
  "前庭疾病": "vestibular-disease",
  "前庭症候群": "vestibular-disease",
  "老犬前庭": "vestibular-disease",
  "vestibular syndrome": "vestibular-disease",
  "old dog vestibular": "vestibular-disease",

  "水腦症": "hydrocephalus",
  "腦積水": "hydrocephalus",
  "水頭症": "hydrocephalus",

  "SM": "syringomyelia",
  "脊髓空洞症": "syringomyelia",
  "脊髓空洞": "syringomyelia",
  "CMSM": "syringomyelia",
  "Chiari畸形": "syringomyelia",

  // 神經肌肉疾病
  "MG": "myasthenia-gravis",
  "重症肌無力": "myasthenia-gravis",
  "肌無力症": "myasthenia-gravis",
  "myasthenia": "myasthenia-gravis",

  "多發性肌炎": "polymyositis",
  "肌炎": "polymyositis",
  "inflammatory myopathy": "polymyositis",

  // 老年和其他神經疾病
  "CDS": "cognitive-dysfunction-syndrome",
  "認知功能障礙": "cognitive-dysfunction-syndrome",
  "認知障礙": "cognitive-dysfunction-syndrome",
  "老年痴呆": "cognitive-dysfunction-syndrome",
  "犬痴呆": "cognitive-dysfunction-syndrome",
  "貓痴呆": "cognitive-dysfunction-syndrome",
  "dementia": "cognitive-dysfunction-syndrome",

  "霍納氏症候群": "horners-syndrome",
  "霍納症候群": "horners-syndrome",
  "Horner": "horners-syndrome",
  "oculosympathetic": "horners-syndrome",

  "顏面神經麻痺": "facial-nerve-paralysis",
  "面神經麻痺": "facial-nerve-paralysis",
  "顏面癱瘓": "facial-nerve-paralysis",
  "facial palsy": "facial-nerve-paralysis",
  "Bell's palsy": "facial-nerve-paralysis",

  "三叉神經炎": "trigeminal-neuritis",
  "下顎麻痺": "trigeminal-neuritis",
  "張口症": "trigeminal-neuritis",
  "dropped jaw": "trigeminal-neuritis",
  "mandibular paralysis": "trigeminal-neuritis"
  // ===== From gastrointestinal-diseases.js =====

  // ==================== 胃部疾病 ====================

  "gastric-dilatation-volvulus": {
    zh: "胃擴張扭轉",
    en: "Gastric Dilatation-Volvulus (GDV)",
    definition: "胃部急性擴張並沿其腸系膜軸旋轉的危及生命緊急狀況，導致胃流出道阻塞、血管壓迫和組織缺血。",
    synonyms: ["GDV", "胃扭轉", "Bloat", "Gastric Torsion", "胃脹氣扭轉"],
    epidemiology: {
      species: "犬（貓極罕見）",
      age: "中老年犬較常見（平均7歲），但任何年齡可發生",
      sex: "公犬略多",
      riskFactors: ["大型深胸犬種（Great Dane、German Shepherd、Standard Poodle、Weimaraner、Irish Setter、Saint Bernard）", "體重>20 kg", "胸深/胸寬比高", "一級親屬有GDV史", "快速進食", "每日一餐大量餵食", "進食後劇烈運動", "膨脹性乾糧", "焦慮性情", "年齡增長"]
    },
    clinicalPresentation: {
      history: ["急性發作（通常數小時內）", "非生產性乾嘔（典型）", "流涎", "腹部膨大", "煩躁不安", "虛弱或倒地", "呼吸困難", "進食後發生"],
      physicalExam: ["腹部明顯膨脹（左側明顯）", "叩診呈鼓音", "非生產性乾嘔", "流涎", "心搏過速", "脈搏弱或無法觸及", "CRT延長", "黏膜蒼白或發紺", "低血壓", "休克徵象", "觸診脾臟可能異位"]
    },
    pathophysiology: "胃擴張（氣體、液體、食物）→ 胃沿腸系膜軸順時針旋轉（從尾側看）90-360度 → 幽門和賁門阻塞 → 胃進一步擴張 → 壓迫後腔靜脈和門脈 → 靜脈回流減少 → 心輸出量下降 → 休克。同時：脾臟隨胃旋轉可能扭轉 → 脾臟充血壞死；胃壁缺血 → 胃壁壞死（尤其大彎側）；再灌注損傷 → SIRS、心律不整、DIC",
    diagnosis: {
      overview: "臨床表現高度提示，腹部X光確認",
      differentials: ["單純胃擴張（無扭轉）", "脾臟扭轉", "腸阻塞", "腹腔腫瘤"],
      initialDB: ["腹部X光（右側臥位最佳）：「雙氣泡」征、「Popeye手臂」征、「C」字型胃、幽門移位至背側", "PCV/TS", "乳酸（>6 mmol/L預後差）", "電解質", "血氣", "ECG"],
      advanced: ["凝血功能", "血液培養（若懷疑敗血症）"]
    },
    treatment: {
      overview: "緊急穩定 + 胃減壓 + 外科手術。這是外科急症！",
      acute: [
        "休克復甦（同時進行）：",
        "  - 兩條大口徑靜脈導管",
        "  - 等張晶體液 60-90 mL/kg/h（第一小時）",
        "  - 膠體液 10-20 mL/kg bolus",
        "胃減壓：",
        "  - 口胃管（首選，若可通過賁門）",
        "  - 經皮穿刺減壓（若口胃管失敗）：右側腹最鼓音處",
        "止痛：Opioids（Fentanyl 2-5 μg/kg IV）",
        "抗心律不整（若有室性心律不整）：",
        "  - Lidocaine: 2 mg/kg IV bolus, then 50-80 μg/kg/min CRI",
        "廣譜抗生素：Ampicillin-Sulbactam 或 Cefazolin + Metronidazole",
        "緊急手術（穩定後立即）：",
        "  - 復位胃和脾臟",
        "  - 評估胃壁和脾臟活性",
        "  - 胃壁壞死：部分胃切除",
        "  - 脾臟扭轉/壞死：脾臟切除",
        "  - 胃固定術（Gastropexy）預防復發"
      ],
      chronic: [
        "術後護理：",
        "  - 持續ECG監測（心律不整高峰在術後12-72小時）",
        "  - 電解質監測和補充",
        "  - 營養支持（術後12-24小時開始小量餵食）",
        "預防復發：",
        "  - 預防性胃固定術（高風險犬）",
        "  - 少量多餐",
        "  - 避免進食後運動",
        "  - 使用慢食碗"
      ]
    },
    prognosis: "整體存活率約80-90%（及時手術）。預後不良因素：乳酸>6 mmol/L、胃壁壞死、脾臟切除、術前心律不整、低血壓時間長。無胃固定術復發率高達80%，有胃固定術復發率<5%。",
    pearls: [
      "「時間就是胃壁」- 延遲手術增加壞死風險",
      "Great Dane終生GDV風險約40%",
      "預防性胃固定術可考慮於高風險犬（如絕育時同時進行）",
      "術後心律不整（室性早搏、室速）常見，峰值在12-72小時",
      "乳酸是良好的預後指標",
      "右側臥X光最能顯示「雙氣泡」征"
    ],
    monitoring: ["ECG（持續監測48-72小時）", "乳酸", "電解質（尤其鉀）", "血壓", "尿量", "傷口/腹部"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Brockman DJ et al: Canine gastric dilatation/volvulus syndrome in a veterinary critical care unit. JAVMA 207:460-464, 1995"
  },

  "gastric-ulcer": {
    zh: "胃潰瘍",
    en: "Gastric Ulcer",
    definition: "胃黏膜缺損深達黏膜下層或更深的病變，可導致出血、穿孔等嚴重併發症。",
    synonyms: ["Gastric Ulceration", "胃糜爛", "Gastroduodenal Ulcer", "Peptic Ulcer"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，中老年較常見",
      sex: "無明顯性別傾向",
      riskFactors: ["NSAIDs使用（最常見原因）", "皮質類固醇", "肝臟疾病", "腎臟疾病", "肥大細胞瘤", "胃泌素瘤", "應激（重症、手術、創傷）", "脊髓疾病", "休克", "Helicobacter感染（角色不明確）"]
    },
    clinicalPresentation: {
      history: ["嘔吐（可能有咖啡渣樣物或鮮血）", "黑便（melena）", "食慾下降", "體重減輕", "腹痛", "虛弱", "NSAID或類固醇用藥史"],
      physicalExam: ["腹部觸診疼痛（上腹部）", "黏膜蒼白（若出血）", "心搏過速", "黑便（直腸檢查）", "可能觸及腹部腫塊（若有腫瘤）", "脫水"]
    },
    pathophysiology: "正常胃黏膜保護機制受損（黏液-碳酸氫鹽屏障、前列腺素、黏膜血流）→ 胃酸和胃蛋白酶對黏膜的損傷 → 糜爛（淺表）→ 潰瘍（深達黏膜下層）。NSAIDs抑制COX-1 → 前列腺素減少 → 黏膜保護減弱。肥大細胞瘤釋放組織胺 → 胃酸分泌增加。",
    diagnosis: {
      overview: "臨床懷疑結合內視鏡確診",
      differentials: ["胃炎", "胃腫瘤", "胃異物", "胰臟炎", "肝膽疾病", "腎衰竭", "Addison病"],
      initialDB: ["CBC（貧血、血小板）", "生化（BUN升高可因消化道出血）", "糞便潛血", "腹部X光", "腹部超聲"],
      advanced: ["上消化道內視鏡（金標準）+活檢", "凝血功能", "胃泌素濃度（若懷疑胃泌素瘤）", "肥大細胞瘤排查"]
    },
    treatment: {
      overview: "停用致病藥物、抑制胃酸、保護黏膜、治療原發病因",
      acute: [
        "停用NSAIDs和皮質類固醇",
        "輸液支持（若脫水或出血）",
        "輸血（若嚴重貧血 PCV<20%）",
        "胃酸抑制：",
        "  - PPI（首選）：Omeprazole 1-2 mg/kg PO q12-24h",
        "  - 或 Pantoprazole 1 mg/kg IV q12-24h（重症）",
        "  - H2阻斷劑：Famotidine 0.5-1 mg/kg PO/IV q12-24h",
        "黏膜保護：",
        "  - Sucralfate: 0.5-1 g PO q8h（空腹，與其他藥物間隔2小時）",
        "  - Misoprostol: 2-5 μg/kg PO q8h（前列腺素類似物）",
        "止吐：Maropitant 1 mg/kg SC/IV q24h",
        "穿孔或無法控制的出血：緊急手術"
      ],
      chronic: [
        "長期胃酸抑制（4-8週或更長）",
        "治療原發病因（腫瘤、肝腎病等）",
        "避免使用胃毒性藥物",
        "若必須使用NSAIDs：選擇COX-2選擇性，併用胃保護劑",
        "飲食：少量多餐、易消化飲食"
      ]
    },
    prognosis: "取決於病因。藥物性潰瘍停藥後預後良好。腫瘤相關預後取決於腫瘤類型。穿孔預後謹慎。",
    pearls: [
      "NSAIDs + 皮質類固醇併用風險顯著增加",
      "BUN升高但Creatinine正常提示消化道出血",
      "肥大細胞瘤應列入鑑別診斷",
      "PPI比H2阻斷劑更有效抑制胃酸",
      "Sucralfate需空腹給予，會影響其他藥物吸收",
      "貓的胃潰瘍較少見但可發生"
    ],
    monitoring: ["PCV/TS", "糞便顏色", "食慾和嘔吐", "腹部疼痛", "內視鏡追蹤（嚴重病例）"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },

  // ==================== 腸道疾病 ====================

  "inflammatory-bowel-disease": {
    zh: "發炎性腸病",
    en: "Inflammatory Bowel Disease (IBD)",
    definition: "一組以胃腸道黏膜慢性炎症細胞浸潤為特徵的疾病，導致持續或反覆的消化道症狀。需要組織病理學確診並排除其他原因。",
    synonyms: ["IBD", "慢性腸病", "Chronic Enteropathy", "淋巴細胞-漿細胞性腸炎", "嗜酸性腸炎"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "中老年較常見，但任何年齡可發生",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（犬：German Shepherd、Basenji、Soft-Coated Wheaten Terrier、Shar-Pei、Boxer）", "品種傾向（貓：Siamese）", "遺傳因素", "腸道菌群失調"]
    },
    clinicalPresentation: {
      history: ["慢性（>3週）間歇性或持續性嘔吐和/或腹瀉", "體重減輕", "食慾改變（增加或減少）", "腸鳴音增加", "排氣增加", "小腸型腹瀉（量大、次數少）vs 大腸型（量少、次數多、裡急後重）"],
      physicalExam: ["體態評分下降", "腹部觸診：腸壁增厚、腸系膜淋巴結腫大", "被毛品質差", "可能有腹水（低蛋白血症）", "口腔潰瘍（貓嚴重病例）"]
    },
    pathophysiology: "遺傳易感性 + 環境觸發因素（飲食抗原、腸道菌群）→ 腸道免疫反應失調 → 黏膜屏障功能受損 → 抗原持續刺激 → 慢性炎症。炎症細胞類型決定分類：淋巴細胞-漿細胞性（最常見）、嗜酸性、肉芽腫性等。",
    diagnosis: {
      overview: "IBD是排除性診斷，需要組織病理學確認",
      differentials: ["食物反應性腸病", "抗生素反應性腸病", "腸道淋巴瘤", "腸道感染（Giardia、寄生蟲、細菌）", "胰外分泌功能不全", "甲狀腺功能亢進（貓）", "腸道異物"],
      initialDB: ["CBC（嗜酸性球？貧血？）", "生化（蛋白、肝腎功能）", "TLI（排除EPI）", "糞便檢查（寄生蟲、Giardia抗原）", "cobalamin/folate", "腹部超聲", "fPLI/cPLI（排除胰臟炎）"],
      advanced: ["上/下消化道內視鏡+活檢（金標準）", "或剖腹探查+全層活檢", "組織病理學（WSAVA標準化評分）", "FISH（細菌黏附）", "免疫組化（排除淋巴瘤）"]
    },
    treatment: {
      overview: "階梯式治療：飲食試驗 → 抗菌治療 → 免疫抑制",
      acute: [
        "排除感染（驅蟲、Giardia治療）",
        "飲食試驗（最少2-4週）：",
        "  - 新蛋白質飲食（Novel protein）",
        "  - 或水解蛋白飲食（Hydrolyzed protein）",
        "  - 嚴格限制，無零食",
        "若飲食無反應，考慮抗菌治療：",
        "  - Metronidazole: 10-15 mg/kg PO q12h x 2-4週",
        "  - 或 Tylosin: 10-20 mg/kg PO q12h"
      ],
      chronic: [
        "免疫抑制治療（飲食和抗菌無效時）：",
        "犬：",
        "  - Prednisone: 1-2 mg/kg PO q12h，逐漸減量",
        "  - Budesonide: 3 mg/m² PO q24h（局部作用，全身副作用較少）",
        "  - 難治性：加用 Azathioprine 2 mg/kg PO q24h（初始）→ q48h",
        "  - 或 Chlorambucil 4-6 mg/m² PO q48h",
        "貓：",
        "  - Prednisolone: 1-2 mg/kg PO q12h，逐漸減量",
        "  - Budesonide: 1 mg/cat PO q24h",
        "  - Chlorambucil: 2 mg/cat PO q48-72h（比Azathioprine安全）",
        "Cobalamin補充（若缺乏）：",
        "  - 犬：250-1500 μg SC q7d x 6週，然後q30d",
        "  - 貓：250 μg SC q7d x 6週",
        "益生菌可能有輔助效果",
        "嚴重低蛋白血症：見PLE治療"
      ]
    },
    prognosis: "多數可良好控制但需長期管理。預後因素：疾病嚴重度、對治療反應、低白蛋白血症（預後差）、組織學類型。嗜酸性腸炎通常對類固醇反應好。需要鑑別淋巴瘤（預後差）。",
    pearls: [
      "IBD和腸道淋巴瘤（尤其貓小細胞淋巴瘤）可能難以區分",
      "Cobalamin缺乏會影響治療反應，需要補充",
      "German Shepherd的IBD常較嚴重且難治",
      "Basenji的免疫增生性腸病預後較差",
      "飲食試驗需要嚴格執行才有診斷價值",
      "全層活檢比內視鏡活檢更能評估深層病變"
    ],
    monitoring: ["體重", "CCECAI或FCEAI臨床評分", "白蛋白", "Cobalamin", "臨床症狀"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Washabau RJ et al: Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. JVIM 24:10-26, 2010"
  },

  "protein-losing-enteropathy": {
    zh: "蛋白質流失性腸病",
    en: "Protein-Losing Enteropathy (PLE)",
    definition: "腸道過度流失蛋白質導致低白蛋白血症的綜合症，可由多種腸道疾病引起。",
    synonyms: ["PLE", "腸道蛋白流失症", "Intestinal Protein Loss"],
    epidemiology: {
      species: "犬較常見，貓少見",
      age: "中年犬較常見",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Yorkshire Terrier、Soft-Coated Wheaten Terrier、Rottweiler、Basenji、Norwegian Lundehund）", "IBD", "腸道淋巴瘤", "淋巴管擴張", "消化道寄生蟲"]
    },
    clinicalPresentation: {
      history: ["慢性腹瀉（小腸型）", "體重減輕", "嘔吐", "腹部膨大（腹水）", "肢體水腫", "呼吸困難（胸水）", "食慾可能正常或下降"],
      physicalExam: ["消瘦", "腹水", "周邊水腫", "胸水（呼吸困難）", "腸壁增厚", "腸系膜淋巴結腫大", "被毛品質差"]
    },
    pathophysiology: "多種機制導致腸道蛋白流失：1）黏膜損傷（IBD、感染）→ 蛋白滲漏；2）淋巴管擴張或阻塞 → 富含蛋白的淋巴液漏入腸腔；3）腫瘤浸潤。低白蛋白血症 → 膠體滲透壓下降 → 水腫、腹水、胸水。同時可能流失免疫球蛋白、抗凝血因子、脂溶性維生素。",
    diagnosis: {
      overview: "確認低蛋白血症，排除其他原因，找出腸道病因",
      differentials: ["蛋白流失性腎病", "肝功能衰竭", "失血", "皮膚大面積傷口", "長期飢餓"],
      initialDB: ["血清蛋白（白蛋白<2.0 g/dL，球蛋白也常低）", "尿蛋白/肌酐比（排除腎流失）", "肝功能（排除肝病）", "膽固醇（常低）", "鈣（常低，低白蛋白校正後）", "糞便檢查", "cobalamin/folate", "腹部超聲（腸壁、淋巴結、淋巴管）"],
      advanced: ["上下消化道內視鏡+活檢", "組織病理學", "淋巴管造影（少用）"]
    },
    treatment: {
      overview: "治療原發腸道疾病 + 支持低白蛋白血症",
      acute: [
        "嚴重低白蛋白血症（<1.5 g/dL）伴腔體積液：",
        "  - 新鮮冷凍血漿 10-20 mL/kg（補充白蛋白短暫）",
        "  - 人工膠體（Hetastarch）5-10 mL/kg bolus",
        "  - 25% Human albumin（有過敏風險）",
        "腹水/胸水：治療性穿刺（若影響呼吸）",
        "輸液支持（注意膠體滲透壓）"
      ],
      chronic: [
        "飲食管理：",
        "  - 超低脂飲食（淋巴管擴張：脂肪<15%乾物質基準）",
        "  - 中鏈三酸甘油酯(MCT)補充（不經淋巴吸收）",
        "  - 高品質蛋白質",
        "  - 可能需水解蛋白或新蛋白飲食",
        "免疫抑制（若為IBD）：",
        "  - Prednisone/Prednisolone: 2 mg/kg PO q12h",
        "  - 常需加用第二線藥物：",
        "    Azathioprine（犬）: 2 mg/kg PO q24h",
        "    Chlorambucil（貓或犬）: 4-6 mg/m² PO q48h",
        "    Cyclosporine: 5 mg/kg PO q12-24h",
        "Cobalamin補充",
        "抗血栓（低白蛋白血症增加血栓風險）：",
        "  - Clopidogrel: 1-2 mg/kg PO q24h",
        "  - 或低劑量Aspirin: 0.5-1 mg/kg PO q24h",
        "營養補充：",
        "  - 脂溶性維生素（若嚴重吸收不良）",
        "  - 鈣和維生素D（若低鈣）"
      ]
    },
    prognosis: "預後謹慎至差，取決於病因。Yorkshire Terrier淋巴管擴張經飲食控制可良好。嚴重IBD或腫瘤預後較差。白蛋白<1.5 g/dL預後不良。血栓栓塞是重要併發症和死因。",
    pearls: [
      "白蛋白和球蛋白同時低提示腸道流失（肝病多見白蛋白低球蛋白正常或高）",
      "總鈣低但離子鈣可能正常（白蛋白結合鈣減少）",
      "血栓風險高：流失抗凝血因子，應考慮預防性抗血栓",
      "Yorkshire Terrier的淋巴管擴張對超低脂飲食反應可能很好",
      "Norwegian Lundehund有特殊的PLE/淋巴管擴張傾向",
      "治療反應可能需要4-6週才見效"
    ],
    monitoring: ["白蛋白（每1-2週）", "體重", "腹圍", "臨床症狀", "血栓警示症狀"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Dossin O, Lavoue R: Protein-losing enteropathies in dogs. Vet Clin North Am Small Anim Pract 41:399-418, 2011"
  },

  "hemorrhagic-gastroenteritis": {
    zh: "出血性胃腸炎",
    en: "Hemorrhagic Gastroenteritis (HGE)",
    definition: "急性、嚴重的出血性腹瀉綜合症，特徵為血性腹瀉、嘔吐和快速血液濃縮。現也稱為急性出血性腹瀉綜合症(AHDS)。",
    synonyms: ["HGE", "AHDS", "Acute Hemorrhagic Diarrhea Syndrome", "出血性腸炎"],
    epidemiology: {
      species: "犬（貓罕見）",
      age: "青年至中年（2-4歲最常見）",
      sex: "無明顯性別傾向",
      riskFactors: ["小型犬種（Miniature Schnauzer、Yorkshire Terrier、Miniature Poodle、Maltese）", "焦慮性情", "都市環境", "先前HGE病史（可復發）"]
    },
    clinicalPresentation: {
      history: ["突發性血性腹瀉（「覆盆子果醬」樣）", "嘔吐", "嗜睡", "食慾廢絕", "數小時內快速惡化", "通常無發燒史"],
      physicalExam: ["血性腹瀉", "脫水", "心搏過速", "CRT延長", "腹部觸診可能疼痛", "體溫通常正常或略低", "休克徵象（嚴重病例）"]
    },
    pathophysiology: "病因不完全明確。可能與Clostridium perfringens腸毒素或其他細菌毒素有關。腸道黏膜急性壞死 → 大量蛋白質、液體和血液流入腸腔 → 血液濃縮（PCV可>60%）→ 低血容量性休克。不是典型的細菌性腸炎。",
    diagnosis: {
      overview: "臨床表現結合顯著血液濃縮，排除其他出血性腹瀉原因",
      differentials: ["犬小病毒腸炎", "腸套疊", "胃腸道異物/穿孔", "凝血障礙", "Addison病", "急性胰臟炎", "細菌性腸炎（Salmonella、Campylobacter）", "寄生蟲（鉤蟲大量感染）", "腸道腫瘤出血"],
      initialDB: ["PCV/TS（PCV顯著升高>55-60%，TS正常或低）", "血糖", "電解質", "糞便檢查（寄生蟲、Parvovirus快篩）", "血塗片"],
      advanced: ["凝血功能", "腹部X光/超聲", "糞便培養（若懷疑細菌感染）", "Cortisol基礎值或ACTH刺激試驗（排除Addison）"]
    },
    treatment: {
      overview: "積極輸液復甦是治療關鍵",
      acute: [
        "靜脈輸液（最重要）：",
        "  - 等張晶體液：休克劑量 60-90 mL/kg/h（第一小時）",
        "  - 之後根據脫水程度和持續流失調整",
        "  - 補鉀（低鉀常見）",
        "膠體液（嚴重病例）：",
        "  - Hetastarch 5-10 mL/kg bolus",
        "止吐：",
        "  - Maropitant 1 mg/kg SC/IV q24h",
        "  - Ondansetron 0.1-0.2 mg/kg IV q8-12h",
        "抗生素（爭議，但嚴重病例常用）：",
        "  - Ampicillin 22 mg/kg IV q8h",
        "  - 或 Metronidazole 10-15 mg/kg IV q12h",
        "胃腸保護：",
        "  - Omeprazole 1 mg/kg PO/IV q12-24h",
        "禁食12-24小時後逐漸恢復餵食"
      ],
      chronic: [
        "恢復期餵食：高消化性低脂飲食",
        "益生菌可能有益",
        "監測復發（可能再發）"
      ]
    },
    prognosis: "及時治療預後良好，多數犬24-72小時內顯著改善。死亡率<10%（及時治療）。可能復發。",
    pearls: [
      "PCV升高但TS正常或低是HGE特徵（與脫水不同）",
      "與Parvovirus鑑別：HGE通常無發燒、白血球正常、Parvo快篩陰性",
      "抗生素使用有爭議，但嚴重病例仍常使用預防繼發感染",
      "輸液反應通常很快，12-24小時內改善",
      "不要低估輸液需求，可能需要大量",
      "恢復後可正常餵食，無需長期飲食限制"
    ],
    monitoring: ["PCV/TS（每4-6小時直到穩定）", "電解質", "血糖", "尿量", "糞便性狀"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },

  "colitis": {
    zh: "結腸炎",
    en: "Colitis",
    definition: "結腸黏膜的炎症，導致大腸型腹瀉（頻繁、量少、可能帶黏液或鮮血、裡急後重）。可為急性或慢性。",
    synonyms: ["Large Bowel Diarrhea", "大腸炎", "大腸型腹瀉"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["飲食不當", "寄生蟲", "細菌感染", "應激", "品種傾向（犬：German Shepherd、Boxer - 組織細胞性潰瘍性結腸炎）"]
    },
    clinicalPresentation: {
      history: ["大腸型腹瀉特徵：", "  - 排便頻繁（>3-4次/日）", "  - 每次量少", "  - 裡急後重（tenesmus）", "  - 排便急迫感", "  - 黏液便", "  - 鮮血（hematochezia）", "體重通常維持（除非嚴重或慢性）", "嘔吐較少見"],
      physicalExam: ["腹部觸診通常無異常", "直腸檢查可能疼痛", "可能觸及增厚的結腸", "肛門區可能有糞便沾染"]
    },
    pathophysiology: "急性：感染、飲食、應激導致結腸黏膜炎症 → 分泌增加、吸收減少 → 腹瀉。慢性：可能與IBD、食物不耐受、菌群失調有關。組織細胞性潰瘍性結腸炎（Boxer、French Bulldog）：與黏膜相關大腸桿菌感染有關。",
    diagnosis: {
      overview: "區分急性vs慢性，排除感染和其他原因",
      differentials: ["感染性（Giardia、Tritrichomonas、Campylobacter、Salmonella、Clostridium、寄生蟲）", "飲食反應性", "IBD（結腸型）", "應激性結腸炎", "結腸腫瘤", "直腸息肉"],
      initialDB: ["糞便檢查（寄生蟲、Giardia抗原）", "糞便培養（Salmonella、Campylobacter）", "糞便Clostridium毒素", "直腸檢查", "糞便細胞學（炎症細胞、原蟲）"],
      advanced: ["結腸鏡+活檢", "腹部超聲", "FISH（E. coli，組織細胞性結腸炎）"]
    },
    treatment: {
      overview: "急性多可自限或飲食調整；慢性需針對病因",
      acute: [
        "急性結腸炎：",
        "  - 飲食：高纖維或低殘渣飲食試驗",
        "  - 驅蟲（經驗性）：Fenbendazole 50 mg/kg PO q24h x 5天",
        "  - Metronidazole: 10-15 mg/kg PO q12h x 5-7天",
        "  - Probiotics",
        "感染性（確診後）：",
        "  - Giardia：Fenbendazole或Metronidazole",
        "  - Tritrichomonas（貓）：Ronidazole 30 mg/kg PO q24h x 14天",
        "  - Clostridium：Metronidazole或Tylosin"
      ],
      chronic: [
        "飲食試驗（4-6週）：",
        "  - 高纖維飲食（添加車前子）",
        "  - 或新蛋白/水解蛋白飲食",
        "慢性特發性結腸炎：",
        "  - Sulfasalazine（犬）: 10-30 mg/kg PO q8-12h",
        "  - 或 Mesalamine（5-ASA）",
        "  - 難治性：Prednisone 1-2 mg/kg PO q12h",
        "組織細胞性潰瘍性結腸炎：",
        "  - Enrofloxacin 5-10 mg/kg PO q24h x 6-8週",
        "  - 預後可良好"
      ]
    },
    prognosis: "急性結腸炎預後良好。慢性結腸炎需要長期管理。組織細胞性潰瘍性結腸炎抗生素治療後預後良好。結腸腫瘤預後取決於類型和分期。",
    pearls: [
      "大腸型vs小腸型腹瀉區分很重要（見臨床表現）",
      "鮮血便提示結腸或直腸問題",
      "Tritrichomonas是貓慢性大腸型腹瀉的常見原因",
      "高纖維飲食對許多慢性結腸炎有效",
      "Boxer的組織細胞性結腸炎需長期Enrofloxacin治療",
      "直腸檢查是評估結腸疾病的重要步驟"
    ],
    monitoring: ["糞便性狀和頻率", "體重", "直腸檢查追蹤"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },

  "constipation-megacolon": {
    zh: "便秘/巨結腸",
    en: "Constipation/Megacolon",
    definition: "便秘為排便困難或減少；巨結腸為結腸持續性擴張伴運動功能障礙，導致頑固性便秘。貓最常見。",
    synonyms: ["Obstipation", "頑固性便秘", "Feline Megacolon", "貓巨結腸"],
    epidemiology: {
      species: "貓最常見，犬少見",
      age: "中老年貓（平均5-8歲）",
      sex: "公貓略多（約70%）",
      riskFactors: ["肥胖", "脫水", "低纖維飲食", "缺乏運動", "疼痛性排便（骨盆骨折、肛門腺疾病）", "神經疾病", "骨盆狹窄（骨折後）", "特發性（最常見）"]
    },
    clinicalPresentation: {
      history: ["排便減少或無排便", "排便困難（tenesmus）", "排便時哭叫", "糞便乾硬", "可能有嘔吐", "食慾下降", "嗜睡", "可能有少量液狀糞便（繞過糞石）"],
      physicalExam: ["腹部觸診：堅硬擴張的結腸（充滿糞便）", "脫水", "體態評估", "直腸檢查：糞便嵌塞、骨盆狹窄評估", "神經學檢查（排除神經原因）", "肛門區檢查"]
    },
    pathophysiology: "特發性巨結腸：結腸平滑肌功能障礙 → 運動力下降 → 糞便滯留 → 水分過度吸收 → 糞便乾硬 → 進一步擴張 → 惡性循環。繼發性：骨盆狹窄、神經病變、代謝問題（低鉀、高鈣、甲狀腺功能低下）可導致。長期擴張 → 不可逆結腸肌肉損傷。",
    diagnosis: {
      overview: "臨床表現結合影像學確認，排除可治療原因",
      differentials: ["特發性巨結腸", "骨盆骨折/狹窄", "神經病變", "代謝性（低鉀、高鈣、甲狀腺功能低下）", "藥物性（Opioids、抗膽鹼藥）", "腫瘤", "直腸狹窄/異物"],
      initialDB: ["腹部X光（結腸擴張程度、糞便量、骨盆結構）", "生化（鉀、鈣、腎功能）", "T4（貓）", "直腸檢查", "神經學檢查"],
      advanced: ["骨盆X光（骨盆狹窄評估）", "腹部超聲", "結腸鏡（排除腫瘤/狹窄）"]
    },
    treatment: {
      overview: "解除糞便嵌塞 + 長期管理預防復發 + 嚴重病例手術",
      acute: [
        "糾正脫水和電解質失衡",
        "糞便嵌塞清除（可能需鎮靜/麻醉）：",
        "  - 溫鹽水灌腸（5-10 mL/kg）",
        "  - 手動碎解糞石（溫和）",
        "  - 避免使用磷酸鹽灌腸（對貓有毒）",
        "灌腸溶液選擇：",
        "  - 溫水或溫鹽水",
        "  - Docusate sodium（軟便劑）",
        "  - Lactulose溶液",
        "多次短療程比一次長時間更安全"
      ],
      chronic: [
        "飲食管理：",
        "  - 高纖維飲食（輕度病例）",
        "  - 或低殘渣飲食（減少糞便量）",
        "  - 增加水分攝入（濕食、飲水噴泉）",
        "緩瀉劑：",
        "  - Lactulose: 0.5 mL/kg PO q8-12h（調整至軟便）",
        "  - Polyethylene glycol(MiraLax): 1/8-1/4 tsp/cat PO q12-24h",
        "促動力藥：",
        "  - Cisapride: 2.5-5 mg/cat PO q8-12h",
        "  - Ranitidine: 1-2 mg/kg PO q12h（輕微促動力）",
        "軟便劑：",
        "  - Docusate sodium: 50 mg/cat PO q12-24h",
        "環境：充足乾淨的貓砂盆、減少應激",
        "手術（內科無效）：",
        "  - 結腸次全切除術（Subtotal colectomy）",
        "  - 術後最初可能腹瀉，多數長期預後良好"
      ]
    },
    prognosis: "輕度便秘：內科管理預後良好。巨結腸：內科可控制一段時間但多數最終需要手術。結腸次全切除術預後良好（>90%改善）。",
    pearls: [
      "貓巨結腸多為特發性（約60%）",
      "磷酸鹽灌腸（Fleet enema）對貓有致命危險（高磷、低鈣）",
      "不要過度灌腸，可能造成結腸損傷",
      "Cisapride是最有效的結腸促動力藥，但可能需要複方藥局配製",
      "結腸切除術後的腹瀉通常在數週至數月內改善",
      "骨盆狹窄嚴重時可能需要骨盆骨切開術"
    ],
    monitoring: ["排便頻率和性狀", "腹部觸診", "體重", "X光追蹤（若需要）"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Washabau RJ: Feline constipation and idiopathic megacolon. In: Bonagura JD, Twedt DC: Kirk's Current Veterinary Therapy XV. Elsevier, 2014"
  },

  // ==================== 食道疾病 ====================

  "esophageal-foreign-body": {
    zh: "食道異物",
    en: "Esophageal Foreign Body",
    definition: "異物滯留於食道無法通過的危急狀況，可導致食道損傷、穿孔和嚴重併發症。",
    synonyms: ["食道卡異物", "Esophageal Obstruction", "食道阻塞"],
    epidemiology: {
      species: "犬最常見，貓較少",
      age: "年輕犬最常見（好奇亂吃）",
      sex: "無明顯性別傾向",
      riskFactors: ["小型犬（相對食道直徑較小）", "年輕好動犬隻", "搶食行為", "常見異物：骨頭（最常見）、魚鉤、針、玩具、食物塊"]
    },
    clinicalPresentation: {
      history: ["進食後急性不適", "流涎", "吞嚥困難", "乾嘔", "反流（非嘔吐）", "頸部不適", "拒食", "煩躁不安", "咳嗽（若壓迫氣管）"],
      physicalExam: ["流涎", "吞嚥痛", "頸部觸診可能有疼痛", "可能觸及頸部異物（頸段食道）", "脫水", "發燒（若有穿孔或感染）", "皮下氣腫（若有穿孔）"]
    },
    pathophysiology: "異物滯留常見部位：胸腔入口、心基部、食道裂孔（生理性狹窄處）。異物壓迫食道黏膜 → 缺血 → 壞死 → 可能穿孔 → 縱隔炎、胸膜炎、膿胸（嚴重併發症）。尖銳異物直接穿刺食道壁。時間越長損傷越嚴重。",
    diagnosis: {
      overview: "病史高度提示，影像學確認位置和併發症",
      differentials: ["食道狹窄", "食道腫瘤", "食道裂孔疝", "血管環異常", "食道運動障礙", "口咽異物"],
      initialDB: ["頸胸部X光（正側位）：顯影異物、食道擴張、氣體積聚", "注意縱隔、胸腔積液/氣腫", "避免使用鋇劑（若懷疑穿孔）"],
      advanced: ["內視鏡（診斷+治療金標準）", "CT（評估穿孔和併發症）", "碘對比劑造影（若懷疑穿孔）"]
    },
    treatment: {
      overview: "這是急症！盡快取出異物，評估和處理併發症",
      acute: [
        "穩定：輸液、止痛、禁食",
        "異物取出（首選內視鏡）：",
        "  - 全身麻醉",
        "  - 內視鏡引導下取出",
        "  - 若無法經口取出，可嘗試推入胃內（鈍性異物）",
        "  - 骨頭可能需碎解後取出",
        "內視鏡失敗或穿孔時：手術取出",
        "  - 頸段：頸側切開",
        "  - 胸段：開胸術",
        "取出後內視鏡評估食道損傷程度"
      ],
      chronic: [
        "術後管理：",
        "  - 輕度損傷：禁食24小時後開始流質餵食",
        "  - 中重度損傷：",
        "    - 胃管餵食7-14天",
        "    - 或經皮胃造廔管(PEG tube)",
        "  - 廣譜抗生素（若懷疑穿孔或嚴重損傷）",
        "  - 胃酸抑制劑（減少反流）",
        "  - Sucralfate懸液",
        "食道狹窄預防/治療：",
        "  - Prednisone: 0.5-1 mg/kg PO q12h x 2-3週",
        "  - 球囊擴張（若形成狹窄）"
      ]
    },
    prognosis: "早期取出（<24小時）且無穿孔預後良好。滯留時間長、穿孔、嚴重壞死預後謹慎至差。食道狹窄是常見併發症（約30-50%嚴重損傷病例）。",
    pearls: [
      "時間是關鍵 - 越早取出，併發症越少",
      "骨頭是最常見的食道異物",
      "不要嘗試讓動物自行嘔出，可能加重損傷",
      "皮下氣腫提示穿孔",
      "內視鏡是首選取出方法",
      "食道狹窄可能在取出後1-3週形成"
    ],
    monitoring: ["食慾和吞嚥功能", "發燒", "胸腔X光（若有穿孔風險）", "反流症狀", "食道狹窄徵象"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },

  // ==================== 胰臟疾病 ====================

  "exocrine-pancreatic-insufficiency": {
    zh: "胰外分泌功能不全",
    en: "Exocrine Pancreatic Insufficiency (EPI)",
    definition: "胰臟外分泌功能不足，導致消化酶缺乏，造成營養吸收不良和消化不良的慢性疾病。",
    synonyms: ["EPI", "胰臟功能不全", "Pancreatic Insufficiency", "消化酶缺乏"],
    epidemiology: {
      species: "犬較常見，貓少見",
      age: "犬：年輕至中年（German Shepherd 1-5歲）；貓：中老年",
      sex: "無明顯性別傾向",
      riskFactors: ["犬：品種傾向（German Shepherd、Rough Collie - 胰腺萎縮）", "貓：慢性胰臟炎後", "胰臟切除術後"]
    },
    clinicalPresentation: {
      history: ["慢性小腸型腹瀉（量大、油脂性）", "體重減輕（儘管食慾旺盛或增加）", "多食（polyphagia）", "脂肪便（steatorrhea）- 灰白色油膩便", "可能有食糞症", "被毛品質差", "腸鳴音增加"],
      physicalExam: ["消瘦/體態評分低", "被毛乾燥粗糙", "可能有皮屑", "腹部觸診通常無異常", "肛門區可能有油脂性糞便沾染"]
    },
    pathophysiology: "犬：胰腺腺泡萎縮（PAA，遺傳性，最常見於German Shepherd）或慢性胰臟炎 → 外分泌組織喪失>90% → 消化酶（脂肪酶、蛋白酶、澱粉酶）缺乏 → 脂肪、蛋白質、碳水化合物消化不良 → 吸收不良 → 腹瀉、消瘦。繼發：腸道菌群過度生長、Cobalamin缺乏常見。",
    diagnosis: {
      overview: "TLI是診斷金標準",
      differentials: ["IBD", "腸道淋巴瘤", "寄生蟲", "SIBO", "其他吸收不良疾病"],
      initialDB: ["血清TLI（Trypsin-Like Immunoreactivity）：", "  - 犬：<2.5 μg/L（正常5.7-45.2）= EPI", "  - 貓：<8 μg/L（正常12-82）= EPI", "  - 需空腹12小時採血", "Cobalamin（常低）", "Folate（可能高，提示SIBO）"],
      advanced: ["糞便彈性蛋白酶（Fecal elastase）", "糞便脂肪定量（較少用）", "腹部超聲（胰臟萎縮）"]
    },
    treatment: {
      overview: "終身消化酶補充 + Cobalamin補充 + 飲食管理",
      acute: [
        "消化酶補充（終身）：",
        "  - 粉狀胰酶製劑（Pancreatin/Pancrelipase）",
        "  - 劑量：初始 1-2 茶匙/餐（犬），1/2-1 茶匙/餐（貓）",
        "  - 與食物混合餵食",
        "  - 根據反應調整劑量",
        "生豬/牛胰臟（替代品，若成本考量）：",
        "  - 30-90 g/餐（需冷凍保存）"
      ],
      chronic: [
        "Cobalamin補充（若缺乏，常見）：",
        "  - 犬：250-1500 μg SC q7d x 6週，然後q30d",
        "  - 貓：250 μg SC q7d x 6週",
        "  - 或口服Cobalamin（較高劑量）",
        "飲食：",
        "  - 高消化性、低纖維",
        "  - 適度脂肪（低脂飲食不一定更好）",
        "  - 少量多餐",
        "抗生素（若有SIBO）：",
        "  - Tylosin 10-20 mg/kg PO q12h",
        "  - 或Metronidazole 10-15 mg/kg PO q12h",
        "維生素補充（若嚴重吸收不良）：",
        "  - 脂溶性維生素（A、D、E、K）"
      ]
    },
    prognosis: "經適當治療預後良好，多數犬貓可維持良好生活品質。需要終身酶補充。部分病例可能難以完全控制體重。",
    pearls: [
      "German Shepherd的PAA有遺傳性，不建議繁殖",
      "TLI是種屬特異性的，犬貓需要分別檢測",
      "Cobalamin缺乏會影響治療反應，必須補充",
      "初始治療可能需要2-4週才見明顯改善",
      "酶預先與食物混合不會增加效果",
      "貓EPI通常繼發於慢性胰臟炎，可能同時有糖尿病"
    ],
    monitoring: ["體重", "糞便性狀", "Cobalamin（治療初期每月）", "食慾和精神狀態"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Westermarck E, Wiberg M: Exocrine pancreatic insufficiency in dogs. Vet Clin North Am Small Anim Pract 33:1165-1179, 2003"
  },

  // ==================== 肝膽疾病 ====================

  "hepatic-lipidosis": {
    zh: "肝臟脂肪沉積症",
    en: "Hepatic Lipidosis",
    definition: "肝臟脂肪過度堆積導致肝功能障礙的疾病，最常見於厭食後的過重貓。是貓最常見的肝臟疾病。",
    synonyms: ["Feline Hepatic Lipidosis", "貓脂肪肝", "Fatty Liver Disease", "FHL"],
    epidemiology: {
      species: "貓（犬罕見且通常繼發於其他疾病）",
      age: "中年貓（平均7歲）",
      sex: "無明顯性別傾向，但過重貓多見",
      riskFactors: ["過重/肥胖（最重要）", "厭食超過2-7天", "應激事件（搬家、新寵物、環境變化）", "潛在疾病（糖尿病、胰臟炎、IBD、膽管炎、腫瘤）"]
    },
    clinicalPresentation: {
      history: ["食慾下降或完全厭食（2天至數週）", "體重減輕", "嘔吐", "嗜睡", "近期應激或環境變化", "可能有潛在疾病症狀"],
      physicalExam: ["黃疸（常見，80-90%）", "肝臟腫大", "消瘦（但可能仍過重）", "脫水", "虛弱", "肌肉萎縮", "嗜睡", "流涎（噁心）", "腹水（嚴重低白蛋白病例）", "肝腦病徵象（嚴重病例）"]
    },
    pathophysiology: "厭食 → 外周脂肪動員增加 → 游離脂肪酸湧入肝臟 → 肝臟代謝能力不足（貓缺乏足夠的脂蛋白合成和分泌能力）→ 三酸甘油酯堆積於肝細胞 → 肝細胞腫脹和功能障礙 → 膽汁淤積和黃疸。過重貓脂肪動員更多，風險更高。厭食本身又加重病情（惡性循環）。",
    diagnosis: {
      overview: "臨床懷疑結合實驗室和影像學，肝臟細胞學或活檢確診",
      differentials: ["膽管炎/膽管肝炎", "肝腫瘤", "淋巴瘤", "胰臟炎", "三體炎（胰臟炎+膽管炎+IBD）", "糖尿病"],
      initialDB: ["CBC（可能有Heinz小體）", "生化：ALT↑、ALP↑↑（可達10倍以上）、膽紅素↑、低鉀常見", "凝血功能（可能延長）", "腹部超聲（肝臟高回聲、腫大）", "尿液分析"],
      advanced: ["肝臟細針抽吸細胞學（可確診，但有出血風險）", "肝臟活檢", "Cobalamin/Folate", "fPLI（排除胰臟炎）", "尋找潛在疾病"]
    },
    treatment: {
      overview: "關鍵是早期積極營養支持（餵食管）+ 支持治療",
      acute: [
        "輸液糾正脫水和電解質（尤其低鉀）：",
        "  - 補鉀：20-40 mEq/L",
        "  - 補磷（若低）",
        "營養支持（最關鍵）：",
        "  - 食道餵食管或胃造廔管（PEG）：首選",
        "  - 不要強迫口服餵食（應激+嗆咳風險）",
        "  - 不要使用食慾刺激劑替代餵食管",
        "餵食計畫：",
        "  - 高蛋白飲食（30-40%蛋白質）",
        "  - 起始：1/3計算熱量需求，3-5天增至全量",
        "  - RER = 70 × (體重kg)^0.75",
        "  - 每日分6-8餐餵食",
        "止吐：Maropitant 1 mg/kg SC/IV q24h",
        "維生素補充：",
        "  - Vitamin K1: 0.5-1.5 mg/kg SC q12h x 3劑（若凝血異常）",
        "  - Vitamin B complex",
        "  - Vitamin E: 10 IU/kg/day"
      ],
      chronic: [
        "持續管餵餵食4-6週或更長",
        "肝臟支持：",
        "  - SAMe (S-adenosylmethionine): 20 mg/kg PO q24h 空腹",
        "  - Ursodiol: 10-15 mg/kg PO q24h（若膽汁淤積明顯）",
        "L-Carnitine: 250-500 mg/cat PO q24h（可能有助脂肪代謝）",
        "治療潛在疾病",
        "逐漸過渡到自主進食後移除餵食管"
      ]
    },
    prognosis: "積極營養支持存活率約60-80%。預後不良因素：嚴重低鉀、嚴重低磷、肝腦病、嚴重凝血障礙、潛在疾病（如淋巴瘤）。恢復後預防復發很重要。",
    pearls: [
      "「不要讓過重貓厭食超過2天」是重要的主人教育",
      "餵食管是救命措施，不是最後手段",
      "強迫口服餵食會增加肝腦病和嗆咳風險",
      "ALP升高通常比ALT更顯著（貓特點）",
      "約50%有潛在疾病誘發厭食",
      "恢復需要4-6週，主人需要耐心和配合"
    ],
    monitoring: ["體重", "肝指數（每週）", "電解質（尤其鉀）", "進食量和嘔吐", "黃疸程度", "神經狀態"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Center SA: Feline hepatic lipidosis. Vet Clin North Am Small Anim Pract 35:225-269, 2005"
  },

  "portosystemic-shunt": {
    zh: "肝門脈分流",
    en: "Portosystemic Shunt (PSS)",
    definition: "門脈血液繞過肝臟直接進入體循環的異常血管通道，導致肝臟功能降低和全身性毒素（如氨）累積。",
    synonyms: ["PSS", "Portosystemic Vascular Anomaly", "PSVA", "肝分流", "Liver Shunt", "門體分流"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "先天性：年輕（多在1歲前診斷）；後天性：任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["先天性肝外分流：小型犬（Yorkshire Terrier、Maltese、Shih Tzu、Miniature Schnauzer、Pug）", "先天性肝內分流：大型犬（Irish Wolfhound、Golden Retriever、Labrador、Australian Cattle Dog）", "貓較少見（波斯貓、喜馬拉雅貓略多）", "後天性：門脈高壓（肝硬化等）"]
    },
    clinicalPresentation: {
      history: ["生長遲緩", "體型小於同窩", "間歇性神經症狀（餐後或蛋白攝入後惡化）", "行為異常（呆滯、盯視、轉圈）", "癲癇", "失明", "下泌尿道症狀（尿結石，尿酸銨）", "多尿多渴", "嘔吐、腹瀉", "流涎（貓）"],
      physicalExam: ["體型小", "肌肉發育不良", "可能有神經症狀", "麻醉恢復延遲史", "可能有銅色虹膜（貓）", "肝臟小（先天性）或正常/大（後天性）"]
    },
    pathophysiology: "門脈血液繞過肝臟 → 1）毒素（氨、芳香族氨基酸、假性神經傳導物質）直接進入體循環 → 肝腦病；2）肝臟營養因子減少 → 肝臟發育不良或萎縮；3）尿酸代謝異常 → 尿酸銨結石。先天性：胚胎期血管未正常閉合；後天性：門脈高壓導致側枝循環開放。",
    diagnosis: {
      overview: "臨床懷疑結合肝功能檢測和影像學確認分流",
      differentials: ["其他肝臟疾病", "腎衰竭（尿素氮升高）", "特發性癲癇", "中毒", "代謝性腦病"],
      initialDB: ["CBC（可能有輕度非再生性貧血、紅血球小）", "生化：BUN低、白蛋白低、肝指數輕度升高或正常、膽固醇低、血糖低", "尿液分析（尿酸銨結晶、尿比重低）", "空腹和餐後膽汁酸（顯著升高）", "空腹血氨（升高）"],
      advanced: ["腹部超聲（尋找分流血管、小肝、腎結石）", "CT血管造影（金標準定位分流）", "門脈造影（手術中）", "肝臟活檢"]
    },
    treatment: {
      overview: "手術結紮/閉塞分流血管是根本治療；內科管理肝腦病",
      acute: [
        "肝腦病急性發作：",
        "  - 停止蛋白攝入",
        "  - 輸液（避免乳酸林格，用0.9% NaCl或含葡萄糖液）",
        "  - Lactulose: 0.5 mL/kg PO q8h 或灌腸",
        "  - 抗生素減少產氨菌：",
        "    Metronidazole 7.5 mg/kg PO q12h",
        "    或 Neomycin 20 mg/kg PO q8h",
        "  - 癲癇控制（避免使用肝代謝藥物）：",
        "    Levetiracetam 20-60 mg/kg IV",
        "  - 低血糖處理"
      ],
      chronic: [
        "內科管理（術前或不適合手術）：",
        "  - 蛋白限制飲食（乳蛋白和植物蛋白較好）",
        "  - Lactulose: 0.5 mL/kg PO q8-12h（調整至每日2-3次軟便）",
        "  - 抗生素：Metronidazole或Amoxicillin",
        "  - SAMe補充",
        "手術治療：",
        "  - Ameroid constrictor：漸進性閉塞",
        "  - Cellophane banding：漸進性閉塞",
        "  - 部分或完全結紮",
        "  - 介入性栓塞（肝內分流）",
        "術後監測門脈高壓徵象",
        "術後膽汁酸可能持續異常（肝臟發育不完全）"
      ]
    },
    prognosis: "手術治療預後良好（80-90%臨床改善）。單一肝外分流手術預後最好。多發性後天分流預後較差。肝內分流手術較複雜。單純內科治療可維持部分病例但長期預後較差。",
    pearls: [
      "餐後膽汁酸是良好的篩檢工具",
      "血氨升高但膽汁酸正常需考慮尿素循環酶缺陷",
      "貓PSS較犬少見但臨床表現類似（常見流涎）",
      "術前穩定很重要，嚴重肝腦病需先內科控制",
      "術後「分流性腦病」可能發生（快速閉塞導致門脈高壓）",
      "年輕時手術預後比年長好（肝臟仍可發育）"
    ],
    monitoring: ["神經狀態", "膽汁酸（術後3個月）", "血氨", "肝指數", "腹部超聲"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Berent AC, Tobias KM: Portosystemic vascular anomalies. Vet Clin North Am Small Anim Pract 39:513-541, 2009"
  },

  "cholangiohepatitis": {
    zh: "膽管肝炎",
    en: "Cholangiohepatitis",
    definition: "膽道系統和肝臟的炎症性疾病，貓最常見的肝膽疾病之一。可分為中性球性（急性/化膿性）和淋巴細胞性（慢性）兩大類。",
    synonyms: ["Cholangitis", "膽管炎", "Feline Cholangitis Complex", "貓膽管炎複合症"],
    epidemiology: {
      species: "貓最常見，犬較少（犬多見慢性肝炎）",
      age: "中性球性：年輕至中年；淋巴細胞性：中老年",
      sex: "公貓略多（中性球性）",
      riskFactors: ["腸道疾病（IBD）", "胰臟炎", "膽道結構異常", "細菌上行感染", "可能與免疫機制有關（淋巴細胞性）"]
    },
    clinicalPresentation: {
      history: ["食慾下降或厭食", "嘔吐", "嗜睡", "體重減輕", "黃疸", "中性球性：急性起病、發燒；淋巴細胞性：慢性病程、間歇性症狀"],
      physicalExam: ["黃疸", "肝臟腫大或萎縮", "腹部觸診疼痛（中性球性）", "發燒（中性球性常見）", "脫水", "可能有腹水"]
    },
    pathophysiology: "中性球性：細菌從腸道經膽管上行感染（常見大腸桿菌、腸球菌）→ 急性化膿性炎症 → 膽汁淤積和肝細胞損傷。淋巴細胞性：可能為免疫介導，也可能是中性球性的慢性演變 → 門脈區淋巴細胞和漿細胞浸潤 → 進展至肝硬化。「三體炎」：膽管炎 + 胰臟炎 + IBD 常同時存在。",
    diagnosis: {
      overview: "需要肝臟活檢確定類型，但臨床可初步區分",
      differentials: ["肝脂肪沉積症", "肝臟腫瘤/淋巴瘤", "FIP", "肝臟毒素", "其他膽道疾病"],
      initialDB: ["CBC：中性球性可見白血球增多、左移；淋巴細胞性白血球正常", "生化：ALT↑、ALP↑、GGT↑、膽紅素↑", "腹部超聲：膽管擴張、膽囊壁增厚、肝臟回聲改變", "凝血功能", "尿液分析"],
      advanced: ["肝臟細針抽吸細胞學", "肝臟活檢（金標準，區分類型）", "膽汁培養和敏感試驗", "fPLI（排除胰臟炎）", "Cobalamin/Folate（評估腸道）"]
    },
    treatment: {
      overview: "中性球性需抗生素；淋巴細胞性需免疫抑制",
      acute: [
        "中性球性膽管炎：",
        "  - 抗生素（長療程4-6週）：",
        "    - Amoxicillin-Clavulanate: 12.5-25 mg/kg PO q12h",
        "    - + Metronidazole: 7.5-10 mg/kg PO q12h",
        "    - 或 Enrofloxacin + Metronidazole",
        "  - 輸液支持",
        "  - 止吐：Maropitant",
        "  - 營養支持（可能需餵食管，因常合併肝脂肪沉積）",
        "淋巴細胞性膽管炎（及慢性期）：",
        "  - Prednisolone: 1-2 mg/kg PO q12h，逐漸減量",
        "  - 難治性可加用Chlorambucil",
        "共同治療：",
        "  - Ursodiol: 10-15 mg/kg PO q24h（利膽、肝保護）",
        "  - SAMe: 90 mg/cat PO q24h 空腹",
        "  - Vitamin K1（若凝血異常）",
        "  - 治療合併的胰臟炎/IBD"
      ],
      chronic: [
        "長期肝臟支持：",
        "  - Ursodiol持續使用",
        "  - SAMe或Silybin",
        "飲食：高品質蛋白質、適度脂肪",
        "監測和治療「三體炎」的各組成部分"
      ]
    },
    prognosis: "中性球性：及時抗生素治療預後良好，但需長療程避免復發。淋巴細胞性：預後較謹慎，可能進展至肝硬化，但許多貓可長期管理。「三體炎」需要同時處理三個器官系統。",
    pearls: [
      "貓的膽管和胰管共同開口，易發生「三體炎」",
      "中性球性較急性，淋巴細胞性較慢性",
      "膽汁培養陽性率不高，經驗性抗生素常需要",
      "淋巴細胞性膽管炎和低度淋巴瘤可能難以區分",
      "肝脂肪沉積常與膽管炎同時存在",
      "Ursodiol對貓膽管疾病有良好證據支持"
    ],
    monitoring: ["肝指數", "膽紅素", "超聲追蹤", "體重和食慾", "Cobalamin"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Rothuizen J et al: WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases. Saunders, 2006"
  },

  "copper-storage-hepatopathy": {
    zh: "銅儲積性肝病",
    en: "Copper Storage Hepatopathy",
    definition: "肝臟銅異常蓄積導致肝細胞損傷和進行性肝病的疾病。可為原發性（遺傳性）或繼發於膽汁淤積。",
    synonyms: ["Copper-Associated Hepatitis", "銅中毒性肝病", "Copper Toxicosis", "銅蓄積症"],
    epidemiology: {
      species: "犬（貓罕見）",
      age: "中年（通常3-7歲出現症狀）",
      sex: "母犬可能略多（某些品種）",
      riskFactors: ["品種傾向：Bedlington Terrier（COMMD1基因突變）、West Highland White Terrier、Skye Terrier、Doberman Pinscher、Labrador Retriever、Dalmatian", "高銅飲食（長期）", "膽汁淤積性疾病（繼發性）"]
    },
    clinicalPresentation: {
      history: ["可能長期無症狀", "慢性進行性症狀：", "  - 食慾下降", "  - 體重減輕", "  - 嘔吐", "  - 多尿多渴", "  - 黃疸", "急性危機（溶血、肝衰竭）可能是首發表現"],
      physicalExam: ["黃疸", "肝臟腫大或（晚期）萎縮", "腹水", "消瘦", "急性期可能有溶血性貧血表現（蒼白、黃疸）"]
    },
    pathophysiology: "原發性：遺傳性銅代謝缺陷（如Bedlington Terrier的COMMD1基因突變）→ 膽汁銅排泄減少 → 肝細胞銅蓄積。繼發性：膽汁淤積 → 膽汁銅排泄障礙 → 銅蓄積。銅蓄積 → 氧化損傷 → 肝細胞壞死 → 慢性肝炎 → 肝硬化 → 肝衰竭。急性大量銅釋放可導致溶血性危機。",
    diagnosis: {
      overview: "肝臟活檢銅定量是金標準",
      differentials: ["其他慢性肝炎", "藥物性肝病", "感染性肝炎", "膽管炎", "肝腫瘤"],
      initialDB: ["CBC（可能有再生性貧血、Heinz小體）", "生化：ALT↑、ALP↑、膽紅素↑（晚期）、白蛋白↓（晚期）", "凝血功能", "腹部超聲"],
      advanced: ["肝臟活檢+組織病理學（銅染色：Rhodanine、Rubeanic acid）", "肝臟銅定量（金標準）：", "  - 正常：<400 μg/g乾重", "  - 升高：400-1000 μg/g", "  - 顯著升高：>1000-2000 μg/g（Bedlington可>10000）", "遺傳檢測（Bedlington Terrier）"]
    },
    treatment: {
      overview: "減少銅攝入 + 銅螯合治療 + 肝臟支持",
      acute: [
        "急性肝衰竭/溶血危機：",
        "  - 輸液支持",
        "  - 輸血（若嚴重溶血）",
        "  - 止吐、肝臟支持",
        "  - 治療肝腦病（若有）"
      ],
      chronic: [
        "銅螯合劑（主要治療）：",
        "  - D-Penicillamine: 10-15 mg/kg PO q12h 空腹",
        "    （副作用：嘔吐、食慾下降，需與食物間隔）",
        "  - Trientine: 10-15 mg/kg PO q12h（副作用較少）",
        "鋅補充（阻止銅吸收）：",
        "  - Zinc gluconate/acetate: 50-100 mg元素鋅 PO q12h",
        "  - 不可與銅螯合劑同時給予（間隔2小時）",
        "  - 可用於維持期或無法耐受螯合劑時",
        "飲食：",
        "  - 低銅飲食（避免肝臟、貝類、堅果）",
        "  - 處方肝臟飲食",
        "肝臟支持：",
        "  - SAMe: 20 mg/kg PO q24h",
        "  - Ursodiol: 10-15 mg/kg PO q24h",
        "  - Vitamin E: 10 IU/kg PO q24h（抗氧化）"
      ]
    },
    prognosis: "早期診斷和治療預後可良好。已有肝硬化預後較差。Bedlington Terrier若未治療可能致命。定期監測和終身治療是必要的。",
    pearls: [
      "Bedlington Terrier的COMMD1檢測可用於篩檢和繁殖決策",
      "肝臟銅定量需要足夠組織量，需向實驗室確認",
      "D-Penicillamine空腹給予效果最好但胃腸副作用多",
      "鋅治療需要數月才能降低肝臟銅含量",
      "繼發性銅蓄積治療原發病更重要",
      "飲食中銅含量往往被低估（自來水管、飼料添加）"
    ],
    monitoring: ["肝指數（每1-2個月）", "肝臟活檢銅定量（每6-12個月，評估治療效果）", "鋅治療時監測血清鋅"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Fieten H et al: Canine models of copper toxicosis for understanding mammalian copper metabolism. Mamm Genome 23:62-75, 2012"
  },

  // ==================== 肛門直腸疾病 ====================

  "anal-sac-disease": {
    zh: "肛門腺疾病",
    en: "Anal Sac Disease",
    definition: "肛門腺（肛門囊）的疾病，包括嵌塞、感染（肛門腺炎）和膿腫形成。是小動物常見的問題。",
    synonyms: ["肛門囊疾病", "Anal Gland Disease", "Anal Sac Impaction", "肛門腺嵌塞", "Anal Sac Abscess"],
    epidemiology: {
      species: "犬最常見，貓較少見",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["小型犬種", "肥胖", "軟便或腹瀉（無法自然排空）", "過敏性皮膚病", "解剖異常（腺管狹窄）", "低纖維飲食"]
    },
    clinicalPresentation: {
      history: ["摩擦屁股（scooting）", "過度舔肛門區", "排便困難或疼痛", "尾根或肛門區腫脹", "坐立不安", "追咬尾巴", "膿腫破裂後可見肛門旁傷口"],
      physicalExam: ["肛門腺腫大、堅硬（嵌塞）", "觸診疼痛（感染/膿腫）", "肛門旁紅腫（膿腫）", "可能有膿性或血性分泌物", "發燒（感染嚴重時）", "肛門旁皮膚破潰（膿腫破裂）"]
    },
    pathophysiology: "正常肛門腺在排便時被擠壓排空。嵌塞：腺體分泌物濃稠或排出口阻塞 → 腺體腫脹 → 不適。感染：細菌入侵（常為糞便菌群）→ 肛門腺炎 → 可能形成膿腫 → 可能穿破皮膚形成廔管。",
    diagnosis: {
      overview: "直腸檢查和肛門腺擠壓即可診斷",
      differentials: ["肛門周圍廔管", "肛門腫瘤（尤其肛門囊腺癌）", "會陰疝", "直腸脫出", "肛門周圍皮膚感染"],
      initialDB: ["直腸檢查和肛門腺觸診", "肛門腺內容物檢查（正常為棕色糊狀，感染為膿性或血性）"],
      advanced: ["分泌物細胞學和培養（反覆感染時）", "腹部/會陰超聲（排除腫瘤）", "直腸鏡（排除直腸疾病）"]
    },
    treatment: {
      overview: "擠壓排空 + 沖洗（感染時）+ 抗生素（膿腫）+ 必要時手術",
      acute: [
        "肛門腺嵌塞：",
        "  - 手動擠壓排空（外部或直腸內）",
        "  - 嚴重嵌塞可能需鎮靜",
        "肛門腺炎/膿腫：",
        "  - 擠壓排空（可能需鎮靜/止痛）",
        "  - 生理鹽水或稀釋Chlorhexidine沖洗",
        "  - 抗生素注入（如Panalog）",
        "  - 全身抗生素（膿腫）：",
        "    Amoxicillin-Clavulanate 12.5-25 mg/kg PO q12h x 7-14天",
        "  - 熱敷促進引流",
        "  - 膿腫破裂：清創、引流、抗生素"
      ],
      chronic: [
        "反覆嵌塞的預防：",
        "  - 定期擠壓（每4-8週）",
        "  - 增加飲食纖維",
        "  - 體重管理",
        "反覆感染或嚴重病例：",
        "  - 肛門腺切除術（Anal sacculectomy）",
        "  - 併發症：暫時性或永久性大便失禁（<5%）"
      ]
    },
    prognosis: "單純嵌塞預後良好。反覆感染可考慮手術切除。肛門腺切除術成功率高但有大便失禁風險。",
    pearls: [
      "定期美容院擠壓可能不必要且可能造成創傷",
      "過敏性皮膚病常與反覆肛門腺問題相關",
      "老年犬肛門腺腫塊需排除腺癌",
      "貓肛門腺問題較少但可發生",
      "肛門腺分泌物有強烈臭味是正常的",
      "雙側同時切除比單側有較高大便失禁風險"
    ],
    monitoring: ["症狀復發", "肛門區檢查", "定期擠壓（若有嵌塞傾向）"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },

  "rectal-prolapse": {
    zh: "直腸脫出",
    en: "Rectal Prolapse",
    definition: "直腸黏膜或全層經肛門脫出體外的病況，可為部分（僅黏膜）或完全（全層）脫出。",
    synonyms: ["直腸脫垂", "Rectal Prolapse", "脫肛"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "幼年動物較常見（腸道寄生蟲相關）",
      sex: "無明顯性別傾向",
      riskFactors: ["腸道寄生蟲（幼年動物最常見原因）", "嚴重腹瀉", "便秘和裡急後重", "難產", "下泌尿道疾病（裡急後重）", "直腸/結腸腫瘤", "會陰疝"]
    },
    clinicalPresentation: {
      history: ["肛門突出紅色腫塊", "排便困難或裡急後重", "腹瀉或便秘史", "可能有血便或黏液便", "舔肛門區"],
      physicalExam: ["圓柱形紅色組織從肛門突出", "部分脫出：僅黏膜", "完全脫出：全層直腸壁", "組織可能水腫、乾燥或壞死", "可能有外傷或潰瘍", "區分脫出vs腸套疊（探針測試）"]
    },
    pathophysiology: "裡急後重（tenesmus）→ 腹壓持續增加 → 直腸黏膜或全層脫出 → 暴露在外的組織水腫、乾燥 → 可能外傷或壞死。若不處理，水腫加重使復位更困難。",
    diagnosis: {
      overview: "臨床診斷明確，需區分脫出類型和尋找原因",
      differentials: ["腸套疊脫出（雙層，探針可插入肛門旁）", "直腸腫瘤", "直腸息肉"],
      initialDB: ["身體檢查確認脫出", "探針測試：直腸脫出探針無法插入組織與肛門之間；腸套疊脫出可以", "糞便檢查（寄生蟲）", "直腸檢查（評估腫塊、狹窄）"],
      advanced: ["腹部X光或超聲（評估腸套疊、腫塊）", "結腸鏡（排除腫瘤/息肉）", "CBC和生化"]
    },
    treatment: {
      overview: "復位脫出組織 + 防止復發 + 治療根本原因",
      acute: [
        "評估組織活性",
        "減輕水腫：",
        "  - 50%葡萄糖溶液或高滲鹽水濕敷15-20分鐘",
        "  - 冷敷",
        "手動復位（可能需鎮靜/麻醉）：",
        "  - 潤滑組織",
        "  - 輕柔推回",
        "復位後防止復發：",
        "  - 荷包縫合（Purse-string suture）：留置3-5天",
        "  - 確保可排便",
        "組織壞死時：直腸切除術（Rectal resection）",
        "治療根本原因：",
        "  - 驅蟲",
        "  - 治療腹瀉/便秘",
        "  - 治療下泌尿道疾病"
      ],
      chronic: [
        "反覆脫出：",
        "  - Colopexy（結腸固定術）",
        "確保治療根本原因",
        "飲食調整（纖維、水分）"
      ]
    },
    prognosis: "早期復位且組織健康預後良好。需要找出並治療根本原因以防復發。壞死組織需要手術切除，預後仍可良好但更複雜。",
    pearls: [
      "幼年動物直腸脫出首先考慮寄生蟲",
      "探針測試可區分直腸脫出和腸套疊脫出",
      "高滲溶液可有效減輕組織水腫",
      "荷包縫合不要太緊，需能排便",
      "反覆脫出需考慮手術固定",
      "組織顏色從紅轉暗紫/黑色提示壞死"
    ],
    monitoring: ["組織活性", "復發", "排便功能", "根本原因控制"],
    reference: "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  }

};
const GASTROINTESTINAL_DISEASE_ALIASES = {
  // 胃部疾病
  "GDV": "gastric-dilatation-volvulus",
  "胃扭轉": "gastric-dilatation-volvulus",
  "胃擴張": "gastric-dilatation-volvulus",
  "bloat": "gastric-dilatation-volvulus",
  "胃脹氣": "gastric-dilatation-volvulus",
  "gastric torsion": "gastric-dilatation-volvulus",

  "胃潰瘍": "gastric-ulcer",
  "gastric ulceration": "gastric-ulcer",
  "peptic ulcer": "gastric-ulcer",

  // 腸道疾病
  "IBD": "inflammatory-bowel-disease",
  "發炎性腸病": "inflammatory-bowel-disease",
  "慢性腸病": "inflammatory-bowel-disease",
  "inflammatory bowel": "inflammatory-bowel-disease",

  "PLE": "protein-losing-enteropathy",
  "蛋白流失": "protein-losing-enteropathy",
  "蛋白質流失": "protein-losing-enteropathy",
  "腸道蛋白流失": "protein-losing-enteropathy",

  "HGE": "hemorrhagic-gastroenteritis",
  "AHDS": "hemorrhagic-gastroenteritis",
  "出血性胃腸炎": "hemorrhagic-gastroenteritis",
  "出血性腸炎": "hemorrhagic-gastroenteritis",
  "血便腹瀉": "hemorrhagic-gastroenteritis",

  "結腸炎": "colitis",
  "大腸炎": "colitis",
  "大腸型腹瀉": "colitis",

  "便秘": "constipation-megacolon",
  "巨結腸": "constipation-megacolon",
  "megacolon": "constipation-megacolon",
  "obstipation": "constipation-megacolon",

  // 食道疾病
  "食道異物": "esophageal-foreign-body",
  "食道卡異物": "esophageal-foreign-body",
  "esophageal obstruction": "esophageal-foreign-body",

  // 胰臟疾病
  "EPI": "exocrine-pancreatic-insufficiency",
  "胰臟功能不全": "exocrine-pancreatic-insufficiency",
  "胰外分泌不全": "exocrine-pancreatic-insufficiency",
  "消化酶缺乏": "exocrine-pancreatic-insufficiency",

  // 肝膽疾病
  "脂肪肝": "hepatic-lipidosis",
  "肝脂肪沉積": "hepatic-lipidosis",
  "貓脂肪肝": "hepatic-lipidosis",
  "fatty liver": "hepatic-lipidosis",

  "PSS": "portosystemic-shunt",
  "肝分流": "portosystemic-shunt",
  "門體分流": "portosystemic-shunt",
  "liver shunt": "portosystemic-shunt",
  "PSVA": "portosystemic-shunt",

  "膽管炎": "cholangiohepatitis",
  "膽管肝炎": "cholangiohepatitis",
  "cholangitis": "cholangiohepatitis",
  "三體炎": "cholangiohepatitis",

  "銅蓄積": "copper-storage-hepatopathy",
  "銅中毒肝病": "copper-storage-hepatopathy",
  "copper toxicosis": "copper-storage-hepatopathy",

  // 肛門直腸疾病
  "肛門腺": "anal-sac-disease",
  "肛門囊": "anal-sac-disease",
  "肛門腺嵌塞": "anal-sac-disease",
  "肛門腺炎": "anal-sac-disease",
  "肛門腺膿腫": "anal-sac-disease",
  "anal gland": "anal-sac-disease",

  "直腸脫出": "rectal-prolapse",
  "脫肛": "rectal-prolapse",
  "直腸脫垂": "rectal-prolapse"
};
const GASTROINTESTINAL_CATEGORIES = {
  "stomach": ["gastric-dilatation-volvulus", "gastric-ulcer"],
  "intestine": ["inflammatory-bowel-disease", "protein-losing-enteropathy", "hemorrhagic-gastroenteritis", "colitis", "constipation-megacolon"],
  "esophagus": ["esophageal-foreign-body"],
  "pancreas": ["exocrine-pancreatic-insufficiency"],
  "liver": ["hepatic-lipidosis", "portosystemic-shunt", "cholangiohepatitis", "copper-storage-hepatopathy"],
  "anorectal": ["anal-sac-disease", "rectal-prolapse"]
  // ===== From urinary-diseases.js =====
  "acute-kidney-injury": {
    zh: "急性腎損傷",
    en: "Acute Kidney Injury (AKI)",
    definition: "腎臟功能在數小時至數天內急劇下降，導致氮質血症、電解質失衡和尿量異常的緊急狀態。",
    synonyms: ["AKI", "急性腎衰竭", "Acute Renal Failure", "ARF", "急性腎功能不全"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，但老年動物風險較高",
      sex: "無明顯性別傾向",
      riskFactors: ["腎毒性藥物（NSAIDs、氨基糖苷類）", "百合中毒（貓）", "葡萄/葡萄乾中毒（犬）", "乙二醇中毒", "脫水", "低血壓", "敗血症", "尿道阻塞", "腎前性因素"]
    },
    clinicalPresentation: {
      history: ["突發嘔吐", "厭食", "嗜睡", "尿量改變（少尿或無尿）", "可能有毒物暴露史", "近期手術或麻醉"],
      physicalExam: ["脫水", "口腔潰瘍（尿毒症）", "口臭（氨味）", "腹部疼痛（腎臟腫大）", "黏膜蒼白", "體溫可低或高", "心律不整（高血鉀）"]
    },
    pathophysiology: "腎前性：腎臟灌注不足 → GFR下降。腎性：直接腎小管損傷 → 細胞壞死 → 腎功能喪失。腎後性：尿路阻塞 → 背壓升高 → 腎損傷。共同結果：氮質血症、電解質失衡（高血鉀）、代謝性酸中毒、液體失衡",
    diagnosis: {
      overview: "基於急性氮質血症病史和臨床表現，需區分腎前性、腎性和腎後性",
      differentials: ["腎前性氮質血症", "腎後性阻塞", "慢性腎臟病急性惡化", "腎盂腎炎"],
      initialDB: ["BUN/Creatinine", "電解質（K+尤其重要）", "尿液分析（比重、沉渣）", "血氣分析", "腹部超聲（腎臟大小、腎盂積水）"],
      advanced: ["SDMA", "尿液蛋白/肌酐比", "腎臟活檢（特定情況）", "尿液培養", "乙二醇/鈣草酸鹽晶體"]
    },
    treatment: {
      overview: "恢復腎灌注、糾正電解質和酸鹼失衡、治療原發病因、支持治療",
      acute: [
        "靜脈輸液復甦：晶體液糾正脫水（計算脫水量 + 維持需求 + 持續損失）",
        "高血鉀處理（K+ >6.5 mEq/L）：",
        "- 10% Calcium gluconate: 0.5-1 mL/kg IV slow（心臟保護）",
        "- Regular insulin: 0.25-0.5 U/kg IV + Dextrose 2 g/U insulin",
        "- Sodium bicarbonate: 1-2 mEq/kg IV slow",
        "利尿劑（恢復水合後若仍少尿）：",
        "- Furosemide: 2-6 mg/kg IV（可持續輸注2-5 mg/kg/h）",
        "- Mannitol: 0.5-1 g/kg IV over 20min（需排除梗阻）",
        "代謝性酸中毒：Sodium bicarbonate（若pH<7.1或HCO3<12）",
        "止吐：Maropitant 1 mg/kg IV/SQ q24h",
        "胃保護：Omeprazole 1 mg/kg PO q12-24h",
        "腎臟替代治療（血液透析）：嚴重或無反應病例"
      ],
      chronic: ["逐漸過渡至腎臟處方飲食", "監測腎功能恢復", "避免腎毒性藥物"]
    },
    prognosis: "取決於病因、嚴重程度和治療反應。腎前性若及時糾正預後良好。腎性損傷可能需要數週恢復，部分可能進展為CKD。存活率約40-60%。少尿/無尿和嚴重高血鉀預後較差。",
    pearls: [
      "尿比重<1.030（犬）或<1.035（貓）伴隨氮質血症提示腎性問題",
      "腎臟大小正常或腫大提示AKI；萎縮提示CKD",
      "貓百合中毒24-72小時後出現腎衰竭",
      "乙二醇中毒治療黃金時間：犬<8-12小時，貓<3小時",
      "尿量目標：>1-2 mL/kg/h"
    ],
    monitoring: ["尿量（導尿管+收集）", "體重（q8-12h）", "BUN/Creatinine（q12-24h）", "電解質（q8-12h）", "血壓", "CVP（若有）"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; IRIS AKI Guidelines"
  },

  "chronic-kidney-disease": {
    zh: "慢性腎臟病",
    en: "Chronic Kidney Disease (CKD)",
    definition: "腎臟結構或功能異常持續超過3個月的進行性、不可逆疾病，為犬貓最常見的腎臟疾病。",
    synonyms: ["CKD", "慢性腎衰竭", "Chronic Renal Failure", "CRF", "腎功能不全"],
    epidemiology: {
      species: "貓較犬更常見",
      age: "老年動物好發（貓>10歲，犬>7歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["老年", "先前AKI", "腎毒性藥物暴露", "腎盂腎炎史", "多囊腎病（波斯貓）", "腎發育不良", "澱粉樣變性"]
    },
    clinicalPresentation: {
      history: ["多飲多尿（PU/PD）", "食慾下降", "體重減輕", "嘔吐", "口臭", "被毛品質變差", "嗜睡", "便秘"],
      physicalExam: ["脫水", "消瘦", "口腔潰瘍", "被毛粗糙", "腎臟可能縮小（觸診）", "黏膜蒼白（貧血）", "高血壓（視網膜病變）"]
    },
    pathophysiology: "功能性腎元持續喪失 → 殘餘腎元代償性肥大 → 高濾過 → 腎絲球硬化 → 進一步腎元喪失（惡性循環）。後果：氮質血症、濃縮能力喪失、電解質失衡、代謝性酸中毒、腎性貧血、腎性繼發性副甲狀腺亢進",
    diagnosis: {
      overview: "基於持續性氮質血症、等張尿、影像學腎臟變化。IRIS分期指導治療",
      differentials: ["急性腎損傷", "腎前性氮質血症", "腎後性阻塞", "甲狀腺亢進（貓）"],
      initialDB: ["BUN/Creatinine", "SDMA", "尿液分析（比重、蛋白）", "UPC（尿蛋白/肌酐比）", "電解質（K+、磷）", "CBC（貧血）", "腹部超聲"],
      advanced: ["血壓測量", "甲狀腺功能（貓）", "PTH和離子鈣", "眼底檢查", "腎臟活檢（特定情況）"]
    },
    irisStaging: {
      stage1: "Creatinine <1.4 mg/dL（犬）或 <1.6 mg/dL（貓）；SDMA <18 μg/dL",
      stage2: "Creatinine 1.4-2.8 mg/dL（犬）或 1.6-2.8 mg/dL（貓）；SDMA 18-35 μg/dL",
      stage3: "Creatinine 2.9-5.0 mg/dL；SDMA 36-54 μg/dL",
      stage4: "Creatinine >5.0 mg/dL；SDMA >54 μg/dL",
      subStaging: "依據蛋白尿（非蛋白尿、臨界蛋白尿、蛋白尿）和血壓（正常、前期高血壓、高血壓、嚴重高血壓）"
    },
    treatment: {
      overview: "減緩疾病進展、控制併發症、維持生活品質",
      acute: [
        "尿毒症危象處理：",
        "- 靜脈輸液糾正脫水",
        "- 止吐：Maropitant 1 mg/kg SQ q24h",
        "- 胃保護：Omeprazole 1 mg/kg PO q12-24h",
        "- 食慾刺激：Mirtazapine 1.88 mg/貓 q48h 或犬 0.5-1 mg/kg q24h"
      ],
      chronic: [
        "飲食管理（腎臟處方飲食）：限制磷、適度蛋白、增加omega-3",
        "磷結合劑（若高磷血症）：Aluminum hydroxide、Calcium carbonate、Lanthanum、Sucroferric oxyhydroxide",
        "蛋白尿控制：",
        "- ACE抑制劑：Benazepril 0.5-1 mg/kg PO q12-24h 或 Enalapril 0.5 mg/kg PO q12-24h",
        "- ARB：Telmisartan 1 mg/kg PO q24h（貓首選）",
        "高血壓控制：Amlodipine 0.1-0.25 mg/kg PO q24h（貓首選）",
        "貧血管理：Darbepoetin 1 μg/kg SQ q1-2週（需補充鐵）",
        "噁心/嘔吐：Maropitant、Ondansetron",
        "代謝性酸中毒：Potassium citrate 或 Sodium bicarbonate",
        "低血鉀：Potassium gluconate 補充",
        "皮下輸液：維持水合（家庭照護）"
      ]
    },
    prognosis: "取決於IRIS分期和併發症控制。Stage 1-2：數年。Stage 3：數月至1-2年。Stage 4：數週至數月。蛋白尿和高血壓加速進展。",
    pearls: [
      "SDMA比Creatinine更早偵測腎功能下降（約40% vs 75%功能喪失）",
      "貓CKD常合併甲狀腺亢進，治療甲亢後腎功能可能惡化",
      "腎臟處方飲食可延長2-3倍存活時間",
      "高磷血症加速CKD進展",
      "血壓>160 mmHg需要治療以保護靶器官"
    ],
    monitoring: ["BUN/Crea/SDMA q2-4週（初期）then q2-4月", "UPC", "血壓q1-3月", "電解質", "PCV", "體重", "生活品質評估"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; IRIS Guidelines 2023"
  },

  "feline-lower-urinary-tract-disease": {
    zh: "貓下泌尿道疾病",
    en: "Feline Lower Urinary Tract Disease (FLUTD)",
    definition: "影響貓膀胱和/或尿道的一系列疾病統稱，表現為排尿困難、血尿、頻尿等症狀。",
    synonyms: ["FLUTD", "貓泌尿症候群", "FUS", "Feline Urologic Syndrome", "貓特發性膀胱炎", "FIC"],
    epidemiology: {
      species: "貓特有",
      age: "1-10歲，好發於中年（2-6歲）",
      sex: "公貓和母貓皆可發生，公貓更易阻塞",
      riskFactors: ["室內生活", "多貓家庭", "緊迫/壓力", "肥胖", "缺乏運動", "乾糧為主", "飲水量少"]
    },
    clinicalPresentation: {
      history: ["頻尿", "排尿困難", "血尿", "亂尿（不在貓砂盆排尿）", "舔舐生殖器", "叫聲痛苦", "反覆發作"],
      physicalExam: ["膀胱可能敏感", "膀胱大小（阻塞時膨大且硬）", "尿道可能觸診到結石", "會陰區可能紅腫"]
    },
    etiology: {
      overview: "FLUTD是症候群，非單一診斷",
      causes: [
        "特發性膀胱炎（FIC）：最常見（55-65%）",
        "尿路結石：10-25%（草酸鈣、鳥糞石）",
        "尿道栓子：10-20%",
        "泌尿道感染：<5%（年輕貓罕見）",
        "解剖異常：尿道狹窄、腫瘤",
        "行為問題"
      ]
    },
    pathophysiology: "FIC：緊迫 → HPA軸失調 → 膀胱GAG層損傷 → 神經性炎症 → 疼痛和臨床症狀。結石：礦物質過飽和 → 結晶形成 → 結石生長 → 阻塞或刺激。栓子：晶體+黏液+細胞碎片 → 尿道阻塞",
    diagnosis: {
      overview: "排除可治療病因（結石、感染），FIC為排除性診斷",
      differentials: ["特發性膀胱炎", "尿路結石", "泌尿道感染", "尿道阻塞", "腫瘤", "解剖異常"],
      initialDB: ["尿液分析（包含沉渣）", "尿液培養", "腹部X光", "腹部超聲"],
      advanced: ["尿道造影", "膀胱鏡", "尿石分析"]
    },
    treatment: {
      overview: "依據病因治療：FIC以環境管理和鎮痛為主；結石依類型處理",
      acute: [
        "疼痛控制：Buprenorphine 0.01-0.02 mg/kg SL q6-8h",
        "解痙：Prazosin 0.25-0.5 mg/貓 PO q8-12h（公貓尿道痙攣）",
        "抗焦慮：短期可考慮Gabapentin 5-10 mg/kg PO",
        "若阻塞：見「尿道阻塞」處理"
      ],
      chronic: [
        "環境豐富化（MEMO）：",
        "- 多個貓砂盆（n+1原則）",
        "- 增加飲水量（流動飲水器、濕食）",
        "- 減少緊迫（貓費洛蒙、安全空間）",
        "- 互動和遊戲",
        "飲食管理：增加水分攝取、泌尿道處方飲食",
        "鳥糞石結石：溶解飲食（若適用）",
        "草酸鈣結石：手術移除（無法溶解）",
        "Amitriptyline：10 mg/貓 PO q24h（頑固性FIC，需監測）",
        "Polysulfated glycosaminoglycan：可考慮（證據有限）"
      ]
    },
    prognosis: "FIC：多數自限性（數天內緩解），但復發率高。結石：移除後預後良好，需預防復發。公貓阻塞若未及時處理可致命。",
    pearls: [
      "年輕貓（<10歲）UTI罕見，不要常規使用抗生素",
      "FIC是排除性診斷，但最常見",
      "環境管理比藥物更重要",
      "公貓反覆阻塞可考慮會陰尿道造口術",
      "草酸鈣結石無法溶解，鳥糞石可溶解"
    ],
    monitoring: ["症狀緩解情況", "尿液分析（追蹤）", "影像學追蹤結石", "體重管理"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; AAFP/ISFM Guidelines on FLUTD"
  },

  "urinary-tract-infection": {
    zh: "泌尿道感染",
    en: "Urinary Tract Infection (UTI)",
    definition: "病原微生物（通常為細菌）在正常無菌的泌尿道內定殖並引起炎症反應的感染性疾病。",
    synonyms: ["UTI", "膀胱炎", "Bacterial Cystitis", "尿路感染"],
    epidemiology: {
      species: "犬較貓常見",
      age: "母犬任何年齡，公犬和貓多為老年",
      sex: "母犬較公犬常見（尿道較短）",
      riskFactors: ["母犬（解剖因素）", "老年", "糖尿病", "腎上腺皮質功能亢進", "免疫抑制", "尿液滯留", "尿路結石", "留置導尿管", "先天性異常"]
    },
    clinicalPresentation: {
      history: ["頻尿", "排尿困難", "血尿", "尿液混濁或惡臭", "亂尿", "舔舐泌尿生殖區"],
      physicalExam: ["膀胱可能敏感", "發燒（若腎盂腎炎）", "會陰區可能發紅", "外陰分泌物（母犬）"]
    },
    pathophysiology: "細菌（多為腸道菌）上行感染 → 黏附於膀胱上皮 → 繁殖 → 炎症反應 → 黏膜損傷 → 臨床症狀。宿主防禦機制受損加重感染：正常尿流、黏膜屏障、免疫功能",
    commonPathogens: ["Escherichia coli（最常見）", "Staphylococcus spp.", "Proteus spp.", "Enterococcus spp.", "Klebsiella spp.", "Pseudomonas（複雜性UTI）"],
    diagnosis: {
      overview: "尿液培養和藥敏試驗是金標準",
      differentials: ["特發性膀胱炎（貓）", "尿路結石", "腫瘤", "前列腺疾病（公犬）"],
      initialDB: ["尿液分析（膀胱穿刺取樣最佳）", "尿液培養和藥敏", "尿沉渣（細菌、WBC）"],
      advanced: ["腹部超聲", "X光（排除結石）", "血糖（排除糖尿病）", "腎上腺功能檢查"]
    },
    utiClassification: {
      simple: "首次或偶發性UTI，無潛在疾病或解剖異常",
      complicated: "反覆感染、有潛在疾病、解剖異常、或感染擴展（腎盂腎炎、前列腺炎）",
      subclinical: "尿液培養陽性但無臨床症狀（通常不治療，除非特殊情況）"
    },
    treatment: {
      overview: "基於尿液培養和藥敏結果選擇抗生素",
      acute: [
        "單純性UTI（經驗性治療，等待培養結果）：",
        "- Amoxicillin: 11-15 mg/kg PO q8h × 7-14天",
        "- Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h",
        "- Trimethoprim-sulfa: 15-30 mg/kg PO q12h",
        "複雜性UTI：依據培養結果，療程較長（4-6週）",
        "腎盂腎炎：見相關條目",
        "鎮痛（若需要）：NSAIDs短期使用（注意腎功能）"
      ],
      chronic: [
        "復發性UTI管理：",
        "- 尋找並治療潛在病因",
        "- 長期低劑量抗生素（夜間給藥）",
        "- 或間歇性自我治療（主人觀察症狀時給藥）",
        "增加水分攝取",
        "定期監測尿液培養"
      ]
    },
    prognosis: "單純性UTI：預後良好。複雜性/復發性：取決於潛在病因控制。",
    pearls: [
      "膀胱穿刺取樣避免污染，是培養金標準",
      "年輕健康貓UTI罕見，需考慮其他病因",
      "無症狀菌尿通常不需治療（除非免疫抑制、即將手術等）",
      "反覆UTI應尋找潛在病因（糖尿病、腎上腺皮質功能亢進）",
      "氟喹諾酮類應保留給多重抗藥性感染"
    ],
    monitoring: ["治療結束後5-7天尿液培養確認清除", "反覆感染需定期培養"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ISCAID Guidelines on UTI"
  },

  "pyelonephritis": {
    zh: "腎盂腎炎",
    en: "Pyelonephritis",
    definition: "腎盂和腎實質的細菌感染，為上泌尿道感染，可為急性或慢性。",
    synonyms: ["腎臟感染", "Upper UTI", "Kidney Infection"],
    epidemiology: {
      species: "犬較貓常見",
      age: "任何年齡，中老年較多",
      sex: "母犬略多",
      riskFactors: ["下泌尿道感染上行", "尿路結石", "先天性異常（異位輸尿管、VUR）", "免疫抑制", "糖尿病", "腎上腺皮質功能亢進", "留置導尿管"]
    },
    clinicalPresentation: {
      history: ["發燒", "嗜睡", "食慾下降", "嘔吐", "腰背痛", "多飲多尿", "可能有下泌尿道症狀"],
      physicalExam: ["發燒", "腎臟區疼痛（腰部觸診）", "腎臟可能腫大", "脫水", "黏膜充血或蒼白"]
    },
    pathophysiology: "細菌從膀胱上行至腎臟 → 腎盂黏膜感染 → 擴展至腎實質 → 化膿性炎症 → 腎間質纖維化（慢性）→ 腎功能喪失。血源性感染較少見但可發生。",
    diagnosis: {
      overview: "臨床表現結合尿液培養陽性和影像學發現",
      differentials: ["下泌尿道感染", "腎結石", "急性腎損傷", "腎膿腫"],
      initialDB: ["尿液分析和培養", "CBC（嗜中性球增多、左移）", "生化（可能氮質血症）", "腹部超聲（腎盂擴張、腎臟腫大、皮質回音改變）"],
      advanced: ["腹部CT", "靜脈腎盂造影", "腎臟穿刺培養"]
    },
    treatment: {
      overview: "長期抗生素治療基於培養結果，支持治療",
      acute: [
        "住院治療（嚴重病例）：",
        "- 靜脈輸液糾正脫水",
        "- IV抗生素（初期）：",
        "  * Ampicillin: 20-40 mg/kg IV q6-8h + Enrofloxacin: 5-10 mg/kg IV q24h",
        "  * 或 Ampicillin-sulbactam: 20-30 mg/kg IV q8h",
        "- 止痛：Buprenorphine或其他鴉片類",
        "- 止吐：Maropitant 1 mg/kg IV q24h"
      ],
      chronic: [
        "口服抗生素（依培養結果）：4-6週療程",
        "常用選擇：",
        "- Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h",
        "- 氟喹諾酮類：Enrofloxacin 5-10 mg/kg PO q24h",
        "- Trimethoprim-sulfa: 15-30 mg/kg PO q12h",
        "治療潛在病因（結石移除、異常矯正）",
        "慢性腎盂腎炎可能需要更長療程"
      ]
    },
    prognosis: "急性若及時治療預後良好。慢性或反覆發作可導致永久性腎損傷和CKD。雙側嚴重感染預後謹慎。",
    pearls: [
      "急性腎盂腎炎是全身性疾病，不只是UTI",
      "超聲可見腎盂擴張但不一定有積水",
      "氮質血症可能是暫時性（腎臟腫脹）或永久性（腎損傷）",
      "抗生素療程需要4-6週以根除腎臟感染",
      "治療後需追蹤尿液培養確認清除"
    ],
    monitoring: ["體溫", "腎功能（BUN/Crea）", "尿液培養（治療中和治療後）", "超聲追蹤"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "polycystic-kidney-disease": {
    zh: "多囊性腎病",
    en: "Polycystic Kidney Disease (PKD)",
    definition: "以腎臟出現多個液體填充囊腫為特徵的遺傳性疾病，隨年齡進展導致腎功能喪失。",
    synonyms: ["PKD", "多囊腎", "Polycystic Kidneys"],
    epidemiology: {
      species: "貓較常見（波斯貓及相關品種），犬少見",
      age: "先天性，但臨床症狀多在中老年出現",
      sex: "無性別傾向",
      breedPredisposition: ["波斯貓（約36-50%發生率）", "喜馬拉雅貓", "英國短毛貓", "異國短毛貓", "蘇格蘭摺耳貓"],
      riskFactors: ["遺傳（常染色體顯性遺傳，PKD1基因突變）"]
    },
    clinicalPresentation: {
      history: ["多飲多尿（PU/PD）", "體重減輕", "食慾下降", "嘔吐", "嗜睡"],
      physicalExam: ["腎臟不規則腫大（雙側觸診）", "腹部觸診可感覺到凹凸不平的腎臟", "脫水", "CKD相關症狀"]
    },
    pathophysiology: "PKD1基因突變 → polycystin-1蛋白異常 → 腎小管上皮細胞增殖和分泌異常 → 囊腫形成和擴大 → 壓迫正常腎實質 → 腎功能進行性喪失。囊腫數量和大小隨年齡增加。",
    diagnosis: {
      overview: "超聲診斷為主，基因檢測可早期確診",
      differentials: ["腎臟腫瘤", "腎臟淋巴瘤", "腎周假性囊腫", "水腎"],
      initialDB: ["腹部超聲（多個囊腫，雙側腎臟）", "BUN/Creatinine/SDMA", "尿液分析", "血壓"],
      advanced: ["PKD1基因檢測（可在幼年進行）", "CT或MRI"]
    },
    geneticTesting: {
      indication: "繁殖前篩檢、早期診斷",
      method: "PCR檢測PKD1基因突變",
      timing: "可在任何年齡進行，推薦繁殖前"
    },
    treatment: {
      overview: "無法治癒，治療目標為延緩CKD進展和控制併發症",
      acute: [
        "尿毒症危象：同CKD處理",
        "囊腫感染：長期抗生素（需穿透囊腫壁）",
        "- Fluoroquinolones較佳穿透性",
        "- 療程4-6週"
      ],
      chronic: [
        "CKD管理（參見CKD條目）：",
        "- 腎臟處方飲食",
        "- 磷結合劑",
        "- 血壓控制",
        "- 蛋白尿控制",
        "- 皮下輸液維持水合",
        "Tolvaptan：在人類PKD有效，獸醫尚無標準用法",
        "囊腫引流：僅用於巨大囊腫引起不適（效果暫時）"
      ]
    },
    prognosis: "進展速度因個體差異大。多數貓在3-10歲出現CKD。平均診斷腎衰竭年齡約7歲。基因檢測陽性不等於一定會發展為腎衰竭。",
    pearls: [
      "超聲10週齡即可檢測到囊腫，但早期可能漏診",
      "基因檢測是唯一100%準確的早期診斷方法",
      "繁殖控制是降低發病率的關鍵",
      "囊腫感染難以治療，抗生素需能穿透囊壁",
      "肝臟也可能有囊腫（較少引起臨床症狀）"
    ],
    monitoring: ["定期超聲（q6-12月）", "腎功能（BUN/Crea/SDMA）", "血壓", "體重"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "protein-losing-nephropathy": {
    zh: "蛋白質流失性腎病",
    en: "Protein-Losing Nephropathy (PLN)",
    definition: "以腎絲球屏障功能障礙導致大量蛋白質經尿液流失為特徵的腎臟疾病。",
    synonyms: ["PLN", "腎絲球疾病", "Glomerulonephritis", "腎絲球腎炎", "蛋白尿性腎病"],
    epidemiology: {
      species: "犬較貓常見",
      age: "中老年犬好發",
      sex: "無明顯性別傾向",
      breedPredisposition: ["Soft-coated Wheaten Terrier", "Bernese Mountain Dog", "English Cocker Spaniel", "Bull Terrier", "Dalmatian", "Samoyed"],
      riskFactors: ["感染性疾病（萊姆病、心絲蟲）", "免疫介導疾病", "腫瘤", "遺傳因素"]
    },
    clinicalPresentation: {
      history: ["初期可能無症狀", "體重減輕", "嗜睡", "水腫", "腹水", "呼吸困難（胸水）", "CKD症狀"],
      physicalExam: ["四肢水腫", "腹水", "體腔積液", "消瘦", "高血壓相關徵象"]
    },
    pathophysiology: "腎絲球屏障損傷（免疫複合物沉積、遺傳缺陷等）→ 通透性增加 → 白蛋白和其他蛋白質流失 → 低白蛋白血症 → 水腫、腹水。同時：高脂血症、凝血亢進（抗凝血酶III流失）→ 血栓栓塞風險增加",
    diagnosis: {
      overview: "基於持續性蛋白尿（UPC > 0.5犬，> 0.4貓）和排除其他蛋白尿原因",
      differentials: ["下泌尿道感染/炎症引起的蛋白尿", "管性蛋白尿", "其他低白蛋白血症原因"],
      initialDB: ["UPC（尿蛋白/肌酐比）", "尿液分析和培養", "BUN/Crea/SDMA", "血漿白蛋白", "血脂", "CBC"],
      advanced: ["抗凝血酶III", "膽固醇", "感染疾病篩檢（萊姆病、心絲蟲等）", "ANA", "腎臟超聲", "腎臟活檢（金標準診斷腎絲球疾病類型）"]
    },
    treatment: {
      overview: "治療原發病因、減少蛋白尿、管理併發症",
      acute: [
        "嚴重低白蛋白血症（<1.5 g/dL）：",
        "- 新鮮冷凍血漿",
        "- 人工膠體（慎用）",
        "血栓栓塞預防：",
        "- Clopidogrel: 1-2 mg/kg PO q24h",
        "- 或/加 低劑量Aspirin: 0.5-1 mg/kg PO q24h"
      ],
      chronic: [
        "減少蛋白尿（腎保護）：",
        "- ACE抑制劑：Enalapril/Benazepril 0.5-1 mg/kg PO q12-24h",
        "- ARB：Telmisartan 1 mg/kg PO q24h",
        "- 可合併使用",
        "高血壓控制：Amlodipine 0.1-0.25 mg/kg PO q24h",
        "腎臟處方飲食（限制蛋白、補充omega-3）",
        "免疫抑制治療（免疫介導性腎絲球腎炎）：",
        "- Mycophenolate: 10-20 mg/kg PO q12h",
        "- 避免長期類固醇（可能加重蛋白尿和促進血栓）",
        "治療原發感染（萊姆病：Doxycycline）",
        "抗凝治療持續進行"
      ]
    },
    prognosis: "取決於原發病因和治療反應。UPC > 3.5和低白蛋白血症預後較差。血栓栓塞是常見致死併發症。",
    pearls: [
      "UPC > 2.0 高度提示腎絲球疾病",
      "必須排除尿路感染和炎症再評估蛋白尿",
      "血栓栓塞風險與蛋白尿嚴重程度相關",
      "腎臟活檢可區分不同類型腎絲球疾病",
      "類固醇在多數情況下不是首選免疫抑制劑"
    ],
    monitoring: ["UPC（q2-4週初期，然後q2-4月）", "血壓", "白蛋白", "腎功能", "血栓症狀"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ACVIM Consensus Statement on PLN"
  },

  "renal-dysplasia": {
    zh: "腎發育不良",
    en: "Renal Dysplasia",
    definition: "腎臟在發育過程中出現異常分化，導致結構和功能異常的先天性疾病。",
    synonyms: ["腎發育異常", "Juvenile Nephropathy", "幼年型腎病", "Familial Nephropathy"],
    epidemiology: {
      species: "犬較常見",
      age: "幼年至青年（通常<2歲出現症狀）",
      sex: "無明顯性別傾向",
      breedPredisposition: ["Shih Tzu", "Lhasa Apso", "Soft-coated Wheaten Terrier", "Standard Poodle", "Alaskan Malamute", "Chow Chow", "Golden Retriever", "Cocker Spaniel"]
    },
    clinicalPresentation: {
      history: ["多飲多尿", "生長遲緩", "食慾不振", "體重不增或減輕", "嘔吐", "嗜睡", "被毛品質差"],
      physicalExam: ["體型較同齡小", "消瘦", "脫水", "腎臟小或觸診不到", "可能有口腔潰瘍", "橡皮頜（腎性骨營養不良）"]
    },
    pathophysiology: "胎兒期腎臟發育異常 → 不成熟或發育不全的腎小管和腎絲球 → 功能性腎元減少 → 代償性肥大不足以彌補 → 進行性腎功能喪失。病理特徵：原始腎小管、不成熟腎絲球、間質纖維化",
    diagnosis: {
      overview: "幼年動物出現CKD表現應懷疑，腎臟活檢確診",
      differentials: ["腎盂腎炎", "腎毒性", "先天性尿路梗阻", "多囊腎病"],
      initialDB: ["BUN/Creatinine", "尿液分析（等張尿）", "電解質", "腹部超聲（小腎臟、皮髓質分界不清）", "X光（可能有骨骼變化）"],
      advanced: ["腎臟活檢（確診）", "離子鈣/PTH（繼發性甲狀旁腺亢進）"]
    },
    treatment: {
      overview: "無法治癒，治療同CKD，預後較差",
      acute: [
        "尿毒症危象：",
        "- 靜脈輸液",
        "- 止吐",
        "- 胃保護"
      ],
      chronic: [
        "CKD支持治療：",
        "- 腎臟處方飲食",
        "- 磷結合劑",
        "- 皮下輸液維持水合",
        "- 促紅血球生成素（若貧血）",
        "腎性骨營養不良管理：",
        "- 磷控制",
        "- 活性維生素D（Calcitriol）慎用"
      ]
    },
    prognosis: "預後差，多數在2歲前進展至終末期腎衰竭。存活時間取決於診斷時腎功能和治療反應。",
    pearls: [
      "幼年犬CKD應高度懷疑腎發育不良",
      "超聲可見小而不規則的腎臟",
      "腎臟活檢是唯一確診方法",
      "繁殖計畫應排除受影響品系",
      "「橡皮頜」是腎性骨營養不良的特徵性表現"
    ],
    monitoring: ["腎功能定期評估", "生長曲線", "鈣磷代謝", "血壓"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "ectopic-ureter": {
    zh: "異位輸尿管",
    en: "Ectopic Ureter",
    definition: "輸尿管開口於膀胱三角區以外的位置（如尿道、陰道、子宮）的先天性異常，導致尿失禁。",
    synonyms: ["EU", "Ureteral Ectopia", "輸尿管異位"],
    epidemiology: {
      species: "犬較貓常見",
      age: "先天性，通常幼年診斷",
      sex: "母犬較公犬更常被診斷（公犬可能症狀較輕）",
      breedPredisposition: ["Siberian Husky", "Labrador Retriever", "Golden Retriever", "Newfoundland", "English Bulldog", "West Highland White Terrier", "Fox Terrier"]
    },
    clinicalPresentation: {
      history: ["出生即有尿失禁（持續滴尿）", "從未完全控制排尿", "會陰區皮膚炎", "反覆泌尿道感染"],
      physicalExam: ["會陰區濕潤或尿灼傷", "可能有外陰發育不全", "膀胱大小可能正常或較小", "可能觸診到擴張的輸尿管"]
    },
    pathophysiology: "胚胎發育期輸尿管芽位置異常 → 輸尿管開口於正常膀胱三角區外 → 尿液繞過尿道括約肌 → 持續性尿失禁。分類：壁內型（沿膀胱壁內延伸開口於遠端）vs 壁外型（完全繞過膀胱）",
    diagnosis: {
      overview: "影像學確診異位開口位置",
      differentials: ["括約肌功能不全", "先天性尿道異常", "下泌尿道感染", "前庭陰道異常"],
      initialDB: ["尿液分析和培養", "腹部超聲（輸尿管擴張、開口位置）", "排泄性靜脈腎盂造影"],
      advanced: ["CT泌尿道造影（首選）", "膀胱鏡和尿道鏡（可同時診斷和治療）", "逆行性尿道造影"]
    },
    treatment: {
      overview: "手術矯正為主，術後可能仍需藥物控制",
      acute: [
        "泌尿道感染治療：抗生素基於培養結果",
        "皮膚護理：保持會陰區清潔乾燥"
      ],
      chronic: [
        "手術選項：",
        "- 膀胱鏡引導雷射消融（壁內型首選）",
        "- 新輸尿管膀胱吻合術（開放手術）",
        "- 腎臟/輸尿管切除（單側，若腎功能差）",
        "術後尿失禁管理（30-50%仍有殘餘尿失禁）：",
        "- Phenylpropanolamine (PPA): 1.5-2 mg/kg PO q8-12h",
        "- 雌激素（絕育母犬）：DES 0.1-1 mg PO q24-72h",
        "術後UTI預防和監測"
      ]
    },
    prognosis: "手術成功率約50-90%。壁內型雷射消融成功率較高。術後仍有尿失禁可能，藥物可改善。",
    pearls: [
      "幼年母犬尿失禁首先考慮異位輸尿管",
      "單側或雙側皆可發生，雙側約50%",
      "CT泌尿道造影是目前最佳診斷方法",
      "膀胱鏡雷射消融創傷小、恢復快",
      "術後殘餘尿失禁常見，可能需要長期藥物控制"
    ],
    monitoring: ["術後尿失禁程度", "尿液培養", "腎功能", "超聲追蹤"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "urethral-obstruction": {
    zh: "尿道阻塞",
    en: "Urethral Obstruction",
    definition: "尿道被物理性阻塞導致無法排尿的緊急狀態，可因結石、栓子、腫瘤或功能性原因引起。",
    synonyms: ["UO", "尿道梗阻", "Blocked Cat", "Urinary Obstruction", "FUO (Feline Urethral Obstruction)"],
    epidemiology: {
      species: "公貓最常見，公犬也可發生",
      age: "貓：1-10歲；犬：任何年齡（結石相關）",
      sex: "公性動物為主（尿道較長較窄）",
      riskFactors: ["公貓（最高風險）", "肥胖", "室內生活", "缺乏運動", "乾糧飲食", "飲水少", "FLUTD病史"]
    },
    clinicalPresentation: {
      history: ["頻繁進出貓砂盆", "排尿姿勢但無尿或少尿", "叫聲痛苦", "嘔吐", "嗜睡", "食慾下降", "最後可能虛脫"],
      physicalExam: ["膀胱極度膨脹且硬（「像網球」）", "腹部疼痛", "心搏過緩（高血鉀）", "低體溫", "脫水", "黏膜蒼白", "陰莖可能外露或有分泌物"]
    },
    pathophysiology: "尿道阻塞 → 膀胱過度膨脹 → 尿液滯留 → 氮質血症 → 高血鉀（危及生命的心律不整）→ 代謝性酸中毒 → 若不治療24-48小時內死亡。膀胱可能破裂（少見）",
    diagnosis: {
      overview: "觸診膨脹膀胱即可診斷，需評估代謝狀態",
      differentials: ["膀胱無張力（神經性）", "尿道痙攣", "尿道腫瘤"],
      initialDB: ["身體觸診（膀胱）", "電解質（K+首要）", "BUN/Creatinine", "血氣分析", "ECG（心律）", "腹部X光（結石位置）"],
      advanced: ["腹部超聲", "尿道造影"]
    },
    treatment: {
      overview: "緊急穩定 → 解除阻塞 → 術後監測和預防復發",
      acute: [
        "代謝穩定（在導尿前）：",
        "- 靜脈通路和輸液：0.9% NaCl 優先（不含K+）",
        "- 嚴重高血鉀處理（K+ >7-8 mEq/L）：",
        "  * 10% Calcium gluconate: 0.5-1 mL/kg IV slow（心臟保護）",
        "  * Regular insulin: 0.25-0.5 U/kg IV + Dextrose",
        "- ECG監測",
        "- 嚴重心搏過緩：Atropine 0.02-0.04 mg/kg IV",
        "解除阻塞：",
        "- 鎮靜/麻醉：Butorphanol + Dexmedetomidine（低劑量若不穩定）",
        "- 逆行沖洗尿道：無菌生理鹽水",
        "- 放置留置導尿管（3.5-5 Fr）",
        "- 若無法導尿：膀胱穿刺暫時減壓",
        "術後輸液：糾正脫水、促進利尿"
      ],
      chronic: [
        "移除導尿管後監測排尿",
        "Prazosin（尿道鬆弛）：0.25-0.5 mg/貓 PO q8-12h × 3-5天",
        "止痛：Buprenorphine 0.01-0.02 mg/kg SL q6-8h",
        "FLUTD長期管理（見相關條目）",
        "反覆阻塞：會陰尿道造口術（PU手術）"
      ]
    },
    prognosis: "及時治療預後良好（>90%存活）。延遲治療可致死。約30-40%會復發。PU手術後阻塞罕見但仍可能UTI。",
    pearls: [
      "公貓尿道阻塞是急診，不能等待",
      "先穩定高血鉀再嘗試導尿",
      "Calcium gluconate保護心臟但不降低血鉀",
      "導尿後24-48小時可能出現「阻塞後利尿」",
      "PU手術改變尿道解剖，不治療潛在病因"
    ],
    monitoring: ["ECG（術中和術後）", "尿量（目標>2 mL/kg/h）", "電解質（q4-8h初期）", "BUN/Creatinine", "移除導尿管後排尿情況"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "bladder-tumor": {
    zh: "膀胱腫瘤",
    en: "Bladder Tumor",
    definition: "膀胱的原發性或轉移性腫瘤，最常見為移行細胞癌(TCC)，好發於犬。",
    synonyms: ["膀胱癌", "Bladder Cancer", "移行細胞癌", "TCC", "Urothelial Carcinoma"],
    epidemiology: {
      species: "犬遠較貓常見",
      age: "老年犬（平均9-11歲）",
      sex: "母犬略多於公犬",
      breedPredisposition: ["Scottish Terrier（風險最高，18-20倍）", "West Highland White Terrier", "Beagle", "Shetland Sheepdog", "Wire Hair Fox Terrier"],
      riskFactors: ["殺蟲劑/除草劑暴露", "環蟲酮暴露（舊式跳蚤藥）", "肥胖", "雌性"]
    },
    clinicalPresentation: {
      history: ["血尿（最常見）", "頻尿", "排尿困難", "反覆「UTI」對抗生素反應差", "排尿不完全", "後期可能有跛行（骨轉移）"],
      physicalExam: ["直腸觸診可能摸到膀胱三角區或尿道腫塊", "膀胱壁增厚", "前列腺受侵犯（公犬）", "副腫瘤骨病變"]
    },
    pathophysiology: "TCC起源於膀胱移行上皮 → 好發於膀胱三角區 → 局部侵犯 → 可能累及尿道和前列腺 → 淋巴結轉移 → 肺轉移。病理特徵：乳頭狀或浸潤性生長",
    diagnosis: {
      overview: "影像學發現病灶，細胞學或組織學確診",
      differentials: ["慢性膀胱炎", "多發性息肉", "其他膀胱腫瘤（少見）"],
      initialDB: ["尿液分析", "腹部超聲（膀胱壁腫塊）", "胸腔X光（轉移篩檢）", "腹部X光（淋巴結腫大）"],
      advanced: ["BRAF突變檢測（尿液PCR，敏感性85%）", "創傷性導尿細胞學", "膀胱鏡活檢", "CT（分期）"]
    },
    staging: {
      T: "T1: 乳頭狀，限於黏膜; T2: 侵犯肌層; T3: 侵犯鄰近器官",
      N: "N0: 無淋巴結轉移; N1: 淋巴結轉移",
      M: "M0: 無遠端轉移; M1: 遠端轉移"
    },
    treatment: {
      overview: "手術切除困難（位置），化療和NSAIDs為主要治療",
      acute: [
        "尿道阻塞處理：",
        "- 支架置放",
        "- 導尿管",
        "- 膀胱造口術（暫時）"
      ],
      chronic: [
        "醫學治療（主要）：",
        "- Piroxicam: 0.3 mg/kg PO q24h（COX抑制劑，抗腫瘤作用）",
        "- 或 Meloxicam: 0.1-0.2 mg/kg PO q24h",
        "化療：",
        "- Mitoxantrone: 5-6 mg/m² IV q3週",
        "- 或 Carboplatin: 300 mg/m² IV q3-4週",
        "- 或 Vinblastine: 2-3 mg/m² IV q1-2週",
        "- 合併NSAID效果更好",
        "手術（選擇性病例）：",
        "- 部分膀胱切除術（非三角區腫瘤）",
        "- 全膀胱切除+尿路改道（少見）",
        "姑息性治療：尿道支架、膀胱造口術"
      ]
    },
    prognosis: "預後謹慎至差。中位生存期：單獨NSAID約6個月，NSAID+化療約10-12個月。尿道阻塞是常見死亡原因。",
    pearls: [
      "TCC好發膀胱三角區，手術切除困難",
      "BRAF V595E突變存在於約85%犬TCC",
      "不建議經腹膀胱穿刺活檢（可能種植轉移）",
      "Piroxicam有直接抗腫瘤作用，不只是止痛",
      "反覆「UTI」治療無效應懷疑膀胱腫瘤"
    ],
    monitoring: ["定期超聲（腫瘤大小）", "尿液分析", "胸腔X光（轉移）", "生活品質評估"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "urinary-incontinence": {
    zh: "尿失禁",
    en: "Urinary Incontinence",
    definition: "不自主排尿的狀態，可因括約肌功能不全、神經性問題或解剖異常引起。",
    synonyms: ["UI", "小便失禁", "Involuntary Urination"],
    epidemiology: {
      species: "犬較貓常見",
      age: "依病因而異（括約肌功能不全多在絕育後數月至數年出現）",
      sex: "絕育母犬最常見（括約肌功能不全）",
      breedPredisposition: ["大型犬", "Boxer", "Doberman", "Old English Sheepdog", "German Shepherd", "Rottweiler", "Irish Setter"],
      riskFactors: ["絕育（母犬）", "肥胖", "尾巴對接", "先天性異常"]
    },
    clinicalPresentation: {
      history: ["休息時滴尿", "床墊濕掉", "會陰區濕潤", "動物本身不自覺", "行為正常"],
      physicalExam: ["會陰區濕潤或尿灼傷", "膀胱大小可能正常", "神經學檢查（若懷疑神經性）", "陰道/外陰檢查"]
    },
    etiology: {
      usmr: "尿道括約肌功能不全(USMI)：絕育母犬最常見",
      neurogenic: "神經性：脊髓疾病、馬尾症候群、椎間盤疾病",
      anatomic: "解剖異常：異位輸尿管、前庭陰道異常",
      overflow: "滿溢性：尿道阻塞、膀胱無張力",
      urgency: "急迫性：膀胱炎、膀胱腫瘤"
    },
    diagnosis: {
      overview: "詳細病史區分真性尿失禁和其他排尿異常，確定病因",
      differentials: ["行為性排尿問題", "多尿", "下泌尿道感染", "異位輸尿管"],
      initialDB: ["尿液分析和培養", "神經學檢查", "腹部超聲", "腹部X光"],
      advanced: ["尿動力學檢查", "CT泌尿道造影", "膀胱鏡", "MRI（脊髓評估）"]
    },
    treatment: {
      overview: "依據病因治療，USMI以藥物為主",
      acute: [
        "感染相關：抗生素治療",
        "阻塞相關：解除阻塞"
      ],
      chronic: [
        "USMI藥物治療：",
        "- Phenylpropanolamine (PPA): 1.5-2 mg/kg PO q8-12h（α促效劑）",
        "- 雌激素（絕育母犬）：",
        "  * Diethylstilbestrol (DES): 0.1-1 mg PO q24h × 5-7天，然後q週",
        "  * 或 Estriol: 2 mg/犬 PO q24h",
        "- 合併PPA和雌激素效果更好",
        "手術選項（藥物無效）：",
        "- 膀胱頸注射填充劑",
        "- 人工尿道括約肌",
        "- 膠原蛋白注射",
        "異位輸尿管：手術矯正",
        "神經性：治療原發病因、間歇性導尿"
      ]
    },
    prognosis: "USMI：藥物控制率約90%。異位輸尿管術後約50-70%改善。神經性：取決於原發病因。",
    pearls: [
      "絕育母犬尿失禁首先考慮USMI",
      "幼年動物尿失禁考慮異位輸尿管",
      "PPA對USMI效果好但有心血管副作用",
      "雌激素需監測骨髓抑制（少見）",
      "真性尿失禁動物不自知，與行為問題不同"
    ],
    monitoring: ["症狀控制程度", "藥物副作用", "定期尿液培養（繼發感染）"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "prostatic-disease": {
    zh: "前列腺疾病",
    en: "Prostatic Disease",
    definition: "影響前列腺的各種疾病統稱，包括良性增生、感染、囊腫和腫瘤，僅見於公犬。",
    synonyms: ["前列腺疾病", "攝護腺疾病", "Prostate Disease"],
    epidemiology: {
      species: "犬（公犬）",
      age: "依疾病類型而異",
      sex: "公犬專有",
      riskFactors: ["未絕育", "年齡（BPH、腫瘤）"]
    },
    diseaseTypes: {
      bph: {
        name: "良性前列腺增生(BPH)",
        age: "中老年未絕育公犬",
        description: "雄激素依賴性前列腺增大",
        symptoms: "可能無症狀、排便困難、血尿、前列腺液滴出"
      },
      prostatitis: {
        name: "前列腺炎",
        age: "任何年齡",
        description: "細菌感染，急性或慢性",
        symptoms: "發燒、疼痛、排尿困難、全身症狀"
      },
      abscess: {
        name: "前列腺膿瘍",
        age: "中老年",
        description: "前列腺炎併發症",
        symptoms: "嚴重全身症狀、發燒、腹痛"
      },
      cyst: {
        name: "前列腺囊腫",
        age: "中老年",
        description: "前列腺內或前列腺旁囊腫",
        symptoms: "大小依賴，可能壓迫周圍結構"
      },
      carcinoma: {
        name: "前列腺癌",
        age: "老年（絕育和未絕育皆可）",
        description: "惡性腫瘤，常見轉移",
        symptoms: "排尿困難、排便困難、後肢跛行（骨轉移）"
      }
    },
    clinicalPresentation: {
      history: ["排便困難（糞便扁平）", "排尿困難", "血尿/尿道分泌物", "後肢僵硬", "發燒（感染）", "嗜睡"],
      physicalExam: ["直腸觸診前列腺：腫大、不對稱、疼痛、硬度改變", "可能觸及腹部腫塊", "睪丸異常（Sertoli cell tumor）", "神經學異常（腫瘤轉移）"]
    },
    diagnosis: {
      overview: "直腸觸診初步評估，影像學和細胞學確診",
      differentials: ["BPH", "前列腺炎/膿瘍", "囊腫", "腫瘤", "前列腺旁囊腫"],
      initialDB: ["直腸觸診", "腹部X光", "腹部超聲", "尿液分析和培養", "前列腺液培養"],
      advanced: ["超聲引導穿刺活檢", "CT（分期）", "前列腺特異性抗原（犬：非特異性）"]
    },
    treatment: {
      overview: "依據病因治療",
      bph: [
        "絕育：最有效治療（4-6週內顯著縮小）",
        "藥物（若不願絕育）：",
        "- Finasteride: 0.1-0.5 mg/kg PO q24h（5α還原酶抑制劑）",
        "- Osaterone acetate（抗雄激素）"
      ],
      prostatitis: [
        "長期抗生素（4-6週以上）：",
        "- Trimethoprim-sulfa: 15-30 mg/kg PO q12h",
        "- 或 Fluoroquinolones: Enrofloxacin 5-10 mg/kg PO q24h",
        "- Chloramphenicol（穿透性佳）",
        "絕育（促進恢復）",
        "止痛"
      ],
      abscess: [
        "手術引流（開放或超聲引導）",
        "部分前列腺切除或去勢",
        "長期抗生素",
        "靜脈輸液支持"
      ],
      carcinoma: [
        "手術切除困難且效果差",
        "化療：Carboplatin、Mitoxantrone",
        "NSAIDs：Piroxicam 0.3 mg/kg PO q24h",
        "放射治療（緩解症狀）",
        "尿道支架（阻塞）",
        "姑息性止痛"
      ]
    },
    prognosis: "BPH：絕育後預後極佳。前列腺炎：治療後預後良好。膿瘍：預後謹慎。前列腺癌：預後差，中位生存期約2-4個月。",
    pearls: [
      "直腸觸診是評估前列腺的基本方法",
      "BPH是未絕育公犬最常見前列腺問題",
      "絕育不預防前列腺癌（可能甚至增加風險）",
      "前列腺液或精液培養比尿液培養更準確",
      "抗生素需能穿透前列腺屏障"
    ],
    monitoring: ["前列腺大小（超聲）", "尿液培養", "臨床症狀", "若腫瘤：定期影像學分期"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "hydronephrosis": {
    zh: "腎水腫",
    en: "Hydronephrosis",
    definition: "因尿路梗阻導致腎盂和腎盞擴張積水，長期可致腎實質萎縮和功能喪失。",
    synonyms: ["腎積水", "水腎", "Renal Pelvis Dilation"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["輸尿管結石", "輸尿管腫瘤", "輸尿管狹窄", "異位輸尿管", "腹腔腫瘤壓迫", "意外輸尿管結紮"]
    },
    clinicalPresentation: {
      history: ["單側可能無症狀", "雙側表現為急性或慢性腎衰竭", "腹部腫脹", "食慾下降", "嘔吐", "若感染可能發燒"],
      physicalExam: ["腹部觸診可能摸到腫大腎臟", "腎區疼痛（急性）", "脫水（若雙側或單腎動物）"]
    },
    pathophysiology: "尿路梗阻 → 尿液回流 → 腎盂壓力升高 → 腎實質缺血 → 腎小管萎縮 → 皮質變薄 → 腎功能喪失。完全梗阻數天內可造成不可逆損傷。部分梗阻可能數週至數月進展。",
    diagnosis: {
      overview: "超聲是診斷首選，需確定梗阻原因和位置",
      differentials: ["腎盂腎炎", "腎周假性囊腫", "多囊腎病", "腎盂擴張（非梗阻性）"],
      initialDB: ["腹部超聲（腎盂擴張、皮質厚度、輸尿管擴張）", "BUN/Creatinine", "尿液分析和培養", "腹部X光（結石？）"],
      advanced: ["CT泌尿道造影", "靜脈腎盂造影", "順行性腎盂造影"]
    },
    treatment: {
      overview: "解除梗阻、保存腎功能、治療感染",
      acute: [
        "緊急減壓（若雙側或單腎）：",
        "- 腎盂穿刺引流",
        "- 輸尿管支架或腎造口術",
        "感染控制：抗生素",
        "輸液支持"
      ],
      chronic: [
        "解除梗阻的手術：",
        "- 輸尿管切開取石",
        "- 輸尿管新植入術",
        "- SUB系統（皮下輸尿管旁路）",
        "- 輸尿管支架",
        "腎切除術（嚴重萎縮無功能且對側腎正常）",
        "感染：長期抗生素"
      ]
    },
    prognosis: "取決於梗阻持續時間、腎皮質厚度和對側腎功能。早期解除梗阻（<1-2週）預後較好。嚴重萎縮（皮質<2-3 mm）功能恢復有限。",
    pearls: [
      "單側腎水腫常因無症狀而延遲診斷",
      "腎皮質厚度是評估腎功能恢復潛力的指標",
      "貓輸尿管結石導致腎水腫越來越常見",
      "SUB系統是貓輸尿管梗阻的有效解決方案",
      "解除梗阻後可能出現阻塞後利尿"
    ],
    monitoring: ["腎功能（若雙側）", "超聲追蹤腎盂大小", "尿液培養", "對側腎評估"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "nephrotoxicity": {
    zh: "腎毒性",
    en: "Nephrotoxicity",
    definition: "外源性物質（藥物、毒物）或內源性物質對腎臟造成的直接損傷，導致急性腎損傷。",
    synonyms: ["腎臟中毒", "藥物性腎損傷", "Toxic Nephropathy", "Drug-induced Nephrotoxicity"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["老年", "已有腎臟疾病", "脫水", "低血壓", "同時使用多種腎毒性藥物"]
    },
    commonNephrotoxins: {
      drugs: [
        "氨基糖苷類抗生素（Gentamicin, Amikacin）",
        "NSAIDs（Carprofen, Meloxicam, Ibuprofen）",
        "ACE抑制劑（過量或脫水時）",
        "Amphotericin B",
        "Cisplatin",
        "Cyclosporine",
        "造影劑"
      ],
      toxins: [
        "乙二醇（防凍劑）",
        "百合植物（貓）",
        "葡萄/葡萄乾（犬）",
        "重金屬（鉛、汞）",
        "蛇毒",
        "蜜蜂/黃蜂毒"
      ],
      endogenous: [
        "肌紅蛋白（橫紋肌溶解）",
        "血紅蛋白（溶血）",
        "高鈣血症",
        "尿酸（腫瘤溶解症候群）"
      ]
    },
    clinicalPresentation: {
      history: ["毒物暴露或可疑藥物使用史", "突然嘔吐", "厭食", "嗜睡", "尿量改變"],
      physicalExam: ["脫水", "腎臟可能腫大且疼痛", "口腔潰瘍（尿毒症）", "可能有特定中毒徵象"]
    },
    pathophysiology: {
      mechanisms: [
        "直接腎小管毒性（氨基糖苷類、重金屬）",
        "腎血流改變（NSAIDs、ACE抑制劑）",
        "結晶沉積（乙二醇→草酸鈣）",
        "急性腎小管壞死",
        "間質性腎炎"
      ],
      etg: "乙二醇 → 乙醇脫氫酶代謝 → 乙醛酸、草酸 → 草酸鈣結晶沉積於腎小管 → 阻塞和毒性 → 急性腎衰竭"
    },
    diagnosis: {
      overview: "病史（暴露史）結合AKI表現",
      differentials: ["其他AKI原因", "腎前性氮質血症", "尿路梗阻"],
      initialDB: ["BUN/Creatinine", "電解質", "尿液分析（結晶、管型）", "血氣", "乙二醇檢測（若懷疑）"],
      advanced: ["藥物血中濃度（氨基糖苷類）", "腎臟活檢", "特定毒物篩檢"]
    },
    treatment: {
      overview: "停止暴露、支持治療、特定解毒劑（若有）",
      acute: [
        "一般措施：",
        "- 停用可疑藥物",
        "- 積極靜脈輸液（促進腎臟灌注和毒物排泄）",
        "- 糾正電解質異常",
        "特定解毒劑：",
        "乙二醇中毒：",
        "- Fomepizole: 犬-首劑20 mg/kg IV，然後15 mg/kg × 3次 q12h；貓-125 mg/kg IV，然後31 mg/kg × 3次 q12h",
        "- 或 Ethanol: 20% 溶液 5-6 mL/kg IV q4-6h（競爭性抑制）",
        "- 黃金治療時間：犬<8-12h，貓<3h",
        "百合中毒（貓）：",
        "- 48-72小時積極輸液利尿",
        "- 無特定解毒劑",
        "葡萄/葡萄乾中毒（犬）：",
        "- 催吐（若剛攝入）",
        "- 活性碳",
        "- 積極輸液48-72小時",
        "支持治療：",
        "- 止吐：Maropitant",
        "- 胃保護：Omeprazole",
        "- 血液透析（嚴重病例）"
      ],
      chronic: ["監測腎功能恢復", "避免再次暴露", "若進展為CKD則長期管理"]
    },
    prognosis: "取決於毒物類型、暴露劑量和治療時機。乙二醇：若在黃金時間內治療預後可好；延遲則預後極差。百合：及時輸液約50-90%存活。氨基糖苷類：停藥後多數可恢復。",
    pearls: [
      "百合對貓極度腎毒性，包括花粉",
      "乙二醇中毒貓的治療窗口極短（<3小時）",
      "NSAIDs在脫水或低血壓動物中腎毒性風險大增",
      "尿液中草酸鈣結晶提示乙二醇中毒",
      "預防勝於治療：避免高風險情況"
    ],
    monitoring: ["尿量", "BUN/Creatinine q12-24h", "電解質", "尿液分析"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ASPCA Animal Poison Control"
  }
  // ===== From endocrine-diseases.js =====

  // ==================== 糖尿病 ====================

  "diabetes-mellitus": {
    zh: "糖尿病",
    en: "Diabetes Mellitus",
    definition: "因胰島素絕對或相對缺乏導致的碳水化合物、脂肪和蛋白質代謝異常，特徵為持續性高血糖和相關臨床症狀。",
    synonyms: ["DM", "Sugar Diabetes", "糖尿病", "Insulin Deficiency Diabetes"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "犬：中老年（7-9歲高峰）；貓：中老年（平均10-13歲）",
      sex: "犬：未絕育母犬風險較高；貓：公貓較多（尤其已絕育肥胖公貓）",
      riskFactors: ["肥胖（尤其貓）", "品種傾向（犬：Samoyed、Australian Terrier、Miniature Schnauzer、Miniature/Toy Poodle；貓：Burmese）", "胰臟炎", "庫欣症", "使用類固醇或黃體素", "懷孕/動情期（母犬）"]
    },
    clinicalPresentation: {
      history: ["多飲多尿（PU/PD）", "多食（polyphagia）", "體重減輕（儘管食慾增加）", "嗜睡", "肌肉萎縮", "貓：後肢無力/跖行姿勢（糖尿病神經病變）"],
      physicalExam: ["消瘦或體態過低", "肌肉量減少", "脫水", "白內障（犬常見，貓罕見）", "肝腫大", "貓：跖行姿勢、被毛不良", "酮酸中毒時：嘔吐、虛弱、Kussmaul呼吸"]
    },
    pathophysiology: "犬：主要為胰島β細胞破壞（類似人類1型DM），與免疫介導、胰臟炎、品種遺傳相關。貓：主要為胰島素阻抗+β細胞功能衰退（類似人類2型DM），胰澱粉樣沉積常見。結果：高血糖 → 腎臟葡萄糖閾值超過 → 滲透性利尿 → PU/PD → 細胞無法利用葡萄糖 → 脂肪分解 → 酮體產生",
    diagnosis: {
      overview: "持續性空腹高血糖結合糖尿確診。排除應激性高血糖（尤其貓）",
      differentials: ["應激性高血糖（貓）", "庫欣症", "肢端肥大症（貓）", "胰臟炎", "腎臟疾病", "甲狀腺功能亢進（貓）"],
      initialDB: [
        "血糖（空腹>200 mg/dL 犬；>250 mg/dL 貓）",
        "尿液分析（糖尿、可能酮尿）",
        "果糖胺（Fructosamine）：反映2-3週平均血糖",
        "CBC、生化全套",
        "尿液培養（UTI常見併發症）"
      ],
      advanced: ["胰臟特異性脂肪酶(Spec cPL/fPL)", "腹部超音波", "糖化血紅蛋白(HbA1c)", "胰島素濃度（懷疑胰島素阻抗時）"]
    },
    treatment: {
      overview: "胰島素治療為主，配合飲食管理。貓部分病例可能緩解",
      acute: [
        "糖尿病酮酸中毒(DKA)：",
        "  - 積極輸液復甦（0.9% NaCl）",
        "  - 短效胰島素(Regular Insulin)：0.1-0.2 U/kg/h IV CRI 或 IM q1-2h",
        "  - 電解質補充（尤其鉀、磷）",
        "  - 監測並糾正酸中毒",
        "  - 當血糖<250 mg/dL時轉為皮下胰島素+輸液加葡萄糖"
      ],
      chronic: [
        "胰島素治療：",
        "犬：",
        "  - Vetsulin (Lente porcine): 0.25-0.5 U/kg SC q12h",
        "  - NPH insulin: 0.25-0.5 U/kg SC q12h",
        "  - Glargine: 若NPH控制不佳",
        "貓：",
        "  - Glargine (Lantus) 或 Detemir (Levemir): 1-2 U/貓 SC q12h（首選）",
        "  - ProZinc (PZI): 1-2 U/貓 SC q12h",
        "飲食管理：",
        "  - 犬：高纖維、複合碳水化合物飲食",
        "  - 貓：高蛋白、低碳水化合物飲食（關鍵！）",
        "  - 定時定量餵食",
        "體重管理（肥胖者減重）",
        "母犬：建議絕育"
      ]
    },
    prognosis: "犬：需終身胰島素治療，適當管理下預後良好，中位生存期約3年。貓：約20-30%可達到糖尿病緩解（尤其早期積極治療+飲食控制），緩解後需監測復發。併發症影響預後。",
    pearls: [
      "貓的應激性高血糖可達300-400 mg/dL，果糖胺有助於區分",
      "犬糖尿病幾乎都需終身胰島素；貓有緩解可能",
      "貓的低碳水化合物飲食非常重要，可提高緩解率",
      "白內障在犬糖尿病極為常見（>80%），貓罕見",
      "Somogyi效應：過量胰島素導致反彈性高血糖",
      "居家血糖監測可改善控制效果"
    ],
    monitoring: ["血糖曲線（每2-4週直到穩定）", "果糖胺（每4-6週）", "體重", "水攝取量", "臨床症狀", "尿液分析（每3-6個月）"],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 甲狀腺功能亢進（貓） ====================

  "hyperthyroidism-cat": {
    zh: "甲狀腺功能亢進（貓）",
    en: "Hyperthyroidism (Feline)",
    definition: "因甲狀腺激素（T3、T4）過度分泌導致的高代謝狀態，是老年貓最常見的內分泌疾病。",
    synonyms: ["Feline Hyperthyroidism", "貓甲亢", "Thyrotoxicosis", "甲狀腺毒症"],
    epidemiology: {
      species: "貓（犬罕見且通常與甲狀腺腫瘤相關）",
      age: "中老年貓（平均12-13歲，>95%超過10歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["年齡", "室內飼養", "罐頭飲食（某些研究）", "使用貓砂（某些研究）", "環境因素（某些研究提示多溴二苯醚等）"]
    },
    clinicalPresentation: {
      history: ["體重減輕（儘管食慾增加或正常）", "多食", "多飲多尿", "嘔吐", "腹瀉/軟便", "過度活躍/不安/易怒", "被毛不良", "虛弱"],
      physicalExam: ["消瘦、肌肉萎縮", "甲狀腺結節可觸及（>80%病例）", "心搏過速", "心雜音或奔馬律", "高血壓", "過度活躍", "被毛粗糙或脫毛"]
    },
    pathophysiology: "95%以上為良性甲狀腺腺瘤或腺瘤樣增生（雙側70%，單側30%），<5%為甲狀腺癌。甲狀腺激素增加 → 基礎代謝率增加 → 蛋白質分解、脂肪動員 → 體重減輕。同時影響心臟（肥厚性心肌病變）、腎臟（GFR增加可能掩蓋潛在CKD）。",
    diagnosis: {
      overview: "血清總T4升高結合典型臨床表現。正常T4不能排除（早期或隱匿性甲亢）",
      differentials: ["慢性腎病", "糖尿病", "腸道疾病（IBD、淋巴瘤）", "肝病", "心臟病"],
      initialDB: [
        "血清總T4（Total T4）：升高確診；正常時需進一步檢查",
        "CBC、生化全套（評估併發症）",
        "尿液分析",
        "血壓測量",
        "胸腔X光"
      ],
      advanced: [
        "游離T4（Free T4）：總T4正常但高度懷疑時",
        "TSH濃度：甲亢時應降低",
        "甲狀腺閃爍掃描(99mTc)：評估異位甲狀腺組織、癌症",
        "心臟超聲（評估甲亢性心臟病）",
        "T3抑制試驗（少用）"
      ]
    },
    treatment: {
      overview: "四種治療選項：藥物、放射碘、手術、飲食。選擇取決於患者狀況和主人因素",
      acute: [
        "嚴重甲亢或甲狀腺風暴（罕見）：",
        "  - Beta-blocker (Atenolol): 6.25-12.5 mg/貓 PO q12-24h",
        "  - 支持治療（輸液、降溫）",
        "  - Methimazole 立即開始"
      ],
      chronic: [
        "1. 藥物治療（最常用初始治療）：",
        "  - Methimazole: 2.5 mg PO q12h 起始，依T4調整",
        "  - Carbimazole: 5 mg PO q8h 或 10-15 mg PO q24h",
        "  - 經皮Methimazole（耳廓內側）：不耐口服時",
        "  - 需終身用藥，監測副作用",
        "",
        "2. 放射碘治療(I-131)（金標準/治癒性）：",
        "  - 單次注射，治癒率>95%",
        "  - 無需麻醉",
        "  - 需專門設施和隔離期",
        "",
        "3. 手術切除（治癒性）：",
        "  - 雙側或單側甲狀腺切除",
        "  - 術前需用藥物穩定",
        "  - 風險：低血鈣、喉返神經損傷",
        "",
        "4. 飲食治療：",
        "  - Hill's y/d（極低碘飲食）",
        "  - 必須是唯一飲食來源",
        "  - 適合無法給藥或不適合其他治療者"
      ]
    },
    prognosis: "治療後預後良好。放射碘治療治癒率>95%。藥物控制需終身。主要影響預後的因素：併發CKD、心臟病、高血壓。治療後需評估潛在腎功能。",
    pearls: [
      "治療前務必評估腎功能 - 甲亢可掩蓋潛在CKD",
      "治療後1個月內重測腎功能",
      "Methimazole副作用：嘔吐、厭食、面部搔抓、骨髓抑制、肝毒性",
      "甲狀腺閃爍掃描是評估是否適合手術的最佳方法",
      "部分「隱匿性甲亢」T4正常但有臨床症狀",
      "放射碘是最佳長期治療選擇（若可行）"
    ],
    monitoring: [
      "藥物治療：T4、腎功能、CBC（前3個月每2-4週，穩定後每3-6個月）",
      "血壓",
      "體重",
      "心臟狀況",
      "藥物副作用"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 甲狀腺功能低下（犬） ====================

  "hypothyroidism-dog": {
    zh: "甲狀腺功能低下（犬）",
    en: "Hypothyroidism (Canine)",
    definition: "因甲狀腺激素（T3、T4）產生不足導致的低代謝狀態，是犬最常見的內分泌疾病之一。",
    synonyms: ["Canine Hypothyroidism", "犬甲低", "甲狀腺功能減退"],
    epidemiology: {
      species: "犬常見，貓罕見（通常為醫源性或放射碘後）",
      age: "中年犬（4-10歲，平均7歲）",
      sex: "無明顯性別傾向，絕育動物可能風險略高",
      riskFactors: ["品種傾向（Golden Retriever、Doberman Pinscher、Irish Setter、Miniature Schnauzer、Dachshund、Cocker Spaniel、Airedale Terrier）", "中大型犬較常見", "絕育"]
    },
    clinicalPresentation: {
      history: ["嗜睡、活動力下降", "體重增加（儘管食慾正常或下降）", "畏寒", "皮膚問題（脫毛、皮膚感染）", "繁殖障礙"],
      physicalExam: ["肥胖", "雙側對稱性脫毛（軀幹、尾巴「鼠尾」）", "皮膚增厚、色素沉著", "皮脂溢出", "反覆皮膚感染", "心搏過緩", "「悲傷面容」（黏液水腫）", "神經肌肉症狀（罕見：虛弱、跛行、面部麻痺）"]
    },
    pathophysiology: "95%為原發性（甲狀腺本身問題）：50%淋巴細胞性甲狀腺炎（免疫介導），50%特發性甲狀腺萎縮。繼發性（腦下垂體TSH不足）和三發性（下視丘TRH不足）罕見。甲狀腺激素減少 → 代謝率下降 → 體重增加、嗜睡、毛髮生長週期異常。",
    diagnosis: {
      overview: "結合臨床症狀、低T4和TSH升高診斷。單獨T4低不能確診（非甲狀腺病態綜合症）",
      differentials: ["非甲狀腺病態綜合症(NTIS/Euthyroid Sick Syndrome)", "庫欣症", "藥物影響（類固醇、磺胺藥、Phenobarbital）", "其他代謝疾病"],
      initialDB: [
        "總T4（Total T4）：低；但正常不能排除、低不能確診",
        "游離T4（Free T4 by ED）：更準確",
        "TSH（犬TSH）：原發性甲低時升高",
        "CBC、生化全套（可能見高膽固醇、輕度貧血）"
      ],
      advanced: [
        "甲狀腺球蛋白自身抗體(TgAA)：陽性提示淋巴細胞性甲狀腺炎",
        "T3抑制試驗",
        "TSH刺激試驗（黃金標準但TSH難取得）",
        "甲狀腺閃爍掃描"
      ]
    },
    treatment: {
      overview: "終身甲狀腺激素補充治療",
      acute: [
        "黏液水腫昏迷（罕見急症）：",
        "  - Levothyroxine IV（若可取得）或高劑量口服",
        "  - 支持治療（保溫、輸液、通氣支持）",
        "  - 類固醇（若懷疑腎上腺功能不全）"
      ],
      chronic: [
        "Levothyroxine (L-T4)：",
        "  - 起始劑量：0.02 mg/kg 或 0.5 mg/m² PO q12h",
        "  - 最大單次劑量：0.8 mg",
        "  - 與食物間隔給藥（空腹吸收較好）",
        "  - 品牌藥物較佳（生物利用度穩定）",
        "",
        "劑量調整：",
        "  - 4-6週後根據T4濃度和臨床反應調整",
        "  - 目標：給藥後4-6小時T4在正常上限或略高"
      ]
    },
    prognosis: "適當補充甲狀腺激素預後極佳。臨床症狀改善時程：活動力1-2週，皮膚3-6個月。需終身治療。",
    pearls: [
      "不要僅憑低T4診斷 - NTIS在病犬很常見",
      "結合fT4和TSH可提高診斷準確性",
      "高膽固醇血症是甲低的常見發現",
      "某些藥物（Phenobarbital、類固醇、磺胺藥）可降低T4",
      "治療反應是最佳確診方式之一",
      "每6-12個月監測一次足夠（穩定後）"
    ],
    monitoring: [
      "治療後4-6週測T4（給藥後4-6小時）",
      "穩定後每6-12個月監測",
      "臨床症狀改善",
      "體重",
      "皮膚狀況"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 腎上腺皮質功能亢進（庫欣症） ====================

  "hyperadrenocorticism": {
    zh: "腎上腺皮質功能亢進",
    en: "Hyperadrenocorticism (Cushing's Syndrome)",
    definition: "因皮質醇長期過量導致的多系統代謝異常。分為腦下垂體依賴型(PDH)、腎上腺腫瘤型(ADH)和醫源性。",
    synonyms: ["Cushing's Syndrome", "庫欣症", "Cushing's Disease", "皮質醇過多症"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "中老年犬（平均9-12歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Poodle、Dachshund、Beagle、Boston Terrier、Boxer、German Shepherd）", "小型犬PDH較多，大型犬ADH較多", "長期類固醇使用（醫源性）"]
    },
    clinicalPresentation: {
      history: ["多飲多尿（最常見，>90%）", "多食", "腹部膨大（「大肚腩」）", "喘氣", "脫毛", "皮膚變薄", "肌肉無力", "嗜睡"],
      physicalExam: ["腹部膨大（肝腫大+肌肉萎縮+脂肪重分布）", "皮膚變薄、脫毛（雙側對稱）", "皮膚鈣質沉著", "粉刺", "皮膚易瘀青", "肌肉萎縮", "喘氣"]
    },
    pathophysiology: "PDH（80-85%）：腦下垂體腫瘤過度分泌ACTH → 雙側腎上腺增生 → 皮質醇過量。ADH（15-20%）：腎上腺腫瘤（腺瘤或癌）自主分泌皮質醇。皮質醇過量 → 糖質新生、蛋白質分解、脂肪重分布、免疫抑制。",
    diagnosis: {
      overview: "三步驟：確認皮質醇過量 → 區分PDH vs ADH → 評估併發症",
      differentials: ["糖尿病", "慢性腎病", "肝病", "甲狀腺功能低下", "醫源性類固醇效應"],
      initialDB: [
        "篩檢試驗（需2種以上）：",
        "  - 尿液皮質醇/肌酸酐比值(UCCR)：高敏感度",
        "  - 低劑量Dexamethasone抑制試驗(LDDS)：首選",
        "  - ACTH刺激試驗：醫源性除外",
        "CBC、生化（典型：ALP↑、ALT↑、高血糖、高膽固醇）",
        "尿液分析（低比重、可能UTI）"
      ],
      advanced: [
        "區分試驗：",
        "  - 高劑量Dexamethasone抑制試驗(HDDS)",
        "  - 內源性ACTH濃度：PDH正常至高，ADH低",
        "影像學：",
        "  - 腹部超音波（腎上腺大小和對稱性）",
        "  - 腹部CT/MRI（腎上腺、腦下垂體）",
        "血壓測量"
      ]
    },
    treatment: {
      overview: "PDH以藥物為主，ADH考慮手術切除",
      acute: [
        "嚴重併發症處理：",
        "  - 血栓栓塞：抗凝治療",
        "  - 糖尿病：胰島素治療",
        "  - 嚴重感染：積極抗生素治療"
      ],
      chronic: [
        "PDH藥物治療：",
        "  - Trilostane（首選）：起始2-4 mg/kg PO q24h（餐後）",
        "    * 4週後ACTH刺激試驗調整劑量",
        "    * 若控制不佳可改q12h",
        "  - Mitotane (o,p'-DDD)：誘導25-50 mg/kg/day分次，維持25-50 mg/kg/week",
        "    * 副作用較多，需密切監測",
        "",
        "ADH治療：",
        "  - 腎上腺切除術（首選，若可行）",
        "  - 術前/術後需類固醇補充",
        "  - 無法手術時：藥物控制同PDH",
        "",
        "腦下垂體巨腺瘤：",
        "  - 放射治療",
        "  - 手術切除（少數中心）"
      ]
    },
    prognosis: "PDH藥物控制下中位生存期約2-2.5年。ADH腺瘤手術切除後預後良好；癌預後差。併發症（血栓、感染、糖尿病）影響預後。",
    pearls: [
      "PU/PD是最敏感的臨床指標",
      "ALP升高（肝臟同工酶誘導）是典型發現",
      "UCCR陰性基本可排除庫欣症",
      "Trilostane需要終身用藥和定期監測",
      "腎上腺危象是Trilostane罕見但嚴重的副作用",
      "貓庫欣症罕見且常併發糖尿病",
      "約10%的犬ADH為惡性"
    ],
    monitoring: [
      "Trilostane：ACTH刺激試驗（起始後10天、4週、3個月，穩定後每3-6個月）",
      "臨床症狀改善",
      "電解質（尤其鈉/鉀）",
      "血壓",
      "併發症監測"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 腎上腺皮質功能低下（愛迪生症） ====================

  "hypoadrenocorticism": {
    zh: "腎上腺皮質功能低下",
    en: "Hypoadrenocorticism (Addison's Disease)",
    definition: "因腎上腺皮質激素（糖皮質激素和/或礦物質皮質激素）產生不足導致的代謝紊亂。可表現為急性危象或慢性非特異性症狀。",
    synonyms: ["Addison's Disease", "愛迪生症", "Adrenocortical Insufficiency", "腎上腺功能不全"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "年輕至中年犬（平均4-5歲，範圍很廣）",
      sex: "母犬較多（約70%）",
      riskFactors: ["品種傾向（Standard Poodle、Portuguese Water Dog、Bearded Collie、West Highland White Terrier、Great Dane、Soft Coated Wheaten Terrier）", "已知遺傳基礎的品種", "自體免疫疾病傾向"]
    },
    clinicalPresentation: {
      history: ["間歇性嘔吐、腹瀉", "嗜睡、虛弱", "食慾下降", "體重減輕", "症狀時好時壞（「住院就好」）", "應激後症狀加重"],
      physicalExam: [
        "典型型（醛固酮+皮質醇不足）：",
        "  - 脫水、低血壓、心搏過緩",
        "  - 虛弱、嗜睡",
        "  - 腹痛",
        "非典型型（僅皮質醇不足）：",
        "  - 較不特異，電解質正常",
        "  - 虛弱、嘔吐、體重減輕"
      ]
    },
    pathophysiology: "原發性（95%）：免疫介導的腎上腺皮質破壞最常見。繼發性：腦下垂體ACTH分泌不足（罕見）或長期類固醇使用後突然停藥。醛固酮缺乏 → 鈉流失、鉀滯留 → 低血鈉、高血鉀 → 心律不整、低血壓。皮質醇缺乏 → 無法應對應激 → 代謝異常。",
    diagnosis: {
      overview: "高度懷疑時進行ACTH刺激試驗確診。經典電解質改變高度提示",
      differentials: ["急性腎衰竭", "尿路阻塞", "腸胃道疾病", "敗血症", "心臟疾病", "藥物毒性"],
      initialDB: [
        "電解質：低Na、高K（Na:K比值<27高度懷疑）",
        "BUN/Creatinine：可能升高（腎前性）",
        "血糖：可能低",
        "CBC：可能無應激白血球圖譜、淋巴球和嗜酸性球增多",
        "ECG：高鉀相關變化（T波高尖、P波消失、QRS增寬）"
      ],
      advanced: [
        "ACTH刺激試驗（確診）：",
        "  - 給予Cosyntropin 5 μg/kg IV",
        "  - 1小時後測皮質醇",
        "  - 基線和刺激後皮質醇均<2 μg/dL 確診",
        "基線皮質醇：<2 μg/dL 高度懷疑",
        "內源性ACTH（區分原發vs繼發）",
        "腹部超音波（腎上腺萎縮）"
      ]
    },
    treatment: {
      overview: "急性危象需緊急處理，慢性需終身激素補充",
      acute: [
        "愛迪生危象（緊急！）：",
        "  - 積極輸液：0.9% NaCl 60-90 mL/kg/h 第一小時",
        "  - 監測並糾正高血鉀（輸液通常足夠）",
        "  - 嚴重高血鉀：",
        "    * Calcium gluconate 10%: 0.5-1.5 mL/kg IV slow（心臟保護）",
        "    * Regular insulin: 0.25-0.5 U/kg + Dextrose",
        "  - 糖皮質激素：",
        "    * Dexamethasone SP: 0.5-2 mg/kg IV（不干擾ACTH刺激試驗）",
        "    * 或 Hydrocortisone: 0.5 mg/kg/h CRI",
        "  - 低血糖處理：Dextrose補充"
      ],
      chronic: [
        "礦物質皮質激素替代：",
        "  - Fludrocortisone (Florinef): 0.01-0.02 mg/kg PO q12-24h",
        "    * 需頻繁調整劑量",
        "  - DOCP (Percorten-V/Zycortal): 2.2 mg/kg IM/SC q25-28天",
        "    * 較穩定，長期較方便",
        "",
        "糖皮質激素替代：",
        "  - Prednisone: 0.1-0.2 mg/kg PO q24h",
        "  - 使用DOCP時通常需要",
        "  - 應激時需增加劑量",
        "",
        "非典型型：僅需Prednisone，但可能進展為典型型"
      ]
    },
    prognosis: "一旦確診並適當補充激素，預後極佳。中位生存期與正常犬相當。需終身治療和監測。",
    pearls: [
      "愛迪生是「偉大的模仿者」- 症狀非特異",
      "「住院就好」是重要線索",
      "Na:K <27 高度懷疑，但<25%病例電解質正常（非典型型）",
      "基線皮質醇>2 μg/dL 基本可排除",
      "應激時需增加Prednisone劑量（手術前2-3倍）",
      "DOCP比Fludrocortisone給藥方便，長期成本可能較低"
    ],
    monitoring: [
      "電解質（起始每週，穩定後每3-6個月）",
      "臨床症狀",
      "體重",
      "應激事件時需調整用藥"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 嗜鉻細胞瘤 ====================

  "pheochromocytoma": {
    zh: "嗜鉻細胞瘤",
    en: "Pheochromocytoma",
    definition: "起源於腎上腺髓質嗜鉻細胞的腫瘤，可分泌兒茶酚胺（腎上腺素、去甲腎上腺素）導致陣發性或持續性高血壓及相關症狀。",
    synonyms: ["Pheo", "嗜鉻細胞瘤", "Adrenal Medullary Tumor", "Chromaffin Cell Tumor"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "老年犬（平均10-11歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["無已知品種傾向", "約50%為惡性", "可能與功能性腎上腺皮質腫瘤並存"]
    },
    clinicalPresentation: {
      history: ["陣發性虛弱或倒地", "不安、焦躁", "喘氣", "嘔吐", "心悸感", "運動不耐", "體重減輕", "症狀可間歇性發作"],
      physicalExam: ["高血壓（可能陣發性）", "心搏過速或心律不整", "眼底病變（視網膜出血、脫離）", "腹部可觸及腫塊（若腫瘤夠大）", "後肢水腫（若侵犯後腔靜脈）", "出血傾向"]
    },
    pathophysiology: "腫瘤自主分泌兒茶酚胺 → 陣發性或持續性血管收縮 → 高血壓 → 靶器官損傷（心臟、眼、腎、腦）。腫瘤可局部侵犯後腔靜脈、腎靜脈。約50%有遠處轉移（肝、肺、淋巴結）。",
    diagnosis: {
      overview: "需高度懷疑。影像學發現腎上腺腫塊結合高血壓提示診斷",
      differentials: ["腎上腺皮質腫瘤", "腎上腺轉移瘤", "其他原因高血壓", "心臟疾病"],
      initialDB: [
        "血壓測量（重複測量，可能陣發性升高）",
        "眼底檢查",
        "腹部超音波（腎上腺腫塊）",
        "CBC、生化（可能高血糖、低血鉀）"
      ],
      advanced: [
        "尿液兒茶酚胺或代謝產物（metanephrines）：敏感度有限",
        "腹部CT/MRI：評估腫瘤範圍和血管侵犯",
        "超音波評估後腔靜脈侵犯",
        "胸腔X光/CT：轉移評估"
      ]
    },
    treatment: {
      overview: "手術切除是首選治療。需術前穩定血壓",
      acute: [
        "高血壓危象：",
        "  - Phentolamine: 0.02-0.1 mg/kg IV bolus",
        "  - Nitroprusside: 1-5 μg/kg/min CRI",
        "心律不整：",
        "  - Beta-blocker（必須在Alpha-blocker之後使用）"
      ],
      chronic: [
        "手術前準備（10-14天）：",
        "  - Phenoxybenzamine (Alpha-blocker): 0.25-1.5 mg/kg PO q12h",
        "  - 目標：血壓正常化、減少手術風險",
        "  - 輸液擴張血容量",
        "",
        "手術切除：",
        "  - 腎上腺切除術（有經驗的外科醫師）",
        "  - 術中準備處理血壓波動",
        "  - 可能需要後腔靜脈腫瘤栓子取出",
        "",
        "無法手術時：",
        "  - Phenoxybenzamine長期控制",
        "  - 化療效果有限"
      ]
    },
    prognosis: "完全切除且無轉移預後可良好（中位生存期>3年）。有血管侵犯或轉移預後較差（中位生存期約1年）。術中死亡風險存在。",
    pearls: [
      "陣發性症狀是重要線索",
      "術前Alpha-blocker準備極為重要",
      "Beta-blocker必須在Alpha-blocker之後使用（避免無對抗的Alpha效應）",
      "術中血壓可能劇烈波動",
      "約50%為惡性，但惡性度的影像學預測困難",
      "可與功能性皮質腫瘤並存"
    ],
    monitoring: [
      "術後血壓",
      "影像學追蹤（復發/轉移）",
      "臨床症狀"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 副甲狀腺功能亢進 ====================

  "hyperparathyroidism": {
    zh: "副甲狀腺功能亢進",
    en: "Hyperparathyroidism",
    definition: "副甲狀腺激素(PTH)過度分泌導致高鈣血症的疾病。分為原發性（副甲狀腺本身問題）和繼發性（對低鈣或高磷的反應）。",
    synonyms: ["HPT", "副甲狀腺功能亢進症", "Primary Hyperparathyroidism", "PHPTH"],
    epidemiology: {
      species: "犬較常見，貓少見",
      age: "老年犬（平均10-11歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Keeshond有遺傳傾向）", "原發性：副甲狀腺腺瘤最常見", "繼發性：CKD、營養性（鈣不足）"]
    },
    clinicalPresentation: {
      history: ["多飲多尿（高鈣血症導致）", "虛弱、嗜睡", "食慾下降", "便秘", "嘔吐", "可能無症狀（偶然發現高鈣）"],
      physicalExam: ["常無特異性發現", "肌肉無力", "脫水", "可能觸及頸部腫塊（若腺瘤夠大）", "心律不整（嚴重高鈣）"]
    },
    pathophysiology: "原發性：副甲狀腺腺瘤（單發最常見）或增生自主分泌PTH → PTH促進骨�ite吸收、腎臟鈣重吸收、腸道鈣吸收 → 高鈣血症。繼發性：CKD → 磷滯留 → 低鈣 → PTH代償性升高。高鈣血症影響腎臟、神經肌肉、心臟功能。",
    diagnosis: {
      overview: "高鈣血症 + PTH不適當升高或正常高值 = 原發性HPT",
      differentials: ["惡性腫瘤相關高鈣血症(HHM)", "維生素D中毒", "肉芽腫性疾病", "腎衰竭（繼發性HPT）", "Addison's disease"],
      initialDB: [
        "離子鈣（首選）或總鈣",
        "磷：原發性HPT通常正常低值或低",
        "PTH（同時測鈣）：原發性升高或不適當正常",
        "PTHrP：腫瘤相關高鈣時升高",
        "腎功能（BUN、Creatinine）",
        "尿液分析"
      ],
      advanced: [
        "頸部超音波：副甲狀腺腫塊",
        "99mTc-sestamibi閃爍掃描：定位病灶",
        "腹部超音波：腎結石、腎鈣化"
      ]
    },
    treatment: {
      overview: "原發性HPT首選手術切除病變腺體",
      acute: [
        "嚴重高鈣血症（>16 mg/dL或有症狀）：",
        "  - 0.9% NaCl積極輸液：促進鈣排泄",
        "  - Furosemide: 2-4 mg/kg IV q8-12h（輸液充足後）",
        "  - Calcitonin: 4-8 IU/kg SC q8-12h（快速但短效）",
        "  - Bisphosphonates: Pamidronate 1-2 mg/kg IV over 2-4h",
        "  - Glucocorticoids: 對淋巴瘤等有效，對原發性HPT無效"
      ],
      chronic: [
        "手術切除：",
        "  - 術前影像定位病灶",
        "  - 副甲狀腺腺瘤切除",
        "  - 術後監測低鈣血症",
        "",
        "超音波引導經皮熱消融/乙醇注射：",
        "  - 非手術替代選項",
        "  - 較少侵入性",
        "",
        "術後管理：",
        "  - 監測血鈣（術後24-72小時最低點）",
        "  - 低鈣血症補充：",
        "    * 輕度：口服鈣補充",
        "    * 嚴重：Calcium gluconate 10%: 0.5-1.5 mL/kg IV slow",
        "  - Calcitriol: 20-30 ng/kg/day（促進鈣吸收）"
      ]
    },
    prognosis: "手術成功切除預後極佳。約2-4%可能復發或為癌。術後低鈣血症通常是暫時性的。",
    pearls: [
      "高鈣血症鑑別：腫瘤最常見，原發性HPT次之",
      "PTH正常但高鈣 = 不適當正常 = 支持原發性HPT",
      "惡性腫瘤高鈣通常PTH低、PTHrP高",
      "術後低鈣血症（「飢餓骨症候群」）需密切監測",
      "Keeshond有遺傳性原發性HPT"
    ],
    monitoring: [
      "術後血鈣（每6-12小時共48-72小時）",
      "穩定後每週至每月",
      "長期每6-12個月追蹤"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 副甲狀腺功能低下 ====================

  "hypoparathyroidism": {
    zh: "副甲狀腺功能低下",
    en: "Hypoparathyroidism",
    definition: "副甲狀腺激素(PTH)分泌不足或作用缺陷導致低鈣血症的疾病。可為原發性（免疫介導、醫源性）或罕見的先天性。",
    synonyms: ["Hypopara", "副甲狀腺功能減退", "PTH Deficiency"],
    epidemiology: {
      species: "犬為主，貓少見",
      age: "中年犬（平均4-8歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["甲狀腺/副甲狀腺手術後（醫源性，最常見）", "品種傾向（原發性免疫介導型：Toy Poodle、Miniature Schnauzer、Labrador、German Shepherd）"]
    },
    clinicalPresentation: {
      history: ["肌肉顫抖、抽搐", "面部搔抓", "步態僵硬", "焦躁不安", "喘氣", "癲癇發作", "嗜睡", "症狀可間歇性發作"],
      physicalExam: ["肌肉強直或顫抖", "肌肉痙攣（尤其面部）", "發燒（肌肉活動）", "心搏過緩", "第三眼瞼突出", "白內障（慢性低鈣）"]
    },
    pathophysiology: "原發性：免疫介導的副甲狀腺破壞。醫源性：甲狀腺手術時意外損傷或切除。PTH缺乏 → 骨鈣釋放減少、腎臟鈣重吸收減少、腸道鈣吸收減少 → 低鈣血症 → 神經肌肉興奮性增加 → 強直、癲癇。",
    diagnosis: {
      overview: "低鈣血症 + PTH低或不適當正常 = 副甲狀腺功能低下",
      differentials: ["腎衰竭（低鈣合併高磷）", "低白蛋白血症（假性低鈣）", "膿毒症", "胰臟炎", "乙二醇中毒", "產後低鈣（哺乳）", "EDTA抗凝血管假性低鈣"],
      initialDB: [
        "離子鈣（首選）：降低",
        "總鈣和白蛋白：校正後總鈣低",
        "磷：升高（腎功能正常時）",
        "PTH（與鈣同時測）：低或不適當正常",
        "腎功能（BUN、Creatinine）：正常排除腎性原因",
        "ECG：QT延長"
      ],
      advanced: [
        "頸部超音波：評估副甲狀腺",
        "鎂濃度：低鎂可加重低鈣症狀",
        "維生素D代謝物"
      ]
    },
    treatment: {
      overview: "急性低鈣血症緊急處理，慢性需終身鈣和維生素D補充",
      acute: [
        "低鈣血症急症（癲癇、強直）：",
        "  - 10% Calcium gluconate: 0.5-1.5 mL/kg IV slow (over 10-20min)",
        "  - 持續ECG監測（心搏過緩立即停止）",
        "  - 避免皮下注射（組織壞死）",
        "  - 可重複給予或CRI: 2.5-3.75 mg/kg/h elemental Ca",
        "控制癲癇：",
        "  - Diazepam（若仍在發作）",
        "  - 鈣補充通常可控制"
      ],
      chronic: [
        "口服鈣補充：",
        "  - Calcium carbonate: 25-50 mg/kg/day elemental Ca 分次給予",
        "  - 或 Calcium gluconate/lactate",
        "",
        "維生素D補充（必需）：",
        "  - Calcitriol（首選）: 20-30 ng/kg/day 起始",
        "    * 作用快、半衰期短，調整方便",
        "  - 或 Dihydrotachysterol: 0.02-0.03 mg/kg/day",
        "  - 或 Ergocalciferol（作用慢，不推薦起始）",
        "",
        "劑量調整：",
        "  - 目標鈣：正常低限（8-9.5 mg/dL）",
        "  - 避免過度補充導致高鈣血症和腎鈣化"
      ]
    },
    prognosis: "適當補充終身預後良好。需終身治療和監測。初期劑量調整期風險較高。",
    pearls: [
      "醫源性是最常見原因 - 甲狀腺手術後需密切監測",
      "離子鈣比總鈣更準確",
      "Calcitriol因半衰期短是首選維生素D",
      "過度補充導致的高鈣血症和腎鈣化需警惕",
      "目標維持鈣在正常低限，不需要正常化",
      "急性時避免碳酸鈣（吸收不夠快）"
    ],
    monitoring: [
      "初期：血鈣每週測量直到穩定",
      "穩定後：每2-4個月",
      "腎功能和尿比重（腎鈣化風險）"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 生長激素過多症（肢端肥大症） ====================

  "hypersomatotropism": {
    zh: "生長激素過多症",
    en: "Hypersomatotropism (Acromegaly)",
    definition: "因生長激素(GH)過度分泌導致的代謝和形態學改變。貓主要由腦下垂體腫瘤引起，犬主要由黃體素相關引起。",
    synonyms: ["Acromegaly", "肢端肥大症", "GH Excess", "巨人症（生長板關閉前）"],
    epidemiology: {
      species: "貓較常見（腦下垂體腫瘤），犬少見（黃體素相關）",
      age: "貓：老年（平均10-11歲）；犬：中年母犬（動情期相關）",
      sex: "貓：公貓較多；犬：未絕育母犬",
      riskFactors: ["貓：無已知品種傾向", "犬：未絕育母犬、外源性黃體素使用"]
    },
    clinicalPresentation: {
      history: ["難以控制的糖尿病（胰島素阻抗明顯）", "體型/體重增加（儘管可能多食）", "下頜骨突出、面部變寬", "呼吸困難或打鼾（軟組織增生）", "多飲多尿"],
      physicalExam: ["下頜骨突出（prognathia inferior）", "頭部和面部寬大", "爪子增大（貓）", "體重增加", "器官腫大（心臟、肝臟、腎臟）", "口腔軟組織增生", "心雜音（心肌病變）"]
    },
    pathophysiology: "貓：腦下垂體GH分泌腫瘤（通常為腺瘤）。犬：黃體素刺激乳腺產生GH。GH過量 → IGF-1升高 → 軟骨、骨骼、軟組織增生 + 胰島素阻抗 → 糖尿病。心臟也受影響導致肥厚性心肌病。",
    diagnosis: {
      overview: "難控制的糖尿病貓應考慮此診斷。IGF-1升高結合臨床特徵",
      differentials: ["單純糖尿病", "甲狀腺功能亢進", "心臟病其他原因", "腎病"],
      initialDB: [
        "IGF-1（血清）：升高強烈支持診斷（>1000 ng/mL高度提示）",
        "血糖和果糖胺：糖尿病證據",
        "CBC、生化全套",
        "心臟超聲：評估心肌病變"
      ],
      advanced: [
        "頭部CT/MRI：腦下垂體腫瘤",
        "GH濃度（不常用，波動大）",
        "腹部超音波：器官腫大"
      ]
    },
    treatment: {
      overview: "貓：放射治療或藥物控制；犬：絕育或停止黃體素",
      acute: [
        "糖尿病控制：",
        "  - 高劑量胰島素（可能需>15 U/貓 q12h）",
        "  - 頻繁監測血糖"
      ],
      chronic: [
        "貓：",
        "  - 放射治療：可控制腫瘤、改善胰島素敏感性",
        "  - 腦下垂體切除術：少數中心",
        "  - Pasireotide（生長抑素類似物）：部分病例有效",
        "  - 保守治療：高劑量胰島素控制糖尿病",
        "",
        "犬：",
        "  - 絕育（首選）：移除黃體素來源",
        "  - 停止外源性黃體素",
        "  - GH和IGF-1應在數週內正常化"
      ]
    },
    prognosis: "犬：絕育後通常可治癒。貓：放射治療後中位生存期約2年；保守治療約1年。心臟病和糖尿病控制影響預後。",
    pearls: [
      "難以控制的糖尿病貓應檢測IGF-1",
      "胰島素需求>1.5-2 U/kg q12h 提示胰島素阻抗",
      "面部和身體變化可能subtle，比較舊照片有幫助",
      "約25%肢端肥大症貓IGF-1可正常（需CT/MRI）",
      "犬肢端肥大症絕育可治癒",
      "治療後糖尿病可能緩解"
    ],
    monitoring: [
      "血糖和糖尿病控制",
      "IGF-1（治療後）",
      "心臟超聲",
      "MRI追蹤腫瘤大小（放療後）"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 生長激素缺乏 ====================

  "growth-hormone-deficiency": {
    zh: "生長激素缺乏",
    en: "Growth Hormone Deficiency",
    definition: "生長激素(GH)分泌不足導致的發育遲緩或成年動物的皮膚和代謝異常。可為先天性或後天性。",
    synonyms: ["GH Deficiency", "Pituitary Dwarfism", "腦下垂體侏儒症", "生長激素不足"],
    epidemiology: {
      species: "犬為主（先天性），貓罕見",
      age: "先天性：幼犬（2-3月齡開始明顯）；後天性：成年",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（先天性）：German Shepherd（常見）、Karelian Bear Dog、Saarloos Wolfdog、Czechoslovakian Wolfdog", "遺傳性（常染色體隱性）"]
    },
    clinicalPresentation: {
      history: ["幼年：生長遲緩、同窩最小", "保留幼年被毛、不換毛", "智力和行為正常", "成年：雙側對稱性脫毛", "嗜睡"],
      physicalExam: ["身材矮小（幼年發病）", "保留幼年被毛（柔軟、綿毛狀）", "雙側對稱性脫毛（軀幹）", "皮膚色素沉著過度", "睪丸發育不全（公犬）", "可能保留乳齒"]
    },
    pathophysiology: "先天性：腦下垂體發育異常（囊腫、發育不全）→ GH和其他腦下垂體激素缺乏。German Shepherd多為腦下垂體囊腫。GH缺乏 → IGF-1減少 → 骨骼發育不全、毛囊週期異常、皮膚變薄。常合併甲狀腺功能低下（繼發性）。",
    diagnosis: {
      overview: "幼年型侏儒症臨床特徵明顯；成年型需功能性檢測",
      differentials: ["先天性甲狀腺功能低下", "先天性腎上腺皮質功能低下", "肝門脈分流", "營養不良", "寄生蟲感染", "其他侏儒原因"],
      initialDB: [
        "IGF-1：降低（篩檢）",
        "CBC、生化全套",
        "甲狀腺功能：常繼發性低下",
        "ACTH刺激試驗：評估腎上腺功能"
      ],
      advanced: [
        "GH刺激試驗（確診）：",
        "  - Clonidine、GHRH或Xylazine刺激",
        "  - GH反應低下確診",
        "頭部MRI/CT：腦下垂體囊腫或發育不全",
        "遺傳檢測（某些品種）"
      ]
    },
    treatment: {
      overview: "GH補充治療效果有限且取得困難；支持治療為主",
      acute: [
        "無急性治療需求"
      ],
      chronic: [
        "生長激素補充（若可取得）：",
        "  - Porcine GH: 0.1 IU/kg SC 3次/週，共4-6週",
        "  - 效果不一，可能導致糖尿病",
        "  - 來源困難",
        "",
        "替代療法：",
        "  - Progestins（刺激乳腺GH）：",
        "    * Medroxyprogesterone: 2.5-5 mg/kg SC q3週",
        "    * 風險：糖尿病、子宮蓄膿、乳腺腫瘤",
        "",
        "甲狀腺激素補充（若繼發性甲低）：",
        "  - Levothyroxine: 標準劑量",
        "",
        "皮膚護理：保濕、預防感染"
      ]
    },
    prognosis: "壽命通常縮短（先天性，約3-5歲）。繼發感染和代謝問題常見死因。治療可改善皮膚症狀但難以改變預後。",
    pearls: [
      "German Shepherd腦下垂體侏儒症有遺傳檢測可用",
      "保留幼年毛是特徵性表現",
      "常合併其他腦下垂體激素缺乏",
      "GH補充風險大於益處（糖尿病風險）",
      "繁殖計畫中應排除帶因者"
    ],
    monitoring: [
      "皮膚狀況",
      "甲狀腺功能",
      "血糖（若使用progestins或GH）",
      "整體生長和發育"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 尿崩症 ====================

  "diabetes-insipidus": {
    zh: "尿崩症",
    en: "Diabetes Insipidus",
    definition: "因抗利尿激素(ADH/AVP)缺乏（中樞性）或腎臟對ADH反應不足（腎源性）導致的大量稀釋尿液和繼發性多飲。",
    synonyms: ["DI", "水尿症", "Central DI", "Nephrogenic DI", "CDI", "NDI"],
    epidemiology: {
      species: "犬貓皆可發生，但罕見",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["頭部創傷", "腦下垂體腫瘤", "腦下垂體手術後", "先天性（罕見）", "腎臟疾病（腎源性）", "藥物（鋰、某些利尿劑）"]
    },
    clinicalPresentation: {
      history: ["極度多飲（可>100 mL/kg/day）", "極度多尿", "尿稀如水", "尿失禁（膀胱容量不足）", "可能有神經症狀（若有腦部病變）"],
      physicalExam: ["通常無特異性發現", "脫水（若無法自由飲水）", "神經學異常（腦部病變時）"]
    },
    pathophysiology: "中樞性(CDI)：下視丘-腦下垂體後葉損傷 → ADH分泌不足 → 腎臟集合管水重吸收減少 → 大量稀釋尿液。腎源性(NDI)：ADH正常但腎臟V2受體或aquaporin-2異常 → 對ADH反應不足。原發性多飲：行為性過度飲水導致的繼發性尿液稀釋。",
    diagnosis: {
      overview: "排除其他PU/PD原因後，水剝奪試驗和DDAVP反應試驗鑑別",
      differentials: ["糖尿病", "庫欣症", "腎衰竭", "肝衰竭", "高鈣血症", "子宮蓄膿", "甲狀腺功能亢進（貓）", "低鈉血症", "原發性多飲"],
      initialDB: [
        "尿比重：極低（<1.005-1.008）",
        "血清滲透壓：正常或略高",
        "尿液滲透壓：低（<血清滲透壓）",
        "CBC、生化全套、尿液分析：排除其他原因",
        "甲狀腺功能（貓）、腎上腺功能（若懷疑）"
      ],
      advanced: [
        "改良式水剝奪試驗：",
        "  - 在監測下限水直到體重減少3-5%或血清滲透壓>320 mOsm/kg",
        "  - 測尿比重和滲透壓",
        "  - 給予DDAVP後再測（區分CDI vs NDI）",
        "",
        "DDAVP試驗反應：",
        "  - CDI：尿液濃縮改善",
        "  - NDI：無反應",
        "  - 原發性多飲：漸進式改善",
        "",
        "頭部MRI：評估下視丘-腦下垂體區"
      ]
    },
    treatment: {
      overview: "CDI對DDAVP反應良好；NDI治療較困難",
      acute: [
        "嚴重脫水時：",
        "  - 輸液補充（注意不要過快糾正鈉）",
        "  - 自由飲水（若可行）"
      ],
      chronic: [
        "中樞性尿崩症(CDI)：",
        "  - Desmopressin (DDAVP)：",
        "    * 滴眼劑入結膜囊：1-4滴 q12-24h",
        "    * 或口服：0.05-0.2 mg q8-12h",
        "    * 劑量依反應調整",
        "",
        "腎源性尿崩症(NDI)：",
        "  - 治療困難",
        "  - Thiazide利尿劑 + 低鈉飲食：可減少20-50%尿量",
        "  - 確保自由飲水",
        "",
        "原發性多飲：",
        "  - 行為修正",
        "  - 漸進式限水"
      ]
    },
    prognosis: "CDI用DDAVP控制良好，預後佳。腦部腫瘤相關預後取決於腫瘤性質。NDI控制較差但可存活。需終身治療。",
    pearls: [
      "完全性CDI尿比重<1.005；部分性可能略高",
      "水剝奪試驗有風險，需在醫院密切監測",
      "DDAVP滴眼劑比口服便宜且有效",
      "過量DDAVP可能導致水中毒（低鈉血症）",
      "創傷後CDI可能是暫時性的",
      "腎髓質沖刷可延長尿液濃縮恢復時間"
    ],
    monitoring: [
      "飲水量和尿量",
      "尿比重",
      "電解質（尤其鈉）",
      "體重"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 高醛固酮症（Conn's症） ====================

  "hyperaldosteronism": {
    zh: "高醛固酮症",
    en: "Hyperaldosteronism (Conn's Syndrome)",
    definition: "腎上腺醛固酮過度分泌導致高血壓、低血鉀和代謝性鹼中毒的疾病。分為原發性（腎上腺腫瘤或增生）和繼發性（腎素-血管緊張素系統活化）。",
    synonyms: ["Conn's Syndrome", "Primary Hyperaldosteronism", "原發性高醛固酮症", "PHA"],
    epidemiology: {
      species: "貓較常見（原發性），犬少見",
      age: "貓：老年（平均13歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["年齡", "原發性：腎上腺腫瘤（單側腺瘤或癌）或雙側增生", "繼發性：心衰竭、肝硬化、腎病"]
    },
    clinicalPresentation: {
      history: ["肌肉無力（低血鉀）", "頸部腹側屈曲（貓特徵性）", "嗜睡", "多飲多尿", "失明（高血壓視網膜病變）"],
      physicalExam: ["全身肌肉無力", "頸部腹側屈曲（無法抬頭）", "高血壓", "眼底病變（視網膜出血、脫離、水腫）", "心雜音或奔馬律"]
    },
    pathophysiology: "原發性：腎上腺腫瘤或增生自主分泌醛固酮。繼發性：低血容量或腎灌流減少 → RAAS活化。醛固酮過量 → 腎臟鈉重吸收和鉀排泄增加 → 高血壓 + 低血鉀 → 肌肉無力、心律不整。",
    diagnosis: {
      overview: "低血鉀 + 高血壓 + 腎上腺腫塊高度提示原發性高醛固酮症",
      differentials: ["慢性腎病（貓常見低血鉀原因）", "甲狀腺功能亢進（貓）", "其他腎上腺腫瘤", "藥物性低血鉀", "原發性高血壓"],
      initialDB: [
        "電解質：低血鉀（通常<3.0 mEq/L）、可能高鈉",
        "血壓：升高",
        "CBC、生化全套",
        "甲狀腺功能（排除甲亢）",
        "腎功能"
      ],
      advanced: [
        "醛固酮濃度：升高",
        "醛固酮/腎素比值(ARR)：升高（原發性）",
        "腹部超音波：腎上腺腫塊或增生",
        "腹部CT：更精確評估腎上腺",
        "眼底檢查"
      ]
    },
    treatment: {
      overview: "手術切除腎上腺腫瘤或藥物控制",
      acute: [
        "低血鉀處理：",
        "  - 口服或靜脈鉀補充（KCl）",
        "  - 嚴重時緩慢IV: 0.5 mEq/kg/h",
        "",
        "高血壓處理：",
        "  - Amlodipine: 0.625-1.25 mg/貓 PO q24h"
      ],
      chronic: [
        "手術治療（首選，若單側腫瘤）：",
        "  - 腎上腺切除術",
        "  - 術前鉀和血壓控制",
        "  - 可能需要術後類固醇補充",
        "",
        "藥物治療（無法手術或雙側病變）：",
        "  - Spironolactone（醛固酮拮抗劑）: 2 mg/kg PO q12h",
        "  - 或 Eplerenone: 較少副作用",
        "  - 鉀補充（若需要）",
        "  - 高血壓藥物（Amlodipine）"
      ]
    },
    prognosis: "手術成功切除良性腫瘤預後良好。惡性腫瘤或雙側增生預後較差。藥物可控制症狀但不治癒。眼睛病變可能不可逆。",
    pearls: [
      "貓的頸部腹側屈曲是低血鉀肌病的特徵",
      "不是所有貓低血鉀都是高醛固酮症 - CKD更常見",
      "腎上腺癌vs腺瘤影像學難以區分",
      "術後對側腎上腺可能萎縮，需監測",
      "Spironolactone可能引起貓的面部皮炎",
      "高血壓視網膜病變可能導致永久失明"
    ],
    monitoring: [
      "血鉀（每週直到穩定）",
      "血壓",
      "臨床症狀",
      "影像追蹤（腫瘤大小）"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 甲狀腺癌 ====================

  "thyroid-carcinoma": {
    zh: "甲狀腺癌",
    en: "Thyroid Carcinoma",
    definition: "起源於甲狀腺上皮細胞的惡性腫瘤。犬甲狀腺腫瘤多為惡性但通常無功能；貓甲狀腺腫瘤多為良性但有功能。",
    synonyms: ["Thyroid Cancer", "甲狀腺惡性腫瘤", "Thyroid Neoplasia"],
    epidemiology: {
      species: "犬為主（惡性多），貓較少（通常良性功能性）",
      age: "犬：老年（平均9-10歲）；貓甲狀腺癌：老年",
      sex: "無明顯性別傾向",
      riskFactors: ["犬：無已知品種傾向，中大型犬可能較多", "貓：長期未治療的甲狀腺功能亢進"]
    },
    clinicalPresentation: {
      history: ["頸部腫塊（漸進性增大）", "呼吸困難或喘息", "吞嚥困難", "聲音改變", "體重減輕", "功能性腫瘤：甲亢症狀"],
      physicalExam: ["頸部可觸及腫塊（常單側）", "腫塊可移動或固定", "頸部淋巴結腫大", "功能性腫瘤：心搏過速、消瘦"]
    },
    pathophysiology: "犬：90%以上甲狀腺腫瘤為惡性（腺癌、濾泡性癌、髓質癌）。約10-20%有功能（分泌甲狀腺激素）。侵襲性強，常侵犯周圍組織和血管，轉移至肺和區域淋巴結常見。貓：甲狀腺腫瘤<5%為惡性，但惡性者侵襲性強。",
    diagnosis: {
      overview: "頸部腫塊 + 影像評估 + 細胞學/組織學確診",
      differentials: ["良性甲狀腺腺瘤（貓）", "甲狀腺增生", "頸部淋巴結腫大", "涎腺腫瘤", "頸部其他腫瘤"],
      initialDB: [
        "甲狀腺功能（T4、TSH）：評估功能狀態",
        "頸部超音波：腫塊大小、侵犯程度、淋巴結",
        "胸腔X光（三視圖）：肺轉移評估",
        "細針抽吸細胞學（若可行）"
      ],
      advanced: [
        "99mTc甲狀腺閃爍掃描：評估功能和異位組織",
        "CT/MRI：術前分期、侵犯評估",
        "組織病理學（切除或活檢）",
        "免疫組織化學（甲狀腺球蛋白、降鈣素）"
      ]
    },
    treatment: {
      overview: "可移動腫瘤首選手術；固定或轉移者考慮其他治療",
      acute: [
        "功能性腫瘤引起甲亢：術前藥物控制"
      ],
      chronic: [
        "手術切除（首選，若腫瘤可移動）：",
        "  - 甲狀腺切除術",
        "  - 可能需要雙側切除",
        "  - 保留副甲狀腺（若可行）",
        "",
        "放射治療：",
        "  - 無法切除或切除不完全",
        "  - 外部放射治療",
        "",
        "放射碘(I-131)：",
        "  - 功能性腫瘤",
        "  - 轉移性分化型甲狀腺癌",
        "  - 高劑量，需專門設施",
        "",
        "化療：",
        "  - Doxorubicin為主",
        "  - 效果有限",
        "",
        "酪氨酸激酶抑制劑：",
        "  - Toceranib: 某些病例可能有效",
        "",
        "術後：",
        "  - 監測甲狀腺功能",
        "  - 低鈣血症管理（若副甲狀腺損傷）",
        "  - 甲狀腺激素補充（若雙側切除）"
      ]
    },
    prognosis: "可完全切除的可移動腫瘤預後較好（中位生存期>2年）。侵犯周圍組織或轉移預後差（中位生存期約3-6個月）。貓甲狀腺癌預後通常較差。",
    pearls: [
      "犬頸部腫塊應考慮甲狀腺癌",
      "腫塊可移動vs固定是重要預後因素",
      "大部分犬甲狀腺腫瘤無功能（T4正常）",
      "術前閃爍掃描有助於評估手術可行性",
      "貓甲狀腺功能亢進惡性比例<5%",
      "轉移常見部位：肺和區域淋巴結"
    ],
    monitoring: [
      "術後：甲狀腺功能、血鈣",
      "影像追蹤（胸腔X光、超音波）",
      "頸部觸診（局部復發）"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 腎上腺腫瘤 ====================

  "adrenal-tumor": {
    zh: "腎上腺腫瘤",
    en: "Adrenal Tumor",
    definition: "起源於腎上腺皮質或髓質的腫瘤。皮質腫瘤可為功能性（分泌皮質醇或醛固酮）或無功能性；髓質腫瘤主要為嗜鉻細胞瘤。",
    synonyms: ["Adrenal Neoplasia", "Adrenocortical Tumor", "腎上腺腫塊"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "老年（犬平均9-11歲；貓平均11-12歲）",
      sex: "功能性皮質腫瘤母犬略多；嗜鉻細胞瘤無性別傾向",
      riskFactors: ["年齡", "大型犬腎上腺依賴性庫欣症(ADH)較多"]
    },
    clinicalPresentation: {
      history: [
        "功能性皮質腫瘤（皮質醇）：庫欣症症狀",
        "功能性皮質腫瘤（醛固酮）：高醛固酮症症狀",
        "嗜鉻細胞瘤：陣發性症狀",
        "無功能性腫瘤：可能無症狀（偶然發現）或腹痛、腹脹"
      ],
      physicalExam: [
        "依功能狀態而異",
        "大型腫瘤可能觸及腹部腫塊",
        "腫瘤出血：急性腹痛、休克",
        "後腔靜脈侵犯：後肢水腫"
      ]
    },
    pathophysiology: "皮質腫瘤：腺瘤（良性）或癌（惡性），約50%各佔一半。功能性者自主分泌皮質激素。髓質腫瘤（嗜鉻細胞瘤）：分泌兒茶酚胺。惡性腫瘤可局部侵犯（後腔靜脈常見）或遠處轉移（肝、肺）。",
    diagnosis: {
      overview: "影像學發現腎上腺腫塊後，評估功能狀態和侵犯範圍",
      differentials: ["腦下垂體依賴性庫欣症（雙側腎上腺增生）", "轉移性腫瘤", "腎上腺增生", "腎上腺囊腫", "其他腹膜後腫塊"],
      initialDB: [
        "腹部超音波：腎上腺大小、對稱性、腫塊特徵",
        "評估後腔靜脈侵犯",
        "皮質醇功能檢測：LDDS、UCCR",
        "內源性ACTH：ADH時低",
        "電解質（高醛固酮症時低血鉀）"
      ],
      advanced: [
        "腹部CT/MRI：精確分期、血管侵犯評估",
        "尿液兒茶酚胺/metanephrines（嗜鉻細胞瘤）",
        "胸腔影像：轉移評估",
        "血壓測量",
        "凝血功能（術前）"
      ]
    },
    treatment: {
      overview: "可切除腫瘤首選手術；無法手術者藥物或保守治療",
      acute: [
        "腫瘤出血/破裂：",
        "  - 輸液復甦",
        "  - 輸血（若需要）",
        "  - 緊急手術（穩定後）",
        "",
        "嗜鉻細胞瘤高血壓危象：見嗜鉻細胞瘤治療"
      ],
      chronic: [
        "手術切除（首選）：",
        "  - 腎上腺切除術",
        "  - 術前穩定（功能性腫瘤：控制皮質醇或血壓）",
        "  - 後腔靜脈腫瘤栓子處理",
        "  - 術後皮質醇補充（對側腎上腺萎縮）",
        "",
        "無法手術的功能性皮質腫瘤：",
        "  - Trilostane或Mitotane控制",
        "  - 劑量可能需較高",
        "",
        "無功能性腫瘤：",
        "  - 小型：監測觀察",
        "  - 大型或進展：考慮手術",
        "",
        "轉移性疾病：",
        "  - 化療（效果有限）",
        "  - 姑息治療"
      ]
    },
    prognosis: "良性腺瘤完全切除預後佳。惡性癌視侵犯和轉移程度而定。有血管侵犯者手術風險和預後較差。中位生存期差異大（數月至數年）。",
    pearls: [
      "腎上腺「偶發瘤」(incidentaloma)：偶然發現，需評估功能和惡性度",
      "腫瘤>2cm惡性可能性增加",
      "後腔靜脈侵犯不一定是手術禁忌，但風險增加",
      "功能性ADH對側腎上腺可能萎縮 - 術後需皮質醇補充",
      "CT對血管侵犯評估優於超音波"
    ],
    monitoring: [
      "術後：皮質醇（腎上腺功能恢復）",
      "影像追蹤（復發/轉移）",
      "藥物治療時：ACTH刺激試驗、電解質"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },

  // ==================== 胰島素瘤 ====================

  "insulinoma": {
    zh: "胰島素瘤",
    en: "Insulinoma",
    definition: "起源於胰島β細胞的功能性腫瘤，分泌過量胰島素導致低血糖。大多數為惡性，但生長緩慢。",
    synonyms: ["Beta Cell Tumor", "胰島細胞瘤", "Insulin-Secreting Tumor", "胰島β細胞腫瘤"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "中老年犬（平均9-10歲，範圍3-14歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向：中大型犬（German Shepherd、Irish Setter、Golden Retriever、Labrador Retriever、Boxer、Standard Poodle）"]
    },
    clinicalPresentation: {
      history: ["發作性虛弱或倒地", "癲癇發作", "運動後症狀", "禁食後症狀", "行為改變、定向障礙", "顫抖", "進食後症狀改善"],
      physicalExam: ["發作間期通常正常", "發作時：虛弱、顫抖、抽搐、昏迷", "可能肥胖（胰島素促進合成代謝）", "腹部觸診通常無異常"]
    },
    pathophysiology: "β細胞腫瘤自主分泌胰島素 → 不受血糖負反饋調控 → 低血糖 → 神經糖原減少症狀（行為改變、定向障礙、癲癇、昏迷）+ 交感神經反應（顫抖、心悸）。進食或運動可誘發症狀（胰島素釋放或葡萄糖消耗）。>90%為惡性，常轉移至肝和區域淋巴結。",
    diagnosis: {
      overview: "低血糖時胰島素不適當升高（Whipple三徵）",
      differentials: ["其他低血糖原因：肝衰竭、敗血症、腎上腺皮質功能低下、腫瘤旁症候群、狩獵犬低血糖、幼犬低血糖、藥物（胰島素過量）"],
      initialDB: [
        "血糖：<60 mg/dL（症狀時同時測胰島素）",
        "血清胰島素：相對於低血糖不適當升高",
        "  - 血糖<60 mg/dL時胰島素應<10 μU/mL",
        "  - 胰島素瘤時通常>20 μU/mL",
        "修正胰島素/葡萄糖比值(AIGR)：>30高度懷疑",
        "CBC、生化全套（排除其他原因）"
      ],
      advanced: [
        "腹部超音波：胰臟腫塊（敏感度約50-70%）",
        "腹部CT：更敏感",
        "肝臟超音波/CT：轉移評估",
        "術中探查：最終診斷"
      ]
    },
    treatment: {
      overview: "手術切除是首選；無法手術或轉移時藥物控制",
      acute: [
        "低血糖急症：",
        "  - 家中：口服糖漿或蜂蜜塗抹牙齦",
        "  - 醫院：Dextrose 50%稀釋後 0.5-1 mL/kg IV bolus",
        "  - 持續監測，可能需要CRI",
        "  - 避免過度葡萄糖刺激胰島素釋放",
        "",
        "癲癇發作：",
        "  - Diazepam（若持續）",
        "  - 葡萄糖補充"
      ],
      chronic: [
        "手術治療（首選）：",
        "  - 部分胰臟切除術（腫瘤所在區）",
        "  - 術中仔細檢查全胰臟和肝臟",
        "  - 轉移灶減瘤（若可行）",
        "  - 術後監測血糖（可能暫時性高血糖或低血糖）",
        "",
        "藥物治療（術後復發或無法手術）：",
        "  - 飲食管理：",
        "    * 少量多餐（4-6餐/天）",
        "    * 高蛋白、高脂肪、低單醣飲食",
        "    * 避免長時間禁食和劇烈運動",
        "",
        "  - Prednisone：0.5-1 mg/kg PO q12h",
        "    * 促進糖質新生、拮抗胰島素",
        "    * 初始常用",
        "",
        "  - Diazoxide：5-30 mg/kg PO q12h",
        "    * 抑制胰島素分泌",
        "    * 可與Prednisone併用",
        "",
        "  - Octreotide（生長抑素類似物）：10-50 μg SC q8-12h",
        "    * 效果不一",
        "",
        "化療：",
        "  - Streptozotocin：有腎毒性，需大量輸液",
        "  - 效果有限"
      ]
    },
    prognosis: "手術完全切除中位生存期約12-18個月。術後復發或轉移常見。藥物控制可維持數月至1年以上。",
    pearls: [
      "Whipple三徵：(1)低血糖症狀 (2)同時血糖低 (3)給葡萄糖後症狀改善",
      "血糖<40-50 mg/dL時測胰島素最有意義",
      "影像學陰性不能排除 - 腫瘤可能很小",
      "術後可能暫時性糖尿病（其他β細胞受抑制）",
      "避免高糖飲食和食物 - 刺激胰島素釋放",
      "運動前應先進食"
    ],
    monitoring: [
      "血糖（定期居家監測）",
      "低血糖發作頻率和嚴重度",
      "影像追蹤（復發/轉移）",
      "藥物副作用"
    ],
    reference: "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  }

};
const ENDOCRINE_DISEASE_ALIASES = {
  // 糖尿病
  "糖尿病": "diabetes-mellitus",
  "糖尿": "diabetes-mellitus",
  "DM": "diabetes-mellitus",
  "diabetes": "diabetes-mellitus",
  "sugar diabetes": "diabetes-mellitus",
  "高血糖": "diabetes-mellitus",

  // 甲狀腺功能亢進（貓）
  "甲亢": "hyperthyroidism-cat",
  "貓甲亢": "hyperthyroidism-cat",
  "甲狀腺功能亢進": "hyperthyroidism-cat",
  "甲狀腺亢進": "hyperthyroidism-cat",
  "hyperthyroidism": "hyperthyroidism-cat",
  "hyperthyroid": "hyperthyroidism-cat",
  "feline hyperthyroidism": "hyperthyroidism-cat",

  // 甲狀腺功能低下（犬）
  "甲低": "hypothyroidism-dog",
  "犬甲低": "hypothyroidism-dog",
  "甲狀腺功能低下": "hypothyroidism-dog",
  "甲狀腺低下": "hypothyroidism-dog",
  "hypothyroidism": "hypothyroidism-dog",
  "hypothyroid": "hypothyroidism-dog",
  "canine hypothyroidism": "hypothyroidism-dog",

  // 腎上腺皮質功能亢進
  "庫欣症": "hyperadrenocorticism",
  "庫欣氏症": "hyperadrenocorticism",
  "cushings": "hyperadrenocorticism",
  "cushing": "hyperadrenocorticism",
  "腎上腺皮質功能亢進": "hyperadrenocorticism",
  "HAC": "hyperadrenocorticism",
  "hyperadrenocorticism": "hyperadrenocorticism",

  // 腎上腺皮質功能低下
  "愛迪生症": "hypoadrenocorticism",
  "愛迪生氏症": "hypoadrenocorticism",
  "addisons": "hypoadrenocorticism",
  "addison": "hypoadrenocorticism",
  "腎上腺皮質功能低下": "hypoadrenocorticism",
  "腎上腺功能不全": "hypoadrenocorticism",
  "hypoadrenocorticism": "hypoadrenocorticism",

  // 嗜鉻細胞瘤
  "嗜鉻細胞瘤": "pheochromocytoma",
  "pheo": "pheochromocytoma",
  "pheochromocytoma": "pheochromocytoma",
  "腎上腺髓質瘤": "pheochromocytoma",

  // 副甲狀腺功能亢進
  "副甲狀腺功能亢進": "hyperparathyroidism",
  "副甲亢": "hyperparathyroidism",
  "HPT": "hyperparathyroidism",
  "hyperparathyroidism": "hyperparathyroidism",
  "高鈣血症": "hyperparathyroidism",

  // 副甲狀腺功能低下
  "副甲狀腺功能低下": "hypoparathyroidism",
  "副甲低": "hypoparathyroidism",
  "hypoparathyroidism": "hypoparathyroidism",
  "低鈣血症": "hypoparathyroidism",

  // 生長激素過多症
  "肢端肥大症": "hypersomatotropism",
  "acromegaly": "hypersomatotropism",
  "GH過多": "hypersomatotropism",
  "生長激素過多": "hypersomatotropism",
  "hypersomatotropism": "hypersomatotropism",

  // 生長激素缺乏
  "生長激素缺乏": "growth-hormone-deficiency",
  "GH缺乏": "growth-hormone-deficiency",
  "侏儒症": "growth-hormone-deficiency",
  "腦下垂體侏儒症": "growth-hormone-deficiency",
  "pituitary dwarfism": "growth-hormone-deficiency",

  // 尿崩症
  "尿崩症": "diabetes-insipidus",
  "DI": "diabetes-insipidus",
  "diabetes insipidus": "diabetes-insipidus",
  "水尿症": "diabetes-insipidus",
  "中樞性尿崩症": "diabetes-insipidus",
  "腎源性尿崩症": "diabetes-insipidus",

  // 高醛固酮症
  "高醛固酮症": "hyperaldosteronism",
  "Conn症": "hyperaldosteronism",
  "conns": "hyperaldosteronism",
  "原發性高醛固酮症": "hyperaldosteronism",
  "hyperaldosteronism": "hyperaldosteronism",

  // 甲狀腺癌
  "甲狀腺癌": "thyroid-carcinoma",
  "甲狀腺腫瘤": "thyroid-carcinoma",
  "thyroid cancer": "thyroid-carcinoma",
  "thyroid carcinoma": "thyroid-carcinoma",

  // 腎上腺腫瘤
  "腎上腺腫瘤": "adrenal-tumor",
  "腎上腺腫塊": "adrenal-tumor",
  "adrenal tumor": "adrenal-tumor",
  "adrenal mass": "adrenal-tumor",
  "腎上腺偶發瘤": "adrenal-tumor",

  // 胰島素瘤
  "胰島素瘤": "insulinoma",
  "insulinoma": "insulinoma",
  "胰島細胞瘤": "insulinoma",
  "beta cell tumor": "insulinoma",
  "低血糖腫瘤": "insulinoma"
  // ===== From dermatological-diseases.js =====

  // ==================== 過敏性皮膚病 ====================

  "atopic-dermatitis": {
    zh: "異位性皮膚炎",
    en: "Atopic Dermatitis",
    definition: "一種遺傳易感性的炎症性和搔癢性皮膚病，與環境過敏原（如塵蟎、花粉、黴菌）的IgE抗體相關。是犬第二常見的過敏性皮膚病（僅次於跳蚤過敏）。",
    synonyms: ["Atopy", "異位性過敏", "Allergic Inhalant Dermatitis", "環境過敏"],
    epidemiology: {
      species: "犬最常見，貓較少見但可發生",
      age: "通常1-3歲發病，6個月至7歲皆可",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（West Highland White Terrier、Labrador、Golden Retriever、German Shepherd、Boxer、Bulldog、Shar-Pei、Dalmatian）", "家族史", "生活環境（室內、城市）", "早期過度清潔環境"]
    },
    clinicalPresentation: {
      history: ["搔癢為主要症狀（可能是唯一症狀）", "季節性發作（初期）逐漸變為全年性", "臉部、耳朵、腳掌、腋下、腹股溝搔抓", "反覆耳炎", "舔腳", "揉臉"],
      physicalExam: ["紅斑", "丘疹", "脫毛", "色素沉著", "苔蘚化（慢性）", "繼發感染（膿皮症、馬拉色菌）", "外耳炎", "結膜炎（部分病例）", "病變分布：臉、耳、腋窩、腹股溝、指間"]
    },
    pathophysiology: "遺傳性皮膚屏障缺陷 + 免疫調節異常 → 過敏原透過皮膚進入 → Th2免疫反應 → IgE產生 → 肥大細胞致敏 → 再次接觸過敏原 → 組織胺和其他介質釋放 → 搔癢和炎症 → 抓傷 → 皮膚屏障進一步破壞 → 繼發感染",
    diagnosis: {
      overview: "臨床診斷為主，基於Favrot標準排除其他搔癢性疾病",
      differentials: ["跳蚤過敏性皮膚炎", "食物過敏", "疥癬", "馬拉色菌皮膚炎", "膿皮症", "接觸性過敏"],
      initialDB: ["完整病史和體檢", "嚴格跳蚤控制試驗", "皮膚刮搔（排除疥癬）", "皮膚細胞學（酵母菌、細菌）", "真菌培養", "食物排除試驗（8-12週）"],
      advanced: ["皮內過敏原測試（金標準）", "血清IgE過敏原測試", "皮膚活檢（非典型病例）"]
    },
    treatment: {
      overview: "多模式治療：避免過敏原、控制搔癢和炎症、修復皮膚屏障、控制繼發感染",
      acute: [
        "急性發作搔癢控制：",
        "- Oclacitinib (Apoquel): 犬 0.4-0.6 mg/kg PO q12h x 14天，之後q24h",
        "- Lokivetmab (Cytopoint): 犬 1-2 mg/kg SC q4-8週",
        "- 短期類固醇：Prednisolone 0.5-1 mg/kg PO q24h x 5-7天",
        "繼發感染治療：",
        "- 抗生素（膿皮症）：Cephalexin 22-30 mg/kg PO q12h",
        "- 抗真菌（馬拉色菌）：Ketoconazole 5-10 mg/kg PO q24h"
      ],
      chronic: [
        "長期管理：",
        "- Oclacitinib或Lokivetmab維持",
        "- Cyclosporine: 5 mg/kg PO q24h（效果需4-6週）",
        "過敏原特異性免疫治療(ASIT)：皮下注射或舌下",
        "皮膚屏障修復：",
        "- 必需脂肪酸補充（Omega-3/6）",
        "- 保濕噴霧/洗劑",
        "- Phytosphingosine產品",
        "藥浴：每週1-2次抗菌/抗真菌/舒緩洗劑",
        "環境控制：減少塵蟎暴露、空氣淨化器"
      ]
    },
    prognosis: "終身管理但可良好控制。早期積極治療可防止皮膚慢性變化。ASIT約60-70%有效。多模式治療效果優於單一藥物。",
    pearls: [
      "Favrot標準：發病<3歲、主要室內、類固醇反應性搔癢、初期無皮膚病變、前腳受累、耳廓受累、耳廓邊緣不受累、腰背部不受累",
      "必須先排除跳蚤過敏和食物過敏",
      "繼發感染是搔癢惡化的常見原因",
      "Oclacitinib不建議用於<12月齡或有腫瘤風險的犬",
      "ASIT是唯一可能改變疾病進程的治療"
    ],
    monitoring: ["搔癢評分（CADESI-4或PVAS）", "繼發感染監測", "藥物副作用（類固醇、Cyclosporine）", "季節性變化"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "food-allergy": {
    zh: "食物過敏",
    en: "Food Allergy",
    definition: "對食物中蛋白質成分產生的免疫介導過敏反應，主要表現為非季節性搔癢性皮膚病，可能伴隨消化道症狀。",
    synonyms: ["Cutaneous Adverse Food Reaction", "食物過敏性皮膚炎", "Food Hypersensitivity", "Dietary Allergy"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，部分在1歲前發病",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（犬：Labrador、Golden Retriever、German Shepherd、Cocker Spaniel、Boxer；貓：Siamese）", "其他過敏病史", "腸道屏障功能異常"]
    },
    clinicalPresentation: {
      history: ["非季節性搔癢", "對類固醇反應較差", "可能伴隨嘔吐、腹瀉", "軟便或排便頻繁", "搔癢可能從幼年開始", "肛門周圍搔癢"],
      physicalExam: ["病變分布類似異位性皮膚炎", "臉部、耳朵、腳掌搔癢", "外耳炎", "肛門周圍紅斑", "可能有膿皮症", "貓：頭頸部皮膚炎、嗜酸性肉芽腫", "腹部和軀幹病變可能更明顯"]
    },
    pathophysiology: "食物抗原通過腸道屏障 → 免疫系統致敏 → 產生食物特異性IgE（部分）或T細胞介導反應 → 再次攝入相同抗原 → 過敏反應 → 皮膚和/或消化道症狀。常見過敏原：牛肉、乳製品、雞肉、小麥、羊肉（犬）；魚、牛肉、乳製品（貓）",
    diagnosis: {
      overview: "排除飲食試驗是唯一可靠的診斷方法",
      differentials: ["異位性皮膚炎", "跳蚤過敏性皮膚炎", "疥癬", "接觸性過敏"],
      initialDB: ["詳細飲食史", "嚴格食物排除試驗（8-12週）", "- 水解蛋白飲食（如Hill's z/d、Royal Canin HP）", "- 或新型蛋白質飲食（之前未接觸過的蛋白質）", "挑戰試驗（確認診斷）"],
      advanced: ["皮膚活檢（非特異性）", "血清IgE食物測試（敏感性/特異性差，不推薦）"]
    },
    treatment: {
      overview: "終身避免致敏食物成分",
      acute: [
        "開始排除飲食試驗前處理繼發感染",
        "搔癢控制（排除試驗期間）：",
        "- Oclacitinib短期使用可接受",
        "- 避免長期類固醇（可能影響試驗結果解讀）"
      ],
      chronic: [
        "確認過敏原後的長期飲食：",
        "- 避免所有含致敏成分的食物",
        "- 選擇適當的商業飲食或自製飲食",
        "- 自製飲食需營養專家配方",
        "逐一挑戰試驗識別具體過敏原",
        "定期飲食評估"
      ]
    },
    prognosis: "嚴格飲食控制下預後極好。一旦識別過敏原，完全避免可控制症狀。某些患者可能對多種食物過敏。",
    pearls: [
      "排除試驗期間必須100%嚴格：無零食、調味藥物、磨牙骨",
      "血清食物過敏測試不可靠，不應作為診斷依據",
      "約30%食物過敏犬同時有環境過敏",
      "排除試驗效果可能需要8-12週才明顯",
      "水解蛋白飲食並非對所有患者都有效"
    ],
    monitoring: ["飲食遵從性", "症狀改善（排除試驗期間每2-4週評估）", "體重和營養狀態", "繼發感染"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "flea-allergy-dermatitis": {
    zh: "跳蚤過敏性皮膚炎",
    en: "Flea Allergy Dermatitis",
    definition: "對跳蚤唾液中過敏原產生的過敏反應，是犬貓最常見的過敏性皮膚病。即使少量跳蚤叮咬也可引起嚴重搔癢。",
    synonyms: ["FAD", "跳蚤過敏", "Flea Bite Hypersensitivity", "Flea Bite Dermatitis"],
    epidemiology: {
      species: "犬貓皆極常見",
      age: "任何年齡，通常1歲後發病",
      sex: "無性別傾向",
      riskFactors: ["有跳蚤暴露", "戶外活動", "多寵物家庭", "溫暖潮濕環境", "未進行跳蚤預防", "其他過敏體質"]
    },
    clinicalPresentation: {
      history: ["劇烈搔癢，尤其腰背部和尾巴根部", "季節性（溫暖月份加重）或全年性（室內）", "可能有發現跳蚤或跳蚤糞便", "反覆發作"],
      physicalExam: ["犬：腰背部、尾巴根部、後腿內側丘疹、脫毛、結痂", "貓：粟粒性皮膚炎、嗜酸性肉芽腫群、對稱性脫毛", "繼發感染（膿皮症、馬拉色菌）", "可能發現跳蚤或跳蚤糞便（梳檢）"]
    },
    pathophysiology: "跳蚤叮咬注入唾液 → 唾液中過敏原致敏 → IgE和T細胞介導的過敏反應 → 單次叮咬可引起數天的搔癢反應。過敏個體對跳蚤唾液中多種蛋白質（如cte f 1）產生反應。",
    diagnosis: {
      overview: "臨床診斷結合跳蚤控制反應試驗",
      differentials: ["異位性皮膚炎", "食物過敏", "疥癬", "皮癬菌感染", "膿皮症"],
      initialDB: ["特徵性病變分布", "發現跳蚤或跳蚤糞便", "梳檢", "跳蚤糞便水試驗（溶解呈紅褐色）", "嚴格跳蚤控制8-12週反應試驗"],
      advanced: ["皮內過敏原測試（跳蚤抗原）", "血清IgE（跳蚤）"]
    },
    treatment: {
      overview: "徹底跳蚤控制是關鍵，需處理患者、同住動物和環境",
      acute: [
        "搔癢控制：",
        "- Oclacitinib: 0.4-0.6 mg/kg PO q12h x 7-14天",
        "- 或短期類固醇：Prednisolone 0.5-1 mg/kg q24h x 5-7天",
        "繼發感染治療",
        "立即開始跳蚤控制"
      ],
      chronic: [
        "終身跳蚤預防（過敏個體）：",
        "口服類：",
        "- Fluralaner (Bravecto): 犬貓 q12週",
        "- Sarolaner (Simparica): 犬 q月",
        "- Afoxolaner (NexGard): 犬 q月",
        "- Spinosad (Comfortis): 犬貓 q月",
        "外用類：",
        "- Selamectin (Revolution): q月",
        "- Fipronil/S-methoprene (Frontline Plus): q月",
        "- Imidacloprid/Flumethrin (Seresto): 項圈，8個月",
        "所有同住動物都需要治療",
        "環境處理：吸塵、清洗寢具、環境噴霧（含IGR）"
      ]
    },
    prognosis: "嚴格跳蚤控制下預後極好。可能需要數週到數月才能完全控制。終身預防對過敏個體至關重要。",
    pearls: [
      "找不到跳蚤不能排除FAD - 過敏貓可能把跳蚤梳掉",
      "單次叮咬可引起2週的搔癢",
      "必須治療所有同住動物",
      "環境中95%的跳蚤是卵、幼蟲、蛹",
      "新型isoxazoline類藥物殺蚤速度快，效果佳"
    ],
    monitoring: ["臨床症狀改善", "跳蚤監測（梳檢）", "環境跳蚤負荷", "藥物遵從性"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  // ==================== 寄生蟲性皮膚病 ====================

  "sarcoptic-mange": {
    zh: "疥癬",
    en: "Sarcoptic Mange",
    definition: "由疥癬蟎(Sarcoptes scabiei var. canis)引起的高度傳染性、劇烈搔癢的皮膚病。是人畜共通傳染病。",
    synonyms: ["Scabies", "犬疥癬", "Sarcoptes Infection", "疥蟎感染"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["接觸感染動物", "收容所", "流浪動物", "犬舍", "野生動物接觸（狐狸）"]
    },
    clinicalPresentation: {
      history: ["劇烈搔癢（與皮膚病變嚴重程度不成比例）", "搔癢持續且進展", "接觸史", "家中其他動物或人可能有症狀"],
      physicalExam: ["初期：耳廓邊緣、肘部、跗部、腹部丘疹和結痂", "後期：全身性、脫毛、結痂、苔蘚化", "耳廓-腳反射陽性（搓耳朵時後腳抓）", "淋巴結腫大"]
    },
    pathophysiology: "疥癬蟎鑽入表皮挖掘隧道 → 產卵 → 生命周期17-21天 → 蟎蟲及其排泄物引起強烈過敏反應 → 劇烈搔癢 → 抓傷和繼發感染",
    diagnosis: {
      overview: "高度懷疑時應進行試驗性治療，因為刮搔陽性率低",
      differentials: ["異位性皮膚炎", "食物過敏", "跳蚤過敏", "接觸性過敏", "皮癬菌感染"],
      initialDB: ["多處皮膚刮搔（耳廓邊緣、肘部、跗部）", "- 陽性率僅20-50%", "耳廓-腳反射", "試驗性治療反應"],
      advanced: ["血清疥癬抗體（ELISA）", "皮膚活檢（非特異性）"]
    },
    treatment: {
      overview: "殺蟎治療，需治療所有接觸動物和環境",
      acute: [
        "首選治療：",
        "- Sarolaner (Simparica): 2 mg/kg PO，每2週一次，共3次",
        "- Fluralaner (Bravecto): 單劑量25-56 mg/kg PO",
        "- Afoxolaner (NexGard): 2.7-6.9 mg/kg PO，每2週共3次",
        "替代治療：",
        "- Selamectin: 6-12 mg/kg局部，每2週共3次",
        "- Ivermectin: 0.2-0.4 mg/kg PO或SC，每週共4-6次",
        "  （注意：Collie及相關品種禁用）",
        "繼發感染治療：抗生素",
        "搔癢控制：短期類固醇"
      ],
      chronic: [
        "所有接觸動物同時治療",
        "環境處理：清洗寢具、吸塵",
        "蟎蟲離開宿主存活時間短（數天）",
        "隔離治療中動物直到痊癒"
      ]
    },
    prognosis: "適當治療預後極好。搔癢可能在蟎蟲清除後持續數週（過敏反應）。",
    pearls: [
      "耳廓-腳反射：搓耳廓邊緣時後腳抓 - 陽性提示疥癬",
      "刮搔陰性不能排除疥癬",
      "高度懷疑時應進行試驗性治療",
      "Isoxazoline類藥物現為首選",
      "人類接觸後可能出現暫時性皮疹（自限性）"
    ],
    monitoring: ["臨床改善", "2-4週後評估", "接觸動物和人的症狀"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "demodectic-mange": {
    zh: "蠕形蟎症",
    en: "Demodectic Mange",
    definition: "由蠕形蟎(Demodex canis犬，D. cati/D. gatoi貓)過度增殖引起的皮膚病。蠕形蟎是正常皮膚微生物群的一部分，免疫功能異常時會過度增殖。",
    synonyms: ["Demodicosis", "毛囊蟎症", "Red Mange", "Demodex Infection"],
    epidemiology: {
      species: "犬最常見，貓較少見",
      age: "幼年型：3-18月齡；成年型：>4歲",
      sex: "無性別傾向",
      riskFactors: ["幼年型：遺傳易感性、短毛純種犬", "成年型：免疫抑制（腫瘤、庫欣症、糖尿病、化療）", "品種傾向（Pit Bull、Shar-Pei、Bulldog、Boston Terrier）"]
    },
    clinicalPresentation: {
      history: ["局部型：1-2個脫毛斑，輕微或無搔癢", "全身型：多處脫毛，可能搔癢（繼發感染）", "成年發病應考慮潛在免疫抑制疾病"],
      physicalExam: ["局部型：臉部、前肢1-5個脫毛斑，輕微鱗屑，可自癒", "全身型：廣泛脫毛、紅斑、毛囊炎、膿皮症", "足蹠型：腳掌腫脹、疼痛、結節", "可能有淋巴結腫大"]
    },
    pathophysiology: "蠕形蟎正常存在於毛囊中，由母犬在哺乳期傳給幼犬。T細胞功能缺陷（遺傳或獲得性）→ 蟎蟲過度增殖 → 毛囊炎 → 繼發細菌感染 → 更嚴重的炎症和免疫抑制 → 惡性循環",
    diagnosis: {
      overview: "深層皮膚刮搔找到大量蠕形蟎即可確診",
      differentials: ["皮癬菌感染", "膿皮症", "疥癬", "過敏性皮膚炎"],
      initialDB: ["深層皮膚刮搔（擠壓皮膚至出血）", "毛髮拔除（拔毛檢查）", "皮膚刮搔需多處採樣", "成年發病需檢查潛在疾病"],
      advanced: ["皮膚活檢（毛囊內蟎蟲）", "免疫功能評估（成年型）", "潛在疾病篩檢（庫欣、糖尿病、腫瘤）"]
    },
    treatment: {
      overview: "殺蟎治療，全身型需要數月治療",
      acute: [
        "首選治療（Isoxazoline類）：",
        "- Fluralaner (Bravecto): 25-56 mg/kg PO，每月一次直到痊癒",
        "- Sarolaner (Simparica): 2 mg/kg PO q月",
        "- Afoxolaner (NexGard): 2.7-6.9 mg/kg PO q月",
        "替代治療：",
        "- Ivermectin: 0.3-0.6 mg/kg PO q24h（逐漸增量）",
        "  （Collie品種禁用，需MDR1基因檢測）",
        "- Milbemycin: 1-2 mg/kg PO q24h",
        "繼發膿皮症治療：長期抗生素"
      ],
      chronic: [
        "治療直到連續2次（間隔1個月）皮膚刮搔陰性",
        "全身型通常需要3-6個月治療",
        "成年型需治療潛在免疫抑制疾病",
        "受影響動物不建議繁殖（遺傳傾向）"
      ]
    },
    prognosis: "局部型：90%自癒，預後極好。全身型幼年：適當治療預後良好。成年型：取決於潛在疾病，可能需要長期管理。",
    pearls: [
      "蠕形蟎症不傳染給其他成年犬或人",
      "幼年局部型多數自癒，可選擇觀察",
      "Isoxazoline類藥物革命性改變了治療",
      "成年發病必須尋找潛在免疫抑制原因",
      "繼發膿皮症是常見併發症，需同時治療"
    ],
    monitoring: ["每月皮膚刮搔（追蹤蟎蟲數量）", "臨床改善", "繼發感染控制", "潛在疾病（成年型）"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "ear-mites": {
    zh: "耳蟎",
    en: "Ear Mites (Otodectes)",
    definition: "由耳蟎(Otodectes cynotis)感染引起的高度傳染性外耳道寄生蟲病，是幼年犬貓外耳炎的最常見原因。",
    synonyms: ["Otodectes cynotis感染", "Otodectic Mange", "Ear Mange", "耳癬"],
    epidemiology: {
      species: "貓最常見，犬亦可感染",
      age: "幼年動物最常見",
      sex: "無性別傾向",
      riskFactors: ["幼年動物", "多動物家庭", "收容所", "繁殖場", "接觸感染動物"]
    },
    clinicalPresentation: {
      history: ["劇烈耳朵搔癢", "頻繁甩頭", "抓耳朵", "黑色耳垢", "傳染給其他動物"],
      physicalExam: ["雙側外耳道大量黑褐色乾燥耳垢（咖啡渣樣）", "耳道紅腫", "耳廓損傷（抓傷）", "可能有頭頸部異位感染", "檢耳鏡可見白色移動蟎蟲"]
    },
    pathophysiology: "耳蟎生活在外耳道表面，以表皮碎屑和組織液為食 → 生命周期約21天 → 蟎蟲活動和排泄物引起刺激和過敏反應 → 搔癢和炎症 → 耳垢產生增加",
    diagnosis: {
      overview: "檢耳鏡直視或耳垢顯微鏡檢查",
      differentials: ["細菌性外耳炎", "馬拉色菌外耳炎", "過敏性外耳炎", "異物"],
      initialDB: ["檢耳鏡檢查（見白色移動蟎蟲）", "耳垢顯微鏡檢查（蟎蟲、卵）", "礦物油塗片"],
      advanced: ["皮膚刮搔（若有異位感染）"]
    },
    treatment: {
      overview: "殺蟎治療，需治療所有接觸動物",
      acute: [
        "全身性治療（首選）：",
        "- Selamectin (Revolution): 6 mg/kg局部，每月一次共2次",
        "- Sarolaner (Simparica): 單劑量",
        "- Fluralaner (Bravecto): 單劑量",
        "- Ivermectin: 0.2-0.3 mg/kg SC，每2週共3次",
        "局部治療：",
        "- Ivermectin耳滴劑",
        "- Milbemycin耳滴劑",
        "- Thiabendazole/Tresaderm",
        "耳道清潔：移除過多耳垢"
      ],
      chronic: [
        "所有接觸動物同時治療",
        "環境清潔（蟎蟲離開宿主存活時間短）",
        "預防性使用含殺蟎成分的預防藥"
      ]
    },
    prognosis: "適當治療預後極好。一般2-3週可清除感染。",
    pearls: [
      "黑色咖啡渣樣耳垢是典型特徵",
      "必須治療所有同住動物",
      "全身性Isoxazoline類藥物非常有效",
      "10%的外耳炎病例可能有耳蟎參與",
      "成年動物單獨感染較少見，應考慮免疫問題"
    ],
    monitoring: ["2-3週後重新檢查", "症狀改善", "其他動物症狀"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  // ==================== 自體免疫性皮膚病 ====================

  "pemphigus": {
    zh: "天疱瘡",
    en: "Pemphigus",
    definition: "一組自體免疫性皮膚病，特徵為針對角質形成細胞間連結蛋白（橋粒）的自身抗體，導致表皮內水疱和膿疱。落葉型天疱瘡是犬貓最常見的類型。",
    synonyms: ["Pemphigus Foliaceus", "落葉型天疱瘡", "PF", "Pemphigus Vulgaris", "尋常型天疱瘡"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，中年（4-6歲）最常見",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（犬：Akita、Chow Chow、Doberman、Dachshund、Newfoundland；貓：無）", "可能由藥物誘發", "可能由慢性皮膚病演變"]
    },
    clinicalPresentation: {
      history: ["落葉型(PF)：臉部開始的膿疱和結痂", "尋常型(PV)：口腔潰瘍、皮膚黏膜交界處病變", "可能有全身症狀（發燒、嗜睡）"],
      physicalExam: ["PF：膿疱（易破裂）、結痂、糜爛、脫毛", "分布：鼻樑、耳廓、眼周、腳墊、全身", "腳墊過度角化", "PV：口腔、皮膚黏膜交界處潰瘍（嚴重型）", "Nikolsky sign可能陽性（壓迫正常皮膚產生水疱）"]
    },
    pathophysiology: "自身抗體（抗橋粒芯蛋白抗體）→ 攻擊角質形成細胞間連結 → 棘層細胞鬆解（acantholysis）→ 表皮內水疱/膿疱形成。PF抗體針對淺層橋粒芯蛋白1；PV抗體針對深層橋粒芯蛋白3",
    diagnosis: {
      overview: "皮膚活檢是診斷金標準",
      differentials: ["膿皮症", "皮癬菌感染", "蠕形蟎症", "紅斑性狼瘡", "藥疹", "表皮代謝壞死"],
      initialDB: ["膿疱細胞學（棘層鬆解細胞）", "皮膚刮搔（排除蟎蟲）", "真菌培養", "皮膚活檢（新鮮膿疱或水疱邊緣）"],
      advanced: ["免疫螢光/免疫組織化學", "抗核抗體(ANA)"]
    },
    treatment: {
      overview: "免疫抑制治療是主要方案",
      acute: [
        "誘導緩解：",
        "- Prednisolone/Prednisone: 2-4 mg/kg/day PO（分次給予）",
        "- 或 Dexamethasone: 0.2-0.4 mg/kg/day",
        "繼發感染治療（若有）",
        "局部治療：Tacrolimus軟膏（局部病變）"
      ],
      chronic: [
        "維持治療（類固醇減量方案）：",
        "- 逐漸減量至最低有效劑量",
        "- 目標：隔日最低劑量",
        "類固醇替代藥物（減少副作用）：",
        "- Azathioprine: 犬 2 mg/kg q24-48h（貓禁用）",
        "- Mycophenolate mofetil: 10-20 mg/kg PO q12h",
        "- Chlorambucil: 貓 0.1-0.2 mg/kg q24-48h",
        "- Cyclosporine: 5-10 mg/kg PO q12-24h",
        "難治病例：",
        "- 金製劑注射",
        "- 人免疫球蛋白(hIVIG)"
      ]
    },
    prognosis: "需終身治療。多數患者可良好控制。約75%需要長期免疫抑制。部分可達到緩解並減藥。預後因類型而異：PF較好，PV較差。",
    pearls: [
      "膿疱易破裂，臨床常見結痂而非膿疱",
      "細胞學見棘層鬆解細胞高度提示天疱瘡",
      "活檢應取新鮮膿疱或水疱邊緣",
      "Azathioprine對貓有嚴重骨髓抑制風險，禁用",
      "藥物誘發型停藥可能緩解"
    ],
    monitoring: ["臨床症狀（每2-4週直到穩定）", "血液檢查（類固醇/免疫抑制劑副作用）", "繼發感染"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "lupus-erythematosus": {
    zh: "紅斑性狼瘡",
    en: "Lupus Erythematosus",
    definition: "自體免疫性疾病，分為系統性紅斑性狼瘡(SLE)和皮膚型紅斑性狼瘡(CLE)。SLE累及多器官系統；CLE主要局限於皮膚。盤狀紅斑性狼瘡(DLE)是最常見的皮膚型。",
    synonyms: ["SLE", "系統性紅斑性狼瘡", "DLE", "盤狀紅斑性狼瘡", "Discoid Lupus Erythematosus", "Cutaneous Lupus"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "SLE：年輕至中年犬；DLE：中年犬",
      sex: "SLE：母犬可能較多",
      riskFactors: ["品種傾向（SLE：Collie、German Shepherd、Shetland Sheepdog；DLE：German Shepherd、Siberian Husky、Collie、Shetland Sheepdog）", "紫外線暴露加重DLE"]
    },
    clinicalPresentation: {
      history: ["DLE：鼻樑脫色和潰瘍", "SLE：多系統症狀（關節痛、腎病、皮膚病變、發燒）"],
      physicalExam: ["DLE：鼻鏡色素脫失、紅斑、結痂、潰瘍、鼻紋消失", "可能擴展到鼻樑和眼周", "SLE：多形性皮膚病變、多發性關節炎、蛋白尿、貧血、血小板減少"]
    },
    pathophysiology: "自身抗體形成（抗核抗體、抗DNA抗體等）→ 免疫複合物沉積 → 補體活化 → 組織損傷。SLE涉及多器官；DLE局限於皮膚基底膜區域免疫複合物沉積",
    diagnosis: {
      overview: "DLE：臨床和活檢；SLE：多系統證據結合血清學",
      differentials: ["天疱瘡", "皮癬菌感染", "蠕形蟎症", "鼻部鱗狀細胞癌", "黏膜皮膚膿皮症"],
      initialDB: ["皮膚活檢（界面皮膚炎、基底膜帶免疫複合物）", "DLE：鼻鏡活檢", "SLE：ANA、LE細胞、Coombs試驗、尿液分析"],
      advanced: ["免疫螢光（基底膜帶）", "抗dsDNA抗體", "關節液分析", "腎臟活檢（SLE）"]
    },
    treatment: {
      overview: "DLE：局部治療和免疫調節；SLE：全身免疫抑制",
      acute: [
        "DLE：",
        "- 避免日曬（防曬霜、限制戶外活動）",
        "- 局部類固醇或Tacrolimus",
        "- 口服維生素E: 400-800 IU q12h",
        "- 必需脂肪酸補充",
        "SLE：",
        "- Prednisolone: 2-4 mg/kg/day誘導",
        "- 治療器官特異性問題"
      ],
      chronic: [
        "DLE（難治病例）：",
        "- Tetracycline + Niacinamide",
        "- 低劑量口服類固醇",
        "SLE維持治療：",
        "- 類固醇減量至最低有效劑量",
        "- 免疫抑制劑（Azathioprine、Mycophenolate）",
        "終身監測和治療"
      ]
    },
    prognosis: "DLE：預後良好，可良好控制但需終身管理。SLE：預後謹慎至差，取決於器官累及程度。腎臟累及預後較差。",
    pearls: [
      "DLE是犬最常見的自體免疫皮膚病",
      "鼻鏡「鵝卵石」紋路消失是DLE早期徵兆",
      "DLE可能進展為SLE（罕見）",
      "SLE診斷需滿足多項標準",
      "避免日曬是DLE管理的重要部分"
    ],
    monitoring: ["DLE：臨床症狀、照片記錄", "SLE：腎功能、CBC、尿液分析、ANA滴度"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  // ==================== 皮脂腺和角化異常 ====================

  "sebaceous-adenitis": {
    zh: "皮脂腺炎",
    en: "Sebaceous Adenitis",
    definition: "一種免疫介導的皮脂腺炎症性疾病，導致皮脂腺破壞、脫毛和嚴重鱗屑。主要影響特定品種犬。",
    synonyms: ["SA", "Granulomatous Sebaceous Adenitis", "肉芽腫性皮脂腺炎"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "1-5歲多見",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Standard Poodle、Akita、Samoyed、Vizsla、German Shepherd）", "遺傳傾向"]
    },
    clinicalPresentation: {
      history: ["進行性脫毛", "皮膚乾燥、鱗屑", "毛髮變粗糙", "可能無症狀或輕微搔癢"],
      physicalExam: ["Standard Poodle型：對稱性脫毛、銀白色鱗屑、毛囊角栓", "Akita型：脂漏、油膩結痂、繼發膿皮症", "分布：背部、頸部、頭頂、耳廓", "毛髮簇狀貼附在鱗屑中"]
    },
    pathophysiology: "病因不明，可能為自體免疫機制 → 淋巴細胞和組織細胞浸潤皮脂腺 → 皮脂腺破壞 → 皮脂分泌減少 → 毛囊角化異常 → 脫毛和鱗屑",
    diagnosis: {
      overview: "皮膚活檢是診斷金標準",
      differentials: ["蠕形蟎症", "皮癬菌感染", "原發性脂漏症", "甲狀腺功能低下", "內分泌性脫毛"],
      initialDB: ["皮膚活檢（早期：皮脂腺周圍肉芽腫性炎症；晚期：皮脂腺缺失）", "皮膚刮搔（排除蟎蟲）", "真菌培養", "甲狀腺功能"],
      advanced: ["多處活檢", "遺傳檢測（繁殖評估）"]
    },
    treatment: {
      overview: "外用油浴治療為主，嚴重病例需全身免疫調節",
      acute: [
        "油浴治療（每週1-2次）：",
        "- 礦物油或嬰兒油塗抹全身",
        "- 浸泡1-2小時",
        "- 溫和洗劑清洗",
        "角質溶解洗劑",
        "繼發感染治療（若有）"
      ],
      chronic: [
        "長期油浴維持",
        "口服必需脂肪酸",
        "免疫調節治療（嚴重病例）：",
        "- Cyclosporine: 5 mg/kg PO q12-24h",
        "- 維生素A: 10,000-30,000 IU q24h",
        "- 合成維生素A酸（慎用）",
        "局部Propylene glycol噴霧"
      ]
    },
    prognosis: "終身管理。Standard Poodle型對治療反應較好。Akita型較難控制。早期治療可能改善預後。毛髮再生可能不完全。",
    pearls: [
      "活檢時機很重要：晚期可能只見皮脂腺缺失",
      "Standard Poodle的SA是常染色體隱性遺傳",
      "油浴是治療基礎，需要主人配合",
      "繼發膿皮症常見於Akita型",
      "繁殖犬應進行皮膚活檢篩檢"
    ],
    monitoring: ["臨床改善", "繼發感染", "皮膚活檢追蹤（繁殖篩檢）"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "seborrhea": {
    zh: "脂漏症",
    en: "Seborrhea",
    definition: "皮膚角化異常導致的鱗屑和/或油膩皮膚狀態。可為原發性（遺傳）或繼發於其他皮膚病。",
    synonyms: ["Seborrheic Dermatitis", "脂漏性皮膚炎", "Keratinization Disorder", "角化異常"],
    epidemiology: {
      species: "犬為主",
      age: "原發性：幼年發病；繼發性：任何年齡",
      sex: "無性別傾向",
      riskFactors: ["原發性：品種傾向（Cocker Spaniel、Springer Spaniel、West Highland White Terrier、Basset Hound、Irish Setter、German Shepherd、Shar-Pei）", "繼發性：過敏、內分泌病、寄生蟲、感染"]
    },
    clinicalPresentation: {
      history: ["皮膚鱗屑（乾性）或油膩（油性）", "皮膚氣味（油性型）", "可能有搔癢（繼發感染或過敏）"],
      physicalExam: ["乾性脂漏(Seborrhea sicca)：乾燥白色鱗屑", "油性脂漏(Seborrhea oleosa)：油膩黃褐色鱗屑、皮膚油膩", "混合型最常見", "常伴隨外耳炎", "繼發馬拉色菌和/或細菌感染"]
    },
    pathophysiology: "原發性：遺傳性角質形成細胞更新加速（正常21-28天→數天）→ 鱗屑堆積、皮脂分泌異常。繼發性：潛在疾病影響角化和皮脂分泌 → 脂漏表現",
    diagnosis: {
      overview: "需排除繼發性原因，原發性脂漏是排除性診斷",
      differentials: ["過敏（異位性、食物、跳蚤）", "甲狀腺功能低下", "庫欣症", "蠕形蟎症", "皮癬菌感染", "皮脂腺炎"],
      initialDB: ["詳細病史", "皮膚刮搔", "皮膚細胞學（酵母菌、細菌）", "真菌培養", "甲狀腺功能", "食物排除試驗"],
      advanced: ["皮膚活檢", "過敏原測試", "內分泌功能全面評估"]
    },
    treatment: {
      overview: "治療潛在病因（繼發性）；症狀控制（原發性）",
      acute: [
        "繼發感染治療：",
        "- 馬拉色菌：Ketoconazole 5-10 mg/kg PO q24h",
        "- 膿皮症：適當抗生素",
        "藥浴治療"
      ],
      chronic: [
        "藥浴療法（每週1-3次根據嚴重程度）：",
        "- 乾性脂漏：保濕洗劑、燕麥洗劑",
        "- 油性脂漏：含硫、水楊酸、過氧化苯甲醯的洗劑",
        "- 混合型：交替使用",
        "- 抗真菌洗劑（Miconazole、Chlorhexidine）",
        "口服治療：",
        "- 必需脂肪酸",
        "- 維生素A（原發性脂漏）",
        "治療潛在疾病"
      ]
    },
    prognosis: "繼發性：治療潛在病因後預後良好。原發性：終身管理，可控制但無法治癒。定期藥浴可維持良好皮膚狀態。",
    pearls: [
      "90%以上的脂漏症是繼發性的",
      "必須排除過敏和內分泌病",
      "馬拉色菌過度生長幾乎總是存在",
      "Cocker Spaniel是原發性脂漏的典型品種",
      "藥浴頻率根據症狀調整"
    ],
    monitoring: ["臨床改善", "繼發感染控制", "潛在疾病管理"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  // ==================== 脫毛疾病 ====================

  "alopecia-x": {
    zh: "X型脫毛症",
    en: "Alopecia X",
    definition: "一種病因不明的非炎症性脫毛疾病，主要影響北歐犬種。皮膚和毛囊對正常激素水平反應異常，導致進行性脫毛。",
    synonyms: ["Growth Hormone Responsive Dermatosis", "Castration Responsive Dermatosis", "黑皮症", "BSD (Black Skin Disease)", "Adrenal Sex Hormone Imbalance"],
    epidemiology: {
      species: "犬",
      age: "1-3歲或>9歲雙峰發病",
      sex: "公犬略多，絕育後也可發生",
      riskFactors: ["品種傾向（Pomeranian、Chow Chow、Alaskan Malamute、Samoyed、Siberian Husky、Keeshond、Miniature Poodle）", "可能有遺傳成分"]
    },
    clinicalPresentation: {
      history: ["進行性脫毛，無搔癢", "從臀部和大腿開始", "皮膚顏色變深", "毛髮再生後可能再次脫落"],
      physicalExam: ["雙側對稱性脫毛", "皮膚色素沉著（黑皮症）", "頭部和四肢毛髮保留", "皮膚無炎症、無結痂", "可能有毛髮質地改變（羊毛狀）"]
    },
    pathophysiology: "病因不明，可能涉及毛囊對多種激素（生長激素、腎上腺性激素、褪黑激素等）反應異常。毛囊進入休止期並停止生長周期。皮膚活檢顯示毛囊萎縮和「火焰狀」毛囊。",
    diagnosis: {
      overview: "排除性診斷，需排除其他內分泌性脫毛",
      differentials: ["甲狀腺功能低下", "庫欣症", "性激素失衡", "蠕形蟎症", "皮癬菌感染", "毛囊發育不良"],
      initialDB: ["完整病史和體檢", "甲狀腺功能（T4、fT4、TSH）", "皮質醇/ACTH刺激試驗", "性激素檢測", "皮膚刮搔", "真菌培養"],
      advanced: ["皮膚活檢（毛囊萎縮、火焰狀毛囊）", "腎上腺性激素panel", "ACTH刺激後性激素", "腹部超音波（腎上腺評估）"]
    },
    treatment: {
      overview: "純粹美容問題，可選擇不治療；多種治療方法效果不定",
      acute: [
        "絕育（未絕育動物）：部分病例有效",
        "觀察等待（純美容問題）"
      ],
      chronic: [
        "藥物治療（效果不一）：",
        "- Melatonin: 3-6 mg PO q8-12h（可能有效）",
        "- Trilostane: 2-5 mg/kg PO q24h（監測腎上腺功能）",
        "- Deslorelin植入（抗GnRH）",
        "局部Minoxidil（效果有限）",
        "微針刺激毛髮生長（實驗性）"
      ]
    },
    prognosis: "對健康無影響，純美容問題。治療效果不可預測。部分犬自發性毛髮再生。可能有周期性變化。",
    pearls: [
      "這是一個美容問題，不影響健康",
      "Pomeranian是最常見的受影響品種",
      "絕育可能促進毛髮再生（機制不明）",
      "治療反應難以預測",
      "皮膚活檢有特徵性但非診斷性發現"
    ],
    monitoring: ["照片記錄毛髮變化", "若使用Trilostane需監測腎上腺功能"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "pattern-baldness": {
    zh: "型態性禿毛",
    en: "Pattern Baldness",
    definition: "一種遺傳性的非炎症性脫毛疾病，表現為特定區域的進行性毛髮稀疏和脫落，類似人類的雄性禿。",
    synonyms: ["Canine Pattern Alopecia", "Pattern Alopecia", "品種相關性禿毛", "Pinnal Alopecia"],
    epidemiology: {
      species: "犬",
      age: "6個月至3歲開始",
      sex: "依亞型不同，公犬或母犬可能更常見",
      riskFactors: ["品種傾向（Dachshund、Chihuahua、Whippet、Italian Greyhound、Boston Terrier、Miniature Pinscher）", "遺傳因素"]
    },
    clinicalPresentation: {
      history: ["進行性、非炎症性脫毛", "特定區域毛髮稀疏", "無搔癢", "從年輕時開始"],
      physicalExam: ["耳廓禿毛（Pinnal alopecia）：耳廓背面進行性脫毛", "腹側型（Ventral pattern）：胸腹部、頸部腹側、大腿內側脫毛", "馬鞍型：軀幹兩側和尾巴", "皮膚正常、無炎症、無色素沉著", "毛髮逐漸稀疏直到完全禿毛"]
    },
    pathophysiology: "遺傳性毛囊對雄激素的敏感性或毛囊微型化。毛囊逐漸縮小，產生越來越細的毛髮直到停止生長。不涉及炎症或免疫機制。",
    diagnosis: {
      overview: "臨床診斷為主，基於典型分布和品種",
      differentials: ["內分泌性脫毛（甲狀腺功能低下、庫欣症）", "毛囊發育不良", "蠕形蟎症"],
      initialDB: ["詳細病史", "特徵性臨床表現", "皮膚刮搔（排除蟎蟲）", "甲狀腺功能（鑑別診斷）"],
      advanced: ["皮膚活檢（毛囊微型化、無炎症）"]
    },
    treatment: {
      overview: "純粹美容問題，通常無需治療",
      acute: [
        "無特異性急性治療",
        "排除其他疾病"
      ],
      chronic: [
        "通常不需要治療（純美容問題）",
        "嘗試性治療（效果不確定）：",
        "- Melatonin: 3-6 mg PO q8-12h",
        "- 局部Minoxidil（效果有限）",
        "防曬保護暴露皮膚"
      ]
    },
    prognosis: "對健康無影響。脫毛通常進行性但限於特定區域。無法恢復。不影響壽命或生活品質。",
    pearls: [
      "這是遺傳性美容問題，不影響健康",
      "Dachshund的耳廓禿毛是典型例子",
      "短毛品種較常見",
      "與人類雄性禿類似機制",
      "無有效治療方法"
    ],
    monitoring: ["照片記錄變化", "防曬（暴露皮膚）"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  // ==================== 其他皮膚病 ====================

  "hot-spot": {
    zh: "急性濕疹",
    en: "Hot Spot (Acute Moist Dermatitis)",
    definition: "急性、局部、表淺性的化膿性皮膚炎，因自我創傷（舔、咬、抓）導致。常在數小時內快速發展，是犬最常見的皮膚急症之一。",
    synonyms: ["Acute Moist Dermatitis", "Pyotraumatic Dermatitis", "急性濕性皮膚炎", "Summer Sores"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["長毛、濃密毛髮品種（Golden Retriever、Labrador、German Shepherd、St. Bernard、Newfoundland）", "夏季/潮濕季節", "游泳後", "跳蚤過敏", "過敏性皮膚炎", "耳炎", "肛門腺問題"]
    },
    clinicalPresentation: {
      history: ["快速發展（數小時）", "劇烈舔或抓某部位", "可能有潛在病因（跳蚤、游泳、耳炎）"],
      physicalExam: ["境界清楚的紅斑、糜爛、滲出病灶", "濕潤、黏稠分泌物", "脫毛", "疼痛", "周圍毛髮粘結", "常見於頭部、頸部、臀部"]
    },
    pathophysiology: "潛在刺激（搔癢、疼痛）→ 自我創傷（舔、咬、抓）→ 表皮損傷 → 繼發細菌感染（葡萄球菌）→ 滲出和炎症 → 更多搔癢 → 惡性循環。熱氣和濕氣加速細菌增殖。",
    diagnosis: {
      overview: "臨床診斷，需尋找潛在誘因",
      differentials: ["深層膿皮症", "蠕形蟎症", "皮癬菌感染", "腫瘤"],
      initialDB: ["臨床表現", "細胞學（球菌）", "評估潛在誘因（跳蚤、耳炎、肛門腺）"],
      advanced: ["皮膚刮搔（排除蟎蟲）", "細菌培養（難治病例）", "皮膚活檢（非典型或不癒合）"]
    },
    treatment: {
      overview: "剃毛、清潔、控制感染和搔癢、治療潛在病因",
      acute: [
        "局部治療：",
        "- 剃毛病灶周圍（充分暴露病灶邊界）",
        "- 清潔消毒（Chlorhexidine、Povidone-iodine）",
        "- 外用抗生素軟膏（Mupirocin、Fusidic acid）",
        "- 局部類固醇噴霧（減少炎症）",
        "全身治療（較大或嚴重病灶）：",
        "- 抗生素：Cephalexin 22-30 mg/kg PO q12h x 7-14天",
        "- 短期類固醇：Prednisolone 0.5-1 mg/kg x 3-5天",
        "- 或 Oclacitinib止癢",
        "伊莉莎白項圈防止繼續自我創傷"
      ],
      chronic: [
        "識別和治療潛在誘因",
        "跳蚤預防",
        "過敏管理",
        "定期梳毛保持皮膚乾燥"
      ]
    },
    prognosis: "適當治療預後極好，通常5-7天癒合。復發常見若未處理潛在誘因。",
    pearls: [
      "剃毛是關鍵步驟 - 病灶常比看起來大",
      "必須找出潛在誘因防止復發",
      "Golden Retriever的臀部熱斑可能是深層膿皮症",
      "頭頸部熱斑常與耳炎相關",
      "夏季游泳後特別容易發生"
    ],
    monitoring: ["48-72小時後評估改善", "潛在誘因處理"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "callus-pressure-sore": {
    zh: "繭/壓瘡",
    en: "Callus/Pressure Sore",
    definition: "繭是反覆壓力或摩擦導致的皮膚增厚和角化過度；壓瘡是持續壓力導致的皮膚和軟組織缺血性壞死。常見於骨突部位。",
    synonyms: ["Callus", "繭", "Decubital Ulcer", "褥瘡", "Pressure Ulcer", "Bed Sore", "Hygromatic Ulcer"],
    epidemiology: {
      species: "犬為主",
      age: "任何年齡，老年或臥床動物更易發生壓瘡",
      sex: "無性別傾向",
      riskFactors: ["繭：大型/巨型犬種、睡硬地面、肥胖", "壓瘡：癱瘓、無法行動、住院、瘦弱、營養不良、老年"]
    },
    clinicalPresentation: {
      history: ["繭：逐漸形成的肘部或跗部厚皮", "壓瘡：臥床動物的皮膚破損"],
      physicalExam: ["繭：肘部、跗部、胸骨的增厚、角化過度、無毛皮膚", "可能有裂隙", "繭膿皮症：繭部位的毛囊炎和癤腫", "壓瘡：骨突部位的紅斑、糜爛、潰瘍、壞死", "可能深達骨骼"]
    },
    pathophysiology: "繭：反覆壓力和摩擦 → 表皮增厚（保護性反應）→ 角化過度 → 毛囊阻塞可導致繭膿皮症。壓瘡：持續壓力 → 局部血流受阻 → 組織缺血 → 細胞死亡 → 壞死和潰瘍",
    diagnosis: {
      overview: "臨床診斷",
      differentials: ["繭膿皮症", "腫瘤", "感染"],
      initialDB: ["臨床表現", "細胞學（若有分泌物）"],
      advanced: ["皮膚活檢（排除腫瘤）", "細菌培養（感染病例）", "X光（評估骨骼累及）"]
    },
    treatment: {
      overview: "繭：減少壓力、軟化皮膚；壓瘡：解除壓力、傷口護理",
      acute: [
        "繭：",
        "- 提供柔軟墊料/床墊",
        "- 肘部護墊",
        "- 保濕軟化劑",
        "繭膿皮症：",
        "- 抗生素（Cephalexin 22-30 mg/kg q12h）3-4週以上",
        "- 溫敷促進引流",
        "壓瘡：",
        "- 解除壓力（勤翻身、使用氣墊床）",
        "- 傷口清創",
        "- 保持傷口濕潤清潔"
      ],
      chronic: [
        "繭預防：",
        "- 永久提供柔軟睡墊",
        "- 體重管理",
        "壓瘡：",
        "- 每2-4小時翻身（臥床動物）",
        "- 營養支持",
        "- 壓力釋放裝置",
        "- 嚴重病例可能需要手術修復"
      ]
    },
    prognosis: "繭：預防性措施下預後良好。繭膿皮症需要長期治療。壓瘡：取決於嚴重程度和潛在疾病，嚴重者預後謹慎。",
    pearls: [
      "大型犬提供適當睡墊是最佳預防",
      "繭膿皮症需要長期抗生素治療",
      "壓瘡預防比治療容易",
      "癱瘓動物需要嚴格的護理計畫",
      "營養狀態影響傷口癒合"
    ],
    monitoring: ["繭大小和狀態", "壓瘡癒合進度", "感染徵象"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "zinc-responsive-dermatosis": {
    zh: "鋅反應性皮膚病",
    en: "Zinc-Responsive Dermatosis",
    definition: "因鋅缺乏或鋅利用障礙導致的皮膚病，表現為結痂、鱗屑和角化過度，尤其在身體開口處和壓力點。",
    synonyms: ["Zinc Deficiency", "鋅缺乏性皮膚病", "Zinc-Dependent Dermatosis"],
    epidemiology: {
      species: "犬",
      age: "依類型不同：症候群I（北歐犬種，任何年齡）；症候群II（快速生長幼犬）",
      sex: "無性別傾向",
      riskFactors: ["症候群I：Siberian Husky、Alaskan Malamute（遺傳性鋅吸收障礙）", "症候群II：快速生長期、高穀物/高鈣飲食、Giant品種幼犬"]
    },
    clinicalPresentation: {
      history: ["身體開口處結痂和鱗屑", "生長快速期發病（症候群II）", "飲食史（高穀物、缺乏肉類）"],
      physicalExam: ["症候群I：眼周、口周、耳廓紅斑、結痂、鱗屑", "肘部、跗部角化過度", "腳墊增厚、裂隙", "症候群II：類似分布但更嚴重", "可能有全身症狀（厭食、生長遲緩）"]
    },
    pathophysiology: "症候群I：遺傳性腸道鋅吸收障礙 → 即使飲食鋅正常也會缺乏。症候群II：飲食鋅不足或被飲食中過量鈣、植酸鹽結合 → 鋅生物利用度降低。鋅是角質形成細胞正常功能所必需 → 缺乏導致角化異常",
    diagnosis: {
      overview: "臨床表現、品種傾向和治療反應",
      differentials: ["皮癬菌感染", "脂漏症", "天疱瘡", "紅斑性狼瘡", "泛發性蠕形蟎症"],
      initialDB: ["詳細飲食史", "臨床表現", "皮膚活檢（角化不全、棘皮症）", "血清鋅濃度（可能正常）"],
      advanced: ["皮膚活檢", "對鋅補充的反應"]
    },
    treatment: {
      overview: "鋅補充是主要治療",
      acute: [
        "症候群I：",
        "- 硫酸鋅：10 mg/kg PO q24h（與食物分開給予）",
        "- 或甲硫胺酸鋅：2 mg/kg PO q24h",
        "- 或葡萄糖酸鋅：5 mg/kg PO q24h",
        "症候群II：",
        "- 糾正飲食（減少植酸、鈣）",
        "- 暫時性鋅補充"
      ],
      chronic: [
        "症候群I：終身鋅補充",
        "症候群II：飲食糾正後通常不需要長期補充",
        "改善需要4-6週"
      ]
    },
    prognosis: "症候群I：需要終身鋅補充，補充後預後良好。症候群II：飲食糾正後預後極好，通常完全恢復。",
    pearls: [
      "Siberian Husky和Alaskan Malamute是症候群I典型品種",
      "鋅最好與食物分開給予以提高吸收",
      "高鈣飲食干擾鋅吸收",
      "血清鋅濃度可能正常（組織缺乏）",
      "治療反應通常在4-6週內可見"
    ],
    monitoring: ["臨床改善", "治療反應", "鋅毒性症狀（罕見）"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  }

};
const DERMATOLOGICAL_DISEASE_ALIASES = {
  // 過敏性皮膚病
  "異位性皮膚炎": "atopic-dermatitis",
  "異位性過敏": "atopic-dermatitis",
  "環境過敏": "atopic-dermatitis",
  "atopy": "atopic-dermatitis",
  "atopic": "atopic-dermatitis",

  "食物過敏": "food-allergy",
  "食物過敏性皮膚炎": "food-allergy",
  "飲食過敏": "food-allergy",
  "food hypersensitivity": "food-allergy",

  "跳蚤過敏": "flea-allergy-dermatitis",
  "跳蚤過敏性皮膚炎": "flea-allergy-dermatitis",
  "FAD": "flea-allergy-dermatitis",
  "flea allergy": "flea-allergy-dermatitis",

  // 寄生蟲性皮膚病
  "疥癬": "sarcoptic-mange",
  "犬疥癬": "sarcoptic-mange",
  "疥蟎": "sarcoptic-mange",
  "scabies": "sarcoptic-mange",
  "sarcoptes": "sarcoptic-mange",

  "蠕形蟎症": "demodectic-mange",
  "蠕形蟎": "demodectic-mange",
  "毛囊蟎": "demodectic-mange",
  "demodicosis": "demodectic-mange",
  "demodex": "demodectic-mange",

  "耳蟎": "ear-mites",
  "耳癬": "ear-mites",
  "otodectes": "ear-mites",

  // 自體免疫性皮膚病
  "天疱瘡": "pemphigus",
  "落葉型天疱瘡": "pemphigus",
  "PF": "pemphigus",
  "pemphigus foliaceus": "pemphigus",

  "紅斑性狼瘡": "lupus-erythematosus",
  "狼瘡": "lupus-erythematosus",
  "SLE": "lupus-erythematosus",
  "DLE": "lupus-erythematosus",
  "盤狀紅斑性狼瘡": "lupus-erythematosus",
  "lupus": "lupus-erythematosus",

  // 皮脂腺和角化異常
  "皮脂腺炎": "sebaceous-adenitis",
  "SA": "sebaceous-adenitis",
  "sebaceous adenitis": "sebaceous-adenitis",

  "脂漏症": "seborrhea",
  "脂漏性皮膚炎": "seborrhea",
  "脂漏": "seborrhea",
  "seborrheic": "seborrhea",

  // 脫毛疾病
  "X型脫毛": "alopecia-x",
  "X型脫毛症": "alopecia-x",
  "黑皮症": "alopecia-x",
  "BSD": "alopecia-x",

  "型態性禿毛": "pattern-baldness",
  "品種相關性禿毛": "pattern-baldness",
  "pattern alopecia": "pattern-baldness",

  // 其他皮膚病
  "急性濕疹": "hot-spot",
  "熱斑": "hot-spot",
  "hot spot": "hot-spot",
  "pyotraumatic dermatitis": "hot-spot",

  "繭": "callus-pressure-sore",
  "壓瘡": "callus-pressure-sore",
  "褥瘡": "callus-pressure-sore",
  "callus": "callus-pressure-sore",
  "pressure sore": "callus-pressure-sore",
  "decubital ulcer": "callus-pressure-sore",

  "鋅反應性皮膚病": "zinc-responsive-dermatosis",
  "鋅缺乏": "zinc-responsive-dermatosis",
  "zinc deficiency": "zinc-responsive-dermatosis",
  "zinc responsive": "zinc-responsive-dermatosis"
  // ===== From ophthalmological-diseases.js =====

  // ============================================================
  // 1. Keratoconjunctivitis Sicca (KCS/Dry Eye) - 乾眼症
  // ============================================================
  "keratoconjunctivitis-sicca": {
    zh: "乾眼症",
    en: "Keratoconjunctivitis Sicca (KCS/Dry Eye)",
    definition: "乾眼症是一種因淚液分泌不足或淚膜質量異常導致的慢性眼表疾病，造成角膜和結膜的發炎與損傷。淚液產量不足會導致眼表乾燥、角膜上皮細胞損傷、繼發性細菌感染，若未治療可能導致角膜潰瘍、疤痕形成甚至失明。",
    synonyms: ["KCS", "Dry Eye Syndrome", "淚液缺乏症", "乾性角結膜炎"],

    epidemiology: {
      species: "主要影響犬隻，貓較少見。犬的發生率約1-4%",
      age: "中老年犬較常見（5-10歲），但免疫介導性KCS可在任何年齡發生",
      sex: "無明顯性別傾向",
      riskFactors: [
        "品種易感性：美國可卡犬、英國鬥牛犬、西施犬、巴哥犬、約克夏、查理士王騎士犬、迷你雪納瑞",
        "免疫介導性疾病（最常見原因，佔大多數病例）",
        "先天性淚腺發育不全",
        "藥物誘發（磺胺類藥物、Etodolac、某些麻醉藥物）",
        "感染性（犬瘟熱病毒）",
        "神經性（顏面神經麻痺影響淚腺支配）",
        "創傷或手術損傷淚腺",
        "代謝性疾病（甲狀腺功能低下、糖尿病、庫興氏症）",
        "放射線治療後",
        "第三眼瞼腺摘除術後（cherry eye手術併發症）"
      ]
    },

    clinicalPresentation: {
      history: [
        "慢性或反覆發作的眼部分泌物（黏液膿性）",
        "眼睛紅腫、結膜充血",
        "頻繁眨眼、瞇眼",
        "眼睛表面失去光澤",
        "對光敏感",
        "用抗生素治療後暫時改善但反覆發作",
        "視力逐漸下降（嚴重病例）",
        "可能有乾鼻症狀（同側鼻腔乾燥）"
      ],
      physicalExam: [
        "黏液膿性眼分泌物（特徵性）",
        "結膜充血與水腫",
        "角膜表面乾燥、無光澤",
        "角膜色素沉著（慢性病例）",
        "角膜血管新生",
        "角膜潰瘍（繼發性）",
        "角膜疤痕形成",
        "瞬膜（第三眼瞼）突出",
        "眼瞼痙攣",
        "Schirmer淚液試驗值降低（<15mm/min為可疑，<10mm/min為確診）"
      ]
    },

    pathophysiology: "KCS的病理機制主要涉及淚腺功能障礙。免疫介導性KCS（最常見）是由於T淋巴細胞浸潤淚腺組織，導致腺泡細胞破壞和纖維化。淚液由水層、脂質層和黏液層組成，任何成分缺乏都會影響淚膜穩定性。水層缺乏最為常見，導致淚液滲透壓升高，引發角膜上皮細胞損傷、發炎介質釋放、杯狀細胞減少（進一步減少黏液層），形成惡性循環。長期缺乏淚液潤滑會導致角膜上皮化生、血管新生、色素沉著，最終可能導致角膜疤痕和視力喪失。",

    diagnosis: {
      overview: "KCS的診斷主要依賴臨床表現和Schirmer淚液試驗（STT）。STT-I測量基礎和反射性淚液分泌，是標準診斷方法。",
      differentials: [
        "細菌性結膜炎",
        "過敏性結膜炎",
        "角膜潰瘍",
        "眼瞼內翻/外翻",
        "睫毛異常（雙行睫、異位睫毛）",
        "前葡萄膜炎",
        "犬瘟熱感染",
        "藥物性眼表毒性"
      ],
      initialDB: [
        "Schirmer淚液試驗（STT-I）：正常值>15mm/min，10-15mm/min為早期/可疑，<10mm/min為確診，<5mm/min為嚴重",
        "螢光素染色：評估角膜上皮完整性",
        "Rose Bengal染色：評估角膜和結膜上皮細胞活性",
        "眼壓測量：排除青光眼",
        "裂隙燈檢查：評估角膜狀況",
        "細菌培養和藥敏試驗（有膿性分泌物時）"
      ],
      advanced: [
        "淚膜破裂時間（TBUT）：評估淚膜穩定性",
        "結膜印記細胞學：評估杯狀細胞密度",
        "淚腺活檢（罕用）：確認淚腺病理變化",
        "神經學檢查：排除神經性KCS",
        "全身性疾病篩檢：甲狀腺功能、血糖等"
      ]
    },

    treatment: {
      overview: "治療目標包括刺激淚液分泌、替代淚液、控制繼發感染、減少發炎反應。免疫介導性KCS通常需要終生治療。",
      acute: [
        "人工淚液：頻繁使用（每2-4小時），選擇不含防腐劑的產品",
        "局部抗生素：控制繼發性細菌感染（如Tobramycin、Ofloxacin）",
        "清潔眼部：溫和清除分泌物",
        "環孢素眼藥（Cyclosporine 0.2-2%）：每日2次，為免疫介導性KCS的首選治療",
        "他克莫司眼藥（Tacrolimus 0.02-0.03%）：對環孢素反應不佳的病例"
      ],
      chronic: [
        "持續使用免疫調節藥物（環孢素或他克莫司）：終生治療",
        "人工淚液維持：根據需要使用",
        "定期監測STT值",
        "黏液溶解劑（Acetylcysteine）：幫助清除黏液分泌物",
        "手術選項（藥物治療失敗時）：腮腺管移位術（Parotid duct transposition）",
        "環境管理：避免乾燥、多風環境，使用加濕器"
      ]
    },

    prognosis: "預後取決於病因和治療反應。免疫介導性KCS若早期診斷並接受適當治療，約70-80%的病例可獲得良好控制。環孢素治療通常在2-6週內見效。未治療或治療反應不佳的病例可能發展為嚴重角膜病變和視力喪失。神經性KCS預後較差，先天性KCS通常需要終生密切管理。",

    pearls: [
      "任何慢性、反覆發作的結膜炎都應檢測STT排除KCS",
      "環孢素需要2-6週才能見到明顯效果，初期需配合人工淚液",
      "單側KCS應考慮神經性病因或局部因素",
      "第三眼瞼腺脫垂（cherry eye）手術應採用腺體復位術而非切除，以避免醫源性KCS",
      "某些犬對環孢素反應不佳，可嘗試他克莫司",
      "STT應在任何眼藥使用前進行，以獲得準確結果"
    ],

    defined: true
  },

  // ============================================================
  // 2. Corneal Ulcer - 角膜潰瘍
  // ============================================================
  "corneal-ulcer": {
    zh: "角膜潰瘍",
    en: "Corneal Ulcer",
    definition: "角膜潰瘍是指角膜上皮的缺損，可延伸至基質層甚至更深層結構。這是小動物最常見的眼科急症之一，若未及時治療可能導致角膜穿孔和失明。根據深度可分為淺層潰瘍（僅上皮層）、基質潰瘍（涉及基質層）和深層潰瘍（接近或達到後彈力膜）。",
    synonyms: ["角膜糜爛", "Corneal Erosion", "Ulcerative Keratitis", "潰瘍性角膜炎"],

    epidemiology: {
      species: "犬貓均常見，為最常見的眼科急症之一",
      age: "任何年齡均可發生，但短頭種犬的發生率較高",
      sex: "無明顯性別傾向",
      riskFactors: [
        "短頭種（Brachycephalic breeds）：巴哥、北京犬、西施犬、波士頓梗、波斯貓等",
        "眼球突出（Exophthalmos）",
        "眼瞼異常：內翻、外翻、眼瞼閉合不全",
        "睫毛異常：雙行睫、異位睫毛",
        "乾眼症（KCS）",
        "外傷：打架、異物、化學灼傷",
        "感染：細菌、病毒（貓疱疹病毒）、真菌",
        "神經麻痺導致眨眼功能障礙",
        "配戴不當的隱形眼鏡（罕見）"
      ]
    },

    clinicalPresentation: {
      history: [
        "急性發作的眼睛疼痛",
        "過度流淚（epiphora）",
        "頻繁眨眼或瞇眼（blepharospasm）",
        "畏光",
        "眼睛紅腫",
        "可能有外傷史",
        "眼部分泌物（黏液性或膿性）",
        "可能拒絕睜眼或用爪搔眼"
      ],
      physicalExam: [
        "螢光素染色陽性（角膜缺損區著色）",
        "結膜充血",
        "角膜水腫（灰白色混濁）",
        "眼瞼痙攣",
        "瞳孔縮小（反射性虹膜痙攣）",
        "前房閃輝（嚴重病例，繼發性葡萄膜炎）",
        "角膜血管新生（慢性或癒合中的潰瘍）",
        "角膜基質溶解/軟化（melting ulcer，嚴重）",
        "後彈力膜膨出（Descemetocele，危急）",
        "角膜穿孔（最嚴重併發症）"
      ]
    },

    pathophysiology: "角膜由外至內分為上皮層、前彈力膜、基質層、後彈力膜（Descemet's membrane）和內皮層。正常角膜上皮有快速再生能力（24-48小時可覆蓋小缺損）。當上皮受損後，基質暴露於淚液中的蛋白酶和細菌產生的膠原酶，可能導致基質溶解（melting）。感染性潰瘍中，細菌（特別是Pseudomonas aeruginosa）和真菌可產生膠原酶，加速基質破壞。若損傷達到後彈力膜，此薄層可能因眼內壓而向外膨出形成Descemetocele，進一步可能破裂導致角膜穿孔。反覆性角膜糜爛（Indolent ulcer/SCCED）則是因基底膜異常，新生上皮無法正常附著。",

    diagnosis: {
      overview: "診斷主要依賴螢光素染色和裂隙燈檢查。需評估潰瘍深度、是否有感染跡象、是否有潛在病因。",
      differentials: [
        "角膜異物",
        "乾眼症（KCS）",
        "青光眼",
        "前葡萄膜炎",
        "角膜營養不良/變性",
        "角膜內皮營養不良",
        "睫毛異常導致的角膜刺激",
        "貓疱疹病毒性角膜炎"
      ],
      initialDB: [
        "螢光素染色：確認上皮缺損，評估範圍和深度",
        "Schirmer淚液試驗：排除KCS",
        "眼壓測量：排除青光眼",
        "裂隙燈檢查：評估潰瘍深度、基質狀況、前房反應",
        "仔細檢查眼瞼和睫毛：排除機械性因素",
        "神經學評估：檢查眨眼反射和角膜敏感度"
      ],
      advanced: [
        "角膜細胞學/刮片：評估感染類型（細菌、真菌）",
        "細菌培養和藥敏試驗：深層或融解性潰瘍必需",
        "真菌培養：疑似真菌感染時",
        "PCR檢測：貓疱疹病毒",
        "角膜共聚焦顯微鏡：評估細胞層次變化",
        "眼部超音波：角膜混濁無法看清眼內結構時"
      ]
    },

    treatment: {
      overview: "治療策略取決於潰瘍深度、是否感染、是否有基質溶解。淺層單純性潰瘍通常可保守治療，深層或複雜性潰瘍可能需要手術介入。",
      acute: [
        "局部廣效抗生素：頻繁使用（每2-6小時），如Tobramycin、Ofloxacin、Chloramphenicol",
        "散瞳劑：Atropine 1%，減輕睫狀肌痙攣和疼痛",
        "止痛：全身性NSAID或opioid",
        "戴伊莉莎白頸圈：防止自我傷害",
        "融解性潰瘍額外治療：血清或EDTA眼藥（抑制膠原酶）、更頻繁的抗生素（每1-2小時）",
        "深層潰瘍/Descemetocele：考慮緊急手術（結膜瓣、角膜移植）",
        "頑固性潰瘍（SCCED）：清創、格子狀角膜切開術、鑽石磨片術"
      ],
      chronic: [
        "持續抗生素治療直至完全癒合",
        "處理潛在病因（KCS、眼瞼異常、睫毛異常）",
        "角膜疤痕管理",
        "長期追蹤監測",
        "若有結構性問題考慮矯正手術"
      ]
    },

    prognosis: "預後取決於潰瘍深度、病因和治療時機。淺層單純性潰瘍在適當治療下通常在3-7天內癒合，預後良好。深層潰瘍和融解性潰瘍預後較謹慎，可能需要數週癒合並可能留下疤痕影響視力。Descemetocele和角膜穿孔為眼科急症，即使手術治療也可能有視力喪失風險。頑固性潰瘍（SCCED）治療後癒合率可達85-95%，但可能需要多次處置。",

    pearls: [
      "所有角膜潰瘍都應檢測STT排除KCS作為潛在病因",
      "融解性潰瘍是眼科急症，需要積極治療和密切監測",
      "避免使用含類固醇的眼藥治療角膜潰瘍（會抑制癒合並加重感染）",
      "Descemetocele不會染色（後彈力膜無細胞），周圍基質會染色形成'凹陷'外觀",
      "短頭種犬應定期眼科檢查，因其解剖結構使其易患角膜疾病",
      "貓的角膜潰瘍應考慮疱疹病毒感染，特別是有呼吸道症狀病史者"
    ],

    defined: true
  },

  // ============================================================
  // 3. Uveitis - 葡萄膜炎
  // ============================================================
  "uveitis": {
    zh: "葡萄膜炎",
    en: "Uveitis",
    definition: "葡萄膜炎是眼球葡萄膜（虹膜、睫狀體和脈絡膜）的發炎。根據受影響部位可分為前葡萄膜炎（虹膜炎和睫狀體炎）、後葡萄膜炎（脈絡膜炎）和全葡萄膜炎。這是一種可能威脅視力的疾病，常為全身性疾病的眼部表現。",
    synonyms: ["虹膜炎", "睫狀體炎", "脈絡膜炎", "Iritis", "Cyclitis", "Choroiditis", "Iridocyclitis"],

    epidemiology: {
      species: "犬貓均常見，是重要的眼科疾病",
      age: "任何年齡，但中老年動物更常見全身性病因",
      sex: "無明顯性別傾向",
      riskFactors: [
        "感染性疾病：犬（犬瘟熱、Ehrlichia、Borrelia、Leptospira、Brucella、真菌感染）；貓（FIP、FeLV、FIV、Toxoplasma、Bartonella、真菌感染）",
        "免疫介導性疾病",
        "水晶體誘發性葡萄膜炎（白內障滲漏、水晶體脫位、白內障手術後）",
        "創傷（穿透傷、鈍傷）",
        "腫瘤（原發性或轉移性眼內腫瘤）",
        "角膜潰瘍（反射性前葡萄膜炎）",
        "特發性（排除其他病因後）"
      ]
    },

    clinicalPresentation: {
      history: [
        "眼睛紅腫、疼痛",
        "畏光、避光",
        "過度流淚",
        "瞇眼、眨眼頻繁",
        "視力下降或失明",
        "瞳孔大小改變",
        "可能有全身性疾病症狀（發燒、食慾不振、體重減輕）"
      ],
      physicalExam: [
        "結膜和鞏膜充血（睫狀充血：環繞角膜緣的深層血管充血）",
        "角膜水腫",
        "前房閃輝（aqueous flare）：因蛋白滲出使房水混濁",
        "前房積膿（hypopyon）或前房積血（hyphema）",
        "瞳孔縮小（miosis）且對散瞳劑反應差",
        "虹膜顏色改變（可能變暗）",
        "虹膜表面可見纖維素沉積",
        "虹膜後黏連（posterior synechia）",
        "眼壓降低（早期）或升高（繼發性青光眼）",
        "玻璃體混濁（後葡萄膜炎）",
        "視網膜脫離、滲出、出血（後葡萄膜炎）"
      ]
    },

    pathophysiology: "葡萄膜炎的核心機制是血-房水屏障和血-視網膜屏障的破壞。正常情況下，這些屏障限制蛋白質和細胞進入眼內。發炎時，血管通透性增加，導致蛋白質、纖維蛋白和發炎細胞滲入房水和玻璃體。前列腺素和其他發炎介質引起血管擴張（充血）、平滑肌收縮（瞳孔縮小）和睫狀體功能障礙（房水產生減少，導致眼壓下降）。持續發炎可導致虹膜後黏連、繼發性青光眼、白內障形成、視網膜脫離等併發症。",

    diagnosis: {
      overview: "葡萄膜炎的診斷基於臨床表現，但更重要的是找出潛在病因，因為這影響治療和預後。需進行全面眼科檢查和全身性疾病篩檢。",
      differentials: [
        "急性青光眼（眼壓升高vs降低）",
        "角膜潰瘍（螢光素染色陽性）",
        "結膜炎（較表淺，無前房變化）",
        "鞏膜炎/表層鞏膜炎",
        "眼內腫瘤",
        "水晶體脫位",
        "視網膜脫離"
      ],
      initialDB: [
        "完整眼科檢查：裂隙燈、眼底鏡",
        "眼壓測量：通常降低，但需排除繼發性青光眼",
        "螢光素染色：排除角膜潰瘍",
        "全血球計數（CBC）",
        "血清生化檢查",
        "尿液分析",
        "胸腔X光：評估全身性疾病、轉移性腫瘤"
      ],
      advanced: [
        "感染性疾病血清學檢測：根據地區和病史選擇（Ehrlichia、Borrelia、Leptospira、Brucella等）",
        "貓：FeLV/FIV檢測、Toxoplasma抗體、FIP相關檢測",
        "眼部超音波：評估後段結構，特別是角膜混濁時",
        "前房穿刺（aqueocentesis）：細胞學、培養、PCR",
        "玻璃體穿刺：後葡萄膜炎診斷",
        "腹部超音波：評估全身性疾病",
        "淋巴結穿刺：疑似腫瘤或全身性感染"
      ]
    },

    treatment: {
      overview: "治療目標是控制發炎、緩解疼痛、預防併發症和處理潛在病因。需同時進行局部和全身性治療。",
      acute: [
        "局部類固醇：Prednisolone acetate 1%或Dexamethasone 0.1%，每4-6小時（需排除角膜潰瘍）",
        "局部散瞳劑：Atropine 1%，維持瞳孔擴張，預防黏連，減輕疼痛",
        "局部NSAID：如Flurbiprofen、Ketorolac（輔助抗發炎）",
        "全身性NSAID或類固醇：根據病因和嚴重程度",
        "全身性止痛",
        "針對病因的特異性治療（抗生素、抗真菌、抗原蟲藥物）"
      ],
      chronic: [
        "維持局部抗發炎治療並逐漸減量",
        "長期免疫抑制治療（免疫介導性病例）",
        "定期監測眼壓（預防繼發性青光眼）",
        "監測白內障形成",
        "處理虹膜後黏連",
        "繼發性青光眼的治療",
        "持續治療潛在全身性疾病"
      ]
    },

    prognosis: "預後取決於病因、嚴重程度、是否及時治療和對治療的反應。特發性和外傷性葡萄膜炎在適當治療下通常預後良好。感染性葡萄膜炎預後取決於能否有效控制感染。腫瘤相關葡萄膜炎預後較差。水晶體誘發性葡萄膜炎可能需要白內障手術。嚴重或慢性葡萄膜炎可能導致永久性視力喪失、繼發性青光眼、視網膜脫離、眼球萎縮（phthisis bulbi）。",

    pearls: [
      "葡萄膜炎常是全身性疾病的眼部表現，務必進行全身性檢查",
      "前房閃輝是葡萄膜炎的特徵性發現，需用聚焦光束在暗室中檢查",
      "使用局部類固醇前必須排除角膜潰瘍",
      "瞳孔縮小是前葡萄膜炎的典型表現，與急性青光眼的瞳孔擴張相反",
      "眼壓降低是前葡萄膜炎早期的特徵，但後期可能因房水排出受阻而升高",
      "貓的葡萄膜炎常與FIP、FeLV、FIV或Toxoplasma有關",
      "犬的單側葡萄膜炎更可能是局部病因（創傷、腫瘤），雙側則考慮全身性疾病"
    ],

    defined: true
  },

  // ============================================================
  // 4. Progressive Retinal Atrophy (PRA) - 進行性視網膜萎縮
  // ============================================================
  "progressive-retinal-atrophy": {
    zh: "進行性視網膜萎縮",
    en: "Progressive Retinal Atrophy (PRA)",
    definition: "進行性視網膜萎縮是一組遺傳性視網膜退化疾病的總稱，特徵是光感受器（視桿細胞和/或視錐細胞）的進行性變性，最終導致失明。這是犬隻最常見的遺傳性眼病之一。根據發病時間和受影響細胞類型可分為早發型（視網膜發育不良）和晚發型（視網膜變性）。",
    synonyms: ["PRA", "視網膜變性", "遺傳性視網膜病變", "Retinal Degeneration", "Rod-Cone Degeneration"],

    epidemiology: {
      species: "主要影響犬隻，貓較少見。已在超過100個犬種中報告",
      age: "發病年齡因品種和PRA類型而異，從幼年（數週齡）到成年（3-5歲或更晚）",
      sex: "大多數為常染色體隱性遺傳，無性別傾向；X連鎖型（如西伯利亞哈士奇）影響公犬",
      riskFactors: [
        "品種易感性（高度品種特異性）",
        "常見於：可卡犬、拉布拉多、黃金獵犬、迷你雪納瑞、玩具貴賓、迷你貴賓、愛爾蘭雪達犬、英國可卡犬",
        "早發型品種：愛爾蘭雪達犬（XLPRA1）、挪威獵麋犬、迷你雪納瑞",
        "晚發型品種：拉布拉多、黃金獵犬、可卡犬、貴賓犬",
        "近親繁殖增加風險",
        "貓：阿比西尼亞貓、索馬利貓、波斯貓"
      ]
    },

    clinicalPresentation: {
      history: [
        "夜盲症（nyctalopia）：通常是最早症狀，在低光環境下視力明顯變差",
        "進行性視力喪失：從周邊視野開始",
        "對光線變化適應能力變差",
        "在不熟悉環境中容易碰撞物體",
        "眼睛反光增強（因視網膜退化）",
        "瞳孔擴大",
        "最終完全失明",
        "發病和進展速度因品種和PRA類型而異"
      ],
      physicalExam: [
        "瞳孔擴張（對光反射減弱或消失）",
        "眼底反光增強（tapetal hyperreflectivity）：因視網膜變薄",
        "視網膜血管萎縮、變細",
        "視神經盤蒼白、萎縮",
        "非反光區（non-tapetal area）色素減少或不規則",
        "晚期：繼發性白內障（約50-75%病例）",
        "眼球可能正常或略小",
        "威脅反射減弱或消失",
        "ERG（視網膜電圖）異常（早於臨床可見病變）"
      ]
    },

    pathophysiology: "PRA是由多種不同基因突變引起的一組疾病，但共同特徵是光感受器的進行性死亡。早發型PRA（視網膜發育不良）中，光感受器未能正常發育或發育後快速退化，通常視桿細胞先受影響，然後是視錐細胞。晚發型PRA中，光感受器正常發育但在成年後開始退化。不同類型的PRA涉及不同基因，包括PDE6B、PRCD、CNGB1等，這些基因編碼對光感受器功能至關重要的蛋白質。光感受器死亡後，視網膜外核層變薄，最終完全消失。繼發性白內障可能因視網膜代謝異常和營養支持減少而發生。",

    diagnosis: {
      overview: "診斷主要依賴眼底檢查、視網膜電圖（ERG）和基因檢測。早期病例眼底可能正常，ERG和基因檢測更有價值。",
      differentials: [
        "突發性後天視網膜變性（SARDS）：急性發病vs漸進性",
        "視神經炎/視神經病變",
        "白內障（若白內障阻礙眼底觀察）",
        "視網膜脫離",
        "青光眼晚期",
        "中樞性失明（腦部病變）",
        "營養性視網膜變性（如牛磺酸缺乏，貓）",
        "犬瘟熱病毒引起的視網膜病變"
      ],
      initialDB: [
        "完整眼科檢查：直接和間接眼底鏡檢查",
        "瞳孔光反射測試",
        "威脅反射測試",
        "暗室行為觀察：評估夜視能力",
        "裂隙燈檢查：評估前段和白內障"
      ],
      advanced: [
        "視網膜電圖（ERG）：金標準，可在眼底變化前檢測功能異常",
        "基因檢測：確認特定PRA類型，用於繁殖篩選",
        "OCT（光學相干斷層掃描）：評估視網膜厚度",
        "眼部超音波：當白內障阻礙眼底觀察時",
        "血液檢查：排除全身性疾病",
        "腦部MRI：排除中樞性病因（若瞳孔反射正常但失明）"
      ]
    },

    treatment: {
      overview: "目前沒有治癒PRA的方法。治療以支持性照護、併發症管理和繁殖控制為主。研究中的基因治療為未來帶來希望。",
      acute: [
        "無急性治療適應症（除非有併發症）",
        "繼發性白內障若造成青光眼需緊急處理"
      ],
      chronic: [
        "抗氧化劑補充：可能減緩進展（Vitamin E、Vitamin C、Omega-3脂肪酸、葉黃素）",
        "避免繁殖：防止遺傳給下一代",
        "環境管理：保持家具位置固定，使用聲音和氣味線索",
        "繼發性白內障管理：若影響生活品質可考慮手術（但視網膜功能已喪失，手術意義有限）",
        "失明犬的生活適應訓練",
        "定期眼科追蹤：監測併發症"
      ]
    },

    prognosis: "PRA是不可逆的進行性疾病，最終會導致完全失明。從夜盲症出現到完全失明的時間因品種和PRA類型而異，可能是數月到數年。繼發性白內障發生在大部分病例中。雖然視力無法挽回，但大多數犬隻在熟悉的環境中適應良好，可維持良好的生活品質。主人教育和環境管理是照護的重要部分。",

    pearls: [
      "夜盲症是PRA的早期特徵性症狀，應詢問低光環境下的視力表現",
      "眼底反光增強是視網膜變薄的結果，是診斷PRA的重要眼底發現",
      "ERG可在眼底變化出現前數月至數年檢測到異常",
      "基因檢測不僅用於診斷，更重要的是用於繁殖篩選以減少疾病發生",
      "繼發性白內障常見，但因視網膜已無功能，白內障手術通常不適用",
      "犬隻適應失明的能力通常很好，特別是在熟悉的環境中",
      "任何易感品種的繁殖犬都應進行基因檢測和眼科認證檢查"
    ],

    defined: true
  },

  // ============================================================
  // 5. Retinal Detachment - 視網膜剝離
  // ============================================================
  "retinal-detachment": {
    zh: "視網膜剝離",
    en: "Retinal Detachment",
    definition: "視網膜剝離是指神經感覺視網膜（neuroretina）與視網膜色素上皮層（RPE）分離。這是眼科急症，若未及時治療會導致永久性視力喪失。根據病因可分為滲出性（非裂孔性）、牽引性和裂孔性三種類型。",
    synonyms: ["視網膜脫離", "Retinal Separation", "Detached Retina"],

    epidemiology: {
      species: "犬貓均可發生",
      age: "任何年齡，老年動物較常見",
      sex: "無明顯性別傾向",
      riskFactors: [
        "高血壓（貓最常見原因，犬也常見）",
        "全身性感染性疾病（犬：Ehrlichia、真菌感染；貓：FIP、FeLV、Toxoplasma）",
        "眼內腫瘤",
        "嚴重葡萄膜炎",
        "創傷",
        "白內障手術後",
        "玻璃體退化和液化",
        "先天性異常：膠原病（如Shih Tzu的視網膜發育不良）",
        "腎臟疾病（與高血壓相關）",
        "甲狀腺功能亢進（貓，與高血壓相關）",
        "糖尿病（較少見）"
      ]
    },

    clinicalPresentation: {
      history: [
        "急性或漸進性視力喪失",
        "可能單側或雙側",
        "雙側剝離表現為突然失明",
        "主人可能注意到瞳孔擴大",
        "行為改變：撞到物體、不願移動、不願跳躍",
        "可能有全身性疾病症狀（多飲多尿、體重減輕等）",
        "高血壓病例可能有神經症狀"
      ],
      physicalExam: [
        "瞳孔擴大、對光反射減弱或消失",
        "威脅反射消失",
        "眼底檢查：視網膜浮起、呈灰白色或灰色",
        "視網膜皺褶或氣球狀隆起",
        "可見視網膜血管走行於脫離的視網膜表面",
        "視網膜下液體積聚（滲出性）",
        "可見視網膜裂孔（裂孔性）",
        "玻璃體混濁或出血",
        "可能伴有眼內出血（hyphema）",
        "高血壓病例：視網膜血管迂曲、出血、水腫"
      ]
    },

    pathophysiology: "視網膜的神經感覺層與色素上皮層之間的潛在空間（視網膜下腔）在正常情況下由多種機制維持貼附。剝離可由三種機制發生：(1)滲出性/漿液性剝離：最常見於小動物，由視網膜下液體積聚引起（高血壓、發炎、腫瘤滲出）；(2)牽引性剝離：玻璃體牽引視網膜（玻璃體纖維化、增殖性玻璃體視網膜病變）；(3)裂孔性剝離：視網膜裂孔允許液化的玻璃體進入視網膜下腔（玻璃體退化、創傷）。一旦剝離，光感受器失去來自脈絡膜的營養和氧氣供應，導致細胞死亡。剝離時間越長，光感受器損傷越嚴重，視力恢復可能性越低。",

    diagnosis: {
      overview: "診斷基於眼科檢查和眼部超音波。更重要的是找出潛在病因（特別是高血壓和全身性疾病），因為這決定治療方向。",
      differentials: [
        "白內障（無法看清眼底時）",
        "玻璃體出血",
        "視網膜變性（PRA等）",
        "視神經病變",
        "中樞性失明",
        "眼內腫瘤",
        "嚴重葡萄膜炎"
      ],
      initialDB: [
        "完整眼科檢查：散瞳後眼底檢查",
        "眼部超音波：確認剝離，評估範圍，排除腫瘤",
        "血壓測量：必須！高血壓是最常見可治療病因",
        "全血球計數（CBC）",
        "血清生化檢查：評估腎功能",
        "尿液分析：蛋白尿、腎臟疾病",
        "甲狀腺功能檢測（貓）"
      ],
      advanced: [
        "感染性疾病檢測：根據病史和臨床表現",
        "心臟超音波：評估心臟疾病（高血壓原因）",
        "腹部超音波：評估腎臟、腎上腺",
        "眼內液體細胞學（玻璃體或視網膜下液穿刺）：疑似腫瘤或感染",
        "CT/MRI：評估眼眶和顱內病變",
        "視網膜電圖（ERG）：評估視網膜功能，判斷視力恢復潛力"
      ]
    },

    treatment: {
      overview: "治療取決於病因和剝離類型。滲出性剝離治療潛在病因後可能復位；牽引性和裂孔性剝離通常需要手術。時間是關鍵因素。",
      acute: [
        "緊急血壓控制（高血壓病例）：Amlodipine 0.625-1.25mg/cat PO q24h 或犬 0.1-0.5mg/kg PO q24h",
        "全身性類固醇（發炎性病例）：Prednisolone 1-2mg/kg/day",
        "針對感染的特異性治療",
        "手術選項（裂孔性或牽引性）：視網膜復位術、玻璃體切除術、鞏膜扣帶術、視網膜雷射光凝固術",
        "眼內注射藥物（特定情況）"
      ],
      chronic: [
        "持續控制血壓",
        "監測視網膜狀態",
        "治療潛在全身性疾病",
        "定期眼科追蹤",
        "視力未恢復者的生活適應"
      ]
    },

    prognosis: "預後取決於剝離類型、持續時間、範圍和潛在病因。高血壓引起的滲出性剝離若能在24-72小時內有效控制血壓，約50-70%可獲得視網膜復位和一定程度的視力恢復。剝離時間越長，光感受器損傷越嚴重，視力恢復可能性越低。完全剝離超過7-14天通常視力恢復希望渺茫。裂孔性和牽引性剝離預後較差，手術成功率因病例而異。腫瘤相關剝離預後不良。",

    pearls: [
      "所有視網膜剝離病例都必須測量血壓——高血壓是最常見且可治療的病因",
      "貓的高血壓視網膜病變非常常見，通常與腎臟疾病或甲狀腺功能亢進有關",
      "滲出性剝離在控制病因後視網膜可能自行復位，但視力恢復取決於剝離持續時間",
      "ERG可評估視網膜是否仍有功能，幫助判斷治療預後",
      "雙側突然失明應高度懷疑高血壓或SARDS",
      "早期診斷和治療對視力保存至關重要——時間就是視力"
    ],

    defined: true
  },

  // ============================================================
  // 6. Lens Luxation - 水晶體脫位
  // ============================================================
  "lens-luxation": {
    zh: "水晶體脫位",
    en: "Lens Luxation",
    definition: "水晶體脫位是指水晶體因懸韌帶（zonular fibers）斷裂而從正常位置移位。完全脫位稱為luxation，部分脫位稱為subluxation。根據水晶體位置分為前脫位（進入前房）和後脫位（進入玻璃體腔）。前脫位是眼科急症。",
    synonyms: ["水晶體脫臼", "Ectopia Lentis", "Dislocated Lens", "晶體脫位"],

    epidemiology: {
      species: "犬較常見，貓也可發生",
      age: "原發性脫位：3-8歲中年犬；繼發性：任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: [
        "原發性（遺傳性）：梗犬類（Jack Russell、Fox Terrier、Rat Terrier、Tibetan Terrier）、邊境牧羊犬、澳洲牧牛犬、Shar-Pei",
        "繼發性原因：",
        "  - 慢性青光眼（眼球腫大拉伸懸韌帶）",
        "  - 慢性葡萄膜炎",
        "  - 眼內腫瘤",
        "  - 外傷",
        "  - 白內障過熟（晶體縮小）",
        "貓：通常繼發於慢性葡萄膜炎或青光眼"
      ]
    },

    clinicalPresentation: {
      history: [
        "急性眼睛疼痛（前脫位）",
        "眼睛紅腫",
        "突然視力喪失",
        "角膜混濁",
        "瞳孔外觀異常",
        "可能有慢性眼疾病史（青光眼、葡萄膜炎）",
        "梗犬類可能無明顯前驅症狀"
      ],
      physicalExam: [
        "前脫位典型表現：",
        "  - 水晶體可見於前房（金色或灰色圓盤狀）",
        "  - 角膜水腫（因水晶體接觸內皮或繼發性青光眼）",
        "  - 瞳孔不規則或無法辨識",
        "  - 眼壓升高（繼發性青光眼）",
        "  - 眼睛疼痛（眼瞼痙攣、畏光）",
        "後脫位表現：",
        "  - 前房加深",
        "  - 虹膜震顫（iridodonesis）",
        "  - 水晶體可見於玻璃體腔（眼底檢查）",
        "  - 可能無症狀或輕微症狀",
        "半脫位表現：",
        "  - 水晶體赤道緣可見",
        "  - 虹膜震顫",
        "  - 水晶體傾斜"
      ]
    },

    pathophysiology: "水晶體由懸韌帶固定在睫狀體上，維持其在瞳孔後方的正常位置。原發性脫位是由於懸韌帶本身的遺傳性缺陷（如ADAMTS17基因突變），導致纖維進行性退化和斷裂。繼發性脫位是因其他眼疾破壞懸韌帶（青光眼的眼球腫大、葡萄膜炎的發炎破壞、腫瘤侵犯、外傷）。前脫位時，水晶體進入前房，可能阻塞瞳孔和房角，導致急性青光眼；水晶體接觸角膜內皮會造成內皮細胞損傷和角膜水腫。後脫位時水晶體沉入玻璃體腔，通常症狀較輕，但可能導致視網膜脫離或慢性葡萄膜炎。",

    diagnosis: {
      overview: "診斷主要依賴臨床檢查。需評估脫位類型、是否繼發青光眼、是否有潛在病因。雙眼都需仔細檢查，因為原發性脫位常為雙側。",
      differentials: [
        "急性青光眼（原發性vs繼發於脫位）",
        "急性葡萄膜炎",
        "角膜水腫（其他原因）",
        "眼內腫瘤",
        "外傷性眼損傷",
        "白內障"
      ],
      initialDB: [
        "完整眼科檢查：裂隙燈檢查水晶體位置",
        "眼壓測量：評估是否繼發青光眼",
        "散瞳檢查（注意：青光眼時禁忌）",
        "眼底檢查：評估後脫位和視網膜狀態",
        "雙眼比較：原發性脫位常影響雙眼"
      ],
      advanced: [
        "眼部超音波：確認水晶體位置，評估玻璃體和視網膜",
        "基因檢測：梗犬類可檢測ADAMTS17突變",
        "視網膜電圖（ERG）：評估視網膜功能（手術前）",
        "檢查對側眼：評估懸韌帶完整性"
      ]
    },

    treatment: {
      overview: "前脫位是眼科急症，需要緊急處理以防止繼發性青光眼和角膜損傷。後脫位和半脫位可能允許更保守的管理。",
      acute: [
        "前脫位緊急處理：",
        "  - 降眼壓藥物：全身性（Mannitol 1-2g/kg IV）和局部（Dorzolamide、Timolol）",
        "  - 縮瞳劑（Pilocarpine）：嘗試將水晶體推回瞳孔後（需謹慎）",
        "  - 緊急手術：晶體摘除術（Intracapsular lens extraction, ICLE）",
        "後脫位急性處理：",
        "  - 散瞳劑：維持水晶體在玻璃體腔",
        "  - 監測眼壓",
        "全身性止痛"
      ],
      chronic: [
        "手術後護理：局部抗生素、抗發炎藥物、監測眼壓",
        "後脫位長期管理：",
        "  - 維持散瞳狀態",
        "  - 定期眼壓監測",
        "  - 若造成問題考慮手術摘除",
        "對側眼預防：",
        "  - 密切監測懸韌帶狀態",
        "  - 考慮預防性晶體摘除（有爭議）",
        "繼發性青光眼的長期管理",
        "失明眼的疼痛管理（可能需要眼球摘除）"
      ]
    },

    prognosis: "預後取決於脫位類型、治療時機和是否有視網膜功能。前脫位若能在24-48小時內手術摘除水晶體，且視網膜功能完好，約50-70%可保留一定視力。延遲治療或已有繼發性青光眼則預後較差。後脫位預後較好，許多病例可長期維持視力，但需持續監測。原發性脫位幾乎必定影響雙眼，對側眼通常在數月至數年內也會發生脫位。繼發性青光眼是主要的視力喪失原因。",

    pearls: [
      "前脫位是眼科急症——時間就是視力",
      "梗犬類的水晶體脫位大多為原發性遺傳性，應檢查對側眼",
      "虹膜震顫（iridodonesis）是早期懸韌帶鬆弛的徵象",
      "急性青光眼病例應仔細檢查是否有水晶體脫位",
      "後脫位時使用散瞳劑，前脫位時考慮縮瞳劑——方向相反",
      "基因檢測可用於繁殖篩選，減少遺傳性脫位發生",
      "貓的水晶體脫位通常繼發於其他眼疾，需找出根本原因"
    ],

    defined: true
  },

  // ============================================================
  // 7. Cherry Eye (Third Eyelid Prolapse) - 第三眼瞼腺脫出
  // ============================================================
  "cherry-eye": {
    zh: "第三眼瞼腺脫出",
    en: "Cherry Eye (Third Eyelid Gland Prolapse)",
    definition: "第三眼瞼腺脫出是指第三眼瞼（瞬膜）的淚腺從其正常位置脫出，在眼內角形成紅色腫塊。第三眼瞼腺負責產生約30-50%的淚液，其脫出和不當處理可能導致乾眼症。",
    synonyms: ["櫻桃眼", "瞬膜腺脫出", "Prolapsed Nictitans Gland", "Nictitans Gland Prolapse"],

    epidemiology: {
      species: "主要影響犬隻，貓和兔子較少見",
      age: "通常發生在2歲以下的幼犬",
      sex: "無明顯性別傾向",
      riskFactors: [
        "品種易感性：美國可卡犬、英國鬥牛犬、鬥牛獒、比格犬、波士頓梗、巴哥犬、沙皮犬、拉薩犬、西施犬、鐵里亞犬",
        "先天性結締組織附著薄弱",
        "第三眼瞼T型軟骨異常",
        "可能有遺傳成分",
        "貓：緬甸貓較易發生"
      ]
    },

    clinicalPresentation: {
      history: [
        "眼內角出現紅色腫塊",
        "通常急性發生",
        "可能單側或雙側（約50%會發展為雙側）",
        "眼睛分泌物增多",
        "可能有輕微不適或搔癢",
        "主人常誤認為是腫瘤"
      ],
      physicalExam: [
        "內眼角可見粉紅色至紅色、光滑、橢圓形腫塊",
        "腫塊為暴露的第三眼瞼腺",
        "腺體可能充血、水腫",
        "輕度結膜充血",
        "可能有黏液性分泌物",
        "腺體長期暴露可能有表面乾燥或慢性發炎改變",
        "Schirmer淚液試驗通常正常（除非已有繼發KCS）"
      ]
    },

    pathophysiology: "第三眼瞼腺正常位於第三眼瞼軟骨基部的內側面，由結締組織纖維固定。當這些附著組織先天薄弱或發育不良時，腺體可能脫出到第三眼瞼的前緣。一旦脫出，腺體暴露於空氣和外界刺激，導致充血、水腫和發炎，使其更難自行復位。長期暴露會導致腺體慢性發炎、纖維化，可能影響其淚液分泌功能。若施行腺體切除而非復位，會失去約30-50%的淚液產量，顯著增加日後發生乾眼症（KCS）的風險。",

    diagnosis: {
      overview: "診斷通常基於典型的臨床外觀，直觀且容易。需與其他眼內角腫塊鑑別。",
      differentials: [
        "第三眼瞼腫瘤（淋巴瘤、腺癌、鱗狀細胞癌）",
        "第三眼瞼囊腫",
        "第三眼瞼軟骨外翻",
        "第三眼瞼異物",
        "Horner's syndrome（第三眼瞼突出但無腺體脫出）"
      ],
      initialDB: [
        "視診：典型外觀即可診斷",
        "Schirmer淚液試驗：評估基線淚液分泌",
        "螢光素染色：排除角膜潰瘍",
        "完整眼科檢查：排除其他眼部異常"
      ],
      advanced: [
        "組織病理學（若腺體外觀異常或懷疑腫瘤）",
        "細胞學檢查（若懷疑腫瘤）",
        "通常不需要進階檢查"
      ]
    },

    treatment: {
      overview: "治療首選是手術復位腺體，而非切除。腺體切除會顯著增加日後發生KCS的風險。有多種手術技術可選。",
      acute: [
        "局部消炎藥：短期使用減輕腫脹（如Dexamethasone眼藥）",
        "人工淚液：保護暴露的腺體",
        "避免用手推回（容易復發）",
        "盡早安排手術"
      ],
      chronic: [
        "手術復位術（首選）：",
        "  - Morgan口袋技術（Pocket technique）",
        "  - 固定縫合技術（Anchoring/tacking technique）",
        "  - 合併技術",
        "術後護理：",
        "  - 伊莉莎白頸圈",
        "  - 局部抗生素",
        "  - 局部抗發炎藥",
        "  - 限制活動",
        "腺體切除（僅作為最後手段）：",
        "  - 腺體嚴重損傷無法復位時",
        "  - 反覆復發且復位失敗時",
        "  - 術後需終生監測和可能使用人工淚液"
      ]
    },

    prognosis: "手術復位的成功率約90-95%，大多數病例可保留腺體功能。復發率因手術技術而異，約5-15%。即使復發，通常可再次手術復位。腺體切除後發生KCS的風險顯著增加（有研究報告達40-60%），因此強烈不建議作為初始治療。早期手術的預後優於長期拖延（腺體長期暴露可能造成不可逆損傷）。雙側發生很常見，一側發生後應監測對側眼。",

    pearls: [
      "絕對不要切除第三眼瞼腺——這會導致高風險的乾眼症",
      "手術復位是標準治療，腺體切除只是最後手段",
      "一側發生後，約50%會影響對側眼，需持續監測",
      "用手推回腺體通常無效且容易復發",
      "手術應由有經驗的眼科醫師執行，以提高成功率",
      "術前和術後都應檢測STT，建立基線並監測腺體功能",
      "主人常誤認為是腫瘤，需提供正確衛教"
    ],

    defined: true
  },

  // ============================================================
  // 8. Entropion - 眼瞼內翻
  // ============================================================
  "entropion": {
    zh: "眼瞼內翻",
    en: "Entropion",
    definition: "眼瞼內翻是指眼瞼邊緣向內翻轉，導致睫毛和眼瞼皮膚摩擦角膜和結膜。這會造成慢性刺激、疼痛、角膜損傷，若不處理可能導致角膜潰瘍、疤痕形成甚至視力喪失。",
    synonyms: ["眼瞼內捲", "Eyelid Inversion", "眼皮內翻"],

    epidemiology: {
      species: "犬比貓更常見",
      age: "先天性/發育性：幼年至青年犬；獲得性：任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: [
        "先天性/發育性內翻易感品種：",
        "  - 沙皮犬（最嚴重）",
        "  - 鬆獅犬",
        "  - 英國鬥牛犬",
        "  - 聖伯納犬",
        "  - 大丹犬",
        "  - 羅威納犬",
        "  - 拉布拉多/黃金獵犬",
        "  - 可卡犬",
        "痙攣性內翻：眼睛疼痛（如角膜潰瘍、結膜炎）引起",
        "瘢痕性內翻：眼瞼創傷或手術後疤痕",
        "老年性內翻：眼瞼組織鬆弛",
        "眼球後縮或眼球萎縮"
      ]
    },

    clinicalPresentation: {
      history: [
        "慢性或反覆的眼睛刺激症狀",
        "過度流淚",
        "頻繁眨眼或瞇眼",
        "眼部分泌物（黏液或膿性）",
        "用爪搔眼",
        "眼睛發紅",
        "症狀可能從幼年開始",
        "症狀在疼痛或發炎時加重（痙攣性成分）"
      ],
      physicalExam: [
        "眼瞼邊緣向內捲曲",
        "睫毛和/或皮膚毛髮接觸眼球表面",
        "結膜充血",
        "角膜血管新生",
        "角膜色素沉著",
        "角膜潰瘍（嚴重病例）",
        "角膜疤痕",
        "眼瞼痙攣（可能加重內翻）",
        "螢光素染色可能顯示角膜上皮損傷"
      ]
    },

    pathophysiology: "眼瞼內翻的原因因類型而異：(1)先天性/發育性：眼瞼解剖結構異常，通常與品種特徵相關（如臉部皮膚鬆弛、眼眶形狀、眼瞼過長）；(2)痙攣性：眼睛疼痛引起眼輪匝肌痙攣，將眼瞼向內拉；(3)瘢痕性：眼瞼損傷癒合後疤痕收縮；(4)老年性：支持組織鬆弛。無論原因，內翻導致睫毛和皮膚持續摩擦角膜，造成機械性刺激、上皮損傷、慢性發炎。長期刺激導致角膜血管新生和色素沉著（保護性反應但影響視力），嚴重者可發生角膜潰瘍、基質溶解、角膜穿孔。",

    diagnosis: {
      overview: "診斷主要基於臨床檢查。需確定內翻的類型、範圍和嚴重程度，並評估是否有痙攣性成分。",
      differentials: [
        "雙行睫（Distichiasis）",
        "異位睫毛（Ectopic cilia）",
        "第三眼瞼內翻",
        "眼瞼外翻（相反方向）",
        "眼瞼腫塊導致的機械性異常",
        "面神經麻痺"
      ],
      initialDB: [
        "詳細眼科檢查：評估眼瞼位置和功能",
        "螢光素染色：評估角膜損傷",
        "Schirmer淚液試驗：排除KCS",
        "評估痙攣性成分：使用局部麻醉後重新評估",
        "雙眼比較"
      ],
      advanced: [
        "通常不需要進階檢查",
        "若懷疑神經性原因可進行神經學檢查",
        "術前照片記錄"
      ]
    },

    treatment: {
      overview: "治療取決於內翻的原因、嚴重程度和患犬年齡。手術矯正是發育性內翻的確定性治療。痙攣性內翻需先處理根本病因。",
      acute: [
        "痙攣性內翻：治療根本眼疾（如角膜潰瘍）",
        "保護角膜：人工淚液、潤滑劑",
        "暫時性措施：臨時縫合固定（temporary tacking）——用於幼犬或等待手術",
        "伊莉莎白頸圈防止自我傷害",
        "治療繼發性角膜損傷"
      ],
      chronic: [
        "手術矯正（確定性治療）：",
        "  - Hotz-Celsus手術：最常用，切除橢圓形皮膚和眼輪匝肌",
        "  - 改良技術：依據內翻位置和程度調整",
        "  - 眼瞼分離術",
        "  - 複雜病例可能需要多次手術",
        "幼犬考量：",
        "  - 可先做臨時固定等待發育成熟",
        "  - 6-12月齡後可做永久性矯正",
        "術後護理：",
        "  - 伊莉莎白頸圈",
        "  - 局部抗生素",
        "  - 監測傷口癒合",
        "  - 追蹤是否需要再次手術"
      ]
    },

    prognosis: "手術矯正的預後通常良好，大多數病例可獲得滿意的解剖和功能結果。輕度至中度內翻一次手術成功率高。嚴重內翻（如沙皮犬）可能需要多次手術才能達到理想結果。術前存在的角膜色素沉著和血管新生可能在術後減輕但不一定完全消退。早期矯正可防止嚴重角膜損傷。矯正過度（overcorrection）可能導致醫源性外翻，矯正不足則需再次手術。",

    pearls: [
      "使用局部麻醉可幫助區分解剖性內翻和痙攣性成分",
      "幼犬的臨時固定術可作為過渡措施，等待頭部發育成熟再做永久矯正",
      "沙皮犬可能需要多階段手術處理複雜的眼瞼和面部皮膚問題",
      "手術前應記錄角膜狀況，作為術後比較基準",
      "寧可輕微矯正不足也不要過度矯正——不足可以再修，過度矯正處理更困難",
      "痙攣性內翻在根本病因解決後可能自行改善",
      "品種特徵（如鬆弛的面部皮膚）可能影響手術計劃"
    ],

    defined: true
  },

  // ============================================================
  // 9. Ectropion - 眼瞼外翻
  // ============================================================
  "ectropion": {
    zh: "眼瞼外翻",
    en: "Ectropion",
    definition: "眼瞼外翻是指眼瞼（主要是下眼瞼）邊緣向外翻轉，導致結膜暴露。這會造成結膜乾燥、慢性發炎和繼發性感染，也會影響淚液的正常分布和排出。",
    synonyms: ["眼瞼外捲", "Eyelid Eversion", "眼皮下垂"],

    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "先天性/發育性：幼年至青年犬；獲得性：任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: [
        "先天性/發育性外翻易感品種：",
        "  - 聖伯納犬",
        "  - 紐芬蘭犬",
        "  - 鬥牛獒犬",
        "  - 大丹犬",
        "  - 可卡犬",
        "  - 巴吉度獵犬",
        "  - 血獵犬",
        "  - 可卡犬、英國鬥牛犬",
        "瘢痕性外翻：眼瞼手術或創傷後",
        "醫源性外翻：內翻手術矯正過度",
        "麻痺性外翻：顏面神經麻痺",
        "老年性外翻：組織鬆弛"
      ]
    },

    clinicalPresentation: {
      history: [
        "慢性流淚（因淚液無法正常排入淚道）",
        "眼周皮膚潮濕、刺激（淚痕）",
        "反覆結膜炎",
        "眼部分泌物",
        "眼睛紅腫",
        "可能與內翻同時存在（「鑽石眼」：內外翻合併）"
      ],
      physicalExam: [
        "下眼瞼外翻、下垂",
        "瞼結膜暴露可見",
        "結膜充血、肥厚",
        "結膜分泌物積聚",
        "淚湖（淚液積聚在下結膜囊）",
        "眼周皮膚濕疹或染色",
        "可能合併角膜暴露（嚴重病例）",
        "可能與內翻合併（「鑽石眼」配置）"
      ]
    },

    pathophysiology: "眼瞼外翻使瞼結膜異常暴露於外界環境，失去眼瞼的正常保護功能。淚液無法正常分布於眼球表面，也無法有效引流入鼻淚管，導致溢淚（epiphora）。暴露的結膜容易乾燥、受到空氣中刺激物和微生物的侵襲，引發慢性結膜炎。先天性外翻與品種特徵相關，如面部皮膚過度鬆弛、眼瞼過長、眼眶結構異常。瘢痕性外翻是因疤痕組織收縮將眼瞼向外拉。某些品種可能同時有外翻和內翻（稱為「鑽石眼」），需要複雜的手術計劃。",

    diagnosis: {
      overview: "診斷基於臨床檢查，直觀明確。需評估外翻程度、是否合併其他眼瞼異常、以及對眼表的影響。",
      differentials: [
        "顏面神經麻痺",
        "眼瞼腫塊",
        "眼眶疾病",
        "單純溢淚（其他原因）"
      ],
      initialDB: [
        "詳細眼科檢查：評估眼瞼位置和功能",
        "螢光素染色：評估角膜和結膜狀態",
        "Schirmer淚液試驗",
        "淚道通暢性檢查（若溢淚嚴重）",
        "神經學評估（若懷疑面神經麻痺）"
      ],
      advanced: [
        "通常不需要進階檢查",
        "術前照片記錄",
        "若懷疑神經性原因進行完整神經學檢查"
      ]
    },

    treatment: {
      overview: "治療取決於外翻的原因和嚴重程度。輕度外翻可能只需保守管理，中重度需要手術矯正。",
      acute: [
        "保護暴露的結膜：人工淚液、潤滑劑",
        "治療繼發性結膜炎：局部抗生素",
        "清潔眼周皮膚",
        "處理任何急性角膜問題"
      ],
      chronic: [
        "保守管理（輕度病例）：",
        "  - 定期使用人工淚液",
        "  - 保持眼周清潔",
        "  - 監測結膜狀態",
        "手術矯正（中重度病例）：",
        "  - V-Y成形術",
        "  - 楔形切除術（Kuhnt-Szymanowski procedure）",
        "  - 眼瞼縮短術",
        "  - 複雜病例可能需要多種技術組合",
        "鑽石眼（合併內翻）：",
        "  - 需要同時處理內翻和外翻",
        "  - 可能需要分階段手術",
        "術後護理：伊莉莎白頸圈、局部抗生素、追蹤"
      ]
    },

    prognosis: "輕度外翻主要是美容問題，對眼睛功能影響有限，保守管理即可。中重度外翻手術矯正通常預後良好。複雜病例（如合併內翻的「鑽石眼」）可能需要多次手術。瘢痕性外翻手術效果取決於疤痕範圍。面神經麻痺引起的外翻預後取決於神經功能是否恢復。總體而言，外翻的預後通常優於內翻，因為對角膜的直接損傷較少。",

    pearls: [
      "外翻比內翻對眼球的威脅較小，但仍需適當管理",
      "某些品種同時有內翻和外翻（鑽石眼），手術計劃需綜合考量",
      "輕度外翻可能是品種特徵的一部分，不一定需要手術",
      "溢淚可能導致眼周皮膚濕疹，需保持乾燥清潔",
      "手術矯正要考慮眼瞼整體張力和長度",
      "面神經麻痺引起的外翻需同時評估神經功能"
    ],

    defined: true
  },

  // ============================================================
  // 10. Distichiasis - 雙行睫
  // ============================================================
  "distichiasis": {
    zh: "雙行睫",
    en: "Distichiasis",
    definition: "雙行睫是指睫毛從瞼板腺（Meibomian gland）開口處異常生長，這些異位睫毛位於正常睫毛行的內側，可能接觸並刺激角膜和結膜。嚴重程度從無症狀到引起顯著角膜損傷不等。",
    synonyms: ["異常睫毛", "副睫毛", "Aberrant Cilia", "雙睫症"],

    epidemiology: {
      species: "犬常見，貓罕見",
      age: "先天性，但症狀可能在幼年至成年期才明顯",
      sex: "無明顯性別傾向",
      riskFactors: [
        "品種易感性：",
        "  - 可卡犬（美國可卡、英國可卡）",
        "  - 騎士查理王獵犬",
        "  - 西施犬",
        "  - 拉薩犬",
        "  - 黃金獵犬",
        "  - 迷你長毛臘腸",
        "  - 約克夏",
        "  - 北京犬",
        "  - 鬥牛犬",
        "遺傳性",
        "通常雙側發生"
      ]
    },

    clinicalPresentation: {
      history: [
        "慢性眼睛刺激",
        "過度流淚",
        "頻繁眨眼",
        "可能無症狀（輕度病例）",
        "反覆結膜炎",
        "症狀可能時好時壞"
      ],
      physicalExam: [
        "瞼緣可見異常細小睫毛從瞼板腺開口長出",
        "睫毛通常柔軟、細小",
        "可能單根或多根成簇",
        "可位於上眼瞼、下眼瞼或兩者",
        "輕微者可能需要放大鏡或裂隙燈才能看見",
        "結膜充血（接觸處）",
        "角膜點狀上皮侵蝕（螢光素染色陽性）",
        "角膜血管新生（慢性病例）"
      ]
    },

    pathophysiology: "雙行睫是瞼板腺分化異常的結果。正常情況下，瞼板腺產生脂質層分泌物，不應有毛髮生長。在雙行睫中，部分腺體上皮細胞異常分化為毛囊，產生從腺體開口長出的睫毛。這些睫毛的方向和硬度決定其對眼表的影響：柔軟、方向適當的睫毛可能不造成問題；粗硬或方向不當的睫毛會持續摩擦角膜，造成慢性刺激和損傷。與異位睫毛（ectopic cilia）不同，雙行睫從瞼緣生長，而異位睫毛從結膜面穿出，後者通常造成更嚴重的角膜損傷。",

    diagnosis: {
      overview: "診斷需要仔細的眼瞼檢查，通常需要放大設備。需區分有症狀和無症狀病例，並評估角膜損傷程度。",
      differentials: [
        "異位睫毛（Ectopic cilia）：從結膜面穿出，症狀通常更嚴重",
        "三行睫（Trichiasis）：正常位置睫毛方向異常",
        "眼瞼內翻",
        "角膜異物",
        "其他角膜炎病因"
      ],
      initialDB: [
        "裂隙燈檢查：放大檢視瞼緣",
        "外翻眼瞼檢查瞼板腺開口",
        "螢光素染色：評估角膜損傷",
        "Schirmer淚液試驗：排除KCS",
        "仔細檢查上下眼瞼和雙眼"
      ],
      advanced: [
        "通常不需要進階檢查",
        "術前照片記錄異常睫毛位置和數量"
      ]
    },

    treatment: {
      overview: "治療取決於是否有臨床症狀。無症狀的雙行睫可能不需要治療。有症狀者需要去除或破壞異常睫毛，有多種方法可選。",
      acute: [
        "保護角膜：人工淚液、潤滑劑",
        "治療繼發性角膜損傷",
        "手動拔除（可作為臨時措施，但睫毛會再生）"
      ],
      chronic: [
        "手動拔除（Epilation）：",
        "  - 簡單但睫毛會在4-6週內再生",
        "  - 可作為臨時或輕度病例的選擇",
        "電燒灼術（Electroepilation）：",
        "  - 用電燒破壞毛囊",
        "  - 較持久但可能需要多次治療",
        "冷凍治療（Cryotherapy）：",
        "  - 最常用的永久性治療",
        "  - 用液態氮冷凍毛囊",
        "  - 成功率約80-90%",
        "  - 併發症：瞼緣脫色、輕微瘢痕",
        "手術切除：",
        "  - 切除含異常毛囊的瞼緣組織",
        "  - 用於局部嚴重病例",
        "雷射治療：",
        "  - 較新技術，精確性高"
      ]
    },

    prognosis: "預後通常良好。許多雙行睫病例是偶然發現，無症狀不需治療。有症狀病例經適當治療後預後良好。冷凍治療成功率高，但約10-20%可能需要再次治療。嚴重角膜損傷若及時處理通常可恢復。治療後應定期追蹤，因為可能有遺漏的睫毛或新的異常睫毛出現。",

    pearls: [
      "雙行睫常是偶然發現——並非所有病例都需要治療",
      "異位睫毛（ectopic cilia）通常症狀更嚴重，需與雙行睫區分",
      "仔細檢查需要裂隙燈或放大鏡，睫毛可能非常細小",
      "手動拔除簡單但非永久性解決方案",
      "冷凍治療是最常用的永久性治療，可能造成輕微瞼緣脫色",
      "治療前應記錄異常睫毛的位置和數量",
      "易感品種應在常規眼科檢查中特別注意瞼緣"
    ],

    defined: true
  },

  // ============================================================
  // 11. Conjunctivitis - 結膜炎
  // ============================================================
  "conjunctivitis": {
    zh: "結膜炎",
    en: "Conjunctivitis",
    definition: "結膜炎是結膜（覆蓋眼球表面和眼瞼內側的透明黏膜）的發炎。這是小動物最常見的眼科問題之一，可能是原發性疾病或繼發於其他眼部或全身性疾病。",
    synonyms: ["紅眼症", "Pink Eye", "眼結膜發炎"],

    epidemiology: {
      species: "犬貓均常見",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: [
        "感染性原因：",
        "  - 細菌（Staphylococcus、Streptococcus、Pseudomonas等）",
        "  - 病毒（犬：犬瘟熱；貓：疱疹病毒、杯狀病毒）",
        "  - 衣原體（貓：Chlamydophila felis）",
        "  - 黴漿菌（貓：Mycoplasma）",
        "過敏性：花粉、塵蟎、食物過敏",
        "刺激性：煙霧、灰塵、化學物質、風",
        "繼發性：",
        "  - 乾眼症（KCS）",
        "  - 眼瞼異常（內翻、外翻）",
        "  - 睫毛異常",
        "  - 鼻淚管阻塞",
        "  - 角膜疾病",
        "免疫介導性"
      ]
    },

    clinicalPresentation: {
      history: [
        "眼睛紅腫",
        "眼部分泌物（可能是漿液性、黏液性或膿性）",
        "眨眼頻繁",
        "用爪搔眼",
        "眼睛周圍毛髮濕潤",
        "可能有打噴嚏、流鼻水等呼吸道症狀（貓傳染性病原）",
        "可能雙側或單側"
      ],
      physicalExam: [
        "結膜充血（發紅）",
        "結膜水腫（chemosis）",
        "眼部分泌物：",
        "  - 漿液性：過敏性或病毒性早期",
        "  - 黏液性：乾眼症或慢性刺激",
        "  - 膿性：細菌感染或嚴重病毒感染繼發細菌",
        "眼瞼腫脹",
        "濾泡形成（結膜內側可見小圓形隆起）",
        "第三眼瞼可能突出",
        "淚溢（epiphora）"
      ]
    },

    pathophysiology: "結膜是高度血管化的黏膜組織，對各種刺激敏感。發炎反應導致血管擴張（充血）、血管通透性增加（水腫）、發炎細胞浸潤和分泌物產生。感染性結膜炎中，病原體直接損傷上皮細胞並引發免疫反應。過敏性結膜炎涉及IgE介導的肥大細胞脫顆粒，釋放組織胺等發炎介質。乾眼症導致的結膜炎是因淚液保護不足，使結膜暴露於環境刺激。慢性結膜炎可能導致結膜增厚、色素沉著、濾泡形成等永久性改變。",

    diagnosis: {
      overview: "診斷結膜炎本身通常直觀，重點在於找出潛在病因，因為這決定治療方向。需排除其他可能的眼睛紅腫原因。",
      differentials: [
        "角膜潰瘍",
        "前葡萄膜炎",
        "青光眼",
        "乾眼症（KCS）作為主因",
        "鞏膜炎/表層鞏膜炎",
        "眼眶疾病",
        "眼瞼異常"
      ],
      initialDB: [
        "完整眼科檢查",
        "螢光素染色：排除角膜潰瘍",
        "Schirmer淚液試驗：排除乾眼症",
        "眼壓測量：排除青光眼",
        "仔細檢查眼瞼和睫毛：排除機械性因素",
        "評估鼻淚管通暢性"
      ],
      advanced: [
        "結膜刮片/細胞學：評估細胞類型、包涵體（衣原體）",
        "細菌培養和藥敏試驗：頑固性或嚴重感染",
        "PCR檢測：貓疱疹病毒、衣原體",
        "過敏原檢測：懷疑過敏時",
        "淚液滲透壓測定"
      ]
    },

    treatment: {
      overview: "治療需針對潛在病因。單純使用廣效抗生素而不找出病因往往導致反覆發作。",
      acute: [
        "清潔眼部：溫和清除分泌物",
        "經驗性廣效抗生素眼藥：如Tobramycin、Ofloxacin、Chloramphenicol（每日3-4次）",
        "細菌性結膜炎：局部抗生素5-7天",
        "病毒性結膜炎：支持性治療，抗生素預防繼發感染",
        "過敏性結膜炎：移除過敏原、抗組織胺、局部肥大細胞穩定劑",
        "貓疱疹病毒：抗病毒藥物（Famciclovir全身、Cidofovir局部）、L-Lysine補充",
        "衣原體：四環素類或阿奇黴素（局部和全身）",
        "伊莉莎白頸圈：防止自我傷害"
      ],
      chronic: [
        "找出並處理潛在病因",
        "乾眼症相關：環孢素或他克莫司眼藥",
        "慢性過敏性：長期抗組織胺、減敏治療",
        "貓慢性疱疹病毒：可能需要長期抗病毒管理",
        "結構性問題：手術矯正（眼瞼異常、鼻淚管阻塞）",
        "免疫介導性：局部類固醇（需排除感染和角膜潰瘍）"
      ]
    },

    prognosis: "預後取決於病因。單純細菌性結膜炎在適當抗生素治療下通常在1-2週內痊癒。過敏性結膜炎可控制但可能反覆發作。病毒性結膜炎（特別是貓疱疹病毒）可能成為慢性或反覆發作。乾眼症相關結膜炎需要長期管理。結構性問題矯正後預後良好。",

    pearls: [
      "結膜炎是常見症狀但不是診斷——必須找出病因",
      "所有結膜炎病例都應檢測淚液分泌（STT）排除KCS",
      "貓的結膜炎高度懷疑疱疹病毒或衣原體",
      "單側結膜炎更可能是局部原因（異物、睫毛異常）",
      "雙側結膜炎更可能是感染性、過敏性或全身性",
      "使用類固醇眼藥前必須排除角膜潰瘍和某些感染（疱疹病毒）",
      "反覆發作的結膜炎需重新評估診斷"
    ],

    defined: true
  },

  // ============================================================
  // 12. Episcleritis - 鞏膜表層炎
  // ============================================================
  "episcleritis": {
    zh: "鞏膜表層炎",
    en: "Episcleritis",
    definition: "鞏膜表層炎是鞏膜表層（episclera）的發炎，位於結膜下方、鞏膜上方的血管結締組織層。這通常是良性、自限性的疾病，但可能反覆發作。需與更嚴重的鞏膜炎區分。",
    synonyms: ["表層鞏膜炎", "Episcleral Inflammation", "節結性表層鞏膜炎"],

    epidemiology: {
      species: "犬較常見，貓少見",
      age: "中年至老年犬",
      sex: "無明顯性別傾向",
      riskFactors: [
        "品種易感性：可卡犬、柯利犬、雪納瑞",
        "免疫介導性疾病",
        "過敏性疾病",
        "常為特發性",
        "可能與全身性免疫疾病相關"
      ]
    },

    clinicalPresentation: {
      history: [
        "眼睛局部發紅",
        "通常無明顯疼痛或輕微不適",
        "視力正常",
        "可能急性或慢性",
        "可能單側或雙側",
        "可能反覆發作"
      ],
      physicalExam: [
        "局部或瀰漫性鞏膜表層充血",
        "充血呈鮭魚粉紅色（區別於結膜的鮮紅色）",
        "節結性表層鞏膜炎：可見局部隆起的肉色或紅色結節",
        "結節通常位於角膜緣附近",
        "輕度結膜充血",
        "無明顯疼痛反應",
        "瞳孔正常",
        "眼壓正常",
        "角膜通常清澈（除非結節侵犯角膜緣）"
      ]
    },

    pathophysiology: "鞏膜表層炎的確切病因通常不明，但被認為是免疫介導性發炎。表層鞏膜是富含血管的疏鬆結締組織，對發炎刺激敏感。發炎可表現為瀰漫性（整個表層鞏膜充血）或節結性（形成局部肉芽腫樣結節）。節結性表層鞏膜炎中，組織學顯示淋巴細胞、漿細胞和組織球浸潤。與較深層的鞏膜炎不同，表層鞏膜炎不會威脅眼球結構完整性，且對治療反應良好。",

    diagnosis: {
      overview: "診斷主要基於臨床表現。需與結膜炎、鞏膜炎和其他原因的眼睛發紅區分。Phenylephrine局部點眼測試可幫助鑑別。",
      differentials: [
        "結膜炎（更表淺，鮮紅色）",
        "鞏膜炎（更深層，更疼痛，可能有視力影響）",
        "前葡萄膜炎",
        "青光眼",
        "眼表腫瘤",
        "角膜緣腫瘤",
        "結節性肉芽腫性表層鞏膜角膜炎（NGK）"
      ],
      initialDB: [
        "完整眼科檢查",
        "Phenylephrine 2.5-10%局部點眼測試：",
        "  - 表層鞏膜血管會收縮、變白",
        "  - 深層鞏膜血管不受影響",
        "眼壓測量",
        "裂隙燈檢查：評估深度",
        "螢光素染色：排除角膜病變"
      ],
      advanced: [
        "組織切片（若懷疑腫瘤或對治療無反應）",
        "全身性疾病篩檢（若懷疑有關聯）",
        "眼部超音波（排除深層病變）"
      ]
    },

    treatment: {
      overview: "大多數表層鞏膜炎對局部類固醇反應良好。節結性表層鞏膜炎可能需要更積極的治療。",
      acute: [
        "局部類固醇眼藥：Prednisolone acetate 1%或Dexamethasone 0.1%，每日3-4次",
        "局部NSAID眼藥：作為輔助或類固醇禁忌時的替代",
        "節結性病變：可能需要結膜下類固醇注射"
      ],
      chronic: [
        "逐漸減量局部類固醇",
        "反覆發作：長期低劑量維持治療",
        "頑固性病例：",
        "  - 全身性類固醇",
        "  - 其他免疫抑制劑（Azathioprine等）",
        "  - 局部環孢素",
        "節結性表層鞏膜炎：",
        "  - 手術切除（復發率高）",
        "  - 冷凍治療",
        "  - 放射線治療（嚴重病例）",
        "監測長期類固醇使用的副作用"
      ]
    },

    prognosis: "單純表層鞏膜炎預後良好，大多數病例在數週內對治療反應良好。但復發常見，某些病例可能需要長期管理。節結性表層鞏膜炎預後較謹慎，可能更頑固且復發率較高。視力預後通常良好，除非病變侵犯角膜造成視軸混濁。",

    pearls: [
      "Phenylephrine測試可區分表層鞏膜炎（血管會收縮）和深層鞏膜炎（血管不收縮）",
      "表層鞏膜炎通常無明顯疼痛，若疼痛明顯應考慮鞏膜炎",
      "節結性表層鞏膜炎需與腫瘤鑑別",
      "長期使用類固醇需監測眼壓和角膜健康",
      "可卡犬、柯利犬較易發生",
      "反覆發作可能提示潛在免疫介導性疾病"
    ],

    defined: true
  },

  // ============================================================
  // 13. Pannus (Chronic Superficial Keratitis) - 角膜血管翳
  // ============================================================
  "pannus": {
    zh: "角膜血管翳",
    en: "Pannus (Chronic Superficial Keratitis)",
    definition: "角膜血管翳，又稱慢性淺層角膜炎，是一種免疫介導性、進行性的角膜疾病，特徵是角膜血管新生、肉芽組織和色素沉著從角膜緣向角膜中央侵入。若不治療會導致視力喪失。",
    synonyms: ["慢性淺層角膜炎", "Chronic Superficial Keratitis", "CSK", "Uberreiter's Syndrome", "德國牧羊犬角膜炎"],

    epidemiology: {
      species: "犬，貓極罕見",
      age: "通常在中年（4-7歲）發病，但可更早",
      sex: "無明顯性別傾向",
      riskFactors: [
        "品種高度易感：",
        "  - 德國牧羊犬（最常見）",
        "  - 比利時牧羊犬",
        "  - 格雷伊獵犬",
        "  - 哈士奇",
        "  - 邊境牧羊犬",
        "  - 澳洲牧羊犬",
        "高海拔地區（紫外線暴露增加）",
        "紫外線照射",
        "遺傳易感性",
        "免疫介導機制"
      ]
    },

    clinicalPresentation: {
      history: [
        "漸進性角膜混濁",
        "通常雙側發病",
        "視力逐漸下降",
        "可能無明顯疼痛或不適",
        "病程緩慢但持續進展",
        "高海拔或日照強烈地區症狀可能更嚴重"
      ],
      physicalExam: [
        "典型表現從角膜外下象限（temporal-ventral）開始",
        "角膜血管新生：血管從角膜緣向中央生長",
        "角膜色素沉著：褐色色素沉積",
        "肉芽組織形成：粉紅色肉芽樣組織",
        "角膜混濁",
        "通常雙側，但嚴重程度可能不對稱",
        "第三眼瞼可能同時受影響（Plasmoma/atypical pannus）",
        "晚期：嚴重色素沉著可能覆蓋整個角膜"
      ]
    },

    pathophysiology: "Pannus是T淋巴細胞介導的免疫反應，針對角膜基質抗原。紫外線照射被認為是重要的觸發和加重因素，可能通過改變角膜蛋白使其具有免疫原性。組織學顯示淋巴細胞、漿細胞浸潤，以及血管新生和纖維化。色素沉著是黑色素細胞從角膜緣遷移的結果。疾病從角膜緣開始，逐漸向角膜中央擴展。同時影響第三眼瞼的情況稱為plasmoma或非典型pannus，結膜也可能受影響。",

    diagnosis: {
      overview: "診斷主要基於臨床表現和品種特徵。典型外觀在易感品種中通常足以診斷。",
      differentials: [
        "角膜潰瘍引起的血管新生",
        "色素性角膜炎（其他原因）",
        "角膜脂質/�ite沉積",
        "角膜腫瘤",
        "乾眼症相關角膜病變",
        "貓嗜酸性角膜炎"
      ],
      initialDB: [
        "詳細眼科檢查",
        "裂隙燈檢查：評估病變深度和範圍",
        "螢光素染色：通常陰性（除非有潰瘍）",
        "Schirmer淚液試驗：排除KCS",
        "眼壓測量",
        "品種和病史評估"
      ],
      advanced: [
        "角膜細胞學/刮片：可見淋巴細胞、漿細胞",
        "組織切片：確診困難病例",
        "通常不需要進階檢查"
      ]
    },

    treatment: {
      overview: "Pannus無法治癒，但可以控制。治療目標是抑制發炎、減緩進展、維持視力。需要終生治療。",
      acute: [
        "局部類固醇：Prednisolone acetate 1%或Dexamethasone 0.1%，每日2-4次",
        "局部環孢素0.2-2%：免疫調節，每日2次",
        "或他克莫司0.02-0.03%：替代環孢素"
      ],
      chronic: [
        "終生維持治療（通常每日1-2次）",
        "環孢素或他克莫司為首選長期用藥",
        "類固醇可用於急性發作或控制不佳時",
        "紫外線防護：",
        "  - 避免正午陽光直射",
        "  - 考慮犬用防紫外線眼鏡（Doggles）",
        "  - 減少戶外活動時間（陽光強烈時）",
        "定期追蹤（每3-6個月）",
        "根據控制情況調整藥物",
        "嚴重色素沉著：角膜表面角膜切除術（superficial keratectomy）可暫時清除色素，但會復發"
      ]
    },

    prognosis: "Pannus是終生疾病，需要持續治療。早期診斷和治療可有效控制進展，大多數病例可維持功能性視力。治療中斷會導致快速惡化。高海拔地區或紫外線暴露多的病例較難控制。嚴重且控制不佳的病例可能失明。預後很大程度取決於主人的配合度和持續用藥。",

    pearls: [
      "Pannus是終生疾病，需要終生治療——這點必須讓主人充分理解",
      "德國牧羊犬的角膜問題應高度懷疑pannus",
      "紫外線是重要的加重因素，高海拔地區更嚴重",
      "犬用防紫外線眼鏡（Doggles）可作為輔助措施",
      "環孢素或他克莫司是長期治療的首選",
      "停藥後通常會快速復發",
      "第三眼瞼同時受影響（plasmoma）是pannus的變異型"
    ],

    defined: true
  },

  // ============================================================
  // 14. Hyphema - 前房出血
  // ============================================================
  "hyphema": {
    zh: "前房出血",
    en: "Hyphema",
    definition: "前房出血是指血液積聚在眼睛前房（角膜和虹膜之間的空間）。這是眼科急症，需要緊急評估以找出病因並防止併發症如繼發性青光眼和視力喪失。",
    synonyms: ["眼前房積血", "Anterior Chamber Hemorrhage", "眼內出血"],

    epidemiology: {
      species: "犬貓均可發生",
      age: "任何年齡，病因決定好發年齡",
      sex: "無明顯性別傾向（外傷性可能公犬較多）",
      riskFactors: [
        "外傷（最常見原因之一）：",
        "  - 鈍傷、穿透傷、車禍",
        "全身性疾病：",
        "  - 凝血障礙（血小板減少、凝血因子缺乏、DIC）",
        "  - 高血壓（特別是貓）",
        "  - 血液寄生蟲（Ehrlichia、Anaplasma）",
        "眼內腫瘤（虹膜黑色素瘤、淋巴瘤等）",
        "嚴重葡萄膜炎",
        "視網膜脫離",
        "慢性青光眼",
        "水晶體脫位",
        "先天性眼異常",
        "醫源性（眼科手術後）"
      ]
    },

    clinicalPresentation: {
      history: [
        "眼睛內可見血液",
        "突然發生（外傷、急性出血）或漸進性（腫瘤、慢性疾病）",
        "可能有外傷史",
        "視力下降",
        "可能有全身性出血傾向（牙齦出血、瘀青、血尿等）",
        "可能有其他疾病症狀（高血壓、腫瘤相關）"
      ],
      physicalExam: [
        "前房內可見紅色血液",
        "輕度：血液懸浮在房水中（雲霧狀）",
        "中度：血液沉積在前房下方（液平面）",
        "重度：前房完全被血液填滿",
        "可能伴有凝血塊",
        "視力受影響程度與出血量相關",
        "可能有眼壓變化（升高或降低）",
        "可能有其他眼部損傷跡象（角膜損傷、虹膜異常）",
        "若有全身性病因可能有其他出血跡象"
      ]
    },

    pathophysiology: "前房出血來自虹膜或睫狀體血管的破裂。外傷時血管機械性破裂。腫瘤可能因血管異常或直接侵犯而出血。葡萄膜炎時發炎導致血管脆弱和通透性增加。全身性凝血障礙使正常的微小出血無法止血。高血壓可能導致視網膜和虹膜血管病變和出血。血液在前房內會沉積，紅血球可能阻塞小樑網影響房水排出，導致繼發性青光眼。血液分解產物也可能對眼內結構造成毒性損害。",

    diagnosis: {
      overview: "前房出血診斷直觀，重點在於找出病因。全面的眼科和全身性檢查至關重要。",
      differentials: [
        "外傷",
        "眼內腫瘤",
        "凝血障礙",
        "高血壓",
        "嚴重葡萄膜炎",
        "視網膜脫離",
        "慢性青光眼",
        "水晶體脫位",
        "先天性異常",
        "感染性疾病（血液寄生蟲）"
      ],
      initialDB: [
        "完整眼科檢查（可能受限於出血量）",
        "眼壓測量（警惕繼發性青光眼）",
        "血壓測量（必須！）",
        "全血球計數（CBC）：評估貧血、血小板",
        "凝血功能檢查：PT、APTT、血小板計數",
        "血清生化檢查",
        "檢查對側眼"
      ],
      advanced: [
        "眼部超音波：評估眼後段、排除腫瘤和視網膜脫離（當無法看清眼底時）",
        "胸腔/腹部X光：評估轉移性腫瘤",
        "感染性疾病血清學：Ehrlichia、Anaplasma等",
        "骨髓穿刺：疑似血液腫瘤或骨髓問題",
        "腹部超音波：評估肝臟、脾臟、腎上腺"
      ]
    },

    treatment: {
      overview: "治療取決於病因。急性處理著重於控制出血、預防併發症和減輕疼痛。",
      acute: [
        "限制活動：減少再出血風險",
        "戴伊莉莎白頸圈：防止自我傷害",
        "局部類固醇：減輕發炎（Prednisolone acetate 1%，每日2-4次）",
        "局部散瞳劑：Atropine 1%，減輕睫狀肌痙攣",
        "監測眼壓：每日或更頻繁",
        "繼發性青光眼處理：降眼壓藥物",
        "全身性止痛",
        "處理潛在病因：",
        "  - 高血壓：降壓藥（Amlodipine）",
        "  - 凝血障礙：輸血、維生素K等",
        "  - 感染：相應抗生素"
      ],
      chronic: [
        "持續監測眼壓",
        "處理潛在病因",
        "腫瘤相關：可能需要眼球摘除",
        "反覆出血或繼發性青光眼失控：可能需要眼球摘除",
        "視力恢復後追蹤"
      ]
    },

    prognosis: "預後取決於病因、出血量和是否發生併發症。輕度外傷性前房出血在1-2週內可能完全吸收，視力恢復良好。嚴重或反覆出血、繼發性青光眼會影響預後。腫瘤相關前房出血預後較差。全身性凝血障礙需要有效控制根本疾病。約30-40%的前房出血會發生再出血，通常在最初3-5天內。",

    pearls: [
      "前房出血是找病因的信號——必須進行全面檢查",
      "所有前房出血病例都應測量血壓",
      "限制活動對預防再出血很重要",
      "密切監測眼壓是防止繼發性青光眼的關鍵",
      "再出血風險在最初幾天最高",
      "單側前房出血更可能是局部原因（外傷、腫瘤）",
      "雙側前房出血高度懷疑全身性疾病（凝血障礙、高血壓）",
      "貓的前房出血應高度懷疑高血壓"
    ],

    defined: true
  },

  // ============================================================
  // 15. Sudden Acquired Retinal Degeneration (SARDS) - 突發性視網膜退化
  // ============================================================
  "sards": {
    zh: "突發性視網膜退化症候群",
    en: "Sudden Acquired Retinal Degeneration Syndrome (SARDS)",
    definition: "突發性視網膜退化症候群是一種病因不明的疾病，導致犬隻急性、完全且不可逆的失明。特徵是視網膜光感受器功能突然喪失，但初期眼底外觀可能完全正常。",
    synonyms: ["SARDS", "突發性失明", "Silent Retina Syndrome", "代謝性中毒性視網膜病變"],

    epidemiology: {
      species: "僅見於犬，貓未有報告",
      age: "中老年犬，平均8-9歲（範圍2-15歲）",
      sex: "母犬可能略多（約60-70%）",
      riskFactors: [
        "中老年犬",
        "母犬較常見",
        "常見品種：迷你雪納瑞、臘腸犬、馬爾濟斯、可卡犬、巴哥犬、比格犬（但任何品種均可發生）",
        "小型至中型犬較常見",
        "許多病例有全身性症狀（多飲多尿、體重增加）",
        "可能與腎上腺或代謝異常有關聯（有爭議）",
        "病因不明"
      ]
    },

    clinicalPresentation: {
      history: [
        "急性完全失明（數天至數週內）",
        "突然在家中撞到物體",
        "不願在不熟悉環境中移動",
        "瞳孔擴大",
        "常伴有全身性症狀：",
        "  - 多飲多尿（PU/PD）約50%病例",
        "  - 體重增加/肥胖",
        "  - 食慾增加",
        "  - 皮膚變化（類似庫興氏症狀）",
        "主人常無法精確指出失明開始時間"
      ],
      physicalExam: [
        "瞳孔擴大且固定（對光反射消失或極弱）",
        "威脅反射消失",
        "眼底檢查初期可能完全正常（！重要特徵）",
        "晚期（數週至數月後）：",
        "  - 視網膜血管萎縮變細",
        "  - 視網膜反光增強（視網膜變薄）",
        "  - 視神經盤蒼白",
        "無前房或玻璃體異常",
        "無葡萄膜炎跡象",
        "眼壓正常"
      ]
    },

    pathophysiology: "SARDS的確切病因仍不明確，是獸醫眼科的重大謎題之一。目前假說包括：(1)免疫介導性機制：可能是針對視網膜光感受器的自體免疫反應；(2)代謝/內分泌異常：許多病例有類似庫興氏症候群的症狀，腎上腺軸可能有關；(3)神經毒性理論：某些代謝產物可能對光感受器有毒性。病理學顯示光感受器外節段（outer segments）快速退化，但視網膜其他層相對保留。這解釋了為什麼ERG早期即異常，但眼底檢查可能正常。目前無證據支持感染性、遺傳性或營養性病因。",

    diagnosis: {
      overview: "診斷基於：急性失明+眼底正常或輕微異常+ERG平坦。需排除其他急性失明原因（視神經病變、中樞性失明）。",
      differentials: [
        "視神經炎",
        "視神經腫瘤",
        "中樞性失明（腦部病變）",
        "視網膜脫離",
        "嚴重葡萄膜炎",
        "急性青光眼",
        "糖尿病性白內障（若白內障阻礙眼底觀察）",
        "免疫介導性視網膜炎（IMR）——可能是SARDS的早期可治療階段"
      ],
      initialDB: [
        "完整眼科檢查：眼底可能正常，PLR消失或極弱",
        "視網膜電圖（ERG）：金標準，顯示完全平坦（extinguished）的反應",
        "血壓測量：排除高血壓視網膜病變",
        "全血球計數（CBC）",
        "血清生化檢查",
        "尿液分析",
        "甲狀腺功能檢測",
        "腎上腺功能檢測（LDDS或ACTH刺激試驗）：許多病例有異常"
      ],
      advanced: [
        "腦部MRI：排除中樞性失明（視交叉、視覺皮質病變）",
        "腦脊液分析：排除中樞神經系統疾病",
        "腹部超音波：評估腎上腺",
        "抗視網膜抗體檢測（研究階段）"
      ]
    },

    treatment: {
      overview: "目前沒有經證實有效的SARDS治療方法。失明是不可逆的。治療以支持性照護和處理併發全身性症狀為主。",
      acute: [
        "目前無有效急性治療",
        "免疫抑制治療（爭議性）：",
        "  - 靜脈注射免疫球蛋白（IVIg）：有些報告聲稱可能有效，但未經充分驗證",
        "  - 高劑量類固醇：無證據支持有效",
        "心理支持：主人常對突然失明感到震驚",
        "環境安全評估"
      ],
      chronic: [
        "失明犬的生活適應：",
        "  - 保持家具位置固定",
        "  - 使用聲音和氣味線索",
        "  - 安全圍欄",
        "  - 避免危險（樓梯、游泳池）",
        "處理全身性症狀：",
        "  - 若有明確庫興氏症候群可考慮治療",
        "  - 飲食管理控制體重",
        "  - 定期監測併發症",
        "定期獸醫追蹤"
      ]
    },

    prognosis: "視力預後極差——失明是永久性的，目前沒有治療方法可以恢復視力。然而，總體生存預後良好，SARDS本身不會縮短壽命。大多數犬可以很好地適應失明，特別是在熟悉的環境中。全身性症狀（PU/PD、體重增加）通常可以管理。心理支持和主人教育是照護的重要部分。",

    pearls: [
      "SARDS的特徵是急性失明但眼底正常——這點與PRA（漸進性，眼底異常）形成對比",
      "ERG是確診SARDS的必要檢查，顯示完全平坦的反應",
      "約50%的SARDS病例有全身性症狀（PU/PD、體重增加），類似庫興氏症候群",
      "必須排除中樞性失明（MRI）和視神經病變",
      "目前無經證實有效的治療，各種治療報告缺乏對照研究",
      "免疫介導性視網膜炎（IMR）可能是SARDS的早期可治療形式，但這仍有爭議",
      "犬隻適應失明的能力通常很好——給主人希望和支持很重要"
    ],

    defined: true
  }

  // ===== From respiratory-diseases.js =====

  // ==================== 上呼吸道疾病 ====================

  "brachycephalic-airway-syndrome": {
    zh: "短頭犬呼吸道症候群",
    en: "Brachycephalic Airway Syndrome (BAS)",
    definition: "短頭犬種因顱顏部結構異常導致的一系列上呼吸道阻塞性問題，包括狹窄鼻孔、軟顎過長、喉囊外翻和氣管發育不全等。",
    synonyms: ["Brachycephalic Obstructive Airway Syndrome", "BOAS", "短頭種氣道症候群", "扁臉犬症候群"],
    epidemiology: {
      species: "犬為主（貓少見：波斯貓、喜馬拉雅貓）",
      age: "先天性，症狀可在任何年齡出現，通常1-4歲明顯",
      sex: "無明顯性別傾向",
      riskFactors: ["短頭犬種（法國鬥牛犬、英國鬥牛犬、巴哥、波士頓梗、北京犬、西施犬）", "肥胖", "高溫高濕環境", "運動", "興奮/緊張"]
    },
    clinicalPresentation: {
      history: ["打鼾（睡眠和清醒時）", "呼吸困難（尤其運動或興奮時）", "運動不耐", "熱不耐", "嘔吐/反胃", "昏厥", "發紺", "睡眠呼吸暫停"],
      physicalExam: ["吸氣性喘鳴(Stridor)", "狹窄鼻孔", "軟顎過長（可視診或需麻醉檢查）", "體型肥胖", "發紺（嚴重時）", "呼吸費力", "張口呼吸"]
    },
    pathophysiology: "原發性異常（狹窄鼻孔、軟顎過長、鼻甲骨肥大、氣管發育不全）→ 氣道阻力增加 → 呼吸努力增加 → 氣道負壓增加 → 繼發性改變（喉囊外翻、喉塌陷、扁桃腺腫大）→ 進一步阻塞 → 惡性循環。慢性缺氧可導致肺動脈高壓和右心衰竭。",
    diagnosis: {
      overview: "臨床表現結合品種特徵，喉鏡和影像學確認具體異常",
      differentials: ["喉麻痺", "氣管塌陷", "喉腫瘤", "異物", "過敏性喉炎", "氣管發育不全"],
      initialDB: ["詳細身體檢查", "頸胸部X光（氣管直徑、肺部）", "輕度鎮靜下喉部檢查（軟顎、喉囊、喉功能）"],
      advanced: ["CT掃描（詳細評估鼻腔和氣道）", "支氣管鏡（評估氣管）", "血氣分析", "心臟超聲（若懷疑右心問題）"]
    },
    treatment: {
      overview: "輕度病例保守管理，中重度需手術矯正",
      acute: [
        "呼吸窘迫緊急處理：",
        "  - 氧氣支持",
        "  - 降溫（若過熱）",
        "  - 鎮靜：Acepromazine 0.01-0.05 mg/kg IV/IM 或 Butorphanol 0.2-0.4 mg/kg",
        "  - 類固醇（減少喉水腫）：Dexamethasone 0.1-0.2 mg/kg IV",
        "  - 必要時緊急氣管切開或插管"
      ],
      chronic: [
        "保守管理：",
        "  - 體重控制（減重對改善症狀至關重要）",
        "  - 避免高溫和劇烈運動",
        "  - 使用胸背帶而非項圈",
        "手術治療（推薦早期進行）：",
        "  - 鼻孔擴大術(Alar fold resection/Wedge resection)",
        "  - 軟顎切除術(Staphylectomy)",
        "  - 喉囊切除術(Laryngeal sacculectomy)",
        "  - 嚴重喉塌陷：永久性氣管切開術"
      ]
    },
    prognosis: "早期手術矯正預後良好（80-90%改善）。年輕、無繼發性改變者預後最佳。嚴重喉塌陷或氣管發育不全預後謹慎。未治療會進行性惡化。",
    pearls: [
      "「早期手術，越年輕越好」- 避免繼發性改變",
      "術後24-48小時是關鍵觀察期，需密切監測呼吸道",
      "肥胖顯著惡化症狀，減重是治療的重要部分",
      "這些犬種麻醉風險高，需特別注意插管和拔管",
      "消化道問題（胃食道逆流、食道裂孔疝）在BAS犬很常見"
    ],
    monitoring: ["呼吸頻率和型態", "運動耐受度", "體重", "睡眠品質", "術後氣道腫脹"],
    reference: "Johnson LR: Textbook of Respiratory Disease in Dogs and Cats. Elsevier, 2020; Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "laryngeal-paralysis": {
    zh: "喉麻痺",
    en: "Laryngeal Paralysis",
    definition: "喉返神經功能障礙導致杓狀軟骨無法正常外展，造成吸氣時喉門狹窄和上呼吸道阻塞。可為先天性或後天性。",
    synonyms: ["Lar Par", "LP", "喉癱瘓", "Geriatric Onset Laryngeal Paralysis Polyneuropathy (GOLPP)"],
    epidemiology: {
      species: "犬為主（貓罕見）",
      age: "先天性：幼犬；後天性：中老年大型犬（9-13歲）",
      sex: "公犬略多",
      riskFactors: ["大型/巨型犬種", "品種傾向（Labrador Retriever、Golden Retriever、St. Bernard、Newfoundland、Irish Setter）", "先天性：Bouvier des Flandres、Bull Terrier、Dalmatian、Husky", "甲狀腺功能低下（有爭議）", "創傷、腫瘤、手術損傷"]
    },
    clinicalPresentation: {
      history: ["進行性吸氣性喘鳴（數月至數年）", "運動不耐", "聲音改變（沙啞）", "咳嗽（尤其進食後）", "熱不耐", "昏厥", "可能有後肢無力（GOLPP）"],
      physicalExam: ["吸氣性喘鳴(Stridor)", "張口呼吸", "呼吸窘迫（嚴重時）", "發紺", "可能有後肢本體感覺異常", "甲狀腺觸診"]
    },
    pathophysiology: "喉返神經病變 → 環杓背側肌麻痺 → 杓狀軟骨無法外展 → 吸氣時喉門狹窄 → 吸氣性阻塞。特發性後天性喉麻痺(GOLPP)現被認為是廣泛性多發性神經病變的一部分，喉部症狀最先出現。",
    diagnosis: {
      overview: "臨床症狀結合喉鏡直視下確認杓狀軟骨運動異常",
      differentials: ["短頭犬呼吸道症候群", "喉腫瘤", "喉塌陷", "氣管塌陷", "異物", "喉創傷"],
      initialDB: ["胸腔X光（吸入性肺炎、巨食道）", "頸部X光", "輕度鎮靜下喉鏡檢查（觀察杓狀軟骨運動）"],
      advanced: ["神經肌肉評估（EMG）", "甲狀腺功能檢測", "透視檢查（吞嚥功能、巨食道）", "CT/MRI（若懷疑腫瘤）", "腦脊液分析"]
    },
    treatment: {
      overview: "輕度症狀可保守管理，中重度需手術治療",
      acute: [
        "呼吸窘迫緊急處理：",
        "  - 氧氣支持",
        "  - 降溫",
        "  - 鎮靜（同BAS）",
        "  - 類固醇（減少喉水腫）",
        "  - 必要時緊急插管或氣管切開"
      ],
      chronic: [
        "保守管理（輕度）：",
        "  - 體重控制",
        "  - 避免高溫和劇烈運動",
        "  - 抬高食碗（若有巨食道）",
        "手術治療：",
        "  - 單側杓狀軟骨外展固定術(Unilateral Arytenoid Lateralization/Tieback)",
        "    最常用，成功率約90%",
        "  - 雙側外展固定（不建議，吸入性肺炎風險高）",
        "  - 部分杓狀軟骨切除術",
        "  - 永久性氣管切開術（末期病例）"
      ]
    },
    prognosis: "單側tieback手術後90%以上改善。主要併發症是吸入性肺炎（10-30%），可能致命。GOLPP犬的神經病變會持續進展。",
    pearls: [
      "「Lar Par的喉鏡檢查需要完美的麻醉深度」- 太深無運動，太淺會假陽性",
      "Doxapram可輔助喉鏡檢查（刺激呼吸）",
      "術後永久改變飲食習慣（小份量、糊狀食物、慢食）以降低吸入性肺炎風險",
      "GOLPP犬同時評估後肢神經功能很重要",
      "術後數週吸氣聲可能仍存在但會改善"
    ],
    monitoring: ["呼吸型態", "進食後咳嗽", "肺炎徵象", "後肢功能（GOLPP）", "體重"],
    reference: "MacPhail CM: Laryngeal disease in dogs and cats. Vet Clin North Am Small Anim Pract 44:19-31, 2014"
  },

  "tracheal-collapse": {
    zh: "氣管塌陷",
    en: "Tracheal Collapse",
    definition: "氣管環軟骨變性導致氣管管腔狹窄的進行性疾病。背側氣管膜可能下垂到管腔內，造成呼吸道阻塞。",
    synonyms: ["Collapsing Trachea", "氣管軟化症", "Tracheomalacia"],
    epidemiology: {
      species: "犬（玩具犬和小型犬為主）",
      age: "中老年犬（6-7歲常見發病）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（吉娃娃、約克夏、博美、玩具貴賓、馬爾濟斯）", "肥胖", "慢性呼吸道疾病", "心臟病（左心房擴大壓迫主支氣管）"]
    },
    clinicalPresentation: {
      history: ["慢性「鵝叫」樣咳嗽", "咳嗽因興奮、運動、飲水、牽繩拉扯而加重", "運動不耐", "呼吸困難", "發紺（嚴重時）", "昏厥"],
      physicalExam: ["誘發咳嗽（觸診氣管）", "「鵝叫」樣咳嗽", "吸氣性或呼氣性喘鳴（取決於塌陷位置）", "可能有心雜音（同時心臟病）", "可能有肺部異常音（若有支氣管炎）"]
    },
    pathophysiology: "氣管環軟骨基質（糖胺聚糖和軟骨素）減少 → 軟骨變軟 → C形軟骨環變扁平 → 背側氣管膜鬆弛下垂 → 管腔狹窄。頸部氣管塌陷在吸氣時惡化，胸腔內氣管塌陷在呼氣時惡化。分級：Grade I (25%塌陷) 到 Grade IV (>75%塌陷)。",
    diagnosis: {
      overview: "臨床表現結合影像學確認",
      differentials: ["慢性支氣管炎", "心臟病（咳嗽）", "喉麻痺", "氣管腫瘤", "異物", "肺炎"],
      initialDB: ["頸胸部X光（吸氣相+呼氣相，可見氣管直徑變化）", "心臟評估（X光、心臟超聲）"],
      advanced: ["透視檢查（動態評估塌陷程度）", "支氣管鏡（直視下分級、評估下呼吸道）", "CT掃描", "BAL（若懷疑併發感染）"]
    },
    treatment: {
      overview: "多數病例可藥物控制，嚴重或難治性病例考慮手術",
      acute: [
        "急性呼吸窘迫：",
        "  - 氧氣支持",
        "  - 鎮靜：Butorphanol 0.05-0.1 mg/kg IV",
        "  - 類固醇：Dexamethasone 0.1-0.25 mg/kg IV",
        "  - 支氣管擴張劑",
        "  - 降溫（若過熱）"
      ],
      chronic: [
        "藥物治療（多數病例首選）：",
        "  - 止咳藥：Hydrocodone 0.22 mg/kg PO q6-12h",
        "    或 Butorphanol 0.5-1 mg/kg PO q6-12h",
        "  - 支氣管擴張劑：Theophylline 10 mg/kg PO q12h",
        "    或 Terbutaline 1.25-5 mg/dog PO q8-12h",
        "  - 類固醇（短期爆發）：Prednisone 0.5-1 mg/kg PO q12-24h",
        "  - 抗生素（若有繼發感染）",
        "管理：",
        "  - 體重控制（至關重要）",
        "  - 使用胸背帶",
        "  - 避免刺激物（煙霧、灰塵）",
        "  - 控制環境溫度和濕度",
        "手術治療（嚴重或難治）：",
        "  - 氣管內支架置入(Intraluminal Stent)",
        "  - 氣管外環(Extraluminal rings)（頸部氣管）"
      ]
    },
    prognosis: "多數犬隻藥物治療可良好控制。疾病會緩慢進展。支架置入可明顯改善症狀但有併發症風險（支架移位、肉芽組織形成）。",
    pearls: [
      "頸部塌陷 → 吸氣時惡化；胸腔內塌陷 → 呼氣時惡化",
      "X光需吸氣和呼氣相才能完整評估",
      "70%病例同時有下呼吸道疾病（支氣管炎、支氣管軟化）",
      "支架是末線治療，非首選",
      "肥胖犬減重後症狀可能顯著改善"
    ],
    monitoring: ["咳嗽頻率和嚴重度", "呼吸頻率", "運動耐受度", "體重", "藥物副作用"],
    reference: "Johnson LR: Tracheal collapse. Diagnosis and medical and surgical treatment. Vet Clin North Am Small Anim Pract 30:1253-1266, 2000"
  },

  // ==================== 感染性呼吸道疾病 ====================

  "kennel-cough": {
    zh: "犬傳染性呼吸道疾病",
    en: "Kennel Cough (Canine Infectious Respiratory Disease Complex, CIRDC)",
    definition: "多種病原體引起的急性傳染性呼吸道感染綜合症，特徵為急性發作的咳嗽。常見於犬群聚環境。",
    synonyms: ["Kennel Cough", "犬舍咳", "Infectious Tracheobronchitis", "CIRDC", "傳染性氣管支氣管炎"],
    epidemiology: {
      species: "犬",
      age: "任何年齡，幼犬和老年犬症狀較嚴重",
      sex: "無性別傾向",
      riskFactors: ["犬群聚環境（犬舍、寵物店、收容所、狗公園、美容院）", "未接種疫苗", "運輸應激", "免疫抑制", "其他呼吸道疾病"]
    },
    clinicalPresentation: {
      history: ["急性發作的咳嗽（暴露後3-10天）", "「嘎」樣乾咳", "咳嗽後可能有作嘔/吐出黏液", "可能有鼻/眼分泌物", "打噴嚏", "輕度發燒", "通常精神食慾正常"],
      physicalExam: ["誘發咳嗽（氣管觸診）", "通常無明顯異常", "可能有鼻/眼分泌物", "肺部聽診通常正常", "嚴重病例可能發燒、肺部囉音"]
    },
    pathophysiology: "病原體（最常見：Bordetella bronchiseptica、犬副流感病毒、犬腺病毒2型、犬呼吸道冠狀病毒、犬流感病毒、支原體）→ 呼吸道上皮感染 → 纖毛損傷 → 氣道炎症和分泌物增加 → 咳嗽反射。混合感染常見。",
    diagnosis: {
      overview: "通常根據典型病史和臨床表現診斷，多數病例無需進一步檢查",
      differentials: ["氣管塌陷", "心臟病", "慢性支氣管炎", "肺炎", "異物", "寄生蟲（肺蟲、心絲蟲）"],
      initialDB: ["多數單純病例不需要", "胸腔X光（若症狀嚴重或持續>2週）", "心臟評估（排除心臟病）"],
      advanced: ["PCR檢測（多種病原體套組）", "BAL細菌培養和敏感性（若懷疑繼發感染）", "支原體培養"]
    },
    treatment: {
      overview: "多數病例自限性，7-14天可自行恢復。支持治療為主，嚴重或高風險病例使用抗生素",
      acute: [
        "輕度、無併發症病例：",
        "  - 支持治療：休息、避免刺激物",
        "  - 止咳藥（若咳嗽影響休息）：Hydrocodone 0.22 mg/kg PO q6-12h",
        "  - 蒸氣吸入（滋潤氣道）",
        "  - 隔離（防止傳播，至少2週）",
        "中重度或高風險病例（幼犬、老年、免疫抑制）：",
        "  - 抗生素：Doxycycline 5-10 mg/kg PO q12-24h x 10-14天",
        "    或 Azithromycin 5-10 mg/kg PO q24h x 3-5天",
        "  - 支氣管擴張劑（若有支氣管痙攣）",
        "嚴重肺炎：",
        "  - 住院、氧氣支持、靜脈輸液",
        "  - 靜脈抗生素"
      ],
      chronic: [
        "預防：",
        "  - 疫苗接種（Bordetella、副流感、腺病毒）",
        "  - 避免高風險環境（若可能）",
        "  - 寄宿前2週接種疫苗"
      ]
    },
    prognosis: "多數單純病例7-14天自行恢復，預後極佳。幼犬或免疫抑制者可能發展為嚴重肺炎。犬流感病毒株可能較嚴重。",
    pearls: [
      "「典型的犬舍咳聽起來像咳出東西但其實沒有」",
      "即使症狀消失後仍可排毒數週",
      "Bordetella疫苗有口服、鼻內、皮下三種給藥途徑",
      "抗生素不能縮短病毒感染病程，但可預防繼發細菌感染",
      "考慮犬流感病毒，尤其是群聚暴發且症狀較嚴重時"
    ],
    monitoring: ["咳嗽頻率和性質", "精神食慾", "呼吸頻率", "發燒", "分泌物性質"],
    reference: "Reagan KL, Sykes JE: Canine Infectious Respiratory Disease. Vet Clin North Am Small Anim Pract 50:405-418, 2020"
  },

  "aspiration-pneumonia": {
    zh: "吸入性肺炎",
    en: "Aspiration Pneumonia",
    definition: "因吸入胃內容物、食物、液體或其他異物進入下呼吸道而引起的肺部炎症和感染。是小動物常見的急性肺炎類型。",
    synonyms: ["Aspiration Pneumonitis", "誤吸性肺炎", "AP"],
    epidemiology: {
      species: "犬較常見，貓亦可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["嘔吐", "巨食道", "喉麻痺", "口咽功能障礙", "意識障礙（麻醉、癲癇）", "強迫灌食", "氣管插管/拔管", "短頭犬種", "重症肌無力", "神經肌肉疾病"]
    },
    clinicalPresentation: {
      history: ["急性呼吸困難", "咳嗽", "發燒", "已知吸入事件或風險因素", "可能有嘔吐或反胃史"],
      physicalExam: ["發燒", "呼吸急促", "呼吸費力", "肺部濕囉音（尤其右中葉區域）", "發紺（嚴重時）", "可能有脫水"]
    },
    pathophysiology: "吸入異物 → 化學性肺損傷（胃酸pH<2.5特別損傷）+ 機械性阻塞 + 細菌感染 → 急性肺損傷 → 肺泡充滿炎性滲出物 → 低氧血症。右中肺葉最常受累（因支氣管角度）。混合性感染常見（厭氧菌+好氧菌）。",
    diagnosis: {
      overview: "病史、臨床表現和胸腔X光",
      differentials: ["社區性肺炎", "心源性肺水腫", "肺出血", "肺腫瘤", "ARDS", "肺栓塞"],
      initialDB: ["胸腔X光（典型：右中葉或雙側腹側肺浸潤）", "CBC（白血球增多伴左移）", "脈搏血氧儀", "血氣分析"],
      advanced: ["氣管沖洗(TTW)或BAL（細胞學+培養）", "血液培養（若敗血症）", "食道評估（若懷疑巨食道）", "吞嚥功能評估"]
    },
    treatment: {
      overview: "氧氣支持、抗生素治療、支持治療、處理原發病因",
      acute: [
        "氧氣支持（維持SpO2 >94%）",
        "靜脈輸液（謹慎，避免肺水腫）",
        "廣譜抗生素（涵蓋厭氧菌）：",
        "  - Ampicillin-Sulbactam 20-30 mg/kg IV q8h",
        "    + Enrofloxacin 5-10 mg/kg IV q24h",
        "  - 或 Clindamycin 10 mg/kg IV q12h + Fluoroquinolone",
        "支氣管擴張劑（若有支氣管痙攣）",
        "霧化治療（生理鹽水+/-支氣管擴張劑）",
        "翻身和叩擊（促進分泌物排出）",
        "嚴重低氧：考慮機械通氣"
      ],
      chronic: [
        "口服抗生素續療（總療程3-6週或X光改善後2週）",
        "處理原發病因：",
        "  - 巨食道：抬高餵食、改變食物質地",
        "  - 喉麻痺：手術矯正",
        "  - 嘔吐控制",
        "營養支持（若厭食）"
      ]
    },
    prognosis: "整體預後中等至良好（存活率約70-80%）。嚴重低氧血症、敗血症、ARDS預後較差。復發性吸入（如未治療的巨食道）預後謹慎。",
    pearls: [
      "右中葉是「吸入性肺炎葉」",
      "麻醉拔管後監測呼吸很重要",
      "胃酸吸入比食物吸入造成更嚴重損傷",
      "X光改變可能在吸入後12-24小時才出現",
      "尋找並處理原發病因以防止復發"
    ],
    monitoring: ["呼吸頻率和努力程度", "SpO2", "體溫", "食慾", "胸腔X光追蹤（7-10天後）"],
    reference: "Tart KM et al: Outcome of dogs with aspiration pneumonia: 127 cases (1997-2013). J Vet Emerg Crit Care 28:339-347, 2018"
  },

  // ==================== 下呼吸道疾病 ====================

  "feline-asthma": {
    zh: "貓氣喘",
    en: "Feline Asthma",
    definition: "貓的慢性下呼吸道發炎性疾病，特徵為氣道高反應性、可逆性支氣管收縮和嗜酸性球浸潤。可能與過敏原暴露相關。",
    synonyms: ["Feline Allergic Bronchitis", "Feline Bronchial Disease", "貓支氣管氣喘", "貓過敏性支氣管炎"],
    epidemiology: {
      species: "貓",
      age: "年輕至中年成貓（2-8歲常見發病）",
      sex: "母貓略多",
      riskFactors: ["品種傾向（暹羅貓）", "室內環境過敏原", "二手煙暴露", "灰塵、香氛、貓砂粉塵"]
    },
    clinicalPresentation: {
      history: ["陣發性咳嗽", "喘息", "呼吸困難", "張口呼吸", "運動不耐", "症狀可能有季節性", "可能有「蹲姿」咳嗽"],
      physicalExam: ["呼氣性喘息（Wheeze）", "呼氣期延長", "呼吸急促", "腹式呼吸", "發紺（嚴重發作時）", "可能有異常呼吸音"]
    },
    pathophysiology: "過敏原暴露 → Th2免疫反應 → 嗜酸性球和肥大細胞浸潤氣道 → 炎性介質釋放 → 支氣管平滑肌收縮 + 黏液分泌增加 + 氣道壁水腫 → 氣道狹窄和氣流受限。慢性可導致氣道重塑。",
    diagnosis: {
      overview: "臨床表現結合胸腔X光的典型改變，排除其他疾病",
      differentials: ["心絲蟲病(HARD)", "肺蟲感染", "細菌性支氣管肺炎", "肺腫瘤", "胸腔積液", "心臟病"],
      initialDB: ["胸腔X光（典型「甜甜圈」和「軌道」徵象、肺過度充氣、右中葉塌陷）", "糞便檢查（排除肺蟲）", "心絲蟲抗體/抗原測試", "心臟評估"],
      advanced: ["BAL（>17%嗜酸性球支持診斷）", "CT掃描", "過敏原測試（幫助有限）", "支氣管激發試驗"]
    },
    treatment: {
      overview: "急性發作緊急處理，長期以類固醇和支氣管擴張劑控制",
      acute: [
        "氣喘急性發作：",
        "  - 最小化處置應激",
        "  - 氧氣支持",
        "  - 快速作用支氣管擴張劑：",
        "    Terbutaline 0.01 mg/kg SC/IM",
        "    或 Albuterol 吸入（若可配合）",
        "  - 短效類固醇：Dexamethasone SP 0.25-0.5 mg/kg IV/IM",
        "  - 穩定後再進一步處置"
      ],
      chronic: [
        "類固醇治療（首選吸入）：",
        "  - 吸入型：Fluticasone 110-220 μg q12h（經貓專用間隔器）",
        "  - 口服：Prednisolone 1-2 mg/kg PO q12h，漸減至最低有效劑量",
        "支氣管擴張劑（輔助）：",
        "  - 吸入型：Albuterol PRN",
        "  - 口服：Terbutaline 0.1-0.2 mg/kg PO q12h",
        "環境管理：",
        "  - 移除或減少過敏原",
        "  - 使用低粉塵貓砂",
        "  - 避免香氛、香煙、噴霧劑",
        "  - 空氣清淨機",
        "其他治療（難治病例）：",
        "  - Cyclosporine 5 mg/kg PO q24h",
        "  - 過敏原特異性免疫治療"
      ]
    },
    prognosis: "多數貓可良好控制。完全治癒不常見。吸入型類固醇可減少全身副作用。急性嚴重發作可能致命。",
    pearls: [
      "貓張口呼吸是緊急狀況",
      "吸入型類固醇需要耐心訓練，但副作用少",
      "AeroKat是常用的貓吸入器間隔器",
      "典型X光但BAL嗜酸性球不高 → 考慮心絲蟲",
      "減重對肥胖的氣喘貓有幫助"
    ],
    monitoring: ["呼吸頻率（居家監測）", "咳嗽和喘息頻率", "運動耐受度", "藥物副作用（若口服類固醇）", "定期胸腔X光"],
    reference: "Trzil JE: Feline Asthma: Diagnostic and Treatment Update. Vet Clin North Am Small Anim Pract 50:375-391, 2020"
  },

  "bronchitis": {
    zh: "支氣管炎",
    en: "Bronchitis (Chronic Bronchitis)",
    definition: "氣管和支氣管的慢性炎症，定義為連續兩個月以上每天咳嗽，且排除其他心肺疾病。犬最常見的慢性咳嗽原因之一。",
    synonyms: ["Chronic Bronchitis", "慢性支氣管炎", "Chronic Obstructive Pulmonary Disease (COPD)"],
    epidemiology: {
      species: "犬（貓的慢性支氣管病變通常歸類為氣喘）",
      age: "中老年犬（>6歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["小型犬", "肥胖", "環境刺激物暴露（香煙、空污）", "先前呼吸道感染", "牙周病"]
    },
    clinicalPresentation: {
      history: ["慢性咳嗽（>2個月）", "咳嗽可能「濕」或「乾」", "運動後或興奮時咳嗽加重", "可能有作嘔或嘔吐", "運動不耐", "夜間咳嗽"],
      physicalExam: ["氣管敏感（誘發咳嗽）", "呼氣期延長或喘息", "肺部可能有濕囉音或乾囉音", "可能肥胖"]
    },
    pathophysiology: "慢性氣道刺激和/或感染 → 持續性炎症 → 杯狀細胞增生、黏液分泌過多 → 纖毛功能下降 → 黏液清除能力下降 → 氣道重塑 → 不可逆性氣道改變。常與氣管塌陷、支氣管擴張症共存。",
    diagnosis: {
      overview: "排除性診斷：排除心臟病、寄生蟲、感染、腫瘤等其他咳嗽原因",
      differentials: ["心臟病", "氣管塌陷", "肺炎", "肺腫瘤", "心絲蟲病", "肺蟲", "異物", "肺纖維化"],
      initialDB: ["胸腔X光（支氣管紋理增強、「甜甜圈」和「軌道」徵象）", "心臟評估（X光、心臟超聲）", "心絲蟲檢測", "糞便檢查（肺蟲）"],
      advanced: ["BAL（非退化性炎症、排除感染和腫瘤）", "氣管沖洗", "支氣管鏡（觀察氣道、採樣）", "CT掃描"]
    },
    treatment: {
      overview: "無法治癒，目標是控制炎症和症狀，改善生活品質",
      acute: [
        "急性惡化：",
        "  - 氧氣支持（若需要）",
        "  - 短期類固醇衝擊",
        "  - 支氣管擴張劑",
        "  - 抗生素（若有繼發感染）"
      ],
      chronic: [
        "抗炎治療：",
        "  - 口服類固醇：Prednisone 0.5-1 mg/kg PO q12h，漸減至最低有效劑量",
        "  - 吸入型類固醇（減少全身副作用）",
        "支氣管擴張劑：",
        "  - Theophylline 10 mg/kg PO q12h（緩釋劑型）",
        "  - Terbutaline 1.25-5 mg/dog PO q8-12h",
        "止咳藥（謹慎使用，保留生產性咳嗽）：",
        "  - Hydrocodone 0.22 mg/kg PO q6-12h",
        "其他治療：",
        "  - 體重控制",
        "  - 避免環境刺激物",
        "  - 霧化治療",
        "  - 抗生素（若有繼發感染，依據培養結果）"
      ]
    },
    prognosis: "無法治癒但多數可良好控制。疾病會緩慢進展。生活品質通常可維持良好。嚴重或難治病例預後謹慎。",
    pearls: [
      "慢性支氣管炎是排除性診斷",
      "避免長期使用全劑量類固醇 → 副作用",
      "吸入型治療在犬比貓更困難",
      "治療期望是「控制」而非「治癒」",
      "環境管理和減重同藥物治療一樣重要"
    ],
    monitoring: ["咳嗽頻率和嚴重度", "運動耐受度", "體重", "藥物副作用", "定期胸腔X光"],
    reference: "Johnson LR: Chronic bronchitis in dogs. Clin Tech Small Anim Pract 19:19-26, 2004"
  },

  // ==================== 肺實質疾病 ====================

  "pulmonary-edema": {
    zh: "肺水腫",
    en: "Pulmonary Edema",
    definition: "肺間質和/或肺泡內液體異常積聚，導致氣體交換障礙。可為心因性或非心因性。",
    synonyms: ["Lung Edema", "肺積水"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡（心因性多見於中老年）",
      sex: "依原發病因而異",
      riskFactors: ["心臟病（二尖瓣疾病、DCM、HCM）", "輸液過量", "電擊", "溺水", "上呼吸道阻塞", "頭部創傷", "癲癇", "敗血症"]
    },
    clinicalPresentation: {
      history: ["急性呼吸困難", "咳嗽（犬）", "張口呼吸（貓）", "端坐呼吸", "可能有心臟病史", "可能有近期創傷、癲癇、電擊史"],
      physicalExam: ["呼吸急促", "呼吸費力", "肺部濕囉音（爆裂音）", "發紺", "心雜音或奔馬律（心因性）", "泡沫狀鼻分泌物（嚴重時）"]
    },
    pathophysiology: "心因性：左心功能不全 → 肺靜脈壓升高 → 肺微血管靜水壓升高 → 液體濾出超過淋巴引流能力 → 間質水腫 → 肺泡水腫。非心因性：肺毛細血管通透性增加（ARDS、神經性、過敏性等）→ 蛋白質和液體滲漏。",
    diagnosis: {
      overview: "胸腔X光確認，鑑別心因性vs非心因性很重要",
      differentials: ["肺炎", "肺出血", "ARDS", "肺腫瘤", "胸腔積液"],
      initialDB: ["胸腔X光（心因性：肺門周圍或尾背側分布；非心因性：尾背側或彌漫性）", "心臟超聲（評估心臟功能）", "SpO2", "BNP/NT-proBNP（鑑別心因性）"],
      advanced: ["血氣分析", "心電圖", "血壓"]
    },
    treatment: {
      overview: "氧氣支持、利尿劑（心因性）、處理原發病因",
      acute: [
        "心因性肺水腫：",
        "  - 氧氣支持",
        "  - 最小化應激",
        "  - 利尿劑：Furosemide 2-4 mg/kg IV（可重複至效果）",
        "  - 血管擴張劑（若血壓允許）：Nitroprusside CRI",
        "  - 正性肌力藥（若心輸出量低）：Dobutamine CRI",
        "  - 鎮靜（減少氧耗）：Butorphanol 0.2-0.3 mg/kg IM",
        "非心因性肺水腫：",
        "  - 氧氣支持",
        "  - 利尿劑效果有限",
        "  - 支持治療",
        "  - 治療原發病因",
        "  - 機械通氣（若嚴重低氧）"
      ],
      chronic: [
        "心因性：長期心臟藥物管理",
        "  - 利尿劑：Furosemide 1-4 mg/kg PO q8-12h",
        "  - Pimobendan 0.25-0.3 mg/kg PO q12h",
        "  - ACEI：Enalapril 0.5 mg/kg PO q12-24h",
        "限鈉飲食",
        "居家呼吸頻率監測"
      ]
    },
    prognosis: "心因性：取決於原發心臟病嚴重程度和反應。非心因性：取決於原發病因。急性肺水腫是緊急狀況，但多數對治療反應良好。",
    pearls: [
      "心因性肺水腫對Furosemide反應通常很快",
      "犬心因性肺水腫以肺門周圍分布為主",
      "貓心因性肺水腫分布較不典型",
      "「不要對肺水腫的貓做太多事」- 最小化應激",
      "居家呼吸頻率監測（>40次/分）可早期發現"
    ],
    monitoring: ["呼吸頻率和型態", "SpO2", "肺部聽診", "尿量（利尿劑反應）", "胸腔X光追蹤"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "pulmonary-fibrosis": {
    zh: "肺纖維化",
    en: "Pulmonary Fibrosis (Idiopathic Pulmonary Fibrosis, IPF)",
    definition: "肺間質進行性纖維化導致肺順應性下降和氣體交換障礙的慢性疾病。病因不明，尤其在West Highland White Terrier中有品種特異性。",
    synonyms: ["Idiopathic Pulmonary Fibrosis", "IPF", "特發性肺纖維化", "Westie Lung Disease"],
    epidemiology: {
      species: "犬（貓罕見）",
      age: "中老年犬（>9歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（West Highland White Terrier最常見）", "其他梗犬（Staffordshire Bull Terrier、Scottish Terrier）", "慢性肺損傷史"]
    },
    clinicalPresentation: {
      history: ["進行性運動不耐（數月至數年）", "呼吸困難", "咳嗽（可能乾咳）", "發紺（晚期）", "昏厥"],
      physicalExam: ["吸氣期爆裂音（Velcro樣囉音）", "呼吸急促", "呼吸淺快", "發紺", "可能有心雜音（繼發性肺高壓、右心衰）"]
    },
    pathophysiology: "反覆的肺泡上皮損傷 → 異常修復反應 → 肌纖維母細胞增生 → 細胞外基質過度沉積 → 肺間質增厚和纖維化 → 肺順應性下降 → 限制性肺病 → 低氧血症 → 可能發展為肺高壓和右心衰竭。",
    diagnosis: {
      overview: "臨床表現結合HRCT或組織病理學確診",
      differentials: ["慢性支氣管炎", "肺腫瘤", "肺炎", "心臟病", "嗜酸性球性支氣管肺病", "肺高壓"],
      initialDB: ["胸腔X光（彌漫性間質紋理、支氣管周圍浸潤）", "SpO2/血氣（低氧血症）", "心臟超聲（排除心臟病、評估肺高壓）", "BNP"],
      advanced: ["高解析度CT(HRCT)（特徵性蜂窩狀改變）", "BAL（非特異性改變）", "肺活檢（確診但風險高）", "6分鐘步行測試"]
    },
    treatment: {
      overview: "無法治癒或逆轉，目標是減緩進展和緩解症狀",
      acute: [
        "急性惡化：",
        "  - 氧氣支持",
        "  - 支氣管擴張劑（若有支氣管痙攣）",
        "  - 類固醇衝擊（效果有限）"
      ],
      chronic: [
        "藥物治療（效果有限）：",
        "  - 類固醇：Prednisone 1-2 mg/kg PO q24h，漸減",
        "  - 支氣管擴張劑：Theophylline",
        "  - 抗纖維化藥物（研究中）：Pirfenidone、Nintedanib",
        "  - 肺高壓治療：Sildenafil 1-3 mg/kg PO q8-12h",
        "支持治療：",
        "  - 體重控制",
        "  - 避免過熱和劇烈運動",
        "  - 居家氧氣（終末期）",
        "  - 止咳藥（若咳嗽影響生活品質）"
      ]
    },
    prognosis: "預後謹慎至差。疾病會進展，存活時間中位數約1-2年（診斷後）。WHWT預後可能較其他品種差。",
    pearls: [
      "「Velcro囉音」是特徵性聽診發現",
      "Westie的IPF有遺傳成分，不建議繁殖",
      "類固醇效果通常令人失望",
      "Sildenafil可改善運動耐受度（若有肺高壓）",
      "居家氧氣可改善終末期生活品質"
    ],
    monitoring: ["呼吸頻率和努力程度", "SpO2", "運動耐受度", "生活品質評估", "定期胸腔X光或CT"],
    reference: "Heikkilä HP et al: Idiopathic pulmonary fibrosis in West Highland White Terriers. Vet Pathol 48:606-610, 2011"
  },

  "pulmonary-thromboembolism": {
    zh: "肺血栓栓塞",
    en: "Pulmonary Thromboembolism (PTE)",
    definition: "肺動脈或其分支被血栓阻塞，導致肺灌注減少和氣體交換障礙的急性危及生命狀況。",
    synonyms: ["PTE", "Pulmonary Embolism", "PE", "肺栓塞"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡（依原發病因）",
      sex: "無性別傾向",
      riskFactors: ["高凝狀態疾病：IMHA、腫瘤、蛋白質流失性腎病/腸病、庫欣症", "心臟病（尤其HCM貓）", "敗血症", "手術/創傷", "長期不動", "中央靜脈導管"]
    },
    clinicalPresentation: {
      history: ["急性呼吸困難", "突發虛弱或昏厥", "咳血（罕見）", "已知高風險疾病史"],
      physicalExam: ["急性呼吸窘迫", "心搏過速", "低血壓（大面積栓塞）", "發紺", "肺部聽診可能正常或有異常音", "可能有原發疾病的相關發現"]
    },
    pathophysiology: "血栓形成（通常來自深靜脈或右心）→ 栓塞進入肺動脈 → 機械性阻塞 + 血管收縮（血栓釋放介質）→ 肺灌注減少 → V/Q不匹配 → 低氧血症。大面積栓塞可導致急性右心衰竭和心因性休克。",
    diagnosis: {
      overview: "高度懷疑結合支持性檢查。確診困難，需排除其他原因",
      differentials: ["肺炎", "肺水腫", "ARDS", "氣胸", "心臟病", "嚴重貧血"],
      initialDB: ["動脈血氣（低氧血症、P(A-a)O2梯度增加、低碳酸血症）", "胸腔X光（可能正常或有非特異性改變）", "D-dimer（升高但非特異性）", "心臟超聲（右心擴大、肺高壓徵象）", "評估原發疾病"],
      advanced: ["CT血管造影(CTPA)（最佳確診方法）", "肺灌注掃描", "凝血功能（PT、PTT、抗凝血酶III、TEG）"]
    },
    treatment: {
      overview: "抗凝治療、支持治療、處理原發病因",
      acute: [
        "氧氣支持",
        "抗凝治療：",
        "  - Unfractionated Heparin: 150-300 U/kg IV bolus，",
        "    followed by 150-300 U/kg SC q6-8h",
        "  - 或 低分子量肝素(LMWH)：Enoxaparin 1 mg/kg SC q12h（犬）",
        "    或 1-1.5 mg/kg SC q12h（貓）",
        "  - 或 Dalteparin 150 U/kg SC q12h",
        "血流動力學支持（若休克）：",
        "  - 輸液（謹慎）",
        "  - 升壓藥（若需要）",
        "溶栓治療（人類使用，動物少見）：",
        "  - tPA：高風險，通常不建議"
      ],
      chronic: [
        "長期抗凝：",
        "  - 繼續LMWH 或",
        "  - 過渡到口服抗凝藥",
        "    Clopidogrel 1-2 mg/kg PO q24h（尤其貓）",
        "    Rivaroxaban（犬，劑量研究中）",
        "治療原發疾病（至關重要）"
      ]
    },
    prognosis: "預後謹慎至差。死亡率高（約50-80%）。取決於栓塞大小、原發疾病和能否控制高凝狀態。",
    pearls: [
      "「想到PTE比確診更重要」- 高風險患者要保持警覺",
      "胸腔X光正常不能排除PTE",
      "D-dimer陰性有助排除（陰性預測值高）",
      "IMHA是犬最常見的高凝狀態",
      "貓動脈血栓栓塞(ATE)是不同疾病（通常是主動脈末端）"
    ],
    monitoring: ["呼吸頻率和努力程度", "SpO2/血氣", "凝血功能（監測抗凝效果）", "原發疾病狀況"],
    reference: "Goggs R et al: Pulmonary thromboembolism. J Vet Emerg Crit Care 19:30-52, 2009"
  },

  // ==================== 胸腔疾病 ====================

  "pleural-effusion": {
    zh: "胸腔積液",
    en: "Pleural Effusion",
    definition: "胸膜腔內液體異常積聚。根據液體性質可分為漏出液、改良型漏出液、滲出液、乳糜液、血液或腫瘤性積液。",
    synonyms: ["胸水", "Hydrothorax", "胸腔積水"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "任何年齡（依病因而異）",
      sex: "依病因而異",
      riskFactors: ["心臟病", "腫瘤", "感染（膿胸）", "創傷", "低蛋白血症", "淋巴管阻塞/損傷"]
    },
    clinicalPresentation: {
      history: ["漸進性或急性呼吸困難", "運動不耐", "咳嗽（犬）", "張口呼吸（貓）", "厭食", "體重減輕"],
      physicalExam: ["呼吸急促或費力", "限制性呼吸型態（淺快）", "腹側肺音減弱或消失", "心音可能低沉", "可能有發燒（感染性）", "可能有腹水"]
    },
    pathophysiology: "漏出液：靜水壓增加（心衰）或膠體滲透壓降低（低蛋白）。滲出液：胸膜炎症或感染增加血管通透性。乳糜液：胸管損傷或阻塞。血胸：創傷、凝血障礙、腫瘤破裂。腫瘤性：直接浸潤或淋巴回流阻塞。",
    diagnosis: {
      overview: "胸腔穿刺術是診斷和治療的關鍵步驟",
      differentials: ["依液體性質分類（見下）"],
      initialDB: ["胸腔X光（評估積液量和分布）", "TFAST超聲（快速確認積液）", "胸腔穿刺術（診斷性+治療性）", "胸水分析（總蛋白、細胞計數、細胞學、必要時培養）"],
      advanced: ["心臟超聲（排除心臟病）", "胸腔CT", "胸腔鏡檢查", "淋巴管造影"]
    },
    treatment: {
      overview: "胸腔穿刺減壓是首要步驟，同時診斷和治療原發病因",
      acute: [
        "治療性胸腔穿刺：",
        "  - 抽出積液以緩解呼吸窘迫",
        "  - 可重複進行",
        "  - 送液體分析",
        "氧氣支持（穩定後再進行穿刺）",
        "根據積液性質進一步治療：",
        "  - 漏出液/改良型漏出液 → 治療原發病（心臟病、低蛋白）",
        "  - 膿性 → 胸管引流 + 抗生素",
        "  - 乳糜 → 保守或手術治療",
        "  - 血性 → 評估凝血、考慮輸血、找出血來源",
        "  - 腫瘤性 → 腫瘤治療"
      ],
      chronic: [
        "反覆積液：放置胸管",
        "特定治療（見各別疾病）",
        "原發病因治療是關鍵"
      ]
    },
    prognosis: "取決於原發病因。感染性（膿胸）經適當治療預後可良好。腫瘤性預後通常較差。心因性取決於心臟病嚴重程度。",
    pearls: [
      "呼吸窘迫的患者先穿刺減壓再拍X光",
      "胸水分析是確定病因的關鍵",
      "三角蛋白 > 2.5 g/dL 或細胞計數 > 5000/μL 提示滲出液",
      "乳糜液三酸甘油脂 > 血清，膽固醇 < 血清",
      "雙側積液常見於心臟病、FIP、腫瘤"
    ],
    monitoring: ["呼吸頻率和努力程度", "積液再積聚速度", "胸腔X光追蹤", "原發病因治療反應"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "pneumothorax": {
    zh: "氣胸",
    en: "Pneumothorax",
    definition: "胸膜腔內存在空氣，導致肺塌陷和呼吸功能障礙。可為自發性、創傷性或醫源性。",
    synonyms: ["氣胸", "PTX", "Collapsed Lung"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["創傷（最常見）", "肺部疾病（肺大泡、肺腫瘤、肺蟲）", "機械通氣", "胸腔穿刺併發症", "食道破裂"]
    },
    clinicalPresentation: {
      history: ["急性呼吸困難", "可能有創傷史", "突發虛弱"],
      physicalExam: ["呼吸急促", "呼吸淺快", "背側肺音減弱或消失", "叩診過度共鳴", "發紺", "皮下氣腫（若有胸壁損傷）"]
    },
    pathophysiology: "空氣進入胸膜腔（來自肺、氣道、食道或胸壁損傷）→ 胸腔負壓消失 → 肺彈性回縮 → 肺塌陷 → 通氣面積減少 → 低氧血症。張力性氣胸：單向閥效應導致空氣持續積聚 → 縱隔移位 → 靜脈回流受阻 → 心輸出量下降 → 休克。",
    diagnosis: {
      overview: "臨床表現結合胸腔X光確診",
      differentials: ["胸腔積液", "橫膈膜疝氣", "肺腫瘤", "肺大泡"],
      initialDB: ["胸腔X光（肺與胸壁分離、肺塌陷、無肺紋理區域）", "TFAST超聲（快速排除積液、確認滑動徵消失）"],
      advanced: ["胸腔CT（尋找肺大泡、腫瘤）", "支氣管鏡（若懷疑氣道損傷）"]
    },
    treatment: {
      overview: "輕度可保守觀察，中重度需胸腔穿刺或胸管引流",
      acute: [
        "張力性氣胸：立即胸腔穿刺減壓（緊急！）",
        "氧氣支持",
        "胸腔穿刺術（治療性）：",
        "  - 輕度（<25%塌陷）：可觀察，可能自行吸收",
        "  - 中度（25-50%塌陷）：胸腔穿刺，可能需重複",
        "  - 重度（>50%塌陷）或持續漏氣：胸管引流",
        "胸管放置（持續漏氣或反覆氣胸）",
        "止痛（創傷性）"
      ],
      chronic: [
        "尋找和治療原發病因：",
        "  - 肺大泡：手術切除",
        "  - 腫瘤：切除或化療",
        "  - 創傷：支持治療，通常會癒合",
        "自發性復發性氣胸：考慮肺葉切除或胸膜固定術"
      ]
    },
    prognosis: "創傷性氣胸經適當治療預後通常良好。自發性氣胸需評估原發病因。復發性或雙側氣胸預後較謹慎。",
    pearls: [
      "張力性氣胸是臨床診斷，不要等X光！",
      "呼氣相X光可更清楚顯示小量氣胸",
      "持續漏氣（胸管持續有氣泡）提示肺或氣道損傷",
      "犬自發性氣胸常與肺大泡相關",
      "皮下氣腫常與氣胸相關但不一定"
    ],
    monitoring: ["呼吸頻率和努力程度", "SpO2", "胸管引流量", "胸腔X光追蹤", "是否持續漏氣"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "pyothorax": {
    zh: "膿胸",
    en: "Pyothorax",
    definition: "胸膜腔內膿性感染，特徵為化膿性胸腔積液。是嚴重的危及生命感染。",
    synonyms: ["Empyema", "化膿性胸膜炎", "Septic Pleuritis"],
    epidemiology: {
      species: "犬貓皆可發生（貓較常見）",
      age: "年輕至中年動物較常見",
      sex: "公貓略多（可能與打架外傷相關）",
      riskFactors: ["穿刺傷（貓咬傷）", "異物吸入（草芒）", "食道穿孔", "肺炎擴散", "胸腔手術後感染"]
    },
    clinicalPresentation: {
      history: ["漸進性呼吸困難", "發燒", "厭食", "嗜睡", "體重減輕", "可能有外傷史"],
      physicalExam: ["發燒", "呼吸困難", "腹側肺音減弱", "心音低沉", "可能有惡臭口氣（厭氧菌感染）", "脫水", "可能有咬傷痕跡"]
    },
    pathophysiology: "細菌進入胸腔（穿刺傷、吸入、血行播散、鄰近器官擴散）→ 胸膜炎症 → 滲出液積聚 → 細菌增殖 → 化膿性積液 → 可能形成纖維蛋白分隔（loculation）→ 敗血症。混合感染常見（厭氧菌+好氧菌）。",
    diagnosis: {
      overview: "胸腔穿刺術獲取膿性液體是診斷關鍵",
      differentials: ["其他胸腔積液類型", "FIP（貓）", "腫瘤性積液"],
      initialDB: ["胸腔X光（胸腔積液）", "胸腔穿刺術", "胸水分析：混濁或膿性、惡臭（厭氧菌）、高蛋白（>3 g/dL）、高白血球（>50,000/μL）、退化性嗜中性球、可能見細菌", "細菌培養和敏感性（需氧+厭氧）", "CBC（嗜中性球增多伴左移）"],
      advanced: ["胸腔CT（評估分隔、尋找異物或原發病灶）", "支氣管鏡（異物）"]
    },
    treatment: {
      overview: "胸管引流和沖洗是治療核心，結合長期抗生素",
      acute: [
        "胸管放置和引流（雙側若雙側積液）",
        "胸腔沖洗：",
        "  - 溫生理鹽水沖洗（10-20 mL/kg）",
        "  - 每8-12小時沖洗直到液體清澈",
        "靜脈抗生素（廣譜，涵蓋厭氧菌）：",
        "  - Ampicillin-Sulbactam 20-30 mg/kg IV q8h",
        "    + Enrofloxacin 5-10 mg/kg IV q24h",
        "  - 或 Clindamycin 10-15 mg/kg IV q12h + Fluoroquinolone",
        "輸液支持",
        "營養支持",
        "止痛"
      ],
      chronic: [
        "胸管保留直到：",
        "  - 24小時引流量 <2 mL/kg",
        "  - 液體性質改善",
        "  - 臨床改善",
        "口服抗生素續療（總療程4-8週）",
        "尋找和處理原發病因：",
        "  - 異物取出",
        "  - 食道修復",
        "難治病例：開胸探查和清創"
      ]
    },
    prognosis: "經積極治療存活率約70-90%。預後因素：早期診斷、適當引流、Actinomyces感染較難治（需更長療程）。",
    pearls: [
      "貓膿胸常與咬傷相關，但常無明顯外傷史",
      "草芒吸入是犬常見原因",
      "惡臭液體強烈提示厭氧菌感染",
      "務必同時做需氧和厭氧培養",
      "胸腔沖洗是治療成功的關鍵"
    ],
    monitoring: ["體溫", "呼吸狀況", "引流液量和性質", "白血球計數", "胸腔X光追蹤"],
    reference: "Barrs VR, Beatty JA: Feline pyothorax - new insights into an old problem. Vet J 179:163-170, 2009"
  },

  "chylothorax": {
    zh: "乳糜胸",
    en: "Chylothorax",
    definition: "胸膜腔內積聚乳糜液（含有乳糜微粒的淋巴液）。可為特發性或繼發於胸管損傷/阻塞。",
    synonyms: ["Chylous Effusion", "乳糜性胸腔積液"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡（貓可能年輕成年較多）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（犬：Afghan Hound、Shiba Inu；貓：Siamese、Himalayan）", "心臟病（尤其右心衰竭）", "前縱隔腫瘤", "胸管損傷（創傷、手術）", "心絲蟲病"]
    },
    clinicalPresentation: {
      history: ["漸進性呼吸困難", "運動不耐", "咳嗽", "厭食", "體重減輕"],
      physicalExam: ["呼吸困難", "呼吸淺快", "腹側肺音減弱", "可能有心雜音或心律不整", "可能消瘦"]
    },
    pathophysiology: "胸管（收集下半身和腸道淋巴液）損傷或阻塞 → 乳糜液滲漏入胸腔。特發性可能與胸管先天異常或淋巴管擴張相關。繼發性原因包括：右心衰竭（胸管回流受阻）、前縱隔腫瘤、心絲蟲、創傷。慢性乳糜胸可導致纖維化胸膜炎。",
    diagnosis: {
      overview: "胸水分析確認乳糜液性質",
      differentials: ["其他胸腔積液", "假性乳糜（高膽固醇積液）"],
      initialDB: ["胸腔穿刺術", "胸水分析：乳白色或粉紅色、三酸甘油脂>血清（診斷標準）、膽固醇<血清", "胸腔X光", "心臟超聲（排除心臟病）", "心絲蟲檢測"],
      advanced: ["胸腔CT（評估縱隔腫瘤、淋巴管）", "淋巴管造影（術前評估）", "前縱隔探查"]
    },
    treatment: {
      overview: "先嘗試保守治療，失敗則考慮手術",
      acute: [
        "治療性胸腔穿刺（緩解症狀）",
        "治療原發病因（若可識別）：",
        "  - 心臟病：心臟藥物",
        "  - 腫瘤：手術/化療",
        "  - 心絲蟲：驅蟲治療"
      ],
      chronic: [
        "保守治療（嘗試2-4週）：",
        "  - 低脂飲食或MCT飲食",
        "    （減少乳糜微粒形成）",
        "  - Rutin 50 mg/kg PO q8h（刺激淋巴巨噬細胞吞噬）",
        "  - Octreotide（減少淋巴流量，效果不一）",
        "  - 反覆胸腔穿刺",
        "手術治療（保守治療失敗）：",
        "  - 胸管結紮(Thoracic Duct Ligation)",
        "  - 心包膜切除術(Pericardiectomy)",
        "  - 胸膜固定術(Pleurodesis)",
        "  - 大網膜引流術",
        "  - 被動胸膜-腹膜分流管（終末期）"
      ]
    },
    prognosis: "保守治療成功率約25-50%。手術治療成功率約50-80%。特發性預後較繼發性好。慢性乳糜胸可導致限制性胸膜炎，預後較差。",
    pearls: [
      "三酸甘油脂>血清是診斷乳糜的關鍵",
      "禁食後抽取的乳糜液可能不呈乳白色",
      "慢性乳糜胸導致免疫抑制（淋巴細胞和蛋白質流失）",
      "手術前建議淋巴管造影評估胸管解剖",
      "合併胸管結紮+心包膜切除效果較單一手術好"
    ],
    monitoring: ["呼吸狀況", "積液再積聚速度", "體重和營養狀況", "淋巴細胞計數", "血清總蛋白"],
    reference: "Singh A et al: Chylothorax in dogs and cats. J Am Anim Hosp Assoc 48:17-23, 2012"
  },

  "lung-lobe-torsion": {
    zh: "肺葉扭轉",
    en: "Lung Lobe Torsion",
    definition: "肺葉沿其長軸旋轉導致支氣管和血管扭結，造成肺葉充血、壞死和胸腔積液的急性危及生命狀況。",
    synonyms: ["Pulmonary Lobe Torsion", "肺扭轉"],
    epidemiology: {
      species: "犬為主（貓罕見）",
      age: "任何年齡，中年犬較常見",
      sex: "無明顯性別傾向",
      riskFactors: ["大型深胸犬種（Afghan Hound、Borzoi、Great Dane）", "小型犬（Pug最常見）", "先前胸腔手術或疾病", "胸腔積液", "肺葉塌陷後再擴張"]
    },
    clinicalPresentation: {
      history: ["急性呼吸困難", "咳嗽（可能咳血）", "厭食", "嗜睡", "可能有先前胸腔疾病史"],
      physicalExam: ["呼吸困難", "發燒", "肺部聽診異常（局部肺音減弱或消失）", "心搏過速", "蒼白或發紺"]
    },
    pathophysiology: "肺葉旋轉（通常180度或更多）→ 支氣管扭結（阻塞氣流）+ 肺靜脈阻塞（阻塞血液回流）而肺動脈相對通暢 → 肺葉充血、水腫 → 壞死 → 胸腔滲血性積液。右中葉（犬）和左前葉/右中葉（貓）最常受累。",
    diagnosis: {
      overview: "胸腔X光和CT可診斷，手術確認",
      differentials: ["肺炎", "肺腫瘤", "肺膿瘍", "胸腔積液其他原因", "肺葉塌陷"],
      initialDB: ["胸腔X光（特徵：受累肺葉呈均質緻密影、位置異常、支氣管走向異常、胸腔積液）", "胸腔穿刺（通常為血性或膿血性滲出液）"],
      advanced: ["胸腔CT（支氣管截斷徵、肺葉位置異常）", "支氣管鏡（可見支氣管扭結）"]
    },
    treatment: {
      overview: "手術切除受累肺葉是唯一根治方法",
      acute: [
        "術前穩定：",
        "  - 氧氣支持",
        "  - 胸腔穿刺（減壓）",
        "  - 輸液支持",
        "  - 抗生素（預防性）",
        "緊急開胸手術：",
        "  - 受累肺葉切除術",
        "  - 術中不要嘗試解開扭轉（可能釋放毒素和血栓）",
        "  - 檢查其他肺葉"
      ],
      chronic: [
        "術後監測：",
        "  - 呼吸功能",
        "  - 感染徵象",
        "  - 胸腔引流",
        "尋找原發病因（若有）"
      ]
    },
    prognosis: "手術治療存活率約70-80%。預後因素：手術時間、是否有敗血症、是否有其他肺葉受累。延遲診斷和治療預後較差。",
    pearls: [
      "「不要解開扭轉」- 直接切除以避免再灌注損傷",
      "右中葉是犬最常扭轉的肺葉",
      "Pug雖為小型犬但肺葉扭轉風險高",
      "支氣管走向異常是重要X光徵象",
      "胸腔積液後再擴張的肺葉有扭轉風險"
    ],
    monitoring: ["呼吸功能", "胸腔引流量", "發燒", "X光追蹤"],
    reference: "Murphy KA, Brisson BA: Evaluation of lung lobe torsion in Pugs: 7 cases (1991-2004). J Am Vet Med Assoc 228:86-90, 2006"
  }

};
const RESPIRATORY_DISEASE_ALIASES = {
  // 上呼吸道疾病
  "短頭犬呼吸道症候群": "brachycephalic-airway-syndrome",
  "短頭犬症候群": "brachycephalic-airway-syndrome",
  "BOAS": "brachycephalic-airway-syndrome",
  "BAS": "brachycephalic-airway-syndrome",
  "扁臉犬": "brachycephalic-airway-syndrome",
  "brachycephalic": "brachycephalic-airway-syndrome",

  "喉麻痺": "laryngeal-paralysis",
  "喉癱瘓": "laryngeal-paralysis",
  "lar par": "laryngeal-paralysis",
  "GOLPP": "laryngeal-paralysis",
  "laryngeal paralysis": "laryngeal-paralysis",

  "氣管塌陷": "tracheal-collapse",
  "氣管軟化": "tracheal-collapse",
  "collapsing trachea": "tracheal-collapse",
  "鵝叫": "tracheal-collapse",

  // 感染性疾病
  "犬舍咳": "kennel-cough",
  "犬傳染性呼吸道疾病": "kennel-cough",
  "CIRDC": "kennel-cough",
  "傳染性氣管支氣管炎": "kennel-cough",
  "kennel cough": "kennel-cough",

  "吸入性肺炎": "aspiration-pneumonia",
  "誤吸性肺炎": "aspiration-pneumonia",
  "aspiration pneumonia": "aspiration-pneumonia",

  // 下呼吸道疾病
  "貓氣喘": "feline-asthma",
  "貓哮喘": "feline-asthma",
  "貓支氣管氣喘": "feline-asthma",
  "feline asthma": "feline-asthma",
  "貓過敏性支氣管炎": "feline-asthma",

  "支氣管炎": "bronchitis",
  "慢性支氣管炎": "bronchitis",
  "chronic bronchitis": "bronchitis",
  "COPD": "bronchitis",

  // 肺實質疾病
  "肺水腫": "pulmonary-edema",
  "肺積水": "pulmonary-edema",
  "pulmonary edema": "pulmonary-edema",

  "肺纖維化": "pulmonary-fibrosis",
  "特發性肺纖維化": "pulmonary-fibrosis",
  "IPF": "pulmonary-fibrosis",
  "Westie lung": "pulmonary-fibrosis",

  "肺血栓栓塞": "pulmonary-thromboembolism",
  "肺栓塞": "pulmonary-thromboembolism",
  "PTE": "pulmonary-thromboembolism",
  "PE": "pulmonary-thromboembolism",
  "pulmonary embolism": "pulmonary-thromboembolism",

  // 胸腔疾病
  "胸腔積液": "pleural-effusion",
  "胸水": "pleural-effusion",
  "pleural effusion": "pleural-effusion",

  "氣胸": "pneumothorax",
  "PTX": "pneumothorax",
  "pneumothorax": "pneumothorax",

  "膿胸": "pyothorax",
  "化膿性胸膜炎": "pyothorax",
  "empyema": "pyothorax",
  "pyothorax": "pyothorax",

  "乳糜胸": "chylothorax",
  "乳糜性胸腔積液": "chylothorax",
  "chylothorax": "chylothorax",

  "肺葉扭轉": "lung-lobe-torsion",
  "肺扭轉": "lung-lobe-torsion",
  "lung torsion": "lung-lobe-torsion"
  // ===== From oncological-diseases.js =====
  "mast-cell-tumor": {
    zh: "肥大細胞瘤",
    en: "Mast Cell Tumor (MCT)",
    definition: "源自肥大細胞的惡性腫瘤，是犬最常見的皮膚腫瘤，貓則以內臟型和皮膚型較常見。腫瘤細胞含有組織胺、肝素等生物活性物質，可導致局部和全身性併發症。",
    synonyms: ["MCT", "Mastocytoma", "肥大細胞腫瘤", "組織胺肉瘤"],
    epidemiology: {
      species: "犬最常見，貓也可發生",
      age: "犬：平均8-9歲；貓：平均10歲",
      sex: "無明顯性別傾向",
      breed: "高風險犬種：拳師犬、波士頓梗、拉布拉多、黃金獵犬、巴哥、比格犬、雪納瑞",
      riskFactors: ["品種傾向", "慢性皮膚炎症", "c-KIT基因突變"]
    },
    clinicalPresentation: {
      history: ["皮膚腫塊（可能存在數月至數年）", "腫塊大小變化（Darier徵象）", "胃腸道症狀（嘔吐、黑便）", "全身性症狀（嗜睡、食慾下降）"],
      physicalExam: ["單一或多發皮膚/皮下腫塊", "外觀多變（從小結節到大腫塊）", "可能有紅腫或潰瘍", "周圍組織水腫", "區域淋巴結腫大", "脾腫大或肝腫大（轉移時）"]
    },
    pathophysiology: "肥大細胞增生失控 → 釋放生物活性介質（組織胺、肝素、前列腺素、細胞激素）→ 局部效應：紅腫、潰瘍、Darier徵象；全身效應：胃酸過多、胃潰瘍、凝血異常、低血壓、過敏樣反應",
    diagnosis: {
      overview: "細針穿刺細胞學常可確診，組織病理學提供分級資訊",
      differentials: ["其他皮膚腫瘤", "脂肪瘤", "組織球瘤", "皮膚感染"],
      initialDB: ["細針穿刺細胞學（高度診斷性）", "腫塊切除生檢", "區域淋巴結穿刺", "腹部超聲（肝脾）"],
      advanced: ["組織病理學分級（Patnaik或Kiupel系統）", "c-KIT突變檢測", "Ki-67增殖指數", "AgNOR計數", "骨髓穿刺（高風險病例）"],
      staging: [
        "第一期：單一腫瘤，限於皮膚，無區域淋巴結轉移",
        "第二期：單一腫瘤，限於皮膚，有區域淋巴結轉移",
        "第三期：多發皮膚腫瘤或大型浸潤性腫瘤，有或無淋巴結轉移",
        "第四期：遠處轉移或全身性肥大細胞增生症"
      ]
    },
    treatment: {
      overview: "治療取決於分級、分期和位置。低分級腫瘤手術切除可能治癒，高分級需多模式治療",
      surgical: [
        "首選治療（低/中分級）",
        "寬邊緣切除：側邊2-3公分，深層一個筋膜面",
        "完整切除邊緣清晰者預後良好",
        "不完整切除考慮再切除或輔助治療"
      ],
      medical: [
        "H1受體拮抗劑：Diphenhydramine 2-4 mg/kg PO q8-12h",
        "H2受體拮抗劑：Famotidine 0.5-1 mg/kg PO q12-24h",
        "胃黏膜保護：Sucralfate 0.5-1 g PO q8h（犬）",
        "化療（高分級或轉移）：",
        "- Vinblastine: 2 mg/m² IV 每週或隔週",
        "- Lomustine (CCNU): 60-90 mg/m² PO q3週",
        "- Prednisone: 1-2 mg/kg PO q24h（輔助或緩和）",
        "標靶治療（c-KIT突變陽性）：",
        "- Toceranib (Palladia): 2.5-2.75 mg/kg PO 隔日",
        "- Masitinib: 12.5 mg/kg PO q24h"
      ],
      radiation: ["術後輔助放療（邊緣不清或不完整切除）", "緩和性放療（不可手術病例）"]
    },
    prognosis: "低分級（Kiupel）/第I級（Patnaik）：手術切除後預後良好，中位生存>2年。高分級/第III級：預後謹慎至差，中位生存4-6個月。c-KIT突變陽性者對標靶治療反應較好。",
    pearls: [
      "「肥大細胞瘤是偉大的模仿者」- 外觀變化多端",
      "Darier徵象：觸摸或操作腫塊後紅腫（組織胺釋放）",
      "手術前後給予H1/H2拮抗劑減少組織胺效應",
      "細針穿刺時要溫柔，避免大量脫顆粒",
      "貓的皮膚型MCT通常行為較良性"
    ],
    monitoring: ["定期身體檢查", "區域淋巴結評估", "腹部超聲（肝脾）", "若化療：CBC每2-3週"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020; Côté E: Clinical Veterinary Advisor, 2nd Ed. 2011"
  },

  "hemangiosarcoma": {
    zh: "血管肉瘤",
    en: "Hemangiosarcoma (HSA)",
    definition: "源自血管內皮細胞的高度惡性腫瘤，具有極高的轉移率。最常見於脾臟、右心房和皮下組織。",
    synonyms: ["HSA", "Angiosarcoma", "血管內皮肉瘤", "惡性血管內皮瘤"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "犬：平均9-11歲",
      sex: "公犬略多",
      breed: "高風險：德國牧羊犬、黃金獵犬、拉布拉多、扁臉犬種",
      riskFactors: ["品種傾向", "年齡", "日曬（皮膚型）"]
    },
    clinicalPresentation: {
      history: ["急性虛弱或倒地（脾臟破裂）", "腹部膨大", "運動不耐", "呼吸困難（心臟型）", "皮膚腫塊（皮膚型）", "間歇性症狀"],
      physicalExam: ["黏膜蒼白", "心搏過速", "脈搏弱", "腹部膨脹或疼痛", "可觸及腹部腫塊", "心音低沉（心包積液）", "皮膚或皮下腫塊"]
    },
    pathophysiology: "腫瘤源自血管內皮 → 形成異常血管腔 → 血管脆弱易破裂 → 急性出血（脾臟型最常見）。高度轉移性：確診時85%以上已有微轉移，常見轉移部位：肝、肺、心臟、大網膜、腦",
    diagnosis: {
      overview: "影像學結合細胞學/組織學確診，但出血風險需謹慎",
      differentials: ["脾臟血腫", "脾臟結節性增生", "其他脾臟腫瘤", "心臟腫瘤", "皮膚血管瘤"],
      initialDB: ["CBC（可能貧血、血小板減少）", "生化", "凝血功能", "腹部超聲", "AFAST", "胸腔X光"],
      advanced: ["心臟超聲", "腹部CT", "細胞學（謹慎，出血風險）", "組織病理學確診", "免疫組織化學（CD31、Factor VIII）"]
    },
    treatment: {
      overview: "手術切除原發腫瘤後輔以化療，但預後仍謹慎",
      surgical: [
        "脾臟切除術（脾臟型）",
        "右心房腫瘤切除（心臟型，技術要求高）",
        "皮膚腫瘤廣泛切除",
        "術中控制出血是關鍵"
      ],
      medical: [
        "術前穩定：輸液、必要時輸血",
        "輔助化療：",
        "- DOX方案：Doxorubicin 30 mg/m² IV q3週（5-6次）",
        "- VAC方案：Vincristine + Doxorubicin + Cyclophosphamide",
        "節拍化療：",
        "- 低劑量Cyclophosphamide 10-15 mg/m² PO q24h",
        "- Piroxicam 0.3 mg/kg PO q48h",
        "I'm-Yunity (PSP蘑菇多醣): 100 mg/kg PO q24h（可能延長生存）"
      ],
      supportive: ["心包穿刺（心包積液）", "輸血（急性出血）", "疼痛管理"]
    },
    prognosis: "整體預後差。脾臟型單獨手術：中位生存19-86天。手術+化療：中位生存約140-180天，1年存活率約10%。皮膚型（真皮層）預後較好。心臟型預後最差。",
    pearls: [
      "「2/3法則」：2/3的脾臟腫塊是惡性，其中2/3是血管肉瘤",
      "急性腹腔出血+脾臟腫塊=高度懷疑HSA",
      "確診時絕大多數已有微轉移",
      "心包積液+心臟腫塊=首先考慮HSA或心臟基底腫瘤",
      "皮膚型需區分真皮層（較良性）和皮下/肌肉層（惡性）"
    ],
    monitoring: ["定期胸腔X光和腹部超聲", "心臟超聲（心臟型）", "CBC監測貧血和血小板"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "soft-tissue-sarcoma": {
    zh: "軟組織肉瘤",
    en: "Soft Tissue Sarcoma (STS)",
    definition: "源自間葉組織（結締組織、肌肉、脂肪、血管、神經鞘等）的惡性腫瘤統稱。包括纖維肉瘤、神經鞘瘤、脂肪肉瘤、平滑肌肉瘤等多種類型。",
    synonyms: ["STS", "間葉腫瘤", "Mesenchymal Tumor", "纖維肉瘤", "Fibrosarcoma"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "犬：平均9-10歲；貓：8-12歲",
      sex: "無明顯性別傾向",
      breed: "犬：大型犬較常見",
      riskFactors: ["注射部位（貓）", "創傷或異物", "放射線暴露"]
    },
    clinicalPresentation: {
      history: ["緩慢生長的皮下腫塊", "可能存在數月至數年", "近期快速增大"],
      physicalExam: ["皮下腫塊，通常堅實", "邊界可觸摸但實際延伸更廣", "可能與深層組織粘連", "表面可能潰瘍", "區域淋巴結通常正常"]
    },
    pathophysiology: "間葉細胞惡性轉化 → 局部浸潤性生長（沿筋膜面延伸）→ 假包膜形成（但腫瘤細胞可能超出）→ 遠處轉移率相對較低（15-40%）但高分級例外",
    diagnosis: {
      overview: "需要組織病理學確診和分級",
      differentials: ["脂肪瘤", "其他皮下腫瘤", "膿腫", "血清腫"],
      initialDB: ["細針穿刺細胞學（診斷率較低）", "楔形或切除生檢", "胸腔X光"],
      advanced: [
        "組織病理學分級（三級系統）：",
        "- 第I級：分化良好，低有絲分裂率，無壞死",
        "- 第II級：中分化",
        "- 第III級：分化差，高有絲分裂率，有壞死",
        "CT/MRI評估腫瘤範圍",
        "區域淋巴結穿刺"
      ]
    },
    treatment: {
      overview: "廣泛手術切除是關鍵，分級決定預後和輔助治療需求",
      surgical: [
        "廣泛切除：側邊3公分，深層至少一個筋膜面",
        "術前CT/MRI規劃手術範圍",
        "第一次手術是最佳治癒機會",
        "復發腫瘤切除更困難"
      ],
      medical: [
        "化療（高分級或轉移）：",
        "- Doxorubicin: 30 mg/m² IV q3週",
        "- Carboplatin: 300 mg/m² IV q3週",
        "- 節拍化療作為輔助選項"
      ],
      radiation: ["術後輔助放療（邊緣不清）", "術前放療（縮小腫瘤）", "緩和性放療"]
    },
    prognosis: "完整切除的低分級腫瘤：預後良好，局部復發率<10%。不完整切除：局部復發率高達50-70%。遠處轉移：與分級相關，第III級轉移率可達40%。",
    pearls: [
      "「你觸摸到的邊界不是真正的邊界」- 腫瘤沿筋膜面延伸",
      "第一次手術切除完整是最重要的預後因素",
      "細針穿刺常無法確診，需要組織生檢",
      "術前影像學評估腫瘤範圍很重要",
      "低分級腫瘤單獨廣泛手術可能治癒"
    ],
    monitoring: ["定期身體檢查（局部復發）", "胸腔X光（轉移）", "術後3、6、12個月評估"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "squamous-cell-carcinoma": {
    zh: "鱗狀上皮細胞癌",
    en: "Squamous Cell Carcinoma (SCC)",
    definition: "源自鱗狀上皮的惡性腫瘤，可發生於皮膚、口腔、鼻腔、甲床、肺等多處。局部侵襲性強，轉移率因部位而異。",
    synonyms: ["SCC", "鱗癌", "表皮癌", "Epidermoid Carcinoma"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "犬：平均9歲；貓：平均12歲",
      sex: "無明顯性別傾向",
      breed: "白毛或淺色犬貓（皮膚型）；大型犬和黑色犬（趾甲床型）",
      riskFactors: ["紫外線暴露", "缺乏色素沉著", "慢性炎症", "乳突狀瘤病毒感染（某些）"]
    },
    clinicalPresentation: {
      history: ["皮膚：長期不癒合的潰瘍", "口腔：流涎、進食困難、口臭", "鼻腔：鼻出血、打噴嚏、面部腫脹", "趾甲床：跛行、趾腫脹"],
      physicalExam: [
        "皮膚型：紅斑、潰瘍、結痂、菜花狀腫塊",
        "口腔型：牙齦或舌頭腫塊、牙齒鬆動、骨溶解",
        "鼻腔型：面部不對稱、鼻出血、鼻分泌物",
        "趾甲床型：趾腫脹、跛行、指甲脫落"
      ]
    },
    pathophysiology: "鱗狀上皮細胞惡性轉化 → 局部浸潤性生長 → 可能破壞周圍骨骼 → 區域淋巴結轉移（口腔型較常見）→ 遠處轉移（皮膚型較少，口腔和趾甲床型較多）",
    diagnosis: {
      overview: "組織病理學確診，影像學評估範圍和轉移",
      differentials: ["其他皮膚腫瘤", "口腔炎症性疾病", "骨肉瘤", "黑色素瘤"],
      initialDB: ["細胞學", "組織生檢", "區域淋巴結穿刺", "胸腔X光"],
      advanced: ["CT/MRI（評估骨侵蝕和腫瘤範圍）", "趾骨X光"]
    },
    treatment: {
      overview: "治療方式取決於部位和範圍，手術和放療是主要方法",
      surgical: [
        "皮膚型：廣泛切除（邊緣1-2公分）",
        "趾甲床型：截趾術",
        "口腔型：下頜骨切除或上頜骨切除",
        "鼻腔型：手術減積（非治癒性）"
      ],
      medical: [
        "化療效果有限：",
        "- Carboplatin: 300 mg/m² IV q3週",
        "- Piroxicam: 0.3 mg/kg PO q24-48h（可能有抗腫瘤活性）",
        "光動力療法（表淺病變）",
        "電化學療法（小型病變）"
      ],
      radiation: ["口腔SCC放療反應較好", "鼻腔SCC的主要治療", "術後輔助放療"]
    },
    prognosis: "皮膚型（非侵蝕性）：廣泛切除後預後良好。趾甲床型：截趾後1年存活率約50%，常有肺轉移。口腔型（犬）：中位生存約1年（手術+放療）。貓口腔SCC：預後差，中位生存2-4個月。",
    pearls: [
      "白貓耳朵和鼻子是皮膚SCC的好發部位",
      "貓口腔SCC是最常見的貓口腔腫瘤，預後很差",
      "趾甲床SCC：黑色犬種更常見，有肺轉移傾向",
      "慢性不癒合的皮膚潰瘍要考慮SCC",
      "早期發現和治療是關鍵"
    ],
    monitoring: ["定期身體檢查", "區域淋巴結評估", "胸腔X光（轉移監測）"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "melanoma": {
    zh: "黑色素瘤",
    en: "Melanoma",
    definition: "源自黑色素細胞的腫瘤，可為良性（皮膚黑色素細胞瘤）或惡性（黑色素瘤）。口腔和甲床黑色素瘤在犬通常為高度惡性。",
    synonyms: ["Malignant Melanoma", "Melanocytoma（良性）", "惡性黑色素瘤"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "犬：平均9-12歲",
      sex: "公犬略多（口腔型）",
      breed: "口腔型：可卡、貴賓、小型臘腸、迷你雪納瑞、黃金獵犬",
      riskFactors: ["口腔色素沉著區域", "品種傾向"]
    },
    clinicalPresentation: {
      history: ["口腔型：流涎、口臭、進食困難、面部腫脹", "趾甲床型：跛行、趾腫脹", "皮膚型：色素性或非色素性皮膚腫塊"],
      physicalExam: [
        "口腔型：牙齦或頰黏膜腫塊，常為深色但可無色素",
        "趾甲床型：趾腫脹，可能有指甲脫落",
        "皮膚型：通常色素沉著的隆起腫塊",
        "區域淋巴結腫大（轉移時）"
      ]
    },
    pathophysiology: "黑色素細胞惡性轉化 → 快速局部生長 → 高度轉移傾向（口腔和甲床型）→ 常見轉移部位：區域淋巴結、肺、肝、腎、腦",
    diagnosis: {
      overview: "組織病理學確診，分期對預後評估很重要",
      differentials: ["其他口腔腫瘤（SCC、纖維肉瘤）", "其他皮膚腫瘤", "肉芽腫"],
      initialDB: ["細胞學（可能見黑色素顆粒）", "組織生檢", "區域淋巴結穿刺", "胸腔X光"],
      advanced: ["CT（頭頸部和胸腔）", "腹部超聲", "免疫組織化學（Melan-A、S100）"]
    },
    treatment: {
      overview: "口腔和甲床型需積極多模式治療，皮膚型手術可能治癒",
      surgical: [
        "口腔型：下頜骨/上頜骨切除，追求清晰邊緣",
        "趾甲床型：截趾術或截肢",
        "皮膚型：廣泛切除（邊緣1-2公分）"
      ],
      medical: [
        "傳統化療效果有限：",
        "- Carboplatin: 300 mg/m² IV q3週",
        "犬黑色素瘤疫苗（Oncept®）：",
        "- 術後免疫治療",
        "- 0.4 mL 經皮注射，q2週 x 4次，之後q6個月加強"
      ],
      radiation: ["口腔黑色素瘤對放療有一定反應", "術後輔助或緩和性放療"]
    },
    prognosis: "口腔型：單獨手術中位生存5-7個月，多模式治療可延長。第I期（<2cm）預後較好。甲床型：截趾後中位生存約12個月，50%有肺轉移。皮膚型：良性多於惡性，手術切除後預後良好。",
    pearls: [
      "口腔黑色素瘤是犬最常見的口腔惡性腫瘤",
      "約1/3的口腔黑色素瘤缺乏色素（無色素型）",
      "腫瘤大小是重要預後因子：<2cm較好",
      "黑色素瘤疫苗是第一個獲FDA批准的犬腫瘤疫苗",
      "皮膚黑色素瘤在犬多為良性，但口腔和甲床型幾乎都是惡性"
    ],
    monitoring: ["每2-3個月身體檢查", "區域淋巴結評估", "胸腔X光", "腹部超聲"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "mammary-tumor": {
    zh: "乳腺腫瘤",
    en: "Mammary Tumor",
    definition: "源自乳腺組織的腫瘤，是未絕育母犬最常見的腫瘤，貓的乳腺腫瘤則多為惡性。",
    synonyms: ["Mammary Gland Tumor", "乳腺癌", "Mammary Carcinoma", "乳房腫瘤"],
    epidemiology: {
      species: "母犬和母貓，偶見公犬貓",
      age: "犬：平均10-11歲；貓：平均10-12歲",
      sex: "未絕育母畜為主，絕育大幅降低風險",
      breed: "犬：貴賓、可卡、德國牧羊犬、馬爾濟斯；貓：暹羅貓風險較高",
      riskFactors: ["未絕育", "晚期絕育", "外源性荷爾蒙暴露", "肥胖", "假懷孕"]
    },
    clinicalPresentation: {
      history: ["乳腺區腫塊", "乳頭分泌物", "潰瘍或發炎", "快速增大", "多發腫塊"],
      physicalExam: ["乳腺鏈上單一或多發腫塊", "腫塊大小不等", "可能與皮膚或深層組織粘連", "區域淋巴結（腋下、腹股溝）腫大", "炎症性乳癌：紅腫、疼痛、水腫"]
    },
    pathophysiology: "荷爾蒙（雌激素、黃體素）刺激乳腺增生 → 基因突變累積 → 良性腫瘤或惡性轉化。犬約50%為良性；貓85-90%為惡性。惡性腫瘤可轉移至區域淋巴結和肺。",
    diagnosis: {
      overview: "組織病理學確診和分類，分期決定預後",
      differentials: ["乳腺增生", "乳腺炎", "其他皮下腫瘤"],
      initialDB: ["細針穿刺細胞學", "胸腔X光（3視圖）", "腹部超聲", "區域淋巴結穿刺"],
      advanced: ["組織病理學（確診和分類）", "荷爾蒙受體檢測", "HER2狀態", "CT分期"]
    },
    treatment: {
      overview: "手術切除是主要治療，化療用於惡性和轉移病例",
      surgical: [
        "乳房切除術選項：",
        "- 腫塊切除術（<0.5cm良性）",
        "- 單側乳腺切除術（同側多發腫塊）",
        "- 區域乳腺切除術",
        "- 雙側乳腺切除術（雙側多發）",
        "同時絕育（若未絕育）",
        "淋巴結切除（若可觸及或轉移）"
      ],
      medical: [
        "化療（惡性、淋巴結轉移或分化差）：",
        "- Doxorubicin: 30 mg/m² IV q3週",
        "- Carboplatin: 300 mg/m² IV q3週",
        "- 5-FU: 150 mg/m² IV 每週（禁用於貓）",
        "抗雌激素藥物效果不確定"
      ],
      radiation: ["局部復發的緩和性放療", "炎症性乳癌（預後仍差）"]
    },
    prognosis: "犬：良性腫瘤手術後治癒；惡性腫瘤2年存活率約25-50%。腫瘤大小是重要預後因子：<3cm較好。貓：預後較差，中位生存約1年（<2cm）至6個月（>3cm）。炎症性乳癌：預後極差。",
    pearls: [
      "絕育時機影響風險：初次發情前絕育風險降低99.5%",
      "犬乳腺腫瘤約50%良性，貓約90%惡性",
      "腫瘤大小是犬最重要的預後因子",
      "炎症性乳癌預後極差，需與乳腺炎鑑別",
      "檢查時要評估整個乳腺鏈和兩側淋巴結"
    ],
    monitoring: ["每2-3個月身體檢查", "胸腔X光", "新腫塊評估"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "hepatocellular-carcinoma": {
    zh: "肝細胞癌",
    en: "Hepatocellular Carcinoma (HCC)",
    definition: "源自肝細胞的原發性惡性肝臟腫瘤，是犬最常見的原發性肝臟惡性腫瘤。可呈巨大型、結節型或彌漫型。",
    synonyms: ["HCC", "肝癌", "Hepatoma", "原發性肝癌"],
    epidemiology: {
      species: "犬較貓常見",
      age: "犬：平均10-11歲",
      sex: "公犬略多",
      breed: "無明顯品種傾向",
      riskFactors: ["年齡", "某些毒素暴露", "慢性肝病（人類，犬少見相關性）"]
    },
    clinicalPresentation: {
      history: ["食慾下降", "體重減輕", "嗜睡", "嘔吐", "多飲多尿", "腹部膨大", "可能無症狀"],
      physicalExam: ["肝腫大或可觸及腫塊", "腹部膨脹（腫塊或腹水）", "黏膜黃染（少見）", "體重減輕", "可能無異常發現（早期）"]
    },
    pathophysiology: "肝細胞惡性轉化 → 三種生長模式：巨大型（單一大腫塊，最常見且預後較好）、結節型（多發結節）、彌漫型（廣泛浸潤，預後最差）。轉移率相對較低（巨大型約0-37%），常見轉移部位：肝內、區域淋巴結、肺。",
    diagnosis: {
      overview: "影像學結合組織病理學確診",
      differentials: ["其他肝臟腫瘤", "結節性增生", "肝臟膿腫", "轉移性肝腫瘤"],
      initialDB: ["CBC", "生化（肝酵素、膽紅素）", "凝血功能", "腹部超聲", "胸腔X光"],
      advanced: ["腹部CT", "超聲引導生檢", "組織病理學確診", "AFP（甲胎蛋白，犬價值有限）"]
    },
    treatment: {
      overview: "巨大型肝葉切除是首選治療，結節型和彌漫型選項有限",
      surgical: [
        "巨大型HCC：肝葉切除術",
        "犬可切除70-80%肝臟",
        "術前評估凝血功能",
        "術中出血控制是關鍵"
      ],
      medical: [
        "傳統化療效果有限",
        "標靶治療（研究中）：",
        "- Toceranib（某些病例可能有效）",
        "支持治療：護肝、止吐、營養支持"
      ],
      radiation: ["立體定向放射治療（SBRT）可能是選項"]
    },
    prognosis: "巨大型HCC手術切除：預後良好，中位生存>3年，甚至治癒。結節型：中位生存約1年。彌漫型：預後差，中位生存<6個月。",
    pearls: [
      "巨大型HCC預後良好，不要因為腫瘤大而放棄手術",
      "肝臟有強大的再生能力",
      "術前需評估凝血功能",
      "與轉移性肝腫瘤鑑別很重要",
      "AFP在犬不是可靠的標記物"
    ],
    monitoring: ["術後定期超聲", "肝功能檢測", "胸腔X光"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "transitional-cell-carcinoma": {
    zh: "移行上皮細胞癌",
    en: "Transitional Cell Carcinoma (TCC)",
    definition: "源自尿路移行上皮的惡性腫瘤，最常見於膀胱三角區。是犬最常見的膀胱腫瘤。",
    synonyms: ["TCC", "膀胱癌", "Urothelial Carcinoma", "泌尿上皮癌"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "犬：平均11歲",
      sex: "母犬風險較高（約2:1）",
      breed: "高風險：蘇格蘭梗（風險高20倍）、西高地白梗、比格、雪特蘭牧羊犬",
      riskFactors: ["品種傾向", "肥胖", "環境殺蟲劑暴露", "Cyclophosphamide使用"]
    },
    clinicalPresentation: {
      history: ["血尿", "頻尿", "排尿困難", "尿淋漓", "反覆「尿道感染」", "尿液異味"],
      physicalExam: ["膀胱觸診可能觸及腫塊", "前列腺或尿道腫大", "腎臟腫大（若有輸尿管阻塞）", "骨骼疼痛（若有骨轉移）"]
    },
    pathophysiology: "移行上皮惡性轉化 → 好發於膀胱三角區（靠近輸尿管開口和尿道）→ 可導致輸尿管阻塞 → 腎後性腎衰竭。轉移至區域淋巴結、肺、脊椎骨常見。",
    diagnosis: {
      overview: "影像學結合細胞學/組織學確診",
      differentials: ["膀胱炎", "膀胱息肉", "其他膀胱腫瘤", "前列腺疾病"],
      initialDB: ["尿液分析和培養", "腹部超聲（膀胱和腎臟）", "胸腔X光", "脊椎X光"],
      advanced: ["膀胱鏡和生檢", "BRAF突變檢測（85%犬TCC陽性）", "CADET BRAF尿液檢測", "CT（分期）", "創傷性導管細胞學"]
    },
    treatment: {
      overview: "手術常受限於腫瘤位置，醫療管理是主要治療方式",
      surgical: [
        "完全切除通常不可行（三角區位置）",
        "部分膀胱切除（特定病例）",
        "輸尿管支架或腎造廔（阻塞時）",
        "尿道支架（尿道阻塞時）"
      ],
      medical: [
        "COX抑制劑（Piroxicam或Meloxicam）是基礎治療：",
        "- Piroxicam: 0.3 mg/kg PO q24h",
        "- Meloxicam: 0.1 mg/kg PO q24h",
        "化療方案：",
        "- Mitoxantrone: 5 mg/m² IV q3週 + Piroxicam",
        "- Carboplatin: 300 mg/m² IV q3週",
        "- Vinblastine: 2.5 mg/m² IV 每週或隔週",
        "標靶治療（BRAF突變陽性）：",
        "- Vemurafenib（研究中）"
      ],
      radiation: ["術中放療", "外部放療（膀胱耐受性有限）"]
    },
    prognosis: "中位生存約4-6個月（單獨NSAIDs）至約1年（NSAIDs+化療）。腫瘤位置和是否阻塞影響預後。轉移發生率約50%於確診後。",
    pearls: [
      "「反覆尿道感染」不見好轉要考慮TCC",
      "CADET BRAF尿液檢測是有用的非侵入性篩檢",
      "不建議經膀胱穿刺取細胞學（腫瘤播種風險）",
      "輸尿管支架可緩解阻塞，改善生活品質",
      "Piroxicam不僅止痛，還有抗腫瘤活性"
    ],
    monitoring: ["腹部超聲q2-3個月", "腎功能", "尿液分析", "胸腔X光"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "nasal-tumor": {
    zh: "鼻腔腫瘤",
    en: "Nasal Tumor",
    definition: "發生於鼻腔或副鼻竇的腫瘤，犬以腺癌和鱗狀上皮細胞癌最常見，貓以淋巴瘤最常見。局部侵襲性強，可侵犯顱腔。",
    synonyms: ["Sinonasal Tumor", "鼻竇腫瘤", "Nasal Carcinoma", "Nasal Adenocarcinoma"],
    epidemiology: {
      species: "犬較貓常見",
      age: "犬：平均9-10歲",
      sex: "公犬略多",
      breed: "長鼻犬種風險較高：可麗牧羊犬、牧羊犬、巴吉度獵犬",
      riskFactors: ["品種（長鼻型）", "城市環境（空氣污染）", "二手煙暴露"]
    },
    clinicalPresentation: {
      history: ["單側鼻分泌物（可能變雙側）", "鼻出血", "打噴嚏", "鼻塞/呼吸音", "面部腫脹或變形", "眼球突出", "神經症狀（侵犯顱腔）"],
      physicalExam: ["單側或雙側鼻分泌物", "面部不對稱", "鼻樑腫脹", "口腔頂部腫塊", "眼球突出", "神經學異常（晚期）"]
    },
    pathophysiology: "鼻腔上皮惡性轉化 → 局部浸潤性生長 → 破壞鼻甲骨和周圍結構 → 可能侵入眼眶或顱腔。遠處轉移率相對較低（<15%於確診時），但局部控制是主要挑戰。",
    diagnosis: {
      overview: "影像學評估範圍，組織病理學確診",
      differentials: ["鼻腔異物", "真菌性鼻炎", "慢性鼻炎", "牙根膿腫"],
      initialDB: ["頭部X光", "胸腔X光", "口腔檢查"],
      advanced: ["CT或MRI（首選，評估範圍和顱腔侵犯）", "鼻腔鏡和生檢", "組織病理學"]
    },
    treatment: {
      overview: "放射治療是主要治療，手術常用於減積或診斷",
      surgical: [
        "鼻甲切除術（減積或診斷）",
        "根治性手術切除通常不可行",
        "手術單獨效果不佳"
      ],
      medical: [
        "化療通常作為輔助：",
        "- Carboplatin: 300 mg/m² IV q3週",
        "- 效果不如放療",
        "貓鼻腔淋巴瘤：化療是主要治療"
      ],
      radiation: [
        "確定性放療：16-20次，總劑量42-57 Gy",
        "中位生存約12-18個月（犬）",
        "緩和性放療：較少次數，用於無法負擔完整療程者",
        "副作用：口腔炎、皮膚反應、晚期可能角膜炎或白內障"
      ]
    },
    prognosis: "犬：單獨手術中位生存3-5個月。放療後中位生存12-18個月，1年存活率約50%。腫瘤侵犯篩板或顱腔預後較差。貓鼻腔淋巴瘤：放療或化療後預後較好，中位生存>1年。",
    pearls: [
      "單側鼻分泌物（尤其帶血）應高度懷疑腫瘤",
      "CT比X光更能評估腫瘤範圍",
      "放療是犬鼻腔腫瘤的標準治療",
      "貓鼻腔腫瘤最常見是淋巴瘤（治療和預後不同）",
      "面部變形通常表示晚期疾病"
    ],
    monitoring: ["定期身體檢查", "症狀監測", "必要時CT追蹤"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "brain-tumor": {
    zh: "腦腫瘤",
    en: "Brain Tumor",
    definition: "發生於腦實質或腦膜的腫瘤，包括原發性（腦膜瘤、膠質瘤、脈絡叢腫瘤等）和轉移性腫瘤。",
    synonyms: ["Intracranial Tumor", "顱內腫瘤", "Meningioma", "Glioma"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "犬：平均9-10歲；貓：平均11-12歲",
      sex: "無明顯性別傾向",
      breed: "犬：拳師犬、黃金獵犬、杜賓犬、法國鬥牛犬（膠質瘤）；短頭犬種（腦膜瘤）",
      riskFactors: ["品種傾向", "年齡"]
    },
    clinicalPresentation: {
      history: ["行為改變", "癲癇發作（新發）", "視力改變", "步態異常", "旋轉或歪頭", "漸進性神經功能下降"],
      physicalExam: ["神經學檢查異常", "意識改變", "腦神經缺陷", "姿勢反應異常", "步態異常", "瞳孔異常", "乳突狀水腫"]
    },
    pathophysiology: "腫瘤生長 → 佔位效應和周圍水腫 → 顱內壓升高 → 腦灌注下降和神經功能障礙。犬最常見：腦膜瘤（額葉區）、膠質瘤（星形細胞瘤、少突膠質細胞瘤）、脈絡叢腫瘤。貓最常見：腦膜瘤（高度可手術切除）。",
    diagnosis: {
      overview: "MRI是金標準診斷工具，某些情況需組織確診",
      differentials: ["腦炎（感染性或免疫媒介性）", "腦血管意外", "腦外傷", "代謝性腦病"],
      initialDB: ["完整神經學檢查", "CBC和生化", "胸腔X光（轉移評估）"],
      advanced: ["MRI（首選）", "CT（MRI無法使用時）", "腦脊液分析（若安全）", "立體定向生檢"]
    },
    treatment: {
      overview: "治療取決於腫瘤類型、位置和可切除性",
      surgical: [
        "顱骨切開術和腫瘤切除",
        "腦膜瘤：可切除性高，尤其貓",
        "膠質瘤：邊界不清，完全切除困難",
        "脈絡叢腫瘤：可能切除但技術挑戰高"
      ],
      medical: [
        "症狀治療：",
        "- 抗癲癇藥物（Phenobarbital、Levetiracetam）",
        "- 類固醇減少水腫：Prednisone 0.5-1 mg/kg PO q12-24h 或 Dexamethasone",
        "化療效果有限",
        "Hydroxyurea（腦膜瘤）：50 mg/kg PO q48-72h"
      ],
      radiation: [
        "確定性放療：腦膜瘤和膠質瘤標準治療",
        "立體定向放射手術（SRS）：單次或少次高劑量",
        "中位生存可達1-2年或更長"
      ]
    },
    prognosis: "犬腦膜瘤：手術+放療中位生存約2年。貓腦膜瘤：手術切除預後良好，中位生存>2年。膠質瘤：預後較差，放療後中位生存約8-14個月。單獨症狀治療：中位生存約2-4個月。",
    pearls: [
      "老年犬新發癲癇應高度懷疑腦腫瘤",
      "貓腦膜瘤通常手術可切除且預後良好",
      "MRI是診斷的金標準",
      "類固醇可快速改善症狀（減少水腫）",
      "腫瘤類型和位置決定治療選項和預後"
    ],
    monitoring: ["神經學狀態", "癲癇頻率", "定期MRI追蹤", "抗癲癇藥物濃度"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "splenic-tumor": {
    zh: "脾臟腫瘤",
    en: "Splenic Tumor",
    definition: "發生於脾臟的腫瘤，包括血管肉瘤（最常見的惡性）、纖維肉瘤、血管瘤、結節性增生等。犬脾臟腫塊約2/3為惡性。",
    synonyms: ["Splenic Mass", "脾臟腫塊", "Splenic Neoplasia"],
    epidemiology: {
      species: "犬較貓常見",
      age: "犬：平均9-11歲",
      sex: "血管肉瘤公犬略多",
      breed: "血管肉瘤：德國牧羊犬、黃金獵犬、拉布拉多",
      riskFactors: ["品種傾向", "年齡"]
    },
    clinicalPresentation: {
      history: ["急性虛弱或倒地", "蒼白", "腹部膨大", "食慾下降", "體重減輕", "間歇性嗜睡"],
      physicalExam: ["黏膜蒼白", "心搏過速", "脈搏弱", "腹部膨脹", "可觸及脾臟腫塊", "腹腔積液（出血）", "低體溫（休克時）"]
    },
    pathophysiology: "脾臟腫瘤類型：惡性（血管肉瘤最常見，其次為纖維肉瘤、平滑肌肉瘤）；良性（血管瘤、結節性增生、血腫）。血管肉瘤容易破裂導致急性腹腔出血。2/3法則：2/3脾臟腫塊是惡性，其中2/3是血管肉瘤。",
    diagnosis: {
      overview: "影像學發現腫塊，組織病理學確診類型",
      differentials: ["血管肉瘤", "血管瘤", "結節性增生", "血腫", "其他肉瘤", "肥大細胞瘤"],
      initialDB: ["CBC（貧血、血小板減少）", "生化", "凝血功能", "腹部超聲", "AFAST", "胸腔X光"],
      advanced: ["腹部CT", "心臟超聲（右心房腫瘤）", "組織病理學（脾臟切除後）"]
    },
    treatment: {
      overview: "脾臟切除術是診斷和治療的關鍵步驟",
      surgical: [
        "脾臟切除術",
        "術前穩定（輸液、必要時輸血）",
        "術中控制出血",
        "完整脾臟送組織病理學"
      ],
      medical: [
        "術前穩定：晶體液、膠體液、必要時輸血",
        "血管肉瘤輔助化療：",
        "- Doxorubicin: 30 mg/m² IV q3週 x 5-6次",
        "- VAC方案",
        "- 節拍化療：低劑量Cyclophosphamide",
        "其他惡性腫瘤依類型而定"
      ],
      supportive: ["輸血支持", "疼痛管理", "營養支持"]
    },
    prognosis: "血管肉瘤：見血管肉瘤條目。其他肉瘤：取決於類型和分級。血管瘤/結節性增生/血腫：脾臟切除後預後良好，可治癒。術前無法確定良惡性，需術後組織病理學。",
    pearls: [
      "「2/3法則」：2/3脾臟腫塊惡性，其中2/3是血管肉瘤",
      "急性腹腔出血+脾臟腫塊=高度懷疑血管肉瘤",
      "術前穿刺細胞學價值有限且有出血風險",
      "脾臟切除是安全的，犬貓可無脾臟生活",
      "術後等待病理報告再決定是否需化療"
    ],
    monitoring: ["術後：傷口和貧血", "血管肉瘤：定期胸腔X光和腹部超聲", "心臟超聲（右心房轉移）"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "histiocytic-sarcoma": {
    zh: "組織球肉瘤",
    en: "Histiocytic Sarcoma",
    definition: "源自樹突細胞或巨噬細胞的惡性腫瘤，包括局部型和播散型（惡性組織球增生症）。是一種高度侵襲性的腫瘤。",
    synonyms: ["HS", "Malignant Histiocytosis", "惡性組織球增生症", "播散型組織球肉瘤"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "犬：平均6-9歲",
      sex: "無明顯性別傾向",
      breed: "高風險：伯恩山犬（遺傳傾向）、平毛尋回犬、羅威那、黃金獵犬",
      riskFactors: ["品種傾向（強烈遺傳因素）"]
    },
    clinicalPresentation: {
      history: ["局部型：肢體腫塊、跛行", "播散型：嗜睡、食慾下降、體重減輕、呼吸困難"],
      physicalExam: [
        "局部型：通常在關節周圍或皮下的腫塊",
        "播散型：多器官受累（脾腫大、肝腫大、淋巴結腫大）",
        "肺部受累：呼吸困難、肺音異常",
        "貧血、血小板減少"
      ]
    },
    pathophysiology: "樹突細胞或巨噬細胞系惡性轉化 → 局部型：單一部位腫塊；播散型：多器官快速浸潤（脾、肝、肺、淋巴結、骨髓）。伯恩山犬有遺傳傾向（可能與HLA相關基因有關）。",
    diagnosis: {
      overview: "組織病理學和免疫組織化學確診",
      differentials: ["淋巴瘤", "其他肉瘤", "轉移性腫瘤", "免疫媒介性疾病"],
      initialDB: ["CBC（可能貧血、血小板減少）", "生化", "腹部超聲", "胸腔X光"],
      advanced: ["組織生檢", "免疫組織化學（CD18、CD11c、CD11d）", "骨髓穿刺", "CT分期"]
    },
    treatment: {
      overview: "局部型可能受益於手術和化療，播散型預後差",
      surgical: [
        "局部型：廣泛手術切除",
        "肢體腫瘤可能需截肢",
        "播散型：手術不是主要治療"
      ],
      medical: [
        "化療方案：",
        "- CCNU (Lomustine): 60-90 mg/m² PO q3週",
        "- Doxorubicin: 30 mg/m² IV q3週",
        "- CCNU + Doxorubicin 交替",
        "標靶治療（研究中）：",
        "- Toceranib可能有一定活性"
      ],
      radiation: ["局部型術後輔助放療"]
    },
    prognosis: "局部型（手術+化療）：中位生存約6-12個月。播散型：預後差，中位生存約3-6個月。伯恩山犬：品種相關，預後特別謹慎。",
    pearls: [
      "伯恩山犬有強烈的品種傾向",
      "需與淋巴瘤鑑別（治療和預後不同）",
      "免疫組織化學對確診很重要",
      "播散型常累及多個器官",
      "某些病例對CCNU有反應"
    ],
    monitoring: ["定期CBC（CCNU骨髓抑制）", "肝功能（CCNU肝毒性）", "影像學追蹤"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "multiple-myeloma": {
    zh: "多發性骨髓瘤",
    en: "Multiple Myeloma",
    definition: "源自骨髓中漿細胞的惡性腫瘤，特徵為單株免疫球蛋白過度分泌，可導致骨病變、腎功能不全和免疫缺陷。",
    synonyms: ["MM", "Plasma Cell Myeloma", "漿細胞骨髓瘤", "骨髓瘤"],
    epidemiology: {
      species: "犬較貓常見",
      age: "犬：平均8-9歲",
      sex: "無明顯性別傾向",
      breed: "德國牧羊犬可能略多",
      riskFactors: ["年齡", "可能的品種傾向"]
    },
    clinicalPresentation: {
      history: ["虛弱", "跛行或骨痛", "出血傾向", "多飲多尿", "視力改變", "反覆感染"],
      physicalExam: ["跛行或骨痛", "黏膜蒼白", "出血徵象（瘀斑、瘀點）", "視網膜病變", "脾腫大或肝腫大", "病理性骨折"]
    },
    pathophysiology: "骨髓漿細胞克隆性增生 → 分泌單株免疫球蛋白（M蛋白）→ 高黏滯血症（視網膜、神經、腎臟病變）；正常免疫球蛋白減少 → 免疫缺陷；骨溶解 → 骨痛、病理性骨折、高血鈣；Bence-Jones蛋白 → 腎損傷",
    diagnosis: {
      overview: "經典診斷標準需滿足：骨髓漿細胞增多、M蛋白血症、溶骨性病變或Bence-Jones蛋白尿",
      differentials: ["淋巴瘤", "慢性感染（反應性漿細胞增多）", "其他骨腫瘤", "Ehrlichia感染"],
      initialDB: ["CBC（可能貧血）", "生化（高蛋白血症、腎指數、高血鈣）", "尿液分析（Bence-Jones蛋白）", "骨骼X光"],
      advanced: ["血清蛋白電泳（M蛋白）", "免疫固定電泳", "骨髓穿刺和生檢", "全身骨骼X光或CT"]
    },
    treatment: {
      overview: "化療是主要治療，支持治療處理併發症",
      medical: [
        "化療方案：",
        "- Melphalan: 0.1 mg/kg PO q24h x 10天，之後隔日",
        "- + Prednisone: 0.5 mg/kg PO q24h",
        "- 或 Melphalan pulse: 7 mg/m² PO q24h x 5天，q3週",
        "- Cyclophosphamide替代方案",
        "高黏滯血症：血漿分離術（緊急）",
        "高血鈣：輸液、Furosemide、Bisphosphonates"
      ],
      supportive: [
        "疼痛管理",
        "輸血（若嚴重貧血）",
        "感染治療",
        "病理性骨折處理"
      ],
      radiation: ["局部骨病變的緩和性放療"]
    },
    prognosis: "中位生存約18-24個月（治療後）。預後不良因素：高血鈣、Bence-Jones蛋白尿、廣泛骨溶解、IgA型。對治療反應率約90%。",
    pearls: [
      "高球蛋白血症+骨溶解=高度懷疑多發性骨髓瘤",
      "血清蛋白電泳可見典型「M峰」",
      "要排除Ehrlichia感染（可導致高球蛋白血症）",
      "Melphalan+Prednisone是經典治療方案",
      "定期監測M蛋白濃度評估治療反應"
    ],
    monitoring: ["血清蛋白電泳（M蛋白）", "CBC", "腎功能", "尿蛋白", "骨骼X光"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "leukemia": {
    zh: "白血病",
    en: "Leukemia",
    definition: "源自骨髓造血細胞的惡性腫瘤，導致異常白血球在骨髓和周邊血液中大量增生。分為急性和慢性，以及淋巴性和髓性類型。",
    synonyms: ["血癌", "Lymphocytic Leukemia", "Myeloid Leukemia", "淋巴性白血病", "髓性白血病"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "急性：中老年；慢性淋巴性白血病：平均10-12歲",
      sex: "無明顯性別傾向",
      breed: "無明顯品種傾向",
      riskFactors: ["貓白血病病毒（FeLV）-貓", "年齡", "化療或放療暴露"]
    },
    clinicalPresentation: {
      history: ["虛弱", "食慾下降", "體重減輕", "發燒", "出血傾向", "反覆感染"],
      physicalExam: [
        "急性白血病：黏膜蒼白、發燒、瘀斑/瘀點、淋巴結腫大、脾腫大/肝腫大",
        "慢性淋巴性白血病：可能無症狀或輕微症狀、淋巴結腫大、脾腫大"
      ]
    },
    pathophysiology: "骨髓造血細胞惡性轉化 → 異常細胞克隆性增生 → 正常造血功能受抑制（貧血、血小板減少、中性粒細胞減少）→ 異常細胞釋放至周邊血液 → 可能浸潤器官（肝、脾、淋巴結）",
    diagnosis: {
      overview: "周邊血液塗片結合骨髓檢查確診",
      differentials: ["淋巴瘤第V期", "感染性疾病", "免疫媒介性疾病", "骨髓發育不良"],
      initialDB: ["CBC和血液塗片", "生化", "FeLV/FIV檢測（貓）", "胸腔X光", "腹部超聲"],
      advanced: ["骨髓穿刺和生檢", "免疫表型分析（流式細胞儀）", "細胞遺傳學", "PARR（淋巴性）"]
    },
    treatment: {
      overview: "治療取決於白血病類型",
      medical: [
        "急性淋巴性白血病（ALL）：",
        "- 類似淋巴瘤的多藥化療方案",
        "- CHOP方案或類似",
        "急性髓性白血病（AML）：",
        "- 預後很差，治療選項有限",
        "- Cytarabine基礎方案",
        "慢性淋巴性白血病（CLL）：",
        "- 可能不需立即治療（觀察等待）",
        "- Chlorambucil: 2-6 mg/m² PO q24-48h",
        "- + Prednisone: 0.5-1 mg/kg PO q24h",
        "- 或單獨Chlorambucil"
      ],
      supportive: ["輸血", "抗生素（感染）", "輸液支持"]
    },
    prognosis: "ALL：預後謹慎至差，中位生存約數週至數月。AML：預後差，中位生存通常<2週。CLL：預後較好，許多犬可存活1-3年或更長。",
    pearls: [
      "急性白血病是急症，需要快速診斷和治療",
      "CLL進展緩慢，可能僅需觀察",
      "血液塗片是第一步診斷工具",
      "骨髓檢查對確診和分類很重要",
      "FeLV陽性貓有較高白血病風險"
    ],
    monitoring: ["CBC定期監測", "骨髓評估（治療反應）", "感染監測"],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020"
  },

  "feline-injection-site-sarcoma": {
    zh: "貓注射部位肉瘤",
    en: "Feline Injection Site Sarcoma (FISS)",
    definition: "發生於貓注射部位的惡性軟組織腫瘤，與疫苗或其他注射藥物相關的慢性炎症反應有關。高度局部侵襲性，需要積極治療。",
    synonyms: ["FISS", "Vaccine-Associated Sarcoma", "疫苗相關肉瘤", "VAS", "注射部位纖維肉瘤"],
    epidemiology: {
      species: "貓特有",
      age: "平均8-11歲（但任何年齡可發生）",
      sex: "無性別傾向",
      breed: "無品種傾向",
      riskFactors: ["疫苗注射（尤其FeLV、狂犬病）", "其他注射藥物", "微晶片植入", "慢性炎症"]
    },
    clinicalPresentation: {
      history: ["注射部位（肩胛間、後肢）的腫塊", "腫塊快速增大", "可能在注射後數月至數年出現"],
      physicalExam: ["皮下或肌肉內腫塊", "通常堅實、邊界不清", "可能與深層組織粘連", "常見部位：肩胛間、後肢、腹側"]
    },
    pathophysiology: "注射/異物 → 慢性炎症反應 → 成纖維細胞增生 → 基因突變累積（p53等）→ 惡性轉化 → 高度局部侵襲性肉瘤。發生率約1/1000-1/10000次注射。建議注射部位選擇便於日後廣泛切除或截肢的位置。",
    diagnosis: {
      overview: "3-2-1原則：>3個月仍存在、>2公分、注射後1個月仍增大，需進一步檢查",
      differentials: ["注射後肉芽腫", "其他軟組織腫瘤", "膿腫"],
      initialDB: ["細針穿刺細胞學", "胸腔X光（3視圖）"],
      advanced: ["CT或MRI（術前規劃，評估腫瘤範圍）", "楔形或切除生檢", "組織病理學"]
    },
    treatment: {
      overview: "積極的多模式治療：廣泛手術+放療+/-化療",
      surgical: [
        "極廣泛切除（側邊5公分，深層兩個筋膜面）",
        "術前CT/MRI規劃很重要",
        "位於肢體：截肢可能是最佳選項",
        "肩胛間：可能需切除棘突或肩胛骨部分",
        "第一次手術是最佳治癒機會"
      ],
      medical: [
        "輔助化療：",
        "- Doxorubicin: 25 mg/m² IV q3週",
        "- Carboplatin: 200-240 mg/m² IV q3週",
        "- 或兩者交替使用"
      ],
      radiation: [
        "術前放療：可能改善邊緣",
        "術後放療：推薦用於不完整切除",
        "確定性放療：不可手術病例"
      ]
    },
    prognosis: "單獨手術：局部復發率30-70%，中位生存約6-12個月。廣泛手術+放療：中位生存約2-3年，局部復發率降低。轉移率約10-25%，肺最常見。",
    pearls: [
      "「3-2-1原則」：持續>3月、>2cm、注射後1月仍增大需檢查",
      "建議疫苗注射於遠端肢體（便於日後截肢）",
      "避免肩胛間注射",
      "第一次手術的邊緣決定預後",
      "這是醫源性腫瘤，預防很重要"
    ],
    monitoring: ["每2-3個月身體檢查", "胸腔X光", "注射部位監測"],
    prevention: [
      "避免不必要的注射",
      "疫苗注射於遠端肢體（右後肢：狂犬病；左後肢：FeLV；右前肢：其他）",
      "使用非佐劑疫苗",
      "記錄注射部位和疫苗批號",
      "注射部位腫塊監測"
    ],
    reference: "Withrow SW: Small Animal Clinical Oncology, 6th Ed. 2020; AAFP Vaccine Guidelines"
  }
  // ===== From infectious-diseases.js =====

  // ==================== 病毒性傳染病 ====================

  "canine-distemper": {
    zh: "犬瘟熱",
    en: "Canine Distemper",
    definition: "由犬瘟熱病毒(CDV)引起的高度傳染性、多系統性疾病，主要影響呼吸系統、消化系統和神經系統。是犬最嚴重的傳染病之一。",
    synonyms: ["Distemper", "CDV感染", "犬瘟", "Canine Distemper Virus Infection", "Hardpad Disease"],
    epidemiology: {
      species: "犬、狐狸、貂、浣熊及其他食肉目動物",
      age: "幼犬(3-6月齡)最易感，未接種疫苗的任何年齡犬皆可感染",
      sex: "無性別傾向",
      riskFactors: ["未接種疫苗", "母源抗體下降期", "收容所或寵物店環境", "接觸野生動物", "免疫抑制狀態", "幼犬斷奶後"]
    },
    clinicalPresentation: {
      history: ["發燒（雙相熱）", "眼鼻分泌物", "咳嗽", "嘔吐腹瀉", "食慾下降", "精神沉鬱", "後期可能出現神經症狀", "癲癇發作", "肌陣攣"],
      physicalExam: ["黏液膿性眼鼻分泌物", "結膜炎", "角膜炎", "肺部異常呼吸音", "脫水", "腹部觸診疼痛", "神經症狀（共濟失調、癲癇、肌陣攣、咀嚼肌抽搐）", "足墊角化過度(Hardpad)", "牙釉質發育不全"]
    },
    pathophysiology: "CDV經飛沫傳播 → 感染上呼吸道和扁桃腺 → 病毒血症 → 擴散至淋巴組織、呼吸道上皮、腸道上皮、皮膚 → 免疫抑制和器官損傷 → 神經系統入侵（經血腦屏障或嗅神經）→ 脫髓鞘和神經元壞死",
    diagnosis: {
      overview: "結合臨床表現、病史和實驗室檢測。幼犬呼吸道+消化道+神經系統症狀高度提示",
      differentials: ["犬傳染性肝炎", "犬小病毒腸炎", "犬副流感", "犬腺病毒", "鉤端螺旋體病", "弓蟲症", "狂犬病", "中毒"],
      initialDB: ["CBC（淋巴球減少症）", "血清生化", "胸腔X光", "結膜或足墊刮片免疫螢光(IFA)", "PCR檢測（結膜、血液、尿液、CSF）"],
      advanced: ["CSF分析（若有神經症狀）", "血清學配對（急性期和恢復期）", "腦部MRI", "病理組織學（包涵體）"]
    },
    treatment: {
      overview: "無特異性抗病毒藥物，以支持治療為主",
      acute: [
        "輸液治療：糾正脫水和電解質失衡",
        "營養支持：管灌餵食（若厭食）",
        "抗生素治療（預防繼發感染）：",
        "  - Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h",
        "  - 或 Ampicillin: 22 mg/kg IV q8h",
        "止吐：Maropitant 1 mg/kg SC/IV q24h",
        "止瀉：支持治療為主",
        "眼部護理：人工淚液、抗生素眼藥"
      ],
      chronic: [
        "神經症狀管理：",
        "  - 癲癇控制：Phenobarbital 2-3 mg/kg PO q12h",
        "  - 或 Levetiracetam: 20-60 mg/kg PO q8h",
        "  - 肌陣攣：通常難以控制",
        "物理治療（若有運動障礙）",
        "長期護理評估"
      ]
    },
    prognosis: "整體預後謹慎至差。輕度呼吸道/消化道症狀者：謹慎但可能康復。出現神經症狀者：預後差，多數建議安樂死。存活者可能有永久性神經後遺症。",
    pearls: [
      "「雙相熱」是特徵：初次發燒後退燒，數天後再發燒伴隨系統症狀",
      "神經症狀可在急性期後數週至數月才出現",
      "肌陣攣（尤其咀嚼肌）幾乎是病理性特徵",
      "足墊角化過度(Hardpad)是晚期特徵",
      "疫苗是最有效的預防措施，核心疫苗"
    ],
    monitoring: ["體溫", "神經學狀態", "呼吸功能", "水合狀態", "食慾和體重"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "canine-infectious-hepatitis": {
    zh: "犬傳染性肝炎",
    en: "Canine Infectious Hepatitis",
    definition: "由犬腺病毒1型(CAV-1)引起的急性傳染病，主要影響肝臟、腎臟、眼睛和血管內皮，可導致急性肝衰竭。",
    synonyms: ["ICH", "Infectious Canine Hepatitis", "CAV-1感染", "Rubarth's Disease", "藍眼病"],
    epidemiology: {
      species: "犬、狐狸、狼、熊及其他犬科動物",
      age: "未接種疫苗的幼犬最易感，尤其1歲以下",
      sex: "無性別傾向",
      riskFactors: ["未接種疫苗", "收容所環境", "接觸野生犬科動物", "免疫抑制"]
    },
    clinicalPresentation: {
      history: ["急性發燒", "嘔吐", "腹痛", "食慾下降", "嗜睡", "腹瀉（可能帶血）", "出血傾向", "可能突然死亡（超急性型）"],
      physicalExam: ["發燒", "扁桃腺腫大", "頸部淋巴結腫大", "肝腫大、觸痛", "腹部疼痛", "黃疸", "瘀斑或瘀點", "「藍眼」（角膜水腫，恢復期）", "腹水", "皮下水腫"]
    },
    pathophysiology: "CAV-1經口鼻感染 → 扁桃腺和局部淋巴結複製 → 病毒血症 → 肝細胞和血管內皮感染 → 肝臟壞死和凝血因子缺乏 → DIC和出血 → 腎臟損傷 → 恢復期免疫複合物沉積於眼睛和腎臟",
    diagnosis: {
      overview: "根據臨床表現、肝臟指數異常和病毒學檢測診斷",
      differentials: ["犬瘟熱", "鉤端螺旋體病", "中毒性肝炎", "膽管炎", "犬小病毒腸炎", "敗血症"],
      initialDB: ["CBC（白血球減少、血小板減少）", "血清生化（ALT↑↑、ALP↑、膽紅素↑、低白蛋白血症）", "凝血功能（PT/PTT延長）", "尿液分析（蛋白尿）", "腹部超音波"],
      advanced: ["PCR（血液、尿液、肝組織）", "血清學", "肝臟細針抽吸或活檢", "病理組織學（核內包涵體）"]
    },
    treatment: {
      overview: "支持治療為主，無特異性抗病毒藥物",
      acute: [
        "積極輸液治療：維持灌注和電解質平衡",
        "血漿輸注：補充凝血因子和白蛋白",
        "輸血（若嚴重出血）",
        "止吐：Maropitant 1 mg/kg SC/IV q24h",
        "肝臟保護：",
        "  - SAMe: 20 mg/kg PO q24h",
        "  - Ursodiol: 10-15 mg/kg PO q24h",
        "抗生素（預防繼發感染）",
        "維生素K1: 1-2.5 mg/kg SC q12h（若凝血異常）",
        "低蛋白飲食（若有肝腦病徵象）"
      ],
      chronic: [
        "恢復期角膜水腫(藍眼)治療：",
        "  - 通常自限性，2-3週消退",
        "  - 避免類固醇眼藥（可能惡化）",
        "  - NSAIDs眼藥（減輕炎症）",
        "腎功能監測"
      ]
    },
    prognosis: "輕度感染預後良好。超急性型和嚴重肝衰竭預後差。存活者通常完全康復。「藍眼」通常自行消退。因疫苗普及，現臨床上罕見。",
    pearls: [
      "現今因疫苗普及已罕見",
      "CAV-2疫苗可交叉保護CAV-1",
      "「藍眼」是恢復期特徵，由免疫複合物引起",
      "病毒可經尿液排出長達6-9個月",
      "與犬瘟熱的鑑別：ICH更急性、更多出血傾向、肝臟指數更高"
    ],
    monitoring: ["肝功能指數", "凝血功能", "眼睛檢查", "腎功能", "精神狀態"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "feline-panleukopenia": {
    zh: "貓瘟/貓小病毒",
    en: "Feline Panleukopenia",
    definition: "由貓小病毒(FPV)引起的高度傳染性、常致命的疾病，特徵為嚴重的白血球減少症和腸道壞死。",
    synonyms: ["FPV", "Feline Parvovirus", "貓瘟", "貓泛白血球減少症", "Feline Distemper", "Feline Infectious Enteritis"],
    epidemiology: {
      species: "貓、浣熊、貂",
      age: "幼貓(2-6月齡)最易感且死亡率最高",
      sex: "無性別傾向",
      riskFactors: ["未接種疫苗", "母源抗體下降期", "收容所或多貓環境", "應激", "併發感染（FeLV、FIV）"]
    },
    clinicalPresentation: {
      history: ["急性發燒", "嚴重嘔吐", "腹瀉（常帶血）", "食慾完全喪失", "嚴重嗜睡", "快速脫水", "可能突然死亡"],
      physicalExam: ["發燒（晚期可能低體溫）", "嚴重脫水", "腹部疼痛", "腸管觸診如「繩索」感", "虛弱", "可能有神經症狀（小腦發育不全幼貓）"]
    },
    pathophysiology: "FPV經口鼻感染 → 咽淋巴組織複製 → 病毒血症 → 攻擊快速分裂細胞（骨髓、腸隱窩、淋巴組織）→ 嚴重白血球減少 → 腸絨毛萎縮和壞死 → 細菌移位和敗血症。子宮內或新生兒感染 → 小腦發育不全",
    diagnosis: {
      overview: "嚴重白血球減少配合臨床表現高度提示",
      differentials: ["FeLV感染", "敗血症", "沙門氏菌病", "其他腸道感染", "中毒", "腸套疊", "異物阻塞"],
      initialDB: ["CBC（嚴重白血球減少<2000/μL、淋巴球減少）", "血清生化（低白蛋白、低血鉀）", "糞便抗原檢測（快篩）", "糞便PCR"],
      advanced: ["血清學", "骨髓抽吸", "腹部超音波", "病理組織學"]
    },
    treatment: {
      overview: "積極支持治療是關鍵，死亡率高但存活者可完全康復",
      acute: [
        "積極輸液治療：",
        "  - 等張晶體液（LRS）糾正脫水",
        "  - 補充鉀離子（20-40 mEq/L）",
        "  - 膠體液（若低白蛋白）",
        "廣譜抗生素（預防敗血症）：",
        "  - Ampicillin: 22 mg/kg IV q8h",
        "  - 加 Enrofloxacin: 5 mg/kg IV q24h（成貓）",
        "  - 或 Metronidazole: 10-15 mg/kg IV q12h",
        "止吐：",
        "  - Maropitant: 1 mg/kg SC/IV q24h",
        "  - Ondansetron: 0.5 mg/kg IV q8-12h（頑固性嘔吐）",
        "營養支持：鼻飼管或食道餵管",
        "輸血（若嚴重貧血或低白蛋白）",
        "干擾素（效果有限）：Feline Interferon-omega"
      ],
      chronic: [
        "恢復期逐漸恢復飲食",
        "小腦發育不全幼貓：",
        "  - 無法治療但可適應",
        "  - 避免高處避免跌落"
      ]
    },
    prognosis: "未治療死亡率高達90%。積極治療存活率約50-70%。存活超過5天者預後改善。小腦發育不全不會進展但為永久性。",
    pearls: [
      "白血球<2000/μL是嚴重預後指標",
      "糞便快篩可能假陽性（近期接種活疫苗）",
      "病毒在環境中非常穩定，可存活超過1年",
      "隔離和消毒極其重要",
      "接種疫苗是最佳預防，核心疫苗",
      "CPV快篩可用於FPV檢測（交叉反應）"
    ],
    monitoring: ["CBC（尤其白血球）", "電解質", "血糖", "體重", "嘔吐/腹瀉頻率", "體溫"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "feline-leukemia-virus": {
    zh: "貓白血病病毒",
    en: "Feline Leukemia Virus (FeLV)",
    definition: "反轉錄病毒感染，可導致免疫抑制、貧血、淋巴瘤及其他腫瘤。是貓最重要的傳染性疾病之一。",
    synonyms: ["FeLV", "貓白血病", "Feline Leukemia"],
    epidemiology: {
      species: "貓",
      age: "幼貓較成貓更易發展持續性感染",
      sex: "公貓可能風險較高（打架傳播）",
      riskFactors: ["戶外活動", "多貓環境", "與感染貓密切接觸", "打架", "母貓傳子代", "共用食碗/貓砂盆"]
    },
    clinicalPresentation: {
      history: ["反覆感染", "體重減輕", "食慾下降", "慢性口炎", "淋巴結腫大", "貧血症狀", "呼吸困難（縱隔淋巴瘤）"],
      physicalExam: ["蒼白黏膜（貧血）", "淋巴結腫大", "發燒", "脾腫大", "可觸及腹部腫塊", "口炎/齒齦炎", "黃疸（免疫介導性溶血）", "神經症狀（脊髓淋巴瘤）"]
    },
    pathophysiology: "FeLV經唾液/鼻分泌物傳播 → 口咽淋巴組織複製 → 病毒血症 → 骨髓感染。結果依宿主免疫力：1)清除感染；2)潛伏感染；3)持續性病毒血症 → 免疫抑制、腫瘤、骨髓抑制",
    diagnosis: {
      overview: "建議所有貓進行FeLV篩檢，尤其新收養貓",
      differentials: ["FIV", "其他慢性感染", "淋巴瘤（其他原因）", "免疫介導性疾病"],
      initialDB: ["FeLV抗原檢測（快篩ELISA）", "CBC（貧血、白血球異常）", "血清生化", "胸腹X光"],
      advanced: ["IFA確認（骨髓或血塗片）", "PCR", "骨髓抽吸/活檢", "淋巴結細針抽吸", "腹部超音波"]
    },
    treatment: {
      overview: "無法治癒病毒感染，以支持治療和管理併發症為主",
      acute: [
        "繼發感染治療：根據感染類型給予適當抗生素/抗真菌藥",
        "貧血處理：",
        "  - 輸血（嚴重貧血）",
        "  - 免疫抑制（若免疫介導性）：Prednisolone 2 mg/kg PO q12h",
        "  - EPO（非再生性）：100 U/kg SC 3次/週",
        "淋巴瘤化療：CHOP協議或單藥Prednisolone"
      ],
      chronic: [
        "支持治療：",
        "  - 高品質飲食",
        "  - 室內飼養",
        "  - 定期健康檢查（每6個月）",
        "  - 即時治療任何疾病",
        "免疫調節劑（效果有限）：",
        "  - Interferon-alpha",
        "  - LTCI (Lymphocyte T-Cell Immunomodulator)",
        "口炎管理：牙齒清潔/拔牙、類固醇、止痛"
      ]
    },
    prognosis: "持續性病毒血症貓：中位生存期約2.5年。進展至淋巴瘤或嚴重貧血者預後差。一些貓可存活多年。",
    pearls: [
      "「隔離-檢測-再檢測」：暴露後需等待30天再檢測",
      "幼貓<16週抵抗力較差，更易發展持續感染",
      "FeLV相關淋巴瘤以縱隔型最常見",
      "骨髓抑制是常見死因",
      "疫苗可預防但非100%有效，室內飼養最佳",
      "FeLV陽性貓應與陰性貓分開飼養"
    ],
    monitoring: ["定期CBC", "體重", "淋巴結檢查", "口腔檢查", "繼發感染徵象"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "feline-immunodeficiency-virus": {
    zh: "貓愛滋病毒",
    en: "Feline Immunodeficiency Virus (FIV)",
    definition: "反轉錄病毒（慢病毒）感染，導致漸進性免疫缺陷，類似人類HIV。感染貓可能多年無症狀。",
    synonyms: ["FIV", "貓愛滋", "Feline AIDS"],
    epidemiology: {
      species: "貓",
      age: "成年貓較常見（打架傳播）",
      sex: "公貓顯著較多（未絕育公貓打架）",
      riskFactors: ["未絕育公貓", "戶外活動", "打架", "流浪貓"]
    },
    clinicalPresentation: {
      history: ["可能多年無症狀", "反覆感染", "慢性口炎", "慢性上呼吸道感染", "體重減輕", "腹瀉", "神經症狀"],
      physicalExam: ["口炎/齒齦炎（最常見）", "淋巴結腫大（初期）", "發燒", "慢性鼻炎", "皮膚感染", "消瘦", "神經異常（後期）"]
    },
    pathophysiology: "FIV主要經咬傷傳播（唾液中病毒）→ 感染CD4+ T淋巴球 → 急性期：發燒、淋巴結腫大 → 潛伏期（數年）→ 漸進性CD4+ T細胞減少 → 免疫缺陷 → 機會性感染和腫瘤",
    diagnosis: {
      overview: "建議所有貓進行FIV篩檢",
      differentials: ["FeLV", "其他慢性感染", "腫瘤", "免疫介導性疾病"],
      initialDB: ["FIV抗體檢測（快篩ELISA）", "CBC", "血清生化", "尿液分析"],
      advanced: ["Western Blot確認", "PCR（區分疫苗抗體和自然感染）", "CD4:CD8比值"]
    },
    treatment: {
      overview: "無法治癒，以支持治療和管理併發症為主",
      acute: [
        "繼發感染治療：",
        "  - 根據感染類型選擇抗生素",
        "  - 可能需要較長療程",
        "口炎治療：",
        "  - 全口拔牙（最有效）",
        "  - Prednisolone: 1-2 mg/kg PO q24h",
        "  - Cyclosporine: 5-7 mg/kg PO q24h",
        "  - 止痛：Buprenorphine 0.02 mg/kg 口腔黏膜"
      ],
      chronic: [
        "支持治療：",
        "  - 室內飼養（保護貓和防止傳播）",
        "  - 高品質飲食",
        "  - 減少應激",
        "  - 定期健康檢查（每6-12個月）",
        "抗反轉錄病毒藥物（效果有限）：",
        "  - AZT (Zidovudine): 5-10 mg/kg PO q12h",
        "  - 需監測骨髓抑制",
        "干擾素（輔助）"
      ]
    },
    prognosis: "比FeLV預後好。許多FIV陽性貓可正常存活多年。中位生存期：診斷後約5年。最終免疫功能衰竭導致死亡。",
    pearls: [
      "FIV不像FeLV那樣容易傳播",
      "日常接觸（舔毛、共用食碗）傳播風險極低",
      "絕育可大幅降低傳播風險（減少打架）",
      "母傳子代傳播可能，但不常見",
      "FIV疫苗曾上市但已停產",
      "FIV陽性貓可與陰性貓共同生活（若無打架）"
    ],
    monitoring: ["體重", "口腔健康", "CBC", "繼發感染徵象", "生活品質"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "feline-infectious-peritonitis": {
    zh: "貓傳染性腹膜炎",
    en: "Feline Infectious Peritonitis (FIP)",
    definition: "由貓冠狀病毒突變株引起的致命性免疫介導性疾病，可表現為滲出型（濕型）或非滲出型（乾型）。",
    synonyms: ["FIP", "傳腹", "貓傳腹", "Feline Corona Virus Mutation"],
    epidemiology: {
      species: "貓",
      age: "幼貓(<2歲)和老年貓(>10歲)風險較高",
      sex: "公貓可能略多",
      riskFactors: ["多貓環境", "收容所", "繁殖場", "應激", "免疫抑制（FeLV/FIV）", "純種貓"]
    },
    clinicalPresentation: {
      history: ["漸進性體重減輕", "頑固性發燒", "食慾下降", "嗜睡", "腹部膨大（濕型）", "眼睛問題", "神經症狀（乾型）"],
      physicalExam: [
        "濕型：腹水、胸水、呼吸困難、波動感腹部",
        "乾型：肉芽腫性病變（腎臟、肝臟、眼睛、CNS）",
        "共同：發燒、黃疸、淋巴結腫大、葡萄膜炎、神經異常"
      ]
    },
    pathophysiology: "腸道冠狀病毒(FECV)感染 → 部分貓體內病毒突變 → 獲得巨噬細胞趨向性 → 病毒血症 → 免疫介導性血管炎 → 肉芽腫形成和/或滲出液產生。細胞免疫弱、體液免疫強 → 濕型；細胞免疫較強 → 乾型",
    diagnosis: {
      overview: "沒有單一確診測試。綜合臨床表現、血液學、滲出液分析和組織病理",
      differentials: ["心臟病", "腫瘤（淋巴瘤）", "肝病", "細菌性腹膜炎", "弓蟲症", "真菌感染"],
      initialDB: [
        "CBC（非再生性貧血、淋巴球減少、嗜中性球增多）",
        "血清生化（高球蛋白血症、低A/G比值<0.4）",
        "滲出液分析：",
        "  - 蛋白質>3.5 g/dL",
        "  - 細胞數低（<5000/μL）",
        "  - 黏稠、黃色、可拉絲",
        "Rivalta試驗陽性"
      ],
      advanced: [
        "滲出液或組織免疫染色",
        "RT-PCR（靈敏度高但需謹慎解釋）",
        "眼睛檢查（葡萄膜炎）",
        "腹部超音波",
        "組織活檢和組織病理"
      ]
    },
    treatment: {
      overview: "傳統認為無法治療，但近年抗病毒藥物帶來希望",
      acute: [
        "支持治療：",
        "  - 營養支持",
        "  - 輸液治療",
        "  - 抽取大量滲出液（緩解呼吸）",
        "抗病毒藥物（近年突破）：",
        "  - GS-441524: 4-6 mg/kg SC q24h × 12週（濕型）",
        "  - GS-441524: 6-8 mg/kg SC q24h × 12週（乾型/眼/神經型）",
        "  - GC376: 15 mg/kg SC q12h",
        "  - Molnupiravir: 研究中"
      ],
      chronic: [
        "姑息治療（若無法獲得抗病毒藥）：",
        "  - Prednisolone: 2-4 mg/kg PO q24h（可能短暫改善）",
        "  - 免疫調節劑（效果有限）",
        "抗病毒治療後：",
        "  - 監測復發",
        "  - 完成完整療程"
      ]
    },
    prognosis: "傳統：幾乎100%致命。GS-441524等抗病毒藥物：緩解率約80-90%，乾型和神經型較難治療。完成治療後可達到長期緩解。",
    pearls: [
      "冠狀病毒抗體陽性不等於FIP",
      "A/G比值<0.4高度提示FIP",
      "滲出液Rivalta試驗是簡單有用的床邊檢測",
      "GS-441524改變了FIP的預後",
      "多貓家庭中FIP貓不需要隔離（病毒突變是個體事件）",
      "減少應激可能降低發病風險"
    ],
    monitoring: ["體重", "食慾", "球蛋白水平", "滲出液量", "神經和眼睛症狀"],
    reference: "Pedersen NC et al: Efficacy and safety of GS-441524. J Feline Med Surg 21:271-281, 2019"
  },

  "feline-calicivirus": {
    zh: "貓杯狀病毒",
    en: "Feline Calicivirus",
    definition: "高度傳染性病毒感染，主要引起上呼吸道疾病和口腔潰瘍，偶爾引起病毒性全身性疾病(VSD)。",
    synonyms: ["FCV", "貓卡里西病毒", "Calicivirus"],
    epidemiology: {
      species: "貓",
      age: "任何年齡，幼貓症狀較重",
      sex: "無性別傾向",
      riskFactors: ["多貓環境", "收容所", "未接種疫苗", "應激", "帶原貓接觸"]
    },
    clinicalPresentation: {
      history: ["打噴嚏", "流鼻涕", "流口水", "口腔疼痛", "不願進食", "跛行（病毒性多發性關節炎）"],
      physicalExam: [
        "口腔潰瘍（舌頭、硬腭、嘴唇邊緣）",
        "結膜炎（較輕）",
        "鼻分泌物",
        "發燒",
        "關節腫脹和疼痛（幼貓）",
        "VSD（毒力強株）：全身水腫、皮膚潰瘍、黃疸、多器官衰竭"
      ]
    },
    pathophysiology: "FCV經口鼻飛沫傳播 → 感染口咽上皮 → 複製導致上皮壞死 → 口腔潰瘍。部分病毒血症 → 關節滑膜炎（跛行）。VSD株：全身血管內皮感染 → DIC、多器官衰竭",
    diagnosis: {
      overview: "通常根據臨床表現診斷，口腔潰瘍是特徵",
      differentials: ["貓皰疹病毒", "貓披衣菌", "貓黴漿菌", "口腔異物", "腎衰竭（口腔潰瘍）"],
      initialDB: ["臨床診斷", "口咽拭子PCR或病毒分離", "CBC", "血清生化"],
      advanced: ["病毒分離和定序（VSD疑似）"]
    },
    treatment: {
      overview: "主要支持治療，大多數可自行康復",
      acute: [
        "支持治療：",
        "  - 輸液維持水合",
        "  - 營養支持（軟食、加溫增加適口性）",
        "  - 鼻飼管（嚴重厭食）",
        "止痛（口腔潰瘍）：",
        "  - Buprenorphine: 0.02 mg/kg 口腔黏膜 q8-12h",
        "抗生素（繼發感染）：",
        "  - Doxycycline: 5 mg/kg PO q12h",
        "  - 或 Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h",
        "蒸氣治療（緩解鼻塞）",
        "清潔眼鼻分泌物"
      ],
      chronic: [
        "慢性帶原貓口炎治療：",
        "  - 全口或部分拔牙",
        "  - 免疫調節（參見FIV口炎治療）",
        "VSD爆發：",
        "  - 積極支持治療",
        "  - 隔離和消毒",
        "  - 血漿輸注（高免疫血清）"
      ]
    },
    prognosis: "一般FCV感染：預後良好，大多1-2週康復。VSD：死亡率高達50%以上。部分貓成為慢性帶原者。",
    pearls: [
      "口腔潰瘍是FCV的特徵（FHV較少見）",
      "帶原貓可終身排毒",
      "疫苗可減輕症狀但不能防止感染",
      "VSD是致命性全身性感染，需緊急處理",
      "FCV有多種血清型，交叉保護有限",
      "與FHV常混合感染"
    ],
    monitoring: ["進食狀況", "口腔潰瘍癒合", "水合狀態", "體溫"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "feline-herpesvirus": {
    zh: "貓皰疹病毒",
    en: "Feline Herpesvirus",
    definition: "由貓皰疹病毒1型(FHV-1)引起的上呼吸道和眼睛疾病，感染後終身潛伏，應激時可再活化。",
    synonyms: ["FHV-1", "Feline Viral Rhinotracheitis", "FVR", "貓鼻氣管炎病毒"],
    epidemiology: {
      species: "貓",
      age: "任何年齡，幼貓症狀較重",
      sex: "無性別傾向",
      riskFactors: ["多貓環境", "收容所", "未接種疫苗", "應激（再活化）", "免疫抑制"]
    },
    clinicalPresentation: {
      history: ["劇烈打噴嚏", "大量眼鼻分泌物", "食慾下降", "發燒", "眼睛問題（結膜炎、角膜潰瘍）", "應激後反覆發作"],
      physicalExam: [
        "黏液膿性眼鼻分泌物",
        "結膜炎、結膜水腫",
        "角膜潰瘍（樹枝狀）",
        "鼻塞",
        "發燒",
        "嗜睡",
        "幼貓可能有肺炎"
      ]
    },
    pathophysiology: "FHV-1經飛沫傳播 → 感染結膜和呼吸道上皮 → 細胞壞死 → 分泌物和炎症 → 急性期後病毒潛伏於三叉神經節 → 應激、免疫抑制或皮質類固醇 → 再活化和排毒",
    diagnosis: {
      overview: "臨床診斷為主，PCR可確認",
      differentials: ["貓杯狀病毒", "貓披衣菌", "貓黴漿菌", "細菌性結膜炎"],
      initialDB: ["臨床表現", "結膜/咽拭子PCR", "螢光素染色（角膜潰瘍）"],
      advanced: ["病毒分離", "眼科檢查（裂隙燈）"]
    },
    treatment: {
      overview: "支持治療和抗病毒藥物（尤其眼睛受累）",
      acute: [
        "支持治療：",
        "  - 輸液維持水合",
        "  - 營養支持（軟食、加溫）",
        "  - 蒸氣治療和輕柔清潔分泌物",
        "  - 鼻飼管（嚴重厭食）",
        "抗病毒藥物：",
        "全身：",
        "  - Famciclovir: 90 mg/kg PO q8h（最有效）",
        "  - 或 40 mg/kg PO q12h（較常用）",
        "眼部：",
        "  - Cidofovir 0.5% 眼藥水 q12h",
        "  - 或 Idoxuridine 0.1% 眼藥水 q4-6h",
        "  - 或 Trifluridine 1% 眼藥水 q4-6h",
        "抗生素（繼發感染）：",
        "  - Doxycycline: 5 mg/kg PO q12h"
      ],
      chronic: [
        "L-Lysine補充：500 mg/貓 PO q24h（效果有爭議）",
        "應激管理",
        "避免皮質類固醇（可能再活化病毒）",
        "慢性角膜後遺症：",
        "  - 角膜黏連分離",
        "  - 人工淚液",
        "  - 可能需要眼科手術"
      ]
    },
    prognosis: "急性感染：預後良好，1-3週康復。病毒終身潛伏，約80%貓成為帶原者。慢性或復發性眼病可能導致永久性損傷。",
    pearls: [
      "樹枝狀角膜潰瘍是FHV的特徵",
      "應激是再活化的主要觸發因素",
      "Famciclovir是目前最有效的全身抗病毒藥",
      "避免眼部使用類固醇（除非確定無活躍感染）",
      "L-Lysine的效果近年研究存疑",
      "幼貓嚴重感染可導致鼻甲骨壞死和慢性鼻炎"
    ],
    monitoring: ["眼睛狀況（螢光素染色）", "呼吸道症狀", "食慾", "體溫"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  // ==================== 細菌性傳染病 ====================

  "bartonellosis": {
    zh: "巴東氏菌病",
    en: "Bartonellosis",
    definition: "由巴東氏菌屬(Bartonella spp.)引起的人畜共通傳染病。貓是主要宿主和保毒者，可傳染給人（貓抓病）。",
    synonyms: ["Cat Scratch Disease", "CSD", "貓抓病", "貓抓熱", "Bartonella Infection"],
    epidemiology: {
      species: "貓（主要宿主）、犬（較少）",
      age: "幼貓較常帶菌",
      sex: "無明顯性別傾向",
      riskFactors: ["跳蚤感染", "戶外活動", "多貓環境", "收容所", "免疫抑制（FIV/FeLV）"]
    },
    clinicalPresentation: {
      history: ["貓：通常無症狀帶菌", "可能有間歇性發燒", "淋巴結腫大", "眼部問題", "人類：抓咬傷後局部淋巴結腫大"],
      physicalExam: [
        "貓：多數體檢正常",
        "可能發現：淋巴結腫大、發燒、葡萄膜炎、心內膜炎（罕見）、神經症狀（罕見）",
        "犬：較多臨床症狀，包括心內膜炎、關節炎"
      ]
    },
    pathophysiology: "跳蚤吸血時排出含菌糞便 → 抓搔時細菌進入傷口 → 血流感染紅血球內 → 菌血症（可持續數月至數年）→ 偶爾引起器官損傷（葡萄膜炎、心內膜炎）",
    diagnosis: {
      overview: "帶菌者檢測或臨床疾病診斷",
      differentials: ["FIV", "FeLV", "淋巴瘤", "其他感染性疾病", "心內膜炎其他原因"],
      initialDB: ["血液培養（需特殊條件）", "PCR（血液）", "血清學（IFA）"],
      advanced: ["眼科檢查", "心臟超音波（心內膜炎）", "組織PCR"]
    },
    treatment: {
      overview: "無症狀帶菌者是否需要治療有爭議。有臨床症狀或人類暴露風險時應治療",
      acute: [
        "一線治療：",
        "  - Doxycycline: 5-10 mg/kg PO q12h × 4-6週",
        "  - 或 Azithromycin: 10 mg/kg PO q24h × 7天，之後 q72h × 9週",
        "替代方案：",
        "  - Enrofloxacin: 5 mg/kg PO q24h（避免幼貓）",
        "  - Rifampin: 10-15 mg/kg PO q24h（併用）"
      ],
      chronic: [
        "跳蚤控制（關鍵預防措施）：",
        "  - 全年跳蚤預防",
        "  - 環境除蚤",
        "預防人類感染：",
        "  - 修剪貓指甲",
        "  - 避免粗暴遊戲",
        "  - 抓咬傷後立即清洗",
        "  - 免疫低下者應特別小心"
      ]
    },
    prognosis: "貓：大多無臨床問題。治療可能無法完全清除感染。犬心內膜炎預後謹慎。人類貓抓病通常自限性。",
    pearls: [
      "貓是Bartonella henselae的主要儲主",
      "跳蚤是主要傳播媒介",
      "無症狀帶菌者是否治療取決於人類暴露風險",
      "免疫低下者（HIV、化療）感染風險高且症狀重",
      "貓抓病經典三徵：抓傷史+局部淋巴結腫大+發燒"
    ],
    monitoring: ["治療後PCR追蹤", "跳蚤控制效果"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "borreliosis": {
    zh: "萊姆病",
    en: "Borreliosis (Lyme Disease)",
    definition: "由伯氏疏螺旋體(Borrelia burgdorferi)引起、經硬蜱傳播的多系統感染性疾病。是北半球最常見的蜱傳疾病。",
    synonyms: ["Lyme Disease", "Lyme Borreliosis", "萊姆氏症"],
    epidemiology: {
      species: "犬（貓感染罕見且通常無症狀）",
      age: "任何年齡，常見於成年犬",
      sex: "無性別傾向",
      riskFactors: ["蜱蟲高發地區（美國東北部、中西部、西海岸；歐洲；亞洲溫帶）", "戶外活動", "未使用蜱蟲預防"]
    },
    clinicalPresentation: {
      history: ["間歇性跛行（移行性多關節炎）", "發燒", "食慾下降", "嗜睡", "淋巴結腫大", "可能有蜱蟲暴露史"],
      physicalExam: ["發燒", "關節腫脹和疼痛（尤其肘關節、腕關節）", "淋巴結腫大", "可能發現蜱蟲", "較少：心臟傳導異常、腎病(Lyme nephritis)"]
    },
    pathophysiology: "受感染硬蜱（主要為肩突硬蜱）叮咬 → 螺旋體傳播（需24-48小時附著）→ 局部複製 → 經血液擴散至關節、心臟、腎臟 → 免疫介導性炎症反應 → 關節炎、心臟炎、腎小球腎炎",
    diagnosis: {
      overview: "流行區加臨床表現配合血清學檢測",
      differentials: ["免疫介導性多關節炎", "其他蜱傳疾病（Anaplasma、Ehrlichia）", "敗血性關節炎", "類風濕性關節炎"],
      initialDB: [
        "血清學（C6抗體SNAP檢測）",
        "CBC（可能正常）",
        "血清生化",
        "尿液分析（尿蛋白）",
        "UPC（蛋白尿評估）"
      ],
      advanced: ["關節液分析（非化膿性）", "Borrelia PCR（關節液）", "腎活檢（Lyme nephritis）", "西方墨點法確認"]
    },
    treatment: {
      overview: "抗生素治療有效，早期治療預後好",
      acute: [
        "一線治療：",
        "  - Doxycycline: 5-10 mg/kg PO q12h × 4週（首選）",
        "替代方案：",
        "  - Amoxicillin: 20 mg/kg PO q8h × 4週",
        "  - 或 Azithromycin: 25 mg/kg PO q24h × 7天",
        "止痛（若關節炎嚴重）：",
        "  - Carprofen: 2.2 mg/kg PO q12h",
        "  - 或 Meloxicam: 0.1 mg/kg PO q24h"
      ],
      chronic: [
        "Lyme腎炎（預後差）：",
        "  - ACE抑制劑：Enalapril 0.5 mg/kg PO q12-24h",
        "  - 低蛋白飲食",
        "  - 支持治療",
        "預防：",
        "  - 蜱蟲預防（Fipronil、Permethrin、Isoxazolines）",
        "  - 疫苗（流行區）",
        "  - 戶外活動後檢查蜱蟲"
      ]
    },
    prognosis: "關節炎型：抗生素治療後預後良好，多數24-48小時改善。Lyme腎炎：預後差，可能進展至腎衰竭。",
    pearls: [
      "蜱蟲需附著24-48小時才能傳播",
      "犬抗體陽性率高但臨床疾病發生率低（<5%）",
      "移行性跛行是典型特徵",
      "Lyme腎炎主要見於Labrador和Golden Retriever",
      "C6抗體可區分疫苗抗體和自然感染",
      "人類的典型紅疹（遊走性紅斑）在犬很少見"
    ],
    monitoring: ["症狀改善", "尿蛋白追蹤", "C6抗體水平"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  // ==================== 真菌性傳染病 ====================

  "blastomycosis": {
    zh: "芽生菌病",
    en: "Blastomycosis",
    definition: "由皮炎芽生菌(Blastomyces dermatitidis)引起的系統性真菌感染，主要影響肺部並可擴散至皮膚、骨骼、眼睛和其他器官。",
    synonyms: ["Blastomyces Infection", "芽生黴菌病", "North American Blastomycosis"],
    epidemiology: {
      species: "犬（最常見）、貓（較少）、人類",
      age: "年輕至中年犬（1-5歲）較常見",
      sex: "公犬較多（戶外活動較多）",
      riskFactors: ["流行區居住（北美五大湖區、密西西比河和俄亥俄河流域）", "靠近水域活動", "獵犬或運動犬", "土壤接觸"]
    },
    clinicalPresentation: {
      history: ["咳嗽", "呼吸困難", "運動不耐", "體重減輕", "皮膚病變", "跛行", "眼睛問題", "發燒"],
      physicalExam: [
        "肺部異常呼吸音",
        "皮膚結節或潰瘍（排膿）",
        "淋巴結腫大",
        "眼部病變（葡萄膜炎、視網膜剝離、失明）",
        "骨骼病變（跛行、腫脹）",
        "發燒、消瘦"
      ]
    },
    pathophysiology: "吸入土壤中的分生孢子 → 轉化為酵母型 → 肺部感染 → 經血液/淋巴擴散至皮膚、骨骼、眼睛、CNS、泌尿生殖系統 → 肉芽腫性炎症",
    diagnosis: {
      overview: "細胞學發現特徵性酵母菌是診斷金標準",
      differentials: ["細菌性肺炎", "肺腫瘤", "其他系統性真菌感染", "結核", "諾卡氏菌"],
      initialDB: [
        "細胞學/組織學（特徵性寬基出芽酵母菌）：",
        "  - 肺灌洗液、淋巴結抽吸、皮膚壓片",
        "胸腔X光（瀰漫性間質至結節性肺浸潤）",
        "尿液抗原檢測（高敏感性）",
        "血清學（交叉反應多，特異性低）"
      ],
      advanced: ["培養（需生物安全措施）", "骨骼X光", "眼科檢查", "腹部超音波"]
    },
    treatment: {
      overview: "長期抗真菌治療，通常需4-6個月以上",
      acute: [
        "一線治療：",
        "  - Itraconazole: 5 mg/kg PO q12h（首選）",
        "  - 或 Fluconazole: 5-10 mg/kg PO q12h（CNS/眼部較佳滲透）",
        "嚴重肺部疾病：",
        "  - 可加 Amphotericin B: 0.5 mg/kg IV q48h（監測腎功能）",
        "眼部病變：",
        "  - Fluconazole + 局部治療",
        "  - 抗炎治療（避免全身類固醇）"
      ],
      chronic: [
        "治療持續時間：",
        "  - 至少4-6個月",
        "  - 停藥標準：臨床緩解後再治療1個月",
        "監測：",
        "  - 尿抗原追蹤",
        "  - 定期X光",
        "  - 肝功能（Itraconazole）"
      ]
    },
    prognosis: "整體存活率約70-75%。肺部病變：預後較好。CNS/嚴重肺部受累：預後較差。眼部病變可能導致永久失明。",
    pearls: [
      "大型厚壁、寬基出芽(broad-based budding)酵母菌是特徵",
      "尿抗原檢測是良好的診斷和監測工具",
      "與組織漿菌病不同，芽生菌病少見免疫正常宿主中的自限感染",
      "Itraconazole需與食物服用增加吸收",
      "治療過程中可能出現Jarisch-Herxheimer樣反應",
      "人畜共通但人傳人或動物傳人罕見"
    ],
    monitoring: ["臨床症狀", "尿抗原", "胸腔X光", "肝功能", "眼科檢查"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "histoplasmosis": {
    zh: "組織漿菌病",
    en: "Histoplasmosis",
    definition: "由莢膜組織漿菌(Histoplasma capsulatum)引起的系統性真菌感染，主要影響肺部和網狀內皮系統。",
    synonyms: ["Histoplasma Infection", "組織胞漿菌病", "Ohio Valley Disease", "Darling's Disease"],
    epidemiology: {
      species: "犬、貓、人類",
      age: "幼年動物較常見嚴重疾病",
      sex: "無明顯性別傾向",
      riskFactors: ["流行區（美國中部和東部、密西西比和俄亥俄河流域）", "接觸鳥糞或蝙蝠糞污染土壤", "挖掘活動", "免疫抑制"]
    },
    clinicalPresentation: {
      history: ["咳嗽", "呼吸困難", "體重減輕", "腹瀉（貓常見）", "發燒", "嗜睡"],
      physicalExam: [
        "犬：肺部異常呼吸音、肝脾腫大、淋巴結腫大、腸道增厚",
        "貓：呼吸困難、皮膚結節/潰瘍、骨骼病變、眼部病變",
        "共同：消瘦、發燒、蒼白黏膜"
      ]
    },
    pathophysiology: "吸入土壤中的小分生孢子 → 肺泡巨噬細胞吞噬 → 酵母型菌在細胞內複製 → 經網狀內皮系統擴散（肝、脾、淋巴結、骨髓）→ 肉芽腫或彌漫性巨噬細胞浸潤",
    diagnosis: {
      overview: "細胞學或組織學發現細胞內酵母菌是診斷依據",
      differentials: ["其他系統性真菌感染", "淋巴瘤", "IBD", "結核", "其他肉芽腫性疾病"],
      initialDB: [
        "細胞學/組織學（細胞內小酵母菌2-4μm）：",
        "  - 骨髓、淋巴結、肝脾抽吸",
        "  - 肺灌洗液、直腸刮片",
        "胸腔X光（結節性或彌漫性間質浸潤）",
        "CBC（非再生性貧血、血小板減少）",
        "尿液抗原檢測"
      ],
      advanced: ["培養（生物安全措施）", "血清學", "腸道超音波/內視鏡"]
    },
    treatment: {
      overview: "長期抗真菌治療",
      acute: [
        "一線治療：",
        "  - Itraconazole: 犬 5 mg/kg PO q12h；貓 10 mg/kg PO q12h",
        "嚴重病例：",
        "  - Amphotericin B: 0.25-0.5 mg/kg IV q48h（誘導）",
        "  - 脂質體Amphotericin B較安全",
        "支持治療：",
        "  - 營養支持",
        "  - 輸血（若嚴重貧血）"
      ],
      chronic: [
        "治療持續時間：",
        "  - 4-6個月或更長",
        "  - 停藥標準：臨床緩解+尿抗原陰性後1個月",
        "貓可能需要更長療程"
      ]
    },
    prognosis: "犬存活率約70-90%。貓預後較謹慎，尤其肺部受累嚴重者。腸道型：預後較好。",
    pearls: [
      "比芽生菌更小（2-4μm vs 8-15μm）",
      "細胞內寄生是特徵",
      "貓比犬更常見皮膚和骨骼病變",
      "腸道受累在犬較常見，可能導致蛋白質流失性腸病",
      "免疫正常宿主可能自限感染",
      "鳥籠、雞舍、洞穴是高風險環境"
    ],
    monitoring: ["臨床症狀", "尿抗原", "CBC", "肝功能", "胸腔X光"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "cryptococcosis": {
    zh: "隱球菌病",
    en: "Cryptococcosis",
    definition: "由隱球菌(Cryptococcus neoformans/gattii)引起的系統性真菌感染，主要影響鼻腔、中樞神經系統和皮膚。",
    synonyms: ["Cryptococcus Infection", "新型隱球菌病"],
    epidemiology: {
      species: "貓（最常見）、犬、人類",
      age: "任何年齡，成年動物較常見",
      sex: "無明顯性別傾向",
      riskFactors: ["鴿糞或桉樹接觸", "免疫抑制（FeLV/FIV）", "全球分布（C. neoformans）或熱帶亞熱帶（C. gattii）"]
    },
    clinicalPresentation: {
      history: ["慢性鼻分泌物", "打噴嚏", "鼻樑腫脹", "神經症狀", "皮膚病變", "眼睛問題"],
      physicalExam: [
        "貓：鼻部腫塊、慢性鼻炎、皮膚結節/潰瘍、CNS症狀、眼部病變",
        "犬：CNS症狀較常見、眼部病變、鼻部病變",
        "共同：發燒（不常見）、淋巴結腫大"
      ]
    },
    pathophysiology: "吸入鴿糞或環境中的酵母菌/孢子 → 鼻腔定植和感染 → 經篩板侵入CNS或經血液擴散 → 皮膚、眼睛、肺部等受累。莢膜多醣是主要毒力因子，抑制吞噬作用",
    diagnosis: {
      overview: "莢膜抗原檢測是高度敏感特異的診斷方法",
      differentials: ["鼻腔腫瘤", "其他真菌感染", "細菌性鼻炎", "腦腫瘤", "腦炎"],
      initialDB: [
        "乳膠凝集試驗(LCAT)或側流層析(LFA)（莢膜抗原檢測）：",
        "  - 血清或CSF",
        "  - 敏感性>90%",
        "細胞學（墨汁染色顯示莢膜）",
        "鼻部影像（CT優於X光）"
      ],
      advanced: ["MRI（CNS病變）", "培養", "CSF分析（CNS受累）", "組織病理"]
    },
    treatment: {
      overview: "長期抗真菌治療，CNS病例需選擇CNS滲透好的藥物",
      acute: [
        "一線治療：",
        "貓/犬鼻腔或皮膚病變：",
        "  - Fluconazole: 50 mg/貓 或 5-10 mg/kg PO q12-24h",
        "  - 或 Itraconazole: 50 mg/貓 或 5 mg/kg PO q12h",
        "CNS病變：",
        "  - Fluconazole（首選，CNS滲透佳）",
        "  - 嚴重時：Amphotericin B + Flucytosine（5-Fluorocytosine）",
        "眼部病變：",
        "  - Fluconazole + 局部抗炎治療"
      ],
      chronic: [
        "治療持續時間：",
        "  - 鼻腔型：2-4個月",
        "  - CNS型：6-12個月或更長",
        "  - 停藥標準：臨床緩解+抗原效價陰性或穩定低",
        "抗原效價監測：每4-8週"
      ]
    },
    prognosis: "鼻腔型：預後良好（>80%治癒）。CNS型：預後謹慎（約50-60%）。眼部受累可能導致永久視力損害。",
    pearls: [
      "貓是最常見受感染的家養動物",
      "抗原檢測是最有用的診斷工具",
      "鼻樑腫脹(\"Clown nose\")是貓的典型表現",
      "Fluconazole是CNS病變首選（滲透性佳）",
      "抗原效價可用於監測治療反應",
      "FIV/FeLV陽性貓感染風險增加但治療反應可良好"
    ],
    monitoring: ["抗原效價（每4-8週）", "臨床症狀", "神經學檢查", "眼科檢查"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "coccidioidomycosis": {
    zh: "球孢子菌病",
    en: "Coccidioidomycosis",
    definition: "由粗球孢子菌(Coccidioides immitis/posadasii)引起的系統性真菌感染，主要影響肺部並可擴散至骨骼、皮膚和其他器官。",
    synonyms: ["Valley Fever", "San Joaquin Valley Fever", "山谷熱", "沙漠風濕症"],
    epidemiology: {
      species: "犬（最常見）、貓（罕見）、人類",
      age: "幼犬和年輕成犬較常見",
      sex: "無明顯性別傾向",
      riskFactors: ["流行區居住（美國西南部、墨西哥北部、中南美洲乾旱地區）", "沙塵暴後", "土壤挖掘活動", "某些品種（Boxer、Pointer、Australian Shepherd、Beagle、Scottish Terrier）"]
    },
    clinicalPresentation: {
      history: ["慢性咳嗽", "呼吸困難", "發燒", "體重減輕", "跛行", "皮膚病變"],
      physicalExam: [
        "肺部異常呼吸音",
        "骨骼病變（長骨、椎體）：腫脹、疼痛",
        "皮膚結節或引流瘻管",
        "淋巴結腫大",
        "眼部病變（葡萄膜炎）",
        "心臟病變（心包炎）"
      ]
    },
    pathophysiology: "吸入土壤中的關節孢子 → 肺泡內轉化為球狀體 → 球狀體破裂釋放內孢子 → 局部複製或經血液/淋巴擴散 → 骨骼、皮膚、眼睛、CNS、心臟受累 → 肉芽腫形成",
    diagnosis: {
      overview: "血清學配合臨床表現和影像學",
      differentials: ["其他系統性真菌感染", "細菌性骨髓炎", "骨腫瘤", "肺腫瘤", "結核"],
      initialDB: [
        "血清學（最常用）：",
        "  - AGID（瓊脂凝膠免疫擴散）",
        "  - EIA（酵素免疫分析）",
        "胸腔X光（支氣管周圍浸潤、肺門淋巴結腫大）",
        "骨骼X光（溶骨性病變）"
      ],
      advanced: [
        "細胞學/組織學（大球狀體含內孢子）",
        "培養（生物安全措施，高度危險）",
        "尿抗原檢測",
        "MRI/CT（骨骼或CNS病變）"
      ]
    },
    treatment: {
      overview: "長期抗真菌治療，常需終身維持",
      acute: [
        "一線治療：",
        "  - Fluconazole: 5-10 mg/kg PO q12h（首選）",
        "  - 或 Itraconazole: 5 mg/kg PO q12h",
        "嚴重或CNS病例：",
        "  - Amphotericin B誘導治療",
        "骨骼病變：",
        "  - 可能需手術清創",
        "  - 延長療程（6-12個月以上）"
      ],
      chronic: [
        "治療持續時間：",
        "  - 肺部型：6-12個月",
        "  - 播散性：12個月以上，常需終身維持",
        "  - 骨骼型：至少12個月",
        "停藥標準：臨床緩解+血清學陰性或穩定低後2-3個月"
      ]
    },
    prognosis: "肺部型：預後良好（約90%可控制）。播散性（尤其骨骼）：預後謹慎，常需終身治療。某些品種（Boxer等）預後較差。",
    pearls: [
      "「山谷熱」因在美國加州聖乔金谷發現而得名",
      "球狀體（spherules）含內孢子是診斷特徵",
      "血清學檢測是最實用的診斷方法",
      "骨骼受累是犬最常見的播散部位",
      "復發常見，可能需要終身維持治療",
      "培養物高度危險，需BSL-3實驗室",
      "雨季後、建築工地等塵土飛揚環境風險增加"
    ],
    monitoring: ["臨床症狀", "血清學效價", "骨骼X光（骨骼型）", "肝功能"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },

  "aspergillosis": {
    zh: "麴菌病",
    en: "Aspergillosis",
    definition: "由麴菌屬(Aspergillus spp.，主要為A. fumigatus)引起的真菌感染，可表現為鼻部、播散性或其他局部形式。",
    synonyms: ["Aspergillus Infection", "麴黴病"],
    epidemiology: {
      species: "犬、貓",
      age: "鼻部型：年輕至中年犬；播散型：任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["鼻部型：中長頭犬種（German Shepherd、Retriever、Rottweiler）", "播散型：免疫抑制、German Shepherd（可能遺傳性免疫缺陷）", "貓：免疫抑制（FeLV/FIV）或長期抗生素/類固醇使用"]
    },
    clinicalPresentation: {
      history: [
        "鼻部型：慢性單側或雙側鼻分泌物（膿血性）、打噴嚏、鼻痛、鼻樑脫色/潰瘍",
        "播散型：嗜睡、厭食、發燒、椎間盤炎/骨髓炎症狀、眼部症狀"
      ],
      physicalExam: [
        "鼻部型：膿血性鼻分泌物、鼻孔周圍潰瘍、鼻痛、鼻樑脫色",
        "播散型：椎體疼痛、後肢無力、葡萄膜炎、視網膜病變、淋巴結腫大"
      ]
    },
    pathophysiology: "吸入普遍存在於環境中的孢子 → 鼻腔定植（正常免疫力宿主）或播散（免疫缺陷）。鼻部型：真菌破壞鼻甲骨。播散型：經血液擴散至椎體、腎臟、眼睛等",
    diagnosis: {
      overview: "鼻部型：影像學+內視鏡+細胞學/培養；播散型：影像學+血清學+組織學",
      differentials: ["鼻部型：鼻腔腫瘤、異物、牙根膿瘍、隱球菌", "播散型：椎間盤炎其他原因、腫瘤"],
      initialDB: [
        "鼻部型：",
        "  - CT或MRI（鼻甲骨破壞、額竇充填）",
        "  - 鼻腔內視鏡（真菌斑塊）",
        "  - 細胞學/組織學（分隔菌絲）",
        "  - 培養",
        "播散型：",
        "  - 脊椎X光或MRI（椎間盤炎）",
        "  - 血清學（Galactomannan抗原）",
        "  - 尿液抗原"
      ],
      advanced: ["組織活檢", "培養和藥敏"]
    },
    treatment: {
      overview: "鼻部型以局部治療為主；播散型需要長期全身抗真菌治療",
      acute: [
        "鼻部型：",
        "  - 局部Clotrimazole灌注（首選）：",
        "    1%溶液，麻醉下經鼻孔或鑽孔灌入，作用1小時",
        "    成功率約70-90%，可能需重複",
        "  - 或局部Enilconazole灌洗（bid × 7-14天）",
        "  - 口服Itraconazole（輔助或無法局部治療時）：5 mg/kg PO q12h",
        "播散型：",
        "  - Itraconazole: 5 mg/kg PO q12h",
        "  - 或 Voriconazole: 4-6 mg/kg PO q12h（較佳但較貴）",
        "  - Amphotericin B（嚴重病例誘導）"
      ],
      chronic: [
        "播散型：",
        "  - 長期治療（6-12個月以上）",
        "  - 預後謹慎",
        "鼻部型：",
        "  - 可能需要重複局部治療",
        "  - 慢性病例預後較差"
      ]
    },
    prognosis: "鼻部型：局部治療成功率70-90%，可能復發。播散型：預後差，尤其German Shepherd（可能有潛在免疫缺陷）。",
    pearls: [
      "鼻部麴菌病是犬最常見的鼻腔真菌感染",
      "CT顯示鼻甲骨破壞是特徵",
      "局部Clotrimazole灌注是鼻部型首選治療",
      "German Shepherd有播散型的品種傾向",
      "播散型常見椎間盤炎表現",
      "Aspergillus是機會性病原，正常動物也有暴露但不發病"
    ],
    monitoring: ["鼻部型：臨床症狀、影像學追蹤", "播散型：神經學檢查、眼科檢查、血清學"],
    reference: "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  }

};
const INFECTIOUS_DISEASE_ALIASES = {
  // 病毒性疾病
  "犬瘟熱": "canine-distemper",
  "犬瘟": "canine-distemper",
  "CDV": "canine-distemper",
  "distemper": "canine-distemper",
  "hardpad": "canine-distemper",

  "犬傳染性肝炎": "canine-infectious-hepatitis",
  "ICH": "canine-infectious-hepatitis",
  "CAV-1": "canine-infectious-hepatitis",
  "藍眼病": "canine-infectious-hepatitis",
  "infectious hepatitis": "canine-infectious-hepatitis",

  "貓瘟": "feline-panleukopenia",
  "貓小病毒": "feline-panleukopenia",
  "FPV": "feline-panleukopenia",
  "貓泛白血球減少症": "feline-panleukopenia",
  "panleukopenia": "feline-panleukopenia",
  "feline parvovirus": "feline-panleukopenia",

  "貓白血病病毒": "feline-leukemia-virus",
  "貓白血病": "feline-leukemia-virus",
  "FeLV": "feline-leukemia-virus",
  "feline leukemia": "feline-leukemia-virus",

  "貓愛滋病毒": "feline-immunodeficiency-virus",
  "貓愛滋": "feline-immunodeficiency-virus",
  "FIV": "feline-immunodeficiency-virus",
  "feline aids": "feline-immunodeficiency-virus",

  "貓傳染性腹膜炎": "feline-infectious-peritonitis",
  "貓傳腹": "feline-infectious-peritonitis",
  "傳腹": "feline-infectious-peritonitis",
  "FIP": "feline-infectious-peritonitis",
  "feline infectious peritonitis": "feline-infectious-peritonitis",

  "貓杯狀病毒": "feline-calicivirus",
  "FCV": "feline-calicivirus",
  "calicivirus": "feline-calicivirus",
  "貓卡里西病毒": "feline-calicivirus",

  "貓皰疹病毒": "feline-herpesvirus",
  "FHV": "feline-herpesvirus",
  "FHV-1": "feline-herpesvirus",
  "貓鼻氣管炎": "feline-herpesvirus",
  "FVR": "feline-herpesvirus",
  "feline viral rhinotracheitis": "feline-herpesvirus",

  // 細菌性疾病
  "巴東氏菌病": "bartonellosis",
  "貓抓病": "bartonellosis",
  "貓抓熱": "bartonellosis",
  "cat scratch disease": "bartonellosis",
  "CSD": "bartonellosis",
  "bartonella": "bartonellosis",

  "萊姆病": "borreliosis",
  "萊姆氏症": "borreliosis",
  "lyme disease": "borreliosis",
  "lyme": "borreliosis",
  "borrelia": "borreliosis",

  // 真菌性疾病
  "芽生菌病": "blastomycosis",
  "芽生黴菌病": "blastomycosis",
  "blastomyces": "blastomycosis",

  "組織漿菌病": "histoplasmosis",
  "組織胞漿菌病": "histoplasmosis",
  "histoplasma": "histoplasmosis",
  "ohio valley disease": "histoplasmosis",

  "隱球菌病": "cryptococcosis",
  "新型隱球菌病": "cryptococcosis",
  "cryptococcus": "cryptococcosis",

  "球孢子菌病": "coccidioidomycosis",
  "山谷熱": "coccidioidomycosis",
  "valley fever": "coccidioidomycosis",
  "coccidioides": "coccidioidomycosis",

  "麴菌病": "aspergillosis",
  "麴黴病": "aspergillosis",
  "aspergillus": "aspergillosis"
  // ===== From musculoskeletal-diseases.js =====

  // ==================== 關節發育疾病 ====================

  "hip-dysplasia": {
    zh: "髖關節發育不良",
    en: "Hip Dysplasia",
    definition: "髖關節的發育異常，導致股骨頭與髖臼不能正確吻合，造成關節鬆弛、異常磨損和繼發性骨關節炎。是大型犬最常見的骨科發育疾病。",
    synonyms: ["Canine Hip Dysplasia", "CHD", "髖關節發育不全", "髖關節形成不良"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "臨床症狀可在4-12月齡開始出現，或成年後因骨關節炎顯現",
      sex: "無明顯性別傾向",
      riskFactors: ["大型至巨型犬種（German Shepherd、Labrador、Golden Retriever、Rottweiler、Saint Bernard）", "遺傳因素（多基因遺傳）", "快速生長", "過度營養", "過度運動（幼犬時期）", "肥胖"]
    },
    clinicalPresentation: {
      history: ["後肢跛行（可單側或雙側）", "起立困難", "運動不耐", "上樓梯困難", "跳躍減少", "「兔跳」步態", "後肢肌肉萎縮", "症狀可能時好時壞"],
      physicalExam: ["Ortolani test陽性（關節鬆弛）", "後肢肌肉萎縮", "髖關節活動範圍減少", "外展時疼痛", "Barlow/Bardens test陽性", "站姿可見後肢基部狹窄"]
    },
    pathophysiology: "遺傳因素 + 環境因素 → 關節鬆弛 → 股骨頭與髖臼不穩定 → 異常應力分布 → 關節軟骨和關節囊損傷 → 骨重塑（骨刺形成、髖臼變淺、股骨頭變形）→ 繼發性骨關節炎。關節鬆弛是起始病因，骨關節炎是最終結果。",
    diagnosis: {
      overview: "X光檢查是確診的標準方法，需評估關節鬆弛度和骨關節炎程度",
      differentials: ["髕骨脫位", "前十字韌帶斷裂", "股骨頭缺血性壞死", "泛骨炎", "腰薦椎疾病", "多發性關節炎"],
      initialDB: ["骨科檢查（Ortolani test）", "髖關節X光（標準伸展位）", "評估骨關節炎程度", "觀察股骨頭覆蓋率和關節吻合度"],
      advanced: ["PennHIP放射檢查（評估鬆弛度指數）", "CT掃描（手術計畫）", "關節液分析（排除感染或免疫性）"]
    },
    treatment: {
      overview: "根據年齡、症狀嚴重度和關節退化程度選擇保守或手術治療",
      acute: [
        "急性疼痛發作管理：",
        "  - 休息和活動限制",
        "  - NSAIDs: Carprofen 2.2 mg/kg PO q12h 或 4.4 mg/kg q24h",
        "  - Meloxicam 0.1 mg/kg PO q24h（維持劑量）",
        "  - 冰敷（急性期）",
        "體重管理"
      ],
      chronic: [
        "保守治療：",
        "  - 體重控制（最重要）",
        "  - 適度規律運動（游泳最佳）",
        "  - NSAIDs長期使用（注意監測）",
        "  - 關節保健品（Glucosamine、Chondroitin、Omega-3）",
        "  - 物理治療和復健",
        "手術選項：",
        "  - 幼犬（<5-6月齡）：JPS（Juvenile Pubic Symphysiodesis）",
        "  - 幼犬-青年犬：TPO/DPO（Triple/Double Pelvic Osteotomy）",
        "  - 成犬：THR（Total Hip Replacement）- 最佳預後",
        "  - FHO（Femoral Head Ostectomy）- 姑息性，適用小型犬"
      ]
    },
    prognosis: "保守治療可維持多數犬的生活品質。THR手術成功率>90%，可恢復正常功能。FHO小型犬預後較好。早期診斷和介入可延緩骨關節炎進展。",
    pearls: [
      "PennHIP在16週齡即可評估，是最準確的鬆弛度測量",
      "OFA評估需24月齡，主要評估骨關節炎而非鬆弛度",
      "體重控制是所有治療的基礎",
      "雙側症狀時應同時評估兩側",
      "繁殖犬應進行髖關節評估篩選"
    ],
    monitoring: ["體重", "跛行評分", "定期X光追蹤", "肝腎功能（若長期使用NSAIDs）", "生活品質評估"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  "elbow-dysplasia": {
    zh: "肘關節發育不良",
    en: "Elbow Dysplasia",
    definition: "肘關節發育異常的總稱，包括內側冠狀突分離(FCP)、肘突不癒合(UAP)、骨軟骨炎(OCD)和肘關節不協調。是大型犬前肢跛行最常見的原因之一。",
    synonyms: ["Canine Elbow Dysplasia", "ED", "肘關節發育不全", "肘關節形成不良"],
    epidemiology: {
      species: "犬為主",
      age: "通常4-10月齡開始出現症狀",
      sex: "公犬略多",
      riskFactors: ["大型犬種（Labrador、Golden Retriever、Rottweiler、German Shepherd、Bernese Mountain Dog）", "遺傳因素", "快速生長", "營養過剩", "過度運動"]
    },
    clinicalPresentation: {
      history: ["前肢跛行（常單側，但50%為雙側）", "運動後加重", "起立僵硬", "行走時肘部外展", "活動力下降", "症狀可能從幼年持續"],
      physicalExam: ["肘關節腫脹", "關節活動時疼痛", "完全伸展和屈曲時疼痛", "肌肉萎縮（前臂肌群）", "關節活動範圍可能減少", "步態異常（划圓步態）"]
    },
    pathophysiology: "遺傳因素 + 生長不協調 → 尺骨-橈骨-肱骨生長速率不匹配 → 關節不協調 → 異常應力 → 軟骨損傷和骨碎片形成。FCP最常見（67%），UAP和OCD較少見。關節不協調導致內側關節面承受過大壓力。",
    diagnosis: {
      overview: "X光檢查是初步診斷標準，但CT或關節鏡可提供更精確評估",
      differentials: ["肩關節OCD", "泛骨炎", "骨折", "全骨炎", "免疫性多發性關節炎"],
      initialDB: ["骨科檢查", "肘關節X光（至少3個角度：AP、ML、flexed ML）", "評估骨關節炎程度", "對側比較"],
      advanced: ["CT掃描（FCP診斷的gold standard）", "關節鏡（診斷和治療）", "MRI（軟骨評估）", "關節液分析"]
    },
    treatment: {
      overview: "手術治療是多數病例的首選，尤其是年輕有症狀的犬",
      acute: [
        "症狀控制：",
        "  - 休息和活動限制",
        "  - NSAIDs: Carprofen或Meloxicam",
        "  - 冰敷",
        "等待手術評估"
      ],
      chronic: [
        "手術治療（建議）：",
        "  - FCP: 關節鏡碎片移除、冠狀突次全切除術、PAUL手術",
        "  - UAP: 肘突固定或移除、尺骨截骨術",
        "  - OCD: 病灶清創",
        "  - 關節不協調: 尺骨/橈骨截骨術",
        "保守治療（輕度或老年）：",
        "  - 體重管理",
        "  - NSAIDs",
        "  - 關節保健品",
        "  - 物理治療",
        "  - 適度運動",
        "末期骨關節炎：關節置換或關節固定術"
      ]
    },
    prognosis: "早期手術治療預後較好，但多數犬仍會發展骨關節炎。晚期診斷或嚴重骨關節炎預後較保守。手術可減緩骨關節炎進展和改善功能。",
    pearls: [
      "X光可能漏診早期FCP，CT更敏感",
      "雙側病例需同時評估兩側",
      "術後仍需長期骨關節炎管理",
      "早期手術（<1歲）預後較佳",
      "繁殖犬應進行肘關節評估篩選"
    ],
    monitoring: ["跛行評分", "關節腫脹", "活動範圍", "X光追蹤", "生活品質"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  // ==================== 韌帶和軟骨疾病 ====================

  "cranial-cruciate-ligament-rupture": {
    zh: "前十字韌帶斷裂",
    en: "Cranial Cruciate Ligament Rupture",
    definition: "膝關節前十字韌帶（CCL/ACL）的部分或完全斷裂，導致關節不穩定、疼痛和繼發性骨關節炎。是犬後肢跛行最常見的骨科原因。",
    synonyms: ["CCL Rupture", "ACL Tear", "Cruciate Disease", "十字韌帶損傷", "前交叉韌帶斷裂"],
    epidemiology: {
      species: "犬常見，貓少見",
      age: "任何年齡，中年犬最常見（4-7歲）",
      sex: "已絕育動物風險較高",
      riskFactors: ["肥胖", "絕育", "品種傾向（Labrador、Rottweiler、Newfoundland、Staffordshire Terrier）", "膝關節結構異常（脛骨平台角度過陡）", "對側CCL斷裂史（40-60%會發生對側斷裂）"]
    },
    clinicalPresentation: {
      history: ["急性後肢跛行（可能在活動中突然發生）", "逐漸惡化的慢性跛行", "起立困難", "坐姿異常（患肢外伸）", "活動力下降", "常見雙側問題"],
      physicalExam: ["膝關節腫脹（尤其內側）", "抽屜試驗陽性（Cranial drawer test）", "脛骨前移試驗陽性（Tibial thrust test）", "膝關節活動時疼痛", "肌肉萎縮（股四頭肌）", "可能有半月板click", "坐姿時患肢外展"]
    },
    pathophysiology: "犬CCL斷裂主要是退化性疾病而非急性創傷（與人類不同）。韌帶退化 → 部分撕裂 → 完全斷裂 → 膝關節不穩定 → 異常負荷 → 軟骨損傷 + 半月板損傷 → 骨關節炎。脛骨平台角度過陡會增加韌帶負荷。",
    diagnosis: {
      overview: "臨床檢查（抽屜試驗）通常足以診斷，影像學用於評估骨關節炎和排除其他問題",
      differentials: ["髕骨脫位", "髖關節疾病", "腰薦椎疾病", "多發性關節炎", "骨腫瘤", "半月板損傷（可併發）"],
      initialDB: ["骨科檢查（抽屜試驗、脛骨前移試驗）", "膝關節X光（關節積液、骨關節炎）", "對側膝關節評估"],
      advanced: ["關節液分析", "MRI（評估半月板和部分撕裂）", "CT（手術計畫，測量脛骨平台角度）", "關節鏡"]
    },
    treatment: {
      overview: "手術治療是>15-20kg犬的首選；小型犬可考慮保守治療",
      acute: [
        "初期穩定：",
        "  - 休息和活動限制",
        "  - NSAIDs止痛",
        "  - 冰敷",
        "安排手術評估"
      ],
      chronic: [
        "手術治療（建議）：",
        "  - TPLO（Tibial Plateau Leveling Osteotomy）- 最常用",
        "  - TTA（Tibial Tuberosity Advancement）",
        "  - CBLO（CORA-Based Leveling Osteotomy）",
        "  - 關節外穩定術（小型犬，lateral suture）",
        "  - TightRope技術",
        "保守治療（<15kg或手術風險高）：",
        "  - 嚴格休息8-12週",
        "  - 體重控制",
        "  - NSAIDs",
        "  - 物理治療",
        "  - 護膝支架",
        "半月板損傷需同時處理"
      ]
    },
    prognosis: "手術治療成功率約90%，可恢復良好功能。保守治療小型犬預後較好，大型犬較差。40-60%犬會發生對側CCL斷裂。骨關節炎會持續進展但可良好管理。",
    pearls: [
      "部分撕裂可能抽屜試驗陰性",
      "鎮靜下檢查更準確",
      "X光看不到韌帶，但可見關節積液和骨關節炎",
      "術後對側預防性體重管理很重要",
      "半月板損傷會影響預後"
    ],
    monitoring: ["跛行評分", "肌肉量評估", "對側膝關節狀態", "體重", "骨關節炎進展"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  "patellar-luxation": {
    zh: "髕骨脫位",
    en: "Patellar Luxation",
    definition: "髕骨從股骨滑車溝脫出，可向內側（最常見）或外側脫位。是小型犬最常見的骨科問題之一。",
    synonyms: ["Luxating Patella", "Slipped Kneecap", "膝蓋骨脫臼", "髕骨脫臼"],
    epidemiology: {
      species: "犬常見，貓少見",
      age: "先天性或幼年發病，症狀可能到成年才明顯",
      sex: "無明顯性別傾向",
      riskFactors: ["小型犬種（Pomeranian、Chihuahua、Yorkshire Terrier、Toy/Miniature Poodle）", "內側脫位>外側", "大型犬外側脫位較多", "遺傳因素"]
    },
    clinicalPresentation: {
      history: ["間歇性後肢跛行（突然提腿、抖腿後恢復）", "「跳躍」步態", "內八或外八步態", "可能無症狀", "雙側常見"],
      physicalExam: ["髕骨可手動脫位和復位", "分級（Grade I-IV）", "股骨和脛骨可能變形", "膝關節可能有腫脹", "可能併發CCL損傷"]
    },
    pathophysiology: "先天性骨骼和軟組織發育異常 → 伸肌機制排列不正 → 髕骨被牽拉出滑車溝 → 反覆脫位 → 軟骨磨損 → 骨關節炎。內側脫位常伴隨股骨內翻、脛骨內旋、滑車溝變淺。",
    diagnosis: {
      overview: "觸診髕骨可脫位即可診斷，X光用於評估骨骼變形和手術計畫",
      differentials: ["前十字韌帶斷裂", "髖關節疾病", "股骨頭缺血性壞死（小型犬）", "脛骨骨折"],
      initialDB: ["骨科檢查和髕骨脫位分級", "膝關節X光（VD和lateral）", "評估骨骼變形程度"],
      advanced: ["CT（嚴重變形病例的手術計畫）", "評估CCL完整性"]
    },
    treatment: {
      overview: "Grade II以上有症狀的病例建議手術治療",
      acute: [
        "急性脫位無法復位：",
        "  - 可嘗試手動復位",
        "  - 休息",
        "  - 止痛藥物"
      ],
      chronic: [
        "分級治療建議：",
        "  - Grade I: 通常不需治療，監測",
        "  - Grade II: 若有症狀，建議手術",
        "  - Grade III-IV: 強烈建議手術",
        "手術技術組合：",
        "  - 滑車溝加深術（Trochleoplasty）",
        "  - 脛骨粗隆移位術（TTT）",
        "  - 關節囊縫縮術",
        "  - 外側或內側支持帶放鬆/緊縮",
        "  - 股骨/脛骨矯正截骨術（嚴重變形）",
        "保守治療（Grade I或手術禁忌）：",
        "  - 體重管理",
        "  - 適度運動",
        "  - 關節保健品",
        "  - NSAIDs（需要時）"
      ]
    },
    prognosis: "手術成功率約90%。Grade I-II預後優良，Grade III-IV預後良好但較高復發率。小型犬預後通常優於大型犬。",
    pearls: [
      "分級：I=可脫位可自動復位；II=可脫位需手動復位；III=持續脫位可手動復位；IV=永久脫位無法復位",
      "雙側手術可同時或分階段進行",
      "大型犬常需更複雜的矯正",
      "CCL損傷是常見併發症",
      "繁殖犬應進行篩選"
    ],
    monitoring: ["跛行評分", "髕骨穩定性", "骨關節炎進展", "對側狀態"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  "osteochondrosis-dissecans": {
    zh: "離斷性骨軟骨炎",
    en: "Osteochondrosis Dissecans (OCD)",
    definition: "軟骨內骨化過程異常，導致關節軟骨和軟骨下骨增厚、壞死，最終軟骨碎片剝離形成關節鼠。常見於肩關節，也可發生於肘、膝和跗關節。",
    synonyms: ["OCD", "Osteochondritis Dissecans", "骨軟骨炎", "離斷性骨軟骨病"],
    epidemiology: {
      species: "犬為主",
      age: "4-8月齡發病，症狀可能延遲出現",
      sex: "公犬較多（約2:1）",
      riskFactors: ["大型至巨型犬種（Labrador、Golden Retriever、Great Dane、Rottweiler）", "快速生長", "營養過剩（鈣、能量）", "遺傳因素"]
    },
    clinicalPresentation: {
      history: ["漸進性跛行", "運動後加重", "休息後改善", "肩關節OCD最常見（前肢跛行）", "可能雙側（25-50%）"],
      physicalExam: ["關節腫脹", "關節活動範圍受限", "完全伸展時疼痛", "肌肉萎縮", "肩OCD：肩關節外展和伸展時疼痛"]
    },
    pathophysiology: "遺傳因素 + 營養因素（過量鈣、能量） + 外傷 → 軟骨內骨化障礙 → 軟骨過度增厚 → 深層軟骨壞死 → 軟骨碎片剝離 → 關節鼠形成 → 關節炎症和骨關節炎。好發於承重區域的關節面。",
    diagnosis: {
      overview: "X光檢查可見軟骨下骨缺損，關節鏡是gold standard",
      differentials: ["肘關節發育不良", "泛骨炎", "肥厚性骨營養不良", "外傷性骨折", "感染性關節炎"],
      initialDB: ["骨科檢查", "病變關節X光（多角度）", "對側比較", "評估其他關節（常多發）"],
      advanced: ["關節鏡（診斷+治療）", "CT或MRI（評估病變範圍）", "關節液分析"]
    },
    treatment: {
      overview: "手術移除碎片是治療標準，尤其對於大型碎片和明顯跛行",
      acute: [
        "診斷確立後：",
        "  - 休息和活動限制",
        "  - NSAIDs止痛",
        "  - 安排手術"
      ],
      chronic: [
        "手術治療（首選）：",
        "  - 關節鏡碎片移除和病灶清創",
        "  - 開放性手術（無關節鏡時）",
        "  - OATs或軟骨移植（大範圍缺損）",
        "保守治療（無明顯碎片或手術禁忌）：",
        "  - 休息4-6週",
        "  - 體重管理",
        "  - NSAIDs",
        "  - 關節保健品",
        "  - 物理治療",
        "術後管理：",
        "  - 限制活動4-6週",
        "  - 物理治療",
        "  - 關節保健品"
      ]
    },
    prognosis: "肩關節OCD手術後預後優良（>90%功能恢復）。肘和跗關節預後較保守。早期診斷和治療預後較好。繼發性骨關節炎會持續進展。",
    pearls: [
      "肩關節OCD預後最好，膝關節最差",
      "雙側發病率高，應評估對側",
      "大型犬幼犬飲食應控制鈣和熱量",
      "X光「典型缺損」可能在病程後期才明顯",
      "關節鏡是診斷和治療的gold standard"
    ],
    monitoring: ["跛行評分", "關節活動範圍", "X光追蹤", "生活品質"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  // ==================== 發育性骨病 ====================

  "panosteitis": {
    zh: "泛骨炎",
    en: "Panosteitis",
    definition: "大型犬的自限性、自發性骨髓炎，特徵為長骨骨髓腔的炎症性病變，導致間歇性跛行。常稱為「生長痛」。",
    synonyms: ["Pano", "Enostosis", "Eosinophilic Panosteitis", "生長痛", "游走性跛行"],
    epidemiology: {
      species: "犬（大型犬）",
      age: "5-18月齡最常見，可達5歲",
      sex: "公犬較多（4:1）",
      riskFactors: ["大型犬種（German Shepherd最常見、Great Dane、Doberman、Golden Retriever、Labrador）", "快速生長期"]
    },
    clinicalPresentation: {
      history: ["急性跛行（單肢或多肢）", "「游走性」跛行（不同肢體輪流）", "發作性（好幾天後復發）", "可能發燒", "食慾下降", "活動力減低"],
      physicalExam: ["長骨觸診疼痛（尤其骨幹中段）", "輕度發燒", "跛行程度不一", "可能多肢同時或輪流受影響", "最常見尺骨，其次肱骨、股骨、脛骨、橈骨"]
    },
    pathophysiology: "病因不明。可能涉及：血管問題、代謝異常、感染、自體免疫。病理變化：骨髓腔脂肪細胞被纖維組織和新生骨取代 → 骨內壓增加 → 疼痛。是自限性疾病，通常會自行消退。",
    diagnosis: {
      overview: "臨床症狀結合典型X光表現可確診",
      differentials: ["肥厚性骨營養不良（HOD）", "骨髓炎", "骨腫瘤", "OCD", "肘/髖關節發育不良", "骨折"],
      initialDB: ["骨科檢查（長骨觸診）", "長骨X光（可能需要多次檢查）", "CBC（可能有輕度嗜酸性球增多）"],
      advanced: ["骨掃描（早期診斷）", "骨活檢（罕需要）"]
    },
    treatment: {
      overview: "支持性治療為主，疾病會自行消退",
      acute: [
        "止痛治療：",
        "  - NSAIDs: Carprofen 2.2 mg/kg PO q12h",
        "  - Meloxicam 0.1 mg/kg PO q24h",
        "休息（避免過度活動）",
        "發燒時支持照護"
      ],
      chronic: [
        "間歇性給予NSAIDs（症狀發作時）",
        "避免過度限制活動",
        "營養適當（避免過度營養）",
        "等待自然消退",
        "監測症狀變化"
      ]
    },
    prognosis: "預後優良。自限性疾病，通常在18-24月齡前自行消退。不會造成永久損傷。",
    pearls: [
      "典型X光：骨髓腔內不規則高密度影（棉花狀）",
      "X光變化可能落後臨床症狀2-3週",
      "「游走性」跛行是特徵",
      "German Shepherd是最常見品種",
      "不需要抗生素治療"
    ],
    monitoring: ["症狀發作頻率和嚴重度", "體重和生長", "X光追蹤（若診斷不確定）"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  "hypertrophic-osteodystrophy": {
    zh: "肥厚性骨營養不良",
    en: "Hypertrophic Osteodystrophy",
    definition: "大型犬幼犬的骨骼發育疾病，影響長骨生長板區域，特徵為生長板周圍的炎症和壞死。通常伴隨全身症狀。",
    synonyms: ["HOD", "Metaphyseal Osteopathy", "骨幹端骨病"],
    epidemiology: {
      species: "犬（大型至巨型犬）",
      age: "2-8月齡（快速生長期）",
      sex: "公犬略多",
      riskFactors: ["大型至巨型犬種（Great Dane、Weimaraner、Irish Setter、German Shepherd）", "營養過剩", "維生素C補充過量（有爭議）", "可能與某些疫苗相關"]
    },
    clinicalPresentation: {
      history: ["急性跛行（可多肢）", "發燒（常39.5-41°C）", "食慾不振", "嗜睡", "不願站立或行走", "四肢末端腫脹"],
      physicalExam: ["長骨骨幹端腫脹、溫熱、疼痛", "最常見橈/尺骨遠端、脛骨遠端", "高燒", "淋巴結腫大", "可能脫水", "可能有膿性眼鼻分泌物（嚴重病例）"]
    },
    pathophysiology: "病因不明，可能涉及：感染因素、免疫反應、營養因素。生長板附近的血管炎 → 血流中斷 → 骨組織壞死 → 炎症反應 → 骨幹端腫脹和疼痛。嚴重病例可能導致生長板損傷和骨骼畸形。",
    diagnosis: {
      overview: "典型臨床表現和X光變化可確診",
      differentials: ["泛骨炎", "骨髓炎", "肥厚性骨關節病（HPO）", "敗血性關節炎", "營養性繼發性甲狀旁腺功能亢進"],
      initialDB: ["骨科檢查", "長骨X光（尤其橈/尺骨、脛骨遠端）", "CBC（可能有白血球增多）", "生化（可能有低蛋白）"],
      advanced: ["血液培養（排除敗血症）", "關節液分析", "骨活檢（罕需要）"]
    },
    treatment: {
      overview: "主要為支持性治療，嚴重病例需積極介入",
      acute: [
        "止痛治療：",
        "  - NSAIDs: Carprofen或Meloxicam",
        "  - 嚴重病例可考慮短期類固醇",
        "輸液支持（脫水或發燒）",
        "營養支持",
        "舒適護理（軟墊、保溫）"
      ],
      chronic: [
        "飲食調整：",
        "  - 改為成犬飼料或控制熱量",
        "  - 避免額外鈣或維生素補充",
        "持續止痛管理",
        "監測生長板損傷",
        "限制過度活動",
        "復發時重新治療"
      ]
    },
    prognosis: "多數病例預後良好，會在數週內改善。嚴重或復發病例可能有骨骼變形後遺症。Weimaraner品種預後可能較差。",
    pearls: [
      "典型X光：生長板附近「雙線徵」（透亮線+硬化線）",
      "與泛骨炎不同：HOD有全身症狀、影響骨幹端",
      "不要額外補充鈣或維生素D",
      "Weimaraner可能有更嚴重的表現",
      "部分病例與犬瘟熱疫苗相關（仍有爭議）"
    ],
    monitoring: ["體溫", "食慾和體重", "跛行和疼痛程度", "X光追蹤（評估骨骼變形）"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  // ==================== 關節炎疾病 ====================

  "osteoarthritis": {
    zh: "骨關節炎",
    en: "Osteoarthritis",
    definition: "關節軟骨退化、關節周圍骨增生和滑膜炎的進行性退化性關節疾病。是犬貓最常見的慢性疼痛原因之一。也稱為退化性關節疾病(DJD)。",
    synonyms: ["OA", "Degenerative Joint Disease", "DJD", "退化性關節炎", "關節退化"],
    epidemiology: {
      species: "犬貓皆常見（犬20%，貓>60%老年貓）",
      age: "隨年齡增加，中老年最常見",
      sex: "無明顯性別傾向",
      riskFactors: ["年齡", "肥胖", "先前關節損傷/手術", "發育性疾病（髖/肘關節發育不良）", "關節不穩定（CCL斷裂）", "工作犬/運動犬"]
    },
    clinicalPresentation: {
      history: ["漸進性跛行", "起立困難（休息後僵硬）", "活動力下降", "上下樓梯困難", "跳躍減少", "「暖機」後改善", "天氣變化時加重", "貓：梳理減少、跳躍改變、如廁習慣改變"],
      physicalExam: ["關節腫脹（骨性或液體性）", "關節活動範圍減少", "活動時疼痛/不適", "肌肉萎縮", "骨贅形成（可觸及）", "關節不穩定（若有前置因素）"]
    },
    pathophysiology: "關節損傷或老化 → 軟骨基質降解（MMPs增加）→ 軟骨細胞死亡 → 軟骨變薄 → 軟骨下骨暴露 → 骨刺形成 → 滑膜炎症 → 關節囊纖維化 → 惡性循環。是不可逆的進行性疾病。",
    diagnosis: {
      overview: "根據臨床症狀和X光變化診斷",
      differentials: ["免疫介導性多發性關節炎", "感染性關節炎", "腫瘤性關節疾病", "神經性疼痛", "軟組織損傷"],
      initialDB: ["完整骨科檢查", "受影響關節X光", "CBC和生化（使用NSAIDs前基線）"],
      advanced: ["關節液分析（排除感染或免疫性）", "進階影像（MRI）", "關節鏡"]
    },
    treatment: {
      overview: "多模式治療：體重管理、運動調整、止痛藥物、營養補充、物理治療",
      acute: [
        "急性發作管理：",
        "  - 休息和活動限制",
        "  - NSAIDs: Carprofen、Meloxicam、Robenacoxib（貓）",
        "  - 冰敷",
        "  - 可考慮短期Tramadol輔助"
      ],
      chronic: [
        "核心治療：",
        "  - 體重管理（最重要）",
        "  - 適度運動（規律、低衝擊）",
        "  - 環境調整（軟墊、坡道、低矮貓砂盆）",
        "藥物治療：",
        "  - NSAIDs長期使用（定期監測肝腎）",
        "  - Librela（bedinvetmab，抗NGF抗體）：犬每月注射",
        "  - Solensia（frunevetmab）：貓每月注射",
        "  - Gabapentin: 5-10 mg/kg q8-12h（神經性疼痛）",
        "  - Amantadine: 3-5 mg/kg q24h（NMDA拮抗）",
        "營養補充：",
        "  - Omega-3脂肪酸（EPA/DHA）",
        "  - Glucosamine/Chondroitin",
        "  - 處方關節飲食",
        "物理治療：",
        "  - 水療（游泳、水中跑步機）",
        "  - 物理復健",
        "  - 針灸（可考慮）",
        "關節注射：",
        "  - 關節內類固醇（慎用）",
        "  - PRP、幹細胞治療（新興）"
      ]
    },
    prognosis: "無法治癒但可良好管理。多數動物經適當治療可維持良好生活品質。體重控制是最有效的介入措施。",
    pearls: [
      "貓的OA被嚴重低估，常誤認為「正常老化」",
      "X光變化與臨床症狀不一定相關",
      "多模式治療比單一藥物更有效",
      "Librela/Solensia是安全有效的新選擇",
      "定期監測NSAIDs的肝腎影響"
    ],
    monitoring: ["疼痛評分", "活動力/生活品質評估", "體重", "肝腎功能（使用NSAIDs時）", "X光追蹤（病程進展）"],
    reference: "Lascelles BD, et al: Joint diseases in canine and feline. JAAHA 55:1-10, 2019"
  },

  "immune-mediated-polyarthritis": {
    zh: "免疫介導性多發性關節炎",
    en: "Immune-Mediated Polyarthritis",
    definition: "免疫系統攻擊關節滑膜導致的非侵蝕性或侵蝕性多發性關節炎。可為原發性（特發性）或繼發於感染、腫瘤或藥物。",
    synonyms: ["IMPA", "Idiopathic Polyarthritis", "免疫性關節炎", "多發性關節炎"],
    epidemiology: {
      species: "犬較常見，貓也可發生",
      age: "任何年齡，年輕至中年成犬最常見",
      sex: "某些類型公犬較多",
      riskFactors: ["品種傾向（Shar-Pei、Akita、German Shepherd、Boxer）", "慢性感染", "腫瘤", "某些藥物", "疫苗接種後"]
    },
    clinicalPresentation: {
      history: ["多關節跛行（常移行性）", "僵硬（尤其休息後）", "發燒", "食慾減退", "嗜睡", "不願行走", "症狀可能時好時壞"],
      physicalExam: ["多個關節腫脹、溫熱", "關節活動時疼痛", "常見腕、跗、膝、肘關節", "發燒", "淋巴結腫大", "可能有原發病的其他發現"]
    },
    pathophysiology: "免疫複合物沉積於滑膜 → 補體活化 → 發炎細胞浸潤 → 滑膜炎症 → 關節積液和疼痛。非侵蝕性不破壞軟骨；侵蝕性（如類風濕）會破壞軟骨和骨。繼發性IMPA需尋找潛在觸發因素。",
    diagnosis: {
      overview: "關節液分析是診斷關鍵，需排除感染和尋找繼發原因",
      differentials: ["敗血性/感染性關節炎", "萊姆病關節炎", "骨關節炎", "離斷性骨軟骨炎", "全身性紅斑狼瘡", "類風濕關節炎"],
      initialDB: ["完整骨科檢查", "多關節X光", "關節液分析（多個關節）", "CBC和生化", "尿液分析"],
      advanced: ["ANA、RF檢測", "傳染病篩檢（Borrelia、Ehrlichia等）", "胸腹X光/超音波（尋找腫瘤/感染源）", "關節液培養", "骨活檢（侵蝕性病例）"]
    },
    treatment: {
      overview: "免疫抑制治療，同時尋找並治療繼發原因",
      acute: [
        "免疫抑制治療：",
        "  - Prednisolone: 2-4 mg/kg/day PO（初始劑量）",
        "  - 分1-2次給予",
        "止痛輔助（若需要）：",
        "  - 避免同時使用NSAIDs和類固醇",
        "繼發性IMPA需同時治療原發病"
      ],
      chronic: [
        "緩慢減量類固醇：",
        "  - 症狀緩解後2-4週開始減量",
        "  - 每2-4週減25%",
        "  - 目標：最低有效劑量或停藥",
        "若類固醇反應差或需長期高劑量：",
        "  - Azathioprine: 2 mg/kg PO q24h（犬）",
        "  - Cyclosporine: 5 mg/kg PO q12-24h",
        "  - Leflunomide: 2-4 mg/kg PO q24h",
        "  - Mycophenolate: 10 mg/kg PO q12h",
        "侵蝕性關節炎可能需要更積極治療"
      ]
    },
    prognosis: "原發性IMPA預後通常良好，多數可達緩解（約70%）。繼發性預後取決於原發病。侵蝕性（類風濕）預後較差。復發常見，可能需長期低劑量維持。",
    pearls: [
      "關節液：典型為非感染性炎症（WBC升高，以中性球為主，無細菌）",
      "Shar-Pei可能有特殊的反覆發燒多發性關節炎",
      "排除感染非常重要（培養！）",
      "藥物誘發型停藥後可能改善",
      "監測類固醇副作用（PU/PD、肝酶升高）"
    ],
    monitoring: ["臨床症狀", "關節液分析（追蹤）", "CBC和生化", "尿液", "類固醇副作用"],
    reference: "Ettinger SJ, Feldman EC: Textbook of Veterinary Internal Medicine, 8th Ed. Elsevier, 2017"
  },

  "septic-arthritis": {
    zh: "化膿性關節炎",
    en: "Septic Arthritis",
    definition: "關節內細菌感染導致的急性炎症性關節疾病。可經血行播散、直接穿刺傷、手術後感染或鄰近組織感染蔓延。屬於骨科急症。",
    synonyms: ["Infectious Arthritis", "Bacterial Arthritis", "感染性關節炎", "關節感染"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["穿刺傷/咬傷", "關節手術後", "免疫抑制", "糖尿病", "菌血症", "慢性關節病"]
    },
    clinicalPresentation: {
      history: ["急性單關節（偶多關節）跛行", "快速進展", "可能有外傷史或近期手術", "發燒", "食慾不振", "不願活動"],
      physicalExam: ["關節明顯腫脹、溫熱", "劇烈疼痛（不願觸碰）", "關節活動嚴重受限", "可能有傷口或瘻管", "發燒", "全身不適"]
    },
    pathophysiology: "細菌進入關節腔 → 快速增殖 → 急性滑膜炎 → 膿性關節積液 → 細菌酵素和炎症介質破壞軟骨 → 軟骨下骨感染 → 骨髓炎。若未及時治療，可在數天內造成不可逆軟骨損傷。",
    diagnosis: {
      overview: "關節液分析和培養是診斷關鍵，需緊急處理",
      differentials: ["免疫介導性關節炎", "痛風性關節炎", "外傷性關節炎", "腫瘤"],
      initialDB: ["關節液分析（細胞學、培養）", "受影響關節X光", "CBC和生化", "尿液分析"],
      advanced: ["血液培養", "關節液PCR（Mycoplasma等）", "進階影像（CT/MRI評估骨髓炎）"]
    },
    treatment: {
      overview: "緊急關節沖洗/清創和全身性抗生素是治療關鍵",
      acute: [
        "關節沖洗/清創：",
        "  - 關節鏡沖洗（首選）",
        "  - 開放性關節切開沖洗",
        "  - 多次沖洗可能需要",
        "經驗性抗生素（培養結果前）：",
        "  - Amoxicillin-Clavulanate 12.5-25 mg/kg PO q12h",
        "  - 或 Cefazolin 22 mg/kg IV q8h（住院時）",
        "  - 根據培養結果調整",
        "止痛（NSAIDs或opioids）",
        "輸液支持"
      ],
      chronic: [
        "抗生素治療療程：",
        "  - 至少4-6週",
        "  - 根據培養/藥敏結果選擇",
        "常見致病菌：Staphylococcus、Streptococcus、E. coli、Pasteurella",
        "關節功能評估",
        "物理治療（感染控制後）",
        "骨髓炎需更長療程"
      ]
    },
    prognosis: "早期診斷和治療預後良好。延遲治療或已有軟骨損傷預後較差。術後感染需取出植入物。骨髓炎可能需要數月治療。",
    pearls: [
      "時間就是軟骨！需緊急處理",
      "關節液：細胞數通常>40,000-100,000/μL，大量退化性中性球",
      "X光早期可能正常，骨溶解需7-14天才顯現",
      "培養陰性不排除感染（可能已用過抗生素）",
      "單次關節穿刺可能不足以控制感染"
    ],
    monitoring: ["臨床改善", "發燒消退", "關節液分析追蹤", "X光（骨髓炎監測）", "白血球和炎症指標"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  // ==================== 骨骼疾病 ====================

  "bone-fracture": {
    zh: "骨折",
    en: "Bone Fracture",
    definition: "骨骼結構的連續性中斷。可為外傷性或病理性，依骨折型態、位置和嚴重程度分類。是小動物最常見的骨科急症之一。",
    synonyms: ["Fracture", "骨裂", "斷骨"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "任何年齡，幼年和老年動物可能更易骨折",
      sex: "無明顯性別傾向",
      riskFactors: ["外傷（車禍、墜落、被踩）", "病理性因素（骨腫瘤、代謝性骨病）", "高樓墜落（貓）", "激烈活動"]
    },
    clinicalPresentation: {
      history: ["明確外傷事件", "急性跛行或不負重", "受傷肢體腫脹", "可能有外傷可見", "開放性骨折可見骨頭露出"],
      physicalExam: ["疼痛（觸診或負重）", "腫脹", "異常活動或角度", "骨摩擦音（crepitus）", "開放性傷口（開放性骨折）", "神經血管評估", "全身外傷評估"]
    },
    pathophysiology: "外力超過骨骼承受能力 → 骨折。骨折癒合過程：血腫形成 → 炎症期 → 軟骨痂形成 → 硬骨痂形成 → 骨重塑。幼年動物癒合較快。病理性骨折因骨質已弱化而在輕微外力下發生。",
    diagnosis: {
      overview: "X光檢查是診斷標準，需評估骨折類型和制定治療計畫",
      differentials: ["關節脫位", "韌帶損傷", "軟組織損傷", "病理性骨折（需查原因）"],
      initialDB: ["完整外傷評估（ABCDE）", "受傷部位X光（至少2個角度）", "全身評估（多發外傷）"],
      advanced: ["CT（複雜骨折的手術計畫）", "骨折處活檢（懷疑病理性時）"]
    },
    treatment: {
      overview: "根據骨折類型、位置、患者因素選擇保守或手術治療",
      acute: [
        "急救穩定：",
        "  - ABCDE評估",
        "  - 止痛：Opioids（Methadone 0.1-0.5 mg/kg）",
        "  - 休克治療（若需要）",
        "  - 傷口處理（開放性骨折）",
        "骨折暫時固定：",
        "  - Robert Jones繃帶",
        "  - 夾板固定",
        "開放性骨折需緊急手術和抗生素"
      ],
      chronic: [
        "保守治療（適用於某些骨折）：",
        "  - 外固定：夾板、石膏（僅限肘/膝以下）",
        "  - 嚴格籠養休息4-8週",
        "手術治療（多數骨折首選）：",
        "  - 骨板固定（最常用）",
        "  - 髓內釘",
        "  - 外固定架",
        "  - 鋼絲/環扎",
        "  - 互鎖髓內釘",
        "術後管理：",
        "  - 止痛",
        "  - 活動限制",
        "  - 物理治療（適時開始）",
        "  - X光追蹤癒合"
      ]
    },
    prognosis: "多數骨折經適當治療可良好癒合。年輕動物預後較好。開放性、粉碎性或關節內骨折預後較保守。病理性骨折需同時處理原發病。",
    pearls: [
      "開放性骨折分級：I=皮膚小傷口，II=軟組織損傷較大，III=嚴重軟組織損傷/污染",
      "開放性骨折需立即抗生素和清創",
      "生長板骨折需特別注意，可能影響生長",
      "病理性骨折要找原因（腫瘤！）",
      "癒合時間：幼犬2-4週，成犬6-12週，老年犬可能更久"
    ],
    monitoring: ["疼痛評估", "X光追蹤（每4-6週）", "傷口護理（手術/開放傷口）", "功能恢復"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  "avascular-necrosis-femoral-head": {
    zh: "股骨頭缺血性壞死",
    en: "Avascular Necrosis of Femoral Head",
    definition: "股骨頭血液供應中斷導致的缺血性壞死，造成股骨頭塌陷和髖關節破壞。主要影響小型犬幼犬。也稱為Legg-Calve-Perthes病。",
    synonyms: ["Legg-Calve-Perthes Disease", "LCPD", "Aseptic Necrosis of Femoral Head", "股骨頭壞死"],
    epidemiology: {
      species: "犬（小型犬）",
      age: "4-12月齡",
      sex: "無明顯性別傾向",
      riskFactors: ["小型犬種（Yorkshire Terrier、Miniature Pinscher、Pomeranian、Toy Poodle、West Highland White Terrier）", "遺傳因素"]
    },
    clinicalPresentation: {
      history: ["漸進性後肢跛行", "單側為主（10-15%雙側）", "運動後加重", "患肢肌肉萎縮", "症狀發展數週到數月"],
      physicalExam: ["髖關節活動時疼痛", "外展和伸展時尤其疼痛", "患肢肌肉萎縮", "髖關節活動範圍可能受限", "可能有骨摩擦音"]
    },
    pathophysiology: "股骨頭骨骺血液供應中斷（原因不明，可能涉及遺傳和解剖因素）→ 股骨頭骨骺缺血壞死 → 骨吸收和弱化 → 在正常負重下塌陷和變形 → 繼發性骨關節炎。與人類的Legg-Calve-Perthes病類似。",
    diagnosis: {
      overview: "X光檢查可見典型股骨頭變化",
      differentials: ["髖關節發育不良", "髖關節脫位", "股骨頸骨折", "敗血性關節炎"],
      initialDB: ["骨科檢查", "髖關節X光（伸展位）", "對側比較", "評估塌陷程度"],
      advanced: ["CT（評估塌陷範圍）", "MRI（早期診斷）"]
    },
    treatment: {
      overview: "手術治療是標準療法，保守治療效果有限",
      acute: [
        "止痛管理：",
        "  - NSAIDs",
        "休息和活動限制",
        "安排手術評估"
      ],
      chronic: [
        "手術治療（首選）：",
        "  - FHO（Femoral Head and Neck Ostectomy）- 最常用",
        "  - THR（Total Hip Replacement）- 較少用於小型犬",
        "保守治療（限特定情況）：",
        "  - 嚴格籠養休息",
        "  - 止痛藥物",
        "  - 物理治療",
        "  - 效果通常不佳",
        "術後復健：",
        "  - 早期物理治療很重要",
        "  - 被動活動範圍訓練",
        "  - 游泳",
        "  - 漸進式負重"
      ]
    },
    prognosis: "FHO手術預後通常優良，小型犬術後功能恢復良好。術後積極復健可改善結果。保守治療預後較差。",
    pearls: [
      "典型X光：股骨頭不規則、密度不均、塌陷、關節間隙增寬",
      "早期X光可能正常",
      "與髖關節發育不良不同：LCPD發生在小型犬、單側為主",
      "FHO後需要積極物理治療",
      "遺傳性疾病，繁殖犬應排除"
    ],
    monitoring: ["跛行改善", "肌肉量恢復", "活動範圍", "X光追蹤（保守治療時）"],
    reference: "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },

  // ==================== 脊椎疾病 ====================

  "wobbler-syndrome": {
    zh: "搖擺症候群",
    en: "Wobbler Syndrome",
    definition: "頸椎脊髓壓迫導致的神經功能障礙，表現為步態不協調（共濟失調）。主要有兩種類型：骨性壓迫（大型犬幼犬）和椎間盤突出相關（大型犬成犬）。",
    synonyms: ["Cervical Spondylomyelopathy", "CSM", "Cervical Vertebral Instability", "CVI", "頸椎脊髓病變", "頸椎不穩定"],
    epidemiology: {
      species: "犬（大型至巨型犬）",
      age: "骨性壓迫型：<3歲；椎間盤型：>5歲",
      sex: "公犬較多",
      riskFactors: ["品種傾向（Great Dane、Doberman Pinscher、Mastiff）", "快速生長", "營養過剩（幼犬時期）"]
    },
    clinicalPresentation: {
      history: ["漸進性後肢無力和共濟失調", "步態不協調（搖擺步態）", "後肢比前肢症狀明顯", "頸部可能僵硬或疼痛", "可能跌倒", "嚴重可發展為四肢癱瘓"],
      physicalExam: ["後肢本體感覺遲鈍", "後肢共濟失調步態", "可能四肢都有症狀（但後肢較重）", "頸部過度伸展或屈曲可能誘發或加重症狀", "脊髓反射可能增強（UMN徵象）", "肌肉萎縮（慢性）"]
    },
    pathophysiology: "頸椎骨異常/椎間盤突出/韌帶肥厚 → 頸椎脊髓壓迫 → 脊髓損傷 → 步態異常和神經功能障礙。Great Dane多為骨性壓迫（C3-C5）；Doberman多為椎間盤突出相關（C5-C7）。慢性壓迫導致脊髓萎縮。",
    diagnosis: {
      overview: "MRI是診斷gold standard，可同時評估脊髓和周圍結構",
      differentials: ["椎間盤疾病", "脊髓腫瘤", "纖維軟骨栓塞", "退化性脊髓病變", "脊椎不穩定/骨折", "椎間盤脊椎炎"],
      initialDB: ["完整神經學檢查", "頸椎X光（篩檢，但敏感度有限）", "排除其他代謝問題"],
      advanced: ["頸椎MRI（首選）", "CT/脊髓造影", "動態研究（屈曲/伸展位）", "腦脊液分析"]
    },
    treatment: {
      overview: "根據壓迫類型和嚴重程度選擇保守或手術治療",
      acute: [
        "保守治療（輕度病例）：",
        "  - 嚴格籠養休息",
        "  - 頸圈限制頸部活動",
        "  - NSAIDs或類固醇（短期）",
        "  - 體重管理"
      ],
      chronic: [
        "保守治療（持續）：",
        "  - 活動限制",
        "  - 體重控制",
        "  - 物理治療",
        "  - 止痛管理",
        "  - 約50%輕度病例可改善",
        "手術治療（中重度或進行性）：",
        "  - 腹側減壓術（ventral slot）",
        "  - 椎間盤開窗術",
        "  - 椎體融合術/椎間墊片",
        "  - 背側椎板切除術（dorsal laminectomy）",
        "術後管理：",
        "  - 密切神經監測",
        "  - 物理治療",
        "  - 活動限制8-12週"
      ]
    },
    prognosis: "保守治療約50%短期改善，但常復發或惡化。手術成功率約70-80%，但併發症風險存在。嚴重脊髓損傷或多節段病變預後較差。",
    pearls: [
      "Great Dane和Doberman是最常見品種，但表現不同",
      "X光敏感度有限，MRI是診斷標準",
      "「搖擺」步態是特徵，後肢比前肢明顯",
      "手術可能導致鄰近節段加速退化（domino lesion）",
      "幼犬營養管理可能有預防作用"
    ],
    monitoring: ["神經學狀態", "步態改善", "疼痛控制", "MRI追蹤（保守治療時）"],
    reference: "Dewey CW, da Costa RC: Practical Guide to Canine and Feline Neurology, 3rd Ed. Wiley-Blackwell, 2016"
  },

  "atlantoaxial-subluxation": {
    zh: "寰樞椎半脫位",
    en: "Atlantoaxial Subluxation",
    definition: "第一頸椎（寰椎）和第二頸椎（樞椎）之間的不穩定或半脫位，導致脊髓壓迫。主要是先天性發育異常，好發於小型犬。可能危及生命。",
    synonyms: ["AA Subluxation", "AA Instability", "Atlantoaxial Instability", "寰樞關節不穩定", "C1-C2不穩定"],
    epidemiology: {
      species: "犬（小型犬為主）",
      age: "先天性病例多在<2歲發病，外傷性可任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["小型犬種（Yorkshire Terrier、Pomeranian、Chihuahua、Toy Poodle）", "先天性齒突發育不全或缺如", "韌帶發育不良", "外傷"]
    },
    clinicalPresentation: {
      history: ["急性或慢性頸部疼痛", "頭部姿勢異常（低頭或仰頭）", "四肢無力或癱瘓", "步態不協調", "可能因輕微外傷或正常活動誘發", "嚴重可呼吸困難或猝死"],
      physicalExam: ["頸部疼痛（觸診或移動時）", "抗拒頸部檢查", "四肢本體感覺異常", "四肢共濟失調或癱瘓", "可能有UMN徵象（四肢反射增強）", "嚴重可能呼吸異常"]
    },
    pathophysiology: "齒突（dens）發育不全/缺如 + 橫韌帶發育不良 → 寰樞椎關節不穩定 → 樞椎向腹側移位 → 頸髓（C1-C2節段）壓迫 → 四肢癱瘓。此節段脊髓包含呼吸中樞，嚴重壓迫可致死。",
    diagnosis: {
      overview: "X光可見典型變化，但操作需極度小心",
      differentials: ["頸椎椎間盤疾病", "頸椎骨折/脫位", "寰枕畸形", "脊椎腫瘤"],
      initialDB: ["神經學檢查", "頸椎X光（側位，neutral position；小心操作！）", "避免過度屈曲頸部"],
      advanced: ["CT（評估骨性結構）", "MRI（評估脊髓和韌帶）", "屈曲位X光（風險高，需鎮靜和小心操作）"]
    },
    treatment: {
      overview: "手術穩定是中重度病例的標準治療，輕度可嘗試保守",
      acute: [
        "緊急穩定：",
        "  - 嚴格限制頸部活動",
        "  - 頸部夾板或支架固定",
        "  - 止痛：Opioids（避免過度鎮靜導致頸部塌陷）",
        "  - 類固醇（脊髓水腫）：Methylprednisolone 30 mg/kg IV或Dexamethasone 0.2-0.5 mg/kg IV",
        "  - 緊急手術評估"
      ],
      chronic: [
        "保守治療（輕度或手術風險高）：",
        "  - 頸部夾板固定6-12週",
        "  - 嚴格籠養",
        "  - 避免頸圈（改用胸背帶）",
        "  - 成功率約30-60%",
        "手術治療（首選，中重度）：",
        "  - 腹側穩定術（ventral stabilization）",
        "  - 背側穩定術",
        "  - 骨水泥或螺釘固定",
        "術後管理：",
        "  - 頸部固定4-8週",
        "  - 活動限制",
        "  - 物理治療（穩定後）"
      ]
    },
    prognosis: "保守治療復發率高。手術成功率約80-90%，但小型犬手術風險較高。輕度病例預後較好。嚴重脊髓損傷預後謹慎。",
    pearls: [
      "這是潛在致命的疾病，處理需極度小心",
      "X光檢查時避免屈曲頸部！可能加重脫位",
      "術後頸部固定很重要",
      "小型犬使用胸背帶而非頸圈",
      "先天性病例可能伴隨其他畸形（水腦等）"
    ],
    monitoring: ["神經學狀態", "呼吸功能", "X光追蹤（穩定性）", "疼痛控制"],
    reference: "Dewey CW, da Costa RC: Practical Guide to Canine and Feline Neurology, 3rd Ed. Wiley-Blackwell, 2016"
  },

  "lumbosacral-disease": {
    zh: "腰薦椎疾病",
    en: "Lumbosacral Disease",
    definition: "腰薦椎交界處（L7-S1）的退化性病變，導致馬尾神經壓迫，表現為後肢和尾部神經功能障礙。也稱為退化性腰薦椎狹窄或馬尾症候群。",
    synonyms: ["Degenerative Lumbosacral Stenosis", "Cauda Equina Syndrome", "Lumbosacral Stenosis", "LS Disease", "馬尾症候群", "腰薦椎狹窄"],
    epidemiology: {
      species: "犬（中大型犬）",
      age: "中老年（>5歲）",
      sex: "公犬較多",
      riskFactors: ["大型犬種（German Shepherd最常見、Rottweiler、Boxer）", "工作犬/警犬", "肥胖", "先天性腰薦椎移行椎"]
    },
    clinicalPresentation: {
      history: ["後肢跛行或無力", "起立困難", "上下樓梯、跳躍困難", "尾巴下垂或活動減少", "排尿/排便問題（重度）", "自殘舔尾部或後肢", "症狀可能時好時壞"],
      physicalExam: ["腰薦椎區域觸診疼痛", "背部伸展（lordosis）時疼痛", "尾巴張力減弱", "後肢本體感覺可能正常或異常", "膝蓋和跟腱反射通常正常", "會陰反射可能減弱", "肛門張力可能減弱"]
    },
    pathophysiology: "L7-S1椎間盤退化 + 椎間關節病變 + 韌帶肥厚 → 椎管狹窄 → 馬尾神經（坐骨神經、陰部神經、尾神經）壓迫 → 後肢疼痛、無力和自主神經功能障礙。與人類的腰椎管狹窄類似。",
    diagnosis: {
      overview: "MRI是診斷gold standard，X光價值有限",
      differentials: ["髖關節疾病", "前十字韌帶斷裂", "退化性脊髓病變", "腰椎椎間盤疾病", "脊髓腫瘤", "前列腺疾病"],
      initialDB: ["完整神經學檢查", "腰薦椎X光（評估結構異常）", "直腸檢查（前列腺、薦骨）"],
      advanced: ["腰薦椎MRI（首選）", "CT/脊髓造影", "肌電圖（EMG）", "動態屈曲/伸展研究"]
    },
    treatment: {
      overview: "根據症狀嚴重度選擇保守或手術治療",
      acute: [
        "保守治療（輕中度）：",
        "  - 嚴格休息4-6週",
        "  - NSAIDs: Carprofen或Meloxicam",
        "  - Gabapentin: 5-10 mg/kg PO q8h（神經痛）",
        "  - 體重管理",
        "  - 避免跳躍、爬樓梯"
      ],
      chronic: [
        "保守治療（持續）：",
        "  - 物理治療和復健",
        "  - 體重控制",
        "  - 適度運動（游泳）",
        "  - 止痛藥物（長期）",
        "  - 針灸（可考慮）",
        "  - 約50%病例可暫時改善",
        "手術治療（重度或保守治療失敗）：",
        "  - 背側椎板切除術（dorsal laminectomy）",
        "  - 椎間孔擴大術",
        "  - 椎間盤切除術",
        "  - 椎體固定術（嚴重不穩定）",
        "術後管理：",
        "  - 活動限制6-8週",
        "  - 物理治療",
        "  - 持續體重管理"
      ]
    },
    prognosis: "保守治療約50%可短期改善，但常復發。手術成功率約70-90%。有大小便失禁者預後較差。早期治療預後較好。",
    pearls: [
      "X光變化與臨床症狀相關性差",
      "MRI可見典型的椎間盤突出和椎管狹窄",
      "German Shepherd是最常見品種",
      "區分LMN（馬尾）和UMN（脊髓）徵象很重要",
      "移行椎可能是發病因素"
    ],
    monitoring: ["疼痛評估", "神經功能（大小便、尾巴、後肢）", "活動力和生活品質", "體重"],
    reference: "Dewey CW, da Costa RC: Practical Guide to Canine and Feline Neurology, 3rd Ed. Wiley-Blackwell, 2016"
  }

};
const MUSCULOSKELETAL_DISEASE_ALIASES = {
  // 髖關節發育不良
  "髖關節發育不良": "hip-dysplasia",
  "髖關節發育不全": "hip-dysplasia",
  "髖關節形成不良": "hip-dysplasia",
  "CHD": "hip-dysplasia",
  "hip dysplasia": "hip-dysplasia",
  "canine hip dysplasia": "hip-dysplasia",

  // 肘關節發育不良
  "肘關節發育不良": "elbow-dysplasia",
  "肘關節發育不全": "elbow-dysplasia",
  "肘關節形成不良": "elbow-dysplasia",
  "ED": "elbow-dysplasia",
  "elbow dysplasia": "elbow-dysplasia",

  // 前十字韌帶斷裂
  "前十字韌帶斷裂": "cranial-cruciate-ligament-rupture",
  "十字韌帶損傷": "cranial-cruciate-ligament-rupture",
  "前交叉韌帶斷裂": "cranial-cruciate-ligament-rupture",
  "CCL斷裂": "cranial-cruciate-ligament-rupture",
  "ACL斷裂": "cranial-cruciate-ligament-rupture",
  "CCL rupture": "cranial-cruciate-ligament-rupture",
  "ACL tear": "cranial-cruciate-ligament-rupture",
  "cruciate disease": "cranial-cruciate-ligament-rupture",

  // 髕骨脫位
  "髕骨脫位": "patellar-luxation",
  "髕骨脫臼": "patellar-luxation",
  "膝蓋骨脫臼": "patellar-luxation",
  "luxating patella": "patellar-luxation",
  "patellar luxation": "patellar-luxation",

  // 離斷性骨軟骨炎
  "離斷性骨軟骨炎": "osteochondrosis-dissecans",
  "骨軟骨炎": "osteochondrosis-dissecans",
  "離斷性骨軟骨病": "osteochondrosis-dissecans",
  "OCD": "osteochondrosis-dissecans",
  "osteochondritis dissecans": "osteochondrosis-dissecans",

  // 泛骨炎
  "泛骨炎": "panosteitis",
  "生長痛": "panosteitis",
  "游走性跛行": "panosteitis",
  "pano": "panosteitis",
  "enostosis": "panosteitis",

  // 肥厚性骨營養不良
  "肥厚性骨營養不良": "hypertrophic-osteodystrophy",
  "骨幹端骨病": "hypertrophic-osteodystrophy",
  "HOD": "hypertrophic-osteodystrophy",
  "metaphyseal osteopathy": "hypertrophic-osteodystrophy",

  // 骨關節炎
  "骨關節炎": "osteoarthritis",
  "退化性關節炎": "osteoarthritis",
  "關節退化": "osteoarthritis",
  "OA": "osteoarthritis",
  "DJD": "osteoarthritis",
  "degenerative joint disease": "osteoarthritis",

  // 免疫介導性多發性關節炎
  "免疫介導性多發性關節炎": "immune-mediated-polyarthritis",
  "免疫性關節炎": "immune-mediated-polyarthritis",
  "多發性關節炎": "immune-mediated-polyarthritis",
  "IMPA": "immune-mediated-polyarthritis",
  "idiopathic polyarthritis": "immune-mediated-polyarthritis",

  // 化膿性關節炎
  "化膿性關節炎": "septic-arthritis",
  "感染性關節炎": "septic-arthritis",
  "關節感染": "septic-arthritis",
  "septic arthritis": "septic-arthritis",
  "infectious arthritis": "septic-arthritis",

  // 骨折
  "骨折": "bone-fracture",
  "骨裂": "bone-fracture",
  "斷骨": "bone-fracture",
  "fracture": "bone-fracture",

  // 股骨頭缺血性壞死
  "股骨頭缺血性壞死": "avascular-necrosis-femoral-head",
  "股骨頭壞死": "avascular-necrosis-femoral-head",
  "Legg-Calve-Perthes": "avascular-necrosis-femoral-head",
  "LCPD": "avascular-necrosis-femoral-head",
  "aseptic necrosis femoral head": "avascular-necrosis-femoral-head",

  // 搖擺症候群
  "搖擺症候群": "wobbler-syndrome",
  "頸椎脊髓病變": "wobbler-syndrome",
  "頸椎不穩定": "wobbler-syndrome",
  "wobbler": "wobbler-syndrome",
  "CSM": "wobbler-syndrome",
  "CVI": "wobbler-syndrome",
  "cervical spondylomyelopathy": "wobbler-syndrome",

  // 寰樞椎半脫位
  "寰樞椎半脫位": "atlantoaxial-subluxation",
  "寰樞關節不穩定": "atlantoaxial-subluxation",
  "C1-C2不穩定": "atlantoaxial-subluxation",
  "AA subluxation": "atlantoaxial-subluxation",
  "atlantoaxial instability": "atlantoaxial-subluxation",

  // 腰薦椎疾病
  "腰薦椎疾病": "lumbosacral-disease",
  "馬尾症候群": "lumbosacral-disease",
  "腰薦椎狹窄": "lumbosacral-disease",
  "LS disease": "lumbosacral-disease",
  "cauda equina syndrome": "lumbosacral-disease",
  "lumbosacral stenosis": "lumbosacral-disease"
  // ===== From hematological-diseases.js =====
  "immune-mediated-thrombocytopenia": {
    zh: "免疫介導性血小板減少",
    en: "Immune-Mediated Thrombocytopenia (ITP)",
    definition: "免疫系統產生針對自身血小板的抗體，導致血小板過早破壞和血小板計數嚴重下降的自體免疫疾病。",
    synonyms: ["ITP", "IMT", "Idiopathic Thrombocytopenic Purpura", "自發性血小板減少性紫癜", "免疫性血小板減少症"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "中年犬（平均5-6歲）",
      sex: "母犬發病率略高",
      riskFactors: ["可卡犬", "古代牧羊犬", "貴賓犬", "德國牧羊犬", "近期疫苗接種", "近期感染", "藥物反應", "腫瘤"]
    },
    clinicalPresentation: {
      history: ["瘀斑或瘀點", "牙齦出血", "鼻出血", "血尿或黑便", "嗜睡", "食慾下降"],
      physicalExam: ["瘀點（針尖狀出血點）", "瘀斑（皮膚大片出血）", "黏膜出血", "視網膜出血", "黏膜蒼白（若有顯著失血）", "脾腫大（部分病例）"]
    },
    pathophysiology: "抗血小板抗體（主要IgG）→ 結合血小板表面 → 網狀內皮系統（主要脾臟）吞噬 → 血小板壽命縮短 → 嚴重血小板減少 → 一次止血功能障礙 → 自發性出血",
    diagnosis: {
      overview: "排除性診斷：嚴重血小板減少（通常<30,000/μL）伴正常或增生骨髓巨核細胞",
      differentials: ["感染性血小板減少（埃利希體、巴貝西蟲）", "DIC", "藥物誘導", "骨髓疾病", "脾臟隔離"],
      initialDB: ["CBC（血小板計數、血塗片檢查）", "網織紅血球計數", "凝血功能（PT、PTT正常）", "血塗片（排除假性血小板減少）", "Coombs試驗（排除Evans Syndrome）"],
      advanced: ["骨髓穿刺（巨核細胞正常或增生）", "抗血小板抗體檢測", "PCR/血清學（埃利希體、巴貝西蟲）", "腹部超聲", "ANA"]
    },
    treatment: {
      overview: "免疫抑制治療為主，嚴重出血需輸血支持",
      acute: [
        "免疫抑制治療：",
        "- Prednisone/Prednisolone: 2 mg/kg PO q12h",
        "- 或 Dexamethasone: 0.3-0.5 mg/kg IV q24h（急性）",
        "聯合免疫抑制（嚴重或難治）：",
        "- Azathioprine: 2 mg/kg PO q24h x 5-7天，後q48h（僅犬）",
        "- 或 Cyclosporine: 5-10 mg/kg PO q12h",
        "- 或 Mycophenolate: 10-20 mg/kg PO q12h",
        "人免疫球蛋白（危及生命出血）：",
        "- Human IV Immunoglobulin (hIVIG): 0.5-1 g/kg IV over 6-12h",
        "- Vincristine: 0.02 mg/kg IV（刺激血小板釋放）",
        "輸血支持（活動性出血）：",
        "- 全血或血小板濃縮液（效果短暫）",
        "- 新鮮冷凍血漿（若有凝血因子消耗）",
        "胃腸道保護：Omeprazole 1 mg/kg PO q24h"
      ],
      chronic: [
        "類固醇緩慢減量（4-6個月）",
        "監測復發（約50%會復發）",
        "長期低劑量免疫抑制（難治病例）",
        "脾臟切除術（反覆復發、藥物無效）"
      ]
    },
    prognosis: "整體預後良好，約70-90%對治療有反應。死亡率5-10%，主要死於嚴重顱內或胃腸道出血。約50%會復發。",
    pearls: [
      "血小板<30,000/μL才會有自發性出血",
      "瘀點是血小板疾病的特徵性表現",
      "血塗片檢查：排除血小板凝集（假性血小板減少）",
      "先排除傳染病（埃利希體），再開始免疫抑制",
      "輸注血小板效果短暫（數小時內被破壞）"
    ],
    monitoring: ["血小板計數q2-3天（急性期）", "CBC週監測（穩定後）", "出血徵象", "類固醇副作用"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "von-willebrand-disease": {
    zh: "乏乏因氏病",
    en: "von Willebrand Disease (vWD)",
    definition: "最常見的遺傳性出血疾病，因von Willebrand因子（vWF）量或功能缺陷導致血小板黏附功能障礙。",
    synonyms: ["vWD", "馮乏布蘭氏病", "馮威里布蘭德氏病", "血管性血友病"],
    epidemiology: {
      species: "犬常見（已報導超過50品種），貓罕見",
      age: "先天性，通常年輕時發現",
      sex: "男女皆可，體染色體遺傳",
      riskFactors: ["杜賓犬（Type 1，最常見70%攜帶者）", "德國短毛指示犬（Type 2）", "蘇格蘭梗（Type 3）", "雪特蘭牧羊犬", "切薩皮克灣獵犬", "金毛獵犬"]
    },
    clinicalPresentation: {
      history: ["輕微創傷後過度出血", "手術後持續出血", "拔牙或換牙時出血", "發情期過度出血", "自發性黏膜出血"],
      physicalExam: ["黏膜表面出血（牙齦、鼻腔）", "瘀斑", "血腫", "關節出血罕見（與血友病不同）", "嚴重病例可見蒼白黏膜"]
    },
    pathophysiology: "vWF缺乏或功能異常 → 血小板無法黏附到損傷血管內皮 → 一次止血障礙 → 黏膜表面出血。Type 1：vWF量減少；Type 2：vWF多聚體異常；Type 3：vWF完全缺乏（最嚴重）",
    diagnosis: {
      overview: "臨床表現結合vWF活性檢測確診",
      differentials: ["ITP", "血小板功能障礙", "血友病", "其他凝血因子缺乏"],
      initialDB: ["血小板計數（正常）", "PT/PTT（通常正常，Type 3可能PTT延長）", "頰黏膜出血時間（BMBT延長）"],
      advanced: ["vWF抗原濃度（vWF:Ag）", "vWF活性（vWF:Act或vWF:RCo）", "多聚體分析", "基因檢測"]
    },
    treatment: {
      overview: "預防性管理為主，出血時補充vWF",
      acute: [
        "控制出血：",
        "- 局部壓迫止血",
        "- 輸注冷沉澱物（Cryoprecipitate）：含高濃度vWF",
        "- 新鮮冷凍血漿（FFP）：10-20 mL/kg",
        "- 全血（若有貧血）",
        "Desmopressin (DDAVP)：",
        "- 1 μg/kg SQ/IV（Type 1有效）",
        "- 術前30-60分鐘給予",
        "- 可使vWF濃度暫時升高2-3倍",
        "- Type 2和3效果差",
        "抗纖溶劑：",
        "- Tranexamic acid: 10-15 mg/kg PO/IV q8h",
        "- Aminocaproic acid: 50-100 mg/kg PO q8h"
      ],
      chronic: [
        "避免手術和創傷",
        "手術前輸注冷沉澱物或FFP",
        "避免使用影響血小板功能的藥物（NSAID、阿斯匹靈）",
        "不建議繁殖"
      ]
    },
    prognosis: "Type 1：預後良好，適當管理下可正常生活。Type 2：預後中等。Type 3：預後謹慎，嚴重出血風險高。",
    pearls: [
      "vWD是犬最常見的遺傳性出血疾病",
      "杜賓犬是最常見受影響品種",
      "BMBT是簡單的篩選測試",
      "DDAVP僅對Type 1有效",
      "甲狀腺功能低下可加重vWD症狀"
    ],
    monitoring: ["出血徵象", "術前vWF評估", "家族史調查"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "hemophilia-a": {
    zh: "A型血友病",
    en: "Hemophilia A",
    definition: "X染色體連鎖遺傳性出血疾病，因凝血因子VIII缺乏導致二次止血功能障礙。",
    synonyms: ["Factor VIII Deficiency", "第八因子缺乏症", "經典血友病", "Classic Hemophilia"],
    epidemiology: {
      species: "犬貓皆可發生，犬較常見",
      age: "先天性，通常幼年時發現",
      sex: "主要影響雄性（X連鎖隱性遺傳），雌性為攜帶者",
      riskFactors: ["德國牧羊犬", "金毛獵犬", "愛爾蘭雪達犬", "聖伯納犬", "迷你雪納瑞", "薩摩耶犬"]
    },
    clinicalPresentation: {
      history: ["關節血腫", "肌肉深部血腫", "手術或創傷後延遲出血", "臍帶斷端出血", "換牙時持續出血"],
      physicalExam: ["關節腫脹（血關節病）", "深部肌肉血腫", "跛行", "蒼白黏膜（嚴重出血）", "黏膜出血較少見（與vWD不同）"]
    },
    pathophysiology: "因子VIII缺乏 → 內源性凝血途徑受損 → 無法有效產生凝血酶 → 纖維蛋白形成不足 → 二次止血障礙 → 延遲性深部組織出血",
    diagnosis: {
      overview: "臨床表現結合PTT延長和因子VIII活性檢測",
      differentials: ["血友病B", "vWD（Type 3可合併因子VIII下降）", "其他凝血因子缺乏", "抗凝血劑中毒"],
      initialDB: ["血小板計數（正常）", "PT（正常）", "PTT/APTT（延長）", "BMBT（正常）"],
      advanced: ["因子VIII活性測定（<25%為輕度，<5%為中度，<1%為重度）", "vWF檢測（排除Type 3 vWD）", "基因檢測"]
    },
    treatment: {
      overview: "急性出血時補充因子VIII，預防性管理避免出血",
      acute: [
        "新鮮冷凍血漿（FFP）：",
        "- 10-20 mL/kg IV",
        "- 可重複q8-12h（因子VIII半衰期約6-12小時）",
        "冷沉澱物（Cryoprecipitate）：",
        "- 含高濃度因子VIII",
        "- 1 unit/10 kg",
        "重組因子VIII（若可獲得）：",
        "- 50-100 IU/kg IV",
        "- 昂貴但效果確定",
        "全血輸注（若有貧血）",
        "抗纖溶劑：",
        "- Tranexamic acid: 10-15 mg/kg PO/IV q8h"
      ],
      chronic: [
        "避免創傷和高風險活動",
        "手術前預防性輸注FFP或冷沉澱物",
        "不建議繁殖",
        "避免肌肉注射",
        "基因諮詢"
      ]
    },
    prognosis: "重度血友病預後謹慎，反覆關節出血可致永久性關節損傷。輕度血友病適當管理下可有良好生活品質。",
    pearls: [
      "PTT延長 + PT正常 = 內源性途徑問題",
      "關節出血是血友病的特徵（vWD較少見）",
      "雌性可為攜帶者（PTT可能輕度延長）",
      "因子VIII半衰期短，需頻繁輸注",
      "Type 3 vWD因子VIII也會下降，需鑑別"
    ],
    monitoring: ["PTT", "出血徵象", "關節狀態", "輸血反應"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "hemophilia-b": {
    zh: "B型血友病",
    en: "Hemophilia B",
    definition: "X染色體連鎖遺傳性出血疾病，因凝血因子IX缺乏導致二次止血功能障礙。",
    synonyms: ["Factor IX Deficiency", "第九因子缺乏症", "Christmas Disease", "聖誕節病"],
    epidemiology: {
      species: "犬貓皆可發生，較血友病A罕見",
      age: "先天性，通常幼年時發現",
      sex: "主要影響雄性（X連鎖隱性遺傳）",
      riskFactors: ["英國史賓格獵犬", "凱恩梗", "聖伯納犬", "愛爾達獵犬", "拉布拉多獵犬", "貓（英國短毛貓）"]
    },
    clinicalPresentation: {
      history: ["與血友病A相似", "關節和肌肉出血", "手術後延遲出血", "臍帶出血", "換牙出血"],
      physicalExam: ["關節血腫", "深部肌肉血腫", "跛行", "蒼白黏膜", "皮下血腫"]
    },
    pathophysiology: "因子IX缺乏 → 內源性凝血途徑受損 → tenase複合物無法正常形成 → 因子X活化不足 → 凝血酶生成減少 → 纖維蛋白形成不足 → 二次止血障礙",
    diagnosis: {
      overview: "臨床與血友病A相似，需特異性因子檢測區分",
      differentials: ["血友病A", "vWD", "其他凝血因子缺乏", "抗凝血劑中毒"],
      initialDB: ["血小板計數（正常）", "PT（正常）", "PTT/APTT（延長）", "BMBT（正常）"],
      advanced: ["因子IX活性測定", "因子VIII活性（正常，排除血友病A）", "基因檢測"]
    },
    treatment: {
      overview: "與血友病A治療原則相似，補充因子IX",
      acute: [
        "新鮮冷凍血漿（FFP）：",
        "- 10-20 mL/kg IV",
        "- 因子IX半衰期較長（約14-24小時），可q12-24h給予",
        "重組因子IX（若可獲得）",
        "全血輸注（若有貧血）",
        "注意：冷沉澱物不含因子IX，對血友病B無效",
        "抗纖溶劑：",
        "- Tranexamic acid: 10-15 mg/kg PO/IV q8h"
      ],
      chronic: [
        "避免創傷",
        "手術前預防性輸注FFP",
        "不建議繁殖",
        "基因諮詢"
      ]
    },
    prognosis: "與血友病A相似，取決於嚴重程度。適當管理下可有合理的生活品質。",
    pearls: [
      "血友病B比血友病A罕見約5-10倍",
      "臨床表現與血友病A無法區分，需實驗室檢測",
      "因子IX半衰期較長，輸注頻率可較低",
      "冷沉澱物對血友病B無效（不含因子IX）",
      "貓的血友病B比血友病A相對常見"
    ],
    monitoring: ["PTT", "出血徵象", "關節狀態", "輸血反應"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "disseminated-intravascular-coagulation": {
    zh: "彌散性血管內凝血",
    en: "Disseminated Intravascular Coagulation (DIC)",
    definition: "繼發於嚴重系統性疾病的複雜凝血病理狀態，特徵為全身性凝血活化導致微血栓形成，繼而消耗凝血因子和血小板引起出血。",
    synonyms: ["DIC", "消耗性凝血病", "Consumptive Coagulopathy", "去纖維蛋白綜合症"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["敗血症", "嚴重創傷", "熱射病", "蛇毒咬傷", "免疫介導性溶血性貧血（IMHA）", "胰臟炎", "腫瘤（血管肉瘤）", "嚴重肝病", "產科急症"]
    },
    clinicalPresentation: {
      history: ["原發疾病症狀", "多處出血", "瘀斑", "血尿或黑便"],
      physicalExam: ["瘀點和瘀斑", "多處出血（靜脈穿刺點、牙齦）", "器官功能障礙徵象", "黏膜蒼白", "休克徵象", "可能有血栓徵象（呼吸窘迫、肢體冷涼）"]
    },
    pathophysiology: "觸發因素（敗血症、創傷等）→ 組織因子釋放 → 系統性凝血活化 → 廣泛微血栓形成 → 凝血因子和血小板消耗 → 同時繼發性纖溶 → 出血傾向。結果：矛盾的血栓形成和出血並存",
    diagnosis: {
      overview: "DIC是臨床綜合診斷，需結合原發疾病和多項凝血異常",
      differentials: ["原發性纖溶", "肝衰竭相關凝血病", "維生素K缺乏", "嚴重血小板減少其他原因"],
      initialDB: [
        "血小板計數（減少）",
        "PT（延長）",
        "PTT（延長）",
        "纖維蛋白原（早期升高，晚期下降）",
        "D-dimer（升高）",
        "抗凝血酶III（AT III）（下降）",
        "血塗片（破碎紅血球/schistocytes）"
      ],
      advanced: ["TEG/ROTEM", "纖維蛋白降解產物（FDP）", "原發病因評估"]
    },
    treatment: {
      overview: "治療原發病因是關鍵，同時支持凝血功能",
      acute: [
        "治療原發病因（最重要！）：",
        "- 敗血症：抗生素、感染源控制",
        "- 創傷：手術止血",
        "- IMHA：免疫抑制",
        "補充凝血成分：",
        "- 新鮮冷凍血漿（FFP）: 10-20 mL/kg IV",
        "- 含凝血因子、抗凝血酶III、纖維蛋白原",
        "- 冷沉澱物（纖維蛋白原、因子VIII）",
        "- 血小板輸注（若嚴重血小板減少且出血）",
        "- 濃縮紅血球（若貧血）",
        "抗凝治療（爭議，血栓傾向為主時）：",
        "- 低分子肝素（LMWH）: 100-200 IU/kg SQ q8-12h",
        "- Unfractionated heparin: 50-100 IU/kg SQ q6-8h",
        "抗纖溶劑（一般避免使用）"
      ],
      chronic: ["持續治療原發病因", "監測凝血功能恢復"]
    },
    prognosis: "預後謹慎至差，死亡率高達50-70%。預後主要取決於原發病因是否可控制。早期識別和積極治療原發病因可改善預後。",
    pearls: [
      "DIC是症候群，不是診斷 - 必須找出並治療原因",
      "「DIC = Death Is Coming」反映其高死亡率",
      "血栓和出血可同時存在",
      "血小板、PT、PTT、纖維蛋白原至少3項異常支持診斷",
      "治療原發病因比補充凝血成分更重要",
      "抗凝治療在犬的DIC中角色仍有爭議"
    ],
    monitoring: ["血小板計數q6-12h", "PT/PTT", "纖維蛋白原", "D-dimer", "AT III", "出血和血栓徵象"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "rodenticide-toxicity": {
    zh: "滅鼠劑中毒",
    en: "Rodenticide Toxicity (Anticoagulant)",
    definition: "攝入抗凝血滅鼠劑導致維生素K依賴性凝血因子合成障礙，引起嚴重出血傾向的中毒。",
    synonyms: ["Anticoagulant Rodenticide Poisoning", "Warfarin Toxicity", "香豆素中毒", "老鼠藥中毒"],
    epidemiology: {
      species: "犬常見，貓較少見",
      age: "任何年齡，幼犬因好奇心較常見",
      sex: "無性別傾向",
      riskFactors: ["戶外活動", "居家有使用滅鼠劑", "鄉村環境", "好奇或貪吃的狗"]
    },
    clinicalPresentation: {
      history: ["已知或懷疑攝入滅鼠劑", "攝入後2-5天出現症狀", "虛弱", "呼吸困難", "跛行", "腹部膨脹"],
      physicalExam: ["黏膜蒼白", "瘀斑和瘀點", "血胸", "心包積血", "腹腔出血", "關節出血", "皮下血腫", "呼吸窘迫"]
    },
    pathophysiology: "抗凝血滅鼠劑抑制維生素K環氧化物還原酶 → 維生素K無法再生 → 維生素K依賴性凝血因子（II、VII、IX、X）合成障礙 → 凝血因子耗竭（攝入後2-5天）→ 嚴重二次止血障礙 → 自發性出血",
    diagnosis: {
      overview: "可疑暴露史 + PT顯著延長（早期）+ 凝血因子下降",
      differentials: ["其他凝血因子缺乏", "DIC", "肝功能衰竭", "血友病", "vWD"],
      initialDB: [
        "PT（顯著延長，通常>正常值2-3倍）",
        "PTT（隨後延長）",
        "血小板計數（正常）",
        "PCV/TS",
        "PIVKA（維生素K拮抗劑誘導蛋白）"
      ],
      advanced: ["凝血因子活性（II、VII、IX、X下降）", "滅鼠劑篩檢（胃內容物、肝臟、血液）", "腹部超聲/X光（腔體出血）"]
    },
    treatment: {
      overview: "維生素K1是解毒劑，嚴重出血需輸血支持",
      acute: [
        "近期攝入（<2-4小時）：",
        "- 催吐（若無禁忌）",
        "- 活性碳：1-2 g/kg PO",
        "維生素K1（Phytonadione）：",
        "- 負荷劑量：2.5-5 mg/kg PO/SQ（分多點注射）",
        "- 口服吸收需脂肪（與食物同服）",
        "- 注意：IV給藥可致過敏反應",
        "嚴重出血（活動性出血或PCV下降）：",
        "- 新鮮冷凍血漿（FFP）: 10-20 mL/kg IV",
        "- 提供即時凝血因子",
        "- 全血（若嚴重貧血）",
        "氧氣支持（若呼吸窘迫/血胸）"
      ],
      chronic: [
        "維生素K1維持治療：",
        "- 第一代抗凝血劑（Warfarin）: 1-2.5 mg/kg PO q12h x 2-4週",
        "- 第二代抗凝血劑（Brodifacoum、Bromadiolone）: 2.5-5 mg/kg PO q12h x 4-6週",
        "停藥後48-72小時複查PT",
        "若PT仍延長，繼續治療2週後再測"
      ]
    },
    prognosis: "及時診斷和治療預後良好。未治療或嚴重腔體出血預後謹慎。關鍵是維生素K1治療足夠時間（第二代滅鼠劑需4-6週）。",
    pearls: [
      "症狀出現在攝入後2-5天（凝血因子耗竭時間）",
      "PT是最先延長的凝血指標（因子VII半衰期最短）",
      "維生素K1口服需與脂肪同服以增加吸收",
      "第二代滅鼠劑半衰期長，需要更長治療時間",
      "停藥後必須複查PT確認",
      "維生素K3（Menadione）對此中毒無效"
    ],
    monitoring: ["PT q24-48h（急性期）", "PCV", "出血徵象", "停藥後48-72h PT"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ASPCA Poison Control Guidelines"
  },

  "evans-syndrome": {
    zh: "乏乏氏症候群",
    en: "Evans Syndrome",
    definition: "免疫介導性溶血性貧血（IMHA）和免疫介導性血小板減少症（ITP）同時或相繼發生的嚴重自體免疫疾病。",
    synonyms: ["Evans Syndrome", "Combined IMHA and ITP", "聯合免疫介導性血液破壞"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "中年犬（平均5-7歲）",
      sex: "母犬略多",
      riskFactors: ["可卡犬", "英國史賓格獵犬", "愛爾蘭雪達犬", "貴賓犬", "古代牧羊犬", "先前有IMHA或ITP病史"]
    },
    clinicalPresentation: {
      history: ["虛弱", "嗜睡", "食慾下降", "運動不耐", "瘀斑", "血尿或黑便", "嘔吐"],
      physicalExam: ["嚴重蒼白黏膜", "黃疸", "瘀點和瘀斑", "心搏過速", "脾腫大", "發燒", "黏膜出血"]
    },
    pathophysiology: "同時產生抗紅血球和抗血小板抗體 → 紅血球在脾臟/肝臟被吞噬破壞（血管外溶血）或補體介導血管內溶血 + 血小板被網狀內皮系統破壞 → 嚴重貧血合併血小板減少 → 組織缺氧 + 出血傾向",
    diagnosis: {
      overview: "同時滿足IMHA和ITP的診斷標準",
      differentials: ["單獨IMHA或ITP", "DIC", "骨髓疾病", "傳染病（巴貝西蟲、埃利希體）", "藥物反應"],
      initialDB: [
        "CBC：貧血（通常PCV<20%）+ 血小板減少（<50,000/μL）",
        "網織紅血球計數（增生性貧血）",
        "血塗片：球形紅血球、自體凝集、血小板減少",
        "直接Coombs試驗（陽性）",
        "膽紅素（升高）",
        "PT/PTT（排除DIC）"
      ],
      advanced: ["骨髓穿刺", "腹部超聲", "PCR（排除傳染病）", "ANA"]
    },
    treatment: {
      overview: "積極免疫抑制治療 + 輸血支持，比單獨IMHA或ITP更具挑戰性",
      acute: [
        "免疫抑制治療（立即開始）：",
        "- Prednisone/Prednisolone: 2 mg/kg PO q12h",
        "- 或 Dexamethasone: 0.3-0.5 mg/kg IV q24h",
        "聯合免疫抑制（通常需要）：",
        "- Azathioprine: 2 mg/kg PO q24h x 5-7天，後q48h（僅犬）",
        "- 或 Cyclosporine: 5-10 mg/kg PO q12h",
        "- 或 Mycophenolate: 10-20 mg/kg PO q12h",
        "危及生命時：",
        "- hIVIG: 0.5-1 g/kg IV over 6-12h",
        "輸血支持：",
        "- 濃縮紅血球：10-20 mL/kg（嚴重貧血）",
        "- 血小板輸注效果短暫但活動性出血時可用",
        "- 交叉配血！",
        "血栓預防（IMHA高風險）：",
        "- 低分子肝素或Clopidogrel",
        "胃腸道保護"
      ],
      chronic: [
        "緩慢減量類固醇（數月）",
        "長期聯合免疫抑制（許多需要）",
        "監測復發",
        "脾臟切除術（難治病例）"
      ]
    },
    prognosis: "預後謹慎至不良。比單獨IMHA或ITP預後差。死亡率可達30-50%。復發常見。需要積極和長期的免疫抑制治療。",
    pearls: [
      "Evans Syndrome比單獨IMHA或ITP更難治療",
      "通常需要聯合免疫抑制劑",
      "輸血可能加速免疫破壞，但嚴重貧血時仍需要",
      "IMHA的血栓風險仍存在，需要預防",
      "復發率高，需要長期追蹤",
      "可能是系統性自體免疫疾病（如SLE）的表現"
    ],
    monitoring: ["CBC q1-2天（急性期）", "網織紅血球", "血塗片", "膽紅素", "出血和血栓徵象"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "aplastic-anemia": {
    zh: "再生不良性貧血",
    en: "Aplastic Anemia",
    definition: "骨髓造血功能衰竭導致全血球減少（紅血球、白血球、血小板皆減少）的嚴重血液疾病。",
    synonyms: ["Bone Marrow Failure", "Pancytopenia", "骨髓衰竭", "全血球減少症", "骨髓發育不全"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["藥物（雌激素、氯黴素、化療藥）", "毒素", "傳染病（貓泛白細胞減少症、埃利希體）", "免疫介導", "輻射暴露", "特發性"]
    },
    clinicalPresentation: {
      history: ["進行性虛弱", "嗜睡", "反覆感染", "出血傾向", "體重下降", "已知藥物或毒素暴露"],
      physicalExam: ["蒼白黏膜", "發燒（感染）", "瘀點和瘀斑", "心搏過速", "呼吸急促", "淋巴結和脾臟不腫大（骨髓源性）"]
    },
    pathophysiology: "骨髓造血幹細胞受損或減少 → 紅血球、粒細胞、血小板生成均減少 → 貧血（組織缺氧）+ 嗜中性球減少（感染風險）+ 血小板減少（出血傾向）",
    diagnosis: {
      overview: "全血球減少 + 非再生性貧血 + 骨髓活檢顯示造血組織減少",
      differentials: ["骨髓腫瘤浸潤（白血病、淋巴瘤）", "骨髓纖維化", "傳染病（埃利希體、巴維西蟲）", "藥物誘導骨髓抑制", "免疫介導性骨髓疾病"],
      initialDB: ["CBC（全血球減少）", "網織紅血球計數（極低或缺乏 = 非再生性）", "血塗片", "血液生化"],
      advanced: ["骨髓穿刺和活檢（造血細胞減少、脂肪增加）", "傳染病篩檢", "藥物和毒素暴露史", "鐵儲存評估"]
    },
    treatment: {
      overview: "移除病因、支持治療、可能需要免疫抑制或骨髓移植",
      acute: [
        "移除可能病因：",
        "- 停用可疑藥物",
        "- 治療潛在傳染病",
        "支持治療：",
        "- 輸血：濃縮紅血球或全血（PCV<15-20%）",
        "- 血小板輸注（活動性出血）",
        "- 廣譜抗生素（嗜中性球減少伴發燒）",
        "免疫抑制治療（免疫介導或特發性）：",
        "- Prednisone: 2 mg/kg PO q12h",
        "- Cyclosporine: 5-10 mg/kg PO q12h",
        "刺激造血：",
        "- 促紅血球生成素（Epoetin）: 100-150 IU/kg SQ 3x/週",
        "- G-CSF（僅短期，有抗體風險）"
      ],
      chronic: [
        "長期免疫抑制（若有反應）",
        "定期監測CBC",
        "造血幹細胞移植（理論上可行但罕見執行）"
      ]
    },
    prognosis: "預後謹慎至差。藥物相關若停藥可能恢復，但需數週至數月。特發性或免疫介導預後較差。死亡通常因感染或出血。",
    pearls: [
      "全血球減少 + 非再生性 = 骨髓問題",
      "骨髓活檢是確診關鍵",
      "雌激素（Sertoli細胞瘤產生）是犬常見原因",
      "貓泛白細胞減少症（貓瘟）可致暫時性骨髓抑制",
      "恢復需要時間，造血恢復可能需數週",
      "嗜中性球<1000/μL時感染風險極高"
    ],
    monitoring: ["CBC q2-3天（急性期）", "發燒和感染徵象", "出血徵象", "網織紅血球"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "iron-deficiency-anemia": {
    zh: "缺鐵性貧血",
    en: "Iron Deficiency Anemia",
    definition: "因鐵缺乏導致血紅蛋白合成不足，產生小球性低色素性貧血的疾病。",
    synonyms: ["Iron Deficiency", "Microcytic Anemia", "Hypochromic Anemia", "低色素小球性貧血"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "幼犬貓（營養性）或任何年齡（慢性失血）",
      sex: "無性別傾向",
      riskFactors: ["慢性胃腸道出血（腫瘤、潰瘍）", "嚴重跳蚤/蜱感染", "凝血障礙", "慢性泌尿道出血", "幼犬貓營養不良", "鉤蟲感染"]
    },
    clinicalPresentation: {
      history: ["進行性虛弱", "運動不耐", "嗜睡", "食慾下降", "可能有異食癖", "黑便或血便"],
      physicalExam: ["蒼白黏膜", "心搏過速", "心雜音（貧血性）", "毛髮乾燥無光澤", "可能有原發疾病徵象（腫塊、跳蚤）"]
    },
    pathophysiology: "鐵流失（慢性出血）或攝取不足 → 體內鐵儲存耗竭 → 血紅蛋白合成不足 → 紅血球體積變小（小球性）且血紅蛋白含量降低（低色素性）→ 組織氧氣輸送減少",
    diagnosis: {
      overview: "小球性低色素性貧血 + 低血清鐵/鐵蛋白 + 找出失血原因",
      differentials: ["慢性疾病性貧血（ACD）", "先天性血紅蛋白病", "鉛中毒", "門脈系統分流"],
      initialDB: [
        "CBC：MCV下降（<60 fL犬，<40 fL貓）、MCHC下降",
        "血塗片：小紅血球、低色素、靶形細胞",
        "網織紅血球計數（可高或低）",
        "糞便潛血測試"
      ],
      advanced: [
        "血清鐵（下降）",
        "總鐵結合力（TIBC）（升高）",
        "血清鐵蛋白（下降）",
        "骨髓鐵染色（儲存鐵缺乏）",
        "腹部影像（尋找出血源）",
        "內視鏡（胃腸道出血）"
      ]
    },
    treatment: {
      overview: "找出並治療失血原因 + 鐵補充",
      acute: [
        "治療原發病因：",
        "- 胃腸道腫瘤：手術切除",
        "- 胃潰瘍：制酸劑",
        "- 跳蚤/蜱：驅蟲",
        "- 鉤蟲：驅蟲劑",
        "鐵補充：",
        "- 口服鐵劑（首選）：",
        "  Ferrous sulfate: 100-300 mg/犬 PO q24h",
        "  或 5-10 mg/kg elemental iron PO q24h",
        "- 注射鐵劑（口服不耐或吸收障礙）：",
        "  Iron dextran: 10-20 mg/kg IM（單次，需謹慎）",
        "輸血（嚴重貧血PCV<12-15%）"
      ],
      chronic: [
        "口服鐵補充至少3-6個月",
        "PCV正常後繼續1-2個月以補充儲存鐵",
        "預防復發（治療慢性失血原因）"
      ]
    },
    prognosis: "若能找出並治療失血原因，預後良好。鐵補充後數週內應見網織紅血球反應，數月內PCV恢復正常。",
    pearls: [
      "成年動物缺鐵性貧血幾乎總是因為慢性失血",
      "幼犬貓可因營養不足或寄生蟲感染",
      "小球性+低色素性是缺鐵性貧血特徵",
      "鐵蛋白是最敏感的早期指標",
      "口服鐵劑可能造成胃腸道不適",
      "治療原因比補鐵更重要"
    ],
    monitoring: ["PCV/網織紅血球q1-2週", "血清鐵", "糞便潛血", "原發疾病狀態"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "polycythemia-vera": {
    zh: "真性紅血球增多症",
    en: "Polycythemia Vera",
    definition: "骨髓造血幹細胞克隆性增生導致紅血球過度生產的骨髓增生性腫瘤，不依賴促紅血球生成素。",
    synonyms: ["Primary Polycythemia", "Primary Erythrocytosis", "原發性紅血球增多症", "真性紅血球增多"],
    epidemiology: {
      species: "犬貓皆可發生，均罕見",
      age: "中老年（犬平均8歲，貓平均10歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["無已知品種傾向"]
    },
    clinicalPresentation: {
      history: ["嗜睡", "虛弱", "運動不耐", "多飲多尿", "癲癇或行為改變", "視力問題"],
      physicalExam: ["黏膜充血或磚紅色", "脾腫大", "神經學異常", "視網膜血管擴張或出血", "高血壓"]
    },
    pathophysiology: "造血幹細胞突變 → 紅血球系不受控增生（不依賴EPO）→ 紅血球數量過多 → 血液黏度增加 → 微循環障礙 → 組織缺氧、血栓形成、器官功能障礙",
    diagnosis: {
      overview: "排除繼發性紅血球增多症後診斷",
      differentials: ["繼發性紅血球增多症（心肺疾病、腎臟腫瘤）", "相對性紅血球增多症（脫水）", "應激性紅血球增多"],
      initialDB: [
        "CBC：PCV明顯升高（犬>65%，貓>55%）",
        "確認非脫水（血漿蛋白正常）",
        "動脈血氣（排除低氧血症）"
      ],
      advanced: [
        "血清促紅血球生成素（EPO）：正常或低（真性）vs 高（繼發性）",
        "腹部超聲（腎臟腫瘤、脾腫大）",
        "心臟超聲（排除先天性心臟病）",
        "胸腔X光",
        "骨髓檢查（紅血球系增生）"
      ]
    },
    treatment: {
      overview: "降低紅血球數量、控制血液黏度、骨髓抑制治療",
      acute: [
        "放血療法（Phlebotomy）：",
        "- 移除10-20 mL/kg血液",
        "- 同時給予等量晶體液",
        "- 目標PCV: 55-60%（犬）、45-50%（貓）",
        "- 可每2-3天重複直到目標",
        "水化治療"
      ],
      chronic: [
        "骨髓抑制藥物：",
        "- Hydroxyurea: 30 mg/kg PO q24h x 7-10天，後15 mg/kg q24h維持",
        "- 監測骨髓抑制",
        "定期放血（若需要）",
        "低劑量阿斯匹靈（預防血栓）：0.5-1 mg/kg q24h"
      ]
    },
    prognosis: "長期預後謹慎但可管理。中位生存時間犬約2-4年。主要併發症為血栓和出血。需要終身治療和監測。",
    pearls: [
      "必須排除繼發性原因（低氧血症、EPO分泌腫瘤）",
      "EPO水平是鑑別真性和繼發性的關鍵",
      "脫水可造成假性紅血球增多（相對性）",
      "放血療法效果快但需反覆進行",
      "Hydroxyurea是長期控制的主要藥物",
      "高黏度血症可致神經和視力症狀"
    ],
    monitoring: ["PCV定期監測", "神經學狀態", "視網膜檢查", "血栓徵象", "Hydroxyurea骨髓毒性（CBC）"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "neutropenia": {
    zh: "嗜中性球減少",
    en: "Neutropenia",
    definition: "循環血液中嗜中性球絕對數量低於正常範圍（犬<3,000/μL，貓<2,500/μL），增加感染風險的病理狀態。",
    synonyms: ["Agranulocytosis", "粒細胞減少症", "白血球減少"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["化療", "輻射", "骨髓疾病", "嚴重感染", "藥物（化療藥、氯黴素、磺胺類）", "免疫介導"]
    },
    clinicalPresentation: {
      history: ["發燒", "嗜睡", "食慾下降", "反覆或難治感染", "化療或藥物使用史"],
      physicalExam: ["發燒", "黏膜異常", "局部感染徵象（口腔潰瘍、肺炎、蜂窩組織炎）", "敗血症徵象（嚴重時）"]
    },
    pathophysiology: "嗜中性球減少機制：1)生成減少（骨髓抑制）、2)破壞增加（免疫介導或感染消耗）、3)分佈改變（邊緣池移動或脾臟隔離）。結果：抵抗細菌和真菌感染能力下降 → 感染風險增加",
    diagnosis: {
      overview: "CBC確認 + 評估原因",
      differentials: ["藥物誘導", "感染性（貓泛白細胞減少症、細小病毒、埃利希體）", "免疫介導", "骨髓疾病", "先天性（週期性造血）"],
      initialDB: ["CBC（嗜中性球絕對計數）", "血塗片（左轉、毒性變化）", "傳染病篩檢"],
      advanced: ["骨髓穿刺", "抗嗜中性球抗體", "藥物史回顧", "腹部超聲"]
    },
    treatment: {
      overview: "治療原發病因 + 支持治療 + 預防感染",
      acute: [
        "移除可能病因（停用可疑藥物）",
        "發燒性嗜中性球減少症（急診！）：",
        "- 立即血液培養",
        "- 經驗性廣譜抗生素：",
        "  Enrofloxacin: 10-20 mg/kg IV q24h",
        "  + Ampicillin-sulbactam: 20-30 mg/kg IV q8h",
        "  或 Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h",
        "嚴重嗜中性球減少（<500/μL）：",
        "- 預防性抗生素（即使未發燒）",
        "- 隔離減少感染暴露",
        "G-CSF（粒細胞集落刺激因子）：",
        "- Filgrastim: 5 μg/kg SQ q24h",
        "- 僅短期使用（可產生抗體）",
        "輸液支持"
      ],
      chronic: [
        "治療原發疾病",
        "免疫介導：免疫抑制治療",
        "監測恢復"
      ]
    },
    prognosis: "取決於原因和嚴重程度。藥物誘導停藥後通常恢復（數天至數週）。感染性嗜中性球減少預後依病原體。免疫介導可能需要長期治療。嗜中性球<500/μL時感染風險極高。",
    pearls: [
      "嗜中性球<500/μL是醫療急症",
      "發燒+嗜中性球減少 = 假設敗血症直到證明並非",
      "化療後嗜中性球低谷通常在7-14天",
      "左轉（帶狀嗜中性球增加）提示骨髓正在反應",
      "G-CSF可加速恢復但有抗體風險"
    ],
    monitoring: ["CBC q1-2天（急性期）", "體溫q4-6h", "感染徵象", "血液培養（若發燒）"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "cyclic-hematopoiesis": {
    zh: "週期性造血",
    en: "Cyclic Hematopoiesis",
    definition: "罕見的先天性造血障礙，特徵為血球計數呈週期性波動，尤其是嗜中性球約每11-14天出現一次嚴重減少。",
    synonyms: ["Grey Collie Syndrome", "Cyclic Neutropenia", "灰色柯利症候群", "週期性嗜中性球減少"],
    epidemiology: {
      species: "犬（主要是柯利犬），貓極罕見",
      age: "先天性，幼犬即可發現",
      sex: "體染色體隱性遺傳，男女皆可",
      riskFactors: ["柯利犬（灰色被毛 = 病態基因純合子）"]
    },
    clinicalPresentation: {
      history: ["灰色或銀灰色被毛", "反覆感染（每10-14天週期性發作）", "生長遲緩", "虛弱", "發燒週期"],
      physicalExam: ["灰色/銀灰色被毛（色素稀釋）", "發育不良", "發燒（感染期）", "口腔潰瘍", "關節腫脹（感染）", "淋巴結腫大"]
    },
    pathophysiology: "AP3B1基因突變 → 造血幹細胞功能障礙 → 嗜中性球生成呈週期性波動（約11-14天週期）→ 週期性嚴重嗜中性球減少 → 反覆細菌感染。同一基因突變也影響黑色素生成 → 灰色被毛",
    diagnosis: {
      overview: "臨床特徵（灰色柯利犬+週期性感染）+ 連續CBC監測",
      differentials: ["其他嗜中性球減少原因", "免疫缺陷", "骨髓疾病"],
      initialDB: ["連續CBC（每2-3天 x 4-6週，記錄週期性變化）", "血塗片"],
      advanced: ["基因檢測（AP3B1突變）", "骨髓穿刺"]
    },
    treatment: {
      overview: "主要為支持治療，無根治方法",
      acute: [
        "感染期治療：",
        "- 廣譜抗生素",
        "- 支持治療",
        "G-CSF可減少週期振幅：",
        "- Filgrastim: 5 μg/kg SQ q24h",
        "- 長期使用有抗體風險",
        "犬類G-CSF（若可獲得）較佳"
      ],
      chronic: [
        "終身管理反覆感染",
        "預防性抗生素（嗜中性球低谷期）",
        "骨髓移植（理論上可治癒但罕見執行）",
        "生活品質評估",
        "不建議繁殖"
      ]
    },
    prognosis: "預後不良。大多數受影響犬在幼年死於感染併發症。少數可存活至成年但生活品質受影響。平均壽命2-3年。",
    pearls: [
      "灰色柯利犬 + 反覆感染 = 高度懷疑週期性造血",
      "連續CBC監測可見約11-14天的嗜中性球週期",
      "血小板和紅血球也有週期性變化但較不顯著",
      "是體染色體隱性遺傳，攜帶者外觀正常",
      "可通過基因檢測篩選攜帶者避免繁殖"
    ],
    monitoring: ["連續CBC追蹤週期", "體溫和感染徵象", "生長發育"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "thrombocytosis": {
    zh: "血小板增多症",
    en: "Thrombocytosis",
    definition: "血小板計數超過正常上限（犬>500,000/μL，貓>600,000/μL）的病理狀態，可為反應性或原發性。",
    synonyms: ["Thrombocythemia", "血小板過多症", "血小板增生"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡（反應性），中老年（原發性）",
      sex: "無性別傾向",
      riskFactors: ["反應性：慢性炎症、感染、腫瘤、缺鐵、脾臟切除後、糖皮質激素", "原發性：骨髓增生性腫瘤"]
    },
    clinicalPresentation: {
      history: ["常因原發疾病就診", "反應性通常無症狀", "原發性可能有血栓或出血症狀"],
      physicalExam: ["原發疾病的徵象", "脾腫大（原發性）", "血栓栓塞徵象（罕見）"]
    },
    pathophysiology: "反應性：炎症細胞因子（IL-6、TPO）→ 刺激巨核細胞增生 → 血小板生成增加。原發性：巨核細胞克隆性增生 → 不受控的血小板生成。極度增多時可能出現血栓或矛盾性出血（功能異常血小板）",
    diagnosis: {
      overview: "確認血小板增多後，區分反應性（常見）和原發性（罕見）",
      differentials: ["反應性血小板增多（最常見）：感染、腫瘤、缺鐵、脾切除後、類固醇", "原發性血小板增多症（罕見）：骨髓增生性腫瘤"],
      initialDB: ["CBC（確認血小板計數，排除凝集假象）", "血塗片", "鐵指標", "炎症指標"],
      advanced: ["骨髓穿刺（巨核細胞增生）", "JAK2突變檢測（若可用）", "腹部影像（腫瘤、脾臟）", "排除潛在疾病"]
    },
    treatment: {
      overview: "反應性：治療原發疾病；原發性：骨髓抑制",
      acute: [
        "反應性血小板增多：",
        "- 治療原發疾病（感染、腫瘤、缺鐵）",
        "- 通常不需特殊治療血小板",
        "- 血小板隨原發疾病控制而下降",
        "原發性血小板增多症：",
        "- Hydroxyurea: 30 mg/kg PO q24h，調整以維持正常血小板",
        "- 血栓預防：低劑量阿斯匹靈 0.5-1 mg/kg q24h"
      ],
      chronic: [
        "反應性：持續治療原發疾病",
        "原發性：終身骨髓抑制治療",
        "定期監測血小板計數"
      ]
    },
    prognosis: "反應性血小板增多：預後取決於原發疾病。原發性血小板增多症：預後謹慎，需終身治療，有血栓和出血風險。",
    pearls: [
      "反應性血小板增多遠比原發性常見",
      "反應性通常<1,000,000/μL，原發性可能更高",
      "極度血小板增多（>2,000,000/μL）可能出現出血（功能異常）",
      "脾切除後血小板可暫時性顯著升高",
      "鐵缺乏性貧血常合併反應性血小板增多"
    ],
    monitoring: ["定期CBC", "血栓和出血徵象", "原發疾病狀態"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "hypereosinophilic-syndrome": {
    zh: "嗜酸性球增多症候群",
    en: "Hypereosinophilic Syndrome (HES)",
    definition: "持續性嗜酸性球顯著增多（>1,500/μL）伴隨器官浸潤和損傷的罕見疾病，排除其他嗜酸性球增多原因後診斷。",
    synonyms: ["HES", "Idiopathic Hypereosinophilia", "特發性嗜酸性球增多症"],
    epidemiology: {
      species: "貓較犬常見",
      age: "中老年（貓平均8-9歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["未知，可能為免疫失調或隱匿性腫瘤"]
    },
    clinicalPresentation: {
      history: ["嘔吐", "腹瀉", "體重下降", "嗜睡", "食慾下降", "皮膚病變"],
      physicalExam: ["腸道增厚（可觸及）", "肝脾腫大", "淋巴結腫大", "皮膚病變（潰瘍、結節）", "呼吸異常（肺浸潤）"]
    },
    pathophysiology: "嗜酸性球失控增生或存活延長 → 組織浸潤（胃腸道、肝臟、脾臟、皮膚、肺等）→ 嗜酸性球釋放毒性顆粒蛋白（MBP、ECP）→ 組織損傷和纖維化 → 器官功能障礙",
    diagnosis: {
      overview: "排除性診斷：持續嗜酸性球增多 + 器官浸潤 + 排除其他原因",
      differentials: ["寄生蟲感染", "過敏性疾病", "嗜酸性球性腸炎", "肥大細胞瘤", "淋巴瘤", "嗜酸性球性白血病"],
      initialDB: ["CBC（嗜酸性球>1,500/μL，常>10,000/μL）", "血塗片", "糞便檢查（排除寄生蟲）", "生化（器官功能）"],
      advanced: ["骨髓穿刺（嗜酸性球增生，排除白血病）", "腹部超聲", "受影響器官活檢", "FeLV/FIV（貓）", "心臟超聲"]
    },
    treatment: {
      overview: "免疫抑制治療為主",
      acute: [
        "糖皮質激素（首選）：",
        "- Prednisone/Prednisolone: 2-4 mg/kg PO q24h",
        "- 逐漸減量至最低有效劑量",
        "難治病例添加：",
        "- Chlorambucil: 2 mg/貓 PO q48-72h",
        "- 或 Hydroxyurea",
        "支持治療：",
        "- 營養支持",
        "- 止吐藥（若嘔吐）"
      ],
      chronic: [
        "長期低劑量類固醇維持",
        "可能需要終身治療",
        "監測器官功能"
      ]
    },
    prognosis: "預後謹慎至差。部分病例對類固醇反應良好可長期控制。難治病例預後不良。貓的HES可能是淋巴瘤前期表現。",
    pearls: [
      "必須徹底排除寄生蟲和其他反應性原因",
      "貓的HES可能進展為淋巴瘤",
      "胃腸道是最常受影響的器官",
      "心臟浸潤可致心肌病（人類常見，獸醫少報導）",
      "嗜酸性球>100,000/μL考慮嗜酸性球性白血病"
    ],
    monitoring: ["定期CBC", "器官功能", "臨床症狀", "類固醇副作用"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Schalm's Veterinary Hematology, 6th Ed."
  },

  "feline-cytauxzoonosis": {
    zh: "貓泰勒蟲病",
    en: "Feline Cytauxzoonosis",
    definition: "由泰勒蟲（Cytauxzoon felis）引起的貓急性致命性血液寄生蟲病，經蜱傳播，導致嚴重血管內增殖和溶血。",
    synonyms: ["Cytauxzoon felis infection", "貓血巴東蟲病", "Bobcat Fever"],
    epidemiology: {
      species: "僅貓科動物",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["戶外活動", "蜱暴露區域", "美國中南部和東南部", "野貓接觸", "春夏季（蜱活躍期）"]
    },
    clinicalPresentation: {
      history: ["急性發病", "高燒", "食慾廢絕", "嗜睡", "呼吸困難", "黃疸", "蜱暴露史"],
      physicalExam: ["高燒（40-41°C）", "黃疸", "蒼白黏膜", "脾腫大", "肝腫大", "呼吸窘迫", "低血壓", "休克", "DIC徵象"]
    },
    pathophysiology: "蜱叮咬傳播 → 原蟲在巨噬細胞內增殖（裂殖體期）→ 感染的巨噬細胞阻塞血管 → 多器官血管阻塞和缺血 → 裂殖子釋放進入紅血球 → 血管內溶血 → SIRS、DIC、多器官衰竭",
    diagnosis: {
      overview: "臨床表現結合血塗片或PCR確診",
      differentials: ["貓傳染性貧血（Mycoplasma haemofelis）", "免疫介導性溶血性貧血", "FIP", "FeLV相關疾病", "敗血症"],
      initialDB: [
        "CBC（貧血、血小板減少、白血球變化）",
        "血塗片：紅血球內可見piroplasm（嗜伊紅色環形或逗點狀）",
        "生化（肝酶升高、膽紅素升高、低蛋白血症）",
        "凝血功能（DIC）"
      ],
      advanced: ["PCR（最敏感）", "肝脾細針抽吸（裂殖體可見）", "組織病理（血管內裂殖體）"]
    },
    treatment: {
      overview: "積極支持治療 + 抗原蟲藥物，即使治療死亡率仍高",
      acute: [
        "抗原蟲治療：",
        "- Atovaquone: 15 mg/kg PO q8h（與脂肪同服）",
        "- + Azithromycin: 10 mg/kg PO q24h",
        "- 治療10天或直到臨床改善",
        "替代方案：",
        "- Imidocarb dipropionate: 2-5 mg/kg IM（效果較差）",
        "積極支持治療（關鍵！）：",
        "- 靜脈輸液",
        "- 輸血（若嚴重貧血）",
        "- 氧氣支持",
        "- 抗凝治療（若DIC）：低分子肝素",
        "- 營養支持（鼻飼管）",
        "退燒（若需要）",
        "監測和治療併發症"
      ],
      chronic: [
        "存活貓可成為帶原者",
        "預防蜱叮咬",
        "監測復發"
      ]
    },
    prognosis: "預後極差，未治療幾乎100%死亡。積極治療（atovaquone+azithromycin+支持療法）存活率約60%。存活貓可能成為終身帶原者。",
    pearls: [
      "「Bobcat Fever」因山貓（bobcat）是天然宿主",
      "裂殖體期是致死關鍵，紅血球內piroplasm期較晚",
      "血塗片陰性不能排除（早期裂殖體期）",
      "Atovaquone+Azithromycin是目前最佳治療方案",
      "蜱預防是唯一有效預防措施",
      "存活貓可作為傳染源（帶原者）"
    ],
    monitoring: ["體溫q4-6h", "PCV", "血小板", "凝血功能", "器官功能", "呼吸狀態"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed."
  }
  // ===== From toxicological-diseases.js =====
  "ethylene-glycol-toxicity": {
    zh: "乙二醇中毒",
    en: "Ethylene Glycol Toxicity",
    definition: "攝入乙二醇（防凍液的主要成分）導致的嚴重中毒，特徵為代謝性酸中毒、急性腎衰竭和神經系統損傷。",
    synonyms: ["防凍液中毒", "Antifreeze Poisoning", "EG Toxicosis"],
    epidemiology: {
      species: "犬貓皆可發生，貓對毒性更敏感",
      age: "任何年齡，年輕好奇動物更常見",
      sex: "無性別傾向",
      riskFactors: ["接觸防凍液", "車庫或車道漏液", "冬季更常見", "甜味吸引動物攝入"]
    },
    clinicalPresentation: {
      history: ["接觸防凍液史", "嘔吐", "多尿多渴", "共濟失調", "虛弱", "癲癇"],
      physicalExam: [
        "第一階段（0.5-12小時）：類醉酒狀態、共濟失調、嘔吐、多尿多渴、中樞神經系統抑制",
        "第二階段（12-24小時）：心肺症狀、心搏過速、呼吸急促",
        "第三階段（24-72小時犬/12-24小時貓）：急性腎衰竭、無尿、嘔吐、口腔潰瘍、昏迷、癲癇"
      ]
    },
    pathophysiology: "乙二醇本身毒性低，但經醇脫氫酶代謝產生有毒代謝物（乙醛酸、草酸）→ 嚴重代謝性酸中毒（高陰離子間隙）→ 草酸鈣結晶沉積於腎小管 → 急性腎小管壞死 → 腎衰竭",
    diagnosis: {
      overview: "病史、臨床表現、高陰離子間隙代謝性酸中毒、尿液草酸鈣結晶、血清乙二醇檢測",
      differentials: ["其他中毒（甲醇、異丙醇）", "急性腎衰竭其他原因", "糖尿病酮酸中毒", "乳酸酸中毒"],
      initialDB: [
        "血氣分析（代謝性酸中毒、高陰離子間隙>20-25 mEq/L）",
        "血清滲透壓（滲透壓間隙升高）",
        "尿液分析（草酸鈣單水或雙水結晶）",
        "BUN/Creatinine",
        "電解質（低鈣）",
        "血糖"
      ],
      advanced: ["血清乙二醇濃度", "即時檢測試劑盒", "腎臟超聲"]
    },
    treatment: {
      overview: "早期給予解毒劑（醇脫氫酶抑制劑）、糾正酸中毒、支持腎功能",
      acute: [
        "若攝入<1-2小時：催吐（若無禁忌症）",
        "解毒劑（越早越好）：",
        "- Fomepizole（4-MP）：犬 20 mg/kg IV 初始，12h後 15 mg/kg，24h後 15 mg/kg，36h後 5 mg/kg",
        "- Fomepizole：貓 125 mg/kg IV q12h x 3劑",
        "- 或 Ethanol 20%：犬 5.5 mL/kg IV q4h x 5劑，然後 q6h x 4劑",
        "- Ethanol：貓 5 mL/kg IV q6h x 5劑",
        "糾正酸中毒：Sodium bicarbonate（根據血氣計算）",
        "積極輸液維持腎灌注",
        "監測並糾正低鈣血症",
        "血液透析（若已腎衰竭且設備可用）"
      ],
      chronic: ["腎衰竭支持治療", "可能需要長期透析"]
    },
    prognosis: "攝入後8小時內（犬）或3小時內（貓）給予解毒劑預後良好。一旦出現腎衰竭，預後極差。貓致死劑量低（1.5 mL/kg），犬約4.4-6.6 mL/kg。",
    pearls: [
      "「時間就是腎臟」- 早期治療至關重要",
      "貓對乙二醇極度敏感，約1茶匙可致死",
      "Wood's燈下尿液可能螢光（某些防凍液含螢光劑）",
      "草酸鈣結晶出現較晚，缺乏不能排除診斷",
      "Fomepizole優於Ethanol（副作用少），但較昂貴",
      "滲透壓間隙 = 測量滲透壓 - 計算滲透壓（正常<10）"
    ],
    monitoring: ["腎功能（BUN/Crea q12-24h）", "尿量", "血氣", "電解質", "滲透壓間隙"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013; Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "chocolate-toxicity": {
    zh: "巧克力中毒",
    en: "Chocolate Toxicity",
    definition: "攝入巧克力中的甲基黃嘌呤類（可可鹼和咖啡因）導致的中毒，主要影響心血管、神經和消化系統。",
    synonyms: ["可可鹼中毒", "Theobromine Toxicity", "Methylxanthine Toxicosis"],
    epidemiology: {
      species: "主要影響犬，貓罕見（較挑食）",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["節日期間（情人節、復活節、聖誕節）", "家中有巧克力存放", "狗的好奇心和食欲"]
    },
    clinicalPresentation: {
      history: ["攝入巧克力史", "嘔吐", "腹瀉", "躁動", "多尿"],
      physicalExam: ["嘔吐", "腹瀉", "多尿多渴", "躁動/過度興奮", "心搏過速", "心律不整", "高熱", "肌肉震顫", "癲癇（嚴重時）", "昏迷（極嚴重時）"]
    },
    pathophysiology: "可可鹼半衰期長（犬約17.5小時）→ 腺苷受體拮抗 → 磷酸二酯酶抑制 → cAMP增加 → 心臟興奮性增加、血管擴張、利尿、中樞神經興奮 → 兒茶酚胺釋放增加 → 心律不整",
    diagnosis: {
      overview: "病史和臨床表現為主要診斷依據",
      differentials: ["咖啡因中毒", "興奮劑中毒", "其他甲基黃嘌呤中毒", "偽乙麻黃鹼中毒"],
      initialDB: ["心電圖（心律不整）", "血壓", "體溫", "基礎生化"],
      advanced: ["血清可可鹼/咖啡因濃度（通常不需要）"]
    },
    treatment: {
      overview: "去污染、支持治療、控制心律不整和癲癇",
      acute: [
        "去污染（攝入<2小時）：",
        "- 催吐：Apomorphine 0.03-0.04 mg/kg IV或結膜下",
        "- 活性炭：1-2 g/kg PO（可每4-6小時重複，因腸肝循環）",
        "輸液支持（促進排泄、糾正脫水）",
        "心律不整治療：",
        "- 室性心律不整：Lidocaine 2 mg/kg IV bolus（犬）",
        "- 心搏過速：β-blocker（Atenolol、Propranolol）",
        "癲癇控制：Diazepam 0.5-1 mg/kg IV",
        "降溫措施（若高熱）",
        "導尿監測尿量",
        "膀胱導尿可減少可可鹼再吸收"
      ],
      chronic: ["監測心臟功能直到症狀消退"]
    },
    prognosis: "輕度中毒預後良好。嚴重中毒若及時治療預後仍可良好。可可鹼LD50約100-200 mg/kg。",
    pearls: [
      "毒性取決於巧克力類型：烘焙巧克力>黑巧克力>牛奶巧克力>白巧克力",
      "可可鹼含量：烘焙巧克力~450 mg/oz，黑巧克力~150 mg/oz，牛奶巧克力~60 mg/oz",
      "白巧克力幾乎不含可可鹼，但高脂肪可導致胰臟炎",
      "症狀可能延遲6-12小時出現",
      "活性炭可重複給予（腸肝循環）",
      "輕度症狀（<20 mg/kg）：輕微胃腸道症狀",
      "中度症狀（20-60 mg/kg）：心血管和神經症狀",
      "重度症狀（>60 mg/kg）：癲癇、死亡風險"
    ],
    monitoring: ["心電圖", "心率", "體溫", "血壓", "尿量", "神經狀態"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "xylitol-toxicity": {
    zh: "木糖醇中毒",
    en: "Xylitol Toxicity",
    definition: "攝入木糖醇（一種常見的人工甜味劑）導致的中毒，在犬引起嚴重低血糖和潛在的肝衰竭。",
    synonyms: ["木糖醇中毒", "Sugar Alcohol Toxicosis", "Birch Sugar Poisoning"],
    epidemiology: {
      species: "主要影響犬，貓罕見（可能無臨床意義）",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["接觸含木糖醇產品（口香糖、糖果、烘焙食品、牙膏、某些藥物）"]
    },
    clinicalPresentation: {
      history: ["攝入含木糖醇產品史", "虛弱", "嘔吐", "共濟失調", "昏厥"],
      physicalExam: [
        "低血糖症狀（攝入後30-60分鐘）：虛弱、嘔吐、共濟失調、震顫、癲癇、昏迷",
        "肝毒性症狀（攝入後12-72小時）：嘔吐、嗜睡、黃疸、出血傾向"
      ]
    },
    pathophysiology: "犬攝入木糖醇 → 快速吸收（30分鐘內）→ 胰島素大量釋放（比葡萄糖刺激強2.5-7倍）→ 嚴重低血糖。高劑量 → 肝細胞氧化損傷 → ATP消耗 → 肝細胞壞死 → 急性肝衰竭、凝血障礙",
    diagnosis: {
      overview: "病史結合低血糖和/或肝功能異常",
      differentials: ["胰島素過量", "胰島素瘤", "其他低血糖原因", "肝毒性其他原因"],
      initialDB: ["血糖（低血糖）", "肝功能（ALT、AST、ALP、Bilirubin）", "凝血功能（PT/PTT）", "電解質（低鉀）"],
      advanced: ["腹部超聲（肝臟評估）"]
    },
    treatment: {
      overview: "糾正低血糖、肝臟保護、支持治療",
      acute: [
        "去污染（若攝入<30分鐘且無症狀）：",
        "- 催吐",
        "- 活性炭效果不確定",
        "低血糖治療：",
        "- Dextrose bolus：0.5-1 g/kg IV（25-50%溶液稀釋）",
        "- Dextrose CRI：2.5-5%維持正常血糖",
        "肝臟保護：",
        "- N-Acetylcysteine（NAC）：140 mg/kg IV loading，然後 70 mg/kg IV q6h",
        "- S-Adenosylmethionine（SAMe）：20 mg/kg PO q24h",
        "- Silymarin（水飛薊）：20-50 mg/kg/day",
        "輸液支持",
        "新鮮冷凍血漿（若凝血障礙）",
        "維生素K1（若PT延長）"
      ],
      chronic: ["持續監測肝功能", "肝臟支持治療"]
    },
    prognosis: "單純低血糖若及時治療預後良好。肝衰竭預後謹慎至差。低血糖劑量：>0.1 g/kg；肝毒性劑量：>0.5 g/kg。",
    pearls: [
      "口香糖木糖醇含量差異大（0.3-1.0 g/片）",
      "低血糖可在攝入後10-60分鐘內快速發展",
      "肝損傷可能延遲至攝入後12-72小時",
      "貓可能不受影響（代謝不同）",
      "許多無糖產品含木糖醇 - 仔細檢查成分",
      "花生醬是常見的隱藏來源",
      "症狀無關時也應監測肝功能48-72小時"
    ],
    monitoring: ["血糖（q1-2h直到穩定）", "肝功能（q12-24h x 72h）", "凝血功能", "精神狀態"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "nsaid-toxicity": {
    zh: "非類固醇消炎藥中毒",
    en: "NSAID Toxicity",
    definition: "攝入過量非類固醇消炎藥（NSAIDs）導致的中毒，主要引起胃腸道潰瘍、腎損傷和肝毒性。",
    synonyms: ["NSAID中毒", "Ibuprofen Toxicity", "Naproxen Toxicity", "消炎止痛藥中毒"],
    epidemiology: {
      species: "犬貓皆可發生，貓更敏感",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["誤食人用NSAIDs", "主人錯誤給藥", "與其他藥物合併使用", "脫水", "腎臟疾病"]
    },
    clinicalPresentation: {
      history: ["攝入NSAIDs史", "嘔吐（可能帶血）", "腹痛", "食慾下降", "黑便", "虛弱"],
      physicalExam: ["嘔吐", "吐血", "黑便", "腹痛", "脫水", "蒼白", "黃疸（肝毒性）", "無尿或少尿（腎衰竭）", "CNS抑制（高劑量）"]
    },
    pathophysiology: "NSAIDs抑制COX-1和COX-2 → 前列腺素合成減少 → 胃黏膜保護下降 → 胃潰瘍、穿孔；腎血流減少 → 急性腎損傷；某些NSAIDs有直接肝毒性",
    diagnosis: {
      overview: "病史結合胃腸道和腎臟損傷徵象",
      differentials: ["其他胃腸道潰瘍原因", "急性腎損傷其他原因", "出血性腸胃炎"],
      initialDB: ["CBC（貧血）", "生化（BUN/Crea、肝酶）", "糞便潛血", "尿液分析"],
      advanced: ["腹部X光/超聲", "內視鏡"]
    },
    treatment: {
      overview: "去污染、胃腸道保護、腎臟支持",
      acute: [
        "去污染（攝入<2小時）：",
        "- 催吐",
        "- 活性炭：1-2 g/kg（可能需重複給予）",
        "胃腸道保護：",
        "- Omeprazole：1-2 mg/kg PO/IV q12-24h",
        "- Sucralfate：0.5-1 g/狗 PO q6-8h（餐前空腹）",
        "- Misoprostol：2-5 μg/kg PO q8h（PGE1類似物）",
        "止吐：Maropitant 1 mg/kg SC/IV q24h",
        "積極輸液（維持腎灌注）",
        "輸血（若嚴重貧血）",
        "肝保護（若有肝損傷）：SAMe、NAC"
      ],
      chronic: ["持續胃腸道保護治療", "監測腎功能恢復"]
    },
    prognosis: "輕度中毒預後良好。嚴重胃腸道穿孔或腎衰竭預後謹慎至差。",
    pearls: [
      "不同NSAIDs毒性劑量差異大",
      "Ibuprofen犬中毒劑量：GI症狀>25 mg/kg，腎毒性>100 mg/kg，CNS毒性>400 mg/kg",
      "Naproxen毒性比Ibuprofen強",
      "貓對所有NSAIDs極度敏感（半衰期長）",
      "不要同時使用多種NSAIDs或NSAIDs+類固醇",
      "Sucralfate與其他口服藥應間隔2小時",
      "腎衰竭可能延遲數天出現"
    ],
    monitoring: ["腎功能", "糞便顏色", "PCV", "腹痛程度", "尿量"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "acetaminophen-toxicity": {
    zh: "對乙醯胺酚中毒",
    en: "Acetaminophen Toxicity",
    definition: "攝入對乙醯胺酚（撲熱息痛/泰諾）導致的中毒，在貓引起變性血紅蛋白血症，在犬主要引起肝損傷。",
    synonyms: ["撲熱息痛中毒", "Paracetamol Toxicity", "Tylenol Poisoning", "泰諾中毒"],
    epidemiology: {
      species: "貓極度敏感，犬較耐受",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["主人錯誤給藥（以為安全）", "貓缺乏葡萄糖醛酸化能力"]
    },
    clinicalPresentation: {
      history: ["攝入對乙醯胺酚史", "虛弱", "呼吸困難", "臉部/爪子腫脹（貓）"],
      physicalExam: [
        "貓：變性血紅蛋白血症（棕色黏膜、發紺）、臉部/爪子水腫、呼吸困難、抑鬱、嘔吐、流涎",
        "犬：嘔吐、嗜睡、黃疸、腹痛、肝腫大（高劑量）"
      ]
    },
    pathophysiology: "貓缺乏葡萄糖醛酸轉移酶 → 無法有效代謝 → 有毒代謝物（NAPQI）累積 → 消耗谷胱甘肽 → 血紅蛋白氧化為變性血紅蛋白 → 組織缺氧；犬高劑量 → 肝臟谷胱甘肽耗盡 → 肝細胞壞死",
    diagnosis: {
      overview: "病史、臨床表現（貓的棕色血液/黏膜）、血液檢測",
      differentials: ["其他變性血紅蛋白血症原因（洋蔥、苯佐卡因）", "溶血性貧血", "肝毒性其他原因"],
      initialDB: [
        "變性血紅蛋白（正常<1%，中毒可>30%）",
        "血液顏色（棕巧克力色）",
        "脈搏血氧儀（讀數可能假性正常或降低）",
        "Heinz小體（血塗片）",
        "肝功能（ALT、ALP）",
        "膽紅素"
      ],
      advanced: ["血清對乙醯胺酚濃度"]
    },
    treatment: {
      overview: "解毒劑（N-乙醯半胱氨酸）、變性血紅蛋白還原、肝保護",
      acute: [
        "去污染（若攝入<1-2小時）：",
        "- 催吐",
        "- 活性炭：1-2 g/kg",
        "解毒劑（越早越好）：",
        "- N-Acetylcysteine（NAC）：140-280 mg/kg IV/PO loading",
        "- 然後 70 mg/kg IV/PO q4-6h x 7劑",
        "還原變性血紅蛋白：",
        "- Ascorbic acid（維生素C）：30 mg/kg PO/IV q6h",
        "- SAMe：20 mg/kg PO q24h",
        "氧氣支持（若低氧血症）",
        "輸血（若PCV<15%或嚴重變性血紅蛋白血症）",
        "積極輸液"
      ],
      chronic: ["肝功能監測", "肝臟支持治療"]
    },
    prognosis: "貓：若及時治療（攝入後2小時內）預後良好；延遲治療預後差。貓致死劑量低至10 mg/kg。犬：中毒劑量較高（>150 mg/kg），預後通常較好。",
    pearls: [
      "貓對對乙醯胺酚極度敏感 - 半片泰諾可致死",
      "棕色/巧克力色血液是變性血紅蛋白血症的特徵性表現",
      "臉部/爪子水腫是貓中毒的早期徵兆",
      "脈搏血氧儀對變性血紅蛋白血症不可靠",
      "NAC是谷胱甘肽前驅物，應盡早給予",
      "永遠不要給貓服用對乙醯胺酚"
    ],
    monitoring: ["變性血紅蛋白%", "PCV", "肝功能", "臨床狀態", "尿液顏色"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "grape-raisin-toxicity": {
    zh: "葡萄/葡萄乾中毒",
    en: "Grape/Raisin Toxicity",
    definition: "攝入葡萄、葡萄乾或相關產品導致的中毒，引起犬的急性腎損傷。毒性成分可能為酒石酸。",
    synonyms: ["葡萄中毒", "葡萄乾中毒", "Grape Toxicosis", "Raisin Toxicosis"],
    epidemiology: {
      species: "主要影響犬，貓和雪貂可能也敏感",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["接觸葡萄/葡萄乾", "某些個體可能更易感（機制不明）"]
    },
    clinicalPresentation: {
      history: ["攝入葡萄/葡萄乾史", "嘔吐（常含葡萄殘渣）", "腹瀉", "食慾下降", "嗜睡", "少尿/無尿"],
      physicalExam: ["嘔吐", "腹瀉", "腹痛", "脫水", "嗜睡", "口腔潰瘍", "腎區疼痛", "無尿（晚期）"]
    },
    pathophysiology: "確切毒素尚不完全清楚（可能為酒石酸及其鉀鹽）→ 腎近端小管壞死 → 急性腎損傷。個體敏感性差異大，某些犬攝入少量即中毒，某些犬大量攝入無症狀",
    diagnosis: {
      overview: "病史結合急性腎損傷",
      differentials: ["乙二醇中毒", "百合中毒", "NSAIDs中毒", "鉤端螺旋體病", "腎前性/腎後性氮血症"],
      initialDB: ["BUN/Creatinine", "電解質", "尿液分析（等比重尿、糖尿、管型）", "尿沉渣"],
      advanced: ["腎臟超聲", "腎臟活檢"]
    },
    treatment: {
      overview: "去污染、積極輸液維持腎灌注、監測腎功能",
      acute: [
        "去污染（攝入<6小時）：",
        "- 催吐",
        "- 活性炭：1-2 g/kg（效果不確定）",
        "積極靜脈輸液：",
        "- 晶體液2倍維持量 x 48-72小時",
        "- 目標：維持良好尿量",
        "監測尿量（導尿）",
        "若少尿/無尿：",
        "- Furosemide：2-4 mg/kg IV bolus，然後CRI",
        "- Mannitol：0.5-1 g/kg IV（若無尿）",
        "止吐：Maropitant、Ondansetron",
        "血液透析（若設備可用且腎衰竭）"
      ],
      chronic: ["持續監測腎功能（至少72小時）", "腎病管理（若永久損傷）"]
    },
    prognosis: "早期積極治療預後可良好。一旦出現無尿性腎衰竭，預後極差。沒有確定的毒性劑量閾值（個體差異大）。",
    pearls: [
      "毒性劑量無法預測 - 建議任何攝入都當作潛在中毒處理",
      "葡萄乾比葡萄濃縮，可能毒性更高",
      "2022年研究提示酒石酸可能是毒性成分",
      "某些無籽葡萄品種可能酒石酸含量較低",
      "嘔吐物中發現葡萄殘渣有診斷價值",
      "腎損傷可能延遲24-72小時出現",
      "不是所有犬都會中毒，但無法預測哪些會"
    ],
    monitoring: ["BUN/Creatinine q12-24h x 72h", "尿量", "尿比重", "電解質"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013; Wegenast CA et al. JAVMA 2022"
  },

  "lily-toxicity": {
    zh: "百合中毒",
    en: "Lily Toxicity",
    definition: "貓攝入真百合屬（Lilium）或萱草屬（Hemerocallis）植物導致的嚴重中毒，引起急性腎衰竭。",
    synonyms: ["百合花中毒", "True Lily Toxicosis", "Easter Lily Poisoning", "Daylily Toxicity"],
    epidemiology: {
      species: "僅影響貓，犬似乎不受影響",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["家中有百合植物", "復活節/春季（百合花季）", "貓愛啃咬植物"]
    },
    clinicalPresentation: {
      history: ["接觸/攝入百合植物（任何部分）", "嘔吐", "食慾下降", "嗜睡", "多尿→無尿"],
      physicalExam: [
        "早期（0-12小時）：嘔吐、流涎、食慾下降",
        "中期（12-24小時）：多尿、脫水、嗜睡",
        "晚期（24-72小時）：無尿、尿毒症症狀（口腔潰瘍、嘔吐、嗜睡、癲癇）"
      ]
    },
    pathophysiology: "毒素成分尚不明確 → 快速吸收 → 腎近端小管壞死 → 急性腎小管壞死 → 急性腎衰竭。所有部分（花、葉、莖、花粉、花瓶水）皆有毒",
    diagnosis: {
      overview: "病史（接觸百合）結合急性腎損傷",
      differentials: ["乙二醇中毒", "葡萄/葡萄乾中毒", "NSAIDs中毒", "尿路阻塞"],
      initialDB: ["BUN/Creatinine", "電解質（高鉀、高磷）", "尿液分析（管型、糖尿）", "尿比重"],
      advanced: ["腎臟超聲", "腎臟活檢"]
    },
    treatment: {
      overview: "去污染、極積極的輸液治療、腎功能支持",
      acute: [
        "去污染（越早越好）：",
        "- 催吐（若攝入<2小時且無症狀）",
        "- 活性炭：1-2 g/kg",
        "極積極的靜脈輸液（關鍵）：",
        "- 晶體液2-3倍維持量 x 48-72小時",
        "- 開始越早越好（理想<6小時）",
        "監測尿量（導尿）",
        "若少尿：",
        "- Furosemide：2-4 mg/kg IV",
        "- Mannitol：0.25-0.5 g/kg IV",
        "糾正電解質異常（尤其高鉀）",
        "血液透析或腹膜透析（若可用）",
        "止吐和營養支持"
      ],
      chronic: ["腎功能監測", "慢性腎病管理（若永久損傷）"]
    },
    prognosis: "攝入後18小時內開始積極輸液治療預後良好。延遲治療或已出現腎衰竭預後極差。即使少量攝入（一片葉子、舔舐花粉）也可致死。",
    pearls: [
      "所有真百合對貓都有致命毒性：復活節百合、亞洲百合、日本百合、虎皮百合、萱草",
      "植物所有部分都有毒，包括花粉和花瓶水",
      "「安全」的百合：鈴蘭百合（心臟毒性不同）、和平百合（不是真百合）",
      "治療窗口窄 - 早期積極治療是關鍵",
      "即使貓看起來正常，接觸後也應立即治療",
      "教育主人：家有貓不要種百合",
      "預後與開始治療時間直接相關"
    ],
    monitoring: ["BUN/Creatinine q12-24h", "尿量", "電解質（K、P）", "尿比重"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "marijuana-toxicity": {
    zh: "大麻中毒",
    en: "Marijuana Toxicity",
    definition: "攝入大麻（Cannabis sativa）或其製品導致的中毒，主要成分四氫大麻酚（THC）引起神經系統症狀。",
    synonyms: ["大麻中毒", "THC Toxicosis", "Cannabis Intoxication", "Pot Poisoning"],
    epidemiology: {
      species: "犬最常見，貓也可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["家中有大麻產品", "大麻合法化地區病例增加", "含THC的食用品更危險（高濃度、延遲吸收）"]
    },
    clinicalPresentation: {
      history: ["可能接觸大麻史（主人可能否認）", "行為異常", "共濟失調", "尿失禁"],
      physicalExam: [
        "神經系統：共濟失調、定向障礙、過度興奮或抑鬱、瞳孔散大、眼球震顫、對刺激過度反應",
        "心血管：心搏過緩（常見）或心搏過速、低血壓",
        "其他：低體溫、流涎、尿失禁、嘔吐、震顫、昏迷（嚴重時）"
      ]
    },
    pathophysiology: "THC經CB1和CB2大麻素受體作用 → 神經傳導改變 → 中樞神經系統抑制/興奮。犬大麻素受體密度高於人類，對THC更敏感。食用品可能含巧克力或木糖醇增加毒性",
    diagnosis: {
      overview: "臨床症狀為主，病史通常不可靠",
      differentials: ["其他中毒（酒精、巴比妥、苯二氮卓）", "前庭疾病", "低血糖", "肝腦病"],
      initialDB: ["血糖", "血壓", "心電圖", "基礎生化", "尿液分析"],
      advanced: ["人用尿液THC快篩（假陰性常見）"]
    },
    treatment: {
      overview: "主要為支持治療，大多數病例自限性",
      acute: [
        "去污染：",
        "- 催吐（若攝入<30分鐘且意識清醒）",
        "- 活性炭：1-2 g/kg（注意誤吸風險）",
        "支持治療：",
        "- 靜脈輸液",
        "- 保暖（若低體溫）",
        "- 心搏過緩：Atropine 0.02-0.04 mg/kg IV（必要時）",
        "防止自傷：安靜環境、適當約束",
        "躁動控制：低劑量Diazepam",
        "防止誤吸（若嚴重意識抑制）",
        "脂肪乳劑（ILE）可能加速恢復（爭議）"
      ],
      chronic: ["通常不需要"]
    },
    prognosis: "大多數病例預後良好，症狀通常在24-72小時內消退。致死率極低，但高濃度食用品或合併其他毒素（巧克力）可能嚴重。",
    pearls: [
      "主人可能否認大麻暴露 - 不要過度依賴病史",
      "典型三聯症：共濟失調、尿失禁、對刺激過度反應",
      "人用THC尿液快篩對犬假陰性率高（~30%）",
      "食用品（brownies、gummies）可能含巧克力、木糖醇或高脂肪",
      "心搏過緩是大麻中毒特徵（與其他中毒不同）",
      "大多數病例支持治療即可恢復",
      "CBD產品通常毒性低，但可能含THC"
    ],
    monitoring: ["心率", "體溫", "神經狀態", "呼吸功能"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "organophosphate-toxicity": {
    zh: "有機磷中毒",
    en: "Organophosphate Toxicity",
    definition: "暴露於有機磷類化合物（農藥、殺蟲劑）導致的膽鹼酯酶抑制中毒，引起膽鹼能危象。",
    synonyms: ["有機磷農藥中毒", "OP Toxicosis", "Anticholinesterase Poisoning", "膽鹼酯酶抑制劑中毒"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["農業環境", "接觸殺蟲劑", "使用蚤藥項圈或噴霧（過量或不當使用）", "工業環境"]
    },
    clinicalPresentation: {
      history: ["接觸農藥/殺蟲劑史", "使用蚤藥產品後", "流涎", "嘔吐", "腹瀉", "呼吸困難"],
      physicalExam: [
        "SLUDGE/DUMBELS症狀（毒蕈鹼樣）：",
        "- S: Salivation（流涎）",
        "- L: Lacrimation（流淚）",
        "- U: Urination（排尿）",
        "- D: Defecation（排便）",
        "- G: GI distress（胃腸不適）",
        "- E: Emesis（嘔吐）",
        "尼古丁樣症狀：肌肉震顫、抽搐、虛弱、麻痺",
        "中樞症狀：躁動、癲癇、昏迷",
        "其他：瞳孔縮小、心搏過緩、支氣管痙攣、呼吸衰竭"
      ]
    },
    pathophysiology: "有機磷不可逆抑制乙醯膽鹼酯酶 → 乙醯膽鹼在突觸累積 → 過度刺激毒蕈鹼受體（腺體、平滑肌、心臟）和尼古丁受體（骨骼肌、神經節）→ 膽鹼能危象。若未及時治療，酶-磷複合物「老化」變得不可逆",
    diagnosis: {
      overview: "臨床症狀結合暴露史、膽鹼酯酶活性下降",
      differentials: ["氨基甲酸酯中毒", "其他膽鹼能藥物過量", "蘑菇中毒（某些種類）"],
      initialDB: ["膽鹼酯酶活性（血液或視網膜）", "血氣（呼吸性酸中毒）", "血糖", "電解質"],
      advanced: ["毒物篩檢確認"]
    },
    treatment: {
      overview: "穩定呼吸、解毒劑（Atropine、2-PAM）、去污染、支持治療",
      acute: [
        "穩定呼吸（最優先）：",
        "- 氧氣支持",
        "- 必要時氣管插管和機械通氣",
        "- 清除呼吸道分泌物",
        "解毒劑：",
        "- Atropine（阻斷毒蕈鹼症狀）：0.2-0.5 mg/kg IV，1/4劑量先給",
        "- 根據分泌物控制重複給藥（可能需要大量）",
        "- 目標：乾燥分泌物，不是瞳孔大小",
        "- Pralidoxime（2-PAM，重新活化膽鹼酯酶）：10-20 mg/kg IV slow，q8-12h",
        "- 2-PAM需在「老化」前使用（越早越好）",
        "去污染：",
        "- 皮膚暴露：肥皂水徹底沖洗",
        "- 口服暴露：活性炭（若已穩定）",
        "癲癇控制：Diazepam",
        "避免使用：Succinylcholine、吩噻嗪類"
      ],
      chronic: ["監測膽鹼酯酶恢復", "注意中間症候群（肌肉無力延遲發作）"]
    },
    prognosis: "及時治療預後可良好。延遲治療或嚴重呼吸抑制預後差。中間症候群可在中毒後1-4天出現。",
    pearls: [
      "SLUDGE是記憶毒蕈鹼症狀的助記詞",
      "呼吸衰竭是主要死因",
      "Atropine劑量按效果調整，不是固定劑量",
      "2-PAM越早給予越有效（在「老化」前）",
      "皮膚去污時工作人員需保護自己（PPE）",
      "Atropine只治療毒蕈鹼症狀，不治療肌肉無力",
      "氨基甲酸酯中毒類似但通常較輕（可逆抑制）"
    ],
    monitoring: ["呼吸功能", "分泌物量", "心率", "膽鹼酯酶活性", "神經肌肉功能"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "pyrethrin-permethrin-toxicity": {
    zh: "除蟲菊酯中毒",
    en: "Pyrethrin/Permethrin Toxicity",
    definition: "暴露於除蟲菊素（天然）或合成除蟲菊酯類（如百滅寧）導致的神經毒性，貓對合成除蟲菊酯極度敏感。",
    synonyms: ["百滅寧中毒", "Permethrin Toxicosis", "Pyrethroid Toxicity", "合成除蟲菊酯中毒"],
    epidemiology: {
      species: "貓對合成除蟲菊酯極度敏感，犬較耐受",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["誤用犬用除蚤產品於貓", "貓與剛使用除蚤產品的犬接觸", "小體型", "年幼或體弱"]
    },
    clinicalPresentation: {
      history: ["接觸除蚤/驅蟲產品史", "誤用犬用產品於貓", "貓舔舐同居犬身上的產品"],
      physicalExam: [
        "神經系統（主要）：肌肉震顫、抽搐、癲癇、共濟失調、過度興奮",
        "「耳尖抽動」是特徵性表現",
        "流涎、嘔吐",
        "瞳孔散大",
        "感覺過敏",
        "低體溫或高體溫",
        "死亡（嚴重時）"
      ]
    },
    pathophysiology: "除蟲菊酯延遲鈉離子通道關閉 → 神經過度興奮 → 反覆動作電位。貓缺乏葡萄糖醛酸化能力 → 代謝慢 → 毒性物質累積。II型除蟲菊酯（如百滅寧）毒性>I型",
    diagnosis: {
      overview: "典型病史（犬用產品用於貓）結合神經症狀",
      differentials: ["有機磷中毒", "蝸牛藥中毒", "癲癇", "低血糖", "低鈣血症"],
      initialDB: ["血糖", "電解質（Ca、Mg）", "體溫", "肝腎功能"],
      advanced: ["毒物篩檢（通常不需要）"]
    },
    treatment: {
      overview: "去污染、肌肉鬆弛劑/抗癲癇、支持治療",
      acute: [
        "去污染（重要）：",
        "- 局部暴露：用溫肥皂水或洗碗精徹底洗浴",
        "- 口服暴露：活性炭（若無癲癇）",
        "控制震顫和癲癇：",
        "- Methocarbamol：44-220 mg/kg IV slow（不超過330 mg/kg/day）",
        "- 或 Diazepam：0.5-2 mg/kg IV（按需重複）",
        "- 或 Propofol CRI（嚴重病例）",
        "脂肪乳劑療法（ILE）：",
        "- 20% Intralipid：1.5 mL/kg IV bolus over 15min",
        "- 然後 0.25 mL/kg/min x 30-60min",
        "- 可顯著加速恢復",
        "體溫控制（降溫若高熱，保暖若低體溫）",
        "靜脈輸液",
        "營養支持（恢復期）"
      ],
      chronic: ["通常完全恢復，無長期後遺症"]
    },
    prognosis: "積極治療預後良好，大多數貓在24-72小時內恢復。延遲治療或嚴重病例可能死亡。脂肪乳劑療法顯著改善預後。",
    pearls: [
      "永遠不要將犬用除蚤產品用於貓",
      "「耳尖抽動」是典型表現",
      "皮膚去污非常重要 - 徹底洗浴",
      "脂肪乳劑療法是近年重要進展",
      "Methocarbamol優於苯二氮卓類控制震顫",
      "警告主人：同居犬使用百滅寧產品後應與貓隔離",
      "低濃度除蟲菊素（貓用產品）通常安全"
    ],
    monitoring: ["震顫程度", "體溫", "心率", "神經狀態"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "lead-toxicity": {
    zh: "鉛中毒",
    en: "Lead Toxicity",
    definition: "攝入或吸入鉛導致的慢性或急性中毒，主要影響神經系統、消化系統和造血系統。",
    synonyms: ["鉛中毒", "Lead Poisoning", "Plumbism", "鉛毒症"],
    epidemiology: {
      species: "犬較常見，貓相對少見",
      age: "幼年動物更常見（啃咬行為、吸收率高）",
      sex: "無性別傾向",
      riskFactors: ["老舊建築（含鉛油漆）", "裝修環境", "接觸電池、彈藥、釣魚墜子、某些玩具"]
    },
    clinicalPresentation: {
      history: ["可能接觸鉛來源史", "嘔吐", "腹痛", "食慾下降", "行為改變", "癲癇"],
      physicalExam: [
        "消化系統：嘔吐、腹瀉或便秘、腹痛、食慾下降",
        "神經系統：行為改變、嗜睡、共濟失調、失明、癲癇（急性）",
        "造血系統：貧血（通常再生性）",
        "其他：牙齦鉛線（慢性，罕見）"
      ]
    },
    pathophysiology: "鉛抑制多種酶系統 → 血紅素合成障礙（δ-ALA脫水酶、血紅素合成酶）→ 貧血和嗜鹼性點彩紅血球；神經毒性（影響神經傳導、髓鞘形成）→ 腦病；GI毒性（平滑肌痙攣）→ 腹絞痛",
    diagnosis: {
      overview: "病史、臨床表現、血液鉛濃度升高",
      differentials: ["其他重金屬中毒", "癲癇其他原因", "胃腸道疾病", "貧血其他原因"],
      initialDB: [
        "血液鉛濃度（>40 μg/dL通常有症狀）",
        "CBC（再生性貧血、嗜鹼性點彩紅血球、有核紅血球）",
        "腹部X光（放射線不透性異物）",
        "生化（肝腎功能）"
      ],
      advanced: ["骨髓檢查", "尿鉛排泄"]
    },
    treatment: {
      overview: "去除鉛來源、螯合治療、控制神經症狀",
      acute: [
        "穩定（若有癲癇）：Diazepam",
        "控制腦水腫（若有）：Mannitol",
        "去除GI道鉛（若X光可見）：",
        "- 內視鏡取出",
        "- 或手術取出（大塊異物）",
        "- 高纖維飲食促進排出（小顆粒）",
        "螯合治療：",
        "- CaEDTA（首選）：25 mg/kg SC q6h x 5天",
        "- 休息5天後可重複療程",
        "- 或 Succimer（DMSA）：10 mg/kg PO q8h x 10天",
        "- D-Penicillamine：10-15 mg/kg PO q8h x 1-2週",
        "避免使用MgSO4或NaSO4（增加鉛吸收）"
      ],
      chronic: ["移除環境中的鉛來源", "可能需要多次螯合療程", "監測血鉛濃度"]
    },
    prognosis: "早期治療預後良好。神經損傷可能部分不可逆。慢性暴露可導致永久性損害。",
    pearls: [
      "幼年動物吸收率高（30-50% vs 成年10%）",
      "嗜鹼性點彩紅血球是重要線索（但不特異）",
      "腹部X光可見放射線不透性異物有診斷價值",
      "GI道鉛異物需先取出再螯合（避免增加吸收）",
      "CaEDTA通過SC給予避免局部刺激",
      "螯合治療期間需補充鋅（螯合劑也結合鋅）",
      "追蹤血鉛濃度確認治療效果"
    ],
    monitoring: ["血鉛濃度", "神經狀態", "CBC", "腎功能"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "zinc-toxicity": {
    zh: "鋅中毒",
    en: "Zinc Toxicity",
    definition: "攝入含鋅物質（硬幣、五金零件、氧化鋅乳膏）導致的中毒，引起溶血性貧血和多器官損傷。",
    synonyms: ["鋅中毒", "Zinc Poisoning", "Penny Toxicosis", "硬幣中毒"],
    epidemiology: {
      species: "犬較常見（喜吞異物），貓罕見",
      age: "幼年動物更常見",
      sex: "無性別傾向",
      riskFactors: ["接觸含鋅物品", "美國1983年後硬幣（高鋅含量）", "五金零件（螺帽、螺栓）", "氧化鋅乳膏"]
    },
    clinicalPresentation: {
      history: ["可能吞入異物史", "嘔吐", "腹瀉", "虛弱", "黃疸", "紅色/褐色尿"],
      physicalExam: [
        "消化系統：嘔吐、腹瀉、腹痛、食慾下降",
        "溶血性貧血：黏膜蒼白、黃疸、心搏過速、虛弱",
        "血紅蛋白尿/血紅蛋白血症",
        "多器官損傷：肝臟、腎臟、胰臟",
        "Heinz小體溶血（可能）"
      ]
    },
    pathophysiology: "胃酸環境中鋅溶解 → 鋅離子被吸收 → 紅血球膜損傷 → 血管內溶血；氧化應激 → Heinz小體形成；直接組織毒性 → 肝、腎、胰臟損傷",
    diagnosis: {
      overview: "病史、X光可見異物、溶血性貧血、血清鋅升高",
      differentials: ["IMHA", "其他溶血性貧血原因", "其他金屬中毒", "洋蔥/大蒜中毒"],
      initialDB: [
        "腹部X光（放射線不透性異物 - 硬幣、金屬物）",
        "CBC（再生性貧血、球形紅血球、Heinz小體）",
        "生化（肝腎功能、膽紅素升高）",
        "網織紅血球計數",
        "尿液分析（血紅蛋白尿）"
      ],
      advanced: ["血清鋅濃度（正常0.7-2.0 μg/mL）", "Coombs試驗（排除IMHA）"]
    },
    treatment: {
      overview: "移除鋅來源、支持溶血、器官功能保護",
      acute: [
        "移除鋅來源（優先）：",
        "- 催吐（若剛攝入且無症狀）",
        "- 內視鏡取出",
        "- 手術取出（若內視鏡失敗）",
        "輸血（若嚴重貧血）：",
        "- pRBC或全血",
        "- 目標PCV >20-25%",
        "輸液支持（維持腎灌注）",
        "止吐：Maropitant",
        "胃腸道保護：Omeprazole、Sucralfate",
        "螯合治療（爭議，通常不需要）",
        "監測並支持器官功能"
      ],
      chronic: ["監測PCV恢復", "肝腎功能追蹤"]
    },
    prognosis: "早期移除鋅來源且積極支持治療預後良好。延遲治療或嚴重溶血預後謹慎。",
    pearls: [
      "美國1983年後1分硬幣含97.5%鋅",
      "胃內酸性環境加速鋅溶解和吸收",
      "X光是快速診斷工具 - 尋找金屬異物",
      "移除異物是治療關鍵",
      "溶血可能在異物移除後持續數天",
      "鋅螯合治療通常不需要（移除來源即可）",
      "氧化鋅乳膏攝入較少引起嚴重中毒（吸收有限）"
    ],
    monitoring: ["PCV/TS", "網織紅血球", "肝腎功能", "尿液顏色"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "metaldehyde-toxicity": {
    zh: "蝸牛藥中毒",
    en: "Metaldehyde Toxicity",
    definition: "攝入含聚乙醛的蝸牛/蛞蝓誘餌導致的嚴重中毒，引起持續性肌肉震顫、癲癇和高熱。",
    synonyms: ["蝸牛餌中毒", "Slug Bait Poisoning", "Snail Bait Toxicosis", "聚乙醛中毒"],
    epidemiology: {
      species: "犬較常見（誘餌有吸引力），貓也可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["花園使用蝸牛餌", "春季和秋季（蝸牛活躍季節）", "犬喜歡誘餌味道（可能含麩皮、糖蜜）"]
    },
    clinicalPresentation: {
      history: ["可能接觸蝸牛藥史", "焦躁", "肌肉震顫", "共濟失調", "癲癇"],
      physicalExam: [
        "神經系統：焦躁、過度興奮、共濟失調、持續性肌肉震顫（「顫動」）、強直陣攣性癲癇",
        "高熱（可達>42°C/108°F）- 因持續肌肉活動",
        "心搏過速、呼吸急促",
        "流涎、腹瀉",
        "角弓反張、刺激敏感",
        "肝衰竭（延遲，2-3天後）"
      ]
    },
    pathophysiology: "聚乙醛在胃中分解為乙醛 → GABA和單胺氧化酶抑制 → 神經興奮性增加 → 持續肌肉震顫 → 代謝產熱 → 惡性高熱 → 橫紋肌溶解、DIC、多器官衰竭",
    diagnosis: {
      overview: "典型臨床表現結合可能的暴露史",
      differentials: ["癲癇", "有機磷中毒", "士的寧中毒", "低血糖", "低血鈣", "腦炎"],
      initialDB: ["血糖", "電解質", "體溫", "肝腎功能", "CK（橫紋肌溶解）", "凝血功能"],
      advanced: ["毒物篩檢（胃內容物聚乙醛）"]
    },
    treatment: {
      overview: "控制震顫/癲癇、積極降溫、支持治療",
      acute: [
        "控制震顫和癲癇（最優先）：",
        "- Methocarbamol：55-220 mg/kg IV slow（首選控制震顫）",
        "- Diazepam：0.5-2 mg/kg IV",
        "- Propofol CRI：2-6 mg/kg/h（嚴重病例）",
        "- Pentobarbital：3-15 mg/kg IV（若上述無效）",
        "積極降溫：",
        "- 冷水浴、風扇、冷靜脈輸液",
        "- 目標：體溫<40°C/104°F",
        "去污染（若剛攝入且可行）：",
        "- 催吐（僅限清醒、無症狀）",
        "- 胃灌洗（麻醉下）",
        "- 活性炭：1-2 g/kg",
        "靜脈輸液（維持腎灌注、預防橫紋肌溶解併發症）",
        "肝臟保護：NAC、SAMe",
        "監測凝血功能（DIC風險）"
      ],
      chronic: ["肝功能監測（2-3天）", "腎功能監測"]
    },
    prognosis: "早期積極治療預後可良好。高熱未控制或發展為多器官衰竭預後差。致死劑量約100-600 mg/kg。",
    pearls: [
      "「shake and bake」- 震顫和高熱是特徵",
      "高熱是主要死因 - 積極降溫至關重要",
      "Methocarbamol比Diazepam更有效控制震顫",
      "肝衰竭可能在24-72小時後延遲出現",
      "教育主人使用寵物安全的替代產品",
      "某些蝸牛藥也含有機磷或氨基甲酸酯",
      "症狀可在攝入後1-3小時迅速出現"
    ],
    monitoring: ["體溫（q15-30min至穩定）", "震顫程度", "肝功能", "腎功能", "凝血功能", "CK"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "mushroom-toxicity": {
    zh: "蘑菇中毒",
    en: "Mushroom Toxicity",
    definition: "攝入有毒蘑菇導致的中毒，症狀取決於蘑菇種類，從輕微胃腸道症狀到致命肝衰竭。",
    synonyms: ["毒蕈中毒", "Toadstool Poisoning", "Mycetism", "野生蘑菇中毒"],
    epidemiology: {
      species: "犬較常見（戶外啃食行為），貓罕見",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["戶外活動", "潮濕環境", "秋季（蘑菇生長季節）", "院子或公園有野生蘑菇"]
    },
    clinicalPresentation: {
      history: ["可能攝入蘑菇史", "症狀取決於蘑菇類型"],
      physicalExam: [
        "A類（肝毒性 - Amanita, Galerina）：6-24小時延遲後GI症狀 → 假性恢復期 → 2-4天肝衰竭、黃疸、凝血障礙、死亡",
        "B類（神經毒性 - Inocybe, Clitocybe）：SLUDGE症狀（毒蕈鹼樣）- 流涎、流淚、排尿、排便",
        "C類（CNS興奮 - Psilocybe）：幻覺、共濟失調、行為異常、心搏過速",
        "D類（CNS抑制 - Amanita muscaria）：抑鬱、共濟失調、昏迷、癲癇",
        "E類（GI刺激 - 多種）：快速發作嘔吐、腹瀉、腹痛",
        "F類（溶血 - Gyromitra）：溶血、肝損傷"
      ]
    },
    pathophysiology: "因蘑菇毒素種類而異。Amatoxins（鵝膏毒素）：抑制RNA聚合酶II → 蛋白質合成停止 → 肝細胞壞死。Muscarine：毒蕈鹼受體激動。Psilocybin：血清素受體作用。",
    diagnosis: {
      overview: "病史結合臨床表現，蘑菇鑑定有助診斷",
      differentials: ["其他中毒", "胃腸道疾病", "肝病其他原因", "神經疾病"],
      initialDB: ["生化（肝腎功能）", "凝血功能", "CBC", "血糖", "電解質"],
      advanced: ["蘑菇鑑定（保留樣本/照片）", "毒素特異性檢測（通常不可用）"]
    },
    treatment: {
      overview: "去污染、支持治療、針對毒素類型特異性治療",
      acute: [
        "去污染：",
        "- 催吐（若攝入<1小時且無症狀）",
        "- 活性炭：1-2 g/kg（可重複）",
        "- 活性炭對Amatoxins重要（腸肝循環）",
        "肝毒性蘑菇（Amanita）特異性治療：",
        "- Silibinin/Silymarin：20-50 mg/kg/day IV/PO",
        "- N-Acetylcysteine：140 mg/kg loading，然後70 mg/kg q6h",
        "- Penicillin G：25-50萬U/kg/day IV",
        "- 高劑量葡萄糖輸液",
        "毒蕈鹼樣症狀：Atropine 0.04 mg/kg IV",
        "輸液支持",
        "止吐",
        "血液透析/血漿置換（Amatoxin中毒，若可用）",
        "肝移植（人類最後手段）"
      ],
      chronic: ["肝功能監測", "凝血功能監測"]
    },
    prognosis: "取決於蘑菇類型。GI刺激型預後良好。肝毒性蘑菇（Amanita）即使治療死亡率高（>50%）。症狀延遲出現（>6小時）提示更危險類型。",
    pearls: [
      "「延遲症狀（>6小時）= 危險蘑菇」",
      "Amanita phalloides（死亡帽蘑菇）是最致命的",
      "保留蘑菇樣本供鑑定（冷藏，不要冷凍）",
      "活性炭可重複給予（腸肝循環）",
      "不要依賴民間辨識方法（外觀不可靠）",
      "假性恢復期後突然惡化是Amatoxin中毒特徵",
      "聯繫毒物中心或真菌學專家協助鑑定"
    ],
    monitoring: ["肝功能（q6-12h初期）", "凝血功能", "腎功能", "血糖", "精神狀態"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  },

  "blue-green-algae-toxicity": {
    zh: "藍綠藻中毒",
    en: "Blue-Green Algae Toxicity",
    definition: "暴露於藍綠藻（藍藻/藍菌）產生的毒素導致的急性中毒，主要引起肝毒性或神經毒性。",
    synonyms: ["藍藻中毒", "Cyanobacteria Toxicosis", "Algal Toxicosis", "藍菌毒素中毒"],
    epidemiology: {
      species: "犬最常見（喜歡游泳、喝池塘水），貓和其他動物也可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["溫暖季節", "停滯水體", "富營養化水域", "藻華期間", "犬游泳或喝受污染水"]
    },
    clinicalPresentation: {
      history: ["接觸池塘、湖泊或停滯水體", "游泳或喝水後不久發病", "發病極快（分鐘至數小時）"],
      physicalExam: [
        "神經毒素（Anatoxin-a）：肌肉震顫、強直、癲癇、呼吸麻痺、快速死亡（分鐘至小時）",
        "肝毒素（Microcystin）：嘔吐、腹瀉（可能帶血）、虛弱、黃疸、肝腫大、休克、DIC（數小時至數天）",
        "皮膚毒素：皮膚刺激、紅疹"
      ]
    },
    pathophysiology: "神經毒素（Anatoxin-a, Anatoxin-a(s)）：尼古丁受體激動（depolarizing block）→ 肌肉麻痺 → 呼吸衰竭。肝毒素（Microcystin, Nodularin）：蛋白磷酸酶抑制 → 肝細胞骨架破壞 → 大量肝細胞壞死 → 急性肝衰竭、休克",
    diagnosis: {
      overview: "典型暴露史結合快速發病、環境評估",
      differentials: ["其他快速作用中毒", "癲癇", "急性肝衰竭其他原因", "感染性疾病"],
      initialDB: ["肝功能（ALT、AST、ALP大幅升高）", "膽紅素", "凝血功能", "血糖", "電解質"],
      advanced: ["水樣本藻毒素檢測", "胃內容物/組織毒素檢測", "肝臟活檢/病理"]
    },
    treatment: {
      overview: "去污染、支持治療、肝臟保護（肝毒素），大多數神經毒素中毒因發展太快而無法有效治療",
      acute: [
        "去污染（若可行）：",
        "- 催吐（若剛暴露且無神經症狀）",
        "- 活性炭：1-2 g/kg",
        "- 皮膚暴露：徹底水洗",
        "神經毒素（支持治療為主）：",
        "- 呼吸支持（可能需要機械通氣）",
        "- 控制癲癇：Diazepam",
        "- Atropine（若為Anatoxin-a(s) - 膽鹼酯酶抑制）",
        "肝毒素：",
        "- 積極輸液",
        "- 肝臟保護：NAC、SAMe、Silymarin",
        "- 新鮮冷凍血漿（凝血障礙）",
        "- Vitamin K1（若PT延長）",
        "- 止吐",
        "膽酸結合劑（Cholestyramine）：可能減少毒素吸收"
      ],
      chronic: ["肝功能監測", "長期肝臟支持"]
    },
    prognosis: "預後通常極差。神經毒素：發病極快，多數在數小時內死亡。肝毒素：死亡率高，存活者可能有永久性肝損傷。",
    pearls: [
      "「看起來像豌豆湯或綠色油漆的水 = 危險」",
      "神經毒素作用極快 - 可能來不及治療",
      "肝毒素相對較慢發展但同樣致命",
      "溫暖天氣+富營養化水體 = 高風險",
      "教育主人：避免讓狗在藻華水體游泳或喝水",
      "即使少量暴露也可能致死",
      "保留水樣本供檢測"
    ],
    monitoring: ["神經功能", "呼吸功能", "肝功能（q6-12h）", "凝血功能", "血糖"],
    reference: "Peterson ME, Talcott PA: Small Animal Toxicology, 3rd Ed. Elsevier, 2013"
  }
  // ===== From reproductive-diseases.js =====
  "pyometra": {
    zh: "子宮蓄膿",
    en: "Pyometra",
    definition: "子宮腔內膿液積聚的嚴重感染性疾病，通常發生在動情週期的黃體期，是未絕育母犬和母貓的常見急症。",
    synonyms: ["子宮積膿", "Uterine Empyema", "Cystic Endometrial Hyperplasia-Pyometra Complex", "CEH-Pyometra"],
    epidemiology: {
      species: "犬較常見，貓也可發生",
      age: "中老年（犬平均7-8歲），但任何年齡未絕育母犬皆可發生",
      sex: "僅限未絕育母犬/母貓",
      breedPredilection: "Collie、Cavalier King Charles Spaniel、Golden Retriever、Rottweiler、Bernese Mountain Dog",
      riskFactors: ["未絕育", "外源性荷爾蒙治療（雌激素、黃體素）", "假懷孕", "不規則發情週期", "從未懷孕"]
    },
    clinicalPresentation: {
      history: ["發情後2-8週發病", "陰道分泌物（開放型）", "多飲多尿", "食慾下降", "嘔吐", "腹部膨大", "嗜睡"],
      physicalExam: ["陰道膿性/血性分泌物（開放型）", "腹部膨大或疼痛", "脫水", "發燒或低體溫", "休克徵象（敗血症）", "子宮觸診增大"]
    },
    pathophysiology: "黃體期高黃體素 → 子宮內膜增生（CEH）→ 子宮免疫力下降 → 細菌（主要為E. coli）上行感染 → 子宮積膿。開放型：子宮頸開放，膿液排出；閉鎖型：子宮頸關閉，膿液積聚，更危險",
    diagnosis: {
      overview: "病史、臨床症狀、影像學確診",
      differentials: ["懷孕", "子宮積液（黏液/血液）", "子宮扭轉", "卵巢囊腫", "陰道炎"],
      initialDB: ["CBC（嗜中性白血球增多伴左移、單核球增多、貧血）", "生化（氮血症、肝酵素升高、低白蛋白血症）", "腹部超聲（擴張的子宮角，管腔內低迴聲液體）"],
      advanced: ["腹部X光", "陰道細胞學", "血液培養（若敗血症）", "凝血功能"]
    },
    treatment: {
      overview: "首選外科卵巢子宮切除術（OVH），穩定後盡快手術",
      acute: [
        "術前穩定：",
        "- 靜脈輸液糾正脫水和電解質失衡",
        "- 廣譜抗生素：Ampicillin-Sulbactam 22 mg/kg IV q8h + Enrofloxacin 5-10 mg/kg IV q24h",
        "- 或 Cefazolin 22 mg/kg IV q8h + Metronidazole 15 mg/kg IV q12h",
        "手術治療：",
        "- 卵巢子宮切除術（OVH）- 首選且治癒性治療",
        "- 術後繼續抗生素7-14天",
        "內科治療（保留生育能力，風險較高）：",
        "- Aglepristone（黃體素拮抗劑）: 10 mg/kg SC q24h x 2-3天",
        "- Cloprostenol（PGF2α類似物）: 1-3 μg/kg SC q12-24h x 3-5天",
        "- 必須密切監測，復發率高"
      ],
      chronic: ["術後抗生素療程完成", "監測復發（內科治療者）"]
    },
    prognosis: "手術治療：預後良好，死亡率約5-8%。閉鎖型和敗血症死亡率較高。內科治療：復發率20-77%，下次發情後建議絕育。",
    pearls: [
      "閉鎖型比開放型更危險，因為沒有引流",
      "多飲多尿是E. coli內毒素干擾腎臟濃縮功能所致",
      "不要等到穩定完美才手術 - 感染源在子宮內",
      "絕育是最好的預防",
      "發情後4-8週是高風險期"
    ],
    monitoring: ["術後腎功能", "體溫", "白血球計數", "傷口癒合"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Nelson RW, Couto CG: Small Animal Internal Medicine, 5th Ed. Elsevier, 2014"
  },

  "dystocia": {
    zh: "難產",
    en: "Dystocia",
    definition: "分娩過程中由於母體或胎兒因素導致的分娩困難，無法順利娩出胎兒，是產科急症。",
    synonyms: ["分娩困難", "Obstructed Labor", "Difficult Birth"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何生育年齡，初產和高齡產婦風險較高",
      sex: "僅限母犬/母貓",
      breedPredilection: "短頭犬種（Bulldog、Boston Terrier、French Bulldog）、小型犬、蘇格蘭折耳貓、波斯貓",
      riskFactors: ["單胎妊娠", "過大胎兒", "骨盆狹窄", "肥胖", "高齡", "子宮惰性", "胎位不正"]
    },
    clinicalPresentation: {
      history: ["妊娠超過預產期（>70天）", "第一產程>24小時無進展", "第二產程>2小時無胎兒產出", "胎兒間隔>2小時", "綠色分泌物無胎兒產出", "虛弱/抑鬱"],
      physicalExam: ["腹部緊張努責", "可見或觸及卡住的胎兒", "陰道分泌物（綠色提示胎盤分離）", "脫水", "虛弱", "胎心率異常（<150或>220 bpm）"]
    },
    pathophysiology: "母體因素：子宮惰性（原發性或繼發性）、骨盆狹窄、陰道/外陰狹窄、子宮扭轉。胎兒因素：過大、畸形、死胎、胎位不正、胎數過多。結果：分娩停滯 → 胎兒窘迫 → 胎兒和/或母體死亡",
    diagnosis: {
      overview: "病史、理學檢查、影像學確診並評估胎兒狀態",
      differentials: ["正常分娩間歇", "假懷孕"],
      initialDB: ["腹部X光（胎兒數目、大小、位置、骨骼畸形）", "腹部超聲（胎心率、胎兒存活）", "陰道檢查（子宮頸擴張、胎兒位置）", "血糖", "電解質", "血鈣"],
      advanced: ["血氣分析", "血鈣（低血鈣可致子宮惰性）"]
    },
    treatment: {
      overview: "根據情況選擇內科或外科治療，胎兒窘迫需緊急剖腹產",
      acute: [
        "內科治療（子宮惰性、子宮頸已擴張、胎兒存活）：",
        "- Oxytocin: 0.25-2 IU IV/IM，可每20-30分鐘重複（最多3次）",
        "- Calcium gluconate 10%: 0.5-1 mL/kg IV slow（監測ECG）",
        "- 輸液糾正脫水",
        "- 葡萄糖補充（若低血糖）",
        "外科治療（剖腹產）指征：",
        "- 內科治療失敗",
        "- 胎兒-母體不成比例",
        "- 胎兒窘迫（心率<150 bpm）",
        "- 骨盆阻塞",
        "- 子宮扭轉/破裂",
        "- 綠色分泌物無進展",
        "- 品種高風險（Bulldog等）",
        "剖腹產技術：",
        "- 術前最小化胎兒藥物暴露",
        "- 快速取出胎兒並復甦"
      ],
      chronic: ["產後子宮復舊監測", "泌乳支持", "考慮未來絕育"]
    },
    prognosis: "及時治療：母犬存活率>90%，胎兒存活率60-90%。延遲治療：母犬和胎兒死亡率顯著增加。短頭犬種剖腹產率可達80-100%。",
    pearls: [
      "綠色分泌物表示胎盤已分離，胎兒缺氧倒數計時開始",
      "Oxytocin過量可致子宮破裂，謹慎使用",
      "低血鈣是子宮惰性的常見原因",
      "胎兒心率正常150-220 bpm，<150 bpm提示窘迫",
      "短頭犬種應計劃性剖腹產"
    ],
    monitoring: ["母犬生命徵象", "胎兒心率", "子宮收縮", "陰道分泌物"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "mastitis": {
    zh: "乳腺炎",
    en: "Mastitis",
    definition: "乳腺組織的炎症或感染，通常發生在哺乳期，可能是細菌感染（敗血性）或非感染性（乳汁鬱積）。",
    synonyms: ["乳房炎", "Mammary Gland Infection", "乳腺感染"],
    epidemiology: {
      species: "犬較常見，貓也可發生",
      age: "哺乳期任何年齡",
      sex: "僅限哺乳中的母犬/母貓",
      breedPredilection: "無特定品種傾向",
      riskFactors: ["哺乳期", "乳頭創傷", "環境衛生差", "幼仔牙齒/指甲傷害", "乳汁鬱積", "早期離乳"]
    },
    clinicalPresentation: {
      history: ["哺乳中或近期哺乳", "乳腺腫脹疼痛", "拒絕讓幼仔吸乳", "食慾下降", "發燒", "嗜睡"],
      physicalExam: ["乳腺腫脹、發熱、疼痛", "乳汁異常（膿性、血性、變色）", "乳腺硬塊或膿瘍", "發燒", "脫水", "敗血症徵象（嚴重病例）"]
    },
    pathophysiology: "細菌（E. coli、Staphylococcus、Streptococcus）經乳頭管上行感染或血行播散 → 乳腺組織感染 → 炎症反應 → 乳汁鬱積加重 → 可能形成膿瘍或進展為敗血症/壞疽",
    diagnosis: {
      overview: "臨床表現結合乳汁檢查",
      differentials: ["乳腺腫瘤", "乳腺增生", "乳汁鬱積（非感染性）"],
      initialDB: ["乳汁細胞學（嗜中性白血球、細菌）", "乳汁細菌培養和藥敏", "CBC（白血球增多）", "血糖（排除低血糖）"],
      advanced: ["超聲（評估膿瘍）", "細針抽吸細胞學"]
    },
    treatment: {
      overview: "抗生素治療、支持療法，膿瘍可能需要引流",
      acute: [
        "抗生素治療（基於培養或經驗性）：",
        "- Amoxicillin-Clavulanate: 12.5-25 mg/kg PO q12h x 2-3週",
        "- 或 Cephalexin: 22-30 mg/kg PO q8-12h",
        "- 或 Enrofloxacin: 5-10 mg/kg PO q24h（若繼續哺乳需謹慎）",
        "支持療法：",
        "- 輸液（若脫水或敗血症）",
        "- 溫敷受影響乳腺",
        "- 輕柔擠奶促進引流",
        "- 止痛：Meloxicam 0.1 mg/kg PO q24h",
        "膿瘍處理：",
        "- 切開引流",
        "- 沖洗",
        "壞疽性乳腺炎：",
        "- 可能需要乳腺切除",
        "- 積極輸液和抗生素",
        "哺乳管理：",
        "- 輕度感染可繼續哺乳（促進引流）",
        "- 嚴重感染或膿瘍需離乳"
      ],
      chronic: ["完成抗生素療程", "環境衛生改善"]
    },
    prognosis: "單純性細菌性乳腺炎：及時治療預後良好。壞疽性乳腺炎：預後謹慎，可能致命。膿瘍：引流後通常預後良好。",
    pearls: [
      "壞疽性乳腺炎是急症，乳腺呈紫黑色",
      "輕度感染讓幼仔繼續吸乳可促進引流",
      "乳汁pH>7.0和白血球增多提示感染",
      "正常乳汁應為白色、無臭、稠度均勻",
      "抗生素選擇需考慮是否繼續哺乳"
    ],
    monitoring: ["乳腺外觀和疼痛", "體溫", "幼仔體重增長", "乳汁性狀"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "eclampsia": {
    zh: "產褥熱/低血鈣",
    en: "Eclampsia (Puerperal Tetany)",
    definition: "哺乳期因大量鈣質流失至乳汁導致的低血鈣危症，表現為神經肌肉興奮性增高和肌肉痙攣。",
    synonyms: ["產褥低血鈣症", "Puerperal Tetany", "Lactation Tetany", "Hypocalcemia of Lactation", "Milk Fever"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "任何生育年齡",
      sex: "僅限哺乳中的母犬",
      breedPredilection: "小型犬（Chihuahua、Pomeranian、Yorkshire Terrier、Toy Poodle）",
      riskFactors: ["小型犬", "大量幼仔", "哺乳高峰期（產後2-4週）", "初產母犬", "營養不良", "妊娠期過量鈣補充"]
    },
    clinicalPresentation: {
      history: ["哺乳中（通常產後1-4週）", "焦躁不安", "步態僵硬", "肌肉顫抖", "喘氣", "癲癇發作"],
      physicalExam: ["肌肉僵硬/強直", "顫抖", "心搏過速", "發燒（肌肉活動產熱）", "瞳孔散大", "喘氣", "癲癇發作", "倒地不起"]
    },
    pathophysiology: "哺乳期乳汁鈣流失 > 腸道吸收和骨骼動員 → 血鈣急劇下降 → 神經肌肉膜興奮性增高 → 肌肉痙攣、強直、癲癇。妊娠期過量鈣補充可抑制PTH和維生素D活化，導致產後適應不良",
    diagnosis: {
      overview: "臨床表現（哺乳母犬+肌肉痙攣）高度懷疑，血鈣確診",
      differentials: ["癲癇（其他原因）", "中毒", "低血糖", "腦炎"],
      initialDB: ["血清總鈣（<7 mg/dL，正常9-11.5 mg/dL）", "離子鈣（<0.8 mmol/L）", "血糖（可能同時低血糖）", "ECG"],
      advanced: ["電解質全套", "肌酐"]
    },
    treatment: {
      overview: "緊急鈣補充是救命措施",
      acute: [
        "靜脈鈣補充（急救）：",
        "- Calcium gluconate 10%: 0.5-1.5 mL/kg IV slow（5-15分鐘）",
        "- 必須監測ECG（心搏過緩、心律不整立即停止）",
        "- 效果通常在15-30分鐘內顯現",
        "控制癲癇（若嚴重）：",
        "- Diazepam: 0.5-1 mg/kg IV",
        "高體溫處理：",
        "- 主動降溫（若體溫>40°C）",
        "後續維持：",
        "- Calcium gluconate: 0.5-1 mL/kg SC q6-8h稀釋給予",
        "- 或 口服鈣補充：Calcium carbonate 25-50 mg/kg/day PO分次",
        "哺乳管理：",
        "- 暫停或減少哺乳24-48小時",
        "- 補餵幼仔",
        "- 逐漸恢復哺乳",
        "嚴重或復發病例：",
        "- 考慮早期離乳"
      ],
      chronic: ["口服鈣和維生素D補充", "營養改善", "下次妊娠避免過量鈣補充"]
    },
    prognosis: "及時治療：預後極佳，通常數分鐘至數小時內恢復。未治療：可能致命。復發常見，尤其繼續哺乳。",
    pearls: [
      "這是緊急情況 - 延遲治療可能致命",
      "IV鈣給予時必須監測心臟",
      "妊娠期過量鈣補充反而增加產後風險",
      "發燒是肌肉活動產熱，不是感染",
      "小型犬大窩更高風險"
    ],
    monitoring: ["血鈣（q12-24h至穩定）", "ECG", "臨床症狀", "幼仔餵養狀態"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "metritis": {
    zh: "子宮炎",
    en: "Metritis",
    definition: "產後子宮的急性細菌感染，通常發生在分娩後一週內，可快速進展為敗血症。",
    synonyms: ["產後子宮炎", "Postpartum Metritis", "Puerperal Metritis", "Acute Metritis"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何生育年齡",
      sex: "僅限產後母犬/母貓",
      breedPredilection: "無特定品種傾向",
      riskFactors: ["難產", "人工助產", "剖腹產", "胎兒/胎盤滯留", "流產", "子宮扭轉", "長時間分娩"]
    },
    clinicalPresentation: {
      history: ["產後1-7天發病", "惡臭陰道分泌物", "發燒", "食慾下降", "忽視幼仔", "嗜睡", "乳汁減少"],
      physicalExam: ["發燒", "脫水", "惡臭血膿性陰道分泌物", "子宮增大", "腹部疼痛", "休克徵象（敗血症）"]
    },
    pathophysiology: "分娩過程子宮頸開放 → 細菌上行感染（E. coli、Streptococcus、Staphylococcus）→ 滯留胎兒/胎盤提供培養基 → 子宮壁感染 → 內毒素血症 → 敗血症",
    diagnosis: {
      overview: "產後病史結合臨床表現",
      differentials: ["子宮蓄膿", "正常產後惡露", "子宮破裂", "腹膜炎"],
      initialDB: ["CBC（嗜中性白血球增多伴左移，或白血球減少若敗血症）", "生化（氮血症、電解質失衡）", "腹部超聲（子宮增大、腔內液體、滯留胎兒/胎盤）", "陰道細胞學和培養"],
      advanced: ["腹部X光", "血液培養", "凝血功能"]
    },
    treatment: {
      overview: "穩定後手術切除感染子宮是首選治療",
      acute: [
        "術前穩定：",
        "- 積極靜脈輸液",
        "- 廣譜抗生素：",
        "  Ampicillin 22 mg/kg IV q8h + Enrofloxacin 5-10 mg/kg IV q24h",
        "  或 Cefazolin 22 mg/kg IV q8h + Metronidazole 15 mg/kg IV q12h",
        "手術治療：",
        "- 卵巢子宮切除術（OVH）- 首選",
        "- 移除感染源",
        "內科治療（保留生育能力，風險高）：",
        "- Prostaglandin F2α: 0.1-0.25 mg/kg SC q12-24h（促進子宮排空）",
        "- 抗生素治療",
        "- 僅限輕度病例和有繁殖價值動物",
        "滯留胎兒/胎盤處理：",
        "- Oxytocin: 0.5-2 IU IM（促進排出）"
      ],
      chronic: ["完成抗生素療程", "監測康復"]
    },
    prognosis: "及時手術治療：預後良好。敗血症病例：預後謹慎，死亡率較高。內科治療：風險較高，可能進展為子宮蓄膿。",
    pearls: [
      "子宮炎 vs 子宮蓄膿：子宮炎是產後急性感染，子宮蓄膿是發情週期相關",
      "惡臭分泌物是特徵性表現",
      "滯留胎兒/胎盤需要移除以控制感染",
      "哺乳管理：抗生素和感染可能影響幼仔",
      "早期識別和治療是關鍵"
    ],
    monitoring: ["體溫", "陰道分泌物", "白血球計數", "幼仔健康"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "ovarian-cysts": {
    zh: "卵巢囊腫",
    en: "Ovarian Cysts",
    definition: "卵巢上形成的液體填充結構，包括濾泡囊腫和黃體囊腫，可導致持續發情或發情異常。",
    synonyms: ["卵巢濾泡囊腫", "Follicular Cysts", "Luteal Cysts", "Cystic Ovarian Disease"],
    epidemiology: {
      species: "犬較常見，貓也可發生",
      age: "中老年未絕育母犬",
      sex: "僅限未絕育母犬/母貓",
      breedPredilection: "無明確品種傾向",
      riskFactors: ["未絕育", "外源性荷爾蒙", "卵巢腫瘤"]
    },
    clinicalPresentation: {
      history: ["持續發情（濾泡囊腫）", "發情週期不規則", "假懷孕症狀", "對公犬持續吸引力", "脫毛", "外陰腫大"],
      physicalExam: ["外陰腫大和分泌物", "乳腺發育", "對稱性脫毛", "可能觸診到卵巢增大", "骨髓抑制徵象（若高雌激素血症嚴重）"]
    },
    pathophysiology: "濾泡囊腫：濾泡未排卵、持續分泌雌激素 → 持續發情、子宮內膜增生、骨髓抑制（嚴重時）。黃體囊腫：黃體持續存在、分泌黃體素 → 假懷孕症狀、子宮蓄膿風險增加",
    diagnosis: {
      overview: "病史、臨床表現、超聲確診",
      differentials: ["卵巢腫瘤", "正常發情週期變異", "外源性荷爾蒙", "卵巢殘餘症候群"],
      initialDB: ["腹部超聲（卵巢囊性結構，>1 cm）", "血清雌二醇（濾泡囊腫時升高）", "血清黃體素（黃體囊腫時升高）", "CBC（若高雌激素血症：貧血、血小板減少）", "陰道細胞學（持續角化細胞）"],
      advanced: ["LH/FSH測定", "腹腔鏡檢查"]
    },
    treatment: {
      overview: "卵巢子宮切除術是根治性治療，內科治療用於保留生育力",
      acute: [
        "手術治療（首選）：",
        "- 卵巢子宮切除術（OVH）",
        "- 根治性，消除復發和子宮蓄膿風險",
        "內科治療（保留生育力）：",
        "濾泡囊腫：",
        "- hCG: 250-500 IU IM（犬），250 IU IM（貓）",
        "- 或 GnRH: 2.2 μg/kg IM",
        "- 促進排卵或黃體化",
        "黃體囊腫：",
        "- Prostaglandin F2α: 0.1-0.25 mg/kg SC q24h x 5-7天",
        "- 促進黃體溶解",
        "高雌激素血症伴骨髓抑制：",
        "- 輸血支持",
        "- 卵巢切除（在可能情況下）"
      ],
      chronic: ["內科治療後監測復發", "考慮絕育"]
    },
    prognosis: "手術治療：預後極佳。內科治療：可能復發，需監測。高雌激素血症伴骨髓抑制：預後謹慎。",
    pearls: [
      "持續發情>3-4週應懷疑濾泡囊腫",
      "高雌激素血症可致骨髓抑制（再生不良性貧血）",
      "超聲是診斷金標準",
      "內科治療後建議下次發情後絕育",
      "卵巢囊腫與子宮蓄膿風險相關"
    ],
    monitoring: ["發情週期", "陰道細胞學", "CBC（若有骨髓抑制史）"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "testicular-tumor": {
    zh: "睪丸腫瘤",
    en: "Testicular Tumor",
    definition: "睪丸組織發生的腫瘤，主要包括Sertoli細胞瘤、精原細胞瘤和間質細胞瘤三種類型。",
    synonyms: ["睪丸癌", "Testicular Neoplasia", "Sertoli Cell Tumor", "Seminoma", "Interstitial Cell Tumor"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "中老年犬（平均10歲）",
      sex: "僅限未絕育公犬",
      breedPredilection: "Boxer、German Shepherd、Afghan Hound、Weimaraner、Shetland Sheepdog",
      riskFactors: ["隱睪症（風險增加10-14倍）", "未絕育", "年齡"]
    },
    clinicalPresentation: {
      history: ["睪丸腫大或萎縮", "女性化症狀（Sertoli細胞瘤）", "脫毛", "乳腺發育", "對公犬吸引力增加"],
      physicalExam: ["單側睪丸腫大", "對側睪丸萎縮（Sertoli細胞瘤）", "乳腺發育", "對稱性脫毛", "包皮下垂", "腹部腫塊（隱睪腫瘤）"]
    },
    pathophysiology: "Sertoli細胞瘤：分泌雌激素 → 女性化症狀、骨髓抑制。精原細胞瘤：生殖細胞來源，通常不分泌荷爾蒙。間質細胞瘤：分泌睪固酮或雌激素，通常良性。隱睪腫瘤：腹腔溫度促進惡性轉化",
    diagnosis: {
      overview: "理學檢查、影像學、組織病理學確診",
      differentials: ["睪丸炎", "睪丸扭轉", "精索囊腫", "鼠蹊疝氣"],
      initialDB: ["睪丸觸診和測量", "腹部超聲（隱睪定位）", "腹部X光（轉移評估）", "胸腔X光（轉移評估）", "CBC（高雌激素血症：貧血、血小板減少、白血球減少）"],
      advanced: ["雌二醇測定", "組織病理學（術後）", "淋巴結細針抽吸"]
    },
    treatment: {
      overview: "手術切除是首選治療",
      acute: [
        "手術治療：",
        "- 雙側睪丸切除術（首選）",
        "- 腹腔探查（隱睪）",
        "- 區域淋巴結評估",
        "高雌激素血症伴骨髓抑制：",
        "- 輸血支持（若嚴重貧血）",
        "- 骨髓恢復需要數週至數月",
        "- 睪丸切除後荷爾蒙效應通常在1-3個月內消退",
        "轉移性疾病：",
        "- 化療（精原細胞瘤對化療敏感）",
        "- 放射治療"
      ],
      chronic: ["術後監測轉移", "骨髓功能恢復監測"]
    },
    prognosis: "良性（大多數間質細胞瘤）：手術後預後極佳。惡性（10-15%的Sertoli細胞瘤和精原細胞瘤可轉移）：取決於分期。高雌激素血症伴骨髓抑制：手術後通常可逆，嚴重病例預後謹慎。",
    pearls: [
      "隱睪是主要風險因素，應建議隱睪犬絕育",
      "三種腫瘤可同時存在",
      "女性化症狀高度提示Sertoli細胞瘤",
      "骨髓抑制可能是致命的",
      "精原細胞瘤對放化療敏感"
    ],
    monitoring: ["CBC恢復（若有骨髓抑制）", "轉移監測", "女性化症狀消退"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Withrow SJ: Small Animal Clinical Oncology, 5th Ed."
  },

  "cryptorchidism": {
    zh: "隱睪症",
    en: "Cryptorchidism",
    definition: "一側或雙側睪丸未能下降至陰囊的發育異常，睪丸可能位於腹腔內或鼠蹊管內。",
    synonyms: ["睪丸未下降", "Retained Testicle", "Undescended Testicle"],
    epidemiology: {
      species: "犬較常見，貓也可發生",
      age: "先天性，通常在幼年發現",
      sex: "僅限公犬/公貓",
      breedPredilection: "Toy Poodle、Pomeranian、Yorkshire Terrier、Chihuahua、Boxer、小型犬",
      riskFactors: ["遺傳因素", "小型犬品種", "家族史"]
    },
    clinicalPresentation: {
      history: ["常規檢查發現睪丸缺失", "繁殖問題", "可能無症狀"],
      physicalExam: ["陰囊內一側或雙側睪丸缺失", "鼠蹊區可能觸及滯留睪丸", "腹部不可觸及（腹腔內）"]
    },
    pathophysiology: "正常睪丸下降：腹腔 → 鼠蹊管 → 陰囊（犬出生後2週內完成，最遲6-8週）。隱睪：gubernaculum或荷爾蒙訊號異常 → 下降停止。滯留睪丸因腹腔溫度 → 精子生成障礙，但睪固酮產生正常。腫瘤風險增加10-14倍",
    diagnosis: {
      overview: "理學檢查為主，影像學定位滯留睪丸",
      differentials: ["睪丸發育不全", "先前手術切除", "睪丸異位"],
      initialDB: ["仔細觸診陰囊和鼠蹊區", "腹部超聲（定位腹腔內睪丸）", "hCG或GnRH刺激試驗（確認睪丸組織存在）"],
      advanced: ["腹腔鏡檢查", "睪固酮測定"]
    },
    treatment: {
      overview: "手術切除滯留睪丸，避免繁殖以防遺傳傳遞",
      acute: [
        "手術治療：",
        "- 雙側睪丸切除術（強烈建議）",
        "- 腹腔內睪丸：腹腔切開或腹腔鏡取出",
        "- 鼠蹊睪丸：鼠蹊切開取出",
        "手術時機：",
        "- 建議6-12月齡手術",
        "- 確認睪丸未下降（等到6-8週以上）",
        "不建議的治療：",
        "- 荷爾蒙治療（hCG/GnRH）促進下降 - 成功率低",
        "- 不應讓隱睪犬繁殖"
      ],
      chronic: ["監測腫瘤發展（若未手術）"]
    },
    prognosis: "手術切除：預後極佳。未治療：腫瘤風險顯著增加（10-14倍），但可能多年無症狀。",
    pearls: [
      "睪丸應在出生後2週內下降，最遲6-8週",
      "這是遺傳性疾病，不應讓隱睪犬繁殖",
      "右側隱睪比左側更常見",
      "腹腔內睪丸腫瘤風險最高",
      "超聲是定位隱睪的首選方法"
    ],
    monitoring: ["若未手術，每6-12個月超聲檢查監測腫瘤"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "benign-prostatic-hyperplasia": {
    zh: "前列腺肥大",
    en: "Benign Prostatic Hyperplasia (BPH)",
    definition: "未絕育老年公犬前列腺的良性增生，是最常見的前列腺疾病，與睪固酮和雌激素作用有關。",
    synonyms: ["良性前列腺增生", "BPH", "Prostatic Hypertrophy", "前列腺增生"],
    epidemiology: {
      species: "犬（貓罕見）",
      age: "中老年公犬（>5歲發生率逐漸增加，9歲以上80-100%有某種程度BPH）",
      sex: "僅限未絕育公犬",
      breedPredilection: "無特定品種，所有未絕育公犬",
      riskFactors: ["未絕育", "年齡增加"]
    },
    clinicalPresentation: {
      history: ["常無症狀", "排便困難/裡急後重", "便秘", "帶狀便", "血尿", "尿道分泌物（血性/透明）", "排尿困難（較少見）"],
      physicalExam: ["直腸檢查：前列腺對稱性增大、平滑、無痛", "腹部觸診可能觸及增大的前列腺"]
    },
    pathophysiology: "睪固酮在前列腺內轉化為DHT（雙氫睪固酮）→ 持續刺激前列腺生長 → 腺體和間質增生 → 對稱性增大 → 壓迫直腸（排便困難）> 尿道（排尿困難較少）",
    diagnosis: {
      overview: "中老年未絕育公犬、對稱性無痛性前列腺增大",
      differentials: ["前列腺炎", "前列腺囊腫", "前列腺癌", "前列腺膿瘍"],
      initialDB: ["直腸檢查", "腹部超聲（對稱性增大、均勻回聲、可能有囊腫）", "尿液分析", "前列腺液細胞學"],
      advanced: ["前列腺穿刺/活檢", "CPSE（犬前列腺特異性酯酶）測定"]
    },
    treatment: {
      overview: "絕育是最有效治療，內科治療用於不適合手術者",
      acute: [
        "手術治療（首選）：",
        "- 睪丸切除術",
        "- 術後4-12週前列腺縮小50-70%",
        "內科治療（暫時性）：",
        "- Finasteride（5α-還原酶抑制劑）: 0.1-0.5 mg/kg PO q24h",
        "  - 減少DHT產生，3-4週見效",
        "- Osaterone（抗雄激素）: 0.25-0.5 mg/kg PO q24h x 7天",
        "- Deslorelin植入物（GnRH激動劑）: 4.7mg SC",
        "  - 初期短暫睪固酮升高，後續抑制",
        "支持療法：",
        "- 糞便軟化劑（若便秘）",
        "- 飲食調整（高纖維）"
      ],
      chronic: ["內科治療需長期維持", "定期監測前列腺大小"]
    },
    prognosis: "良性疾病，絕育後預後極佳。內科治療有效但需長期維持，停藥後復發。",
    pearls: [
      "BPH本身很少造成尿道阻塞（與人類不同）",
      "便秘比排尿困難更常見",
      "超聲下囊腫常見，是BPH的一部分",
      "血性尿道分泌物（與排尿無關）是特徵",
      "絕育是根治方法"
    ],
    monitoring: ["前列腺大小（超聲）", "臨床症狀", "排便排尿功能"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "prostatitis": {
    zh: "前列腺炎",
    en: "Prostatitis",
    definition: "前列腺的細菌感染，可分為急性和慢性，通常由尿道上行感染引起。",
    synonyms: ["前列腺感染", "Bacterial Prostatitis", "Prostatic Infection"],
    epidemiology: {
      species: "犬（貓罕見）",
      age: "中老年公犬",
      sex: "主要影響未絕育公犬（絕育公犬少見但可發生）",
      breedPredilection: "無特定品種傾向",
      riskFactors: ["BPH", "尿道感染", "免疫抑制", "前列腺囊腫"]
    },
    clinicalPresentation: {
      history: [
        "急性：發燒、嗜睡、食慾下降、排尿困難、血尿、步態僵硬",
        "慢性：反覆尿道感染、血尿、不孕"
      ],
      physicalExam: [
        "急性：發燒、脫水、腹部/腰部疼痛、直腸檢查前列腺疼痛和可能增大、僵硬步態",
        "慢性：可能無明顯異常或輕度前列腺不對稱"
      ]
    },
    pathophysiology: "細菌（E. coli最常見）上行感染經尿道進入前列腺 → 急性炎症反應 → 膿瘍形成（嚴重時）。BPH導致前列腺防禦機制下降，增加感染風險。慢性感染可能抗生素難以穿透",
    diagnosis: {
      overview: "臨床表現結合前列腺液或尿液培養",
      differentials: ["BPH", "前列腺膿瘍", "前列腺癌", "尿道感染"],
      initialDB: ["CBC（白血球增多，急性）", "尿液分析和培養", "前列腺液細胞學和培養", "腹部超聲", "直腸檢查"],
      advanced: ["前列腺穿刺活檢", "血液培養（若敗血症）"]
    },
    treatment: {
      overview: "長期抗生素治療，絕育可輔助治療",
      acute: [
        "急性前列腺炎：",
        "- 靜脈輸液（若脫水或敗血症）",
        "- 抗生素（基於培養或經驗性）：",
        "  急性期：Enrofloxacin 5-10 mg/kg IV/PO q24h",
        "  或 Trimethoprim-Sulfa 15 mg/kg PO q12h",
        "- 療程：4-6週",
        "- 止痛",
        "慢性前列腺炎：",
        "- 抗生素需具有良好前列腺穿透性：",
        "  Enrofloxacin、Trimethoprim-Sulfa、Clindamycin",
        "- 療程：6-12週",
        "- 定期尿液/前列腺液培養監測",
        "絕育：",
        "- 建議感染控制後進行",
        "- 減少復發風險"
      ],
      chronic: ["長期抗生素", "定期培養確認清除", "考慮絕育"]
    },
    prognosis: "急性前列腺炎：適當治療預後良好。慢性前列腺炎：可能難以根治，復發常見。絕育可改善預後。",
    pearls: [
      "急性前列腺炎時前列腺按摩是禁忌（可致敗血症）",
      "慢性感染時前列腺血液屏障阻礙抗生素穿透",
      "Fluoroquinolones和Trimethoprim-Sulfa有良好前列腺穿透性",
      "治療後需確認培養陰性",
      "BPH是常見的誘發因素"
    ],
    monitoring: ["臨床症狀", "尿液培養（治療中和停藥後）", "前列腺超聲"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "prostatic-abscess": {
    zh: "前列腺膿瘍",
    en: "Prostatic Abscess",
    definition: "前列腺內形成的膿液積聚，是前列腺炎的嚴重併發症，可能導致敗血症和腹膜炎。",
    synonyms: ["前列腺化膿", "Prostatic Suppuration"],
    epidemiology: {
      species: "犬（貓罕見）",
      age: "中老年公犬",
      sex: "主要影響未絕育公犬",
      breedPredilection: "無特定品種傾向",
      riskFactors: ["慢性前列腺炎", "BPH", "免疫抑制", "前列腺囊腫感染"]
    },
    clinicalPresentation: {
      history: ["發燒", "嗜睡", "食慾下降", "嘔吐", "排尿困難", "血尿/膿尿", "腹部疼痛", "步態僵硬"],
      physicalExam: ["發燒", "脫水", "腹部疼痛", "直腸檢查：前列腺增大、不對稱、疼痛、可能波動感", "休克徵象（若破裂）"]
    },
    pathophysiology: "慢性前列腺炎 → 感染局部化 → 膿瘍形成 → 可能多發或單發。破裂風險：膿瘍→腹腔 → 敗血性腹膜炎。常見細菌：E. coli、Staphylococcus、Streptococcus、Proteus",
    diagnosis: {
      overview: "臨床表現結合影像學確診",
      differentials: ["前列腺囊腫", "前列腺炎", "前列腺癌", "副前列腺囊腫"],
      initialDB: ["CBC（白血球增多伴左移）", "生化（氮血症）", "腹部超聲（前列腺內低迴聲/無迴聲區，可能有碎屑）", "尿液培養"],
      advanced: ["超聲引導穿刺（診斷性，需謹慎）", "CT", "腹腔液分析（若懷疑破裂）"]
    },
    treatment: {
      overview: "外科引流結合長期抗生素治療",
      acute: [
        "術前穩定：",
        "- 靜脈輸液",
        "- 廣譜抗生素：",
        "  Ampicillin-Sulbactam 22 mg/kg IV q8h + Enrofloxacin 5-10 mg/kg IV q24h",
        "手術治療：",
        "- 膿瘍引流和沖洗（超聲引導或手術）",
        "- 前列腺部分切除或網膜包裹術",
        "- 同時睪丸切除術",
        "- 放置引流管",
        "術後管理：",
        "- 長期抗生素（6-12週）",
        "- 定期超聲監測",
        "膿瘍破裂：",
        "- 緊急剖腹探查",
        "- 腹腔灌洗",
        "- 可能需要引流管"
      ],
      chronic: ["完成抗生素療程", "定期超聲監測復發"]
    },
    prognosis: "未破裂且及時手術：預後中等至良好。膿瘍破裂/敗血性腹膜炎：預後謹慎至差。復發可能，尤其未同時絕育。",
    pearls: [
      "前列腺膿瘍破裂是外科急症",
      "單純抗生素治療通常不足以控制",
      "絕育是治療的重要組成部分",
      "超聲引導穿刺有破裂風險，需謹慎",
      "復發率較高，需長期監測"
    ],
    monitoring: ["體溫", "白血球計數", "超聲監測", "尿液培養"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "paraphimosis": {
    zh: "陰莖嵌頓",
    en: "Paraphimosis",
    definition: "陰莖在勃起後無法縮回包皮內的緊急狀況，可導致陰莖水腫、缺血和壞死。",
    synonyms: ["包皮嵌頓", "陰莖外露", "Penis Entrapment"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "任何年齡",
      sex: "僅限公犬/公貓",
      breedPredilection: "長毛犬（毛髮纏繞）、小型犬",
      riskFactors: ["包皮開口狹窄", "包皮過短", "毛髮纏繞", "交配後", "人工採精後", "創傷", "腫瘤"]
    },
    clinicalPresentation: {
      history: ["陰莖無法縮回", "過度舔舐生殖器", "焦躁不安", "交配或勃起後發生"],
      physicalExam: ["陰莖外露", "陰莖腫脹、充血", "黏膜乾燥或損傷", "可能有毛髮纏繞", "包皮開口緊縮", "陰莖變色（缺血）"]
    },
    pathophysiology: "勃起後陰莖無法縮回 → 包皮環狀壓迫 → 靜脈和淋巴回流受阻 → 陰莖水腫加重 → 動脈血供受損 → 缺血 → 壞死",
    diagnosis: {
      overview: "臨床診斷明確",
      differentials: ["正常勃起", "陰莖脫垂", "陰莖骨折", "陰莖腫瘤"],
      initialDB: ["視診和觸診", "評估陰莖存活性"],
      advanced: ["無需額外檢查，除非懷疑潛在疾病"]
    },
    treatment: {
      overview: "緊急處理以恢復陰莖血流和保護組織",
      acute: [
        "非手術治療（輕度、早期）：",
        "- 清潔陰莖",
        "- 移除毛髮纏繞（若有）",
        "- 潤滑（水溶性潤滑劑、生理鹽水）",
        "- 高滲溶液減輕水腫（50%葡萄糖或高滲鹽水濕敷）",
        "- 輕柔壓迫減少水腫",
        "- 嘗試手動復位",
        "手術治療（復位失敗或包皮狹窄）：",
        "- 鎮靜或全身麻醉",
        "- 包皮切開術擴大開口",
        "- 陰莖復位",
        "- 包皮縫合",
        "嚴重壞死：",
        "- 陰莖截除術",
        "- 尿道造口術",
        "術後護理：",
        "- Elizabethan collar",
        "- 抗生素（若黏膜損傷）",
        "- 止痛"
      ],
      chronic: ["包皮整形術（若反覆發作）", "監測排尿功能"]
    },
    prognosis: "早期處理：預後良好。延遲治療或嚴重壞死：可能需要截除，但排尿和生活品質通常可維持。",
    pearls: [
      "這是緊急狀況 - 延遲可致陰莖壞死",
      "高滲溶液可有效減輕水腫",
      "毛髮纏繞是常見且可預防的原因",
      "長毛犬建議定期修剪包皮周圍毛髮",
      "交配後監測對種公犬很重要"
    ],
    monitoring: ["陰莖存活性", "排尿功能", "傷口癒合"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "vaginal-hyperplasia": {
    zh: "陰道增生",
    en: "Vaginal Hyperplasia",
    definition: "發情期雌激素刺激導致陰道黏膜過度增生和水腫，組織可能突出於陰門外。",
    synonyms: ["陰道脫垂", "Vaginal Prolapse", "Vaginal Edema", "Vaginal Fold Prolapse"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "年輕母犬（1-3歲），初次或第二次發情",
      sex: "僅限未絕育母犬",
      breedPredilection: "大型犬（Boxer、Mastiff、German Shepherd、Labrador Retriever、Bulldog）",
      riskFactors: ["未絕育", "年輕", "大型犬品種", "發情期"]
    },
    clinicalPresentation: {
      history: ["發情期出現", "陰道組織突出", "過度舔舐", "排尿困難", "無法交配"],
      physicalExam: ["粉紅色/紅色組織從陰門突出", "組織水腫", "黏膜乾燥或損傷", "可能有潰瘍", "通常在陰道底部"]
    },
    pathophysiology: "發情前期/發情期雌激素升高 → 陰道黏膜增生和水腫 → 組織突出 → 暴露導致乾燥和創傷 → 黃體期雌激素下降後自然消退（但下次發情可能復發）",
    diagnosis: {
      overview: "臨床診斷明確，需區分真性脫垂",
      differentials: ["真性陰道脫垂", "陰道腫瘤", "陰道息肉", "尿道脫垂", "傳染性性病腫瘤(TVT)"],
      initialDB: ["視診", "陰道鏡檢查", "陰道細胞學（確認發情期）"],
      advanced: ["組織活檢（若懷疑腫瘤）", "腹部超聲"]
    },
    treatment: {
      overview: "保護組織、等待消退，絕育可預防復發",
      acute: [
        "保守治療（大多數病例）：",
        "- 保持組織濕潤和清潔",
        "- 水溶性潤滑劑保護",
        "- Elizabethan collar防止舔舐",
        "- 等待發情結束後自然消退（通常7-14天）",
        "促進消退：",
        "- 誘導排卵：hCG 500-1000 IU IM或",
        "- GnRH 2.2 μg/kg IM",
        "- 縮短發情期，加速消退",
        "手術治療（嚴重壞死或潰瘍）：",
        "- 增生組織切除",
        "- 陰道固定術",
        "絕育：",
        "- 黃體期或發情間期進行",
        "- 預防復發（下次發情幾乎100%復發）"
      ],
      chronic: ["絕育預防復發", "若保留繁殖力需人工授精"]
    },
    prognosis: "預後良好。多數發情結束後消退。絕育後不復發。若不絕育，下次發情幾乎必定復發。",
    pearls: [
      "這是增生而非真正的脫垂",
      "發情結束後自然消退",
      "復發率極高，建議絕育",
      "保持組織濕潤是護理重點",
      "可能影響自然交配，需人工授精"
    ],
    monitoring: ["組織狀態", "發情週期", "排尿功能"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "transmissible-venereal-tumor": {
    zh: "傳染性性病腫瘤",
    en: "Transmissible Venereal Tumor (TVT)",
    definition: "一種通過交配傳播的性傳播腫瘤，主要影響外生殖器，可經由活腫瘤細胞直接移植傳染。",
    synonyms: ["TVT", "Sticker Tumor", "Venereal Granuloma", "Transmissible Sarcoma", "犬傳染性生殖器腫瘤"],
    epidemiology: {
      species: "犬（貓罕見）",
      age: "性成熟犬，1-8歲最常見",
      sex: "公犬和母犬皆可感染",
      breedPredilection: "無特定品種，流浪犬和未絕育犬高風險",
      riskFactors: ["未絕育", "流浪", "多重交配對象", "免疫抑制"]
    },
    clinicalPresentation: {
      history: ["生殖器腫塊", "血性分泌物", "過度舔舐生殖器", "交配困難"],
      physicalExam: ["菜花狀、易碎、出血性腫塊", "陰莖/包皮（公犬）或陰道/外陰（母犬）", "可能轉移至鼻腔、口腔、皮膚", "區域淋巴結可能腫大"]
    },
    pathophysiology: "腫瘤細胞本身是傳染原 → 交配或直接接觸時細胞移植 → 2-6個月潛伏期 → 腫瘤生長 → 免疫功能正常時可能自發消退，免疫抑制時進展和轉移",
    diagnosis: {
      overview: "臨床表現結合細胞學/組織病理學確診",
      differentials: ["其他生殖器腫瘤", "陰道增生", "肉芽腫", "乳頭狀瘤"],
      initialDB: ["腫塊印片或細針抽吸細胞學（特徵性圓細胞，細胞質空泡）", "組織病理學", "區域淋巴結評估"],
      advanced: ["胸腔X光（轉移評估）", "腹部超聲"]
    },
    treatment: {
      overview: "Vincristine化療是首選治療，治癒率高",
      acute: [
        "化療（首選）：",
        "- Vincristine: 0.5-0.7 mg/m² IV 每週一次",
        "- 持續至腫瘤消退後2-3週（通常4-8次）",
        "- 治癒率>90%",
        "- 注意血管外滲（嚴重組織壞死）",
        "監測血球計數：",
        "- 每次治療前CBC",
        "- 嗜中性白血球<2000/μL時延遲治療",
        "替代治療：",
        "- Doxorubicin: 30 mg/m² IV q3週",
        "- 手術切除（復發率較高，用於局部小腫瘤）",
        "- 放射治療（有效但較少使用）",
        "轉移性疾病：",
        "- 化療仍有效",
        "- 可能需要更長療程"
      ],
      chronic: ["治療後監測復發", "建議絕育"]
    },
    prognosis: "對Vincristine反應極佳，治癒率>90%。轉移性疾病預後較差但仍可能反應。免疫功能正常時可能自發消退（少數）。",
    pearls: [
      "TVT是唯一已知通過活細胞移植傳播的腫瘤",
      "腫瘤細胞有獨特的染色體數目（57-64 vs 正常78）",
      "Vincristine是首選治療，反應率極高",
      "避免血管外滲 - 造成嚴重組織壞死",
      "絕育和控制流浪犬是預防關鍵"
    ],
    monitoring: ["腫瘤大小（每次治療前）", "CBC", "復發監測"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Withrow SJ: Small Animal Clinical Oncology, 5th Ed."
  },

  "pseudopregnancy": {
    zh: "假懷孕",
    en: "Pseudopregnancy",
    definition: "未懷孕母犬在黃體期表現出懷孕和哺乳行為的生理或病理狀態，與黃體素下降和泌乳素升高有關。",
    synonyms: ["假孕", "False Pregnancy", "Pseudocyesis", "Phantom Pregnancy", "偽妊娠"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "任何年齡未絕育母犬",
      sex: "僅限未絕育母犬",
      breedPredilection: "Afghan Hound、Beagle、Dachshund（可能較常見）",
      riskFactors: ["未絕育", "發情週期正常", "某些個體反覆發生"]
    },
    clinicalPresentation: {
      history: ["發情後4-9週出現", "乳腺腫大和泌乳", "築巢行為", "對玩具的母性行為", "食慾改變", "體重增加", "嗜睡或焦躁"],
      physicalExam: ["乳腺腫大", "乳汁分泌", "腹部可能輕度膨脹", "行為改變"]
    },
    pathophysiology: "正常黃體期結束 → 黃體素急劇下降 → 泌乳素相對升高 → 乳腺發育和泌乳 → 母性行為。犬的黃體期長度（約2個月）無論懷孕與否相似，因此假懷孕很常見",
    diagnosis: {
      overview: "病史和臨床表現，需排除真懷孕和子宮蓄膿",
      differentials: ["真懷孕", "子宮蓄膿", "乳腺腫瘤", "甲狀腺功能減退"],
      initialDB: ["腹部超聲（排除懷孕和子宮蓄膿）", "腹部X光", "乳腺檢查"],
      advanced: ["無需額外檢查"]
    },
    treatment: {
      overview: "大多數自限性，2-3週消退；嚴重症狀可藥物治療",
      acute: [
        "保守治療（大多數病例）：",
        "- 減少刺激乳腺（避免自舔、熱敷）",
        "- 移除築巢材料和「收養」的玩具",
        "- Elizabethan collar（若過度舔乳）",
        "- 減少食物量（減少泌乳刺激）",
        "- 增加運動分散注意力",
        "藥物治療（嚴重或持續症狀）：",
        "- Cabergoline（泌乳素抑制劑）: 5 μg/kg PO q24h x 5-10天",
        "- 或 Bromocriptine: 10-30 μg/kg PO q12h",
        "- 副作用：嘔吐（與食物同服減少）",
        "不建議：",
        "- 擠奶（刺激更多泌乳）",
        "- 利尿劑（無效）",
        "乳腺炎併發症：",
        "- 若繼發感染需抗生素"
      ],
      chronic: ["反覆嚴重假懷孕建議絕育", "下次發情後可能復發"]
    },
    prognosis: "自限性疾病，通常2-3週自行消退。不影響未來繁殖力。反覆嚴重發作者建議絕育。",
    pearls: [
      "假懷孕是犬正常生理的一部分，非疾病",
      "狼群中可能有利於群體育幼（非繁殖母狼協助哺乳）",
      "不要擠奶 - 會刺激更多泌乳",
      "首要排除真懷孕和子宮蓄膿",
      "Cabergoline效果良好但非必要"
    ],
    monitoring: ["症狀消退", "乳腺是否感染"],
    reference: "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  }
  // ===== From immunological-diseases.js =====

  // ==================== 全身性自體免疫疾病 ====================

  "systemic-lupus-erythematosus": {
    zh: "系統性紅斑性狼瘡",
    en: "Systemic Lupus Erythematosus (SLE)",
    definition: "一種多系統自體免疫疾病，特徵為產生多種自體抗體（尤其是抗核抗體ANA），導致免疫複合物沉積於多個器官系統，引起廣泛的組織損傷和發炎反應。",
    synonyms: ["SLE", "Lupus", "狼瘡", "紅斑狼瘡"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "年輕至中年犬（平均5歲）",
      sex: "無明顯性別傾向，部分研究顯示母犬略多",
      riskFactors: ["品種傾向（German Shepherd、Shetland Sheepdog、Collie、Beagle、Poodle、Irish Setter）", "遺傳因素", "紫外線暴露", "某些藥物可能誘發"]
    },
    clinicalPresentation: {
      history: ["週期性發燒", "多關節疼痛和跛行", "皮膚病變", "虛弱和嗜睡", "食慾下降和體重減輕", "症狀常呈週期性惡化和緩解"],
      physicalExam: ["發燒", "多關節腫脹和疼痛（非侵蝕性多發性關節炎）", "皮膚病變（紅斑、脫毛、潰瘍、光敏感）", "淋巴結腫大", "脾腫大", "黏膜蒼白（若有溶血性貧血）", "肌肉萎縮", "腎臟觸診可能正常"]
    },
    pathophysiology: "遺傳易感性 + 環境因素（紫外線、感染、藥物）→ 免疫耐受性喪失 → 產生多種自體抗體（抗核抗體、抗dsDNA抗體、抗紅血球/血小板抗體）→ 形成免疫複合物 → 沉積於腎絲球、關節、皮膚、血管等 → 補體活化和發炎 → 多器官損傷。主要受影響系統包括：關節、皮膚、腎臟、血液系統。",
    diagnosis: {
      overview: "需符合多項臨床和實驗室標準，無單一確診測試",
      differentials: ["感染性多發性關節炎", "類風濕性關節炎", "其他自體免疫疾病（IMHA、ITP）", "腫瘤相關症候群", "萊姆病", "多發性肌炎"],
      initialDB: ["CBC（貧血、血小板減少、白血球減少）", "生化全套（BUN/Creatinine升高提示腎損傷）", "尿液分析（蛋白尿）", "尿蛋白/肌酐比值", "關節穿刺和滑液分析", "Coombs試驗"],
      advanced: ["抗核抗體(ANA)測試 - 高效價陽性為特徵", "抗dsDNA抗體", "LE細胞試驗（現較少用）", "皮膚活檢（免疫螢光）", "腎臟活檢", "胸腹X光和超音波"]
    },
    treatment: {
      overview: "免疫抑制治療是基石，需長期維持並監測併發症",
      acute: [
        "Prednisolone/Prednisone: 2-4 mg/kg/day PO 分次給予",
        "嚴重病例可使用 Dexamethasone: 0.3-0.5 mg/kg IV",
        "支持治療：輸液、輸血（若有嚴重貧血）",
        "治療繼發感染"
      ],
      chronic: [
        "免疫抑制維持治療：",
        "  - Prednisolone: 逐漸減量至最低有效劑量（0.5-1 mg/kg q48h）",
        "  - 添加其他免疫抑制劑以減少類固醇用量：",
        "    - Azathioprine (犬): 2 mg/kg PO q24h，穩定後q48h",
        "    - Cyclosporine: 5 mg/kg PO q12h",
        "    - Mycophenolate mofetil: 10-20 mg/kg PO q12h",
        "    - Leflunomide: 2-4 mg/kg PO q24h",
        "腎臟保護（若有蛋白尿）：",
        "  - ACE抑制劑或ARB",
        "  - 低蛋白飲食",
        "避免紫外線暴露",
        "定期監測血液學和腎功能"
      ]
    },
    prognosis: "謹慎至不良。SLE是慢性疾病，需終身治療。腎臟受累是主要預後不良因素。1年存活率約50-60%。緩解期可持續數月，但復發常見。",
    pearls: [
      "ANA陽性不等於SLE - 需結合臨床症狀",
      "SLE診斷需排除感染性原因",
      "皮膚和關節症狀通常對治療反應較好",
      "腎臟和血液學異常決定預後",
      "避免使用可能誘發狼瘡的藥物（如hydralazine、procainamide）"
    ],
    monitoring: ["CBC（每2-4週初期，穩定後每1-3月）", "生化和尿液分析（監測腎功能）", "尿蛋白/肌酐比", "臨床症狀追蹤", "ANA效價（判斷活動度）"],
    reference: "Day MJ: Clinical Immunology of the Dog and Cat, 2nd Ed. Manson Publishing, 2012"
  },

  "immune-mediated-polyarthritis": {
    zh: "免疫介導性多發性關節炎",
    en: "Immune-Mediated Polyarthritis (IMPA)",
    definition: "免疫系統攻擊關節滑膜導致的非感染性關節發炎，可為原發性（特發性）或繼發於其他疾病。是犬最常見的多發性關節炎原因。",
    synonyms: ["IMPA", "Idiopathic Polyarthritis", "Type I IMPA", "免疫性關節炎"],
    epidemiology: {
      species: "犬為主，貓較少見",
      age: "中年犬最常見（4-6歲平均），但任何年齡可發生",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Akita、Weimaraner、German Shepherd、Doberman、Retriever、Spaniel）", "慢性感染病灶", "腫瘤", "藥物反應", "疫苗接種後（罕見）"]
    },
    clinicalPresentation: {
      history: ["多關節僵硬和疼痛", "不願行走或運動", "週期性跛行", "發燒", "食慾下降", "嗜睡"],
      physicalExam: ["多關節腫脹和疼痛（腕、跗、膝、肘最常見）", "關節活動受限", "發燒", "淋巴結腫大", "脊椎疼痛（部分病例）", "肌肉萎縮（慢性病例）"]
    },
    pathophysiology: "分為四種類型：Type I（特發性，最常見50-65%）：無明確病因。Type II（繼發於感染）：遠端感染刺激免疫反應。Type III（繼發於腸道疾病）：腸道發炎導致抗原進入引發關節反應。Type IV（繼發於腫瘤）：腫瘤抗原刺激。免疫複合物沉積於滑膜 → 補體活化 → 嗜中性球浸潤 → 關節損傷。",
    diagnosis: {
      overview: "關節穿刺滑液分析是診斷關鍵，需排除感染",
      differentials: ["感染性關節炎（細菌、萊姆病、黴菌）", "類風濕性關節炎", "SLE", "退化性關節疾病", "骨關節炎", "關節腫瘤"],
      initialDB: ["多關節穿刺和滑液分析（嗜中性球增多但無菌培養）", "滑液細菌培養（排除感染）", "CBC、生化、尿液分析", "關節X光", "胸腹X光（尋找原發病灶）"],
      advanced: ["ANA測試", "類風濕因子", "萊姆病血清學", "滑液PCR", "腹部超音波", "骨髓檢查（若懷疑腫瘤）"]
    },
    treatment: {
      overview: "免疫抑制治療為主，需尋找並治療繼發原因",
      acute: [
        "Prednisolone: 2 mg/kg/day PO 分次給予",
        "疼痛管理：在免疫抑制生效前可短期使用",
        "關節保護：限制活動"
      ],
      chronic: [
        "免疫抑制維持：",
        "  - Prednisolone: 逐漸減至最低有效劑量",
        "  - 頑固病例添加第二線藥物：",
        "    - Azathioprine: 2 mg/kg PO q24-48h",
        "    - Leflunomide: 2-4 mg/kg PO q24h",
        "    - Cyclosporine: 5 mg/kg PO q12h",
        "治療原發病（若為繼發性）：",
        "  - 感染病灶清除",
        "  - 腫瘤治療",
        "  - 腸道疾病治療",
        "物理治療和體重管理",
        "關節保護補充品（葡萄糖胺、軟骨素、omega-3）"
      ]
    },
    prognosis: "Type I 預後良好，多數可達緩解，但復發率約25-30%。繼發性IMPA預後取決於原發病治療效果。早期治療預後較好。",
    pearls: [
      "滑液WBC >5000/μL且嗜中性球>10-20%高度提示",
      "必須排除感染性原因再開始免疫抑制",
      "需檢查多個關節，單一關節可能誤導",
      "類固醇停藥前需確認緩解且維持數月",
      "復發時重新評估是否有新發原發病"
    ],
    monitoring: ["臨床症狀（跛行、發燒）", "關節檢查", "滑液分析（判斷緩解）", "CBC（藥物副作用）", "肝腎功能"],
    reference: "Webb AA et al: Immune-mediated polyarthritis in dogs. Compend Contin Educ Vet 24:144-159, 2002"
  },

  // ==================== 免疫介導性肌肉疾病 ====================

  "masticatory-muscle-myositis": {
    zh: "咀嚼肌炎",
    en: "Masticatory Muscle Myositis (MMM)",
    definition: "一種侷限於咀嚼肌群（顳肌、咬肌、翼狀肌、二腹肌）的自體免疫性肌炎，由針對咀嚼肌特有的2M肌纖維的自體抗體引起。",
    synonyms: ["MMM", "Eosinophilic Myositis", "Atrophic Myositis", "咬肌炎", "顳肌炎"],
    epidemiology: {
      species: "犬，貓非常罕見",
      age: "年輕至中年犬（平均3歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["大型犬品種（German Shepherd、Labrador、Golden Retriever、Cavalier King Charles Spaniel、Rottweiler、Doberman）", "可能有遺傳傾向"]
    },
    clinicalPresentation: {
      history: ["張嘴困難或無法張嘴", "咀嚼疼痛", "拒絕進食或飲水", "流涎", "頭部觸碰敏感", "急性期可能發燒", "慢性期顳肌和咬肌萎縮"],
      physicalExam: ["急性期：咀嚼肌腫脹和疼痛", "慢性期：嚴重顳肌和咬肌萎縮", "張嘴受限（可能<1-2cm）", "眼球外凸或眼球內陷（因肌肉腫脹或萎縮）", "可能有眼瞼和結膜水腫", "無四肢肌肉受累"]
    },
    pathophysiology: "咀嚼肌含有獨特的2M型肌纖維（四肢肌肉沒有）→ 免疫系統產生針對2M纖維的自體抗體 → 抗體介導的肌肉損傷 → 急性期發炎和腫脹 → 慢性期肌肉萎縮和纖維化。若不治療，嚴重纖維化導致永久性張嘴受限。",
    diagnosis: {
      overview: "2M抗體檢測是確診標準",
      differentials: ["三叉神經炎", "破傷風", "眼外肌肌炎", "顳下頜關節疾病", "逆行性肌病", "感染性肌炎", "咀嚼肌腫瘤"],
      initialDB: ["2M肌纖維抗體檢測（免疫組織化學或ELISA）- 特異性和敏感性高", "CK可能升高（急性期）", "CBC（可能有輕度嗜酸球增多）"],
      advanced: ["咀嚼肌活檢（若抗體陰性但高度懷疑）", "肌電圖", "顳下頜關節X光或CT（排除關節問題）"]
    },
    treatment: {
      overview: "早期積極免疫抑制治療可防止永久性纖維化",
      acute: [
        "Prednisolone: 2 mg/kg/day PO（高劑量開始）",
        "維持高劑量直到症狀明顯改善（通常2-4週）",
        "疼痛管理",
        "軟食或流質餵食（若張嘴困難）"
      ],
      chronic: [
        "Prednisolone: 逐漸減量至最低有效劑量",
        "  - 每2-4週減量25%",
        "  - 最終目標：0.5-1 mg/kg q48h 或停藥",
        "  - 總療程通常6-12個月",
        "頑固病例添加：",
        "  - Azathioprine: 2 mg/kg PO q24-48h",
        "  - Cyclosporine: 5 mg/kg PO q12h",
        "物理治療：被動張嘴運動（在麻醉下）",
        "營養支持（必要時管灌餵食）"
      ]
    },
    prognosis: "早期治療預後良好，多數可完全恢復功能。慢性病例已有纖維化者功能恢復有限。復發率約15-35%。",
    pearls: [
      "急性期治療最重要 - 避免纖維化",
      "2M抗體在類固醇治療後可能轉陰",
      "慢性期CK可能正常",
      "不要在麻醉前測試張嘴程度（可能造成下頜骨折）",
      "逐漸減藥，太快減量易復發"
    ],
    monitoring: ["張嘴程度", "咀嚼肌大小（照片記錄）", "CK", "2M抗體（判斷復發風險）", "藥物副作用"],
    reference: "Evans J et al: Canine inflammatory myopathies: a clinicopathologic review of 200 cases. J Vet Intern Med 18:679-691, 2004"
  },

  "extraocular-myositis": {
    zh: "眼外肌肌炎",
    en: "Extraocular Myositis",
    definition: "一種罕見的自體免疫性肌炎，專門影響眼外肌（控制眼球運動的肌肉），導致雙側眼球突出和眼球運動受限。",
    synonyms: ["EOM", "Extraocular Polymyositis", "眼球突出肌炎"],
    epidemiology: {
      species: "犬，貓非常罕見",
      age: "年輕成年犬最常見（<2歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["Golden Retriever品種傾向明顯", "可能有遺傳因素"]
    },
    clinicalPresentation: {
      history: ["急性雙側眼球突出", "眼睛外觀異常", "可能有輕微視力變化", "通常無全身症狀"],
      physicalExam: ["雙側對稱性眼球突出（exophthalmos）", "眼球運動受限", "結膜充血和水腫", "第三眼瞼突出", "角膜可能因暴露而乾燥或潰瘍", "眼壓通常正常", "視力通常保留", "無咀嚼肌受累"]
    },
    pathophysiology: "眼外肌含有獨特的肌纖維類型 → 免疫系統產生針對這些纖維的自體抗體 → 肌肉發炎和腫脹 → 眼球被向前推出。急性期主要為發炎和水腫，慢性反覆發作可能導致纖維化和肌肉限制性改變。",
    diagnosis: {
      overview: "臨床表現結合影像學診斷",
      differentials: ["眼眶腫瘤", "眼眶蜂窩組織炎", "眼眶膿瘍", "青光眼", "眼眶出血", "咀嚼肌炎波及眼眶"],
      initialDB: ["眼科檢查（眼壓、眼底、視力）", "眼眶超音波（顯示眼外肌腫脹）", "CK（可能正常或輕度升高）"],
      advanced: ["眼眶MRI或CT（金標準，顯示眼外肌選擇性腫脹）", "眼外肌活檢（罕需要）", "排除全身性肌炎的檢查"]
    },
    treatment: {
      overview: "免疫抑制治療，保護角膜",
      acute: [
        "Prednisolone: 2 mg/kg/day PO",
        "角膜保護：",
        "  - 人工淚液頻繁使用",
        "  - 若有角膜潰瘍需適當治療",
        "  - 考慮暫時性眼瞼縫合（嚴重突出）"
      ],
      chronic: [
        "Prednisolone: 緩慢減量",
        "  - 總療程通常3-6個月",
        "頑固或復發病例：",
        "  - Azathioprine: 2 mg/kg PO q24-48h",
        "  - Cyclosporine: 5 mg/kg PO q12h",
        "定期眼科追蹤"
      ]
    },
    prognosis: "單次發作治療預後良好。部分病例可能復發。慢性反覆發作可能導致永久性眼球運動受限。視力預後通常良好。",
    pearls: [
      "Golden Retriever突然雙側眼突要高度懷疑此病",
      "與咀嚼肌炎不同，眼外肌肌炎不影響咀嚼",
      "MRI顯示眼外肌「紡錘形」腫脹很特徵",
      "角膜暴露是主要併發症風險",
      "需與眼眶腫瘤鑑別（通常單側）"
    ],
    monitoring: ["眼球位置", "眼球運動範圍", "角膜健康", "眼壓", "視力"],
    reference: "Carpenter JL et al: Canine bilateral extraocular polymyositis. Vet Pathol 26:510-512, 1989"
  },

  // ==================== 過敏和過敏反應 ====================

  "anaphylaxis": {
    zh: "過敏性休克",
    en: "Anaphylaxis",
    definition: "一種嚴重的、可能致命的全身性速發型超敏反應（I型過敏反應），在接觸過敏原後數分鐘至數小時內發生，主要影響心血管、呼吸和消化系統。",
    synonyms: ["Anaphylactic Shock", "Anaphylactic Reaction", "嚴重過敏反應", "過敏性反應"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["先前過敏史", "昆蟲叮咬（蜜蜂、黃蜂、火蟻）", "藥物過敏史", "疫苗反應史", "食物過敏", "輸血反應"]
    },
    clinicalPresentation: {
      history: ["近期接觸已知或潛在過敏原", "藥物或疫苗注射後", "昆蟲叮咬後", "進食某種食物後", "症狀在數分鐘至1小時內急速發展"],
      physicalExam: ["犬主要表現（肝臟為休克器官）：", "  - 急性嘔吐和腹瀉（常帶血）", "  - 虛脫", "  - 低血壓和休克", "  - 蒼白黏膜", "  - 心搏過速", "貓主要表現（肺和腸道為休克器官）：", "  - 呼吸窘迫（支氣管痙攣）", "  - 喘鳴", "  - 嘔吐", "  - 搔癢（頭部）", "  - 流涎", "共同表現：顏面/耳朵水腫、蕁麻疹、躁動"]
    },
    pathophysiology: "先前致敏 → IgE抗體附著於肥大細胞 → 再次接觸過敏原 → 過敏原橋接IgE → 肥大細胞脫顆粒 → 大量釋放組織胺、白三烯、前列腺素等介質 → 血管擴張、血管通透性增加、平滑肌收縮 → 低血壓、水腫、支氣管痙攣。犬的肝靜脈收縮導致肝鬱血和門脈高壓。",
    diagnosis: {
      overview: "主要依據臨床表現和病史，為臨床診斷",
      differentials: ["其他休克原因（敗血症、心因性、出血性）", "急性胃腸疾病", "急性呼吸窘迫", "熱射病", "中毒"],
      initialDB: ["快速臨床評估（ABC）", "血壓", "PCV/TS", "血氣分析", "血糖"],
      advanced: ["過敏原檢測（穩定後）", "組織胺/tryptase測量（研究用途）"]
    },
    treatment: {
      overview: "緊急處理！快速給予腎上腺素和支持治療",
      acute: [
        "立即處理（這是緊急情況！）：",
        "Epinephrine (Adrenaline) - 一線藥物：",
        "  - 1:1000 (1 mg/mL): 0.01 mg/kg IM 或 0.01-0.02 mg/kg IV（緩慢）",
        "  - 可每5-15分鐘重複",
        "建立靜脈通路：",
        "  - 晶體液快速bolus：犬 20-30 mL/kg，貓 10-15 mL/kg",
        "  - 可重複直到血壓穩定",
        "氧氣支持",
        "Diphenhydramine (H1 blocker): 1-2 mg/kg IM/IV",
        "Famotidine (H2 blocker): 0.5-1 mg/kg IV",
        "Dexamethasone: 0.1-0.2 mg/kg IV（預防二次反應）",
        "支氣管痙攣（尤其貓）：",
        "  - Terbutaline: 0.01 mg/kg SC/IM",
        "  - 嚴重時考慮氣管插管"
      ],
      chronic: [
        "監測二次反應（可能在4-12小時後發生）",
        "至少觀察12-24小時",
        "出院時：",
        "  - 處方腎上腺素自動注射器（主人教育使用）",
        "  - 抗組織胺備用",
        "  - 識別並避免過敏原",
        "  - 過敏測試和考慮減敏治療"
      ]
    },
    prognosis: "及時治療預後良好，未治療可能致命。過敏性休克可在數分鐘內致死。二次反應可能發生。",
    pearls: [
      "Epinephrine是唯一能救命的一線藥物 - 不要延遲給予",
      "犬的過敏性休克主要是消化道症狀（肝臟休克器官）",
      "貓的過敏性休克主要是呼吸道症狀",
      "類固醇不能逆轉急性反應，但可預防二次反應",
      "疫苗後建議觀察15-30分鐘"
    ],
    monitoring: ["生命徵象（每5-15分鐘初期）", "血壓", "呼吸狀態", "尿量", "觀察二次反應"],
    reference: "Shmuel DL, Cortes Y: Anaphylaxis in dogs and cats. J Vet Emerg Crit Care 23:377-394, 2013"
  },

  "atopy": {
    zh: "異位性皮膚炎",
    en: "Atopy (Atopic Dermatitis)",
    definition: "一種遺傳傾向的發炎性皮膚病，對環境過敏原（如塵蟎、花粉、黴菌）產生IgE介導的過敏反應，導致慢性搔癢性皮膚炎。是犬第二常見的過敏性皮膚病。",
    synonyms: ["Atopic Dermatitis", "CAD", "Canine Atopic Dermatitis", "Environmental Allergy", "異位性皮炎"],
    epidemiology: {
      species: "犬常見，貓較少見（但存在）",
      age: "通常1-3歲發病，6月齡前和7歲後發病較少",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（West Highland White Terrier、Labrador、Golden Retriever、German Shepherd、Boxer、French Bulldog、English Bulldog、Shar Pei）", "遺傳因素", "城市環境", "室內飼養"]
    },
    clinicalPresentation: {
      history: ["慢性反覆搔癢", "症狀可能有季節性（初期）或全年性（後期）", "搔抓臉部、腳掌、腋下、腹股溝", "舔腳", "外耳炎反覆發作", "症狀隨年齡可能加重"],
      physicalExam: ["典型分布：臉部、耳朵、腋下、腹部、腹股溝、肛周、趾間", "紅斑、丘疹", "脫毛（舔/抓導致）", "苔蘚化（慢性）", "色素沉著（慢性）", "外耳炎", "繼發感染（細菌、酵母菌）常見"]
    },
    pathophysiology: "皮膚屏障功能缺陷（絲聚蛋白等異常）→ 過敏原經皮膚進入 → 樹突細胞呈遞抗原 → Th2免疫反應 → B細胞產生IgE → IgE結合肥大細胞 → 再次接觸過敏原 → 肥大細胞脫顆粒 → 組織胺等介質釋放 → 搔癢和發炎。慢性發炎導致皮膚屏障進一步受損，形成惡性循環。",
    diagnosis: {
      overview: "臨床診斷為主，需排除其他搔癢原因",
      differentials: ["跳蚤過敏性皮膚炎", "食物過敏", "疥癬", "蠕形蟎", "接觸性皮膚炎", "細菌或酵母菌感染"],
      initialDB: ["詳細病史（發病年齡、季節性、分布）", "完整皮膚檢查", "皮膚刮搔（排除寄生蟲）", "皮膚細胞學（評估感染）", "嚴格跳蚤控制試驗（8週）", "食物排除試驗（8-12週）"],
      advanced: ["過敏原特異性IgE血清學檢測", "皮內過敏原測試（金標準，用於免疫治療規劃）", "皮膚活檢（非典型病例）"]
    },
    treatment: {
      overview: "多模式治療：減少過敏原暴露、控制感染、止癢、免疫調節",
      acute: [
        "急性發作止癢：",
        "  - Oclacitinib (Apoquel): 0.4-0.6 mg/kg PO q12h x 14天，然後q24h",
        "  - Prednisolone: 0.5-1 mg/kg PO q24h 短期使用",
        "  - Lokivetmab (Cytopoint): 2 mg/kg SC（效果持續4-8週）",
        "治療繼發感染：",
        "  - 抗生素（細菌感染）",
        "  - 抗黴菌藥（酵母菌感染）",
        "  - 藥浴",
        "外耳炎治療"
      ],
      chronic: [
        "長期管理策略：",
        "1. 過敏原避免（減少暴露）",
        "2. 皮膚屏障修復：",
        "   - 必需脂肪酸補充（omega-3/6）",
        "   - 保濕噴霧/乳液",
        "   - 頻繁洗澡（適當洗劑）",
        "3. 藥物控制搔癢：",
        "   - Oclacitinib: 0.4-0.6 mg/kg PO q24h",
        "   - Lokivetmab: 2 mg/kg SC q4-8週",
        "   - Cyclosporine: 5 mg/kg PO q24h（效果需4-6週）",
        "4. 過敏原特異性免疫治療(ASIT)：",
        "   - 皮下注射或舌下含服",
        "   - 60-70%犬隻有改善",
        "   - 需6-12個月見效",
        "5. 預防繼發感染"
      ]
    },
    prognosis: "終身疾病，無法治癒但可良好控制。早期診斷和多模式治療可提供良好生活品質。",
    pearls: [
      "異位性皮膚炎是排除性診斷",
      "跳蚤控制和食物排除試驗是診斷過程必需步驟",
      "Apoquel和Cytopoint是目前最有效的止癢選擇",
      "免疫治療是唯一可能改變疾病進程的治療",
      "繼發感染是搔癢加重的常見原因"
    ],
    monitoring: ["搔癢評分", "皮膚病變範圍和嚴重度", "繼發感染", "藥物副作用", "生活品質"],
    reference: "Hensel P et al: Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification. BMC Vet Res 11:196, 2015"
  },

  "vaccine-reaction": {
    zh: "疫苗反應",
    en: "Vaccine Reaction",
    definition: "接種疫苗後發生的不良反應，範圍從輕微局部反應到嚴重全身性過敏反應。大多數反應輕微且自限，但嚴重反應可能危及生命。",
    synonyms: ["Vaccine Adverse Event", "Post-vaccination Reaction", "Vaccinosis", "疫苗副作用", "疫苗不良反應"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，幼年動物首次接種和老年動物可能風險稍高",
      sex: "小型犬和絕育動物風險可能較高",
      riskFactors: ["先前疫苗反應史", "小型犬品種", "同時接種多種疫苗", "疫苗類型（活病毒疫苗風險可能較高）", "品種傾向（Dachshund、Pug、Boston Terrier等小型犬）"]
    },
    clinicalPresentation: {
      history: ["疫苗接種後數分鐘至數天發生", "常見反應通常在24-48小時內", "過敏反應通常在數分鐘至數小時內"],
      physicalExam: ["輕微反應（常見）：", "  - 注射部位腫脹或疼痛", "  - 輕度發燒", "  - 食慾下降", "  - 嗜睡", "中度反應：", "  - 蕁麻疹（犬面部腫脹常見）", "  - 嘔吐", "  - 腹瀉", "嚴重反應（罕見）：", "  - 過敏性休克（見anaphylaxis）", "  - 虛脫", "  - 呼吸困難", "延遲反應（貓）：", "  - 注射部位肉瘤（罕見但嚴重）"]
    },
    pathophysiology: "可能機制包括：1) Type I超敏反應（IgE介導，對疫苗成分過敏）。2) Type III超敏反應（免疫複合物）。3) 直接毒性（某些疫苗成分）。4) 活病毒疫苗感染（免疫功能低下動物）。貓注射部位肉瘤可能與疫苗佐劑引起的慢性發炎有關。",
    diagnosis: {
      overview: "根據疫苗接種時間和臨床表現診斷",
      differentials: ["與疫苗無關的疾病", "感染", "其他過敏反應", "注射部位感染"],
      initialDB: ["詳細病史（疫苗類型、接種時間）", "完整身體檢查", "嚴重反應：CBC、生化、血壓"],
      advanced: ["注射部位腫塊：細針抽吸或活檢", "免疫功能評估（若懷疑免疫缺陷）"]
    },
    treatment: {
      overview: "根據反應嚴重程度處理",
      acute: [
        "輕微反應（觀察為主）：",
        "  - 休息",
        "  - 冷敷注射部位（若腫脹）",
        "  - 通常24-48小時自行緩解",
        "中度反應（蕁麻疹、面部腫脹）：",
        "  - Diphenhydramine: 1-2 mg/kg IM/PO",
        "  - Dexamethasone: 0.1-0.2 mg/kg IV/IM（一次劑量）",
        "嚴重反應（過敏性休克）：",
        "  - 見過敏性休克處理",
        "  - Epinephrine: 0.01 mg/kg IM",
        "  - 靜脈輸液",
        "  - 氧氣支持"
      ],
      chronic: [
        "記錄反應並通報（疫苗不良反應監測系統）",
        "未來疫苗接種建議：",
        "  - 與獸醫討論風險效益",
        "  - 考慮分開接種（不同次就診）",
        "  - 預先給予抗組織胺",
        "  - 疫苗接種後觀察30分鐘",
        "  - 考慮效價檢測替代常規加強",
        "  - 避免已知引起反應的特定疫苗",
        "貓：考慮使用非佐劑疫苗"
      ]
    },
    prognosis: "輕中度反應預後極好。嚴重過敏反應若及時治療預後良好。",
    pearls: [
      "小型犬比大型犬更易發生反應",
      "同時接種多種疫苗增加風險",
      "貓注射部位腫塊持續>3個月或>2cm需活檢",
      "疫苗接種後建議觀察15-30分鐘",
      "有反應史者可預先給予抗組織胺"
    ],
    monitoring: ["接種後觀察15-30分鐘", "告知主人注意事項", "追蹤任何注射部位腫塊（尤其貓）"],
    reference: "Moore GE et al: Adverse events diagnosed within three days of vaccine administration in dogs. JAVMA 227:1102-1108, 2005"
  },

  "drug-hypersensitivity": {
    zh: "藥物過敏",
    en: "Drug Hypersensitivity",
    definition: "藥物或其代謝物引起的免疫介導不良反應。可為IgE介導的速發型反應或細胞介導的延遲型反應，範圍從皮疹到致命的全身反應。",
    synonyms: ["Drug Allergy", "Drug Reaction", "Adverse Drug Reaction", "藥物不良反應", "藥物過敏反應"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["先前藥物反應史", "同時使用多種藥物", "肝腎功能不全（影響藥物代謝）", "免疫系統疾病", "品種傾向（某些藥物）"]
    },
    clinicalPresentation: {
      history: ["近期開始使用新藥物", "既往對該藥或相關藥物有反應", "症狀在用藥後數分鐘到數週出現"],
      physicalExam: ["皮膚反應（最常見）：", "  - 紅斑、丘疹", "  - 蕁麻疹", "  - 面部水腫", "  - 搔癢", "  - 嚴重：表皮壞死溶解(TEN)、多形性紅斑", "全身反應：", "  - 發燒", "  - 淋巴結腫大", "  - 器官損傷（肝、腎、血液）", "過敏性休克（見該條目）"]
    },
    pathophysiology: "Type I（IgE介導）：速發型，分鐘至小時內，蕁麻疹、過敏性休克。Type II（細胞毒性）：抗體攻擊藥物結合的細胞，如藥物性IMHA/ITP。Type III（免疫複合物）：血清病樣反應，數天至週。Type IV（細胞介導）：延遲型，數天至週，接觸性皮膚炎。",
    diagnosis: {
      overview: "主要依據病史和時間關係",
      differentials: ["非免疫性藥物不良反應", "其他過敏（環境、食物）", "感染性皮膚病", "自體免疫疾病", "腫瘤"],
      initialDB: ["詳細用藥史（包括OTC和補充品）", "症狀和用藥的時間關係", "CBC、生化（評估器官損傷）", "尿液分析", "皮膚檢查"],
      advanced: ["皮膚活檢", "淋巴球轉化試驗（研究性）", "藥物激發試驗（有風險，罕用）"]
    },
    treatment: {
      overview: "停止致敏藥物是最重要步驟",
      acute: [
        "立即停止可疑藥物",
        "輕中度反應：",
        "  - 抗組織胺：Diphenhydramine 1-2 mg/kg",
        "  - 皮質類固醇：Prednisolone 0.5-1 mg/kg",
        "嚴重反應/過敏性休克：",
        "  - 見過敏性休克處理",
        "支持治療：",
        "  - 輸液（維持血壓和腎灌流）",
        "  - 皮膚護理（若有皮膚反應）"
      ],
      chronic: [
        "記錄過敏藥物於病歷",
        "告知主人避免該藥物和同類藥物",
        "若需使用同類藥物：",
        "  - 權衡風險效益",
        "  - 在可監測環境下使用",
        "  - 預先給予抗組織胺",
        "脫敏（極少數情況，如無替代藥物時）"
      ]
    },
    prognosis: "停藥後多數預後良好。嚴重反應如TEN、過敏性休克預後謹慎。",
    pearls: [
      "常見引起過敏的藥物：抗生素（青黴素類、磺胺類）、NSAIDs、某些疫苗",
      "犬對磺胺類藥物反應可能很嚴重（Type III）",
      "停藥後反應可能需數天至數週才完全消退",
      "交叉反應：對青黴素過敏可能對頭孢類也過敏",
      "藥物相關血液病（IMHA/ITP）停藥後仍可能需要免疫抑制治療"
    ],
    monitoring: ["臨床症狀消退", "血液學（若有影響）", "肝腎功能", "完全停藥後追蹤"],
    reference: "Noli C et al: Cutaneous drug reactions in dogs: a retrospective study of 45 cases. Vet Dermatol 6:13-20, 1995"
  },

  "contact-dermatitis": {
    zh: "接觸性皮膚炎",
    en: "Contact Dermatitis",
    definition: "皮膚直接接觸刺激物或過敏原後發生的發炎反應。可分為刺激性接觸性皮膚炎（非免疫性）和過敏性接觸性皮膚炎（免疫介導，Type IV過敏反應）。",
    synonyms: ["Contact Allergy", "Allergic Contact Dermatitis", "Irritant Contact Dermatitis", "接觸性過敏"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "任何年齡，過敏性需先前致敏（通常>6月齡）",
      sex: "無明顯性別傾向",
      riskFactors: ["短毛或無毛品種（皮膚暴露較多）", "接觸植物、地毯、清潔劑", "過敏體質（異位性皮膚炎者更易）"]
    },
    clinicalPresentation: {
      history: ["搔癢或疼痛", "與特定環境或物質接觸後發生", "症狀局限於接觸區域", "可能季節性（植物相關）"],
      physicalExam: ["病變分布於毛髮稀疏/接觸區域：", "  - 腹部、腋下、腹股溝", "  - 趾間、腳掌墊", "  - 耳廓、口周", "  - 陰囊", "刺激性：紅斑、水腫、可能水泡或糜爛", "過敏性：紅斑、丘疹、搔癢、慢性可苔蘚化"]
    },
    pathophysiology: "刺激性接觸性皮膚炎：直接皮膚損傷，不需致敏，任何動物都可發生。過敏性接觸性皮膚炎：Type IV遲發型超敏反應 → 接觸過敏原 → 表皮細胞呈遞抗原 → T細胞致敏 → 再次接觸 → T細胞介導發炎反應（24-48小時後）。",
    diagnosis: {
      overview: "病史和病變分布是關鍵，貼布試驗可確認",
      differentials: ["異位性皮膚炎", "食物過敏", "細菌或酵母菌感染", "蠕形蟎", "疥癬", "藥物反應"],
      initialDB: ["詳細環境史", "皮膚檢查和病變分布", "皮膚刮搔（排除寄生蟲）", "細胞學（排除感染）"],
      advanced: ["限制試驗（移除懷疑物質觀察改善）", "貼布試驗（patch test）- 確診過敏性接觸性皮膚炎", "皮膚活檢"]
    },
    treatment: {
      overview: "避免接觸是根本，對症治療緩解症狀",
      acute: [
        "識別並避免接觸原：",
        "  - 常見原因：植物（wandering jew、草）、地毯染料、清潔劑、藥物外用劑、金屬（鎳）",
        "清潔皮膚：溫水沖洗去除殘留",
        "止癢：",
        "  - 局部皮質類固醇（短期）",
        "  - Prednisolone: 0.5-1 mg/kg PO短期",
        "  - 抗組織胺（效果有限）",
        "治療繼發感染"
      ],
      chronic: [
        "完全避免接觸原（最重要）",
        "環境修改：",
        "  - 更換清潔劑",
        "  - 移除有問題的植物",
        "  - 穿保護衣物/鞋套",
        "皮膚屏障保護（局部保濕劑）",
        "若無法完全避免：",
        "  - 間歇性止癢治療",
        "  - 脫敏療法（研究中，不常用）"
      ]
    },
    prognosis: "若能識別並避免接觸原，預後極好。無法避免者需長期管理。",
    pearls: [
      "接觸性皮膚炎在犬比想像中少見",
      "病變分布在毛髮稀疏區域是重要線索",
      "Wandering Jew（吊竹梅）是犬常見的植物過敏原",
      "貼布試驗需在獸醫皮膚專科進行",
      "過敏性接觸性皮膚炎需要先前致敏期"
    ],
    monitoring: ["皮膚病變改善", "避免接觸的執行", "復發"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  // ==================== 神經系統免疫疾病 ====================

  "immune-mediated-meningitis": {
    zh: "免疫介導性腦膜炎",
    en: "Immune-Mediated Meningitis (Steroid-Responsive Meningitis-Arteritis)",
    definition: "一種免疫介導的軟腦膜和脊髓膜發炎，常伴隨全身性壞死性動脈炎。是犬最常見的腦膜炎類型，對皮質類固醇反應良好。",
    synonyms: ["SRMA", "Steroid-Responsive Meningitis-Arteritis", "Juvenile Polyarteritis Syndrome", "Beagle Pain Syndrome", "類固醇反應性腦膜炎"],
    epidemiology: {
      species: "犬，貓非常罕見",
      age: "年輕犬（6-18月齡最常見）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Beagle、Bernese Mountain Dog、Boxer、German Short-haired Pointer、Weimaraner、Nova Scotia Duck Tolling Retriever）"]
    },
    clinicalPresentation: {
      history: ["急性頸部疼痛和僵硬", "發燒", "不願移動", "拒絕低頭進食/飲水", "嗜睡", "步態僵硬"],
      physicalExam: ["頸部劇烈疼痛（操作時可能嚎叫）", "頸部僵硬（難以彎曲）", "發燒（>39.5°C）", "脊椎疼痛", "抑鬱、嗜睡", "通常無神經功能缺損（急性期）", "慢性期可能有輕度共濟失調"]
    },
    pathophysiology: "推測為免疫複合物介導的血管炎，主要影響腦膜和脊髓膜的軟腦膜血管。IgA在腦脊液中顯著升高是特徵。遺傳易感性 + 未知觸發因素 → 免疫系統異常活化 → 血管壁免疫複合物沉積 → 血管炎和腦膜炎 → 疼痛和發炎反應。",
    diagnosis: {
      overview: "腦脊液分析顯示特徵性嗜中性球增多",
      differentials: ["感染性腦膜炎（細菌、真菌、原蟲）", "椎間盤疾病", "腦膜瘤", "肉芽腫性腦膜腦炎(GME)", "壞死性腦炎"],
      initialDB: ["CBC（白血球增多、中性球增多）", "生化（可能正常）", "腦脊液分析：", "  - 蛋白升高", "  - 細胞數顯著升高（常>100/μL）", "  - 嗜中性球為主（急性期>70-80%）"],
      advanced: ["腦脊液IgA測定（特徵性升高）", "腦脊液培養（排除感染）", "MRI（腦膜強化）", "急性期蛋白（CRP、Haptoglobin升高）"]
    },
    treatment: {
      overview: "高劑量免疫抑制性皮質類固醇是治療基石",
      acute: [
        "Prednisolone: 2-4 mg/kg/day PO 分次給予",
        "疼痛管理：",
        "  - Gabapentin: 5-10 mg/kg PO q8-12h",
        "休息和支持照護"
      ],
      chronic: [
        "Prednisolone長期療程：",
        "  - 高劑量維持4-6週",
        "  - 緩慢減量（每2-4週減25%）",
        "  - 總療程通常6-12個月",
        "  - 部分需更長或終身治療",
        "復發或頑固病例加用：",
        "  - Azathioprine: 2 mg/kg PO q24-48h",
        "  - Cyclosporine: 5 mg/kg PO q12h",
        "監測腦脊液（評估緩解）"
      ]
    },
    prognosis: "早期積極治療預後良好，多數可達完全緩解。復發率約20-30%。太早或太快減藥會增加復發風險。慢性病例可能有永久神經損傷。",
    pearls: [
      "年輕大型犬頸部劇痛+發燒高度懷疑SRMA",
      "急性期腦脊液嗜中性球>70%是特徵",
      "類固醇反應通常在24-48小時內明顯",
      "減藥太快是復發的主要原因",
      "腦脊液IgA是疾病活動度的良好指標"
    ],
    monitoring: ["臨床症狀（疼痛、發燒）", "腦脊液分析（減藥前和停藥後）", "急性期蛋白", "藥物副作用"],
    reference: "Lowrie M et al: Steroid responsive meningitis-arteritis: a prospective study of potential disease markers. J Small Anim Pract 50:79-89, 2009"
  },

  // ==================== 免疫缺陷疾病 ====================

  "primary-immunodeficiency": {
    zh: "原發性免疫缺陷",
    en: "Primary Immunodeficiency",
    definition: "遺傳性免疫系統發育或功能缺陷，導致對感染的易感性增加。包括多種不同的疾病，影響不同的免疫成分（B細胞、T細胞、吞噬細胞或補體）。",
    synonyms: ["PID", "Congenital Immunodeficiency", "先天性免疫缺陷", "遺傳性免疫缺陷"],
    epidemiology: {
      species: "犬貓皆可發生，犬較多報導",
      age: "通常在幼年期發現（母源抗體消退後）",
      sex: "部分疾病為X連鎖（影響公犬為主）",
      riskFactors: ["品種傾向（依疾病類型）：", "  - IgA缺乏：German Shepherd、Shar Pei、Beagle", "  - SCID：Basset Hound、Welsh Corgi、Jack Russell Terrier", "  - 吞噬功能缺陷：Irish Setter、Weimaraner", "近親繁殖"]
    },
    clinicalPresentation: {
      history: ["反覆感染（呼吸道、皮膚、腸道）", "感染難以根除或頻繁復發", "對常規抗生素反應差", "生長發育遲緩", "同窩幼犬可能有類似問題"],
      physicalExam: ["營養不良、生長遲緩", "反覆性皮膚感染", "慢性呼吸道感染跡象", "淋巴結可能萎縮（B/T細胞缺陷）或腫大（慢性感染）", "脾臟萎縮（部分病例）"]
    },
    pathophysiology: "各類型機制不同：1) B細胞/抗體缺陷（最常見）：無法產生足夠抗體，易受細菌感染。2) T細胞缺陷：細胞免疫缺陷，易受病毒、真菌、原蟲感染。3) 重症複合免疫缺陷(SCID)：B和T細胞都缺陷，最嚴重。4) 吞噬功能缺陷：嗜中性球功能異常，易受細菌和真菌感染。5) 補體缺陷：罕見。",
    diagnosis: {
      overview: "懷疑需進行免疫功能評估",
      differentials: ["繼發性免疫缺陷（病毒感染、藥物、營養）", "解剖異常（如支氣管擴張）", "慢性隱蔽感染源", "糖尿病", "庫欣症"],
      initialDB: ["CBC（可能白血球減少或正常）", "血清蛋白電泳（低γ球蛋白血症？）", "血清IgG、IgM、IgA定量", "感染病原培養和鑑定"],
      advanced: ["淋巴球亞群分析（流式細胞儀）", "淋巴球功能試驗", "嗜中性球功能試驗", "基因檢測（已知突變）", "骨髓檢查"]
    },
    treatment: {
      overview: "支持治療為主，預防和積極治療感染",
      acute: [
        "積極治療現有感染：",
        "  - 根據培養結果選擇抗生素",
        "  - 療程通常需延長",
        "支持照護"
      ],
      chronic: [
        "感染預防：",
        "  - 預防性抗生素（爭議性）",
        "  - 避免暴露於感染源",
        "  - 良好營養",
        "免疫球蛋白缺乏：",
        "  - 血漿輸注（暫時性改善）",
        "  - 人或犬免疫球蛋白注射（若可取得）",
        "嚴重病例（SCID）：",
        "  - 骨髓移植（理論上可行，實際困難）",
        "  - 基因治療（研究中）",
        "不建議繁殖"
      ]
    },
    prognosis: "取決於缺陷類型和嚴重程度。IgA缺乏可能無症狀或僅輕微問題。SCID預後極差，多數在幼年期死亡。部分疾病可透過支持治療維持一定生活品質。",
    pearls: [
      "反覆感染的幼犬應懷疑免疫缺陷",
      "IgA缺乏是最常見的免疫球蛋白缺乏",
      "SCID犬隻在母源抗體消退後（8-12週齡）開始出現問題",
      "某些品種有已知的遺傳缺陷，可進行基因篩檢",
      "繁殖前應篩檢，不建議帶因者繁殖"
    ],
    monitoring: ["感染頻率和嚴重度", "生長發育", "免疫指標", "生活品質"],
    reference: "Felsburg PJ: Overview of immune system development in the dog. Vet Immunol Immunopathol 87:121-127, 2002"
  },

  // ==================== 血管炎 ====================

  "vasculitis": {
    zh: "血管炎",
    en: "Vasculitis",
    definition: "血管壁的發炎，可為免疫介導性或感染性。皮膚血管炎是最常見的表現，但也可影響內臟血管。",
    synonyms: ["血管發炎", "Cutaneous Vasculitis", "Immune-Mediated Vasculitis", "皮膚血管炎"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Jack Russell Terrier、Greyhound、German Shepherd、Rottweiler、Dachshund）", "藥物暴露", "感染", "疫苗接種", "自體免疫疾病", "腫瘤"]
    },
    clinicalPresentation: {
      history: ["皮膚病變（潰瘍、壞死）", "跛行（若關節或肌肉血管受累）", "發燒", "食慾下降", "近期藥物使用或疫苗接種"],
      physicalExam: ["皮膚血管炎（最常見）：", "  - 點狀出血、紫斑", "  - 皮膚壞死和潰瘍", "  - 耳翼、尾尖、腳墊、口腔黏膜最常受累", "  - 四肢遠端水腫", "狂犬病疫苗部位局部血管炎（犬）", "Greyhound的特發性血管炎", "全身性血管炎：", "  - 發燒", "  - 多器官症狀"]
    },
    pathophysiology: "可能機制：1) Type III超敏反應：免疫複合物沉積於血管壁 → 補體活化 → 嗜中性球浸潤 → 血管損傷。2) Type II（ANCA相關，犬罕見）。3) 直接感染血管內皮。4) 藥物直接毒性。結果：血管通透性增加、出血、血栓形成、組織缺血和壞死。",
    diagnosis: {
      overview: "皮膚活檢是確診關鍵，同時尋找潛在原因",
      differentials: ["感染性皮膚病", "凝血障礙", "血管腫瘤", "冷凝球蛋白血症", "DIC", "SLE"],
      initialDB: ["完整皮膚檢查", "CBC（血小板、貧血）", "凝血功能", "尿液分析", "血清蛋白", "ANA（排除SLE）"],
      advanced: ["皮膚活檢（含深層真皮和皮下組織）", "免疫組織化學", "傳染病篩檢（萊姆病、立克次體等）", "腫瘤篩檢", "冷凝球蛋白檢測"]
    },
    treatment: {
      overview: "移除潛在原因，免疫抑制治療",
      acute: [
        "識別並移除潛在原因：",
        "  - 停止可疑藥物",
        "  - 治療感染",
        "支持照護：",
        "  - 傷口照護",
        "  - 保護受影響部位"
      ],
      chronic: [
        "免疫抑制治療（若為免疫介導）：",
        "  - Prednisolone: 1-2 mg/kg PO q12-24h",
        "  - 緩慢減量",
        "頑固病例添加：",
        "  - Pentoxifylline: 10-15 mg/kg PO q8-12h（改善血流）",
        "  - Azathioprine: 2 mg/kg PO q24-48h",
        "  - Dapsone: 1 mg/kg PO q8h（慎用，監測副作用）",
        "  - Niacinamide + Tetracycline組合",
        "局部治療：傷口敷料、感染控制",
        "若有腫瘤需治療原發病"
      ]
    },
    prognosis: "取決於潛在原因和嚴重程度。藥物相關血管炎停藥後預後良好。特發性血管炎可能需長期治療。全身性血管炎預後較差。",
    pearls: [
      "活檢應取病變邊緣，包含深層組織",
      "狂犬病疫苗相關血管炎是已知實體",
      "Pentoxifylline對某些病例有益",
      "尋找潛在原因很重要（藥物、感染、腫瘤）",
      "部分病例可能永遠找不到原因（特發性）"
    ],
    monitoring: ["皮膚病變癒合", "新病變出現", "全身症狀", "藥物副作用"],
    reference: "Nichols PR et al: Cutaneous vasculitis in dogs: a retrospective study of 72 cases. Vet Dermatol 12:281-292, 2001"
  },

  // ==================== 幼犬特殊疾病 ====================

  "juvenile-cellulitis": {
    zh: "幼犬蜂窩組織炎",
    en: "Juvenile Cellulitis (Puppy Strangles)",
    definition: "幼犬的急性肉芽腫性和膿性皮膚淋巴結炎，病因不明但推測為免疫介導，與細菌感染無直接關係。以顏面腫脹和下頜淋巴結腫大為特徵。",
    synonyms: ["Puppy Strangles", "Juvenile Sterile Granulomatous Dermatitis and Lymphadenitis", "幼犬膿皮症"],
    epidemiology: {
      species: "犬",
      age: "幼犬（3週-6月齡，最常見3-16週齡）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Golden Retriever、Dachshund、Gordon Setter、Labrador、Beagle、Pointer）", "可能有遺傳因素", "同窩多隻發病常見"]
    },
    clinicalPresentation: {
      history: ["急性顏面腫脹", "耳朵腫脹和分泌物", "下頜腫塊", "發燒", "食慾下降", "精神沉鬱", "可能有跛行（關節炎）"],
      physicalExam: ["顏面腫脹（眼瞼、嘴唇、口鼻部）", "耳廓內側丘疹、膿皰和結痂", "下頜淋巴結顯著腫大（可能破潰流膿）", "耳道膿性分泌物", "肛周可能有病變", "可能有關節腫脹（無菌性關節炎）", "發燒"]
    },
    pathophysiology: "確切病因不明，推測為免疫系統異常反應。可能與皮膚毛囊或皮脂腺抗原的自體免疫反應有關。病灶培養通常為無菌（除非繼發感染）。肉芽腫性發炎和化膿是組織學特徵。",
    diagnosis: {
      overview: "典型年齡和臨床表現通常足以診斷",
      differentials: ["蠕形蟎感染", "細菌性毛囊炎", "皮癬菌感染", "天疱瘡", "藥物反應"],
      initialDB: ["皮膚刮搔（排除蠕形蟎）", "細胞學（化膿性肉芽腫性發炎）", "細菌培養（通常無菌）"],
      advanced: ["皮膚活檢（肉芽腫性脂肪腺炎）", "關節穿刺（若有關節炎）"]
    },
    treatment: {
      overview: "高劑量免疫抑制性皮質類固醇是治療基石",
      acute: [
        "Prednisolone: 2 mg/kg/day PO（高劑量）",
        "  - 維持高劑量直到病變明顯改善",
        "局部治療：",
        "  - 溫熱敷軟化結痂",
        "  - 輕柔清潔",
        "繼發感染治療：",
        "  - 抗生素（若有繼發細菌感染）",
        "疼痛管理"
      ],
      chronic: [
        "Prednisolone緩慢減量：",
        "  - 每1-2週減25%",
        "  - 總療程通常4-8週",
        "  - 太早停藥會復發",
        "頑固病例可加用Cyclosporine",
        "支持照護（營養、保溫）"
      ]
    },
    prognosis: "早期治療預後良好，多數完全康復。延遲治療可能留下永久疤痕。復發罕見。嚴重病例可能有致命風險（若不治療）。",
    pearls: [
      "這不是細菌感染！不要只用抗生素",
      "早期使用類固醇是關鍵，可防止疤痕",
      "同窩幼犬應密切觀察",
      "類固醇可能需使用4-8週",
      "沒有對類固醇反應要重新評估診斷"
    ],
    monitoring: ["病變改善", "淋巴結大小", "體重和生長", "藥物副作用（免疫抑制下的感染風險）"],
    reference: "Scott DW et al: Juvenile cellulitis in dogs: a retrospective study of 18 cases. J Am Anim Hosp Assoc 31:211-217, 1995"
  },

  // ==================== 貓特殊免疫疾病 ====================

  "eosinophilic-granuloma-complex": {
    zh: "嗜酸性肉芽腫複合症",
    en: "Eosinophilic Granuloma Complex (EGC)",
    definition: "貓的一組皮膚黏膜發炎性疾病，特徵為嗜酸性球浸潤。包括三種主要表現：無痛性潰瘍、嗜酸性斑塊和嗜酸性肉芽腫。通常與過敏反應有關。",
    synonyms: ["EGC", "Feline Eosinophilic Granuloma", "Rodent Ulcer", "Indolent Ulcer", "貓嗜酸性肉芽腫"],
    epidemiology: {
      species: "貓（犬罕見）",
      age: "任何年齡，年輕至中年貓較常見",
      sex: "嗜酸性肉芽腫在母貓可能較常見",
      riskFactors: ["過敏體質（跳蚤過敏、食物過敏、環境過敏）", "遺傳傾向", "免疫系統異常"]
    },
    clinicalPresentation: {
      history: ["口唇潰瘍（無痛性潰瘍）", "腹部或大腿內側紅斑斑塊", "嘴唇或下巴腫脹", "舔舐或搔癢（嗜酸性斑塊）", "可能無搔癢（無痛性潰瘍、肉芽腫）"],
      physicalExam: ["無痛性潰瘍(Indolent Ulcer)：", "  - 上唇紅棕色邊緣清楚的潰瘍", "  - 通常無痛", "  - 可單側或雙側", "嗜酸性斑塊(Eosinophilic Plaque)：", "  - 腹部、大腿內側", "  - 紅色、隆起、濕潤、可能潰瘍", "  - 通常很癢", "嗜酸性肉芽腫(Eosinophilic Granuloma)：", "  - 線形肉芽腫：大腿後側黃粉色線形病變", "  - 下巴/嘴唇：無痛腫脹", "  - 口腔：舌頭或軟齶結節", "  - 腳墊腫脹"]
    },
    pathophysiology: "推測為對各種過敏原的異常免疫反應，導致嗜酸性球和肥大細胞活化、組織浸潤和發炎介質釋放。過敏原可能包括：跳蚤唾液、食物成分、環境過敏原、蚊蟲叮咬。部分病例可能有遺傳性傾向，對抗原反應異常。",
    diagnosis: {
      overview: "臨床表現特徵性，但需尋找潛在過敏原因",
      differentials: ["鱗狀細胞癌（無痛性潰瘍）", "其他腫瘤", "感染（細菌、真菌、病毒）", "自體免疫疾病", "外傷"],
      initialDB: ["完整皮膚檢查", "細胞學（大量嗜酸性球）", "皮膚刮搔（排除蠕形蟎）", "跳蚤梳檢", "CBC（可能嗜酸性球增多）"],
      advanced: ["皮膚活檢（確診，尤其排除腫瘤）", "食物排除試驗（8-12週）", "過敏原檢測", "FeLV/FIV檢測"]
    },
    treatment: {
      overview: "處理潛在過敏原因 + 控制發炎",
      acute: [
        "嚴格跳蚤控制（所有貓+環境）",
        "止癢/消炎治療：",
        "  - Prednisolone: 1-2 mg/kg PO q24h x 2-4週，然後減量",
        "  - Methylprednisolone acetate: 4 mg/kg SC（效果持續2-4週）",
        "繼發感染治療"
      ],
      chronic: [
        "長期過敏管理：",
        "1. 持續跳蚤預防",
        "2. 食物排除試驗（水解蛋白或新蛋白質飲食）",
        "3. 環境過敏考慮免疫治療",
        "頑固病例藥物選擇：",
        "  - Cyclosporine (Atopica): 7 mg/kg PO q24h（需4-6週見效）",
        "  - Chlorambucil: 0.1-0.2 mg/kg PO q24-48h",
        "  - Methylprednisolone pulse therapy",
        "新型治療：",
        "  - 干細胞治療（研究中）",
        "避免長期類固醇（糖尿病風險）"
      ]
    },
    prognosis: "若能控制潛在過敏原，預後良好。特發性病例可能需長期管理。部分病例會復發。口腔病變可能影響進食。",
    pearls: [
      "EGC是過敏的表現，不是單一疾病",
      "跳蚤過敏是最常見原因，即使未發現跳蚤",
      "無痛性潰瘍需與口唇鱗狀細胞癌鑑別",
      "長期類固醇使用在貓有糖尿病風險",
      "治療需找出並控制潛在過敏原"
    ],
    monitoring: ["病變大小和外觀", "搔癢程度", "體重和血糖（若使用類固醇）", "復發"],
    reference: "Bloom PB: Canine and feline eosinophilic skin diseases. Vet Clin North Am Small Anim Pract 36:141-160, 2006"
  },

  // ==================== 血液免疫疾病 ====================

  "cold-agglutinin-disease": {
    zh: "冷凝集素病",
    en: "Cold Agglutinin Disease",
    definition: "一種少見的自體免疫性溶血性貧血亞型，特徵為在低溫下，IgM抗體（冷凝集素）與紅血球結合導致紅血球凝集和補體介導的溶血。通常影響暴露於低溫的末梢部位。",
    synonyms: ["Cold Hemagglutinin Disease", "CAD", "Cold Autoimmune Hemolytic Anemia", "冷型自體免疫性溶血性貧血"],
    epidemiology: {
      species: "犬貓皆罕見",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["淋巴系統腫瘤", "慢性感染", "自體免疫疾病", "寒冷環境暴露"]
    },
    clinicalPresentation: {
      history: ["暴露於寒冷後症狀加重", "耳尖、尾尖、腳趾發紫或壞死", "虛弱", "運動不耐", "尿液變色（血紅素尿）"],
      physicalExam: ["末梢部位紫紺、壞死（耳尖、尾尖、腳趾、鼻尖、陰囊）", "黏膜蒼白", "黃疸（溶血）", "脾腫大", "心搏過速", "發燒（若有繼發感染）"]
    },
    pathophysiology: "IgM冷凝集素在低溫（<30°C）下與紅血球表面抗原結合 → 紅血球凝集（末梢低溫部位）→ 微血管阻塞 → 缺血和壞死。同時 IgM 固定補體 → 補體介導的血管內溶血（當血液回到溫暖的中心部位）。可為原發性或繼發於其他疾病（淋巴瘤、感染）。",
    diagnosis: {
      overview: "血液樣本在低溫下凝集是診斷關鍵",
      differentials: ["其他IMHA類型（溫型）", "感染性貧血", "凝血障礙", "血管炎", "冷凍傷"],
      initialDB: ["CBC（貧血、可能自動凝集）", "血液抹片（紅血球凝集，復溫後消失）", "生化（膽紅素升高）", "尿液分析（血紅素尿）", "Direct Coombs試驗（可能陽性）"],
      advanced: ["冷凝集素效價測定", "骨髓檢查（排除淋巴瘤）", "傳染病篩檢（Mycoplasma等）", "影像學檢查（尋找潛在腫瘤）"]
    },
    treatment: {
      overview: "避免寒冷暴露 + 治療潛在疾病 + 免疫抑制",
      acute: [
        "避免寒冷暴露（最重要）：",
        "  - 保持溫暖環境",
        "  - 保護末梢部位",
        "嚴重貧血：",
        "  - 輸血（血液需加溫至37°C）",
        "  - 氧氣支持",
        "壞死組織處理"
      ],
      chronic: [
        "免疫抑制治療（若為原發性）：",
        "  - Prednisolone: 2 mg/kg PO q12h（效果可能不如溫型IMHA好）",
        "  - Chlorambucil: 0.1-0.2 mg/kg PO q24-48h（因為IgM）",
        "  - Mycophenolate: 10 mg/kg PO q12h",
        "治療繼發原因（若有）：",
        "  - 淋巴瘤化療",
        "  - 感染治療",
        "長期寒冷避免"
      ]
    },
    prognosis: "原發性病例若能避免寒冷，預後可接受。繼發於腫瘤者預後取決於腫瘤治療效果。可能留下永久性末梢組織損傷。",
    pearls: [
      "血液樣本在室溫下放置可能看到凝集",
      "溫型IMHA遠比冷型常見",
      "冷凝集素效價需在37°C和4°C下比較",
      "輸血時血液必須加溫",
      "類固醇對冷型IMHA效果不如溫型好"
    ],
    monitoring: ["PCV/貧血程度", "網織紅血球（骨髓反應）", "末梢循環狀態", "潛在疾病進展"],
    reference: "Swann JW, Skelly BJ: Systematic review of evidence relating to the treatment of immune-mediated hemolytic anemia in dogs. J Vet Intern Med 27:1-9, 2013"
  }

};
const IMMUNOLOGICAL_DISEASE_ALIASES = {
  // 系統性紅斑性狼瘡
  "系統性紅斑性狼瘡": "systemic-lupus-erythematosus",
  "紅斑狼瘡": "systemic-lupus-erythematosus",
  "狼瘡": "systemic-lupus-erythematosus",
  "SLE": "systemic-lupus-erythematosus",
  "lupus": "systemic-lupus-erythematosus",

  // 免疫介導性多發性關節炎
  "免疫介導性多發性關節炎": "immune-mediated-polyarthritis",
  "免疫性關節炎": "immune-mediated-polyarthritis",
  "多發性關節炎": "immune-mediated-polyarthritis",
  "IMPA": "immune-mediated-polyarthritis",
  "polyarthritis": "immune-mediated-polyarthritis",

  // 咀嚼肌炎
  "咀嚼肌炎": "masticatory-muscle-myositis",
  "咬肌炎": "masticatory-muscle-myositis",
  "顳肌炎": "masticatory-muscle-myositis",
  "MMM": "masticatory-muscle-myositis",
  "masticatory myositis": "masticatory-muscle-myositis",

  // 眼外肌肌炎
  "眼外肌肌炎": "extraocular-myositis",
  "眼球突出肌炎": "extraocular-myositis",
  "EOM": "extraocular-myositis",
  "extraocular myositis": "extraocular-myositis",

  // 過敏性休克
  "過敏性休克": "anaphylaxis",
  "嚴重過敏反應": "anaphylaxis",
  "過敏性反應": "anaphylaxis",
  "anaphylactic shock": "anaphylaxis",

  // 異位性皮膚炎
  "異位性皮膚炎": "atopy",
  "異位性皮炎": "atopy",
  "環境過敏": "atopy",
  "atopic dermatitis": "atopy",
  "CAD": "atopy",

  // 疫苗反應
  "疫苗反應": "vaccine-reaction",
  "疫苗副作用": "vaccine-reaction",
  "疫苗不良反應": "vaccine-reaction",
  "vaccine adverse event": "vaccine-reaction",

  // 藥物過敏
  "藥物過敏": "drug-hypersensitivity",
  "藥物不良反應": "drug-hypersensitivity",
  "藥物過敏反應": "drug-hypersensitivity",
  "drug allergy": "drug-hypersensitivity",

  // 接觸性皮膚炎
  "接觸性皮膚炎": "contact-dermatitis",
  "接觸性過敏": "contact-dermatitis",
  "contact allergy": "contact-dermatitis",

  // 免疫介導性腦膜炎
  "免疫介導性腦膜炎": "immune-mediated-meningitis",
  "類固醇反應性腦膜炎": "immune-mediated-meningitis",
  "SRMA": "immune-mediated-meningitis",
  "steroid responsive meningitis": "immune-mediated-meningitis",

  // 原發性免疫缺陷
  "原發性免疫缺陷": "primary-immunodeficiency",
  "先天性免疫缺陷": "primary-immunodeficiency",
  "遺傳性免疫缺陷": "primary-immunodeficiency",
  "PID": "primary-immunodeficiency",
  "immunodeficiency": "primary-immunodeficiency",

  // 血管炎
  "血管炎": "vasculitis",
  "血管發炎": "vasculitis",
  "皮膚血管炎": "vasculitis",
  "cutaneous vasculitis": "vasculitis",

  // 幼犬蜂窩組織炎
  "幼犬蜂窩組織炎": "juvenile-cellulitis",
  "幼犬膿皮症": "juvenile-cellulitis",
  "puppy strangles": "juvenile-cellulitis",

  // 嗜酸性肉芽腫複合症
  "嗜酸性肉芽腫複合症": "eosinophilic-granuloma-complex",
  "嗜酸性肉芽腫": "eosinophilic-granuloma-complex",
  "貓嗜酸性肉芽腫": "eosinophilic-granuloma-complex",
  "EGC": "eosinophilic-granuloma-complex",
  "rodent ulcer": "eosinophilic-granuloma-complex",
  "無痛性潰瘍": "eosinophilic-granuloma-complex",

  // 冷凝集素病
  "冷凝集素病": "cold-agglutinin-disease",
  "冷型自體免疫性溶血性貧血": "cold-agglutinin-disease",
  "cold hemagglutinin disease": "cold-agglutinin-disease"
  // ===== From ent-diseases.js =====

  // ==================== 耳部疾病 ====================

  "otitis-externa": {
    zh: "外耳炎",
    en: "Otitis Externa",
    definition: "外耳道的炎症反應，是小動物最常見的耳部疾病。涉及外耳道皮膚和軟骨結構，常伴有繼發性細菌或酵母菌感染。",
    synonyms: ["Ear Infection", "External Ear Canal Inflammation", "外耳道炎", "耳道炎"],
    epidemiology: {
      species: "犬最常見，貓較少見",
      age: "任何年齡，但慢性病例多見於成年犬",
      sex: "無明顯性別傾向",
      riskFactors: ["垂耳犬種（Cocker Spaniel、Basset Hound、Labrador）", "耳道狹窄品種（Shar-Pei）", "多毛耳道（Poodle）", "游泳習慣", "過敏性皮膚炎", "內分泌疾病（甲狀腺功能低下）", "耳道異物", "濕度高的環境"]
    },
    clinicalPresentation: {
      history: ["搖頭", "抓耳", "耳臭味", "耳分泌物", "觸摸耳朵時疼痛或退縮", "頭部傾斜（若伴中耳炎）", "聽力下降"],
      physicalExam: ["耳廓紅腫", "耳道水腫和增厚", "耳分泌物（蠟樣、膿性或乾燥碎屑）", "耳道狹窄（慢性病例）", "觸診耳根部疼痛", "可能有耳血腫並發"]
    },
    pathophysiology: "原發因素（過敏、異物、寄生蟲等）→ 耳道微環境改變 → 正常菌群失衡 → 繼發感染（Malassezia、Staphylococcus、Pseudomonas）→ 炎症反應 → 耳道增厚和狹窄 → 惡性循環。慢性病例可能導致耳道鈣化和永久性結構改變。",
    diagnosis: {
      overview: "耳鏡檢查和細胞學是基本診斷工具，需識別原發病因",
      differentials: ["過敏性皮膚炎（最常見原發因素）", "耳疥蟲（Otodectes cynotis）", "異物", "耳息肉或腫瘤", "中耳炎併發", "自體免疫疾病"],
      initialDB: ["耳鏡檢查（評估耳道和鼓膜）", "耳分泌物細胞學（細菌、酵母菌、炎症細胞）", "耳疥蟲檢查", "皮膚檢查（尋找過敏徵象）"],
      advanced: ["細菌培養和藥敏試驗（慢性或難治病例）", "耳道X光或CT（懷疑中耳炎）", "過敏原測試", "甲狀腺功能檢測", "皮膚活檢（懷疑自體免疫）"]
    },
    treatment: {
      overview: "清潔耳道、控制感染和炎症、治療原發病因",
      acute: [
        "耳道清潔：",
        "  - 溫和清潔液沖洗（若鼓膜完整）",
        "  - 嚴重病例可能需要鎮靜下深層清潔",
        "  - 避免使用刺激性清潔劑",
        "局部用藥（依細胞學結果選擇）：",
        "  - 複合製劑：抗生素+抗真菌+類固醇（如Otomax、Mometamax）",
        "  - Malassezia為主：Miconazole、Clotrimazole",
        "  - 細菌為主：Fluoroquinolone（Marbofloxacin）、Polymyxin B",
        "止痛/抗發炎：短期口服類固醇（嚴重病例）"
      ],
      chronic: [
        "識別並控制原發因素：",
        "  - 過敏管理（食物試驗、環境控制、免疫治療）",
        "  - 內分泌疾病治療",
        "維持治療：",
        "  - 定期清潔（每1-2週）",
        "  - 預防性局部用藥",
        "難治性Pseudomonas感染：",
        "  - 全身性抗生素（Fluoroquinolone）",
        "  - Tris-EDTA清潔增強抗生素效果",
        "嚴重慢性病例：",
        "  - 手術（垂直耳道切除術或全耳道切除術）"
      ]
    },
    prognosis: "急性病例經適當治療預後良好。慢性病例需要長期管理，預後取決於能否控制原發因素。嚴重慢性增生性改變可能需要手術。",
    pearls: [
      "80%犬外耳炎與潛在過敏性疾病相關",
      "鼓膜必須在使用耳藥前評估完整性",
      "棒狀桿菌（Pseudomonas）感染預後較差，需積極治療",
      "單側外耳炎應考慮異物或腫瘤",
      "治療後應追蹤細胞學確認感染清除"
    ],
    monitoring: ["治療7-14天後複檢", "耳鏡和細胞學追蹤", "慢性病例每1-3個月追蹤", "監測原發疾病控制狀況"],
    reference: "Rosser EJ: Causes of otitis externa. Vet Clin North Am Small Anim Pract 34:459-468, 2004"
  },

  "otitis-media-interna": {
    zh: "中/內耳炎",
    en: "Otitis Media/Interna",
    definition: "中耳（鼓室）和/或內耳（迷路）的炎症和感染。多為外耳炎的延伸，也可經由咽鼓管或血行感染。可導致嚴重的神經學症狀。",
    synonyms: ["Middle Ear Infection", "Inner Ear Infection", "中耳炎", "內耳炎", "Labyrinthitis"],
    epidemiology: {
      species: "犬較常見，貓也可發生（常與鼻咽息肉相關）",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["慢性外耳炎", "鼓膜破裂", "垂耳犬種", "上呼吸道感染", "鼻咽息肉（貓）", "外傷"]
    },
    clinicalPresentation: {
      history: ["慢性外耳炎病史", "頭部傾斜（患側低）", "眼球震顫", "步態不穩/共濟失調", "面神經麻痺（眼瞼下垂、唇下垂）", "Horner氏症候群", "聽力下降", "疼痛表現"],
      physicalExam: ["鼓膜混濁、膨出或破裂", "耳道分泌物", "頭部傾斜", "水平或旋轉性眼球震顫", "位置性斜視", "面神經麻痺徵象", "Horner氏症候群（縮瞳、眼瞼下垂、眼球內陷、第三眼瞼突出）", "前庭性共濟失調"]
    },
    pathophysiology: "感染途徑：(1)外耳炎經鼓膜蔓延（最常見）、(2)咽鼓管上行感染、(3)血行感染。中耳感染 → 炎症和膿液積聚 → 若未控制則侵犯內耳 → 前庭和耳蝸損傷 → 平衡和聽力障礙。鄰近神經（面神經、交感神經）也可能受累。",
    diagnosis: {
      overview: "結合臨床神經學檢查、耳鏡檢查和影像學診斷",
      differentials: ["周邊前庭疾病（特發性前庭症候群）", "中樞前庭疾病", "耳毒性藥物", "甲狀腺功能低下相關前庭病變", "顱內腫瘤", "鼻咽息肉（貓）"],
      initialDB: ["完整神經學檢查", "耳鏡檢查（評估鼓膜）", "耳分泌物細胞學和培養", "顱骨X光（鼓室混濁）"],
      advanced: ["CT或MRI（金標準）", "腦脊液分析（若懷疑中樞問題）", "電診斷測試（BAER聽力測試）", "肌電圖（評估面神經功能）"]
    },
    treatment: {
      overview: "長期全身性抗生素治療，必要時手術引流",
      acute: [
        "全身性抗生素治療（4-8週或更長）：",
        "  - 經驗性選擇：Amoxicillin-Clavulanate、Fluoroquinolone",
        "  - 依培養結果調整",
        "  - Pseudomonas感染：Enrofloxacin 或併用療法",
        "疼痛控制：NSAIDs或Gabapentin",
        "抗發炎：短期類固醇（減輕水腫）",
        "前庭症狀支持治療：",
        "  - 止吐藥（Maropitant）",
        "  - 防跌倒保護",
        "面神經麻痺：人工淚液（防止角膜乾燥）"
      ],
      chronic: [
        "若藥物治療無效：",
        "  - 鼓室骨泡切開術（Bulla Osteotomy）",
        "  - 垂直耳道切除術合併鼓室骨泡切開術",
        "  - 全耳道切除術合併鼓室骨泡切開術（TECA-LBO）",
        "術後持續抗生素2-4週",
        "長期監測復發"
      ]
    },
    prognosis: "早期治療預後較好。前庭症狀多數可改善，但部分可能遺留永久性頭部傾斜。面神經麻痺恢復較慢。聽力損失可能永久。貓的鼻咽息肉相關中耳炎手術後預後良好。",
    pearls: [
      "鼓膜完整不能排除中耳炎",
      "CT/MRI是診斷中耳炎的金標準",
      "老年犬急性發作需區分中耳炎和特發性前庭症候群",
      "貓中耳炎常與鼻咽息肉相關，需評估鼻咽部",
      "抗生素療程不足是治療失敗的常見原因"
    ],
    monitoring: ["神經學症狀改善", "影像追蹤（治療4-6週後）", "聽力評估", "面神經功能恢復"],
    reference: "Gotthelf LN: Diagnosis and treatment of otitis media in dogs and cats. Vet Clin North Am Small Anim Pract 34:469-487, 2004"
  },

  "aural-hematoma": {
    zh: "耳血腫",
    en: "Aural Hematoma",
    definition: "耳廓軟骨與皮膚之間的血液積聚，形成波動性腫脹。通常因搖頭或抓耳導致血管破裂，與潛在耳部問題相關。",
    synonyms: ["Ear Hematoma", "Auricular Hematoma", "耳殼血腫", "耳翼血腫"],
    epidemiology: {
      species: "犬較常見，貓較少",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["垂耳犬種", "外耳炎", "耳疥蟲", "過敏性疾病", "凝血障礙", "頻繁搖頭的任何原因"]
    },
    clinicalPresentation: {
      history: ["耳廓突然腫脹", "頻繁搖頭或抓耳", "外耳炎症狀", "可能有近期外傷"],
      physicalExam: ["耳廓內側波動性腫脹", "通常位於耳廓凹面", "可能整個耳廓腫脹", "耳廓發熱", "觸診液體感", "同時檢查外耳道（尋找原發問題）"]
    },
    pathophysiology: "搖頭或抓耳 → 耳廓軟骨和皮膚之間剪切力 → 血管破裂 → 血液積聚形成血腫。若不治療，血腫會機化形成纖維組織 → 耳廓變形（「花椰菜耳」）。免疫介導機制也可能參與。",
    diagnosis: {
      overview: "臨床診斷為主，需尋找潛在原因",
      differentials: ["膿腫", "腫瘤", "蜂窩組織炎", "異物反應"],
      initialDB: ["耳廓觸診（確認波動性腫脹）", "細針抽吸（排除膿腫、確認血液）", "耳鏡檢查（尋找外耳炎）", "耳分泌物細胞學"],
      advanced: ["凝血功能檢測（若反覆發生或雙側）", "過敏原測試（若懷疑過敏）"]
    },
    treatment: {
      overview: "排出血腫內容物並防止復發，同時治療原發病因",
      acute: [
        "保守治療（小型血腫或無法手術）：",
        "  - 細針抽吸（高復發率）",
        "  - 抽吸後注射類固醇",
        "手術治療（推薦）：",
        "  - 切開引流+縫合固定（多處縫合消除死腔）",
        "  - 放置引流管",
        "  - 術後包紮固定",
        "同時治療原發病因（外耳炎等）",
        "使用伊莉莎白項圈防止搖頭和抓耳"
      ],
      chronic: [
        "治療潛在耳部疾病（過敏、感染）",
        "若已纖維化變形，美容手術可選擇性進行",
        "預防復發的耳部保健"
      ]
    },
    prognosis: "及時手術治療預後良好，耳廓外觀可保持。未治療或延遲治療會導致永久性耳廓變形。復發率與潛在病因控制相關。",
    pearls: [
      "耳血腫本身是症狀，必須尋找並治療原發病因",
      "單純抽吸復發率高達80%",
      "手術後適當包紮固定很重要",
      "預防搖頭是術後護理的關鍵",
      "雙側或反覆發生應檢查凝血功能"
    ],
    monitoring: ["術後24-48小時檢查", "7-10天拆線", "持續監測外耳炎控制", "追蹤耳廓外觀"],
    reference: "Joyce JA: Aural hematoma surgery. Clin Tech Small Anim Pract 19:15-19, 2004"
  },

  "ear-polyp": {
    zh: "耳息肉",
    en: "Ear Polyp",
    definition: "外耳道或中耳的良性炎症性增生組織。貓較常見，稱為炎症性息肉或鼻咽息肉。可阻塞耳道或經咽鼓管生長至鼻咽部。",
    synonyms: ["Inflammatory Polyp", "Nasopharyngeal Polyp", "Aural Inflammatory Polyp", "炎症性息肉", "鼻咽息肉"],
    epidemiology: {
      species: "貓最常見，犬罕見",
      age: "年輕貓（<5歲）最常見",
      sex: "無明顯性別傾向",
      riskFactors: ["幼貓上呼吸道感染史", "可能與Calicivirus或Herpesvirus感染相關", "先天性異常（懷疑）"]
    },
    clinicalPresentation: {
      history: ["單側耳道分泌物", "搖頭", "外耳炎症狀", "呼吸有聲音（鼾聲）-若息肉在鼻咽部", "吞嚥困難", "聲音改變", "前庭症狀（若累及中耳）"],
      physicalExam: ["耳鏡可見耳道內粉紅色或紅色腫塊", "鼓膜後方可見腫塊（若在中耳）", "開口檢查可見鼻咽部腫塊（軟顎後方）", "可能伴有頭部傾斜、Horner氏症候群"]
    },
    pathophysiology: "病因不完全清楚，可能與上呼吸道感染後的慢性炎症反應相關。息肉起源於中耳或咽鼓管上皮，可向外生長進入外耳道，或向內生長進入鼻咽部。組織學上為纖維血管性結締組織，覆蓋呼吸道上皮。",
    diagnosis: {
      overview: "耳鏡和口腔/鼻咽檢查，影像學評估中耳",
      differentials: ["外耳道腫瘤（鱗狀細胞癌、耵聹腺癌）", "肉芽腫", "膽脂瘤", "異物反應"],
      initialDB: ["耳鏡檢查（鎮靜下）", "口腔和鼻咽檢查（鉤拉軟顎觀察）", "顱骨X光", "細胞學（若可取樣）"],
      advanced: ["CT或MRI（評估中耳和息肉範圍）", "組織病理學確診", "BAER聽力測試"]
    },
    treatment: {
      overview: "手術切除是主要治療方式",
      acute: [
        "耳道息肉：",
        "  - 牽引摘除（Traction avulsion）",
        "  - 術後可能需要短期類固醇減少炎症",
        "鼻咽息肉：",
        "  - 經口牽引摘除",
        "  - 可能需要軟顎切開以利摘除",
        "術後抗生素（預防感染）",
        "術後類固醇（減少復發）"
      ],
      chronic: [
        "若復發或累及中耳：",
        "  - 腹側鼓室骨泡切開術（VBO）",
        "  - 徹底清除中耳內息肉組織",
        "術後神經學監測（面神經、Horner氏症候群）"
      ]
    },
    prognosis: "單純牽引摘除復發率約30-50%。合併VBO復發率大幅降低（<10%）。術後Horner氏症候群常見但多為暫時性。聽力預後取決於中耳損傷程度。",
    pearls: [
      "貓的耳息肉常與鼻咽息肉相連，需同時評估",
      "牽引摘除要確保完整摘除基部",
      "術後類固醇可能減少復發率",
      "Horner氏症候群是VBO常見併發症",
      "年輕貓單側外耳炎/中耳炎應考慮息肉"
    ],
    monitoring: ["術後神經學監測", "耳鏡追蹤（1、3、6個月）", "症狀復發監測"],
    reference: "Anderson DM et al: Management of inflammatory polyps in 37 cats. Vet Rec 147:684-687, 2000"
  },

  "deafness": {
    zh: "聾",
    en: "Deafness",
    definition: "部分或完全喪失聽覺能力。可為先天性或後天性，單側或雙側，傳導性或感覺神經性。",
    synonyms: ["Hearing Loss", "Hearing Impairment", "聽力喪失", "耳聾", "失聰"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "先天性聾出生即有，後天性可任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["白色被毛/藍眼（與Piebald或Merle基因相關）", "品種傾向（Dalmatian、Bull Terrier、Australian Cattle Dog、白貓）", "老年（退化性）", "慢性外/中耳炎", "耳毒性藥物", "噪音暴露", "頭部外傷"]
    },
    clinicalPresentation: {
      history: ["對聲音無反應或反應降低", "叫喚不理睬", "容易受驚", "睡覺時難以喚醒", "吠叫過大聲（自我聽覺回饋喪失）", "訓練困難", "幼犬時期未對聲音定向"],
      physicalExam: ["聲音測試反應（鈴聲、拍手）", "耳道和鼓膜檢查", "神經學檢查（排除其他神經問題）", "眼部檢查（尋找與聾相關的眼睛異常）"]
    },
    pathophysiology: "傳導性聾：外耳或中耳問題阻止聲音傳導（如耳道阻塞、鼓膜破裂、滲出性中耳炎）。感覺神經性聾：內耳（柯蒂氏器）或聽神經損傷。先天性聾常與色素細胞發育異常相關（缺乏黑色素細胞導致血管紋發育不良）。老年性聾為漸進性柯蒂氏器退化。",
    diagnosis: {
      overview: "需區分傳導性和感覺神經性聾，BAER是金標準",
      differentials: ["傳導性聾：外耳炎、中耳炎、耳道腫瘤、鼓膜穿孔", "感覺神經性聾：先天性、老年退化、耳毒性、噪音損傷、感染", "中樞性聾（罕見）：腦幹病變"],
      initialDB: ["聲音反應測試（不精確但有篩檢價值）", "耳鏡檢查", "鼓室評估", "神經學檢查"],
      advanced: ["BAER（腦幹聽覺誘發電位）-金標準", "CT/MRI（評估中耳和腦幹）", "鼓室壓力圖"]
    },
    treatment: {
      overview: "治療可治療的原因，先天性感覺神經性聾無法治癒",
      acute: [
        "傳導性聾：",
        "  - 治療外耳炎",
        "  - 清除耳道阻塞物",
        "  - 手術治療中耳炎",
        "停用耳毒性藥物（若為藥物引起）"
      ],
      chronic: [
        "先天性感覺神經性聾：",
        "  - 無法治癒",
        "  - 手語/視覺信號訓練",
        "  - 環境管理（安全的圍欄區域）",
        "  - 震動項圈用於召回",
        "老年性聾：",
        "  - 無特效治療",
        "  - 適應性訓練",
        "助聽器（有限成功）"
      ]
    },
    prognosis: "傳導性聾若病因可治療，預後良好。先天性感覺神經性聾為永久性。老年性聾為漸進性。聾的動物經適當訓練可有良好生活品質。",
    pearls: [
      "Dalmatian的先天性聾發生率約30%（單側或雙側）",
      "單側聾的動物適應良好，常被忽視",
      "BAER是診斷幼犬先天性聾的金標準",
      "白色被毛和藍眼與聾的相關性因品種而異",
      "繁殖選擇應排除雙側聾的個體"
    ],
    monitoring: ["治療性聾的聽力追蹤", "行為適應評估", "安全環境維護"],
    reference: "Strain GM: Deafness in Dogs and Cats. CABI Publishing, 2011"
  },

  // ==================== 鼻部疾病 ====================

  "rhinitis": {
    zh: "鼻炎",
    en: "Rhinitis",
    definition: "鼻腔黏膜的炎症。可為急性或慢性，感染性或非感染性。是小動物常見的上呼吸道問題。",
    synonyms: ["Nasal Inflammation", "鼻腔炎症", "Nasal Cavity Inflammation"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "任何年齡，幼年動物感染性原因較多，老年動物腫瘤較多",
      sex: "無明顯性別傾向",
      riskFactors: ["短頭種（解剖特徵）", "未接種疫苗（病毒性）", "戶外活動（真菌、異物）", "免疫抑制", "牙科疾病"]
    },
    clinicalPresentation: {
      history: ["打噴嚏", "鼻分泌物（漿液性、黏液性、膿性或血性）", "鼻塞聲", "反向打噴嚏", "鼻出血", "嗅覺下降", "面部變形（慢性/腫瘤）", "食慾下降"],
      physicalExam: ["鼻分泌物", "呼吸音異常", "面部對稱性評估", "口腔檢查（牙齒、硬顎）", "眼部檢查（眼分泌物、眼球突出）", "淋巴結觸診", "氣流測試（鏡子或棉花）"]
    },
    pathophysiology: "感染性：病毒（犬瘟熱、副流感、貓皰疹病毒、貓杯狀病毒）→ 黏膜損傷 → 繼發細菌感染。真菌（Aspergillus、Cryptococcus）→ 組織侵犯和破壞。非感染性：過敏、異物、腫瘤、牙根膿瘍、口鼻瘻管。慢性炎症可導致淋巴漿細胞性鼻炎（尤其貓）。",
    diagnosis: {
      overview: "需區分感染性/非感染性，良性/惡性，以及識別潛在原因",
      differentials: ["感染性：病毒、細菌、真菌（Aspergillus-犬、Cryptococcus-貓）", "腫瘤（鼻腔腺癌、淋巴瘤、鱗狀細胞癌）", "異物", "牙科疾病/口鼻瘻管", "淋巴漿細胞性鼻炎", "過敏性鼻炎"],
      initialDB: ["詳細病史和身體檢查", "鼻分泌物細胞學", "顱骨X光或CT", "口腔檢查（鎮靜下）", "真菌血清學（Aspergillus、Cryptococcus）"],
      advanced: ["鼻鏡檢查和活檢", "CT（首選影像）", "MRI（評估顱內侵犯）", "真菌培養", "PCR檢測（病毒、真菌）"]
    },
    treatment: {
      overview: "針對病因治療",
      acute: [
        "細菌性鼻炎：",
        "  - 廣效抗生素（Amoxicillin-Clavulanate、Doxycycline）",
        "  - 療程2-4週",
        "病毒性鼻炎（貓）：",
        "  - 支持治療",
        "  - 抗病毒藥物（Famciclovir for FHV）",
        "  - L-lysine補充（證據有限）",
        "支持治療：",
        "  - 蒸氣吸入（鬆解分泌物）",
        "  - 鼻腔沖洗（生理鹽水）",
        "  - 確保進食（嗅覺下降影響食慾）"
      ],
      chronic: [
        "真菌性鼻炎：",
        "  - Aspergillus：局部Clotrimazole灌注或全身Itraconazole",
        "  - Cryptococcus：Fluconazole或Itraconazole長期治療",
        "淋巴漿細胞性鼻炎：",
        "  - 類固醇（Prednisolone）",
        "  - 可能需要免疫抑制治療",
        "腫瘤：放射治療、化療或姑息治療",
        "異物：鼻鏡取出"
      ]
    },
    prognosis: "感染性鼻炎經適當治療預後良好。慢性淋巴漿細胞性鼻炎需長期管理。真菌性鼻炎治療時間長但可治癒。鼻腔腫瘤預後較差。",
    pearls: [
      "單側症狀提示異物、牙科問題或腫瘤",
      "貓慢性鼻炎常為多因子",
      "CT比X光更能評估鼻腔病變範圍",
      "Aspergillus鼻炎的犬常有鼻平面色素脫失",
      "任何慢性鼻炎應排除腫瘤"
    ],
    monitoring: ["症狀改善追蹤", "真菌治療需定期血清學或影像追蹤", "腫瘤需定期分期評估"],
    reference: "Plickert HD et al: Rhinitis and sinusitis in dogs and cats. Vet Clin North Am Small Anim Pract 44:75-89, 2014"
  },

  "nasal-foreign-body": {
    zh: "鼻腔異物",
    en: "Nasal Foreign Body",
    definition: "外來物質滯留於鼻腔內，引起局部刺激、炎症和感染。常見於戶外活動的犬。",
    synonyms: ["Nasal Obstruction", "Intranasal Foreign Body", "鼻內異物"],
    epidemiology: {
      species: "犬較常見，貓少見",
      age: "任何年齡，年輕活潑犬較多",
      sex: "無明顯性別傾向",
      riskFactors: ["戶外活動", "在草叢中奔跑嗅聞", "獵犬", "狗公園活動"]
    },
    clinicalPresentation: {
      history: ["突發性打噴嚏（通常很劇烈）", "單側鼻分泌物", "用爪子扒鼻子", "可能有戶外活動後突發症狀", "鼻出血", "症狀可能在數天後減輕但不完全消失"],
      physicalExam: ["單側鼻分泌物（漿液性→黏液膿性）", "間歇性打噴嚏", "可能可見異物（前鼻孔）", "面部無變形", "氣流單側減少"]
    },
    pathophysiology: "異物（植物材料如草芒最常見）經由吸入或從口腔進入鼻腔 → 黏膜刺激和損傷 → 局部炎症反應 → 繼發細菌感染 → 可能形成肉芽腫包圍異物。若不移除，可能導致慢性化膿性鼻炎或鼻腔骨質溶解。",
    diagnosis: {
      overview: "鼻鏡檢查是診斷和治療的主要方法",
      differentials: ["鼻炎（感染性、過敏性）", "鼻腔腫瘤", "真菌性鼻炎", "牙科疾病", "口鼻瘻管"],
      initialDB: ["詳細病史（特別是症狀突發性）", "鼻腔視診", "顱骨X光"],
      advanced: ["鼻鏡檢查（前視鏡和後視鏡）", "CT（若鼻鏡無法識別）", "逆行沖洗"]
    },
    treatment: {
      overview: "鼻鏡下取出異物",
      acute: [
        "全身麻醉下鼻鏡檢查和取出：",
        "  - 前視鏡直接觀察和取出",
        "  - 後視鏡經口腔觀察鼻咽部",
        "  - 使用抓取鉗、沖洗或吸引",
        "術後可能需要：",
        "  - 短期抗生素（若有繼發感染）",
        "  - 抗發炎藥物",
        "逆行沖洗（若鏡下無法取出）"
      ],
      chronic: [
        "若異物已形成肉芽腫包圍：",
        "  - 可能需要手術切開取出",
        "移除後的感染控制：",
        "  - 抗生素療程",
        "  - 後續鼻鏡追蹤"
      ]
    },
    prognosis: "異物完整移除後預後極好。多數動物症狀迅速緩解。延遲治療可能導致慢性鼻炎或局部骨質破壞。",
    pearls: [
      "草芒（foxtail）是最常見的鼻腔異物",
      "突發劇烈打噴嚏是典型症狀",
      "鼻鏡檢查需仔細探查所有鼻道",
      "後視鏡檢查不可遺漏",
      "異物可能碎裂，需確保完整移除"
    ],
    monitoring: ["術後24-48小時症狀應明顯改善", "若症狀持續需重新評估", "完整移除後通常不需長期追蹤"],
    reference: "Tasker S et al: Aetiology and diagnosis of persistent nasal disease in the dog: a retrospective study of 42 cases. J Small Anim Pract 40:473-478, 1999"
  },

  "epistaxis": {
    zh: "鼻出血",
    en: "Epistaxis",
    definition: "鼻腔出血。可為單側或雙側，急性或慢性，可能是局部或全身性疾病的徵象。",
    synonyms: ["Nosebleed", "Nasal Hemorrhage", "流鼻血"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，但不同年齡層病因有差異",
      sex: "無明顯性別傾向",
      riskFactors: ["鼻腔腫瘤（老年犬）", "凝血障礙", "外傷", "真菌感染", "高血壓（貓）", "滅鼠藥中毒"]
    },
    clinicalPresentation: {
      history: ["鼻孔流血", "打噴嚏帶血", "吞嚥血液後嘔吐", "可能有已知凝血問題", "可能有滅鼠藥接觸史", "可能伴隨其他出血徵象"],
      physicalExam: ["鼻孔血跡", "面部是否變形", "結膜出血（若全身性凝血問題）", "皮膚瘀斑", "牙齦出血", "心臟雜音（若高血壓或心臟病）", "眼底檢查（高血壓視網膜病變）"]
    },
    pathophysiology: "局部原因：鼻腔腫瘤侵犯血管、真菌感染破壞組織、異物創傷、炎症性損傷。全身原因：血小板減少（免疫介導、骨髓問題）、凝血因子缺乏（滅鼠藥中毒、肝病、遺傳性）、血管異常（血管炎）、高血壓（尤其貓）。",
    diagnosis: {
      overview: "需區分局部和全身原因，緊急控制出血",
      differentials: ["局部：鼻腔腫瘤、真菌感染、異物、外傷、炎症", "全身：凝血障礙（滅鼠藥、免疫介導血小板減少、vWD）、高血壓、血管炎、蜱傳疾病"],
      initialDB: ["病史（外傷、毒物接觸）", "完整身體檢查", "CBC（血小板計數）", "凝血功能（PT、aPTT）", "血壓測量"],
      advanced: ["頰黏膜出血時間（BMBT）", "von Willebrand因子測定", "鼻腔影像（CT首選）", "鼻鏡檢查和活檢", "骨髓檢查", "蜱傳疾病PCR", "腹部超音波（肝臟評估）"]
    },
    treatment: {
      overview: "控制出血、治療根本原因",
      acute: [
        "緊急止血：",
        "  - 保持冷靜（減少血壓升高）",
        "  - 冰敷鼻樑",
        "  - 輕度鎮靜（若動物焦慮）",
        "  - 腎上腺素浸濕棉球局部壓迫",
        "  - 嚴重時可能需要鼻腔填塞",
        "若為凝血障礙：",
        "  - 新鮮冷凍血漿（FFP）",
        "  - 維生素K1（滅鼠藥中毒）：2.5-5 mg/kg PO/SC q12h",
        "  - 血小板輸注（嚴重血小板減少）",
        "輸血（若貧血嚴重）"
      ],
      chronic: [
        "針對病因治療：",
        "  - 腫瘤：放射治療、化療或姑息治療",
        "  - 真菌感染：抗真菌治療",
        "  - 高血壓：降壓藥（Amlodipine）",
        "  - 免疫介導血小板減少：免疫抑制",
        "滅鼠藥中毒：維生素K1療程4-6週"
      ]
    },
    prognosis: "取決於根本原因。單純外傷預後好。凝血障礙若可糾正預後良好。鼻腔腫瘤預後謹慎至不良。高血壓控制後可減少復發。",
    pearls: [
      "雙側鼻出血更提示全身性問題",
      "單側鼻出血加面部變形高度懷疑腫瘤",
      "滅鼠藥中毒出血可能在暴露後數天才出現",
      "貓鼻出血應常規測量血壓",
      "凝血檢測應在輸血前完成"
    ],
    monitoring: ["出血量和頻率", "PCV追蹤", "凝血功能（若為凝血障礙）", "血壓監測（若高血壓）"],
    reference: "Bissett SA et al: Epistaxis in dogs: a retrospective study of 200 cases (1998-2001). J Am Vet Med Assoc 230:1040-1044, 2007"
  },

  "nasopharyngeal-polyp": {
    zh: "鼻咽息肉",
    en: "Nasopharyngeal Polyp",
    definition: "起源於中耳或咽鼓管的良性炎症性增生組織，向鼻咽部生長。是年輕貓常見的上呼吸道阻塞原因。",
    synonyms: ["Inflammatory Polyp", "Feline Nasopharyngeal Polyp", "鼻咽炎症性息肉", "貓鼻咽息肉"],
    epidemiology: {
      species: "貓（犬罕見）",
      age: "年輕貓最常見（1-5歲），但可發生於任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["幼貓時期上呼吸道感染史", "可能與病毒感染（Calicivirus、Herpesvirus）相關"]
    },
    clinicalPresentation: {
      history: ["漸進性呼吸有聲音（鼾聲、喘鳴）", "打噴嚏", "鼻分泌物", "吞嚥困難", "聲音改變", "張口呼吸", "可能有中耳炎相關症狀（頭傾斜、前庭症狀）"],
      physicalExam: ["吸氣或呼氣時鼾聲", "開口檢查軟顎後方可見粉紅色腫塊", "可能有耳道分泌物", "可能有前庭症狀或Horner氏症候群"]
    },
    pathophysiology: "病因不完全清楚，可能與中耳或咽鼓管的慢性炎症反應相關。組織學上為血管化的纖維結締組織，覆蓋呼吸道上皮或鱗狀上皮。息肉可從中耳經咽鼓管生長至鼻咽部，或同時向外耳道方向生長。",
    diagnosis: {
      overview: "口腔檢查、耳鏡和影像學",
      differentials: ["鼻咽腫瘤（淋巴瘤、鱗狀細胞癌）", "肉芽腫", "異物", "膿腫", "鼻後孔狹窄"],
      initialDB: ["口腔檢查（鉤拉軟顎觀察鼻咽）", "耳鏡檢查", "顱骨X光"],
      advanced: ["CT（評估息肉範圍和中耳狀況）", "組織病理學（確診）", "BAER聽力測試"]
    },
    treatment: {
      overview: "手術摘除",
      acute: [
        "經口牽引摘除：",
        "  - 鎮靜或全身麻醉",
        "  - 鉤拉軟顎暴露息肉",
        "  - 使用止血鉗夾住息肉基部",
        "  - 輕柔持續牽引直到完整摘除",
        "術後類固醇：",
        "  - 可能減少復發率",
        "  - Prednisolone 1-2 mg/kg PO逐漸減量"
      ],
      chronic: [
        "若復發或有中耳累及：",
        "  - 腹側鼓室骨泡切開術（VBO）",
        "  - 徹底清除中耳內息肉組織",
        "  - 合併經口摘除鼻咽部息肉",
        "術後監測：",
        "  - Horner氏症候群（常見，多為暫時性）",
        "  - 聽力評估"
      ]
    },
    prognosis: "單純牽引摘除復發率約30-50%。合併VBO大幅降低復發率。術後Horner氏症候群常見但多於數週至數月內恢復。整體預後良好。",
    pearls: [
      "年輕貓有上呼吸道症狀應考慮息肉",
      "息肉常與中耳相連，即使耳道外觀正常",
      "CT可評估中耳是否累及，幫助決定手術方式",
      "術後類固醇使用有爭議但可能有益",
      "Horner氏症候群是VBO的預期併發症"
    ],
    monitoring: ["術後定期口腔和耳部檢查", "呼吸症狀監測", "神經學狀態（若有VBO）"],
    reference: "Veir JK et al: Feline inflammatory polyps: historical, clinical, and PCR findings for feline calicivirus and feline herpes virus-1 in 28 cases. J Feline Med Surg 4:195-199, 2002"
  },

  "oronasal-fistula": {
    zh: "口鼻瘻管",
    en: "Oronasal Fistula",
    definition: "口腔與鼻腔之間的異常通道。最常見於上頷犬齒拔除後或牙周病導致的骨質破壞。導致口腔內容物進入鼻腔。",
    synonyms: ["Oronasal Communication", "口鼻廔管", "Palatal Fistula"],
    epidemiology: {
      species: "犬較常見（尤其小型犬），貓較少",
      age: "中老年動物多見",
      sex: "無明顯性別傾向",
      riskFactors: ["嚴重牙周病", "上頷犬齒拔除（不當技術）", "小型犬種（Dachshund、Poodle、Yorkshire Terrier）", "口腔腫瘤切除後", "外傷", "先天性腭裂"]
    },
    clinicalPresentation: {
      history: ["進食時打噴嚏", "單側鼻分泌物（常含食物殘渣）", "慢性鼻炎", "拔牙後症狀", "口臭"],
      physicalExam: ["口腔檢查可見瘻管開口（通常在上頷犬齒區）", "可能用探針確認通道", "鼻分泌物", "牙周病或缺牙徵象"]
    },
    pathophysiology: "牙周病：上頷犬齒周圍骨質破壞 → 齒槽骨和硬顎吸收 → 口腔與鼻腔相通。拔牙後：不當拔牙技術損傷鼻腔底部 → 癒合不良形成瘻管。口腔內容物（食物、液體、細菌）進入鼻腔 → 慢性鼻炎和感染。",
    diagnosis: {
      overview: "口腔檢查和探查確診",
      differentials: ["原發性鼻炎", "鼻腔異物", "鼻腔腫瘤", "真菌性鼻炎"],
      initialDB: ["詳細口腔檢查（鎮靜下）", "牙周探針探查", "牙科X光或CT"],
      advanced: ["顱骨CT（評估瘻管範圍和鼻腔狀況）", "鼻鏡檢查", "鼻分泌物細胞學和培養"]
    },
    treatment: {
      overview: "手術修補瘻管",
      acute: [
        "瘻管修補術：",
        "  - 全身麻醉、適當定位",
        "  - 清創瘻管邊緣",
        "  - 黏膜瓣技術閉合（單層或雙層）",
        "  - 無張力縫合很重要",
        "  - 常用技術：旋轉瓣、推進瓣",
        "術前/術後抗生素",
        "止痛藥"
      ],
      chronic: [
        "術後護理：",
        "  - 軟食2-3週",
        "  - 避免咀嚼玩具",
        "  - 伊莉莎白項圈防止舔舐",
        "  - 抗生素療程7-14天",
        "若初次修補失敗：",
        "  - 等待4-6週再次手術",
        "  - 考慮不同瓣技術或補綴材料",
        "預防：",
        "  - 正確的拔牙技術",
        "  - 牙周病早期治療"
      ]
    },
    prognosis: "手術修補成功率約75-85%。小型瘻管預後較好。需要第二次手術的約15-25%。癒合後鼻炎症狀應改善。",
    pearls: [
      "上頷犬齒拔除後應常規檢查是否有口鼻通道",
      "若拔牙時發現口鼻通道，應立即修補",
      "無張力縫合是成功的關鍵",
      "雙層閉合比單層更可靠",
      "小型犬因骨質薄更易發生"
    ],
    monitoring: ["術後10-14天複檢", "縫線拆除", "長期追蹤症狀是否復發"],
    reference: "Marretta SM: Maxillofacial surgery. Vet Clin North Am Small Anim Pract 28:1285-1296, 1998"
  },

  // ==================== 咽喉及唾液腺疾病 ====================

  "pharyngitis": {
    zh: "咽炎",
    en: "Pharyngitis",
    definition: "咽部（包括口咽和鼻咽）的炎症。可為原發性或繼發於全身性疾病。常伴隨扁桃腺炎。",
    synonyms: ["Sore Throat", "Throat Inflammation", "喉嚨發炎"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["上呼吸道感染", "反覆嘔吐", "異物", "口腔疾病", "免疫抑制", "群居環境（犬舍）"]
    },
    clinicalPresentation: {
      history: ["吞嚥困難或疼痛", "乾咳或作嘔", "拒食或厭食", "流涎", "聲音改變", "發燒", "頸部觸診敏感"],
      physicalExam: ["咽部黏膜紅腫", "扁桃腺腫大（若有扁桃腺炎）", "可能有黏液或膿性分泌物", "頸部淋巴結腫大", "發燒", "脫水（若進食困難）"]
    },
    pathophysiology: "感染性：病毒（犬瘟熱、犬副流感、貓皰疹病毒）→ 黏膜損傷 → 繼發細菌感染。非感染性：胃酸反流、異物刺激、化學物質刺激、免疫介導。炎症導致咽部水腫和疼痛 → 吞嚥困難。",
    diagnosis: {
      overview: "臨床檢查和排除其他咽部疾病",
      differentials: ["扁桃腺炎", "咽部異物", "咽部腫瘤", "軟顎過長", "狂犬病（鑑別診斷）", "重症肌無力（若有巨食道）"],
      initialDB: ["詳細病史", "口腔和咽部檢查（鎮靜下）", "頸部觸診", "體溫測量"],
      advanced: ["頸部X光", "內視鏡檢查", "培養和藥敏試驗", "活檢（若懷疑腫瘤）"]
    },
    treatment: {
      overview: "支持治療和針對病因治療",
      acute: [
        "感染性咽炎：",
        "  - 抗生素（Amoxicillin-Clavulanate）7-14天",
        "  - 止痛/抗發炎（NSAIDs或短期類固醇）",
        "支持治療：",
        "  - 軟食或流質食物",
        "  - 確保水分攝取",
        "  - 必要時靜脈輸液",
        "異物：鎮靜下取出"
      ],
      chronic: [
        "反覆發作：",
        "  - 尋找潛在原因（免疫問題、反流）",
        "  - 管理胃食道反流",
        "  - 考慮扁桃腺切除（若反覆扁桃腺炎）",
        "腫瘤性：適當的腫瘤治療"
      ]
    },
    prognosis: "單純感染性咽炎預後良好。異物移除後恢復快。慢性或反覆發作需要找出根本原因。",
    pearls: [
      "吞嚥困難伴神經學症狀應考慮狂犬病",
      "慢性嘔吐的動物常有繼發性咽炎",
      "短頭種更容易有咽部問題",
      "群居環境中可能有傳染性病原",
      "鎮靜下完整的口咽檢查很重要"
    ],
    monitoring: ["症狀改善", "進食和飲水恢復", "體重維持", "若反覆發作需進一步檢查"],
    reference: "Hawkins EC: Disorders of the pharynx. In: Nelson RW, Couto CG (eds): Small Animal Internal Medicine, 5th Ed. Elsevier, 2014"
  },

  "tonsillitis": {
    zh: "扁桃腺炎",
    en: "Tonsillitis",
    definition: "扁桃腺（位於咽部的淋巴組織）的炎症和腫大。犬較常見，可為原發性或繼發於其他疾病。",
    synonyms: ["Tonsillar Inflammation", "扁桃體炎", "Tonsillar Enlargement"],
    epidemiology: {
      species: "犬較常見，貓少見",
      age: "年輕犬較多（<3歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["小型犬", "慢性嘔吐", "慢性咳嗽", "口腔感染", "免疫抑制"]
    },
    clinicalPresentation: {
      history: ["乾咳或作嘔", "吞嚥困難", "拒食", "流涎", "口臭", "發燒", "頸部淋巴結腫大"],
      physicalExam: ["扁桃腺從扁桃腺窩突出", "扁桃腺紅腫", "可能有膿點或膿性分泌物", "口腔其他部位可能正常", "頸部淋巴結腫大"]
    },
    pathophysiology: "原發性：細菌感染（Streptococcus、Staphylococcus、E. coli）導致扁桃腺發炎。繼發性（更常見）：慢性嘔吐的胃酸刺激、慢性咳嗽的呼吸道分泌物刺激、牙周病細菌擴散、全身性感染的局部表現。扁桃腺腫大可能導致上呼吸道部分阻塞。",
    diagnosis: {
      overview: "口腔檢查即可診斷，需尋找潛在原因",
      differentials: ["扁桃腺腫瘤（淋巴瘤、鱗狀細胞癌）", "反應性增生", "全身性淋巴瘤累及"],
      initialDB: ["口腔檢查", "扁桃腺外觀評估", "全身檢查（尋找原發病）", "CBC"],
      advanced: ["扁桃腺培養和藥敏", "細針抽吸細胞學", "活檢（若懷疑腫瘤）", "胸腔X光（若慢性咳嗽）"]
    },
    treatment: {
      overview: "抗生素治療原發性扁桃腺炎，治療潛在原因",
      acute: [
        "抗生素治療：",
        "  - Amoxicillin-Clavulanate 12.5-25 mg/kg PO q12h",
        "  - 療程10-14天",
        "止痛/抗發炎：",
        "  - NSAIDs短期使用",
        "支持治療：",
        "  - 軟食",
        "  - 確保水分攝取"
      ],
      chronic: [
        "尋找並治療潛在原因：",
        "  - 胃食道反流管理",
        "  - 牙周病治療",
        "  - 慢性咳嗽原因診治",
        "扁桃腺切除術（適應症）：",
        "  - 反覆扁桃腺炎（>2-3次/年）",
        "  - 扁桃腺腫大導致呼吸困難",
        "  - 疑似腫瘤"
      ]
    },
    prognosis: "原發性扁桃腺炎對抗生素反應良好。繼發性扁桃腺炎預後取決於原發病。扁桃腺腫瘤預後依腫瘤類型而異。",
    pearls: [
      "扁桃腺炎常為繼發性，需尋找原因",
      "單側扁桃腺腫大應高度懷疑腫瘤",
      "小型犬的扁桃腺問題較常見",
      "慢性嘔吐是常見的潛在原因",
      "扁桃腺切除很少需要，除非有明確適應症"
    ],
    monitoring: ["症狀改善", "扁桃腺大小追蹤", "潛在原因控制"],
    reference: "Hawkins EC: Disorders of the pharynx. In: Nelson RW, Couto CG (eds): Small Animal Internal Medicine, 5th Ed. Elsevier, 2014"
  },

  "sialadenitis": {
    zh: "唾液腺炎",
    en: "Sialadenitis",
    definition: "唾液腺（主要為腮腺、下頷腺、舌下腺或顴腺）的炎症。可為感染性或免疫介導性。犬較常見。",
    synonyms: ["Salivary Gland Inflammation", "唾腺炎"],
    epidemiology: {
      species: "犬較常見，貓少見",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["唾液腺管阻塞", "外傷", "鄰近組織感染", "免疫介導疾病"]
    },
    clinicalPresentation: {
      history: ["唾液腺區域腫脹", "疼痛（尤其進食時）", "拒食", "流涎（可能帶血）", "發燒", "可能有眼部症狀（顴腺炎累及眼窩）"],
      physicalExam: ["唾液腺區域腫脹、發熱、疼痛", "下頷腺：下頷角後方", "腮腺：耳根下方", "顴腺：眼眶下方/顴弓區", "舌下腺：舌下區域", "可能有膿性分泌物從唾液管排出"]
    },
    pathophysiology: "感染性：細菌經由唾液管逆行感染或血行感染。阻塞性：唾液管結石或狹窄導致唾液滯留和繼發感染。免疫介導性：壞死性唾液腺化生（Necrotizing Sialometaplasia）-可能與免疫介導機制相關。炎症導致腺體腫脹和疼痛，可能形成膿瘍。",
    diagnosis: {
      overview: "臨床檢查、影像學和細胞學/組織學",
      differentials: ["唾液囊腫（Sialocele）", "唾液腺腫瘤", "淋巴結腫大", "膿瘍", "顴腺黏液囊腫"],
      initialDB: ["詳細體格檢查", "細針抽吸細胞學", "頭部X光或超音波"],
      advanced: ["CT或MRI", "唾液管造影", "活檢", "培養和藥敏"]
    },
    treatment: {
      overview: "抗生素治療感染，必要時手術引流或切除",
      acute: [
        "抗生素治療：",
        "  - 廣效抗生素（Amoxicillin-Clavulanate、Clindamycin）",
        "  - 療程2-4週",
        "止痛/抗發炎：",
        "  - NSAIDs",
        "熱敷（促進引流）",
        "若有膿瘍形成：",
        "  - 切開引流",
        "  - 沖洗"
      ],
      chronic: [
        "若對藥物治療無反應或反覆發作：",
        "  - 唾液腺切除術",
        "壞死性唾液腺化生：",
        "  - 可能需要類固醇或免疫抑制",
        "  - 可能自行緩解",
        "若有結石阻塞：",
        "  - 結石移除或腺體切除"
      ]
    },
    prognosis: "感染性唾液腺炎對抗生素治療反應良好。反覆發作可能需要手術。壞死性唾液腺化生預後通常良好。腫瘤需根據類型評估。",
    pearls: [
      "顴腺炎可能被誤診為眶周蜂窩組織炎",
      "進食時疼痛加劇是特徵性表現",
      "細針抽吸可區分炎症和腫瘤",
      "壞死性唾液腺化生可能模擬腫瘤",
      "Terrier犬種更易發生唾液腺問題"
    ],
    monitoring: ["症狀改善", "腫脹消退", "進食恢復正常", "若手術則追蹤癒合"],
    reference: "Spangler WL, Culbertson MR: Salivary gland disease in dogs and cats: 245 cases (1985-1988). J Am Vet Med Assoc 198:465-469, 1991"
  },

  "sialocele": {
    zh: "唾液囊腫",
    en: "Sialocele",
    definition: "唾液在組織中積聚形成的假性囊腫（無上皮內襯）。最常見於下頷腺-舌下腺複合體。是犬最常見的唾液腺疾病。",
    synonyms: ["Salivary Mucocele", "Ranula（舌下型）", "唾液黏液囊腫", "蝦蟆腫（舌下型）"],
    epidemiology: {
      species: "犬較常見，貓少見",
      age: "2-4歲多見",
      sex: "無明顯性別傾向，部分研究顯示公犬較多",
      riskFactors: ["外傷", "唾液管阻塞", "品種傾向（German Shepherd、Poodle、Dachshund）"]
    },
    clinicalPresentation: {
      history: ["漸進性無痛腫脹", "可能有進食困難（舌下型）", "呼吸困難（咽部型）", "頸部腫塊（頸部型）"],
      physicalExam: ["軟性、波動性、無痛腫脹", "頸部型：下頷或上頸部腫脹", "舌下型（Ranula）：舌下單側或雙側藍紫色腫脹", "咽部型：咽部腫脹（可能危及呼吸道）", "顴腺型：眼周或眶後腫脹"]
    },
    pathophysiology: "唾液腺或唾液管損傷（外傷或阻塞）→ 唾液滲漏至周圍組織 → 炎症反應形成肉芽組織包圍 → 唾液持續積聚形成假性囊腫。下頷腺-舌下腺複合體最常累及。囊腫可向頸部（最常見）、舌下或咽部方向發展。",
    diagnosis: {
      overview: "臨床表現和抽吸細胞學",
      differentials: ["膿瘍", "血腫", "淋巴結腫大", "腫瘤", "甲狀腺囊腫", "鰓裂囊腫"],
      initialDB: ["觸診特徵", "細針抽吸：透明至淡黃色黏稠液體，細胞學見唾液（黏蛋白、少量細胞）", "位置評估判斷類型"],
      advanced: ["頸部超音波", "唾液管造影", "CT（評估範圍和相關結構）"]
    },
    treatment: {
      overview: "手術切除受累唾液腺是根治方法",
      acute: [
        "緊急情況（咽部型危及呼吸）：",
        "  - 抽吸減壓",
        "  - 必要時氣管切開",
        "  - 計畫性手術",
        "單純抽吸（暫時性措施）：",
        "  - 抽出唾液減輕症狀",
        "  - 通常會復發"
      ],
      chronic: [
        "根治性手術：",
        "  - 下頷腺-舌下腺複合體切除（最常用）",
        "  - 囊腫壁不需完全切除",
        "  - 需識別並切除受累側腺體",
        "舌下型（Ranula）：",
        "  - 囊腫造袋術（Marsupialization）或",
        "  - 合併唾液腺切除",
        "顴腺囊腫：",
        "  - 顴腺切除（需眶下入路）"
      ]
    },
    prognosis: "唾液腺切除後預後極好，復發率低（<5%）。單純抽吸復發率高。咽部型若及時處理預後良好。",
    pearls: [
      "囊腫可能在對側形成（雙側需評估）",
      "術中識別正確側別很重要",
      "抽吸液的黏稠特性有助於診斷",
      "舌下型可能影響進食和呼吸",
      "造袋術復發率較腺體切除高"
    ],
    monitoring: ["術後腫脹消退", "進食和吞嚥功能", "對側是否發生"],
    reference: "Bellenger CR, Simpson DJ: Canine sialadenitis: 60 clinical cases. J Small Anim Pract 33:376-380, 1992"
  },

  "zygomatic-mucocele": {
    zh: "顴骨黏液囊腫",
    en: "Zygomatic Mucocele",
    definition: "顴腺（Zygomatic Gland）唾液滲漏形成的假性囊腫。顴腺位於眼眶下方，囊腫常導致眼周或眶後腫脹。相對少見但需與眼眶疾病鑑別。",
    synonyms: ["Zygomatic Sialocele", "Zygomatic Salivary Mucocele", "顴腺囊腫", "顴腺黏液囊腫"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "中年犬較多",
      sex: "無明顯性別傾向",
      riskFactors: ["外傷", "腺體或管道阻塞", "原因常不明"]
    },
    clinicalPresentation: {
      history: ["眼周漸進性腫脹", "眼球突出", "可能有眼部不適", "開口困難（若範圍大）", "通常無疼痛"],
      physicalExam: ["眼眶下方或眶後波動性腫脹", "眼球偏位或突出", "第三眼瞼突出", "開口時可能加重腫脹", "口腔檢查可能見上頷後區腫脹"]
    },
    pathophysiology: "顴腺位於眼眶腹側，唾液管開口於上頷第一臼齒對側口腔黏膜。腺體或管道損傷 → 唾液滲漏 → 在眶周組織積聚形成假性囊腫 → 可能向眶後或頰部擴展。由於位置關係，常模擬眼眶腫瘤或膿瘍。",
    diagnosis: {
      overview: "需與眼眶疾病鑑別，影像學和抽吸細胞學有幫助",
      differentials: ["眶後膿瘍", "眼眶腫瘤", "顴腺腫瘤", "顴腺炎", "外傷性血腫", "蜂窩組織炎"],
      initialDB: ["眼科檢查", "口腔檢查（評估口腔內腫脹）", "細針抽吸：透明黏稠唾液樣液體", "眼壓測量"],
      advanced: ["CT或MRI（最有價值）", "超音波", "唾液管造影"]
    },
    treatment: {
      overview: "顴腺切除是根治方法",
      acute: [
        "暫時減壓（若有急性眼球壓迫）：",
        "  - 細針抽吸",
        "  - 計畫性手術"
      ],
      chronic: [
        "顴腺切除術：",
        "  - 通常經由口腔入路",
        "  - 或結合眶下入路",
        "  - 需識別並結紮唾液管",
        "  - 保護眼眶內結構",
        "術後管理：",
        "  - 抗生素預防感染",
        "  - 止痛藥",
        "  - 軟食數天"
      ]
    },
    prognosis: "手術切除後預後良好。眼球功能通常可保留。復發罕見。",
    pearls: [
      "顴骨黏液囊腫常被誤診為眶後膿瘍或腫瘤",
      "抽吸液的黏稠特性是關鍵診斷線索",
      "CT可清楚顯示囊腫範圍和與眼眶關係",
      "眶後膿瘍通常有疼痛，囊腫通常無痛",
      "口腔入路是最常用的手術途徑"
    ],
    monitoring: ["眼球位置恢復", "視力保持", "腫脹消退", "術後感染監測"],
    reference: "Cannon MS et al: Clinical and diagnostic imaging findings in dogs with zygomatic sialadenitis: 11 cases (1990-2009). J Am Vet Med Assoc 239:1211-1218, 2011"
  }

};
const ENT_DISEASE_ALIASES = {
  // 耳部疾病
  "外耳炎": "otitis-externa",
  "耳道炎": "otitis-externa",
  "耳朵感染": "otitis-externa",
  "ear infection": "otitis-externa",
  "外耳道炎": "otitis-externa",

  "中耳炎": "otitis-media-interna",
  "內耳炎": "otitis-media-interna",
  "中內耳炎": "otitis-media-interna",
  "middle ear infection": "otitis-media-interna",
  "inner ear infection": "otitis-media-interna",

  "耳血腫": "aural-hematoma",
  "耳殼血腫": "aural-hematoma",
  "耳翼血腫": "aural-hematoma",
  "ear hematoma": "aural-hematoma",

  "耳息肉": "ear-polyp",
  "炎症性息肉": "ear-polyp",
  "inflammatory polyp": "ear-polyp",

  "聾": "deafness",
  "耳聾": "deafness",
  "失聰": "deafness",
  "聽力喪失": "deafness",
  "hearing loss": "deafness",

  // 鼻部疾病
  "鼻炎": "rhinitis",
  "鼻腔炎": "rhinitis",
  "流鼻涕": "rhinitis",
  "nasal inflammation": "rhinitis",

  "鼻腔異物": "nasal-foreign-body",
  "鼻內異物": "nasal-foreign-body",
  "nasal foreign body": "nasal-foreign-body",

  "鼻出血": "epistaxis",
  "流鼻血": "epistaxis",
  "鼻血": "epistaxis",
  "nosebleed": "epistaxis",

  "鼻咽息肉": "nasopharyngeal-polyp",
  "鼻咽炎症性息肉": "nasopharyngeal-polyp",
  "貓鼻咽息肉": "nasopharyngeal-polyp",
  "nasopharyngeal polyp": "nasopharyngeal-polyp",

  "口鼻瘻管": "oronasal-fistula",
  "口鼻廔管": "oronasal-fistula",
  "oronasal fistula": "oronasal-fistula",

  // 咽喉及唾液腺疾病
  "咽炎": "pharyngitis",
  "喉嚨發炎": "pharyngitis",
  "sore throat": "pharyngitis",

  "扁桃腺炎": "tonsillitis",
  "扁桃體炎": "tonsillitis",
  "tonsil infection": "tonsillitis",

  "唾液腺炎": "sialadenitis",
  "唾腺炎": "sialadenitis",
  "salivary gland inflammation": "sialadenitis",

  "唾液囊腫": "sialocele",
  "唾液黏液囊腫": "sialocele",
  "蝦蟆腫": "sialocele",
  "ranula": "sialocele",
  "salivary mucocele": "sialocele",

  "顴骨黏液囊腫": "zygomatic-mucocele",
  "顴腺囊腫": "zygomatic-mucocele",
  "顴腺黏液囊腫": "zygomatic-mucocele",
  "zygomatic sialocele": "zygomatic-mucocele"
  // ===== From dental-diseases.js =====
  "periodontal-disease": {
    zh: "牙周病",
    en: "Periodontal Disease",
    definition: "影響牙齒支持結構(牙齦、牙周韌帶、齒槽骨、牙骨質)的慢性進行性炎症疾病，是小動物最常見的口腔疾病。",
    synonyms: ["牙周炎", "Periodontitis", "Gum Disease", "牙齦炎（早期）", "Gingivitis"],
    epidemiology: {
      species: "犬貓皆非常常見",
      age: "隨年齡增加，3歲以上超過80%有不同程度牙周病",
      sex: "無性別傾向",
      breed: "小型犬種（玩具犬、吉娃娃、約克夏）風險較高",
      riskFactors: ["口腔衛生不佳", "牙齒擁擠/咬合不正", "軟食飲食", "免疫抑制", "糖尿病", "乾燥症"]
    },
    clinicalPresentation: {
      history: ["口臭", "進食困難或疼痛", "流涎", "抓撓臉部", "拒絕硬食", "牙齒鬆動或脫落"],
      physicalExam: ["牙齦紅腫", "牙齦出血（探針觸碰或自發性）", "牙結石堆積", "牙齦萎縮", "牙根暴露", "牙齒鬆動", "膿性分泌物", "口腔瘻管"]
    },
    pathophysiology: "牙菌斑累積 → 細菌毒素和宿主免疫反應 → 牙齦炎(可逆) → 持續發炎 → 牙周韌帶破壞 → 齒槽骨吸收 → 牙周炎(不可逆) → 牙齒鬆動和脫落。細菌可能進入血流影響心臟、肝臟、腎臟",
    diagnosis: {
      overview: "視診結合全身麻醉下口腔檢查和牙科X光",
      differentials: ["齒齦口腔炎", "口腔腫瘤", "牙齒吸收(貓)", "牙根膿瘍"],
      initialDB: ["清醒時口腔視診", "全身麻醉下完整口腔檢查", "牙周探針檢查（測量牙周囊袋深度）"],
      advanced: ["全口牙科X光", "細菌培養（頑固病例）", "組織病理學（排除腫瘤）"]
    },
    staging: {
      stage1: "牙齦炎：牙齦發炎但無附著喪失，可逆",
      stage2: "早期牙周炎：<25%附著喪失",
      stage3: "中度牙周炎：25-50%附著喪失",
      stage4: "重度牙周炎：>50%附著喪失"
    },
    treatment: {
      overview: "專業牙科治療（洗牙和牙周治療）結合居家護理",
      acute: [
        "全身麻醉下專業牙科治療：",
        "- 超音波洗牙去除牙結石",
        "- 牙齦下刮治和根面整平",
        "- 牙根拋光",
        "- 牙周囊袋沖洗",
        "嚴重病例考慮拔牙",
        "疼痛管理：Meloxicam 0.1 mg/kg PO q24h（犬）或單次（貓）",
        "抗生素（嚴重感染）：Amoxicillin-Clavulanate 12.5-25 mg/kg PO q12h"
      ],
      chronic: [
        "居家口腔護理：",
        "- 每日刷牙（最有效）",
        "- 牙科咀嚼物/潔牙骨",
        "- 口腔沖洗液/凝膠",
        "- 處方牙科飲食",
        "定期專業牙科檢查和治療（每6-12個月）"
      ]
    },
    prognosis: "早期牙齦炎可完全逆轉。牙周炎破壞不可逆但可控制進展。居家護理配合良好者預後較佳。",
    pearls: [
      "牙周病是最常見但最被忽視的寵物疾病",
      "口臭不正常！是牙周病的警訊",
      "小型犬牙齦萎縮更快，需更積極治療",
      "僅靠洗牙不夠，需配合居家護理",
      "嚴重牙周病可能與全身性疾病（心臟、腎臟）相關"
    ],
    monitoring: ["定期口腔檢查", "牙周囊袋深度追蹤", "X光評估骨流失進展"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "tooth-resorption": {
    zh: "牙齒吸收",
    en: "Tooth Resorption (FORL)",
    definition: "牙齒硬組織（牙本質、牙骨質、牙釉質）被破牙細胞進行性吸收破壞的疾病，貓最常見的口腔疾病之一。",
    synonyms: ["FORL", "Feline Odontoclastic Resorptive Lesion", "貓齒吸收性病變", "TR", "頸部病變", "Neck Lesion"],
    epidemiology: {
      species: "貓極為常見（50-70%的成年貓），犬少見",
      age: "隨年齡增加，中老年貓好發",
      sex: "無明確性別傾向",
      breed: "暹羅貓、阿比西尼亞貓可能風險較高",
      riskFactors: ["年齡增長", "牙周病", "確切病因不明"]
    },
    clinicalPresentation: {
      history: ["可能無症狀（早期）", "進食時疼痛反應（頭偏斜、食物掉落）", "流涎", "拒絕進食", "偏好軟食", "下顎顫抖"],
      physicalExam: ["牙齦增生覆蓋病變", "牙冠缺損或「粉紅點」", "牙齦線處牙齒凹陷", "牙齒斷裂", "探針觸碰極度疼痛", "下顎顫抖（jaw chattering）"]
    },
    pathophysiology: "破牙細胞（類似破骨細胞）活化 → 牙骨質和牙本質吸收 → 病變通常始於牙頸部（牙齦線）→ 進展至牙冠和牙根 → 牙根可能與齒槽骨融合（置換性吸收）→ 牙冠斷裂",
    diagnosis: {
      overview: "麻醉下口腔檢查結合牙科X光確診",
      differentials: ["蛀牙（貓罕見）", "牙齒斷裂", "牙周病"],
      initialDB: ["麻醉下口腔檢查", "牙科探針檢查", "全口牙科X光（必要！）"],
      advanced: ["組織病理學（少需要）"]
    },
    classification: {
      type1: "Type 1：牙根結構完整可見，牙周韌帶可辨識 → 需完整拔牙",
      type2: "Type 2：牙根與齒槽骨融合（置換性吸收），牙周韌帶消失 → 可行牙冠截除術",
      type3: "Type 3：同一顆牙同時有Type 1和Type 2特徵"
    },
    treatment: {
      overview: "拔牙或牙冠截除術是唯一有效治療",
      acute: [
        "Type 1病變：完整拔牙",
        "Type 2病變：牙冠截除術（保留融合的牙根）",
        "Type 3病變：根據各牙根情況決定",
        "術前/術後疼痛管理：",
        "- Buprenorphine 0.02 mg/kg SL/IV q6-8h",
        "- Meloxicam 0.1 mg/kg PO 單次或短期",
        "- 局部神經阻斷"
      ],
      chronic: [
        "定期口腔檢查和X光追蹤其他牙齒",
        "無有效預防方法"
      ]
    },
    prognosis: "拔牙後預後良好，疼痛緩解。但其他牙齒可能陸續發生病變，需定期追蹤。",
    pearls: [
      "貓齒吸收是貓最痛苦的口腔疾病之一",
      "牙科X光是診斷必需 - 60%病變在X光才能發現",
      "「粉紅點」是牙齦組織長入吸收腔",
      "Type 2病變不需（也無法）完整拔牙",
      "沒有任何治療能阻止或逆轉病變進展"
    ],
    monitoring: ["定期全口X光（每6-12個月）", "監測其他牙齒", "觀察進食行為"],
    reference: "Reiter AM, Soltero-Rivera MM: Applied Feline Oral Anatomy and Tooth Resorption. J Feline Med Surg 2014; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "gingivostomatitis": {
    zh: "齒齦口腔炎",
    en: "Gingivostomatitis",
    definition: "口腔黏膜和牙齦的嚴重慢性炎症，特徵為疼痛劇烈且對傳統治療反應差，主要見於貓。",
    synonyms: ["FCGS", "Feline Chronic Gingivostomatitis", "貓慢性齒齦口腔炎", "Caudal Stomatitis", "尾側口腔炎", "Lymphocytic-Plasmacytic Stomatitis"],
    epidemiology: {
      species: "貓為主，犬罕見",
      age: "任何年齡，成年貓多見",
      sex: "無性別傾向",
      riskFactors: ["FIV/FeLV感染", "杯狀病毒感染", "免疫介導因素", "牙菌斑不耐受"]
    },
    clinicalPresentation: {
      history: ["嚴重口腔疼痛", "流涎（可能帶血）", "拒絕進食或進食困難", "體重減輕", "毛髮凌亂（無法理毛）", "躲藏", "觸碰頭部時退縮"],
      physicalExam: ["牙齦嚴重紅腫增生", "口腔黏膜潰瘍", "尾側口腔（顎舌弓）增生性炎症", "舌炎", "唇炎", "極度疼痛", "口臭", "消瘦"]
    },
    pathophysiology: "確切機制不明。推測為對口腔細菌/牙菌斑的異常免疫反應。病毒感染（杯狀病毒）可能在某些病例扮演角色。組織學顯示淋巴細胞-漿細胞浸潤",
    diagnosis: {
      overview: "臨床表現典型，組織病理學確認",
      differentials: ["牙周病", "口腔腫瘤（鱗狀細胞癌）", "嗜酸性肉芽腫複合症", "慢性腎病繼發口腔潰瘍", "感染性口腔炎"],
      initialDB: ["完整口腔檢查（需麻醉）", "全口牙科X光", "FIV/FeLV檢測", "基礎血檢"],
      advanced: ["組織病理學（淋巴細胞-漿細胞浸潤）", "病毒PCR（杯狀病毒）", "細菌培養"]
    },
    treatment: {
      overview: "全口或近全口拔牙是最有效治療，配合疼痛管理和免疫調節",
      acute: [
        "第一線治療 - 全口拔牙或近全口拔牙：",
        "- 移除所有臼齒和前臼齒",
        "- 嚴重病例可能需拔除犬齒和門齒",
        "- 約60-80%病例顯著改善或治癒",
        "疼痛管理：",
        "- Buprenorphine 0.02-0.03 mg/kg SL/IV q6-8h",
        "- Gabapentin 5-10 mg/kg PO q8-12h",
        "- NSAIDs（短期，注意腎功能）"
      ],
      chronic: [
        "拔牙後仍有症狀的病例：",
        "- 免疫調節：Cyclosporine 7.5 mg/kg PO q24h",
        "- 類固醇：Prednisolone 1-2 mg/kg PO q24h（逐漸減量）",
        "- Interferon omega",
        "- 幹細胞治療（實驗性）",
        "長期疼痛管理",
        "營養支持（可能需要食道餵管）"
      ]
    },
    prognosis: "全口拔牙後60-80%顯著改善或治癒。20-30%需要額外免疫調節治療。少數病例頑固難治。FIV陽性病例預後較差。",
    pearls: [
      "「沒有牙齒總比疼痛的牙齒好」- 貓沒有牙齒仍能正常進食",
      "尾側口腔炎（顎舌弓處）是本病特徵",
      "單純洗牙和藥物治療效果通常不持久",
      "完整拔除所有牙根很重要 - 殘留牙根會導致復發",
      "即使拔牙後，部分貓需要長期免疫抑制治療"
    ],
    monitoring: ["口腔炎症程度", "體重", "進食能力", "疼痛評估", "藥物副作用"],
    reference: "Jennings MW, et al: Feline Chronic Gingivostomatitis. Vet Clin North Am Small Anim Pract 2015; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "tooth-fracture": {
    zh: "牙齒斷裂",
    en: "Tooth Fracture",
    definition: "牙齒硬組織（牙釉質、牙本質、牙髓腔）的創傷性斷裂，可能導致牙髓暴露和感染。",
    synonyms: ["斷牙", "Broken Tooth", "Fractured Tooth", "牙齒外傷"],
    epidemiology: {
      species: "犬較常見（咀嚼硬物），貓也可見",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["咀嚼硬物（骨頭、蹄、冰塊、籠子）", "創傷", "玩耍時撞擊", "車禍"]
    },
    clinicalPresentation: {
      history: ["咀嚼硬物後", "創傷後", "可能無症狀", "進食時疼痛", "臉部腫脹（若有膿瘍）"],
      physicalExam: ["牙冠缺損或斷裂", "牙髓暴露（粉紅或黑點）", "牙齒變色（灰/粉/紫色）", "牙齦瘻管", "臉部腫脹", "觸診疼痛"]
    },
    pathophysiology: "牙齒斷裂 → 若牙髓暴露：細菌入侵 → 牙髓炎 → 牙髓壞死 → 根尖周圍炎 → 牙根膿瘍。牙髓未暴露：牙本質小管可能導致細菌滲透（較慢）。牙齒變色提示牙髓出血或壞死",
    diagnosis: {
      overview: "視診結合牙科X光評估牙髓和牙根狀態",
      differentials: ["牙齒磨耗", "牙齒吸收", "發育異常"],
      initialDB: ["口腔檢查", "牙科探針", "牙科X光"],
      advanced: ["牙髓活力測試", "CT（複雜病例）"]
    },
    classification: {
      uncomplicated: "非複雜性骨折：僅牙釉質或牙釉質+牙本質，牙髓未暴露",
      complicated: "複雜性骨折：牙髓暴露",
      crownFracture: "牙冠骨折：僅影響牙冠",
      rootFracture: "牙根骨折：影響牙根",
      crownRootFracture: "牙冠-牙根骨折：兩者皆影響"
    },
    treatment: {
      overview: "根據骨折類型和牙髓狀態決定治療",
      acute: [
        "非複雜性骨折（牙髓未暴露）：",
        "- 牙本質封閉劑保護暴露的牙本質",
        "- 定期X光追蹤",
        "複雜性骨折（牙髓暴露）：",
        "- 急性（<48小時）：活髓治療可能可行",
        "- 慢性或感染：根管治療或拔牙",
        "根管治療（保留牙齒功能）",
        "拔牙（若根管治療不可行或飼主選擇）",
        "疼痛管理"
      ],
      chronic: [
        "根管治療後定期X光追蹤",
        "牙冠修復（重要功能牙）"
      ]
    },
    prognosis: "非複雜性骨折：預後良好。複雜性骨折及時根管治療：成功率85-95%。延遲治療：可能發展為牙根膿瘍。",
    pearls: [
      "「任何比牙齒硬的東西都不應該給狗咬」",
      "犬齒和上顎第四前臼齒最常斷裂",
      "牙齒變色=牙髓受損，需要評估和可能治療",
      "牙髓暴露48小時內治療成功率較高",
      "無症狀不代表沒問題 - 牙髓可能已壞死"
    ],
    monitoring: ["定期X光追蹤（6-12個月）", "牙根周圍病變", "牙齒變色變化"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "tooth-root-abscess": {
    zh: "牙根膿瘍",
    en: "Tooth Root Abscess",
    definition: "牙根尖端周圍組織的細菌感染，形成膿瘍，常由牙周病或牙髓疾病進展而來。",
    synonyms: ["Periapical Abscess", "根尖周圍膿瘍", "Dental Abscess", "牙齒膿瘍", "Apical Abscess"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "任何年齡，成年動物多見",
      sex: "無性別傾向",
      riskFactors: ["牙齒斷裂", "嚴重牙周病", "牙髓壞死", "牙齒磨耗"]
    },
    clinicalPresentation: {
      history: ["臉部腫脹", "眼下腫脹或流膿（上顎裂齒）", "鼻腔分泌物", "進食困難", "流涎", "抓撓臉部"],
      physicalExam: ["臉部腫脹", "皮膚瘻管流膿（眼下、下顎）", "口腔瘻管", "口鼻瘻管", "受影響牙齒鬆動", "牙齦腫脹", "淋巴結腫大"]
    },
    pathophysiology: "牙髓感染（經斷裂、蛀牙或牙周病進入）→ 牙髓壞死 → 細菌經根尖擴散 → 根尖周圍炎 → 膿瘍形成 → 可能穿透骨骼和皮膚形成瘻管",
    diagnosis: {
      overview: "臨床表現結合牙科X光",
      differentials: ["臉部腫瘤", "外傷性腫脹", "唾液腺疾病", "鼻竇炎", "眼眶蜂窩織炎"],
      initialDB: ["口腔檢查", "牙科X光（根尖周圍透亮區）", "牙科探針"],
      advanced: ["CT（評估骨破壞範圍）", "細菌培養和藥敏"]
    },
    treatment: {
      overview: "拔牙是標準治療，根管治療是替代選項",
      acute: [
        "手術拔牙（首選）：",
        "- 完整移除病牙和牙根",
        "- 清創感染組織",
        "- 瘻管通常會自行癒合",
        "根管治療（保留重要牙齒）：",
        "- 需要專業牙科設備",
        "- 成功率約85-90%",
        "抗生素：",
        "- Amoxicillin-Clavulanate 12.5-25 mg/kg PO q12h x 7-14天",
        "- 或 Clindamycin 5.5-11 mg/kg PO q12h",
        "疼痛管理：NSAID + 鴉片類"
      ],
      chronic: [
        "瘻管護理直到癒合",
        "術後X光確認完整拔除"
      ]
    },
    prognosis: "拔牙後預後良好，瘻管通常1-2週內癒合。根管治療成功率高但需追蹤。",
    pearls: [
      "眼下腫脹/瘻管 → 首先考慮上顎第四前臼齒或第一臼齒膿瘍",
      "「carnassial tooth abscess」是上顎裂齒膿瘍的經典表現",
      "單純抗生素無法治癒 - 必須移除感染源",
      "瘻管會反覆癒合又破裂，直到牙齒處理",
      "術前抗生素可減少菌血症風險"
    ],
    monitoring: ["瘻管癒合", "腫脹消退", "術後X光", "復發跡象"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "malocclusion": {
    zh: "咬合不正",
    en: "Malocclusion",
    definition: "上下顎牙齒或顎骨的異常對齊關係，可能導致功能障礙、疼痛或組織損傷。",
    synonyms: ["咬合異常", "錯咬合", "Abnormal Bite", "Bad Bite", "牙齒錯位"],
    epidemiology: {
      species: "犬較常見（品種繁殖），貓也可見",
      age: "幼年時發現，可能持續終生",
      sex: "無性別傾向",
      breed: "短頭犬種（下顎前突）、長頭犬種（上顎前突）、小型犬（牙齒擁擠）",
      riskFactors: ["遺傳", "乳齒殘留", "創傷", "發育異常"]
    },
    clinicalPresentation: {
      history: ["咀嚼困難", "抓食而非咬食", "可能無症狀", "牙齒刺傷軟組織"],
      physicalExam: [
        "Class I（齒性錯咬合）：顎骨關係正常，個別牙齒錯位",
        "Class II（下顎後縮）：下顎相對過短",
        "Class III（下顎前突）：下顎相對過長",
        "犬齒錯位：下顎犬齒刺傷硬顎",
        "前牙錯咬合：門齒對齊異常",
        "軟組織創傷/潰瘍"
      ]
    },
    pathophysiology: "遺傳因素（顎骨生長不協調）或局部因素（乳齒殘留、創傷）→ 牙齒或顎骨錯位 → 咬合干擾 → 可能導致牙齒撞擊軟組織 → 疼痛和組織損傷",
    diagnosis: {
      overview: "臨床檢查評估咬合關係和組織損傷",
      differentials: ["正常變異（品種特徵）", "創傷性錯位"],
      initialDB: ["完整口腔檢查", "咬合關係評估", "軟組織損傷檢查"],
      advanced: ["頭顱X光", "牙科X光", "CT（複雜病例）", "咬合模型"]
    },
    treatment: {
      overview: "根據是否造成疼痛或損傷決定治療。治療目標是舒適的咬合，非美觀",
      acute: [
        "造成軟組織損傷的牙齒：",
        "- 牙冠縮短和活髓治療",
        "- 拔牙",
        "- 牙齒移動（矯正）",
        "乳齒殘留造成的錯咬合：",
        "- 及早拔除乳齒",
        "矯正治療（選擇性病例）：",
        "- 傾斜板（incline plane）",
        "- 活動式或固定式矯正器"
      ],
      chronic: [
        "定期監測避免組織損傷",
        "不繁殖有遺傳性咬合不正的動物"
      ]
    },
    prognosis: "治療後可達到舒適功能性咬合。遺傳性咬合不正建議絕育不繁殖。",
    pearls: [
      "「舒適的咬合比完美的咬合更重要」",
      "下顎犬齒刺傷硬顎是最需要治療的情況",
      "乳齒8-12週還沒脫落就要考慮拔除",
      "短頭犬種的Class III咬合是「品種特徵」但仍可能有問題",
      "遺傳性咬合不正不應繁殖，會傳給後代"
    ],
    monitoring: ["軟組織損傷", "牙齒移動", "矯正器適應", "定期複查"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "retained-deciduous-teeth": {
    zh: "殘留乳齒",
    en: "Retained Deciduous Teeth",
    definition: "乳齒在恆齒萌出後未能正常脫落而持續存在的情況，可導致咬合不正和牙周問題。",
    synonyms: ["滯留乳齒", "Persistent Deciduous Teeth", "Persistent Primary Teeth", "乳齒未脫"],
    epidemiology: {
      species: "犬較常見（尤其小型犬），貓較少見",
      age: "4-6月齡以上（正常換牙期）",
      sex: "無性別傾向",
      breed: "小型犬種（約克夏、玩具貴賓、吉娃娃、博美）",
      riskFactors: ["小型犬品種", "遺傳傾向"]
    },
    clinicalPresentation: {
      history: ["飼主注意到「雙排牙」", "可能無症狀", "口臭"],
      physicalExam: ["乳齒和恆齒同時存在（同一位置）", "最常見於犬齒", "牙齒擁擠", "恆齒錯位", "牙齒間食物殘渣堆積", "早期牙周病徵象"]
    },
    pathophysiology: "正常情況：恆齒萌出 → 乳齒牙根吸收 → 乳齒脫落。異常：乳齒牙根未完全吸收 → 乳齒持續存在 → 恆齒被迫在異常位置萌出 → 咬合不正、牙齒擁擠、食物堆積 → 牙周病",
    diagnosis: {
      overview: "臨床檢查即可診斷，X光確認牙根狀態",
      differentials: ["額外牙（多生牙）", "正常換牙過程中"],
      initialDB: ["口腔檢查", "牙科X光（確認乳齒牙根存在）"],
      advanced: ["不需要進階檢查"]
    },
    treatment: {
      overview: "及早拔除殘留乳齒是治療原則",
      acute: [
        "手術拔除殘留乳齒：",
        "- 必須完整移除整個乳齒牙根",
        "- 避免損傷鄰近恆齒牙根",
        "- 小心操作，乳齒牙根細長易斷",
        "最佳時機：發現即拔除，最好在絕育手術時一併處理",
        "「7-7-7規則」：",
        "- 7月齡以上同位置乳齒恆齒並存超過7天就該拔"
      ],
      chronic: [
        "若已造成恆齒錯位：可能需矯正",
        "已有牙周病：同時治療牙周病"
      ]
    },
    prognosis: "及早拔除預後極佳，恆齒通常會移動到正確位置。延遲治療可能導致永久性咬合不正和牙周病。",
    pearls: [
      "「同一位置不該有兩顆牙」",
      "小型犬絕育術前一定要檢查是否有殘留乳齒",
      "乳齒犬齒最常殘留",
      "完整拔除牙根很重要 - 殘留牙根會導致問題",
      "早拔比晚拔好 - 越早拔恆齒位置越正常"
    ],
    monitoring: ["恆齒位置", "咬合發育", "牙周健康"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "enamel-hypoplasia": {
    zh: "牙釉質發育不全",
    en: "Enamel Hypoplasia",
    definition: "牙釉質在發育期間形成不完全或異常，導致牙齒表面缺陷、變色和敏感。",
    synonyms: ["牙釉質發育不良", "Enamel Defects", "Enamel Dysplasia", "牙釉質缺損"],
    epidemiology: {
      species: "犬貓皆可見",
      age: "幼年發育期受影響，終生可見",
      sex: "無性別傾向",
      riskFactors: ["幼年時高燒（犬瘟熱）", "營養不良", "創傷（發育期牙胚）", "某些藥物（四環素）", "遺傳因素"]
    },
    clinicalPresentation: {
      history: ["牙齒表面粗糙或凹陷", "牙齒變色（棕/黃）", "可能有幼年疾病史", "牙齒敏感", "容易堆積牙菌斑"],
      physicalExam: ["牙齒表面凹陷、坑洞或缺損", "牙釉質變薄或缺失", "牙齒變色", "暴露的牙本質", "多顆牙齒對稱受影響（全身性原因）", "單顆牙齒受影響（局部創傷）"]
    },
    pathophysiology: "牙釉質形成（成釉細胞功能）在發育期間受干擾 → 牙釉質厚度減少、結構異常或完全缺失 → 暴露的牙本質 → 敏感、容易磨耗、容易蛀牙和感染",
    diagnosis: {
      overview: "臨床檢查評估牙釉質缺陷範圍和程度",
      differentials: ["牙齒磨耗", "牙齒斷裂", "牙齒吸收", "蛀牙"],
      initialDB: ["口腔檢查", "牙科X光（評估牙髓狀態）"],
      advanced: ["組織病理學（少需要）"]
    },
    treatment: {
      overview: "保護暴露的牙本質，預防併發症",
      acute: [
        "輕度病例：",
        "- 牙本質封閉劑/黏著劑保護",
        "- 氟化物應用",
        "- 加強口腔衛生",
        "中度病例：",
        "- 樹脂修復覆蓋缺陷",
        "- 牙冠（重要功能牙）",
        "嚴重病例伴牙髓暴露或感染：",
        "- 根管治療",
        "- 拔牙"
      ],
      chronic: [
        "定期口腔檢查和專業清潔",
        "居家口腔護理（刷牙、抗菌漱口水）",
        "避免硬食和咀嚼硬物"
      ]
    },
    prognosis: "輕度病例良好管理下預後好。嚴重病例可能需要多次治療或拔牙。",
    pearls: [
      "犬瘟熱是犬牙釉質發育不全的經典原因（「distemper teeth」）",
      "受影響牙齒的發育時間可回推疾病發生時間",
      "對稱性多顆牙受影響提示全身性原因",
      "單顆牙受影響提示局部創傷",
      "這些牙齒需要更積極的預防性護理"
    ],
    monitoring: ["牙齒敏感度", "繼發感染", "修復物完整性", "牙髓狀態"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "oral-tumor": {
    zh: "口腔腫瘤",
    en: "Oral Tumor",
    definition: "發生於口腔組織（牙齦、舌頭、硬顎、軟顎、扁桃腺）的腫瘤性病變，包括良性和惡性腫瘤。",
    synonyms: ["口腔癌", "Oral Cancer", "Oral Neoplasia", "口腔新生物"],
    epidemiology: {
      species: "犬貓皆可見，犬更常見",
      age: "中老年動物多見",
      sex: "公犬某些腫瘤較多",
      breed: "大型犬、深色皮膚品種（黑色素瘤）、可卡犬（乳突瘤）",
      commonTypes: {
        dog: ["惡性黑色素瘤", "鱗狀細胞癌", "纖維肉瘤", "棘皮瘤", "齒齦瘤(Epulis)"],
        cat: ["鱗狀細胞癌（最常見）", "纖維肉瘤"]
      }
    },
    clinicalPresentation: {
      history: ["口腔腫塊", "口臭加重", "流涎（可能帶血）", "進食困難", "體重減輕", "臉部腫脹或不對稱", "牙齒鬆動"],
      physicalExam: ["口腔可見腫塊", "潰瘍性或增生性病變", "出血", "牙齒鬆動或移位", "骨骼破壞", "淋巴結腫大", "臉部不對稱"]
    },
    pathophysiology: "取決於腫瘤類型。惡性腫瘤特徵為局部侵襲性（骨骼破壞）和可能的遠處轉移（黑色素瘤高度轉移性）",
    diagnosis: {
      overview: "組織病理學確診，影像學評估範圍和轉移",
      differentials: ["齒齦瘤(良性)", "牙齦增生", "嗜酸性肉芽腫", "感染性肉芽腫", "牙根膿瘍"],
      initialDB: ["口腔檢查", "組織切片/細針抽吸細胞學", "區域淋巴結評估"],
      advanced: ["頭顱X光或CT（評估骨骼侵犯）", "胸腔X光（轉移篩檢）", "腹部超聲", "全身CT"]
    },
    treatment: {
      overview: "根據腫瘤類型和分期決定，常需要多模式治療",
      acute: [
        "手術切除（首選）：",
        "- 需要寬邊界切除（1-2 cm）",
        "- 可能需要部分顎骨切除術",
        "- 邊界乾淨是預後關鍵",
        "放射治療：",
        "- 輔助治療或姑息治療",
        "- 對鱗狀細胞癌和黑色素瘤有效",
        "化學治療：",
        "- 某些腫瘤類型有效",
        "- Carboplatin, Doxorubicin等",
        "黑色素瘤疫苗（犬）：Oncept"
      ],
      chronic: [
        "疼痛管理",
        "營養支持（可能需要餵管）",
        "定期追蹤復發和轉移"
      ]
    },
    prognosis: {
      melanoma: "惡性黑色素瘤：高度惡性，易轉移。手術+放療+疫苗中位生存期可達12-18個月",
      scc_dog: "犬鱗狀細胞癌：局部侵襲性強但轉移率較低。完整切除預後較好",
      scc_cat: "貓鱗狀細胞癌：預後差，中位生存期2-4個月。常位於舌下難以完整切除",
      fibrosarcoma: "纖維肉瘤：局部侵襲性強，需積極寬邊界切除",
      epulis: "齒齦瘤：多為良性，完整切除預後極佳"
    },
    pearls: [
      "口腔腫塊一定要切片！視診無法區分良惡性",
      "貓口腔腫瘤幾乎都是惡性",
      "犬惡性黑色素瘤是口腔最常見的惡性腫瘤",
      "CT比X光更能評估骨骼侵犯範圍",
      "早期發現和寬邊界切除是最佳治療策略"
    ],
    monitoring: ["定期口腔檢查", "區域淋巴結", "胸腔X光（轉移）", "局部復發徵象"],
    reference: "Withrow SJ, Vail DM: Withrow and MacEwen's Small Animal Clinical Oncology, 5th Ed. Saunders, 2013; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "epulis": {
    zh: "齒齦瘤",
    en: "Epulis",
    definition: "起源於牙周韌帶的牙齦腫塊，大多為良性，是犬最常見的口腔腫塊。",
    synonyms: ["牙齦瘤", "Gingival Epulis", "Peripheral Odontogenic Fibroma", "周邊牙源性纖維瘤"],
    epidemiology: {
      species: "犬常見，貓罕見",
      age: "中老年犬多見",
      sex: "無明確性別傾向",
      breed: "拳師犬、牛頭犬較常見",
      riskFactors: ["品種傾向"]
    },
    clinicalPresentation: {
      history: ["牙齦腫塊", "可能無症狀", "出血（若有創傷）", "進食困難（若腫塊大）"],
      physicalExam: ["牙齦上光滑、堅實的腫塊", "顏色與正常牙齦相近", "通常無潰瘍", "可能導致牙齒移位", "通常單發"]
    },
    pathophysiology: "起源於牙周韌帶的細胞。傳統分類：纖維性(fibromatous)、骨性(ossifying)、棘皮性(acanthomatous)。新分類將棘皮性齒齦瘤歸類為「棘皮瘤性成釉細胞瘤」",
    diagnosis: {
      overview: "臨床懷疑需組織病理學確診和分類",
      differentials: ["惡性口腔腫瘤（黑色素瘤、鱗狀細胞癌、纖維肉瘤）", "牙齦增生", "肉芽腫"],
      initialDB: ["口腔檢查", "組織切片"],
      advanced: ["牙科X光或CT（評估骨骼侵犯，尤其棘皮性）"]
    },
    types: {
      peripheral_odontogenic_fibroma: "周邊牙源性纖維瘤（纖維性/骨性）：良性，局部切除通常足夠",
      acanthomatous_ameloblastoma: "棘皮瘤性成釉細胞瘤：局部侵襲性強，可破壞骨骼，需寬邊界切除"
    },
    treatment: {
      overview: "手術切除，切除範圍取決於類型",
      acute: [
        "周邊牙源性纖維瘤：",
        "- 局部切除含受影響牙齒",
        "- 邊界通常足夠",
        "- 復發率低",
        "棘皮瘤性成釉細胞瘤：",
        "- 需要寬邊界切除（至少1 cm）",
        "- 常需部分顎骨切除術",
        "- 邊界不足易復發",
        "- 放射治療可作為輔助或替代"
      ],
      chronic: [
        "定期追蹤復發",
        "棘皮瘤性需更密切監測"
      ]
    },
    prognosis: "周邊牙源性纖維瘤：完整切除後預後極佳，很少復發。棘皮瘤性成釉細胞瘤：寬邊界切除預後好，邊界不足復發率高。不轉移。",
    pearls: [
      "雖然稱為「良性」，棘皮瘤性會破壞骨骼，必須積極治療",
      "切片很重要 - 外觀無法區分類型",
      "X光/CT可顯示棘皮瘤性的骨破壞",
      "拳師犬特別容易長齒齦瘤",
      "與惡性腫瘤不同，齒齦瘤不會轉移"
    ],
    monitoring: ["局部復發", "鄰近牙齒狀態", "骨骼變化"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "oral-papilloma": {
    zh: "口腔乳突瘤",
    en: "Oral Papilloma",
    definition: "由犬乳突瘤病毒(CPV)引起的良性口腔腫瘤，特徵為多發性菜花狀增生，常見於幼犬。",
    synonyms: ["口腔疣", "Oral Warts", "Canine Oral Papillomatosis", "犬口腔乳突瘤病", "Viral Papilloma"],
    epidemiology: {
      species: "犬為主（病毒種特異性），貓非常罕見",
      age: "幼犬和年輕犬（<2歲）最常見",
      sex: "無性別傾向",
      riskFactors: ["免疫系統未成熟", "免疫抑制", "與感染犬接觸"]
    },
    clinicalPresentation: {
      history: ["口腔內多發腫塊", "突然出現", "可能快速增生", "通常無症狀", "偶有進食困難或流涎"],
      physicalExam: ["多發性菜花狀/疣狀腫塊", "白色到粉紅色", "表面粗糙", "常見於唇、牙齦、舌頭", "偶見於咽喉、食道", "一般無疼痛"]
    },
    pathophysiology: "犬乳突瘤病毒(CPV)感染 → 口腔黏膜上皮細胞增生 → 典型菜花狀乳突瘤形成 → 免疫系統產生反應 → 通常1-5個月內自發消退",
    diagnosis: {
      overview: "典型臨床表現通常足以診斷",
      differentials: ["鱗狀細胞癌（老年動物）", "纖維瘤", "齒齦瘤"],
      initialDB: ["臨床檢查（特徵性外觀）"],
      advanced: ["組織病理學（非典型病例）", "免疫組織化學", "PCR（確認病毒）"]
    },
    treatment: {
      overview: "大多數病例會自發消退，不需治療",
      acute: [
        "觀察等待（首選）：",
        "- 大多數1-5個月內自發消退",
        "- 免疫系統產生保護性抗體",
        "干預指征（嚴重病例）：",
        "- 數量極多影響進食",
        "- 持續超過3-4個月不消退",
        "- 免疫抑制動物",
        "治療選項：",
        "- 手術切除（可能刺激免疫反應）",
        "- 冷凍治療",
        "- 電灼",
        "- 自體疫苗（爭議）",
        "- Interferon（免疫抑制病例）",
        "- Imiquimod（局部免疫調節）"
      ],
      chronic: [
        "消退後通常產生終生免疫"
      ]
    },
    prognosis: "免疫正常動物預後極佳，幾乎100%會自發消退。免疫抑制動物可能持續或惡變（罕見）。",
    pearls: [
      "「看起來可怕但通常會自己好」",
      "具傳染性 - 建議與其他幼犬隔離",
      "潛伏期1-2個月",
      "切除一個病灶有時會加速其他病灶消退",
      "老年犬的單發口腔乳突瘤要小心 - 可能是鱗狀細胞癌",
      "消退後具終生免疫"
    ],
    monitoring: ["腫塊消退進展", "進食能力", "是否有新病灶"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "cleft-palate": {
    zh: "顎裂",
    en: "Cleft Palate",
    definition: "先天性顎部發育缺陷，硬顎和/或軟顎中線未能完全閉合，導致口腔與鼻腔相通。",
    synonyms: ["裂顎", "Palatoschisis", "原發性顎裂", "繼發性顎裂", "唇裂（Cleft Lip）"],
    epidemiology: {
      species: "犬貓皆可見",
      age: "先天性，出生即可見",
      sex: "無性別傾向",
      breed: "短頭犬種（鬥牛犬、波士頓梗、拳師犬）、貴賓犬、臘腸犬、暹羅貓",
      riskFactors: ["遺傳因素", "懷孕期間營養缺乏（葉酸）", "藥物暴露（類固醇、某些抗癲癇藥）", "病毒感染"]
    },
    clinicalPresentation: {
      history: ["新生兒吸吮困難", "奶從鼻孔流出", "反覆吸入性肺炎", "生長遲緩", "咳嗽、打噴嚏（進食時）"],
      physicalExam: ["硬顎和/或軟顎可見裂隙", "唇裂（可能伴隨）", "鼻腔分泌物", "肺炎徵象", "發育不良"]
    },
    pathophysiology: "胚胎發育第25-28天顎板未能融合 → 口腔與鼻腔相通 → 吸吮時奶/食物進入鼻腔 → 吸入性肺炎風險 → 營養不良和感染",
    diagnosis: {
      overview: "出生後視診即可診斷",
      differentials: ["後天性口鼻瘻管（創傷、腫瘤、牙周病）", "其他先天性缺陷"],
      initialDB: ["口腔檢查", "胸腔X光（吸入性肺炎）"],
      advanced: ["CT（評估缺陷範圍）", "評估其他先天性異常"]
    },
    treatment: {
      overview: "手術修復是唯一根治方法，但需等待至足夠大",
      acute: [
        "支持性照護（幼年期）：",
        "- 管餵（胃管或食道餵管）避免吸入",
        "- 治療吸入性肺炎",
        "- 營養支持促進生長",
        "手術修復：",
        "- 等待至8-12週齡以上（組織夠大）",
        "- 黏膜皮瓣修復術",
        "- 可能需要多次手術",
        "- 軟顎裂較硬顎裂難修復"
      ],
      chronic: [
        "術後追蹤檢查癒合",
        "營養管理",
        "不建議繁殖"
      ]
    },
    prognosis: "輕度缺陷手術修復後預後良好。嚴重缺陷或多次手術失敗預後謹慎。吸入性肺炎是主要死因。有些嚴重病例選擇安樂死。",
    pearls: [
      "所有新生兒都應檢查有無顎裂",
      "「奶從鼻子出來」是經典警訊",
      "管餵是手術前的生命線",
      "太早手術組織太薄易失敗",
      "這是遺傳性疾病 - 絕對不繁殖",
      "手術成功需要良好的組織處理和無張力縫合"
    ],
    monitoring: ["體重增長", "呼吸狀態", "手術傷口癒合", "復發（裂開）"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "jaw-fracture": {
    zh: "顎骨骨折",
    en: "Jaw Fracture",
    definition: "下顎骨或上顎骨的骨折，常由創傷引起，也可能是病理性骨折（腫瘤、牙周病）。",
    synonyms: ["下顎骨折", "Mandibular Fracture", "上顎骨折", "Maxillary Fracture", "顎骨斷裂"],
    epidemiology: {
      species: "犬貓皆可見",
      age: "任何年齡，年輕動物多創傷性，老年動物需考慮病理性",
      sex: "無性別傾向（創傷較常見於公動物）",
      riskFactors: ["創傷（車禍、墜落、打架）", "嚴重牙周病（病理性骨折）", "口腔腫瘤", "骨質疏鬆"]
    },
    clinicalPresentation: {
      history: ["創傷史", "無法閉合嘴巴", "流涎", "拒絕進食", "臉部腫脹或不對稱", "出血"],
      physicalExam: ["臉部腫脹/不對稱", "咬合不正", "異常活動度", "骨摩擦感", "口腔出血", "牙齒鬆動或移位", "疼痛", "可能有其他創傷"]
    },
    pathophysiology: "外力超過骨骼強度 → 骨折。創傷性：直接撞擊或間接力傳導。病理性：骨骼已被疾病（腫瘤、嚴重牙周病）弱化 → 輕微外力即可骨折",
    diagnosis: {
      overview: "影像學確診骨折類型和位置",
      differentials: ["顳顎關節脫位", "軟組織損傷", "其他頭部創傷"],
      initialDB: ["口腔檢查（小心處理）", "頭顱X光（多角度）", "牙科X光"],
      advanced: ["CT（複雜骨折）", "評估潛在病理性原因"]
    },
    treatment: {
      overview: "穩定骨折、恢復咬合功能。方法取決於骨折類型和位置",
      acute: [
        "初步穩定和疼痛管理",
        "非手術治療（穩定、簡單骨折）：",
        "- 膠帶嘴套（tape muzzle）",
        "- 跨弓連接（interdental wiring）",
        "手術固定（不穩定、複雜骨折）：",
        "- 鋼絲固定",
        "- 骨板和螺絲",
        "- 外固定架",
        "- 丙烯酸夾板",
        "下顎聯合分離：環扎鋼絲（cerclage）",
        "抗生素（開放性骨折）",
        "疼痛管理：Opioids + NSAIDs"
      ],
      chronic: [
        "軟食飲食4-6週",
        "口腔衛生維護",
        "定期X光追蹤癒合"
      ]
    },
    prognosis: "簡單骨折良好固定後預後良好。病理性骨折取決於潛在疾病。嚴重粉碎性骨折或感染預後謹慎。",
    pearls: [
      "「恢復咬合比完美解剖復位更重要」",
      "貓下顎聯合常見分離而非真正骨折",
      "老年小型犬的病理性骨折常因嚴重牙周病",
      "開放性骨折（口腔內）需要抗生素",
      "過多的內固定物可能損害血供"
    ],
    monitoring: ["癒合進度（X光）", "咬合功能", "感染徵象", "進食能力"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "temporomandibular-joint-disorder": {
    zh: "顳顎關節疾病",
    en: "Temporomandibular Joint Disorder (TMJ)",
    definition: "影響顳顎關節（連接下顎與顱骨的關節）的疾病，包括脫位、骨折、關節炎、發育異常等。",
    synonyms: ["TMJ Disorder", "TMJ Disease", "顳下顎關節疾病", "TMD", "下顎關節問題"],
    epidemiology: {
      species: "犬貓皆可見",
      age: "依病因而異",
      sex: "無性別傾向",
      breed: "愛爾蘭雪達犬、巴吉度獵犬（發育異常）",
      riskFactors: ["創傷", "關節炎", "發育異常", "腫瘤", "感染"]
    },
    clinicalPresentation: {
      history: ["張嘴困難", "閉嘴困難", "進食時疼痛", "頭部傾斜", "咀嚼單側", "「喀喀」聲"],
      physicalExam: [
        "脫位：下顎偏移、無法閉合或張開",
        "骨折：疼痛、腫脹、異常活動度",
        "關節炎：張嘴受限、疼痛、骨摩擦感",
        "發育異常：開口受限、關節不對稱",
        "腫瘤：腫塊、變形"
      ]
    },
    pathophysiology: "創傷性脫位：關節囊撕裂，關節頭移位。骨關節炎：軟骨退化、骨刺形成。發育異常（如關節發育不全）：關節結構異常影響功能。顳顎關節強直：關節融合導致無法張嘴",
    diagnosis: {
      overview: "臨床檢查結合影像學",
      differentials: ["咀嚼肌炎", "三叉神經炎", "口腔腫瘤", "牙科疾病"],
      initialDB: ["神經學和口腔檢查", "麻醉下關節觸診和活動度評估", "頭顱X光"],
      advanced: ["CT（首選，細節評估）", "MRI（軟組織病變）", "關節液分析"]
    },
    treatment: {
      overview: "根據具體病因治療",
      acute: [
        "TMJ脫位（急性）：",
        "- 麻醉下閉合復位",
        "- 放置物體（如注射筒）於臼齒區輔助復位",
        "- 復位後可能需暫時限制張嘴（膠帶嘴套）",
        "TMJ骨折：",
        "- 保守治療或手術固定",
        "- 取決於骨折類型和移位程度",
        "疼痛管理：NSAIDs、Gabapentin"
      ],
      chronic: [
        "骨關節炎：",
        "- NSAIDs長期使用",
        "- 關節保護劑（Glucosamine、Chondroitin）",
        "- 軟食",
        "關節強直：",
        "- 手術切除關節（condylectomy）",
        "- 下顎聯合切開術（增加張口範圍）",
        "腫瘤：根據類型手術或放療"
      ]
    },
    prognosis: "急性脫位復位後預後良好。骨關節炎可管理但通常進展性。關節強直手術後可改善功能但可能復發。",
    pearls: [
      "貓TMJ脫位常是創傷後「下巴掉下來」",
      "無法張嘴（鎖顎）vs 無法閉嘴 - 鑑別診斷不同",
      "CT比X光更能評估TMJ結構",
      "慢性脫位可能無法完全復位",
      "雙側關節強直導致完全無法張嘴 - 需緊急處理"
    ],
    monitoring: ["關節活動度", "疼痛程度", "進食能力", "復發"],
    reference: "Holmstrom SE: Veterinary Dentistry: A Team Approach, 3rd Ed. Saunders, 2019; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "masticatory-muscle-myositis": {
    zh: "咀嚼肌炎",
    en: "Masticatory Muscle Myositis (MMM)",
    definition: "咀嚼肌群（顳肌、咬肌）的免疫介導性炎症疾病，特徵為急性腫脹或慢性萎縮，導致張嘴困難。",
    synonyms: ["MMM", "咬肌炎", "Eosinophilic Myositis", "Atrophic Myositis", "顳肌炎"],
    epidemiology: {
      species: "犬為主，貓非常罕見",
      age: "年輕至中年犬（3歲平均）",
      sex: "無性別傾向",
      breed: "大型犬種（德國牧羊犬、黃金獵犬、拉不拉多、羅威納、杜賓犬）、騎士查理王小獵犬",
      riskFactors: ["遺傳傾向", "免疫因素"]
    },
    clinicalPresentation: {
      history: [
        "急性期：臉部腫脹、疼痛、無法張嘴、拒食",
        "慢性期：顳肌萎縮、張嘴受限",
        "可能反覆急性發作和緩解"
      ],
      physicalExam: [
        "急性：顳肌和咬肌腫脹、疼痛、眼球突出（肌肉腫脹壓迫）、發燒、淋巴結腫大",
        "慢性：顳肌嚴重萎縮（「骷髏頭」外觀）、張嘴受限（可能<1-2 cm）、咬合正常（與TMJ疾病鑑別）"
      ]
    },
    pathophysiology: "免疫系統針對咀嚼肌特有的2M肌纖維（type 2M myofibers）產生自身抗體 → 補體介導的肌肉炎症和壞死 → 急性腫脹和疼痛 → 反覆發作 → 肌肉纖維化和萎縮 → 永久性張嘴受限",
    diagnosis: {
      overview: "臨床表現結合2M抗體檢測確診",
      differentials: ["顳顎關節疾病", "多發性肌炎", "外傷性肌炎", "三叉神經病變", "咀嚼肌腫瘤", "破傷風"],
      initialDB: ["CK（急性期升高）", "2M抗體檢測（特異性診斷）", "CBC（可能有嗜酸性球增多）"],
      advanced: ["肌肉活檢（確診）", "MRI（評估肌肉病變）", "EMG"]
    },
    treatment: {
      overview: "免疫抑制治療，早期治療預防不可逆萎縮",
      acute: [
        "免疫抑制劑量類固醇：",
        "- Prednisolone/Prednisone: 1-2 mg/kg PO q12h",
        "- 維持4-6週後逐漸減量",
        "- 總療程通常需要4-6個月或更長",
        "嚴重病例可考慮：",
        "- Azathioprine 1-2 mg/kg PO q24-48h（與類固醇合用）",
        "- Mycophenolate",
        "營養支持（若無法進食）",
        "疼痛管理"
      ],
      chronic: [
        "長期低劑量類固醇維持（很多需要）",
        "最低有效劑量維持",
        "物理治療增加張嘴範圍（纖維化後效果有限）",
        "軟食飲食"
      ]
    },
    prognosis: "早期治療（肌肉萎縮前）預後良好，可完全恢復。延遲治療或已有纖維化：永久性張嘴受限。需長期免疫抑制治療。復發常見（約50%）。",
    pearls: [
      "「只影響咀嚼肌」- 四肢肌肉不受影響",
      "2M抗體檢測是診斷金標準",
      "急性腫脹期是治療黃金時期 - 延遲會導致纖維化",
      "張嘴受限但咬合正常 - 與TMJ疾病區別",
      "類固醇不能太早停 - 容易復發",
      "治療前做CK和2M抗體（類固醇會影響結果）"
    ],
    monitoring: ["張嘴範圍", "肌肉萎縮程度", "2M抗體效價", "類固醇副作用", "復發徵象"],
    reference: "Melmed C, et al: Masticatory Muscle Myositis: Retrospective Study. J Vet Intern Med 2004; Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  }
  // ===== From behavioral-other-diseases.js =====

  // ==================== 行為疾病 ====================

  "separation-anxiety": {
    zh: "分離焦慮",
    en: "Separation Anxiety",
    definition: "當動物與主人或依附對象分離時產生的過度焦慮反應，表現為破壞行為、過度吠叫、排泄異常等問題行為。",
    synonyms: ["Separation Anxiety Disorder", "分離焦慮症", "Attachment Disorder"],
    epidemiology: {
      species: "犬最常見，貓較少見但可發生",
      age: "任何年齡，收養犬和幼年時期創傷者更常見",
      sex: "無明顯性別傾向",
      riskFactors: ["收容所收養", "早期斷奶", "過度依附", "生活環境突變（搬家、家庭成員變化）", "缺乏社會化訓練", "長期獨處經驗不足", "先前創傷經歷"]
    },
    clinicalPresentation: {
      history: ["主人離開時或離開前出現焦慮行為", "破壞家具或門窗（試圖逃脫）", "不當排泄（僅在獨處時）", "過度吠叫或嚎叫", "過度流涎", "厭食（獨處時）", "主人返家時過度興奮"],
      physicalExam: ["可能因自我傷害導致皮膚損傷", "指甲磨損（抓門）", "牙齒磨損（咬籠子）", "體重減輕（嚴重厭食者）", "一般體檢通常無異常"]
    },
    pathophysiology: "過度依附導致主人離開時產生恐慌反應 → 下視丘-腦下垂體-腎上腺軸活化 → 皮質醇升高 → 焦慮行為表現。可能涉及血清素和多巴胺系統失調。幼年時期不安全依附模式的形成是重要病因。",
    diagnosis: {
      overview: "主要依據行為史和排除其他醫學問題。問題行為必須只在分離時或預期分離時發生",
      differentials: ["不完全的居家訓練", "領地標記", "無聊/運動不足", "噪音恐懼症", "其他焦慮症", "認知功能障礙（老年）", "醫學問題導致的排泄異常"],
      initialDB: ["詳細行為史評估", "影像/錄影紀錄獨處行為", "完整身體檢查", "基本血檢（排除甲狀腺問題）", "尿液分析（排除UTI）"],
      advanced: ["行為專家評估", "甲狀腺功能檢測", "神經學檢查（若懷疑認知問題）"]
    },
    treatment: {
      overview: "結合行為修正、環境管理和必要時藥物治療的綜合方案",
      acute: [
        "環境管理：安全空間設置、活動玩具、開著廣播/電視",
        "漸進式脫敏：練習短時間分離並逐漸延長",
        "反制約化訓練：分離與正向刺激（零食玩具）配對",
        "減少離開和返家時的互動強度",
        "考慮日托或寵物保姆（過渡期）"
      ],
      chronic: [
        "藥物治療：",
        "  - Fluoxetine (Reconcile): 犬 1-2 mg/kg PO q24h",
        "  - Clomipramine (Clomicalm): 犬 1-3 mg/kg PO q12h",
        "  - Trazodone: 2-5 mg/kg PO（情境使用）",
        "持續行為修正訓練",
        "建立固定且可預測的日程",
        "鼓勵獨立性（獨自遊戲、獨自休息）"
      ]
    },
    prognosis: "多數犬隻經適當治療可顯著改善。治療成功需要主人的配合和耐心。嚴重病例可能需要數月治療。藥物通常需持續6-12個月再逐漸減量。",
    pearls: [
      "離開時不要過度道別或返家時過度激動",
      "處罰會加重焦慮，絕對禁止",
      "藥物治療效果通常需4-6週才顯現",
      "影像記錄對診斷和監測進展非常有價值",
      "區分真正的分離焦慮和單純無聊破壞很重要"
    ],
    monitoring: ["行為日誌", "影像記錄進展", "藥物副作用（若使用）", "體重和食慾", "生活品質評估"],
    reference: "Overall KL: Manual of Clinical Behavioral Medicine for Dogs and Cats. Mosby, 2013"
  },

  "noise-phobia": {
    zh: "噪音恐懼症",
    en: "Noise Phobia",
    definition: "對特定聲音（如雷聲、煙火、槍聲）產生的持續性、過度且不合理的恐懼反應，導致逃避行為和生理應激反應。",
    synonyms: ["Noise Aversion", "Noise Anxiety", "Storm Phobia", "Thunder Phobia", "聲音恐懼症"],
    epidemiology: {
      species: "犬最常見，貓亦可發生",
      age: "可任何年齡發生，常隨年齡惡化",
      sex: "無明顯性別傾向，部分研究顯示已絕育母犬較多",
      riskFactors: ["牧羊犬品種（Border Collie、Australian Shepherd）", "Beagle、German Shepherd", "缺乏早期聲音社會化", "先前創傷經歷", "其他焦慮問題共病"]
    },
    clinicalPresentation: {
      history: ["聽到特定聲音時顫抖、躲藏", "試圖逃脫（抓門、跳窗）", "過度喘氣和流涎", "不當排泄", "破壞行為", "黏著主人", "拒絕進食", "提前對暴風雨預兆反應"],
      physicalExam: ["發作時心搏過速", "瞳孔放大", "過度喘氣", "肛門腺自發排空", "顫抖", "可能有自傷痕跡", "平時檢查通常正常"]
    },
    pathophysiology: "聲音刺激 → 杏仁核恐懼反應活化 → 交感神經系統亢奮 → 戰鬥或逃跑反應。持續暴露導致致敏化（越來越敏感）而非習慣化。暴風雨恐懼可能還涉及氣壓變化和靜電感知。",
    diagnosis: {
      overview: "根據病史和對特定聲音的可預測恐懼反應診斷",
      differentials: ["分離焦慮", "廣泛性焦慮", "認知功能障礙", "疼痛相關行為", "聽力問題"],
      initialDB: ["詳細行為史", "觸發因素識別", "嚴重程度評估", "排除醫學問題的體檢", "聽力評估（老年）"],
      advanced: ["行為專家評估", "焦慮評分量表", "甲狀腺功能（若懷疑）"]
    },
    treatment: {
      overview: "結合環境管理、脫敏訓練和藥物的多模式治療",
      acute: [
        "發作時的管理：",
        "  - 提供安全藏身處（窩、浴室、地下室）",
        "  - 白噪音或音樂遮蔽",
        "  - 壓力衣/雷衣(ThunderShirt)",
        "  - 保持鎮定，不過度安撫也不忽視",
        "急性藥物：",
        "  - Sileo (Dexmedetomidine oromucosal gel): 按體重給藥",
        "  - Trazodone: 5-10 mg/kg PO（事件前1-2小時）",
        "  - Alprazolam: 0.02-0.1 mg/kg PO（事件前30-60分鐘）"
      ],
      chronic: [
        "系統性脫敏和反制約化訓練（使用錄音）",
        "長期藥物（嚴重病例）：",
        "  - Fluoxetine: 1-2 mg/kg PO q24h",
        "  - Clomipramine: 1-3 mg/kg PO q12h",
        "信息素產品（Adaptil）",
        "營養補充（L-theanine、alpha-casozepine）"
      ]
    },
    prognosis: "不治療會持續惡化。早期介入預後較好。脫敏訓練需數月。約80%犬隻經適當治療可獲改善。",
    pearls: [
      "暴風雨恐懼往往比單純噪音恐懼更難治療",
      "不要強迫暴露於恐懼刺激",
      "Sileo是FDA核准的犬噪音恐懼專用藥物",
      "藥物治療通常需長期維持",
      "錄音脫敏的音量必須從非常低開始"
    ],
    monitoring: ["恐懼反應嚴重程度評估", "行為改變日誌", "藥物副作用", "生活品質"],
    reference: "Overall KL: Manual of Clinical Behavioral Medicine for Dogs and Cats. Mosby, 2013"
  },

  "compulsive-disorder": {
    zh: "強迫症",
    en: "Compulsive Disorder",
    definition: "重複性、儀式化的行為模式，超出正常範圍且干擾正常功能，動物難以自行停止。相當於人類的強迫症(OCD)。",
    synonyms: ["Canine Compulsive Disorder", "CCD", "Feline Compulsive Disorder", "Stereotypy", "刻板行為"],
    epidemiology: {
      species: "犬貓皆可發生，表現形式不同",
      age: "通常青年期開始（1-3歲）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（犬：Doberman-追尾巴、Bull Terrier-旋轉、German Shepherd-追尾巴；貓：Siamese/Burmese-羊毛吸吮）", "環境應激", "社會隔離", "運動不足", "早期斷奶"]
    },
    clinicalPresentation: {
      history: ["重複性行為難以打斷", "追尾巴/咬尾巴", "旋轉/繞圈", "吸吮羊毛或布料（貓）", "舔空氣/咬空氣（fly-snapping）", "自我舔舐（肢端舔皮炎）", "凝視（光影追逐）", "固定路線走動"],
      physicalExam: ["自傷導致的皮膚病變", "尾巴損傷", "肢端皮膚增厚或潰瘍", "可能無明顯異常"]
    },
    pathophysiology: "可能涉及基底核和額葉皮質的神經迴路異常，血清素和多巴胺系統失調。最初可能作為應對機制出現，後來脫離原始刺激而持續。遺傳因素和環境因素共同作用。",
    diagnosis: {
      overview: "根據重複行為的特徵和排除醫學原因診斷",
      differentials: ["癲癇（部分發作）", "神經系統疾病", "皮膚疾病", "消化道疾病（fly-snapping）", "視力問題", "疼痛"],
      initialDB: ["詳細行為史和影像記錄", "完整神經學檢查", "皮膚檢查", "基本血檢", "影像記錄行為發作"],
      advanced: ["腦部MRI（排除結構性病變）", "腦電圖（排除癲癇）", "消化道內視鏡（fly-snapping）", "行為專家評估"]
    },
    treatment: {
      overview: "結合環境富化、行為修正和藥物治療",
      acute: [
        "環境管理：增加運動量、心智刺激",
        "移除觸發因素（若可識別）",
        "不要懲罰或強化強迫行為",
        "提供替代行為出口"
      ],
      chronic: [
        "藥物治療（通常必需）：",
        "  - Fluoxetine: 犬 1-2 mg/kg PO q24h；貓 0.5-1 mg/kg PO q24h",
        "  - Clomipramine: 犬 1-3 mg/kg PO q12h；貓 0.25-0.5 mg/kg PO q24h",
        "  - 可加用 Gabapentin 輔助",
        "行為修正：中斷重導向訓練",
        "環境富化：益智玩具、嗅聞遊戲、規律運動",
        "可預測的日常作息"
      ]
    },
    prognosis: "完全治癒罕見，但多數可良好控制。早期治療效果較好。藥物通常需終身使用。部分病例可減量維持。",
    pearls: [
      "行為開始時可能有明確觸發因素，後來變得自發",
      "Doberman的吸吮flank和Bull Terrier的旋轉有強烈遺傳成分",
      "藥物效果通常需6-8週才顯現",
      "單純增加運動量通常不足以控制",
      "需排除癲癇，尤其是fly-snapping行為"
    ],
    monitoring: ["行為頻率和強度記錄", "自傷程度", "藥物副作用", "生活品質評估"],
    reference: "Overall KL: Manual of Clinical Behavioral Medicine for Dogs and Cats. Mosby, 2013"
  },

  "aggression": {
    zh: "攻擊行為",
    en: "Aggression",
    definition: "對人或其他動物表現出威脅或傷害性行為，包括咆哮、露齒、撲咬等。為最常見的犬行為問題，也是最危險的。",
    synonyms: ["Aggressive Behavior", "Canine Aggression", "Feline Aggression"],
    epidemiology: {
      species: "犬貓皆常見，表現形式不同",
      age: "社會成熟期（1-3歲）常見發作",
      sex: "未絕育公犬較常見某些類型攻擊",
      riskFactors: ["缺乏社會化", "遺傳傾向", "過去創傷經歷", "醫學問題（疼痛、神經疾病）", "不當訓練（懲罰式）", "資源競爭環境"]
    },
    clinicalPresentation: {
      history: ["分類攻擊類型：", "- 恐懼相關攻擊（最常見）", "- 資源守護攻擊", "- 領地攻擊", "- 狩獵行為", "- 疼痛誘發攻擊", "- 遊戲攻擊", "- 重導向攻擊", "- 特發性攻擊（罕見）"],
      physicalExam: ["評估疼痛來源", "神經學檢查", "甲狀腺觸診", "完整身體檢查", "觀察與主人互動"]
    },
    pathophysiology: "攻擊是正常行為的一部分，但病態攻擊涉及閾值降低、反應過度或情境不適當。可能涉及杏仁核過度活化、前額葉皮質抑制功能不足、血清素系統異常。甲狀腺功能低下可能與攻擊行為相關。",
    diagnosis: {
      overview: "詳細行為評估以分類攻擊類型並排除醫學原因",
      differentials: ["疼痛相關攻擊", "癲癇（發作後攻擊）", "腦腫瘤", "甲狀腺功能低下", "肝腦病", "狂犬病", "中毒"],
      initialDB: ["完整行為史（觸發因素、目標、預警信號、後果）", "醫學史回顧", "完整身體檢查", "基本血檢和甲狀腺功能", "神經學檢查"],
      advanced: ["行為專家評估", "腦部影像（若懷疑神經問題）", "特定情境觀察"]
    },
    treatment: {
      overview: "以安全為首要考量，結合行為修正和必要時藥物治療",
      acute: [
        "安全管理最優先：",
        "  - 避免觸發情境",
        "  - 適當使用口套（訓練後）",
        "  - 隔離管理（必要時）",
        "  - 兒童和高風險個體保護",
        "治療任何醫學問題"
      ],
      chronic: [
        "行為修正（需專業指導）：",
        "  - 脫敏和反制約化",
        "  - 避免懲罰式訓練",
        "  - 增強替代行為",
        "  - 「無免費午餐」計畫（資源守護）",
        "藥物治療（輔助）：",
        "  - Fluoxetine: 1-2 mg/kg PO q24h",
        "  - Trazodone: 情境使用",
        "  - 考慮絕育（未絕育公犬同種攻擊）"
      ]
    },
    prognosis: "因攻擊類型而異。恐懼相關攻擊經適當訓練預後較好。特發性攻擊預後差。有咬傷史者復發風險高。安樂死可能是某些嚴重病例的必要選項。",
    pearls: [
      "準確分類攻擊類型是成功治療的關鍵",
      "懲罰會加重恐懼相關攻擊",
      "「支配」理論已過時，應避免對抗性訓練",
      "任何突發攻擊行為變化應考慮醫學問題",
      "預後評估需考慮家庭情況和安全風險"
    ],
    monitoring: ["攻擊事件記錄", "觸發因素追蹤", "安全狀況評估", "治療進展評估"],
    reference: "Overall KL: Manual of Clinical Behavioral Medicine for Dogs and Cats. Mosby, 2013"
  },

  "coprophagia": {
    zh: "食糞症",
    en: "Coprophagia",
    definition: "攝食糞便的行為，可食用自己的、其他動物的、或其他物種的糞便。在某些情況下為正常行為，但也可能是行為或醫學問題的表現。",
    synonyms: ["Stool Eating", "Feces Eating", "食糞行為"],
    epidemiology: {
      species: "犬最常見（據估計16-23%的犬有此行為）",
      age: "任何年齡，幼犬更常見",
      sex: "無明顯性別傾向",
      riskFactors: ["多犬家庭", "貪食傾向（Labrador等）", "注意力尋求行為", "食物不足或營養不良史", "限制性環境（如籠養過久）", "與消化問題相關"]
    },
    clinicalPresentation: {
      history: ["吃自己的糞便（autocoprophagia）", "吃同種其他動物糞便（allocoprophagia）", "吃其他物種糞便（如貓砂盆內糞便、草食動物糞便）", "可能伴隨嘔吐或腹瀉", "口臭"],
      physicalExam: ["通常無異常發現", "評估身體狀況和營養狀態", "腹部觸診", "口腔檢查"]
    },
    pathophysiology: "行為性：可能是注意力尋求、無聊、焦慮、模仿行為或習得行為。母犬舔食幼犬糞便是正常母性行為。醫學性：營養吸收不良導致糞便含有未消化營養素，刺激攝食行為。胰外分泌功能不全(EPI)是常見醫學原因。",
    diagnosis: {
      overview: "需區分正常行為、行為問題和醫學問題",
      differentials: ["正常母性行為", "EPI（胰外分泌功能不全）", "腸道吸收不良", "腸道寄生蟲", "飢餓/營養不良", "認知功能障礙（老年）", "焦慮/壓力相關"],
      initialDB: ["詳細飲食史", "糞便檢查（寄生蟲）", "糞便消化評估", "基本血檢", "TLI（排除EPI）"],
      advanced: ["營養評估", "行為評估", "維生素B12/葉酸（若懷疑吸收不良）"]
    },
    treatment: {
      overview: "針對病因治療，結合環境管理和行為修正",
      acute: [
        "環境管理：",
        "  - 立即清理糞便",
        "  - 限制進入貓砂盆區域",
        "  - 遛狗時牽繩控制",
        "  - 不要懲罰（會強化注意力尋求）",
        "治療任何醫學問題（EPI、寄生蟲等）"
      ],
      chronic: [
        "飲食調整：",
        "  - 高品質、易消化飲食",
        "  - 確保足夠的餵食量",
        "  - 添加消化酶（若有吸收問題）",
        "厭惡劑（效果不一）：",
        "  - 糞便添加物（For-Bid, Deter等）",
        "  - 辣椒醬塗抹糞便（需主人先放置）",
        "行為訓練：",
        "  - 「離開」命令訓練",
        "  - 重導向到其他活動",
        "增加運動和心智刺激"
      ]
    },
    prognosis: "若為醫學原因導致，治療原發病後可改善。行為性食糞症管理難度較高，需持續環境控制。多數情況下可透過管理減少行為頻率。",
    pearls: [
      "偶爾食用草食動物糞便可能是正常犬行為",
      "懲罰往往適得其反，犬會學習在主人不在時吃糞便",
      "商業厭惡劑效果研究有限",
      "務必排除EPI，這是可治療的醫學原因",
      "幼犬食糞多為探索行為，常會自行停止"
    ],
    monitoring: ["行為頻率記錄", "糞便品質", "體重和身體狀況", "若有醫學治療需追蹤效果"],
    reference: "Hart BL et al: The paradox of canine conspecific coprophagy. Vet Med Sci 4:106-114, 2018"
  },

  "pica": {
    zh: "異食症",
    en: "Pica",
    definition: "持續性攝食非食物物質的行為，如石頭、布料、塑膠、紙張等。可能導致腸道阻塞或中毒等嚴重併發症。",
    synonyms: ["異物攝食", "異嗜癖", "Non-nutritive Ingestion"],
    epidemiology: {
      species: "犬貓皆可發生，貓常見羊毛/布料吸吮",
      age: "幼年動物較常見，可持續至成年",
      sex: "無明顯性別傾向",
      riskFactors: ["早期斷奶（貓）", "品種傾向（貓：Siamese、Burmese；犬：Labrador）", "環境應激", "無聊/缺乏刺激", "強迫行為傾向", "營養缺乏", "消化道疾病"]
    },
    clinicalPresentation: {
      history: ["攝食石頭、布料、塑膠、金屬等", "吸吮羊毛（貓常見）", "可能有嘔吐、腹瀉、厭食", "便秘或排便困難", "腹痛表現", "可能無症狀直到發生阻塞"],
      physicalExam: ["腹部觸診可能摸到異物", "腹痛", "脫水（若有嘔吐）", "可能因異物導致口腔損傷"]
    },
    pathophysiology: "多因子：行為性（強迫症、焦慮、無聊）、營養性（礦物質缺乏、吸收不良）、神經性（腦部疾病）。貓的羊毛吸吮可能與早期斷奶和遺傳有關。幼犬異食可能是正常探索行為但應逐漸消失。",
    diagnosis: {
      overview: "確認異食行為並排除醫學原因",
      differentials: ["正常幼年探索行為", "強迫症", "營養缺乏", "腸道疾病", "腦部疾病", "焦慮相關行為", "注意力尋求"],
      initialDB: ["詳細病史（攝食物品種類和頻率）", "完整身體檢查", "血液檢查（CBC、生化、微量元素）", "腹部X光（若懷疑異物）", "糞便檢查"],
      advanced: ["腹部超音波", "內視鏡（取出異物/評估）", "行為專家評估", "甲狀腺功能"]
    },
    treatment: {
      overview: "移除危險異物接觸、治療醫學原因、行為修正",
      acute: [
        "若有異物阻塞：內視鏡或手術取出",
        "環境管理：",
        "  - 移除所有可能被攝食的物品",
        "  - 監督活動時間",
        "  - 使用籠子（安全時間）",
        "  - 口套（戶外使用，訓練後）"
      ],
      chronic: [
        "環境富化：增加適當的咀嚼玩具",
        "增加運動和心智刺激",
        "行為修正：「離開」命令訓練",
        "飲食調整：",
        "  - 高纖維飲食可能有幫助",
        "  - 確保營養完整",
        "藥物治療（若為強迫行為）：",
        "  - Fluoxetine: 犬 1-2 mg/kg；貓 0.5-1 mg/kg PO q24h",
        "  - Clomipramine: 犬 1-3 mg/kg；貓 0.25-0.5 mg/kg PO q12-24h"
      ]
    },
    prognosis: "取決於病因。幼年探索行為通常會自然減少。強迫性異食預後較謹慎，需長期管理。異物阻塞是嚴重併發症。",
    pearls: [
      "區分正常幼年探索和病態異食很重要",
      "貓羊毛吸吮常與分離焦慮或強迫症共病",
      "環境管理比藥物更重要",
      "X光可能無法顯示所有異物（布料等）",
      "懲罰可能導致躲藏進食異物"
    ],
    monitoring: ["行為頻率記錄", "腸道健康（嘔吐、排便）", "藥物副作用（若使用）", "環境安全評估"],
    reference: "Overall KL: Manual of Clinical Behavioral Medicine for Dogs and Cats. Mosby, 2013"
  },

  "acral-lick-dermatitis": {
    zh: "肢端舔皮炎",
    en: "Acral Lick Dermatitis",
    definition: "因持續性舔舐而在肢體末端（通常是腕部或跗部）形成的肉芽腫性皮膚病變。常為多因子疾病，涉及心理和皮膚因素。",
    synonyms: ["Acral Lick Granuloma", "Lick Granuloma", "肢端舔肉芽腫", "ALD"],
    epidemiology: {
      species: "犬為主，貓罕見",
      age: "中年犬最常見（>5歲）",
      sex: "公犬可能較多",
      riskFactors: ["大型犬（Doberman、Great Dane、Labrador、Golden Retriever、German Shepherd、Irish Setter）", "無聊/環境刺激不足", "焦慮", "過敏", "關節疾病", "神經病變"]
    },
    clinicalPresentation: {
      history: ["持續舔舐特定部位", "病變逐漸擴大和增厚", "病程常數月至數年", "可能有搔癢或疼痛史", "單側較常見"],
      physicalExam: ["堅硬、隆起、無毛的肉芽腫性斑塊", "常見於腕部背側或跗部", "可能有繼發感染", "病變可能潰瘍", "周圍皮膚可能正常或有舔舐痕跡"]
    },
    pathophysiology: "初始觸發因素（搔癢、疼痛、焦慮）→ 舔舐 → 皮膚損傷 → 癒合過程中搔癢 → 更多舔舐 → 惡性循環。舔舐可能釋放內啡肽，產生自我增強效應。深層細菌感染很常見。可能涉及神經炎症機制。",
    diagnosis: {
      overview: "識別潛在觸發因素是成功治療的關鍵",
      differentials: ["過敏性皮膚炎", "黴菌感染", "寄生蟲", "關節疾病", "骨腫瘤", "神經病變", "異物", "腫瘤"],
      initialDB: ["詳細病史（發作時間、環境變化）", "全面皮膚檢查", "皮膚刮搔", "深層細菌培養", "皮膚細胞學", "病變部位X光（排除骨病變）"],
      advanced: ["皮膚活檢", "過敏原檢測", "神經學評估", "行為評估", "進階影像（關節）"]
    },
    treatment: {
      overview: "多模式治療：處理感染、減少舔舐、治療潛在病因",
      acute: [
        "防止繼續舔舐：",
        "  - 伊莉莎白項圈（E-collar）",
        "  - 繃帶或襪子覆蓋",
        "  - 苦味劑噴霧",
        "感染控制：",
        "  - 長期抗生素（6-8週或更長）",
        "  - 依據培養結果選擇（深層感染常見）",
        "局部治療：類固醇軟膏、Tacrolimus"
      ],
      chronic: [
        "行為/心理治療：",
        "  - 增加運動和環境富化",
        "  - Fluoxetine: 1-2 mg/kg PO q24h",
        "  - Clomipramine: 1-3 mg/kg PO q12h",
        "治療潛在病因：",
        "  - 過敏管理",
        "  - 關節炎疼痛控制",
        "  - 神經病變治療",
        "進階治療（難治病例）：",
        "  - 雷射消融",
        "  - 放射治療",
        "  - 手術切除（高復發率）",
        "  - 針灸"
      ]
    },
    prognosis: "治療困難，復發率高。早期病變預後較好。需要長期管理。徹底痊癒不常見，但可良好控制。",
    pearls: [
      "這是一個複雜的多因子疾病，不是「純行為問題」",
      "深層細菌感染幾乎都存在，需長期抗生素",
      "單純手術切除復發率極高",
      "藥物效果通常需6-8週顯現",
      "必須同時處理心理和皮膚兩方面"
    ],
    monitoring: ["病變大小和外觀記錄（照片）", "舔舐行為頻率", "感染控制效果", "藥物副作用"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  "excessive-barking": {
    zh: "過度吠叫",
    en: "Excessive Barking",
    definition: "吠叫頻率、持續時間或情境超出正常範圍，影響動物福利或造成社會問題的行為。吠叫本身是正常犬行為，但過度時需要介入。",
    synonyms: ["Problem Barking", "Nuisance Barking", "過度叫"],
    epidemiology: {
      species: "犬",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（小型犬、獵犬、牧羊犬）", "缺乏社會化", "焦慮問題", "環境刺激過多", "注意力強化", "無聊"]
    },
    clinicalPresentation: {
      history: ["需識別吠叫類型：", "- 警戒/領地吠叫", "- 焦慮/恐懼吠叫（分離焦慮）", "- 注意力尋求吠叫", "- 興奮吠叫", "- 社交/回應吠叫", "- 強迫性吠叫", "- 疼痛/不適吠叫", "- 認知功能障礙（老年）"],
      physicalExam: ["通常無異常", "評估聽力", "評估疼痛來源", "神經學檢查（老年犬）"]
    },
    pathophysiology: "吠叫是犬的正常溝通方式。過度吠叫可能因環境（觸發因素過多）、學習（被強化）、情緒（焦慮、恐懼）或醫學（疼痛、認知衰退、聽力損失）因素導致。",
    diagnosis: {
      overview: "確定吠叫類型和觸發因素，排除醫學問題",
      differentials: ["正常警戒行為", "分離焦慮", "噪音恐懼", "認知功能障礙", "疼痛", "聽力損失", "強迫行為", "犬腦炎"],
      initialDB: ["詳細行為史（何時、何地、針對誰、持續多久）", "影像/錄音記錄", "完整身體檢查", "聽力評估", "神經學檢查（老年）"],
      advanced: ["甲狀腺功能（若懷疑）", "行為專家評估", "腦部影像（若懷疑神經問題）"]
    },
    treatment: {
      overview: "根據吠叫類型針對性治療",
      acute: [
        "不要大聲喊叫制止（會強化吠叫）",
        "不要懲罰",
        "移除或減少觸發因素（若可能）",
        "治療任何醫學問題"
      ],
      chronic: [
        "警戒/領地吠叫：",
        "  - 脫敏訓練（對觸發刺激）",
        "  - 「安靜」命令訓練",
        "  - 限制視線到觸發區域",
        "分離焦慮吠叫：見分離焦慮治療",
        "注意力尋求吠叫：",
        "  - 完全忽視直到安靜",
        "  - 獎勵安靜行為",
        "一般管理：",
        "  - 增加運動量",
        "  - 環境富化",
        "  - 基礎服從訓練",
        "藥物（輔助，針對焦慮型）：",
        "  - 參見分離焦慮或噪音恐懼用藥"
      ]
    },
    prognosis: "取決於根本原因。注意力尋求型經正確訓練改善快。焦慮相關吠叫需要更長期治療。認知功能障礙相關可能難以改善。",
    pearls: [
      "止吠項圈（電擊或噴霧）可能導致更多行為問題",
      "聲帶切除術是不人道且無效的方法",
      "準確識別吠叫類型是成功治療的關鍵",
      "老年犬突發過度吠叫應考慮認知障礙",
      "一致性訓練比懲罰更有效"
    ],
    monitoring: ["吠叫頻率和情境記錄", "鄰居回饋", "生活品質評估", "訓練進展"],
    reference: "Overall KL: Manual of Clinical Behavioral Medicine for Dogs and Cats. Mosby, 2013"
  },

  "feline-hyperesthesia": {
    zh: "貓過敏綜合症",
    en: "Feline Hyperesthesia Syndrome",
    definition: "貓的神經行為異常，特徵為皮膚敏感過度、背部肌肉抽動、突發性焦躁和自殘行為。病因不明，可能涉及神經、皮膚和行為多重因素。",
    synonyms: ["Feline Hyperesthesia", "Rolling Skin Disease", "Twitchy Cat Syndrome", "Rippling Skin Disorder", "貓過敏症候群"],
    epidemiology: {
      species: "貓",
      age: "年輕成年至中年（1-5歲常見發病）",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Siamese、Burmese、Abyssinian、Persian）", "焦慮傾向", "環境應激"]
    },
    clinicalPresentation: {
      history: ["發作性皮膚抽動（背部「波浪」）", "突然激動奔跑", "盯著尾巴或背部並攻擊", "尾巴追咬", "過度梳理或自殘", "瞳孔放大", "發聲（嚎叫）", "觸摸背部時誇張反應", "發作可持續數秒到數分鐘"],
      physicalExam: ["發作時：背部肌肉抽動、瞳孔放大、焦躁", "可能有自殘造成的皮膚病變", "發作間期可能完全正常", "皮膚檢查（排除過敏/感染）", "神經學檢查"]
    },
    pathophysiology: "病因不明。可能假說包括：部分癲癇發作、強迫症、皮膚敏感問題、脊髓/神經病變。可能是多重因素的最終共同表現。焦慮和應激是常見觸發因素。",
    diagnosis: {
      overview: "排除性診斷，需排除其他皮膚和神經疾病",
      differentials: ["跳蚤過敏性皮膚炎", "食物過敏", "皮膚感染（黴菌、細菌）", "脊髓疾病", "癲癇", "疼痛（脊椎/肌肉）", "強迫症", "心因性脫毛"],
      initialDB: ["詳細病史和影像記錄發作", "完整皮膚檢查（刮搔、梳檢）", "神經學檢查", "基本血檢", "嚴格跳蚤控制試驗"],
      advanced: ["脊椎X光/MRI", "腦電圖（若懷疑癲癇）", "皮膚活檢", "食物排除試驗", "行為專家評估"]
    },
    treatment: {
      overview: "多模式治療：減少觸發因素、行為修正、藥物控制",
      acute: [
        "發作時不要嘗試安撫或限制（可能被咬傷）",
        "提供安靜環境讓發作結束",
        "記錄發作（時間、持續、觸發因素）"
      ],
      chronic: [
        "環境管理：",
        "  - 減少應激源",
        "  - 建立可預測的日程",
        "  - 環境富化",
        "  - 費洛蒙產品（Feliway）",
        "藥物治療：",
        "  - Gabapentin: 5-10 mg/kg PO q8-12h（首選）",
        "  - Fluoxetine: 0.5-1 mg/kg PO q24h",
        "  - Clomipramine: 0.25-0.5 mg/kg PO q24h",
        "  - Phenobarbital: 若懷疑癲癇成分",
        "徹底跳蚤防治",
        "Omega-3脂肪酸補充"
      ]
    },
    prognosis: "病程波動，可能終身存在。多數貓可透過管理獲得良好生活品質。嚴重自殘病例預後謹慎。",
    pearls: [
      "這是排除性診斷，必須先排除其他原因",
      "影像記錄發作對診斷很有幫助",
      "許多貓同時有多重問題（如跳蚤過敏+焦慮）",
      "Gabapentin現被認為是良好首選藥物",
      "可能需要嘗試多種治療組合"
    ],
    monitoring: ["發作頻率和嚴重度記錄", "自殘程度", "藥物副作用", "生活品質"],
    reference: "Overall KL: Manual of Clinical Behavioral Medicine for Dogs and Cats. Mosby, 2013"
  },

  "psychogenic-alopecia": {
    zh: "心因性脫毛",
    en: "Psychogenic Alopecia",
    definition: "貓因過度梳理導致的脫毛，被認為與心理壓力或焦慮有關。然而，多數過度梳理病例實際上有皮膚疾病根本原因，真正的心因性脫毛較罕見。",
    synonyms: ["Feline Psychogenic Alopecia", "Overgrooming", "過度梳理症", "Barbering"],
    epidemiology: {
      species: "貓",
      age: "任何年齡",
      sex: "無明顯性別傾向",
      riskFactors: ["品種傾向（Siamese、Burmese、Abyssinian、Himalayan）", "環境變化/應激", "多貓家庭衝突", "焦慮傾向"]
    },
    clinicalPresentation: {
      history: ["腹部、內側大腿、側腹脫毛", "可能有舔舐行為被觀察到或隱藏進行", "毛髮斷裂而非脫落", "無搔抓", "近期環境變化（搬家、新寵物、新家庭成員）"],
      physicalExam: ["對稱性或不對稱性脫毛", "毛髮斷裂（非連根脫落）", "皮膚外觀正常（無紅腫、鱗屑）", "脫毛區域毛髮容易被拔起", "可能有輕微皮膚炎"]
    },
    pathophysiology: "真正心因性：應激或焦慮導致過度梳理作為自我安撫或轉移行為。然而，研究顯示>90%過度梳理的貓有潛在皮膚問題（過敏最常見）。梳理本身可以釋放內啡肽。",
    diagnosis: {
      overview: "心因性脫毛是排除性診斷！必須先徹底排除所有皮膚疾病",
      differentials: ["跳蚤過敏性皮膚炎（最常見）", "食物過敏", "環境過敏（異位性皮膚炎）", "皮癬菌感染", "疥癬", "蠕形蟎感染", "膿皮症", "貓過敏綜合症"],
      initialDB: ["詳細病史", "嚴格跳蚤控制試驗（8-12週）", "皮膚刮搔", "真菌培養", "皮膚細胞學", "拔毛檢查（毛球端）"],
      advanced: ["食物排除試驗（8-12週）", "皮內過敏原測試或血清IgE", "皮膚活檢", "環境和行為評估"]
    },
    treatment: {
      overview: "首先治療任何潛在皮膚問題，同時進行環境管理",
      acute: [
        "徹底跳蚤控制（所有貓+環境）",
        "食物排除試驗（水解蛋白或新蛋白質飲食）",
        "治療任何發現的皮膚問題"
      ],
      chronic: [
        "若確定為心因性：",
        "環境修正：",
        "  - 識別並減少應激源",
        "  - 提供更多垂直空間和藏身處",
        "  - 資源充足（貓砂盆、食碗、水碗）",
        "  - 使用費洛蒙（Feliway）",
        "  - 建立可預測的日常作息",
        "藥物治療：",
        "  - Fluoxetine: 0.5-1 mg/kg PO q24h",
        "  - Clomipramine: 0.25-0.5 mg/kg PO q24h",
        "  - Amitriptyline: 0.5-1 mg/kg PO q12-24h",
        "環境富化：互動玩具、抓板、高處棲息"
      ]
    },
    prognosis: "若為真正心因性並能改善環境，預後良好。若潛在皮膚病未被識別，治療將失敗。藥物通常需數週才見效。",
    pearls: [
      "不要輕易診斷「心因性」- 超過90%有皮膚問題",
      "跳蚤過敏是最常見原因，即使未發現跳蚤",
      "毛球端如果是尖的而非斷裂的，不是梳理導致",
      "貓可能只在主人不在時梳理",
      "真正的心因性脫毛相對罕見"
    ],
    monitoring: ["毛髮生長照片記錄", "梳理行為觀察", "藥物副作用", "環境改變反應"],
    reference: "Miller WH et al: Muller & Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },

  // ==================== 其他疾病 ====================

  "obesity": {
    zh: "肥胖症",
    en: "Obesity",
    definition: "體重超過理想體重20%以上或體態評分(BCS)達到過重/肥胖標準。肥胖是小動物最常見的營養問題，與多種健康問題相關。",
    synonyms: ["Overweight", "過重", "體重過重"],
    epidemiology: {
      species: "犬貓皆常見，患病率約25-40%",
      age: "中年動物最常見，風險隨年齡增加",
      sex: "已絕育動物風險較高",
      riskFactors: ["絕育", "年齡增長", "過度餵食", "缺乏運動", "品種傾向（犬：Labrador、Beagle、Cocker Spaniel、Cavalier King Charles）", "自由採食", "高熱量零食"]
    },
    clinicalPresentation: {
      history: ["體重逐漸增加", "運動不耐", "呼吸困難", "行動遲緩", "主人可能不認為是問題"],
      physicalExam: ["體態評分(BCS) 7-9/9 或 4-5/5", "肋骨難以觸及", "無法識別腰線", "腹部下垂", "頸部和四肢脂肪堆積"]
    },
    pathophysiology: "能量攝入 > 能量消耗 → 脂肪組織堆積。脂肪組織是活躍的內分泌器官，產生促炎細胞因子（adipokines）→ 慢性低度發炎 → 胰島素阻抗、關節壓力增加、呼吸功能下降、免疫功能異常。",
    diagnosis: {
      overview: "根據體重和體態評分診斷，評估相關併發症",
      differentials: ["腹水", "器官腫大", "腫瘤", "甲狀腺功能低下（犬）", "庫欣症（犬）", "肢端肥大症（貓）"],
      initialDB: ["精確體重測量", "體態評分(BCS)", "肌肉狀態評分(MCS)", "完整身體檢查", "基本血檢（血糖、肝指數、血脂）"],
      advanced: ["甲狀腺功能（若懷疑）", "空腹胰島素/胰島素阻抗評估", "DEXA掃描（體組成分析）", "關節X光（若有跛行）"]
    },
    treatment: {
      overview: "熱量限制結合增加活動量的長期體重管理計畫",
      acute: [
        "設定目標體重（理想體重或分階段目標）",
        "計算每日熱量需求並減少20-30%",
        "選擇減重處方飲食或減少現有飲食量",
        "消除或限制零食"
      ],
      chronic: [
        "飲食管理：",
        "  - 減重處方飲食（高蛋白、高纖維、低熱量）",
        "  - 精確測量每餐份量",
        "  - 分次餵食（每日2-4次）",
        "  - 避免自由採食",
        "  - 零食熱量<每日總熱量10%",
        "運動計畫：",
        "  - 漸進式增加活動量",
        "  - 犬：散步、游泳、玩耍",
        "  - 貓：互動玩具、雷射筆、爬架",
        "環境管理：",
        "  - 食物球/益智餵食器",
        "  - 分散食物增加活動",
        "目標：每週減重1-2%體重"
      ]
    },
    prognosis: "配合良好可成功減重，但維持是長期挑戰。減重可改善糖尿病、關節炎、壽命等相關問題。",
    pearls: [
      "肥胖使貓糖尿病風險增加4倍",
      "減重速度過快可導致貓肝脂肪沉積",
      "主人教育和配合是成功關鍵",
      "定期回診（2-4週）監測進展很重要",
      "減重後維持需終身飲食管理"
    ],
    monitoring: ["每2-4週體重測量", "BCS追蹤", "調整飲食計畫", "併發症監測"],
    reference: "German AJ: The growing problem of obesity in dogs and cats. J Nutr 136:1940S-1946S, 2006"
  },

  "failure-to-thrive": {
    zh: "生長發育障礙",
    en: "Failure to Thrive",
    definition: "幼年動物無法達到預期的生長速度和發育里程碑，表現為體重增加緩慢或停滯、發育遲緩。通常有潛在醫學或營養原因。",
    synonyms: ["Fading Puppy/Kitten Syndrome", "Neonatal Mortality", "生長遲緩", "發育不良"],
    epidemiology: {
      species: "犬貓幼仔",
      age: "新生兒至幼年期（<6月齡最常見）",
      sex: "無明顯性別傾向",
      riskFactors: ["早產", "低出生體重", "產道感染暴露", "母乳不足", "大窩（競爭餵食）", "先天性缺陷", "環境溫度不當"]
    },
    clinicalPresentation: {
      history: ["體重增加緩慢或停滯", "吸乳無力", "活動力差", "與同窩比較明顯較小", "哭叫（飢餓或不適）", "腹瀉或便秘"],
      physicalExam: ["體重低於同齡正常值", "體態評分過低", "肌肉量不足", "脫水", "低體溫", "可能有先天缺陷（腭裂、心臟缺陷）"]
    },
    pathophysiology: "多因子：感染（病毒、細菌、寄生蟲）、營養不足（母乳不足、吸乳問題）、先天缺陷（心臟、消化道、代謝）、環境因素（溫度、衛生）、同種異體溶血（新生兒溶血）。新生兒的免疫力和體溫調節能力有限。",
    diagnosis: {
      overview: "全面評估以識別潛在原因",
      differentials: ["感染（敗血症、病毒如犬瘟熱/貓瘟）", "寄生蟲", "先天性心臟病", "肝門脈分流", "腎發育不全", "消化道畸形", "代謝疾病", "新生兒同種異體溶血", "母乳不足"],
      initialDB: ["精確體重和生長曲線", "完整身體檢查（包括先天缺陷篩檢）", "糞便檢查（寄生蟲）", "血糖測量", "PCV/TS"],
      advanced: ["CBC和生化檢查", "傳染病篩檢（CPV、FPV、FeLV/FIV）", "尿液分析", "腹部/心臟超音波", "影像學檢查（心臟、骨骼）"]
    },
    treatment: {
      overview: "支持治療同時診斷和處理潛在原因",
      acute: [
        "支持治療：",
        "  - 保溫（維持環境溫度：第一週29-32°C，之後漸減）",
        "  - 輸液（皮下或靜脈，注意劑量）",
        "  - 低血糖處理（口服糖水或靜脈葡萄糖）",
        "  - 營養支持（管灌餵食或奶瓶餵食）",
        "感染控制：",
        "  - 廣效抗生素（若懷疑敗血症）",
        "  - 驅蟲"
      ],
      chronic: [
        "針對病因治療（手術矯正缺陷等）",
        "營養補充：",
        "  - 補充餵食或人工餵養",
        "  - 適當配方奶（犬貓專用）",
        "  - 逐漸過渡到固體食物",
        "環境優化：",
        "  - 適當溫濕度控制",
        "  - 減少應激",
        "  - 確保足夠餵食機會"
      ]
    },
    prognosis: "取決於根本原因。營養性問題經糾正預後良好。先天性缺陷依嚴重程度而異。嚴重敗血症或重大畸形預後差。",
    pearls: [
      "體重是最重要的監測指標，應每日測量",
      "新生兒正常應每日增重5-10%",
      "低體溫比低血糖更緊急處理",
      "先餵奶再刺激排尿排便（模仿母獸）",
      "單獨隔離弱仔可能進一步惡化"
    ],
    monitoring: ["每日體重", "體溫", "進食量", "尿液和糞便", "活動力和行為"],
    reference: "Peterson ME, Kutzler MA: Small Animal Pediatrics. Elsevier, 2011"
  },

  "cachexia": {
    zh: "惡病質",
    en: "Cachexia",
    definition: "與慢性疾病相關的代謝異常狀態，表現為肌肉和脂肪組織的進行性消耗，即使有足夠營養攝入也無法完全逆轉。與單純飢餓不同。",
    synonyms: ["Cancer Cachexia", "Cardiac Cachexia", "消耗症", "惡液質"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，老年動物更常見（因潛在疾病多）",
      sex: "無明顯性別傾向",
      riskFactors: ["惡性腫瘤（最常見原因）", "慢性心衰竭", "慢性腎病", "慢性感染", "嚴重發炎性疾病"]
    },
    clinicalPresentation: {
      history: ["漸進性體重減輕", "肌肉消瘦", "食慾可能正常或下降", "虛弱", "活動力下降", "已知潛在疾病史"],
      physicalExam: ["肌肉萎縮（明顯於顳肌、腰背肌、四肢）", "脂肪減少", "骨骼突出", "可能有腹水（蛋白減少）", "潛在疾病的相關發現"]
    },
    pathophysiology: "與飢餓不同，惡病質主要消耗肌肉而非脂肪。慢性疾病 → 促炎細胞因子（TNF-α、IL-1、IL-6）升高 → 代謝改變（蛋白質分解增加、合成減少）→ 肌肉萎縮 + 脂肪分解。腫瘤還會產生特定惡病質因子。靜息能量消耗通常增加。",
    diagnosis: {
      overview: "診斷惡病質本身並識別潛在疾病",
      differentials: ["單純飢餓/營養不良", "吸收不良", "糖尿病", "甲狀腺功能亢進（貓）", "EPI", "慢性感染", "神經肌肉疾病"],
      initialDB: ["體重和體態評分(BCS)歷史比較", "肌肉狀態評分(MCS)", "CBC和生化全套", "總蛋白/白蛋白", "尿液分析"],
      advanced: ["影像學（胸腹X光、超音波）", "細胞學/組織病理", "腫瘤標記", "心臟評估", "內分泌檢測"]
    },
    treatment: {
      overview: "治療潛在疾病是根本，同時提供營養支持",
      acute: [
        "診斷並治療潛在疾病",
        "營養支持：",
        "  - 高蛋白、高脂肪飲食",
        "  - 適口性優先（讓動物願意吃）",
        "  - 考慮食慾刺激劑",
        "水分和電解質平衡"
      ],
      chronic: [
        "營養管理：",
        "  - 高品質蛋白質來源",
        "  - 增加omega-3脂肪酸（EPA/DHA）",
        "  - 少量多餐",
        "  - 必要時管灌餵食",
        "食慾刺激劑：",
        "  - Mirtazapine: 貓 1.88 mg PO或經皮q48h",
        "  - Capromorelin (Entyce/Elura): 依體重給藥",
        "潛在疾病治療",
        "支持性照護（疼痛管理、抗噁心等）"
      ]
    },
    prognosis: "取決於潛在疾病。惡病質本身是疾病嚴重程度和預後的指標。癌症惡病質預後通常不佳。早期營養介入可能改善生活品質。",
    pearls: [
      "惡病質vs飢餓：惡病質主要消耗肌肉，飢餓主要消耗脂肪",
      "即使食慾正常也可能發生惡病質",
      "肌肉狀態評分(MCS)比體態評分(BCS)更能反映惡病質",
      "Omega-3脂肪酸可能有助於減緩肌肉流失",
      "營養支持不能完全逆轉惡病質，但可改善生活品質"
    ],
    monitoring: ["體重（每1-2週）", "BCS和MCS", "食慾和進食量", "生活品質評估", "潛在疾病進展"],
    reference: "Freeman LM: Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats. J Vet Intern Med 26:3-17, 2012"
  },

  "dehydration": {
    zh: "脫水",
    en: "Dehydration",
    definition: "體液減少導致的水分和電解質不足狀態。可由攝入不足、流失過多或兩者兼有引起。是許多疾病的常見併發症。",
    synonyms: ["Hypovolemia", "Fluid Deficit", "低血容量"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "幼年和老年動物更易發生且更危險",
      sex: "無性別傾向",
      riskFactors: ["嘔吐/腹瀉", "腎臟疾病", "糖尿病", "發燒", "攝水不足", "環境過熱", "出血"]
    },
    clinicalPresentation: {
      history: ["嘔吐和/或腹瀉", "不喝水或無法喝水", "多尿", "發燒", "環境暴露（高溫）"],
      physicalExam: ["皮膚彈性下降（皮膚皺褶延遲回復）", "黏膜乾燥", "眼球凹陷", "微血管充盈時間(CRT)延長", "心搏過速", "脈搏弱", "嗜睡", "尿量減少"]
    },
    pathophysiology: "體液流失或攝入不足 → 細胞外液減少 → 血容量減少 → 組織灌流不足 → 器官功能障礙。脫水程度通常以體重百分比估計（<5%輕度，5-10%中度，>10%重度）。電解質失衡（低鈉、低鉀）和酸鹼異常常伴隨發生。",
    diagnosis: {
      overview: "臨床評估脫水程度並識別原因",
      differentials: ["急性腸胃炎", "腎衰竭", "糖尿病/DKA", "腎上腺皮質功能低下", "敗血症", "出血", "熱衰竭/中暑"],
      initialDB: ["體格檢查（評估脫水程度）", "PCV/TS（總蛋白升高提示血液濃縮）", "BUN（腎前性升高）", "尿比重", "電解質", "血氣分析（酸鹼狀態）"],
      advanced: ["完整生化", "腹部影像", "感染疾病檢測", "內分泌檢測"]
    },
    treatment: {
      overview: "補充液體、糾正電解質失衡、治療原發病",
      acute: [
        "評估脫水程度和計算輸液量：",
        "  - 補充量(mL) = 體重(kg) × 脫水%(小數) × 1000",
        "  - 加上維持量和持續流失量",
        "靜脈輸液（中重度）：",
        "  - 等張晶體液（LRS、0.9% NaCl、Plasmalyte）",
        "  - 休克劑量（必要時）：犬 60-90 mL/kg/h；貓 40-60 mL/kg/h",
        "  - 通常前4-6小時補充脫水量的50%",
        "皮下輸液（輕度，居家）",
        "電解質補充（尤其鉀）"
      ],
      chronic: [
        "治療原發病",
        "口服補液（輕度，可自行飲水）",
        "居家皮下輸液（慢性腎病等）",
        "確保充足飲水機會",
        "濕食促進水分攝取"
      ]
    },
    prognosis: "取決於脫水程度和原發病。單純脫水經適當補液預後良好。嚴重脫水伴休克需緊急處理。",
    pearls: [
      "皮膚彈性測試在老年和消瘦動物不可靠",
      "貓的皮膚彈性測試應在頸部進行",
      "過快補液可能導致肺水腫",
      "監測尿量是評估補液效果的好指標",
      "幼年和老年動物對脫水更敏感"
    ],
    monitoring: ["體重（每日）", "皮膚彈性", "CRT和黏膜濕潤度", "尿量", "PCV/TS", "電解質"],
    reference: "DiBartola SP: Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice, 4th Ed. Elsevier, 2012"
  },

  "hypothermia": {
    zh: "低體溫症",
    en: "Hypothermia",
    definition: "核心體溫低於正常範圍（犬<37.5°C/99.5°F；貓<37.2°C/99°F）。可為輕度、中度或重度，嚴重時危及生命。",
    synonyms: ["Low Body Temperature", "體溫過低"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "新生兒和老年動物風險最高",
      sex: "無性別傾向",
      riskFactors: ["新生兒（體溫調節不全）", "老年動物", "小型犬種", "低體脂", "麻醉/手術", "外傷/休克", "疾病末期", "環境暴露", "濕冷環境"]
    },
    clinicalPresentation: {
      history: ["環境暴露（低溫、濕冷）", "長時間麻醉", "外傷", "重病/衰弱", "新生兒或老年"],
      physicalExam: ["輕度(32-37°C)：顫抖、心搏過速、外周血管收縮", "中度(28-32°C)：顫抖減少或停止、心搏過緩、嗜睡、肌肉僵硬", "重度(<28°C)：昏迷、心律不整、固定瞳孔、呼吸微弱"]
    },
    pathophysiology: "體溫下降 → 代謝率降低 → 心輸出量減少 → 組織氧合降低。復溫過程中可能發生「復溫休克」：外周血管擴張導致冷血回流中心 → 核心體溫進一步下降 + 心律不整風險增加。嚴重低體溫影響凝血功能、藥物代謝和心肌功能。",
    diagnosis: {
      overview: "直接測量核心體溫並評估嚴重程度",
      differentials: ["原發性低體溫（環境）", "繼發性低體溫：休克、敗血症、嚴重創傷、甲狀腺功能低下、腎上腺功能低下、低血糖、神經疾病、麻醉/藥物"],
      initialDB: ["直腸體溫測量", "心電圖（心律不整）", "血糖", "PCV/TS", "血壓", "血氣分析"],
      advanced: ["完整血液檢查", "凝血功能", "內分泌檢測（若懷疑）", "影像學（若有外傷）"]
    },
    treatment: {
      overview: "逐漸復溫同時支持心血管功能",
      acute: [
        "輕度低體溫：",
        "  - 被動外部復溫（毛毯、保暖墊）",
        "  - 避免熱源直接接觸皮膚（燙傷）",
        "中度低體溫：",
        "  - 主動外部復溫（熱水袋包裹、Bair hugger）",
        "  - 溫熱靜脈輸液（37-40°C）",
        "  - 監測心律",
        "重度低體溫：",
        "  - 核心復溫（溫熱靜脈輸液、溫熱灌洗）",
        "  - 緊急心肺監測",
        "  - 治療心律不整（可能需要CPR）",
        "  - 避免過快復溫",
        "目標復溫速度：0.5-1.5°C/小時"
      ],
      chronic: [
        "識別並治療原發病",
        "預防措施（尤其手術中）",
        "環境保護（老年、幼年動物）"
      ]
    },
    prognosis: "輕中度低體溫經適當復溫預後良好。重度低體溫死亡率高。「病人不死直到溫暖且死亡」- 低體溫本身有保護作用。",
    pearls: [
      "標準體溫計可能無法讀取極低溫度",
      "復溫過程中持續監測心律很重要",
      "Osborn波(J波)是低體溫的ECG特徵",
      "新生兒保溫優先於其他處理",
      "手術中預防性保溫很重要"
    ],
    monitoring: ["持續體溫監測", "ECG", "血壓", "血糖", "電解質", "尿量"],
    reference: "Brodeur A et al: Hypothermia and targeted temperature management in cats and dogs. J Vet Emerg Crit Care 27:151-163, 2017"
  }

};
const BEHAVIORAL_OTHER_DISEASE_ALIASES = {
  // 行為疾病
  "分離焦慮": "separation-anxiety",
  "分離焦慮症": "separation-anxiety",
  "separation anxiety": "separation-anxiety",

  "噪音恐懼": "noise-phobia",
  "噪音恐懼症": "noise-phobia",
  "雷聲恐懼": "noise-phobia",
  "暴風雨恐懼": "noise-phobia",
  "煙火恐懼": "noise-phobia",
  "storm phobia": "noise-phobia",
  "thunder phobia": "noise-phobia",

  "強迫症": "compulsive-disorder",
  "強迫行為": "compulsive-disorder",
  "刻板行為": "compulsive-disorder",
  "OCD": "compulsive-disorder",
  "CCD": "compulsive-disorder",
  "追尾巴": "compulsive-disorder",
  "tail chasing": "compulsive-disorder",

  "攻擊行為": "aggression",
  "攻擊": "aggression",
  "咬人": "aggression",
  "aggressive": "aggression",

  "食糞": "coprophagia",
  "食糞症": "coprophagia",
  "吃大便": "coprophagia",
  "coprophagy": "coprophagia",

  "異食": "pica",
  "異食症": "pica",
  "吃異物": "pica",
  "異嗜": "pica",

  "肢端舔皮炎": "acral-lick-dermatitis",
  "舔肉芽腫": "acral-lick-dermatitis",
  "ALD": "acral-lick-dermatitis",
  "lick granuloma": "acral-lick-dermatitis",

  "過度吠叫": "excessive-barking",
  "亂叫": "excessive-barking",
  "一直叫": "excessive-barking",
  "barking": "excessive-barking",

  "貓過敏綜合症": "feline-hyperesthesia",
  "貓過敏症候群": "feline-hyperesthesia",
  "皮膚抽動": "feline-hyperesthesia",
  "hyperesthesia": "feline-hyperesthesia",
  "rolling skin": "feline-hyperesthesia",
  "twitchy cat": "feline-hyperesthesia",

  "心因性脫毛": "psychogenic-alopecia",
  "過度梳理": "psychogenic-alopecia",
  "舔毛": "psychogenic-alopecia",
  "overgrooming": "psychogenic-alopecia",

  // 其他疾病
  "肥胖": "obesity",
  "肥胖症": "obesity",
  "過重": "obesity",
  "過胖": "obesity",
  "overweight": "obesity",

  "生長發育障礙": "failure-to-thrive",
  "生長遲緩": "failure-to-thrive",
  "發育不良": "failure-to-thrive",
  "長不大": "failure-to-thrive",
  "fading puppy": "failure-to-thrive",
  "fading kitten": "failure-to-thrive",

  "惡病質": "cachexia",
  "惡液質": "cachexia",
  "消耗症": "cachexia",
  "癌症惡病質": "cachexia",
  "cancer cachexia": "cachexia",

  "脫水": "dehydration",
  "缺水": "dehydration",
  "dehydrated": "dehydration",

  "低體溫": "hypothermia",
  "低體溫症": "hypothermia",
  "體溫過低": "hypothermia",
  "失溫": "hypothermia"
  // ===== From emergency-critical-care-diseases.js =====
  "cardiopulmonary-arrest": {
    zh: "心肺驟停",
    en: "Cardiopulmonary Arrest (CPA)",
    definition: "心臟和呼吸功能突然停止，導致組織灌注和氧氣輸送完全中斷的危及生命緊急狀況。",
    synonyms: ["CPA", "Cardiac Arrest", "心跳停止", "Cardiorespiratory Arrest"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡，老年或重症動物風險較高",
      sex: "無性別傾向",
      riskFactors: ["麻醉期間", "嚴重創傷", "休克", "呼吸衰竭", "嚴重心律不整", "電解質失衡（高血鉀）", "敗血症", "重度低體溫"]
    },
    clinicalPresentation: {
      history: ["突然倒下", "失去意識", "可能有前驅症狀（呼吸困難、心律不整）"],
      physicalExam: ["無意識", "無呼吸或瀕死呼吸", "無可觸及脈搏", "瞳孔散大", "黏膜蒼白或發紺", "無角膜反射"]
    },
    pathophysiology: "心臟停止泵血 → 腦部和重要器官缺氧 → 4-6分鐘內開始不可逆腦損傷 → 細胞死亡 → 多器官衰竭",
    diagnosis: {
      overview: "臨床診斷：無意識、無呼吸、無脈搏。確認後立即開始CPR",
      differentials: ["深度麻醉", "嚴重休克", "癲癇發作後狀態"],
      initialDB: ["ECG（心搏停止、心室纖維顫動、無脈性電氣活動）", "ETCO2監測（評估CPR品質）"],
      advanced: ["血氣分析", "電解質（尤其鉀離子）", "乳酸"]
    },
    treatment: {
      overview: "遵循RECOVER指南進行心肺復甦術（CPR）：基礎生命支持(BLS)和高級生命支持(ALS)",
      acute: [
        "基礎生命支持(BLS)：",
        "- 胸外按壓：100-120次/分鐘，深度為胸腔寬度的1/3-1/2",
        "- 每2分鐘換人避免疲勞",
        "- 犬側臥或仰臥，貓側臥",
        "- 通氣：氣管插管，10次/分鐘，避免過度通氣",
        "高級生命支持(ALS)：",
        "- Epinephrine（低劑量）: 0.01 mg/kg IV q3-5min",
        "- Epinephrine（高劑量）: 0.1 mg/kg IV（長時間CPR）",
        "- Atropine: 0.04 mg/kg IV（迷走神經介導的心搏停止）",
        "- Vasopressin: 0.8 U/kg IV（替代或輔助Epinephrine）",
        "- 電擊除顫：VF/pulseless VT: 2-4 J/kg 外部, 0.5-1 J/kg 內部",
        "- 糾正可逆原因（4H's和4T's）"
      ],
      chronic: ["復甦後護理", "神經功能評估", "針對原發病因治療"]
    },
    prognosis: "整體存活至出院率約6%（犬）和5%（貓）。院內心搏停止比院外好。早期識別和高品質CPR是關鍵。",
    pearls: [
      "「時間就是大腦」- 每延遲1分鐘存活率下降7-10%",
      "高品質胸外按壓是最重要的：足夠深度、充分回彈、最少中斷",
      "ETCO2 > 15 mmHg 提示有效CPR",
      "記住4H's：Hypoxia、Hypovolemia、Hypothermia、Hypo/Hyperkalemia",
      "記住4T's：Tension pneumothorax、Tamponade、Toxins、Thromboembolism"
    ],
    monitoring: ["ECG", "ETCO2", "動脈血壓", "瞳孔大小和反射", "神經功能"],
    reference: "RECOVER Guidelines 2012; Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "respiratory-distress": {
    zh: "呼吸窘迫",
    en: "Respiratory Distress",
    definition: "呼吸系統無法維持正常氣體交換，導致低氧血症和/或高碳酸血症的危急狀態。",
    synonyms: ["呼吸困難", "Dyspnea", "Respiratory Failure", "呼吸衰竭"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["短頭犬種", "心臟病", "肺部疾病", "氣道阻塞", "胸腔疾病", "神經肌肉疾病"]
    },
    clinicalPresentation: {
      history: ["呼吸急促或費力", "運動不耐", "咳嗽", "發紺", "姿勢異常（端坐呼吸）", "張口呼吸（貓）"],
      physicalExam: ["呼吸急促或緩慢", "呼吸費力（吸氣性/呼氣性/混合性）", "發紺", "異常呼吸音", "頸部伸展", "腹式呼吸", "矛盾呼吸"]
    },
    pathophysiology: "根據病因不同：上呼吸道阻塞 → 吸氣性困難；下呼吸道疾病 → 呼氣性困難；肺實質疾病 → 限制性呼吸；胸腔疾病 → 淺快呼吸。共同結果：低氧血症、呼吸疲勞、呼吸衰竭",
    diagnosis: {
      overview: "快速評估呼吸型態定位問題所在，穩定後進一步檢查",
      differentials: ["上呼吸道阻塞", "下呼吸道疾病（氣喘、支氣管炎）", "肺實質疾病（肺炎、肺水腫）", "胸腔積液/氣胸", "心臟疾病", "橫膈膜疝氣"],
      initialDB: ["脈搏血氧儀(SpO2)", "胸腔聽診", "快速穩定後胸腔X光", "TFAST/AFAST超聲"],
      advanced: ["血氣分析", "CT", "支氣管鏡", "心臟超聲"]
    },
    treatment: {
      overview: "「先穩定再診斷」：氧氣支持、減少應激、針對病因治療",
      acute: [
        "氧氣支持：流量氧氣、氧氣籠、鼻導管（50-100 mL/kg/min）",
        "最小化應激和處置",
        "鎮靜（若焦躁）：Butorphanol 0.2-0.4 mg/kg IM/IV",
        "上呼吸道阻塞：考慮緊急氣管切開術",
        "氣胸：緊急胸腔穿刺減壓",
        "胸腔積液：治療性胸腔穿刺",
        "肺水腫：Furosemide 2-4 mg/kg IV",
        "嚴重時：氣管插管和機械通氣"
      ],
      chronic: ["針對原發病因治療", "長期氧氣治療（若需要）"]
    },
    prognosis: "取決於病因和嚴重程度。早期識別和氧氣支持可顯著改善預後。",
    pearls: [
      "貓張口呼吸是嚴重呼吸窘迫的徵兆",
      "呼吸型態可幫助定位問題：吸氣性=上呼吸道；呼氣性=下呼吸道",
      "應激可快速使呼吸窘迫動物失代償",
      "穩定前避免過多處置",
      "TFAST可快速排除胸腔積液和氣胸"
    ],
    monitoring: ["呼吸頻率和型態", "SpO2", "黏膜顏色", "精神狀態", "血氣"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "status-epilepticus": {
    zh: "癲癇持續狀態",
    en: "Status Epilepticus",
    definition: "持續超過5分鐘的癲癇發作，或兩次以上發作之間未完全恢復意識的危及生命緊急狀況。",
    synonyms: ["SE", "持續性癲癇", "Continuous Seizure Activity"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["特發性癲癇", "腦部結構性病變", "代謝性疾病", "中毒", "感染性腦炎", "先前癲癇控制不佳"]
    },
    clinicalPresentation: {
      history: ["癲癇發作史", "近期藥物改變或漏服", "可能暴露毒物", "近期疾病"],
      physicalExam: ["持續或反覆的全身性或局部性癲癇發作", "發作間期意識未恢復", "自主神經症狀（流涎、排尿排便）", "高體溫", "心搏過速"]
    },
    pathophysiology: "持續的神經元過度放電 → 興奮性神經傳導物質（谷氨酸）釋放 → GABA抑制機制耗竭 → 神經元損傷 → 腦水腫 → 繼發性腦損傷",
    diagnosis: {
      overview: "臨床診斷明確，需同時排除和治療可逆原因",
      differentials: ["特發性癲癇", "症狀性癲癇（腦腫瘤、腦炎）", "代謝性（低血糖、肝腦病、尿毒症）", "中毒"],
      initialDB: ["血糖（立即）", "體溫", "電解質（Ca、Na）", "BUN/Crea", "肝功能", "血氣"],
      advanced: ["腦脊液分析", "MRI", "毒物篩檢", "抗癲癇藥物濃度"]
    },
    treatment: {
      overview: "快速終止癲癇發作、防止復發、治療可逆原因、預防繼發性損傷",
      acute: [
        "ABC：確保呼吸道通暢，給予氧氣",
        "建立靜脈通路",
        "低血糖：Dextrose 0.5-1 g/kg IV（稀釋至25%）",
        "第一線抗癲癇藥：",
        "- Diazepam: 0.5-1 mg/kg IV（可重複至3次）",
        "- 或 Midazolam: 0.2-0.5 mg/kg IV/IM/IN",
        "第二線（若Benzodiazepines無效）：",
        "- Levetiracetam: 60 mg/kg IV over 5min",
        "- 或 Phenobarbital: 4-6 mg/kg IV slow（可重複至16-24 mg/kg總量）",
        "難治性SE：",
        "- Propofol: 1-4 mg/kg IV bolus, then 0.1-0.6 mg/kg/min CRI",
        "- 或 Ketamine: 5 mg/kg IV bolus, then 5-20 μg/kg/min CRI",
        "降溫措施（若高體溫）",
        "治療腦水腫：Mannitol 0.5-1 g/kg IV over 20min"
      ],
      chronic: ["長期抗癲癇藥物", "治療潛在病因", "定期監測藥物濃度"]
    },
    prognosis: "及時治療預後可良好。持續時間越長，預後越差且神經損傷風險越高。死亡率約25-30%。",
    pearls: [
      "「時間就是大腦」- 癲癇超過30分鐘可導致永久性腦損傷",
      "快速血糖檢測是第一步",
      "Diazepam直腸給藥是院外急救選項",
      "高體溫是常見併發症，需積極降溫",
      "即使發作停止，仍需密切監測復發"
    ],
    monitoring: ["癲癇活動", "體溫", "血糖", "呼吸功能", "神經功能", "抗癲癇藥物濃度"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "acute-abdomen": {
    zh: "急性腹症",
    en: "Acute Abdomen",
    definition: "突發性嚴重腹痛伴隨全身症狀的臨床綜合症，常需要緊急外科或內科介入。",
    synonyms: ["急腹症", "Surgical Abdomen", "Abdominal Emergency"],
    epidemiology: {
      species: "犬貓皆常見",
      age: "任何年齡",
      sex: "依病因而異",
      riskFactors: ["異物攝入史", "未絕育", "特定品種（深胸犬GDV）", "腫瘤", "外傷"]
    },
    clinicalPresentation: {
      history: ["突發腹痛", "嘔吐", "腹部膨大", "虛弱", "不願移動", "食慾下降"],
      physicalExam: ["腹部緊張或疼痛", "腹部膨脹", "「祈禱姿勢」", "發燒或低體溫", "休克徵象", "黏膜顏色異常", "腸音改變"]
    },
    pathophysiology: "多種病因可導致：器官扭轉/阻塞 → 缺血壞死；器官破裂 → 腹膜炎；感染/炎症 → SIRS/敗血症。共同結果：劇烈腹痛、全身炎症反應、休克",
    diagnosis: {
      overview: "快速分類：需要緊急手術 vs 可內科治療。穩定後進一步檢查",
      differentials: ["GDV", "腸阻塞/套疊", "脾扭轉", "子宮蓄膿/子宮扭轉", "腹腔出血", "膀胱破裂", "膽囊破裂", "腸系膜扭轉", "急性胰臟炎", "腹膜炎"],
      initialDB: ["腹部X光（正側位）", "AFAST超聲", "PCV/TS", "乳酸", "電解質", "血糖"],
      advanced: ["腹部超聲", "腹腔穿刺", "CT", "診斷性腹腔灌洗"]
    },
    treatment: {
      overview: "穩定、止痛、針對病因治療（手術或內科）",
      acute: [
        "靜脈通路和積極輸液復甦",
        "止痛：Opioids（Methadone 0.2-0.5 mg/kg IV）",
        "廣譜抗生素（若懷疑感染/穿孔）",
        "根據診斷決定手術或內科治療",
        "GDV：胃減壓 + 緊急手術",
        "腹腔出血：輸血 + 可能手術探查",
        "膀胱破裂：穩定 + 手術修復"
      ],
      chronic: ["術後護理", "針對原發病因長期管理"]
    },
    prognosis: "取決於病因和及時診斷治療。早期識別和外科介入可顯著改善預後。",
    pearls: [
      "急性腹症是臨床綜合症，不是診斷",
      "AFAST是快速評估腹腔積液的有力工具",
      "乳酸升高提示組織灌注不足",
      "不要因為等待診斷而延遲穩定和止痛",
      "某些情況下探查性開腹術是診斷和治療"
    ],
    monitoring: ["腹部疼痛程度", "生命體徵", "乳酸", "PCV/TS", "尿量"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "hemorrhagic-shock": {
    zh: "失血性休克",
    en: "Hemorrhagic Shock",
    definition: "因大量血液流失導致組織灌注不足的低血容量性休克。",
    synonyms: ["出血性休克", "Hypovolemic Shock (Hemorrhagic)", "低血容量休克"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["創傷", "腹腔腫瘤破裂（血管肉瘤）", "凝血障礙", "手術併發症", "抗凝血劑中毒"]
    },
    clinicalPresentation: {
      history: ["創傷史", "腫瘤病史", "虛弱/倒地", "腹部膨大", "蒼白"],
      physicalExam: ["心搏過速", "脈搏弱或無法觸及", "黏膜蒼白", "CRT延長", "低血壓", "精神抑鬱", "低體溫", "呼吸急促"]
    },
    pathophysiology: "血液流失（>20-30%血容量）→ 心臟前負荷下降 → 心輸出量減少 → 代償性心搏過速和血管收縮 → 組織灌注不足 → 無氧代謝和乳酸堆積 → 細胞損傷 → 器官衰竭",
    diagnosis: {
      overview: "臨床表現結合PCV/TS下降（急性出血早期可能正常）",
      differentials: ["其他類型休克", "心臟疾病", "敗血症"],
      initialDB: ["PCV/TS（序列監測）", "乳酸", "血壓", "AFAST超聲", "凝血功能（PT/PTT）", "血型"],
      advanced: ["CT（尋找出血來源）", "TEG/ROTEM"]
    },
    treatment: {
      overview: "控制出血、恢復血容量、維持組織灌注",
      acute: [
        "直接壓迫止血（外傷）",
        "靜脈輸液復甦：",
        "- 晶體液：10-20 mL/kg IV bolus（犬）；5-10 mL/kg（貓）",
        "- 膠體液：5-10 mL/kg IV",
        "- 高滲鹽水：4 mL/kg IV over 5-10min",
        "輸血指征（PCV<20-25%或急性大量出血）：",
        "- 濃縮紅血球：10-20 mL/kg",
        "- 全血：20-25 mL/kg",
        "- 新鮮冷凍血漿（若凝血障礙）",
        "避免過度稀釋（允許性低血壓直到止血）",
        "手術控制出血（若內出血持續）",
        "Tranexamic acid: 10-15 mg/kg IV（抗纖溶）"
      ],
      chronic: ["監測復發出血", "治療潛在病因", "鐵補充"]
    },
    prognosis: "取決於出血原因和能否控制。創傷性出血若及時控制預後可良好。腫瘤破裂預後較差。",
    pearls: [
      "急性出血早期PCV可能正常（血液濃縮）",
      "序列PCV監測比單次更有意義",
      "AFAST可快速評估腹腔積血",
      "允許性低血壓（MAP 60-80 mmHg）直到手術止血",
      "注意「死亡三聯症」：低體溫、酸中毒、凝血病"
    ],
    monitoring: ["PCV/TS q30-60min", "血壓", "乳酸", "尿量", "凝血功能", "AFAST追蹤"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "distributive-shock": {
    zh: "分佈性休克",
    en: "Distributive Shock",
    definition: "血管阻力異常降低導致血液分佈異常、組織灌注不足的休克類型，包括敗血性休克和過敏性休克。",
    synonyms: ["Vasodilatory Shock", "血管擴張性休克", "Septic Shock", "Anaphylactic Shock"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["感染（敗血症）", "過敏原暴露", "SIRS", "嚴重胰臟炎", "燒傷"]
    },
    clinicalPresentation: {
      history: ["感染病灶", "過敏原暴露", "近期手術或創傷", "發燒或低體溫"],
      physicalExam: ["高動力相（早期，犬）：心搏過速、脈搏洪大、黏膜充血、CRT縮短",
                   "低動力相（晚期或貓）：心搏過緩、脈搏弱、黏膜蒼白、CRT延長、低體溫"]
    },
    pathophysiology: "敗血性：感染 → 全身炎症反應 → 血管擴張、毛細血管通透性增加 → 有效循環血量減少。過敏性：過敏原 → IgE介導的肥大細胞脫顆粒 → 組織胺釋放 → 血管擴張、支氣管痙攣",
    diagnosis: {
      overview: "臨床表現結合感染或過敏原暴露史",
      differentials: ["其他類型休克", "心臟疾病"],
      initialDB: ["乳酸", "血糖", "電解質", "血壓", "CBC", "生化", "凝血功能", "血氣"],
      advanced: ["血液培養", "感染源檢查", "前降鈣素原"]
    },
    treatment: {
      overview: "液體復甦、血管升壓藥、控制感染源（敗血性）或過敏反應",
      acute: [
        "敗血性休克：",
        "- 積極輸液：晶體液20-30 mL/kg IV bolus（犬）",
        "- 若對輸液無反應：Norepinephrine 0.1-2 μg/kg/min CRI",
        "- 或 Dopamine 5-15 μg/kg/min CRI",
        "- 廣譜抗生素（1小時內給予）",
        "- 控制感染源（引流、手術）",
        "過敏性休克：",
        "- Epinephrine: 0.01-0.02 mg/kg IV/IM（首選）",
        "- 輸液支持",
        "- Diphenhydramine: 2 mg/kg IM/IV",
        "- Dexamethasone: 0.5-1 mg/kg IV（預防遲發反應）",
        "- 支氣管痙攣：Albuterol 或 Aminophylline"
      ],
      chronic: ["治療原發感染", "避免過敏原", "器官功能支持"]
    },
    prognosis: "敗血性休克死亡率約40-60%。過敏性休克若及時治療預後較好。早期識別和積極治療是關鍵。",
    pearls: [
      "犬敗血性休克常見高動力相（與人類相似）",
      "貓通常表現為低動力相和低體溫",
      "乳酸是組織灌注和預後的重要指標",
      "敗血症「黃金一小時」：早期輸液和抗生素改善存活",
      "過敏性休克Epinephrine是第一線藥物"
    ],
    monitoring: ["血壓", "乳酸", "尿量", "精神狀態", "體溫", "CVP"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "cardiogenic-shock": {
    zh: "心源性休克",
    en: "Cardiogenic Shock",
    definition: "因心臟泵功能嚴重衰竭導致心輸出量不足、組織灌注不良的休克類型。",
    synonyms: ["心因性休克", "Pump Failure Shock"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "心臟病好發年齡",
      sex: "依心臟病類型而異",
      riskFactors: ["擴張性心肌病(DCM)", "肥厚性心肌病(HCM)", "嚴重心律不整", "瓣膜疾病", "心臟壓塞", "心肌炎"]
    },
    clinicalPresentation: {
      history: ["已知心臟病史", "運動不耐", "昏厥", "呼吸困難", "咳嗽"],
      physicalExam: ["心搏過速或過緩", "心律不整", "脈搏弱", "黏膜蒼白或發紺", "CRT延長", "肺部濕囉音", "頸靜脈怒張", "肝腫大", "腹水"]
    },
    pathophysiology: "心肌收縮力下降或結構異常 → 心輸出量減少 → 代償性神經內分泌活化 → 鈉水滯留、血管收縮 → 後負荷增加 → 進一步惡化心功能 → 組織缺氧",
    diagnosis: {
      overview: "臨床表現結合心臟病證據，心臟超聲確認",
      differentials: ["其他類型休克", "肺部疾病"],
      initialDB: ["心臟超聲（TFAST/完整）", "ECG", "胸腔X光", "血壓", "乳酸", "心肌標記物（cTnI）"],
      advanced: ["NT-proBNP", "連續心臟超聲監測"]
    },
    treatment: {
      overview: "改善心臟功能、減輕心臟負擔、支持灌注",
      acute: [
        "謹慎輸液（避免加重肺水腫）",
        "正性肌力藥物：",
        "- Dobutamine: 2.5-10 μg/kg/min CRI（首選）",
        "- 或 Pimobendan: 0.25-0.3 mg/kg PO q12h",
        "利尿劑（若有肺水腫）：Furosemide 2-4 mg/kg IV",
        "血管擴張劑（謹慎）：Nitroprusside CRI",
        "心律不整治療",
        "氧氣支持",
        "心臟壓塞：緊急心包穿刺"
      ],
      chronic: ["長期心臟藥物（ACEI、Pimobendan、利尿劑）", "限鈉飲食", "活動限制"]
    },
    prognosis: "取決於潛在心臟病類型和嚴重程度。急性失代償預後謹慎至差。",
    pearls: [
      "與其他休克不同，大量輸液可能有害",
      "Dobutamine可增加心輸出量而不明顯增加後負荷",
      "心臟壓塞需要緊急心包穿刺",
      "貓的心源性休克常與動脈血栓栓塞(ATE)相關",
      "ECG監測心律不整很重要"
    ],
    monitoring: ["ECG", "血壓", "呼吸頻率", "SpO2", "尿量", "乳酸", "連續心臟超聲"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "obstructive-shock": {
    zh: "梗阻性休克",
    en: "Obstructive Shock",
    definition: "因心臟充盈或射血受到機械性阻礙導致心輸出量下降的休克類型。",
    synonyms: ["阻塞性休克", "Mechanical Obstruction Shock"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "依病因而異",
      sex: "無性別傾向",
      riskFactors: ["心包疾病", "縱隔腫瘤", "肺栓塞", "張力性氣胸", "嚴重腹脹（GDV）"]
    },
    clinicalPresentation: {
      history: ["呼吸困難", "虛弱", "昏厥", "已知心包疾病或腫瘤"],
      physicalExam: ["頸靜脈怒張", "心音低沉（心包積液）", "奇脈", "脈搏弱", "低血壓", "CRT延長", "腹部膨脹（GDV）"]
    },
    pathophysiology: "心臟壓塞：心包積液壓迫心臟 → 舒張充盈受限；張力性氣胸：胸腔壓力升高 → 靜脈回流受阻；肺栓塞：肺動脈阻塞 → 右心後負荷急性增加。共同結果：心輸出量急劇下降",
    diagnosis: {
      overview: "高度懷疑結合快速超聲和影像學確認",
      differentials: ["心源性休克", "其他類型休克"],
      initialDB: ["TFAST超聲（心包積液）", "胸腔X光（氣胸、腫瘤）", "ECG（電交替）", "血壓"],
      advanced: ["完整心臟超聲", "CT血管造影（肺栓塞）"]
    },
    treatment: {
      overview: "解除機械性梗阻是關鍵",
      acute: [
        "心臟壓塞：緊急心包穿刺",
        "張力性氣胸：緊急胸腔穿刺減壓",
        "GDV：胃減壓 + 緊急手術",
        "肺栓塞：抗凝治療 + 支持治療",
        "輸液支持（謹慎，可能加重某些情況）",
        "氧氣支持"
      ],
      chronic: ["治療潛在病因", "心包切除術（反覆心包積液）", "長期抗凝（肺栓塞）"]
    },
    prognosis: "取決於能否及時解除梗阻和潛在病因。心包穿刺後通常立即改善。",
    pearls: [
      "心包積液的Beck三徵：低血壓、頸靜脈怒張、心音低沉",
      "TFAST可快速診斷心包積液",
      "張力性氣胸是臨床診斷，不要等X光",
      "解除梗阻後通常戲劇性改善",
      "輸液可能暫時改善但需解除根本原因"
    ],
    monitoring: ["血壓", "頸靜脈壓", "心臟超聲", "呼吸功能", "尿量"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "tension-pneumothorax": {
    zh: "張力性氣胸",
    en: "Tension Pneumothorax",
    definition: "胸腔內空氣持續單向積聚，形成正壓導致肺塌陷、縱隔移位和心血管功能障礙的危及生命緊急狀況。",
    synonyms: ["張力氣胸", "Tension PTX", "壓力性氣胸"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["胸部穿刺傷", "肋骨骨折", "機械通氣併發症", "肺部疾病", "食道破裂", "氣管損傷"]
    },
    clinicalPresentation: {
      history: ["創傷", "急性呼吸窘迫", "突然惡化"],
      physicalExam: ["嚴重呼吸困難", "發紺", "頸靜脈怒張", "氣管偏移（對側）", "患側叩診過度共鳴", "患側呼吸音消失", "休克徵象", "皮下氣腫"]
    },
    pathophysiology: "肺或胸壁損傷形成單向閥 → 吸氣時空氣進入胸腔，呼氣時無法排出 → 胸腔壓力進行性升高 → 患側肺完全塌陷 → 縱隔向對側移位 → 對側肺受壓 → 大血管扭折 → 靜脈回流受阻 → 心輸出量驟降 → 休克",
    diagnosis: {
      overview: "這是臨床診斷，不要等待影像學確認！",
      differentials: ["單純氣胸", "大量胸腔積液", "橫膈膜疝氣"],
      initialDB: ["臨床表現即可診斷", "TFAST超聲（快速確認）", "治療後X光確認"],
      advanced: ["穩定後完整胸腔X光"]
    },
    treatment: {
      overview: "立即胸腔減壓是救命措施",
      acute: [
        "立即胸腔穿刺減壓：",
        "- 7-8肋間，背部1/3處",
        "- 使用大口徑針頭或導管",
        "- 三向活栓連接抽吸",
        "胸腔引流管放置（持續漏氣）",
        "氧氣支持",
        "輸液支持",
        "止痛",
        "穩定後尋找和修復漏氣來源"
      ],
      chronic: ["胸腔引流直到漏氣停止", "手術修復（持續漏氣）", "監測復發"]
    },
    prognosis: "及時減壓預後良好。延遲治療可導致心跳停止和死亡。",
    pearls: [
      "這是臨床診斷 - 不要等X光！",
      "「穿刺減壓是診斷也是治療」",
      "機械通氣患者特別要警惕",
      "皮下氣腫是重要線索",
      "減壓後通常戲劇性改善"
    ],
    monitoring: ["呼吸功能", "SpO2", "血壓", "胸腔引流量", "是否持續漏氣"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "cardiac-tamponade": {
    zh: "心臟壓塞",
    en: "Cardiac Tamponade",
    definition: "心包腔內液體或氣體快速積聚壓迫心臟，導致心室舒張充盈受限和心輸出量下降的危急狀態。",
    synonyms: ["心包填塞", "Pericardial Tamponade", "心包壓塞"],
    epidemiology: {
      species: "犬較常見，貓罕見",
      age: "中老年犬（腫瘤相關）",
      sex: "公犬略多（血管肉瘤）",
      riskFactors: ["心臟腫瘤（血管肉瘤、心臟基底腫瘤）", "特發性心包積液", "凝血障礙", "創傷", "心臟破裂"]
    },
    clinicalPresentation: {
      history: ["運動不耐", "虛弱", "昏厥", "腹部膨大", "呼吸困難"],
      physicalExam: ["Beck三徵：低血壓、頸靜脈怒張、心音低沉", "奇脈（吸氣時脈搏減弱）", "心搏過速", "黏膜蒼白", "CRT延長", "腹水"]
    },
    pathophysiology: "心包積液快速積聚 → 心包壓力升高 → 心室舒張受限 → 心臟充盈減少 → 心輸出量下降 → 代償性心搏過速和血管收縮 → 組織灌注不足 → 休克",
    diagnosis: {
      overview: "高度懷疑結合心臟超聲確診",
      differentials: ["充血性心衰竭", "限制性心肌病", "腹腔積液其他原因"],
      initialDB: ["TFAST超聲（心包積液、右心房/心室塌陷）", "胸腔X光（球形心影）", "ECG（低電壓、電交替）", "血壓"],
      advanced: ["完整心臟超聲", "心包液分析", "細胞學"]
    },
    treatment: {
      overview: "心包穿刺是救命措施",
      acute: [
        "心包穿刺術：",
        "- 右側臥位，4-6肋間心尖區",
        "- 超聲引導更安全",
        "- 使用大口徑導管",
        "- 引流直到負壓或臨床改善",
        "輸液支持（穿刺前後）",
        "監測心律不整（穿刺中）",
        "心包液送檢（細胞學、培養）"
      ],
      chronic: [
        "特發性：可能需反覆穿刺或心包切除術",
        "腫瘤相關：化療（血管肉瘤）、手術（心臟基底腫瘤）",
        "心包切除術（經常復發或結紮性心包炎）"
      ]
    },
    prognosis: "特發性心包積液：預後較好，尤其心包切除術後。腫瘤相關：預後差，血管肉瘤中位生存期約1-4個月。",
    pearls: [
      "積液量和速度決定臨床表現 - 慢性積聚可耐受更大量",
      "「拿走一點就改善很多」- 小量引流可顯著改善",
      "右心房塌陷是超聲診斷的敏感指標",
      "穿刺後立即改善具有診斷價值",
      "心包液顏色和細胞學幫助判斷病因"
    ],
    monitoring: ["血壓", "心率", "超聲追蹤心包積液", "尿量", "再積聚跡象"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "acute-respiratory-distress-syndrome": {
    zh: "急性呼吸窘迫綜合症",
    en: "Acute Respiratory Distress Syndrome (ARDS)",
    definition: "各種原因導致的急性、彌漫性肺部炎症反應，特徵為肺水腫、低氧血症和肺順應性下降。",
    synonyms: ["ARDS", "急性肺損傷", "ALI", "Acute Lung Injury"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["敗血症（最常見）", "吸入性肺炎", "重度創傷", "胰臟炎", "輸血反應", "溺水", "煙霧吸入"]
    },
    clinicalPresentation: {
      history: ["誘發因素後24-72小時出現", "進行性呼吸困難", "對氧氣治療反應差"],
      physicalExam: ["呼吸急促", "費力呼吸", "發紺", "雙側肺部濕囉音", "低氧血症（對氧氣反應差）", "可能合併休克"]
    },
    pathophysiology: "觸發因素 → 全身或肺部炎症反應 → 肺泡-毛細血管屏障損傷 → 通透性增加 → 富含蛋白質的肺水腫 → 肺泡塌陷和分流 → 難治性低氧血症 → 肺纖維化（晚期）",
    diagnosis: {
      overview: "基於急性起病、雙側肺浸潤、低氧血症、排除心源性肺水腫",
      differentials: ["心源性肺水腫", "肺炎", "肺出血", "肺腫瘤"],
      initialDB: ["胸腔X光（雙側彌漫性浸潤）", "血氣分析（PaO2/FiO2 <300為ALI，<200為ARDS）", "心臟超聲（排除心源性）", "SpO2"],
      advanced: ["CT", "支氣管肺泡灌洗", "肺活檢"]
    },
    treatment: {
      overview: "治療原發病因、肺保護性通氣策略、支持治療",
      acute: [
        "治療原發病因（敗血症：抗生素、感染源控制）",
        "氧氣支持（高流量、氧氣籠）",
        "機械通氣（嚴重時）：",
        "- 低潮氣量（6-8 mL/kg）",
        "- 適當PEEP",
        "- 允許性高碳酸血症",
        "保守輸液策略（避免加重肺水腫）",
        "利尿劑（謹慎使用）",
        "俯臥位通氣（可能有益）"
      ],
      chronic: ["逐漸脫機", "肺復健", "監測肺纖維化"]
    },
    prognosis: "預後謹慎至差。獸醫文獻報告死亡率50-100%。早期識別和積極治療可能改善預後。",
    pearls: [
      "ARDS是症候群，不是診斷 - 必須尋找和治療原因",
      "PaO2/FiO2比值是診斷和嚴重度指標",
      "心源性肺水腫對利尿劑反應好，ARDS反應差",
      "肺保護性通氣策略在人類已證實降低死亡率",
      "獸醫ARDS診斷標準仍在發展中"
    ],
    monitoring: ["SpO2", "血氣", "呼吸功能", "胸腔X光", "器官功能"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "transfusion-reaction": {
    zh: "輸血反應",
    en: "Transfusion Reaction",
    definition: "輸血過程中或之後發生的不良反應，範圍從輕微發燒到危及生命的溶血反應或過敏反應。",
    synonyms: ["輸血不良反應", "Blood Transfusion Reaction"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["先前輸血史", "血型不合", "交叉配血不合", "血液製品污染", "貓（DEA 1.1陰性犬首次輸血風險低）"]
    },
    clinicalPresentation: {
      history: ["輸血過程中或之後出現症狀", "先前輸血史"],
      physicalExam: [
        "急性溶血反應：發燒、寒顫、嘔吐、低血壓、血紅蛋白尿、休克",
        "非溶血性發燒反應：發燒、寒顫（無溶血證據）",
        "過敏反應：蕁麻疹、臉部腫脹、呼吸困難、休克",
        "輸血相關循環超負荷(TACO)：呼吸困難、咳嗽、肺水腫",
        "輸血相關急性肺損傷(TRALI)：急性呼吸窘迫、低氧血症"
      ]
    },
    pathophysiology: "急性溶血：血型不合 → 抗體介導的紅血球破壞 → 血管內溶血 → 血紅蛋白血症/尿 → 腎損傷、DIC。過敏：供血者血漿蛋白引發IgE介導反應。TRALI：供血者抗白血球抗體攻擊受血者白血球 → 肺毛細血管損傷",
    diagnosis: {
      overview: "臨床表現結合時間關係（輸血期間或之後）",
      differentials: ["敗血症", "原發疾病惡化", "藥物反應"],
      initialDB: ["血漿顏色（溶血呈粉紅/紅）", "尿液顏色（血紅蛋白尿）", "直接Coombs試驗", "PCV/TS", "血塗片"],
      advanced: ["血型和交叉配血複查", "血液培養", "凝血功能", "膽紅素"]
    },
    treatment: {
      overview: "立即停止輸血、對症支持治療",
      acute: [
        "立即停止輸血（保留血袋送檢）",
        "維持靜脈通路（新輸液套）",
        "急性溶血反應：",
        "- 積極輸液維持腎灌注",
        "- 監測尿量",
        "- 利尿劑若尿量減少",
        "過敏反應：",
        "- Diphenhydramine: 2 mg/kg IM/IV",
        "- 嚴重時：Epinephrine 0.01 mg/kg IM/IV",
        "- Dexamethasone: 0.5-1 mg/kg IV",
        "非溶血性發燒反應：",
        "- 退燒藥（非類固醇）",
        "- 可考慮減速繼續（輕微反應）",
        "TACO：利尿劑、氧氣",
        "TRALI：氧氣支持、機械通氣（若需要）"
      ],
      chronic: ["記錄反應類型供未來輸血參考", "未來使用洗滌紅血球或白血球過濾"]
    },
    prognosis: "非溶血性發燒反應：通常預後良好。急性溶血反應：取決於嚴重程度，可能致命。TRALI：支持治療下多數可恢復。",
    pearls: [
      "貓必須在首次輸血前進行血型鑑定",
      "犬首次輸血急性溶血反應罕見（無預形成抗體）",
      "發燒可能是溶血或非溶血性，需鑑別",
      "疑似反應時先停輸血再評估",
      "輸血速度：前15-30分鐘慢（0.5-1 mL/kg/h），監測反應"
    ],
    monitoring: ["體溫", "心率", "呼吸率", "血壓", "尿液顏色", "黏膜顏色"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "cerebral-edema": {
    zh: "腦水腫",
    en: "Cerebral Edema",
    definition: "腦組織內水分異常積聚導致顱內壓升高的危急狀態，可導致腦疝和死亡。",
    synonyms: ["腦腫脹", "Brain Edema", "Intracranial Edema", "顱內高壓"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["頭部創傷", "腦腫瘤", "腦炎", "缺氧", "代謝異常（低血糖、DKA）", "肝腦病", "中毒"]
    },
    clinicalPresentation: {
      history: ["頭部創傷", "癲癇", "已知腦部疾病", "代謝疾病", "意識改變"],
      physicalExam: ["意識改變（嗜睡→昏迷）", "瞳孔異常（散大、不等大、對光反射消失）", "姿勢異常（去腦強直、去皮質強直）", "Cushing反射（高血壓+心搏過緩）", "呼吸異常", "乳突狀病灶"]
    },
    pathophysiology: "血管源性水腫：血腦屏障破壞 → 血漿滲漏至白質。細胞毒性水腫：細胞能量衰竭 → 離子泵失效 → 細胞內水分積聚。間質性水腫：腦脊液迴流受阻。結果：顱內壓升高 → 腦灌注壓下降 → 缺血 → 腦疝",
    diagnosis: {
      overview: "臨床神經學評估，影像學確認",
      differentials: ["腦腫瘤", "腦炎", "顱內出血", "代謝性腦病"],
      initialDB: ["神經學檢查（改良Glasgow昏迷量表）", "血糖", "電解質", "血氣", "眼底檢查"],
      advanced: ["MRI（首選）", "CT", "腦脊液分析（若無腦疝風險）"]
    },
    treatment: {
      overview: "降低顱內壓、維持腦灌注、治療原發病因",
      acute: [
        "一般措施：",
        "- 頭部抬高15-30度",
        "- 避免頸部壓迫（影響靜脈回流）",
        "- 維持正常血壓（MAP >80 mmHg）",
        "- 避免高熱",
        "- 控制癲癇",
        "高滲療法：",
        "- Mannitol: 0.5-1.5 g/kg IV over 15-20min（可重複q4-6h）",
        "- 高滲鹽水(7.5%): 4 mL/kg IV over 5-10min",
        "過度通氣（短期）：目標PaCO2 30-35 mmHg",
        "類固醇（血管源性水腫/腫瘤）：",
        "- Dexamethasone: 0.5-1 mg/kg IV",
        "治療原發病因"
      ],
      chronic: ["監測神經功能", "復健", "長期治療原發病因"]
    },
    prognosis: "取決於病因和嚴重程度。創傷性腦損傷：輕度預後良好，重度預後差。腦腫瘤相關：取決於腫瘤類型。",
    pearls: [
      "改良Glasgow昏迷量表可追蹤進展",
      "Cushing反射（高血壓+心搏過緩）是腦疝的晚期徵兆",
      "Mannitol需要完整的血腦屏障才能發揮最佳效果",
      "過度通氣效果短暫且可能反彈",
      "維持正常血糖和體溫很重要"
    ],
    monitoring: ["神經學狀態（q1-2h）", "瞳孔大小和反射", "血壓", "血糖", "電解質", "PaCO2"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "coagulopathy": {
    zh: "凝血病",
    en: "Coagulopathy",
    definition: "凝血功能障礙導致出血傾向或異常血栓形成的病理狀態。",
    synonyms: ["凝血障礙", "Bleeding Disorder", "Clotting Disorder", "DIC"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡（先天性年輕、後天性任何年齡）",
      sex: "先天性某些為X連鎖（公犬）",
      riskFactors: ["抗凝血劑中毒", "敗血症", "嚴重創傷", "肝病", "腫瘤", "IMHA", "先天性凝血因子缺乏"]
    },
    clinicalPresentation: {
      history: ["自發性出血", "輕微創傷後過度出血", "手術後出血不止", "血尿/血便", "瘀青"],
      physicalExam: ["瘀斑", "瘀點", "血腫", "黏膜出血", "腔體出血（胸腔、腹腔、關節）", "蒼白（若嚴重出血）"]
    },
    pathophysiology: "一次止血障礙（血小板問題）：瘀點、黏膜出血。二次止血障礙（凝血因子問題）：深部血腫、關節出血、延遲出血。DIC：觸發因素 → 系統性凝血活化 → 微血栓形成 → 凝血因子和血小板消耗 → 出血",
    diagnosis: {
      overview: "臨床表現結合凝血檢測",
      differentials: ["血小板減少症", "血小板功能障礙", "凝血因子缺乏", "維生素K缺乏/中毒", "DIC", "肝功能衰竭"],
      initialDB: ["血小板計數", "PT（外源性途徑）", "PTT/APTT（內源性途徑）", "纖維蛋白原", "D-dimer", "血塗片"],
      advanced: ["TEG/ROTEM", "特異性凝血因子測定", "von Willebrand因子", "抗Xa活性", "PIVKA"]
    },
    treatment: {
      overview: "控制出血、補充缺乏成分、治療原發病因",
      acute: [
        "抗凝血劑中毒：",
        "- Vitamin K1: 2.5-5 mg/kg PO/SQ q12h x 4-6週",
        "- 急性出血：新鮮冷凍血漿(FFP) 10-20 mL/kg",
        "DIC：",
        "- 治療原發病因",
        "- FFP補充凝血因子",
        "- 抗凝治療（某些情況）：低分子肝素",
        "血小板減少/功能障礙：",
        "- 血小板輸注",
        "- 治療原發病因（免疫抑制若IMTP）",
        "先天性凝血因子缺乏：",
        "- FFP或冷沉澱物（含因子VIII、vWF）",
        "- Desmopressin（輕度vWD）"
      ],
      chronic: ["長期維生素K（某些中毒）", "避免創傷/手術", "遺傳諮詢"]
    },
    prognosis: "取決於病因。抗凝血劑中毒：及時治療預後良好。DIC：預後謹慎至差，取決於原發病因。先天性：可管理但需終身注意。",
    pearls: [
      "瘀點提示血小板問題，血腫提示凝血因子問題",
      "PT延長：維生素K缺乏、肝病、華法林中毒",
      "PTT延長：肝素效應、因子VIII/IX/XI缺乏",
      "DIC是「消耗性凝血病」",
      "維生素K1口服吸收需要脂肪"
    ],
    monitoring: ["PT/PTT", "血小板計數", "纖維蛋白原", "D-dimer", "臨床出血徵象"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },

  "hypoxemia": {
    zh: "低氧血症",
    en: "Hypoxemia",
    definition: "動脈血氧分壓(PaO2)低於正常範圍（<80 mmHg室內空氣）的病理狀態，導致組織氧氣供應不足。",
    synonyms: ["低血氧", "Arterial Hypoxemia", "缺氧"],
    epidemiology: {
      species: "犬貓皆可發生",
      age: "任何年齡",
      sex: "無性別傾向",
      riskFactors: ["呼吸系統疾病", "心臟病", "神經肌肉疾病", "麻醉", "高海拔"]
    },
    clinicalPresentation: {
      history: ["呼吸困難", "運動不耐", "發紺", "虛弱", "昏厥"],
      physicalExam: ["呼吸急促或異常", "發紺（PaO2<50 mmHg才明顯）", "心搏過速", "精神異常", "端坐呼吸"]
    },
    pathophysiology: "五種機制：1)通氣不足 → CO2升高，O2下降；2)擴散障礙 → 氣體交換受損；3)V/Q不匹配 → 灌注區無通氣；4)分流 → 血液繞過肺泡；5)低吸入氧分壓。結果：組織缺氧 → 無氧代謝 → 乳酸堆積 → 器官功能障礙",
    diagnosis: {
      overview: "動脈血氣分析確診，評估機制指導治療",
      differentials: ["肺實質疾病", "胸腔疾病", "心臟疾病", "上呼吸道阻塞", "神經肌肉疾病"],
      initialDB: ["動脈血氣（PaO2、PaCO2）", "SpO2（脈搏血氧儀）", "P(A-a)O2梯度", "胸腔X光"],
      advanced: ["CT", "心臟超聲", "肺功能測試", "支氣管鏡"]
    },
    treatment: {
      overview: "提供氧氣、治療原發病因",
      acute: [
        "氧氣支持：",
        "- 流量氧氣（Flow-by）：FiO2 25-40%",
        "- 氧氣籠：可達40-60%",
        "- 鼻導管：50-100 mL/kg/min（FiO2 30-50%）",
        "- 面罩：短期高濃度",
        "- 機械通氣：嚴重低氧血症",
        "針對機制治療：",
        "- 通氣不足：改善通氣、機械輔助",
        "- V/Q不匹配：氧氣通常有效",
        "- 分流：高FiO2效果有限，需PEEP",
        "- 擴散障礙：氧氣有效",
        "治療原發病因"
      ],
      chronic: ["長期氧氣治療（若需要）", "治療潛在疾病"]
    },
    prognosis: "取決於病因和嚴重程度。可逆原因治療後預後良好。慢性肺病可能需要長期管理。",
    pearls: [
      "SpO2 90%約等於PaO2 60 mmHg（氧解離曲線）",
      "發紺需要至少5 g/dL脫氧血紅蛋白，嚴重貧血可能不發紺",
      "P(A-a)O2梯度正常提示通氣不足；增大提示肺實質問題",
      "對氧氣反應好提示V/Q不匹配；反應差提示分流",
      "高流量氧氣長時間使用需注意氧毒性"
    ],
    monitoring: ["SpO2", "動脈血氣", "呼吸頻率和型態", "精神狀態", "乳酸"],
    reference: "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  }
